Query 013214
Match_columns 447
No_of_seqs 403 out of 2990
Neff 9.5
Searched_HMMs 46136
Date Fri Mar 29 01:34:14 2013
Command hhsearch -i /work/01045/syshi/csienesis_hhblits_a3m/013214.a3m -d /work/01045/syshi/HHdatabase/Cdd.hhm -o /work/01045/syshi/hhsearch_cdd/013214hhsearch_cdd -cpu 12 -v 0
No Hit Prob E-value P-value Score SS Cols Query HMM Template HMM
1 KOG0575 Polo-like serine/threo 100.0 4.9E-50 1.1E-54 388.3 21.4 259 143-409 6-269 (592)
2 KOG0192 Tyrosine kinase specif 100.0 5.5E-49 1.2E-53 378.2 25.7 269 143-420 31-310 (362)
3 KOG0615 Serine/threonine prote 100.0 4.5E-50 9.7E-55 370.9 15.0 249 156-409 173-437 (475)
4 KOG0581 Mitogen-activated prot 100.0 2.7E-49 5.8E-54 363.2 19.0 244 156-409 80-335 (364)
5 KOG0195 Integrin-linked kinase 100.0 2.6E-49 5.6E-54 347.5 16.1 369 32-414 26-447 (448)
6 KOG0591 NIMA (never in mitosis 100.0 6.1E-50 1.3E-54 353.0 11.9 249 156-408 20-280 (375)
7 KOG0595 Serine/threonine-prote 100.0 5.3E-48 1.1E-52 357.6 20.9 247 155-408 10-267 (429)
8 KOG0598 Ribosomal protein S6 k 100.0 4.8E-48 1E-52 354.9 17.3 240 156-402 26-270 (357)
9 KOG0197 Tyrosine kinases [Sign 100.0 2.5E-47 5.5E-52 365.8 17.8 259 147-417 200-465 (468)
10 KOG0616 cAMP-dependent protein 100.0 2.8E-45 6E-50 325.9 17.0 235 155-400 44-283 (355)
11 KOG0592 3-phosphoinositide-dep 100.0 3.3E-45 7.2E-50 349.3 16.7 248 155-409 73-338 (604)
12 KOG0198 MEKK and related serin 100.0 8.9E-45 1.9E-49 338.9 17.1 255 154-416 16-283 (313)
13 KOG0588 Serine/threonine prote 100.0 9.3E-45 2E-49 353.1 16.9 244 157-409 14-263 (786)
14 KOG0583 Serine/threonine prote 100.0 7.5E-44 1.6E-48 345.7 22.2 253 154-415 16-280 (370)
15 KOG0593 Predicted protein kina 100.0 1.5E-44 3.2E-49 322.0 14.5 248 156-409 3-284 (396)
16 KOG0582 Ste20-like serine/thre 100.0 3.9E-43 8.6E-48 327.9 22.8 258 146-409 17-293 (516)
17 KOG0611 Predicted serine/threo 100.0 3.2E-44 6.9E-49 330.8 14.8 245 156-411 54-305 (668)
18 KOG0597 Serine-threonine prote 100.0 2.6E-44 5.7E-49 343.6 14.5 244 156-409 3-251 (808)
19 KOG0578 p21-activated serine/t 100.0 3.6E-44 7.7E-49 344.9 15.4 245 156-409 274-523 (550)
20 PHA02988 hypothetical protein; 100.0 1.4E-42 2.9E-47 329.5 24.7 256 150-415 15-281 (283)
21 KOG0605 NDR and related serine 100.0 3.2E-43 6.9E-48 335.9 18.0 249 155-408 141-444 (550)
22 KOG0201 Serine/threonine prote 100.0 3E-44 6.6E-49 335.1 9.9 247 154-409 12-263 (467)
23 KOG0033 Ca2+/calmodulin-depend 100.0 1.5E-44 3.2E-49 313.0 6.5 247 156-409 12-267 (355)
24 KOG0661 MAPK related serine/th 100.0 9.3E-44 2E-48 334.5 12.5 247 155-409 10-291 (538)
25 KOG0600 Cdc2-related protein k 100.0 4.2E-43 9.1E-48 332.3 17.0 249 155-408 117-399 (560)
26 KOG1187 Serine/threonine prote 100.0 2E-42 4.2E-47 335.1 21.8 267 145-415 65-354 (361)
27 KOG1026 Nerve growth factor re 100.0 3E-43 6.5E-48 353.6 16.2 260 148-417 481-766 (774)
28 KOG0659 Cdk activating kinase 100.0 1.2E-42 2.7E-47 304.7 17.7 248 156-409 3-281 (318)
29 KOG0194 Protein tyrosine kinas 100.0 1.8E-42 4E-47 337.4 20.4 292 119-419 123-426 (474)
30 KOG0193 Serine/threonine prote 100.0 5.4E-43 1.2E-47 338.0 15.4 267 147-421 386-661 (678)
31 cd05102 PTKc_VEGFR3 Catalytic 100.0 2.6E-41 5.6E-46 329.2 24.7 253 155-415 7-336 (338)
32 KOG0694 Serine/threonine prote 100.0 2.2E-42 4.9E-47 338.8 17.2 242 153-403 366-613 (694)
33 cd05612 STKc_PRKX_like Catalyt 100.0 4.5E-42 9.7E-47 327.4 18.3 243 156-409 2-254 (291)
34 cd05631 STKc_GRK4 Catalytic do 100.0 1.6E-41 3.5E-46 322.6 21.5 248 157-409 2-261 (285)
35 PTZ00263 protein kinase A cata 100.0 6.5E-42 1.4E-46 331.9 18.2 244 155-409 18-271 (329)
36 cd05571 STKc_PKB Catalytic dom 100.0 8.3E-42 1.8E-46 330.4 18.8 240 162-409 2-251 (323)
37 KOG0580 Serine/threonine prote 100.0 1.3E-42 2.7E-47 300.4 11.4 245 156-410 23-274 (281)
38 KOG4721 Serine/threonine prote 100.0 1.1E-42 2.5E-47 332.3 11.8 250 147-416 118-371 (904)
39 cd05064 PTKc_EphR_A10 Catalyti 100.0 9.6E-41 2.1E-45 314.0 24.3 251 155-413 5-265 (266)
40 KOG0599 Phosphorylase kinase g 100.0 3.4E-42 7.5E-47 302.6 12.5 249 156-409 18-283 (411)
41 cd05600 STKc_Sid2p_Dbf2p Catal 100.0 2.5E-41 5.4E-46 328.5 19.6 247 156-409 2-257 (333)
42 KOG0610 Putative serine/threon 100.0 5E-41 1.1E-45 311.4 20.3 248 156-408 78-391 (459)
43 cd05595 STKc_PKB_beta Catalyti 100.0 3.4E-41 7.4E-46 326.0 20.1 240 162-409 2-251 (323)
44 KOG0589 Serine/threonine prote 100.0 1.1E-41 2.3E-46 326.0 15.5 247 155-409 4-258 (426)
45 PTZ00426 cAMP-dependent protei 100.0 4.4E-41 9.5E-46 327.1 19.6 245 154-409 29-284 (340)
46 cd05593 STKc_PKB_gamma Catalyt 100.0 4.7E-41 1E-45 325.7 19.7 240 162-409 2-251 (328)
47 KOG0585 Ca2+/calmodulin-depend 100.0 2.1E-41 4.6E-46 318.3 15.9 251 156-412 98-375 (576)
48 cd05628 STKc_NDR1 Catalytic do 100.0 1.1E-40 2.4E-45 327.7 21.0 250 156-409 2-293 (363)
49 cd05585 STKc_YPK1_like Catalyt 100.0 6.3E-41 1.4E-45 322.7 18.8 239 163-409 1-247 (312)
50 cd05626 STKc_LATS2 Catalytic d 100.0 1E-40 2.3E-45 330.0 20.6 250 156-409 2-305 (381)
51 cd05614 STKc_MSK2_N N-terminal 100.0 1.1E-40 2.5E-45 323.8 20.2 248 156-409 1-267 (332)
52 cd05599 STKc_NDR_like Catalyti 100.0 6.9E-41 1.5E-45 329.5 18.7 249 156-409 2-296 (364)
53 cd05573 STKc_ROCK_NDR_like Cat 100.0 4.3E-41 9.3E-46 329.1 16.5 249 156-409 2-285 (350)
54 cd07848 STKc_CDKL5 Catalytic d 100.0 1.7E-40 3.8E-45 315.7 20.0 250 156-409 2-284 (287)
55 KOG0032 Ca2+/calmodulin-depend 100.0 2.6E-40 5.5E-45 320.8 21.3 249 155-409 35-293 (382)
56 KOG2345 Serine/threonine prote 100.0 3E-41 6.6E-46 293.1 13.1 259 150-414 16-301 (302)
57 cd05601 STKc_CRIK Catalytic do 100.0 5.2E-41 1.1E-45 325.9 16.3 249 156-409 2-263 (330)
58 cd05594 STKc_PKB_alpha Catalyt 100.0 7.1E-41 1.5E-45 324.2 16.9 240 162-409 2-252 (325)
59 cd05096 PTKc_DDR1 Catalytic do 100.0 7.5E-40 1.6E-44 314.0 23.7 252 155-411 5-303 (304)
60 cd06649 PKc_MEK2 Catalytic dom 100.0 1E-39 2.3E-44 316.8 24.9 248 154-410 4-302 (331)
61 KOG0663 Protein kinase PITSLRE 100.0 1.6E-40 3.5E-45 299.9 17.6 251 153-409 74-361 (419)
62 cd05629 STKc_NDR_like_fungal C 100.0 1.3E-40 2.8E-45 329.0 18.5 249 156-409 2-305 (377)
63 KOG0660 Mitogen-activated prot 100.0 6E-41 1.3E-45 306.9 14.9 248 157-409 24-310 (359)
64 cd05592 STKc_nPKC_theta_delta 100.0 2.1E-40 4.6E-45 319.5 19.4 239 162-408 2-247 (316)
65 cd05106 PTKc_CSF-1R Catalytic 100.0 7.4E-40 1.6E-44 322.7 23.4 253 154-414 37-373 (374)
66 cd05590 STKc_nPKC_eta Catalyti 100.0 1.8E-40 4E-45 320.5 18.5 234 162-403 2-241 (320)
67 cd05048 PTKc_Ror Catalytic Dom 100.0 9.3E-40 2E-44 310.0 23.0 249 156-412 6-282 (283)
68 cd05596 STKc_ROCK Catalytic do 100.0 2.3E-40 5.1E-45 325.9 19.5 250 155-409 43-304 (370)
69 cd05104 PTKc_Kit Catalytic dom 100.0 1E-39 2.2E-44 322.0 23.9 249 156-412 36-373 (375)
70 cd05584 STKc_p70S6K Catalytic 100.0 3.4E-40 7.4E-45 319.1 20.1 241 161-409 2-256 (323)
71 cd05625 STKc_LATS1 Catalytic d 100.0 2.4E-40 5.2E-45 327.7 19.4 249 156-409 2-305 (382)
72 KOG4717 Serine/threonine prote 100.0 2.8E-40 6.1E-45 312.7 18.8 243 157-409 20-270 (864)
73 cd05598 STKc_LATS Catalytic do 100.0 1.2E-40 2.7E-45 329.1 17.2 249 156-409 2-301 (376)
74 cd05052 PTKc_Abl Catalytic dom 100.0 1.8E-39 4E-44 304.7 23.9 248 156-413 7-262 (263)
75 cd05608 STKc_GRK1 Catalytic do 100.0 6.6E-40 1.4E-44 310.7 21.0 243 163-409 1-257 (280)
76 cd05605 STKc_GRK4_like Catalyt 100.0 5.9E-40 1.3E-44 311.9 20.7 249 156-409 1-261 (285)
77 cd05588 STKc_aPKC Catalytic do 100.0 5.2E-40 1.1E-44 318.6 20.2 241 162-409 2-262 (329)
78 PTZ00267 NIMA-related protein 100.0 3.3E-39 7.2E-44 327.7 26.7 248 153-409 65-323 (478)
79 cd05591 STKc_nPKC_epsilon Cata 100.0 3.3E-40 7.1E-45 319.0 18.5 240 162-409 2-254 (321)
80 KOG1095 Protein tyrosine kinas 100.0 4.9E-40 1.1E-44 341.8 20.4 255 156-418 693-966 (1025)
81 cd05114 PTKc_Tec_Rlk Catalytic 100.0 2.2E-39 4.8E-44 302.9 23.0 245 156-410 5-255 (256)
82 cd05587 STKc_cPKC Catalytic do 100.0 7.1E-40 1.5E-44 317.1 20.2 246 156-409 1-257 (324)
83 cd05116 PTKc_Syk Catalytic dom 100.0 3.1E-39 6.8E-44 302.1 23.6 244 162-413 2-255 (257)
84 cd08228 STKc_Nek6 Catalytic do 100.0 4.3E-39 9.3E-44 302.7 24.7 253 156-414 3-266 (267)
85 cd05620 STKc_nPKC_delta Cataly 100.0 5.9E-40 1.3E-44 316.4 18.8 240 161-408 1-247 (316)
86 cd07859 STKc_TDY_MAPK_plant Ca 100.0 1E-39 2.2E-44 317.8 20.5 249 156-409 1-290 (338)
87 cd05570 STKc_PKC Catalytic dom 100.0 6.7E-40 1.4E-44 316.4 18.9 240 162-409 2-252 (318)
88 cd05621 STKc_ROCK2 Catalytic d 100.0 6.1E-40 1.3E-44 322.7 18.9 250 155-409 43-304 (370)
89 cd05093 PTKc_TrkB Catalytic do 100.0 5.8E-39 1.3E-43 305.5 25.1 253 155-416 5-282 (288)
90 cd05589 STKc_PKN Catalytic dom 100.0 1E-39 2.2E-44 315.9 20.1 244 157-409 1-257 (324)
91 cd05033 PTKc_EphR Catalytic do 100.0 6.2E-39 1.3E-43 301.6 24.8 250 156-413 5-265 (266)
92 cd05068 PTKc_Frk_like Catalyti 100.0 4.2E-39 9.2E-44 301.8 23.5 248 156-413 7-261 (261)
93 cd05072 PTKc_Lyn Catalytic dom 100.0 2.6E-39 5.7E-44 303.2 22.1 248 156-413 7-261 (261)
94 cd05618 STKc_aPKC_iota Catalyt 100.0 1.1E-39 2.4E-44 316.2 20.1 242 161-409 1-262 (329)
95 PF07714 Pkinase_Tyr: Protein 100.0 4E-40 8.8E-45 308.6 16.4 244 159-410 3-259 (259)
96 cd05616 STKc_cPKC_beta Catalyt 100.0 9.7E-40 2.1E-44 316.0 19.4 245 156-408 1-256 (323)
97 cd06650 PKc_MEK1 Catalytic dom 100.0 6.4E-39 1.4E-43 311.4 25.1 245 155-409 5-299 (333)
98 cd05619 STKc_nPKC_theta Cataly 100.0 1.1E-39 2.4E-44 314.5 19.4 239 162-408 2-247 (316)
99 cd07871 STKc_PCTAIRE3 Catalyti 100.0 1.6E-39 3.4E-44 309.4 20.1 247 156-409 6-285 (288)
100 KOG0196 Tyrosine kinase, EPH ( 100.0 7.5E-41 1.6E-45 330.5 11.3 260 149-418 625-896 (996)
101 cd05575 STKc_SGK Catalytic dom 100.0 9.5E-40 2.1E-44 316.0 18.3 235 162-404 2-242 (323)
102 cd05622 STKc_ROCK1 Catalytic d 100.0 1.5E-39 3.3E-44 320.1 20.0 252 154-410 42-305 (371)
103 PHA03212 serine/threonine kina 100.0 2.7E-39 5.9E-44 319.9 21.8 244 153-409 90-376 (391)
104 cd05597 STKc_DMPK_like Catalyt 100.0 2.1E-39 4.6E-44 314.6 20.4 251 156-409 2-266 (331)
105 cd05607 STKc_GRK7 Catalytic do 100.0 3.9E-39 8.5E-44 304.9 21.4 242 163-409 1-250 (277)
106 KOG1989 ARK protein kinase fam 100.0 2E-39 4.3E-44 327.5 20.4 261 154-424 36-322 (738)
107 PTZ00283 serine/threonine prot 100.0 5E-39 1.1E-43 326.8 23.6 251 152-409 29-297 (496)
108 cd05049 PTKc_Trk Catalytic dom 100.0 7E-39 1.5E-43 303.4 22.8 248 156-411 6-279 (280)
109 cd05627 STKc_NDR2 Catalytic do 100.0 9E-40 1.9E-44 321.0 17.1 249 156-409 2-293 (360)
110 cd05062 PTKc_IGF-1R Catalytic 100.0 7.6E-39 1.7E-43 302.9 22.8 250 154-411 5-276 (277)
111 cd05615 STKc_cPKC_alpha Cataly 100.0 2.8E-39 6.1E-44 312.7 20.1 239 157-403 2-246 (323)
112 PLN00034 mitogen-activated pro 100.0 4.3E-39 9.2E-44 315.3 21.6 244 156-409 75-328 (353)
113 cd05582 STKc_RSK_N N-terminal 100.0 5.8E-40 1.3E-44 316.9 15.2 236 161-405 2-245 (318)
114 cd05094 PTKc_TrkC Catalytic do 100.0 1.4E-38 3.1E-43 303.3 24.4 252 156-416 6-285 (291)
115 cd05108 PTKc_EGFR Catalytic do 100.0 1.1E-38 2.3E-43 307.8 23.6 255 155-418 7-273 (316)
116 cd05090 PTKc_Ror1 Catalytic do 100.0 1.3E-38 2.7E-43 302.3 23.6 249 156-412 6-282 (283)
117 cd05113 PTKc_Btk_Bmx Catalytic 100.0 8.1E-39 1.8E-43 299.2 21.8 246 156-411 5-256 (256)
118 cd05059 PTKc_Tec_like Catalyti 100.0 9.8E-39 2.1E-43 298.5 22.4 245 156-410 5-255 (256)
119 cd08229 STKc_Nek7 Catalytic do 100.0 1.4E-38 2.9E-43 299.3 23.4 253 156-414 3-266 (267)
120 cd05084 PTKc_Fes Catalytic dom 100.0 1.7E-38 3.6E-43 296.2 23.7 242 162-411 2-251 (252)
121 cd06625 STKc_MEKK3_like Cataly 100.0 1.7E-38 3.7E-43 297.8 23.6 249 156-409 3-260 (263)
122 cd05602 STKc_SGK1 Catalytic do 100.0 1.7E-39 3.7E-44 314.5 17.2 237 162-406 2-244 (325)
123 cd07869 STKc_PFTAIRE1 Catalyti 100.0 6.2E-39 1.3E-43 307.6 20.8 248 155-409 5-288 (303)
124 cd07862 STKc_CDK6 Catalytic do 100.0 6.4E-39 1.4E-43 305.4 20.7 247 156-409 2-287 (290)
125 cd05148 PTKc_Srm_Brk Catalytic 100.0 8.4E-39 1.8E-43 299.7 21.2 249 155-413 6-261 (261)
126 cd05045 PTKc_RET Catalytic dom 100.0 2.3E-38 4.9E-43 301.7 24.3 252 156-415 1-288 (290)
127 cd05115 PTKc_Zap-70 Catalytic 100.0 2.2E-38 4.8E-43 296.4 23.8 244 162-414 2-256 (257)
128 cd05051 PTKc_DDR Catalytic dom 100.0 1.7E-38 3.7E-43 303.2 23.5 253 154-411 4-295 (296)
129 cd05630 STKc_GRK6 Catalytic do 100.0 1.1E-38 2.3E-43 303.3 21.8 248 157-409 2-261 (285)
130 cd05105 PTKc_PDGFR_alpha Catal 100.0 1.8E-38 3.8E-43 314.4 24.3 254 154-415 36-399 (400)
131 KOG0577 Serine/threonine prote 100.0 4.2E-40 9.1E-45 316.0 12.2 244 155-409 26-278 (948)
132 cd05617 STKc_aPKC_zeta Catalyt 100.0 4.3E-39 9.3E-44 311.9 19.5 235 162-403 2-248 (327)
133 cd05623 STKc_MRCK_alpha Cataly 100.0 3.9E-39 8.5E-44 312.9 18.9 251 156-409 2-266 (332)
134 cd06646 STKc_MAP4K5 Catalytic 100.0 8.4E-39 1.8E-43 300.8 20.5 249 155-410 9-266 (267)
135 cd05098 PTKc_FGFR1 Catalytic d 100.0 2.3E-38 5.1E-43 304.1 24.0 256 155-418 18-304 (307)
136 cd05060 PTKc_Syk_like Catalyti 100.0 2.7E-38 5.9E-43 295.7 23.7 245 161-414 1-256 (257)
137 cd05080 PTKc_Tyk2_rpt2 Catalyt 100.0 4.8E-38 1E-42 298.4 25.6 249 157-414 6-282 (283)
138 cd05632 STKc_GRK5 Catalytic do 100.0 1.3E-38 2.8E-43 302.7 21.7 248 157-409 2-261 (285)
139 cd05624 STKc_MRCK_beta Catalyt 100.0 3.6E-39 7.7E-44 313.0 18.1 251 156-409 2-266 (331)
140 cd05071 PTKc_Src Catalytic dom 100.0 2.9E-38 6.2E-43 296.5 23.3 248 156-414 7-261 (262)
141 cd05604 STKc_SGK3 Catalytic do 100.0 2.5E-39 5.4E-44 313.4 16.6 236 162-405 2-243 (325)
142 cd05101 PTKc_FGFR2 Catalytic d 100.0 3.6E-38 7.8E-43 302.4 24.4 257 154-418 14-301 (304)
143 cd08529 STKc_FA2-like Catalyti 100.0 2.6E-38 5.6E-43 295.3 22.8 246 156-409 1-253 (256)
144 cd05092 PTKc_TrkA Catalytic do 100.0 3.3E-38 7.1E-43 299.1 23.8 248 155-411 5-279 (280)
145 cd05054 PTKc_VEGFR Catalytic d 100.0 4.7E-38 1E-42 305.7 25.2 252 156-415 8-335 (337)
146 KOG4257 Focal adhesion tyrosin 100.0 5.1E-39 1.1E-43 310.3 18.0 249 158-415 392-651 (974)
147 cd05089 PTKc_Tie1 Catalytic do 100.0 4.8E-38 1E-42 300.5 24.7 254 156-419 3-281 (297)
148 cd05099 PTKc_FGFR4 Catalytic d 100.0 5.5E-38 1.2E-42 302.5 25.3 257 155-419 12-299 (314)
149 cd07853 STKc_NLK Catalytic dom 100.0 1.2E-38 2.6E-43 314.4 21.1 249 156-409 1-288 (372)
150 cd05603 STKc_SGK2 Catalytic do 100.0 4.1E-39 8.9E-44 311.4 17.4 235 162-404 2-242 (321)
151 cd05085 PTKc_Fer Catalytic dom 100.0 5.8E-38 1.3E-42 292.1 24.4 242 162-411 2-249 (250)
152 cd08224 STKc_Nek6_Nek7 Catalyt 100.0 8.4E-38 1.8E-42 293.7 25.6 253 156-414 3-266 (267)
153 KOG0658 Glycogen synthase kina 100.0 6.8E-40 1.5E-44 300.6 10.8 250 153-415 22-314 (364)
154 cd05091 PTKc_Ror2 Catalytic do 100.0 2.1E-38 4.5E-43 300.8 21.5 249 156-412 6-282 (283)
155 cd05039 PTKc_Csk_like Catalyti 100.0 4.7E-38 1E-42 293.8 23.5 243 156-412 7-255 (256)
156 cd05053 PTKc_FGFR Catalytic do 100.0 2.2E-38 4.9E-43 302.1 21.8 253 154-414 11-292 (293)
157 KOG0574 STE20-like serine/thre 100.0 1.3E-40 2.8E-45 296.3 5.5 244 156-409 34-283 (502)
158 cd05067 PTKc_Lck_Blk Catalytic 100.0 3.7E-38 8E-43 295.3 22.5 246 156-412 7-259 (260)
159 KOG0594 Protein kinase PCTAIRE 100.0 6.1E-39 1.3E-43 294.7 16.7 248 156-409 12-302 (323)
160 cd05032 PTKc_InsR_like Catalyt 100.0 3.4E-38 7.3E-43 298.2 22.2 248 156-411 7-276 (277)
161 cd05070 PTKc_Fyn_Yrk Catalytic 100.0 4E-38 8.6E-43 295.1 22.5 246 156-412 7-259 (260)
162 cd05075 PTKc_Axl Catalytic dom 100.0 6.2E-38 1.3E-42 295.6 23.9 249 158-413 2-271 (272)
163 cd05066 PTKc_EphR_A Catalytic 100.0 7.3E-38 1.6E-42 294.5 24.2 250 156-413 5-266 (267)
164 cd05035 PTKc_Axl_like Catalyti 100.0 7.4E-38 1.6E-42 295.1 23.8 250 157-413 1-272 (273)
165 cd05097 PTKc_DDR_like Catalyti 100.0 8.5E-38 1.8E-42 298.5 24.5 252 155-411 5-294 (295)
166 cd05082 PTKc_Csk Catalytic dom 100.0 4.7E-38 1E-42 293.9 22.2 243 156-413 7-256 (256)
167 cd05088 PTKc_Tie2 Catalytic do 100.0 4.1E-38 8.8E-43 301.9 22.3 253 156-418 8-285 (303)
168 cd08219 STKc_Nek3 Catalytic do 100.0 4.1E-38 8.8E-43 294.1 21.6 245 156-409 1-252 (255)
169 cd06631 STKc_YSK4 Catalytic do 100.0 6.1E-38 1.3E-42 294.6 22.8 249 156-408 1-261 (265)
170 cd05043 PTK_Ryk Pseudokinase d 100.0 1.1E-37 2.4E-42 295.3 24.6 256 153-416 4-279 (280)
171 cd05069 PTKc_Yes Catalytic dom 100.0 8.2E-38 1.8E-42 293.0 23.4 246 156-412 7-259 (260)
172 cd05036 PTKc_ALK_LTK Catalytic 100.0 8.2E-38 1.8E-42 295.8 23.5 249 155-411 6-276 (277)
173 cd05055 PTKc_PDGFR Catalytic d 100.0 1.1E-37 2.4E-42 298.8 24.6 253 154-413 34-301 (302)
174 cd05109 PTKc_HER2 Catalytic do 100.0 1E-37 2.3E-42 295.4 24.2 254 155-417 7-272 (279)
175 cd05063 PTKc_EphR_A2 Catalytic 100.0 1.3E-37 2.7E-42 293.0 24.3 250 156-413 6-267 (268)
176 cd06628 STKc_MAPKKK_Byr2_like 100.0 9.4E-38 2E-42 293.6 23.4 247 157-409 2-264 (267)
177 cd00192 PTKc Catalytic domain 100.0 7.2E-38 1.6E-42 292.8 22.4 242 162-411 2-262 (262)
178 cd05056 PTKc_FAK Catalytic dom 100.0 1.8E-37 3.9E-42 292.3 25.1 252 156-416 7-268 (270)
179 cd06645 STKc_MAP4K3 Catalytic 100.0 4.5E-38 9.9E-43 295.8 20.9 247 156-409 10-265 (267)
180 cd05111 PTK_HER3 Pseudokinase 100.0 1.5E-37 3.3E-42 294.4 24.6 252 156-416 8-271 (279)
181 cd05586 STKc_Sck1_like Catalyt 100.0 6.2E-39 1.4E-43 311.3 15.3 239 163-408 1-252 (330)
182 cd05061 PTKc_InsR Catalytic do 100.0 1.5E-37 3.2E-42 295.8 24.1 252 155-414 6-279 (288)
183 cd05050 PTKc_Musk Catalytic do 100.0 9.8E-38 2.1E-42 297.0 22.9 250 155-412 5-288 (288)
184 PRK13184 pknD serine/threonine 100.0 1.1E-37 2.4E-42 326.4 25.3 257 156-416 3-293 (932)
185 cd05609 STKc_MAST Catalytic do 100.0 8.1E-38 1.8E-42 300.1 22.5 253 156-412 2-273 (305)
186 cd05095 PTKc_DDR2 Catalytic do 100.0 1.7E-37 3.7E-42 296.6 24.4 252 155-411 5-295 (296)
187 KOG0690 Serine/threonine prote 100.0 1.5E-39 3.3E-44 292.4 9.5 238 156-401 169-411 (516)
188 cd07876 STKc_JNK2 Catalytic do 100.0 6.5E-38 1.4E-42 307.7 22.0 246 155-409 21-315 (359)
189 cd08221 STKc_Nek9 Catalytic do 100.0 1.3E-37 2.9E-42 290.7 23.0 246 156-409 1-253 (256)
190 cd05073 PTKc_Hck Catalytic dom 100.0 1.8E-37 4E-42 290.6 23.8 248 155-413 6-260 (260)
191 cd05107 PTKc_PDGFR_beta Cataly 100.0 1.4E-37 3E-42 308.0 24.1 251 156-414 38-400 (401)
192 cd05079 PTKc_Jak1_rpt2 Catalyt 100.0 2.4E-37 5.2E-42 293.7 24.7 252 154-413 3-283 (284)
193 cd05034 PTKc_Src_like Catalyti 100.0 1.1E-37 2.4E-42 292.0 22.1 248 155-412 6-260 (261)
194 cd05100 PTKc_FGFR3 Catalytic d 100.0 1.6E-37 3.5E-42 301.9 23.8 262 146-417 5-297 (334)
195 cd06613 STKc_MAP4K3_like Catal 100.0 2.2E-37 4.7E-42 290.1 23.9 248 155-409 3-260 (262)
196 cd06615 PKc_MEK Catalytic doma 100.0 1.9E-37 4.1E-42 297.9 24.0 244 156-409 2-287 (308)
197 PF00069 Pkinase: Protein kina 100.0 1.5E-38 3.4E-43 297.4 15.9 248 157-409 1-257 (260)
198 cd05081 PTKc_Jak2_Jak3_rpt2 Ca 100.0 2.9E-37 6.3E-42 293.1 24.8 251 154-413 3-283 (284)
199 cd05580 STKc_PKA Catalytic dom 100.0 1.1E-37 2.4E-42 297.0 21.8 243 156-409 2-254 (290)
200 cd05065 PTKc_EphR_B Catalytic 100.0 2.7E-37 5.8E-42 290.9 23.9 250 156-413 5-268 (269)
201 KOG1094 Discoidin domain recep 100.0 1.4E-38 3E-43 305.5 15.1 253 156-413 539-804 (807)
202 cd05103 PTKc_VEGFR2 Catalytic 100.0 3.6E-37 7.8E-42 300.5 25.3 253 155-415 7-341 (343)
203 cd05112 PTKc_Itk Catalytic dom 100.0 2.4E-37 5.2E-42 289.0 23.0 245 156-410 5-255 (256)
204 cd05058 PTKc_Met_Ron Catalytic 100.0 4.3E-37 9.3E-42 288.3 24.3 246 162-415 2-261 (262)
205 KOG0667 Dual-specificity tyros 100.0 4.3E-38 9.4E-43 308.5 18.0 242 156-409 187-502 (586)
206 KOG0586 Serine/threonine prote 100.0 4.2E-38 9E-43 305.7 17.6 251 149-410 50-307 (596)
207 cd07872 STKc_PCTAIRE2 Catalyti 100.0 1E-37 2.3E-42 299.9 20.4 247 156-409 7-286 (309)
208 cd06655 STKc_PAK2 Catalytic do 100.0 2.1E-37 4.7E-42 295.9 22.4 251 150-409 14-269 (296)
209 cd06626 STKc_MEKK4 Catalytic d 100.0 4.3E-37 9.3E-42 288.4 24.1 248 156-408 1-260 (264)
210 cd08223 STKc_Nek4 Catalytic do 100.0 3.4E-37 7.4E-42 288.0 23.2 246 156-409 1-254 (257)
211 cd06643 STKc_SLK Catalytic dom 100.0 3E-37 6.4E-42 292.8 22.9 245 157-409 7-262 (282)
212 KOG4279 Serine/threonine prote 100.0 2.6E-38 5.7E-43 308.4 15.4 241 160-408 580-831 (1226)
213 PTZ00036 glycogen synthase kin 100.0 1.2E-37 2.6E-42 312.8 20.8 243 154-409 65-351 (440)
214 cd06640 STKc_MST4 Catalytic do 100.0 5.1E-37 1.1E-41 290.4 23.8 244 156-409 5-253 (277)
215 cd07875 STKc_JNK1 Catalytic do 100.0 1.8E-37 4E-42 305.1 21.5 246 155-409 24-318 (364)
216 cd06654 STKc_PAK1 Catalytic do 100.0 3.4E-37 7.4E-42 294.5 22.7 248 153-409 18-270 (296)
217 cd08227 PK_STRAD_alpha Pseudok 100.0 3.9E-37 8.6E-42 298.3 23.4 246 160-409 3-307 (327)
218 cd05057 PTKc_EGFR_like Catalyt 100.0 7.9E-37 1.7E-41 289.4 24.8 255 155-418 7-273 (279)
219 cd05083 PTKc_Chk Catalytic dom 100.0 3.4E-37 7.4E-42 287.7 22.0 241 156-412 7-253 (254)
220 cd07863 STKc_CDK4 Catalytic do 100.0 1.4E-37 3E-42 295.8 19.7 247 156-409 1-285 (288)
221 cd05041 PTKc_Fes_like Catalyti 100.0 6.1E-37 1.3E-41 285.4 23.5 242 162-411 2-250 (251)
222 cd05047 PTKc_Tie Catalytic dom 100.0 4.7E-37 1E-41 289.5 23.0 243 162-414 2-269 (270)
223 smart00219 TyrKc Tyrosine kina 100.0 5.2E-37 1.1E-41 286.6 23.1 245 158-410 2-258 (258)
224 cd05046 PTK_CCK4 Pseudokinase 100.0 5.2E-37 1.1E-41 289.8 23.3 250 155-411 5-274 (275)
225 cd06622 PKc_MAPKK_PBS2_like Ca 100.0 3.1E-37 6.8E-42 293.1 21.9 246 156-409 2-262 (286)
226 cd07874 STKc_JNK3 Catalytic do 100.0 2.1E-37 4.6E-42 303.6 21.3 246 155-409 17-311 (355)
227 cd06630 STKc_MEKK1 Catalytic d 100.0 4.7E-37 1E-41 288.9 22.7 251 156-409 1-264 (268)
228 cd05578 STKc_Yank1 Catalytic d 100.0 1.3E-37 2.7E-42 291.3 18.6 247 156-408 1-254 (258)
229 PHA03207 serine/threonine kina 100.0 2.7E-37 5.8E-42 306.6 22.0 243 155-409 92-375 (392)
230 cd05040 PTKc_Ack_like Catalyti 100.0 4.1E-37 9E-42 287.5 22.0 242 162-411 2-256 (257)
231 cd06609 STKc_MST3_like Catalyt 100.0 3.6E-37 7.7E-42 290.9 21.7 245 156-409 2-251 (274)
232 cd06610 STKc_OSR1_SPAK Catalyt 100.0 5.3E-37 1.1E-41 288.2 22.8 249 156-409 2-264 (267)
233 cd05076 PTK_Tyk2_rpt1 Pseudoki 100.0 6E-37 1.3E-41 289.5 23.1 233 162-410 2-273 (274)
234 cd05087 PTKc_Aatyk1_Aatyk3 Cat 100.0 7.5E-37 1.6E-41 288.0 23.5 244 162-411 2-268 (269)
235 cd08218 STKc_Nek1 Catalytic do 100.0 4.2E-37 9.1E-42 287.3 21.6 246 156-409 1-253 (256)
236 cd06644 STKc_STK10_LOK Catalyt 100.0 8.5E-37 1.9E-41 291.1 23.9 246 156-409 13-269 (292)
237 cd05042 PTKc_Aatyk Catalytic d 100.0 8.3E-37 1.8E-41 287.6 23.4 243 162-410 2-267 (269)
238 cd06619 PKc_MKK5 Catalytic dom 100.0 8.5E-37 1.8E-41 289.2 23.5 240 156-409 2-253 (279)
239 cd06632 STKc_MEKK1_plant Catal 100.0 7.9E-37 1.7E-41 285.5 23.0 247 156-409 1-255 (258)
240 cd05577 STKc_GRK Catalytic dom 100.0 4.1E-37 8.9E-42 291.0 21.1 241 163-408 1-253 (277)
241 cd05574 STKc_phototropin_like 100.0 7E-37 1.5E-41 295.1 23.1 249 156-409 2-289 (316)
242 cd06651 STKc_MEKK3 Catalytic d 100.0 8.9E-37 1.9E-41 287.0 23.1 249 155-409 2-261 (266)
243 PTZ00284 protein kinase; Provi 100.0 3.6E-37 7.7E-42 312.6 21.8 246 152-409 126-438 (467)
244 cd05077 PTK_Jak1_rpt1 Pseudoki 100.0 1.2E-36 2.7E-41 285.4 23.9 233 162-410 2-261 (262)
245 cd06612 STKc_MST1_2 Catalytic 100.0 6E-37 1.3E-41 286.1 21.5 245 155-409 3-253 (256)
246 cd06652 STKc_MEKK2 Catalytic d 100.0 1.7E-36 3.7E-41 284.8 24.4 248 156-409 3-261 (265)
247 cd06611 STKc_SLK_like Catalyti 100.0 4.5E-37 9.8E-42 291.1 20.6 246 156-409 6-262 (280)
248 cd08220 STKc_Nek8 Catalytic do 100.0 1.1E-36 2.4E-41 284.3 22.9 245 156-409 1-253 (256)
249 cd06629 STKc_MAPKKK_Bck1_like 100.0 1.1E-36 2.3E-41 287.2 22.6 251 156-409 2-269 (272)
250 cd05572 STKc_cGK_PKG Catalytic 100.0 1E-36 2.2E-41 285.9 22.2 238 163-408 1-251 (262)
251 cd05044 PTKc_c-ros Catalytic d 100.0 6.7E-37 1.5E-41 288.1 21.0 242 162-411 2-268 (269)
252 cd06642 STKc_STK25-YSK1 Cataly 100.0 5.5E-37 1.2E-41 290.2 20.5 244 156-409 5-253 (277)
253 cd06624 STKc_ASK Catalytic dom 100.0 2.5E-36 5.5E-41 284.2 24.7 246 156-409 9-265 (268)
254 cd07873 STKc_PCTAIRE1 Catalyti 100.0 6.5E-37 1.4E-41 293.3 21.0 247 156-409 7-286 (301)
255 cd05110 PTKc_HER4 Catalytic do 100.0 1.4E-36 3E-41 291.3 23.3 255 155-418 7-273 (303)
256 PTZ00266 NIMA-related protein 100.0 6.7E-37 1.5E-41 321.7 22.7 249 155-409 13-295 (1021)
257 KOG4278 Protein tyrosine kinas 100.0 1.4E-37 3.1E-42 299.9 16.0 252 156-417 268-527 (1157)
258 cd05038 PTKc_Jak_rpt2 Catalyti 100.0 1.7E-36 3.8E-41 287.4 23.3 253 155-413 4-283 (284)
259 cd08217 STKc_Nek2 Catalytic do 100.0 1.6E-36 3.6E-41 284.2 22.8 246 156-409 1-262 (265)
260 cd06656 STKc_PAK3 Catalytic do 100.0 7.6E-37 1.7E-41 292.2 20.8 248 153-409 17-269 (297)
261 cd06620 PKc_MAPKK_Byr1_like Ca 100.0 7.5E-37 1.6E-41 290.3 20.2 247 155-411 5-268 (284)
262 cd06623 PKc_MAPKK_plant_like C 100.0 2.2E-36 4.8E-41 283.5 23.0 248 156-409 2-256 (264)
263 cd07861 STKc_CDK1_euk Catalyti 100.0 7.8E-37 1.7E-41 290.1 20.2 248 156-409 1-282 (285)
264 cd07847 STKc_CDKL1_4 Catalytic 100.0 8.1E-37 1.8E-41 290.1 20.2 249 156-409 2-283 (286)
265 cd07832 STKc_CCRK Catalytic do 100.0 2E-36 4.3E-41 287.4 22.7 249 156-409 1-282 (286)
266 KOG0579 Ste20-like serine/thre 100.0 4.6E-38 1E-42 303.9 11.3 245 157-409 34-289 (1187)
267 cd07868 STKc_CDK8 Catalytic do 100.0 2.2E-36 4.8E-41 291.7 22.9 241 160-409 6-314 (317)
268 cd07878 STKc_p38beta_MAPK11 Ca 100.0 6.8E-37 1.5E-41 298.7 19.4 244 156-409 16-298 (343)
269 cd06648 STKc_PAK_II Catalytic 100.0 2.7E-36 5.8E-41 286.7 22.8 245 156-409 20-269 (285)
270 cd05633 STKc_GRK3 Catalytic do 100.0 1.9E-36 4.2E-41 286.8 21.6 240 163-409 2-255 (279)
271 cd06638 STKc_myosinIIIA Cataly 100.0 2.5E-36 5.4E-41 286.9 22.3 249 153-410 16-284 (286)
272 cd06637 STKc_TNIK Catalytic do 100.0 1.2E-36 2.7E-41 286.7 20.0 246 154-409 5-269 (272)
273 cd05074 PTKc_Tyro3 Catalytic d 100.0 4.2E-36 9.2E-41 283.3 23.4 250 157-413 1-272 (273)
274 KOG0584 Serine/threonine prote 100.0 1.5E-37 3.3E-42 302.2 13.7 252 149-408 34-295 (632)
275 cd05611 STKc_Rim15_like Cataly 100.0 1.9E-36 4.1E-41 283.6 20.8 240 161-408 2-247 (260)
276 cd06607 STKc_TAO Catalytic dom 100.0 3.8E-36 8.2E-41 288.8 23.3 244 155-409 15-267 (307)
277 cd06658 STKc_PAK5 Catalytic do 100.0 9.7E-37 2.1E-41 290.8 19.0 243 158-409 25-272 (292)
278 KOG0986 G protein-coupled rece 100.0 4.4E-38 9.5E-43 294.2 9.4 244 156-404 186-436 (591)
279 cd06659 STKc_PAK6 Catalytic do 100.0 1.1E-36 2.3E-41 291.2 19.3 244 157-409 23-271 (297)
280 cd05086 PTKc_Aatyk2 Catalytic 100.0 6.8E-36 1.5E-40 281.4 24.3 243 162-410 2-266 (268)
281 cd06605 PKc_MAPKK Catalytic do 100.0 1.7E-36 3.7E-41 284.6 19.9 244 156-409 2-257 (265)
282 cd05037 PTK_Jak_rpt1 Pseudokin 100.0 4.4E-36 9.6E-41 280.7 22.6 231 162-410 2-258 (259)
283 KOG4645 MAPKKK (MAP kinase kin 100.0 2.4E-38 5.1E-43 327.9 7.5 251 152-409 1232-1494(1509)
284 cd07846 STKc_CDKL2_3 Catalytic 100.0 1.2E-36 2.6E-41 288.9 18.5 249 156-409 2-283 (286)
285 cd06641 STKc_MST3 Catalytic do 100.0 6.2E-36 1.3E-40 283.0 23.2 243 157-409 6-253 (277)
286 KOG0199 ACK and related non-re 100.0 5.5E-37 1.2E-41 299.6 16.2 246 156-410 111-369 (1039)
287 KOG0983 Mitogen-activated prot 100.0 4.7E-37 1E-41 270.4 14.1 245 157-409 94-349 (391)
288 cd07841 STKc_CDK7 Catalytic do 100.0 3.9E-36 8.6E-41 287.3 21.6 249 156-409 1-282 (298)
289 cd05078 PTK_Jak2_Jak3_rpt1 Pse 100.0 1.7E-36 3.7E-41 283.7 18.7 234 162-411 2-258 (258)
290 cd07833 STKc_CDKL Catalytic do 100.0 3E-36 6.5E-41 286.5 20.5 250 156-409 2-285 (288)
291 cd08528 STKc_Nek10 Catalytic d 100.0 6.2E-36 1.3E-40 281.6 22.3 249 156-411 1-268 (269)
292 cd06917 STKc_NAK1_like Catalyt 100.0 4.4E-36 9.6E-41 283.8 21.3 245 156-409 2-255 (277)
293 cd06639 STKc_myosinIIIB Cataly 100.0 8.8E-36 1.9E-40 283.9 23.4 252 149-409 16-287 (291)
294 cd06608 STKc_myosinIII_like Ca 100.0 5.6E-36 1.2E-40 282.3 21.8 247 154-409 5-272 (275)
295 cd05613 STKc_MSK1_N N-terminal 100.0 5.9E-36 1.3E-40 285.0 22.2 248 156-409 1-268 (290)
296 PHA03211 serine/threonine kina 100.0 4.4E-36 9.5E-41 300.9 22.1 243 154-409 168-455 (461)
297 cd07839 STKc_CDK5 Catalytic do 100.0 1.4E-36 3E-41 288.3 17.3 248 156-409 1-281 (284)
298 cd05583 STKc_MSK_N N-terminal 100.0 4.6E-36 9.9E-41 285.5 20.5 253 157-412 2-266 (288)
299 cd05579 STKc_MAST_like Catalyt 100.0 3.2E-36 7E-41 282.2 19.0 243 163-410 1-255 (265)
300 cd06636 STKc_MAP4K4_6 Catalyti 100.0 6.3E-36 1.4E-40 283.6 21.2 251 149-409 10-279 (282)
301 cd06614 STKc_PAK Catalytic dom 100.0 1.1E-35 2.3E-40 282.6 22.7 247 154-409 18-270 (286)
302 cd06635 STKc_TAO1 Catalytic do 100.0 1.7E-35 3.7E-40 285.6 24.4 244 157-411 27-279 (317)
303 cd06647 STKc_PAK_I Catalytic d 100.0 6.6E-36 1.4E-40 285.2 21.1 247 154-409 18-269 (293)
304 cd06653 STKc_MEKK3_like_1 Cata 100.0 1.7E-35 3.7E-40 277.9 23.5 248 156-409 3-261 (264)
305 cd06627 STKc_Cdc7_like Catalyt 100.0 1.8E-35 3.9E-40 275.5 23.4 245 156-408 1-250 (254)
306 cd05122 PKc_STE Catalytic doma 100.0 1.6E-35 3.5E-40 275.0 22.8 244 157-409 2-251 (253)
307 PHA03209 serine/threonine kina 100.0 7.1E-36 1.5E-40 292.8 21.3 240 155-409 66-351 (357)
308 cd06621 PKc_MAPKK_Pek1_like Ca 100.0 2.4E-35 5.1E-40 280.5 24.2 246 156-409 2-266 (287)
309 cd08530 STKc_CNK2-like Catalyt 100.0 9.4E-36 2E-40 277.9 20.9 244 156-409 1-253 (256)
310 cd08225 STKc_Nek5 Catalytic do 100.0 6.2E-36 1.4E-40 279.4 19.6 246 156-409 1-254 (257)
311 KOG0696 Serine/threonine prote 100.0 3.1E-37 6.7E-42 285.3 10.5 240 156-403 350-595 (683)
312 cd06606 STKc_MAPKKK Catalytic 100.0 2.7E-35 5.7E-40 274.7 23.7 249 156-409 1-257 (260)
313 cd06617 PKc_MKK3_6 Catalytic d 100.0 1.7E-35 3.6E-40 280.7 22.3 244 156-409 2-261 (283)
314 cd05581 STKc_PDK1 Catalytic do 100.0 4.9E-36 1.1E-40 283.6 18.5 247 156-409 2-277 (280)
315 cd07867 STKc_CDC2L6 Catalytic 100.0 1.7E-35 3.6E-40 285.5 22.5 241 160-409 6-314 (317)
316 cd08215 STKc_Nek Catalytic dom 100.0 2.3E-35 4.9E-40 275.2 22.6 246 156-409 1-255 (258)
317 cd07860 STKc_CDK2_3 Catalytic 100.0 9.7E-36 2.1E-40 282.5 20.2 248 156-409 1-281 (284)
318 PHA03390 pk1 serine/threonine- 100.0 1.7E-35 3.6E-40 278.6 21.3 230 163-409 24-262 (267)
319 KOG0604 MAP kinase-activated p 100.0 6.6E-37 1.4E-41 272.7 11.0 240 156-409 62-322 (400)
320 cd05606 STKc_beta_ARK Catalyti 100.0 1.9E-35 4.1E-40 279.9 21.7 238 163-409 2-255 (278)
321 cd07850 STKc_JNK Catalytic dom 100.0 1.4E-35 3.1E-40 290.4 21.5 246 155-409 16-311 (353)
322 cd06633 STKc_TAO3 Catalytic do 100.0 7.4E-35 1.6E-39 280.6 26.2 242 157-409 23-273 (313)
323 KOG0596 Dual specificity; seri 100.0 2.3E-36 5E-41 289.0 14.7 249 153-409 359-627 (677)
324 cd07843 STKc_CDC2L1 Catalytic 100.0 1.5E-35 3.2E-40 282.7 20.2 248 156-409 6-290 (293)
325 cd06616 PKc_MKK4 Catalytic dom 100.0 1.8E-35 3.8E-40 281.4 20.2 244 156-409 5-267 (288)
326 cd07835 STKc_CDK1_like Catalyt 100.0 2E-35 4.4E-40 280.2 20.3 247 157-409 1-280 (283)
327 cd07840 STKc_CDK9_like Catalyt 100.0 2.3E-35 5.1E-40 280.0 20.7 248 157-409 1-284 (287)
328 cd08216 PK_STRAD Pseudokinase 100.0 4.9E-35 1.1E-39 281.9 23.2 249 157-409 4-295 (314)
329 cd06657 STKc_PAK4 Catalytic do 100.0 3.2E-35 7E-40 280.3 21.6 241 160-409 25-270 (292)
330 PHA03210 serine/threonine kina 100.0 1.4E-35 3E-40 302.4 20.4 251 155-409 148-454 (501)
331 cd07845 STKc_CDK10 Catalytic d 100.0 2.1E-35 4.6E-40 283.8 20.5 249 155-409 7-290 (309)
332 cd07836 STKc_Pho85 Catalytic d 100.0 3.2E-35 6.8E-40 278.9 21.3 247 156-409 1-281 (284)
333 KOG0607 MAP kinase-interacting 100.0 3.2E-36 7E-41 270.4 13.1 242 160-408 83-360 (463)
334 cd06634 STKc_TAO2 Catalytic do 100.0 4.3E-35 9.4E-40 281.6 21.8 245 156-411 16-269 (308)
335 cd05123 STKc_AGC Catalytic dom 100.0 3.8E-35 8.3E-40 272.9 20.2 235 163-405 1-240 (250)
336 PLN00009 cyclin-dependent kina 100.0 5E-35 1.1E-39 279.2 21.4 248 156-409 3-284 (294)
337 cd07870 STKc_PFTAIRE2 Catalyti 100.0 5.6E-35 1.2E-39 278.4 21.7 248 155-409 5-288 (291)
338 cd07844 STKc_PCTAIRE_like Cata 100.0 3.8E-35 8.2E-40 279.5 20.3 247 156-409 6-288 (291)
339 KOG4236 Serine/threonine prote 100.0 1.7E-36 3.8E-41 287.7 10.9 241 160-409 569-819 (888)
340 cd07849 STKc_ERK1_2_like Catal 100.0 2.8E-35 6E-40 286.4 19.7 248 155-409 5-292 (336)
341 cd07855 STKc_ERK5 Catalytic do 100.0 1.6E-35 3.4E-40 287.9 18.0 250 155-409 5-294 (334)
342 cd07837 STKc_CdkB_plant Cataly 100.0 4.9E-35 1.1E-39 279.3 21.0 248 156-409 2-291 (295)
343 cd07858 STKc_TEY_MAPK_plant Ca 100.0 2.5E-35 5.3E-40 286.9 19.3 252 156-413 6-297 (337)
344 cd07842 STKc_CDK8_like Catalyt 100.0 7.6E-35 1.6E-39 280.7 22.2 250 156-409 1-313 (316)
345 cd07831 STKc_MOK Catalytic dom 100.0 6.3E-35 1.4E-39 276.5 21.3 244 157-409 1-279 (282)
346 PHA02882 putative serine/threo 100.0 1.3E-34 2.8E-39 276.5 23.4 251 154-410 11-293 (294)
347 cd07865 STKc_CDK9 Catalytic do 100.0 6.4E-35 1.4E-39 280.3 21.3 251 154-409 11-307 (310)
348 KOG0662 Cyclin-dependent kinas 100.0 5.6E-36 1.2E-40 248.4 11.9 248 156-409 3-283 (292)
349 KOG0612 Rho-associated, coiled 100.0 1E-36 2.2E-41 312.0 9.2 251 154-409 74-338 (1317)
350 KOG0614 cGMP-dependent protein 100.0 7E-37 1.5E-41 289.4 7.2 239 156-402 421-665 (732)
351 cd08226 PK_STRAD_beta Pseudoki 100.0 1.2E-34 2.5E-39 281.1 23.0 244 162-409 5-308 (328)
352 cd07834 STKc_MAPK Catalytic do 100.0 4E-35 8.8E-40 284.5 18.8 255 156-415 1-297 (330)
353 cd06618 PKc_MKK7 Catalytic dom 100.0 2.1E-34 4.6E-39 275.2 23.1 246 155-409 15-273 (296)
354 KOG0200 Fibroblast/platelet-de 100.0 1.4E-34 3E-39 299.7 22.9 258 147-414 290-580 (609)
355 cd05118 STKc_CMGC Catalytic do 100.0 1.1E-34 2.4E-39 274.9 20.3 247 157-409 1-280 (283)
356 cd07838 STKc_CDK4_6_like Catal 100.0 2.4E-34 5.3E-39 273.1 22.5 246 157-409 1-284 (287)
357 KOG1006 Mitogen-activated prot 100.0 7.2E-37 1.6E-41 268.3 4.6 246 156-409 65-327 (361)
358 cd07864 STKc_CDK12 Catalytic d 100.0 7.1E-35 1.5E-39 279.1 18.9 250 155-409 7-299 (302)
359 cd07852 STKc_MAPK15 Catalytic 100.0 1.2E-34 2.5E-39 282.2 19.8 249 155-409 7-295 (337)
360 KOG0603 Ribosomal protein S6 k 100.0 3.9E-35 8.3E-40 286.5 14.3 233 156-409 323-563 (612)
361 PTZ00024 cyclin-dependent prot 100.0 3.6E-34 7.7E-39 278.5 20.9 247 159-409 13-313 (335)
362 cd08222 STKc_Nek11 Catalytic d 100.0 2.5E-34 5.3E-39 269.3 18.8 246 156-409 1-257 (260)
363 cd05610 STKc_MASTL Catalytic d 100.0 6E-34 1.3E-38 299.2 23.4 144 155-301 4-152 (669)
364 cd07857 STKc_MPK1 Catalytic do 100.0 4.5E-34 9.8E-39 277.4 20.7 249 156-409 1-292 (332)
365 cd07879 STKc_p38delta_MAPK13 C 100.0 3.1E-34 6.7E-39 279.7 19.6 250 155-415 15-305 (342)
366 cd07829 STKc_CDK_like Catalyti 100.0 3.4E-34 7.3E-39 271.4 19.0 247 157-409 1-279 (282)
367 cd07830 STKc_MAK_like Catalyti 100.0 1E-33 2.3E-38 268.4 21.7 245 157-409 1-280 (283)
368 cd07880 STKc_p38gamma_MAPK12 C 100.0 6.7E-34 1.5E-38 277.4 20.4 243 156-408 16-297 (343)
369 cd07856 STKc_Sty1_Hog1 Catalyt 100.0 7.5E-34 1.6E-38 275.3 20.5 246 154-409 9-288 (328)
370 KOG1035 eIF-2alpha kinase GCN2 100.0 1.3E-34 2.7E-39 299.0 15.7 243 156-408 480-870 (1351)
371 cd07877 STKc_p38alpha_MAPK14 C 100.0 9.9E-34 2.2E-38 276.4 21.0 246 154-409 16-300 (345)
372 KOG0666 Cyclin C-dependent kin 100.0 3.7E-35 8E-40 262.7 9.8 249 156-409 25-337 (438)
373 cd07851 STKc_p38 Catalytic dom 100.0 2.7E-34 5.8E-39 280.3 16.6 245 155-409 15-298 (343)
374 cd07866 STKc_BUR1 Catalytic do 100.0 5.4E-34 1.2E-38 274.0 18.4 251 154-409 7-308 (311)
375 KOG1025 Epidermal growth facto 100.0 4.7E-34 1E-38 283.5 16.4 255 155-418 696-962 (1177)
376 cd07854 STKc_MAPK4_6 Catalytic 100.0 6.8E-34 1.5E-38 277.3 16.6 247 155-409 5-300 (342)
377 cd05576 STKc_RPK118_like Catal 100.0 1.4E-33 3.1E-38 260.6 17.9 215 166-403 4-223 (237)
378 KOG0695 Serine/threonine prote 100.0 4.1E-34 8.9E-39 258.3 12.1 240 156-402 251-503 (593)
379 KOG2052 Activin A type IB rece 100.0 2.7E-33 5.8E-38 262.0 17.5 256 154-416 210-506 (513)
380 KOG0587 Traf2- and Nck-interac 100.0 3.5E-33 7.7E-38 280.1 19.0 245 156-409 20-282 (953)
381 PLN00113 leucine-rich repeat r 100.0 9.7E-33 2.1E-37 304.2 24.0 246 156-417 691-955 (968)
382 KOG4250 TANK binding protein k 100.0 2E-33 4.3E-38 276.8 16.2 252 157-416 15-313 (732)
383 KOG3653 Transforming growth fa 100.0 7.5E-33 1.6E-37 260.8 18.8 256 156-418 211-508 (534)
384 KOG0671 LAMMER dual specificit 100.0 6.1E-34 1.3E-38 261.9 9.7 243 154-409 88-406 (415)
385 KOG1151 Tousled-like protein k 100.0 8.4E-34 1.8E-38 264.7 10.6 251 156-408 464-740 (775)
386 smart00220 S_TKc Serine/Threon 100.0 5.3E-32 1.1E-36 249.6 22.0 237 165-408 2-240 (244)
387 KOG0608 Warts/lats-like serine 100.0 7E-33 1.5E-37 268.3 13.6 240 157-401 631-917 (1034)
388 KOG0669 Cyclin T-dependent kin 100.0 3.5E-34 7.6E-39 249.5 3.8 250 155-409 17-315 (376)
389 KOG1027 Serine/threonine prote 100.0 2.3E-33 4.9E-38 280.2 6.8 240 157-409 511-767 (903)
390 KOG0984 Mitogen-activated prot 100.0 1.1E-31 2.5E-36 227.5 11.8 212 156-374 47-273 (282)
391 KOG0670 U4/U6-associated splic 100.0 7.7E-32 1.7E-36 256.0 9.6 243 156-409 433-746 (752)
392 PLN03224 probable serine/threo 100.0 7.1E-30 1.5E-34 256.1 21.9 250 153-409 143-500 (507)
393 PLN03225 Serine/threonine-prot 100.0 2.5E-30 5.3E-35 265.6 18.7 246 153-409 130-450 (566)
394 KOG0664 Nemo-like MAPK-related 100.0 3.4E-32 7.4E-37 239.7 3.1 250 156-410 54-344 (449)
395 KOG1024 Receptor-like protein 100.0 3.8E-30 8.2E-35 237.0 13.7 255 156-418 285-560 (563)
396 KOG0665 Jun-N-terminal kinase 100.0 2.3E-30 5E-35 233.2 10.5 247 154-409 16-310 (369)
397 KOG0668 Casein kinase II, alph 100.0 1.3E-29 2.8E-34 218.2 11.4 241 155-409 38-322 (338)
398 KOG0576 Mitogen-activated prot 100.0 1.9E-30 4E-35 253.3 4.7 246 156-408 16-270 (829)
399 cd00180 PKc Catalytic domain o 100.0 1.2E-27 2.6E-32 215.2 21.0 206 163-409 1-214 (215)
400 KOG1152 Signal transduction se 100.0 9.3E-29 2E-33 237.9 8.9 195 156-356 562-771 (772)
401 smart00221 STYKc Protein kinas 100.0 5.7E-27 1.2E-31 213.8 20.4 199 157-360 1-207 (225)
402 KOG1345 Serine/threonine kinas 100.0 3.2E-28 7E-33 214.5 9.7 252 145-408 12-283 (378)
403 smart00750 KIND kinase non-cat 99.9 1.2E-26 2.6E-31 204.1 17.1 165 235-416 1-172 (176)
404 KOG1290 Serine/threonine prote 99.9 2.2E-26 4.8E-31 217.8 17.9 129 152-287 75-222 (590)
405 PLN00181 protein SPA1-RELATED; 99.9 1.7E-27 3.7E-32 256.2 10.9 195 206-409 28-265 (793)
406 KOG1165 Casein kinase (serine/ 99.9 1.3E-25 2.7E-30 203.5 19.7 258 153-419 26-305 (449)
407 KOG1167 Serine/threonine prote 99.9 5.3E-26 1.2E-30 212.4 11.6 244 155-409 36-381 (418)
408 KOG1163 Casein kinase (serine/ 99.9 2.9E-24 6.2E-29 186.7 14.4 259 155-422 15-293 (341)
409 KOG1164 Casein kinase (serine/ 99.9 1.4E-23 3.1E-28 202.3 20.9 255 156-417 19-301 (322)
410 COG0515 SPS1 Serine/threonine 99.9 1E-21 2.2E-26 188.7 23.3 250 157-409 2-275 (384)
411 KOG0590 Checkpoint kinase and 99.9 2.3E-24 5E-29 220.9 4.9 246 159-408 322-584 (601)
412 PRK09188 serine/threonine prot 99.9 1.8E-22 3.9E-27 194.6 15.5 168 148-329 11-195 (365)
413 KOG4412 26S proteasome regulat 99.9 8E-23 1.7E-27 169.0 7.9 103 37-139 69-172 (226)
414 KOG1240 Protein kinase contain 99.9 6.4E-23 1.4E-27 210.8 6.0 244 156-409 24-291 (1431)
415 KOG4412 26S proteasome regulat 99.9 5.4E-22 1.2E-26 164.1 7.0 109 30-138 96-204 (226)
416 KOG0603 Ribosomal protein S6 k 99.9 1.3E-22 2.7E-27 199.1 3.4 222 163-403 2-232 (612)
417 PRK10359 lipopolysaccharide co 99.8 4.3E-21 9.4E-26 172.3 9.8 170 154-348 30-216 (232)
418 KOG1023 Natriuretic peptide re 99.8 3.3E-20 7.2E-25 182.1 13.6 212 204-418 1-229 (484)
419 cd05147 RIO1_euk RIO kinase fa 99.8 2.2E-20 4.7E-25 165.7 10.6 137 161-303 3-167 (190)
420 PF14531 Kinase-like: Kinase-l 99.8 1.1E-20 2.4E-25 174.8 7.1 231 154-400 11-288 (288)
421 PRK12274 serine/threonine prot 99.8 2.9E-19 6.3E-24 157.2 13.3 186 159-358 6-211 (218)
422 cd05145 RIO1_like RIO kinase f 99.8 4.8E-19 1E-23 157.6 13.9 139 160-304 2-168 (190)
423 KOG4158 BRPK/PTEN-induced prot 99.8 3.5E-19 7.7E-24 165.4 12.3 196 208-410 274-511 (598)
424 PRK10345 hypothetical protein; 99.8 4.9E-19 1.1E-23 158.6 12.4 135 156-300 3-156 (210)
425 KOG1166 Mitotic checkpoint ser 99.8 8.5E-19 1.8E-23 183.8 15.9 258 146-423 689-963 (974)
426 PHA02743 Viral ankyrin protein 99.8 2.5E-19 5.4E-24 155.5 9.7 107 30-136 47-158 (166)
427 PHA02859 ankyrin repeat protei 99.8 3.2E-19 7E-24 160.8 7.5 135 4-142 52-195 (209)
428 KOG0509 Ankyrin repeat and DHH 99.8 6.3E-19 1.4E-23 172.6 8.9 113 30-142 68-181 (600)
429 KOG0606 Microtubule-associated 99.8 9.8E-19 2.1E-23 180.1 10.4 225 136-404 64-307 (1205)
430 KOG0509 Ankyrin repeat and DHH 99.8 3E-19 6.4E-24 174.8 6.2 126 13-142 89-215 (600)
431 PF12796 Ank_2: Ankyrin repeat 99.8 2E-18 4.4E-23 133.7 9.7 88 44-135 1-88 (89)
432 PHA02791 ankyrin-like protein; 99.8 2.6E-18 5.6E-23 160.9 11.4 107 30-138 84-192 (284)
433 PHA02791 ankyrin-like protein; 99.7 5.8E-18 1.2E-22 158.5 11.0 100 34-135 24-123 (284)
434 PHA02741 hypothetical protein; 99.7 4.2E-18 9E-23 148.5 9.1 102 30-131 50-157 (169)
435 PHA02736 Viral ankyrin protein 99.7 1.1E-18 2.4E-23 149.8 4.9 100 34-133 49-153 (154)
436 PHA02741 hypothetical protein; 99.7 6.6E-18 1.4E-22 147.2 9.4 110 33-142 14-135 (169)
437 PRK14879 serine/threonine prot 99.7 1.1E-16 2.4E-21 144.9 17.6 134 161-302 2-143 (211)
438 PHA02795 ankyrin-like protein; 99.7 2.3E-18 4.9E-23 167.5 6.2 130 5-134 151-290 (437)
439 PHA02878 ankyrin repeat protei 99.7 1.1E-17 2.5E-22 170.2 11.2 108 29-136 156-265 (477)
440 PHA02859 ankyrin repeat protei 99.7 1.7E-17 3.6E-22 149.6 10.4 109 33-141 44-160 (209)
441 PHA02874 ankyrin repeat protei 99.7 1.7E-17 3.6E-22 167.0 11.4 107 30-136 114-220 (434)
442 KOG0508 Ankyrin repeat protein 99.7 3.4E-18 7.4E-23 160.9 5.7 104 30-133 107-210 (615)
443 KOG0512 Fetal globin-inducing 99.7 1.9E-17 4.2E-22 136.2 8.6 94 42-135 65-159 (228)
444 KOG0512 Fetal globin-inducing 99.7 1.5E-17 3.2E-22 136.9 7.7 95 33-127 90-185 (228)
445 PHA02875 ankyrin repeat protei 99.7 2.9E-17 6.3E-22 164.3 11.4 100 37-136 99-198 (413)
446 PLN03192 Voltage-dependent pot 99.7 2.7E-17 5.8E-22 177.3 11.5 111 29-139 547-688 (823)
447 PHA02743 Viral ankyrin protein 99.7 1.7E-17 3.6E-22 144.1 7.7 113 29-141 9-130 (166)
448 PHA02884 ankyrin repeat protei 99.7 4.5E-17 9.7E-22 152.5 11.1 99 43-141 36-139 (300)
449 PHA02946 ankyin-like protein; 99.7 3.9E-17 8.4E-22 163.7 11.0 112 29-141 61-175 (446)
450 KOG1033 eIF-2alpha kinase PEK/ 99.7 2.4E-18 5.3E-23 166.1 1.5 170 224-405 330-508 (516)
451 PHA02875 ankyrin repeat protei 99.7 5.8E-17 1.3E-21 162.2 10.7 107 29-135 124-231 (413)
452 PHA02716 CPXV016; CPX019; EVM0 99.7 4.4E-17 9.6E-22 169.0 10.0 107 31-137 203-350 (764)
453 PHA03095 ankyrin-like protein; 99.7 6.9E-17 1.5E-21 164.5 11.2 111 30-140 37-153 (471)
454 KOG0502 Integral membrane anky 99.7 5.1E-17 1.1E-21 138.7 8.1 104 34-137 154-257 (296)
455 PHA02878 ankyrin repeat protei 99.7 9.2E-17 2E-21 163.6 11.4 111 30-142 191-303 (477)
456 TIGR03724 arch_bud32 Kae1-asso 99.7 3.4E-16 7.4E-21 140.4 13.8 129 163-302 2-138 (199)
457 PHA02884 ankyrin repeat protei 99.7 9E-17 1.9E-21 150.5 10.0 112 14-126 45-157 (300)
458 PHA02798 ankyrin-like protein; 99.7 6.8E-17 1.5E-21 164.9 9.7 107 29-135 60-177 (489)
459 smart00090 RIO RIO-like kinase 99.7 2.1E-16 4.6E-21 145.0 11.8 141 157-304 30-199 (237)
460 PHA03095 ankyrin-like protein; 99.7 1.1E-16 2.4E-21 163.1 9.9 101 32-132 214-316 (471)
461 PHA03100 ankyrin repeat protei 99.7 1.5E-16 3.4E-21 162.3 10.4 101 36-136 137-247 (480)
462 PRK09605 bifunctional UGMP fam 99.7 1.2E-15 2.7E-20 157.0 15.8 134 157-302 335-476 (535)
463 PHA02716 CPXV016; CPX019; EVM0 99.7 2.4E-16 5.3E-21 163.5 10.3 109 31-139 167-317 (764)
464 PHA02798 ankyrin-like protein; 99.7 2.5E-16 5.5E-21 160.7 10.3 105 30-134 99-214 (489)
465 PHA03100 ankyrin repeat protei 99.7 2.9E-16 6.3E-21 160.3 10.3 95 39-133 105-203 (480)
466 KOG0590 Checkpoint kinase and 99.6 1.2E-17 2.7E-22 171.6 -0.7 251 154-408 19-285 (601)
467 PHA02874 ankyrin repeat protei 99.6 6.2E-16 1.3E-20 155.7 11.5 69 66-134 117-185 (434)
468 KOG4177 Ankyrin [Cell wall/mem 99.6 1.5E-16 3.3E-21 168.2 7.3 108 25-132 525-632 (1143)
469 PHA02876 ankyrin repeat protei 99.6 5.1E-16 1.1E-20 164.9 10.7 113 30-142 365-479 (682)
470 KOG0508 Ankyrin repeat protein 99.6 6.6E-16 1.4E-20 145.7 9.3 112 31-142 75-186 (615)
471 PRK01723 3-deoxy-D-manno-octul 99.6 4.4E-15 9.6E-20 136.5 14.1 138 157-302 37-191 (239)
472 cd05144 RIO2_C RIO kinase fami 99.6 1.9E-15 4.1E-20 135.4 11.2 135 157-304 17-176 (198)
473 KOG0510 Ankyrin repeat protein 99.6 5.3E-16 1.2E-20 155.2 8.1 99 34-132 267-367 (929)
474 PHA02730 ankyrin-like protein; 99.6 1E-15 2.2E-20 156.1 9.9 114 18-137 362-493 (672)
475 KOG4214 Myotrophin and similar 99.6 5.9E-16 1.3E-20 113.9 5.6 92 43-135 5-96 (117)
476 PHA02795 ankyrin-like protein; 99.6 1.1E-15 2.4E-20 148.8 9.1 121 15-142 131-257 (437)
477 PHA02736 Viral ankyrin protein 99.6 4.9E-16 1.1E-20 133.4 5.2 107 33-141 10-128 (154)
478 PHA02989 ankyrin repeat protei 99.6 1.9E-15 4.1E-20 154.5 10.2 107 29-135 97-214 (494)
479 PHA02989 ankyrin repeat protei 99.6 2.5E-15 5.4E-20 153.7 10.7 113 16-134 51-175 (494)
480 PHA02917 ankyrin-like protein; 99.6 2.4E-15 5.2E-20 156.8 10.7 108 29-136 21-168 (661)
481 KOG4214 Myotrophin and similar 99.6 7.6E-16 1.7E-20 113.4 4.8 85 28-113 23-107 (117)
482 KOG0510 Ankyrin repeat protein 99.6 2.3E-15 4.9E-20 150.8 8.8 118 22-144 293-415 (929)
483 KOG0514 Ankyrin repeat protein 99.6 7.9E-16 1.7E-20 140.8 4.8 107 36-142 264-410 (452)
484 PHA02946 ankyin-like protein; 99.6 3.9E-15 8.4E-20 149.3 9.9 112 30-142 95-211 (446)
485 PF13857 Ank_5: Ankyrin repeat 99.6 8.7E-16 1.9E-20 107.2 3.5 55 59-113 1-56 (56)
486 PF12796 Ank_2: Ankyrin repeat 99.6 5.7E-15 1.2E-19 114.2 7.8 64 40-103 26-89 (89)
487 PHA02876 ankyrin repeat protei 99.6 7E-15 1.5E-19 156.3 11.0 106 31-136 298-405 (682)
488 PHA02917 ankyrin-like protein; 99.6 6.2E-15 1.3E-19 153.7 10.3 104 30-133 386-513 (661)
489 PHA02730 ankyrin-like protein; 99.6 8.8E-15 1.9E-19 149.3 9.5 100 35-134 36-145 (672)
490 PF13637 Ank_4: Ankyrin repeat 99.6 6.6E-15 1.4E-19 102.1 6.0 54 40-93 1-54 (54)
491 KOG0514 Ankyrin repeat protein 99.6 6.3E-15 1.4E-19 134.9 7.4 90 39-128 339-429 (452)
492 cd05119 RIO RIO kinase family, 99.5 3.3E-14 7.2E-19 126.1 11.4 134 161-304 3-165 (187)
493 PHA02792 ankyrin-like protein; 99.5 6.9E-15 1.5E-19 148.5 7.0 113 17-132 354-479 (631)
494 PLN03192 Voltage-dependent pot 99.5 2E-14 4.2E-19 155.2 10.9 96 37-132 522-617 (823)
495 cd00204 ANK ankyrin repeats; 99.5 4.6E-14 9.9E-19 115.8 10.5 101 36-136 3-103 (126)
496 PTZ00322 6-phosphofructo-2-kin 99.5 4.4E-14 9.6E-19 148.2 11.9 96 42-137 84-186 (664)
497 cd05120 APH_ChoK_like Aminogly 99.5 1.1E-13 2.4E-18 117.7 11.7 131 160-302 3-138 (155)
498 KOG0195 Integrin-linked kinase 99.5 2.7E-14 5.9E-19 126.9 7.7 111 21-136 53-163 (448)
499 KOG4177 Ankyrin [Cell wall/mem 99.5 2.4E-14 5.3E-19 151.7 8.8 107 37-143 504-610 (1143)
500 KOG0505 Myosin phosphatase, re 99.5 2.2E-14 4.7E-19 138.0 6.3 114 29-142 95-267 (527)
No 1
>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]
Probab=100.00 E-value=4.9e-50 Score=388.29 Aligned_cols=259 Identities=27% Similarity=0.474 Sum_probs=233.6
Q ss_pred CCCCCcccCCCCcCcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeE
Q 013214 143 REVPEYEIDPHELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLG 217 (447)
Q Consensus 143 ~~~~~~~i~~~~~~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~ 217 (447)
..+|..-.++....|...+.||+|||..+| .+|+.||+|++++..+....+.+...+|+++.+.++|||||++++
T Consensus 6 ~~ip~~i~D~~~~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~ 85 (592)
T KOG0575|consen 6 PEIPEVIEDPRSKRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYH 85 (592)
T ss_pred CCCCCeeecCCcceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeee
Confidence 356666667777889999999999998876 479999999999888888888899999999999999999999999
Q ss_pred EEEeCCceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeec
Q 013214 218 AVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297 (447)
Q Consensus 218 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Df 297 (447)
+|++.+.+|++.|+|..++|..+++++++++|.++..++.||+.||.|||+++ |+|||||..|+|++++.+|||+||
T Consensus 86 ~FEDs~nVYivLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDF 162 (592)
T KOG0575|consen 86 FFEDSNNVYIVLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDF 162 (592)
T ss_pred EeecCCceEEEEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEeccc
Confidence 99999999999999999999999999999999999999999999999999999 999999999999999999999999
Q ss_pred ccccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCC
Q 013214 298 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAP 377 (447)
Q Consensus 298 g~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 377 (447)
|+|..+.....+ ....+|||.|.|||++....++..+||||+||+||.|+.|++||...+-.+....+.... ..+
T Consensus 163 GLAt~le~~~Er-k~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~-Y~~--- 237 (592)
T KOG0575|consen 163 GLATQLEYDGER-KKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNE-YSM--- 237 (592)
T ss_pred ceeeeecCcccc-cceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcC-ccc---
Confidence 999988755333 345789999999999999999999999999999999999999999998888877774444 222
Q ss_pred hhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 378 AKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 378 ~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
|...|.+.++||.++|+.||.+|||+++++.+
T Consensus 238 P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 238 PSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred ccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 33678999999999999999999999999975
No 2
>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]
Probab=100.00 E-value=5.5e-49 Score=378.18 Aligned_cols=269 Identities=43% Similarity=0.748 Sum_probs=231.8
Q ss_pred CCCCCcccCCCCcCcccceeeecceEEEEE---EcCeE-EEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEE
Q 013214 143 REVPEYEIDPHELDFTNSVEITKGTFILAF---WRGIQ-VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGA 218 (447)
Q Consensus 143 ~~~~~~~i~~~~~~~~~~~~lg~G~~~~~~---~~g~~-vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 218 (447)
...+.+++++..+.+.. .+|.|+||.|+ |.|+. ||+|++......... .+.|.+|+.+|.+++|||||+++|+
T Consensus 31 ~~~~~~~i~~~~l~~~~--~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~HpNIV~f~G~ 107 (362)
T KOG0192|consen 31 DELPEEEIDPDELPIEE--VLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDES-RKAFRREASLLSRLRHPNIVQFYGA 107 (362)
T ss_pred ccccceecChHHhhhhh--hcccCCceeEEEEEeCCceeEEEEEecchhcChHH-HHHHHHHHHHHHhCCCCCeeeEEEE
Confidence 34456677776655544 49999999876 88999 999999876655444 7899999999999999999999999
Q ss_pred EEeCC-ceEEEEeccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCC-CEEE
Q 013214 219 VTQSS-PMMIVTEYLPKGDLRAFLKR--KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG-NLKV 294 (447)
Q Consensus 219 ~~~~~-~~~lv~e~~~~g~L~~~l~~--~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~-~vkl 294 (447)
+.++. .+++||||+++|+|.+++.+ .+.++...+..++.||+.||.|||+.++ ||||||||+|||++.++ ++||
T Consensus 108 ~~~~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI 185 (362)
T KOG0192|consen 108 CTSPPGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKI 185 (362)
T ss_pred EcCCCCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEE
Confidence 99887 79999999999999999988 5779999999999999999999999985 99999999999999997 9999
Q ss_pred eecccccccccCCCCCcccCCCCCcccCCcccC--CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcC-C
Q 013214 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFK--NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-R 371 (447)
Q Consensus 295 ~Dfg~~~~~~~~~~~~~~~~~~t~~y~aPE~~~--~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~-~ 371 (447)
+|||+++...... ...+...||+.|||||++. ...++.|+||||||+++|||+||+.||.+....+....+.... +
T Consensus 186 ~DFGlsr~~~~~~-~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~R 264 (362)
T KOG0192|consen 186 ADFGLSREKVISK-TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLR 264 (362)
T ss_pred CCCccceeecccc-ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCC
Confidence 9999998765432 2334467899999999999 5689999999999999999999999999999866666664444 6
Q ss_pred CCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhhcc
Q 013214 372 PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINHK 420 (447)
Q Consensus 372 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~~~~~ 420 (447)
+.++. .+++.+..+|++||..||.+||++.+++..|+.+.+.+...
T Consensus 265 p~~p~---~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~~ 310 (362)
T KOG0192|consen 265 PPIPK---ECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISSA 310 (362)
T ss_pred CCCCc---cCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhccc
Confidence 66543 37789999999999999999999999999999998877543
No 3
>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]
Probab=100.00 E-value=4.5e-50 Score=370.94 Aligned_cols=249 Identities=24% Similarity=0.375 Sum_probs=216.8
Q ss_pred CcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHH----HHHHHHHHHHHHhcCCCCcccceeEEEEeCCceE
Q 013214 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDD----RVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM 226 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~----~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 226 (447)
.|...+.||+|+||.|. .+|+.||||++.+....... ......+|+++|++++|||||+++++|...+..|
T Consensus 173 ~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~Y 252 (475)
T KOG0615|consen 173 YYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSSY 252 (475)
T ss_pred eeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCceE
Confidence 57778899999999885 58999999999875543322 2344679999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCC---CCEEEeeccccccc
Q 013214 227 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS---GNLKVADFGVSKLL 303 (447)
Q Consensus 227 lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~---~~vkl~Dfg~~~~~ 303 (447)
+||||++||+|.+.+-.++.+.+..-..++.|++.|+.|||++| |+||||||+|||+..+ ..+||+|||+|+..
T Consensus 253 mVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDFGlAK~~ 329 (475)
T KOG0615|consen 253 MVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDFGLAKVS 329 (475)
T ss_pred EEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEecccchhhcc
Confidence 99999999999999999999999999999999999999999999 9999999999999876 67999999999987
Q ss_pred ccCCCCCcccCCCCCcccCCcccCCCCCC---CchhHHHHHHHHHHHHhCCCCCCCCCCCc-hHHHHHhcCCCCCCCChh
Q 013214 304 TVKEDRPLTCQDTSCRYVAPEVFKNEEYD---TKVDVFSFALILQEMIEGCPPFTMKHDNE-VPKAYAARQRPPFKAPAK 379 (447)
Q Consensus 304 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~---~~~Di~slG~~l~~l~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~ 379 (447)
+. .......+|||.|.|||++.+..+. .++|+||+||++|-+++|.+||....... ..+++..+...-.+..+.
T Consensus 330 g~--~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w~ 407 (475)
T KOG0615|consen 330 GE--GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQWD 407 (475)
T ss_pred cc--ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhhh
Confidence 63 3445678899999999999876433 47899999999999999999999888776 667774444444456788
Q ss_pred hhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 380 LYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 380 ~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
.++++..+||.+||..||++|||+.|++++
T Consensus 408 ~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 408 RISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred hhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 899999999999999999999999999976
No 4
>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]
Probab=100.00 E-value=2.7e-49 Score=363.21 Aligned_cols=244 Identities=28% Similarity=0.464 Sum_probs=212.7
Q ss_pred CcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCc-eEEEE
Q 013214 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP-MMIVT 229 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~-~~lv~ 229 (447)
+++....||+|.-|.|+ .+++.+|+|.+... .+....+++.+|+++++..+||+||++||.|.++.. +.++|
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~--~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~m 157 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN--IDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICM 157 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc--CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeeh
Confidence 45556789999999886 47999999999544 466777889999999999999999999999999995 99999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 013214 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHE-NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (447)
Q Consensus 230 e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~-~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~ 308 (447)
|||++|+|.++++..+++++....+++.++++||.|||. ++ |+||||||+|||++..|.|||||||.+..+...
T Consensus 158 EYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS-- 232 (364)
T KOG0581|consen 158 EYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS-- 232 (364)
T ss_pred hhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccHHhhhh--
Confidence 999999999999998999999999999999999999996 66 999999999999999999999999999876543
Q ss_pred CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC-----CCCchHHHHHhcCCCCCCCChhhhHH
Q 013214 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMK-----HDNEVPKAYAARQRPPFKAPAKLYAR 383 (447)
Q Consensus 309 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (447)
.-.++.||..|||||.+.+..|+.++||||||++++|+.+|+.||... ...++...+..+..|.++.. .+|+
T Consensus 233 -~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~--~fS~ 309 (364)
T KOG0581|consen 233 -IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEG--EFSP 309 (364)
T ss_pred -hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcc--cCCH
Confidence 335677999999999999999999999999999999999999999875 22334445544444444322 4899
Q ss_pred HHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 384 GLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 384 ~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
+++.+|..||++||.+|||+.++++|
T Consensus 310 ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 310 EFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred HHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 99999999999999999999999986
No 5
>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]
Probab=100.00 E-value=2.6e-49 Score=347.52 Aligned_cols=369 Identities=29% Similarity=0.436 Sum_probs=300.8
Q ss_pred CCCCCccchhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCCCCCCccc
Q 013214 32 DDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLG 111 (447)
Q Consensus 32 d~~~~~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tpl~ 111 (447)
|.|.-|--|-+|||+||..|+..+++.|++.|+.+|..|.-..||||+|+..||.++|+.|++..+|+|+.|..|+||||
T Consensus 26 dln~gddhgfsplhwaakegh~aivemll~rgarvn~tnmgddtplhlaaahghrdivqkll~~kadvnavnehgntplh 105 (448)
T KOG0195|consen 26 DLNVGDDHGFSPLHWAAKEGHVAIVEMLLSRGARVNSTNMGDDTPLHLAAAHGHRDIVQKLLSRKADVNAVNEHGNTPLH 105 (448)
T ss_pred ccccccccCcchhhhhhhcccHHHHHHHHhcccccccccCCCCcchhhhhhcccHHHHHHHHHHhcccchhhccCCCchh
Confidence 33333444667799999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccccchHHHHHHHHHhCCCCCCCccc-----------------------ccccCCCCCc--------------------
Q 013214 112 DAIYYKNHEVIKLLEKHGAKPLMAPMH-----------------------VKHAREVPEY-------------------- 148 (447)
Q Consensus 112 ~a~~~~~~~~~~~L~~~~a~~~~~~~~-----------------------~~~~~~~~~~-------------------- 148 (447)
|||.+|...+++-|+..|+.+++-+.. +.++..+|.-
T Consensus 106 yacfwgydqiaedli~~ga~v~icnk~g~tpldkakp~l~~~l~e~aek~gq~~nripfkdt~wkgtktr~rdatlsr~~ 185 (448)
T KOG0195|consen 106 YACFWGYDQIAEDLISCGAAVNICNKKGMTPLDKAKPMLKNTLLEIAEKHGQSPNRIPFKDTTWKGTKTRTRDATLSRYT 185 (448)
T ss_pred hhhhhcHHHHHHHHHhccceeeecccCCCCchhhhchHHHHHHHHHHHHhCCCCCccccccccccccccccccccccccc
Confidence 999999999999999999987654432 2233333311
Q ss_pred ccCCCCcCccc-ceeeecceEEEEEEcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEE
Q 013214 149 EIDPHELDFTN-SVEITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227 (447)
Q Consensus 149 ~i~~~~~~~~~-~~~lg~G~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 227 (447)
.|+..++++.. ..+-.+|..+.+.|+|.++++|++..... ....-++|.+|.-.|+-+.||||+.+++.|.+...+.+
T Consensus 186 gid~~~lnl~tkl~e~hsgelwrgrwqgndivakil~vr~~-t~risrdfneefp~lrifshpnilpvlgacnsppnlv~ 264 (448)
T KOG0195|consen 186 GIDVSSLNLITKLAESHSGELWRGRWQGNDIVAKILNVREV-TARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVI 264 (448)
T ss_pred CcchhhhhhhhhhccCCCcccccccccCcchhhhhhhhhhc-chhhcchhhhhCcceeeecCCchhhhhhhccCCCCceE
Confidence 12222222211 11224688889999999999999976543 33344779999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCCCCeEe-CCCCCCCEEEcCCCCEEEe--ecccccc
Q 013214 228 VTEYLPKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPIIH-RDLEPSNILRDDSGNLKVA--DFGVSKL 302 (447)
Q Consensus 228 v~e~~~~g~L~~~l~~~~~--l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H-~Dikp~Nill~~~~~vkl~--Dfg~~~~ 302 (447)
+..||+.|+|+..+++... .+..++.+++.+++.|+.|||+..+ ++- --+.+..+++|++.+.+|+ |--++..
T Consensus 265 isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep--~ipr~~lns~hvmidedltarismad~kfsfq 342 (448)
T KOG0195|consen 265 ISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEP--MIPRFYLNSKHVMIDEDLTARISMADTKFSFQ 342 (448)
T ss_pred eeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcch--hhhhhhcccceEEecchhhhheecccceeeee
Confidence 9999999999999997654 6788999999999999999999884 444 4688999999998876654 4333321
Q ss_pred cccCCCCCcccCCCCCcccCCcccCCCCCC---CchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcC-CCCCCCCh
Q 013214 303 LTVKEDRPLTCQDTSCRYVAPEVFKNEEYD---TKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RPPFKAPA 378 (447)
Q Consensus 303 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~---~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~ 378 (447)
. ......|.||+||.+...+.+ ..+|+|||++++|||.|.+.||.+..+.+....+..++ ++.+ +
T Consensus 343 e--------~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~i---p 411 (448)
T KOG0195|consen 343 E--------VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHI---P 411 (448)
T ss_pred c--------cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccC---C
Confidence 1 122346889999999776443 47999999999999999999999999999888876666 5554 5
Q ss_pred hhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHH
Q 013214 379 KLYARGLKELIEECWNEKPAKRPTFRQIITRLESIN 414 (447)
Q Consensus 379 ~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~ 414 (447)
+..+..+.++|.-|+..||.+||.+..++..|+++.
T Consensus 412 pgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 412 PGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred CCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 678899999999999999999999999999999864
No 6
>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]
Probab=100.00 E-value=6.1e-50 Score=352.98 Aligned_cols=249 Identities=27% Similarity=0.468 Sum_probs=215.4
Q ss_pred CcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeE-EEEeCCc-eEEE
Q 013214 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLG-AVTQSSP-MMIV 228 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~-~~~~~~~-~~lv 228 (447)
+|++.++||+|+||.++ ++|..+|.|.+.-+. .+....++...|+.+|++++||||+++++ .+..+.. ++|+
T Consensus 20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~-md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGM-MDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhh-ccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 68888999999999886 689999999998554 46677788999999999999999999998 4554444 8999
Q ss_pred EeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCC-CeEeCCCCCCCEEEcCCCCEEEeeccccccc
Q 013214 229 TEYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPV-PIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (447)
Q Consensus 229 ~e~~~~g~L~~~l~~----~~~l~~~~~~~i~~ql~~~l~~lH~~~~~-~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~ 303 (447)
||||++|+|..+++. ...+++.++|+++.|++.||.+||+.-++ .|+||||||.||+++.+|.+||+|||+++++
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 999999999999863 34599999999999999999999994432 4899999999999999999999999999987
Q ss_pred ccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHH
Q 013214 304 TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYAR 383 (447)
Q Consensus 304 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (447)
.... ....+..|||.||+||.+.+.+|+.++||||+||++|||+.-++||.+.+..++...+.....++++ ...||.
T Consensus 179 ~s~~-tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p--~~~YS~ 255 (375)
T KOG0591|consen 179 SSKT-TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLP--DEHYST 255 (375)
T ss_pred cchh-HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCc--HHHhhh
Confidence 7542 3345678999999999999999999999999999999999999999999888888888666555542 367999
Q ss_pred HHHHHHHHHcccCCCCCCCHHHHHH
Q 013214 384 GLKELIEECWNEKPAKRPTFRQIIT 408 (447)
Q Consensus 384 ~l~~li~~cl~~dp~~Rps~~~~l~ 408 (447)
.+..+|..|+..||+.||+...++.
T Consensus 256 ~l~~li~~ci~vd~~~RP~t~~~v~ 280 (375)
T KOG0591|consen 256 DLRELINMCIAVDPEQRPDTVPYVQ 280 (375)
T ss_pred HHHHHHHHHccCCcccCCCcchHHH
Confidence 9999999999999999999744444
No 7
>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]
Probab=100.00 E-value=5.3e-48 Score=357.64 Aligned_cols=247 Identities=31% Similarity=0.536 Sum_probs=215.6
Q ss_pred cCcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEE
Q 013214 155 LDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 229 (447)
-+|...++||+|+|++|| .++..||||.+.+... ..+..+.+..|+.+|+.++|||||++++++..++.+|+||
T Consensus 10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l-~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL-NKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc-CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 367777889999999887 4789999999987654 5667788899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCC------CCEEEeeccccccc
Q 013214 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS------GNLKVADFGVSKLL 303 (447)
Q Consensus 230 e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~------~~vkl~Dfg~~~~~ 303 (447)
|||+||+|.+|+++.+.+++.++..++.||+.||++||+++ |+||||||+|||++.. -.+||+|||+|+.+
T Consensus 89 EyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L 165 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFL 165 (429)
T ss_pred EeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchhhhC
Confidence 99999999999999999999999999999999999999999 9999999999999865 45899999999987
Q ss_pred ccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHH
Q 013214 304 TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYAR 383 (447)
Q Consensus 304 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (447)
... ......+|++.|||||++..++|+.|+|+||+|+++|++++|+.||...+..++...+.... ...+..+...+.
T Consensus 166 ~~~--~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~-~~~~~~~~~~s~ 242 (429)
T KOG0595|consen 166 QPG--SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGN-EIVPVLPAELSN 242 (429)
T ss_pred Cch--hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccc-cccCchhhhccC
Confidence 633 33355789999999999999999999999999999999999999999999988887663333 333334555667
Q ss_pred HHHHHHHHHcccCCCCCCCHHHHHH
Q 013214 384 GLKELIEECWNEKPAKRPTFRQIIT 408 (447)
Q Consensus 384 ~l~~li~~cl~~dp~~Rps~~~~l~ 408 (447)
.+.+++...++.+|.+|.++.+...
T Consensus 243 ~~~~Ll~~ll~~~~~~~~~~~~~~~ 267 (429)
T KOG0595|consen 243 PLRELLISLLQRNPKDRISFEDFFD 267 (429)
T ss_pred chhhhhhHHHhcCccccCchHHhhh
Confidence 7889999999999999988876554
No 8
>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]
Probab=100.00 E-value=4.8e-48 Score=354.86 Aligned_cols=240 Identities=30% Similarity=0.483 Sum_probs=216.3
Q ss_pred CcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|+..+.||+|+||.|+ .+++.+|+|++++..+...+..+....|..+|..++||+||+++-.|++...+|+|+|
T Consensus 26 dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld 105 (357)
T KOG0598|consen 26 DFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLD 105 (357)
T ss_pred heeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEe
Confidence 68888999999999886 4789999999998887777778889999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCC
Q 013214 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (447)
Q Consensus 231 ~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~ 310 (447)
|+.||.|..+|++.+.+++..+..++.+|+.||.|||+.| |+||||||+|||+|.+|+++|+|||+++..-.. ...
T Consensus 106 ~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~-~~~ 181 (357)
T KOG0598|consen 106 YLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLKD-GDA 181 (357)
T ss_pred ccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhcccC-CCc
Confidence 9999999999999999999999999999999999999999 999999999999999999999999999854332 234
Q ss_pred cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHHH
Q 013214 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIE 390 (447)
Q Consensus 311 ~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 390 (447)
....+||+.|||||++.+..|+..+|+||||+++|+|++|.+||...+..+..+.+.....+. .+..++.+.+++++
T Consensus 182 t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~---~p~~ls~~ardll~ 258 (357)
T KOG0598|consen 182 TRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPL---PPGYLSEEARDLLK 258 (357)
T ss_pred cccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCC---CCccCCHHHHHHHH
Confidence 455789999999999999999999999999999999999999999999888877775444233 24447889999999
Q ss_pred HHcccCCCCCCC
Q 013214 391 ECWNEKPAKRPT 402 (447)
Q Consensus 391 ~cl~~dp~~Rps 402 (447)
++|..||++|..
T Consensus 259 ~LL~rdp~~RLg 270 (357)
T KOG0598|consen 259 KLLKRDPRQRLG 270 (357)
T ss_pred HHhccCHHHhcC
Confidence 999999999963
No 9
>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]
Probab=100.00 E-value=2.5e-47 Score=365.78 Aligned_cols=259 Identities=34% Similarity=0.581 Sum_probs=227.2
Q ss_pred CcccCCCCcCcccceeeecceEEEE---EEcCe-EEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeC
Q 013214 147 EYEIDPHELDFTNSVEITKGTFILA---FWRGI-QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS 222 (447)
Q Consensus 147 ~~~i~~~~~~~~~~~~lg~G~~~~~---~~~g~-~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 222 (447)
.+++++.. ++..+.||+|.||.| .|+|. +||+|.++.....+ ++|.+|+++|++++|++||+++++|..+
T Consensus 200 ~wei~r~~--l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~----~~f~~Ea~iMk~L~H~~lV~l~gV~~~~ 273 (468)
T KOG0197|consen 200 PWEIPREE--LKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSP----EAFLREAQIMKKLRHEKLVKLYGVCTKQ 273 (468)
T ss_pred CeeecHHH--HHHHHHhcCCccceEEEEEEcCCCcccceEEeccccCh----hHHHHHHHHHHhCcccCeEEEEEEEecC
Confidence 44555544 344568999999976 47877 99999998654333 5678999999999999999999999999
Q ss_pred CceEEEEeccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccc
Q 013214 223 SPMMIVTEYLPKGDLRAFLKR--KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS 300 (447)
Q Consensus 223 ~~~~lv~e~~~~g~L~~~l~~--~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~ 300 (447)
+.++||||||+.|+|.++|+. ...+...+.+.++.|||+|++||++++ +|||||..+|||++++..+||+|||++
T Consensus 274 ~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLA 350 (468)
T KOG0197|consen 274 EPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLA 350 (468)
T ss_pred CceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccc
Confidence 899999999999999999987 455899999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCCCCChh
Q 013214 301 KLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAK 379 (447)
Q Consensus 301 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (447)
+...............+..|.|||.+..+.++.++||||||++||||+| |+.||..++..++.+.+..+.+.+- |.
T Consensus 351 r~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~---P~ 427 (468)
T KOG0197|consen 351 RLIGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPR---PE 427 (468)
T ss_pred cccCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCC---CC
Confidence 9655444444455566888999999999999999999999999999999 9999999999999999988887775 45
Q ss_pred hhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhh
Q 013214 380 LYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSI 417 (447)
Q Consensus 380 ~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~~ 417 (447)
.+|+++.++|..||..+|++|||+..+...++++.+.-
T Consensus 428 ~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~ 465 (468)
T KOG0197|consen 428 GCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTST 465 (468)
T ss_pred CCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhcc
Confidence 68899999999999999999999999999999887643
No 10
>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]
Probab=100.00 E-value=2.8e-45 Score=325.87 Aligned_cols=235 Identities=27% Similarity=0.498 Sum_probs=214.4
Q ss_pred cCcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEE
Q 013214 155 LDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 229 (447)
.+|...+-||.|+||+|. .+|..+|+|++.+..+...++.+...+|..+|+.+.||+++++++.+.+.+.+++||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 367788899999999874 478999999999888778888899999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 013214 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (447)
Q Consensus 230 e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~ 309 (447)
||++||.|.+++++.+++++..++.++.|++.|++|||+.+ |++||+||+|||+|.+|.+||+|||+|+....
T Consensus 124 eyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~---- 196 (355)
T KOG0616|consen 124 EYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSG---- 196 (355)
T ss_pred eccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecC----
Confidence 99999999999999999999999999999999999999999 99999999999999999999999999987652
Q ss_pred CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHH
Q 013214 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELI 389 (447)
Q Consensus 310 ~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 389 (447)
.....+|||.|+|||++.+.+++.++|+||||+++|||+.|.+||...+...+.+.+. .+...+ |+..++.+++|+
T Consensus 197 rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~-~~~v~f---P~~fs~~~kdLl 272 (355)
T KOG0616|consen 197 RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKIL-EGKVKF---PSYFSSDAKDLL 272 (355)
T ss_pred cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHH-hCcccC---CcccCHHHHHHH
Confidence 2345789999999999999999999999999999999999999999999987777773 333443 345788999999
Q ss_pred HHHcccCCCCC
Q 013214 390 EECWNEKPAKR 400 (447)
Q Consensus 390 ~~cl~~dp~~R 400 (447)
+++|+.|-.+|
T Consensus 273 ~~LL~vD~t~R 283 (355)
T KOG0616|consen 273 KKLLQVDLTKR 283 (355)
T ss_pred HHHHhhhhHhh
Confidence 99999999999
No 11
>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]
Probab=100.00 E-value=3.3e-45 Score=349.28 Aligned_cols=248 Identities=28% Similarity=0.496 Sum_probs=219.6
Q ss_pred cCcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeEEEEeCCceEEE
Q 013214 155 LDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIV 228 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv 228 (447)
.+|..++.||+|+|.+|+ .++..+|||++.+..+..+..+.....|-..|.++ .||.|+++|-.|.++..+|+|
T Consensus 73 ~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFv 152 (604)
T KOG0592|consen 73 NDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFV 152 (604)
T ss_pred hhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEE
Confidence 378888999999999886 47899999999888777766677788899999999 899999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 013214 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (447)
Q Consensus 229 ~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~ 308 (447)
+||+++|+|.+++++-+.+++..+..++.+|+.||+|||++| ||||||||+|||+|++|++||+|||.++.++....
T Consensus 153 Le~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~ 229 (604)
T KOG0592|consen 153 LEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKILSPSQK 229 (604)
T ss_pred EEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccccCChhhc
Confidence 999999999999999999999999999999999999999999 99999999999999999999999999987754321
Q ss_pred C----------Cc--ccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCC
Q 013214 309 R----------PL--TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKA 376 (447)
Q Consensus 309 ~----------~~--~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 376 (447)
. .. .++.||..|.+||++.....++.+|+|+|||++|+|+.|.+||.+.+.--+.+.+... ...|
T Consensus 230 ~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l-~y~f-- 306 (604)
T KOG0592|consen 230 SQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQAL-DYEF-- 306 (604)
T ss_pred cccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHh-cccC--
Confidence 1 11 4478999999999999999999999999999999999999999998887776666332 2333
Q ss_pred ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 377 PAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 377 ~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
++..++.+.+||+++|..||.+|++.++|.+|
T Consensus 307 -p~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 307 -PEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred -CCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 34567899999999999999999999888775
No 12
>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]
Probab=100.00 E-value=8.9e-45 Score=338.86 Aligned_cols=255 Identities=27% Similarity=0.499 Sum_probs=208.1
Q ss_pred CcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCC--ceE
Q 013214 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS--PMM 226 (447)
Q Consensus 154 ~~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~--~~~ 226 (447)
..++...+.||+|+||.|+. +|+..|||.+.... .. ..+.+.+|+.+|++++|||||+++|...... .++
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~--~~-~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~ 92 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELED--SP-TSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYN 92 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeeccc--ch-hHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeE
Confidence 44677788999999999872 47899999887652 11 2677899999999999999999999754444 689
Q ss_pred EEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcC-CCCEEEeecccccccc
Q 013214 227 IVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD-SGNLKVADFGVSKLLT 304 (447)
Q Consensus 227 lv~e~~~~g~L~~~l~~~~-~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~-~~~vkl~Dfg~~~~~~ 304 (447)
+.|||+++|+|.+++.+.+ ++++..+..+..|+++||.|||++| ++||||||+|||++. ++.+||+|||++....
T Consensus 93 i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~ 169 (313)
T KOG0198|consen 93 IFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLE 169 (313)
T ss_pred eeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCccccccc
Confidence 9999999999999999876 7999999999999999999999999 999999999999999 7999999999988665
Q ss_pred c--CCCCCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCC-CCCchHHHHHhcCCCCCCCChhh
Q 013214 305 V--KEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMK-HDNEVPKAYAARQRPPFKAPAKL 380 (447)
Q Consensus 305 ~--~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 380 (447)
. ..........||+.|||||++..+ ...+.+|||||||++.||+||+.||... ...+....+.... ..+..+..
T Consensus 170 ~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~--~~P~ip~~ 247 (313)
T KOG0198|consen 170 SKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGRED--SLPEIPDS 247 (313)
T ss_pred cccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccC--CCCCCCcc
Confidence 3 112223456789999999999853 3345999999999999999999999974 2222222222222 23345667
Q ss_pred hHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhh
Q 013214 381 YARGLKELIEECWNEKPAKRPTFRQIITRLESINNS 416 (447)
Q Consensus 381 ~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~ 416 (447)
+|.+.++++.+|+..||++|||+.+++++--.-.+.
T Consensus 248 ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~ 283 (313)
T KOG0198|consen 248 LSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNS 283 (313)
T ss_pred cCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhccc
Confidence 899999999999999999999999999886554433
No 13
>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]
Probab=100.00 E-value=9.3e-45 Score=353.08 Aligned_cols=244 Identities=27% Similarity=0.428 Sum_probs=214.9
Q ss_pred cccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEec
Q 013214 157 FTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (447)
Q Consensus 157 ~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 231 (447)
|+.++-||.|+.|.|. .+|+.+|||++.+...........+.+|+-+|+.+.|||++++|++++...++|+|.||
T Consensus 14 wkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEy 93 (786)
T KOG0588|consen 14 WKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEY 93 (786)
T ss_pred eeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEe
Confidence 4455679999999875 58999999999876444555667789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCCc
Q 013214 232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPL 311 (447)
Q Consensus 232 ~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~ 311 (447)
++||.|.+++.+.+++++.++.++++||+.|+.|||..+ |+|||+||+|+|++..++|||+|||+|.... +....
T Consensus 94 v~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~--~gklL 168 (786)
T KOG0588|consen 94 VPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEV--PGKLL 168 (786)
T ss_pred cCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeeccc--CCccc
Confidence 999999999999999999999999999999999999999 9999999999999999999999999998643 33455
Q ss_pred ccCCCCCcccCCcccCCCCCC-CchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHHH
Q 013214 312 TCQDTSCRYVAPEVFKNEEYD-TKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIE 390 (447)
Q Consensus 312 ~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 390 (447)
...+|+|.|.|||++.+.+|. .++||||.|++||.|++|+.||++.+...+...+..+. |.. +..+|.++++||+
T Consensus 169 eTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~---f~M-Ps~Is~eaQdLLr 244 (786)
T KOG0588|consen 169 ETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGV---FEM-PSNISSEAQDLLR 244 (786)
T ss_pred cccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCc---ccC-CCcCCHHHHHHHH
Confidence 667899999999999999887 58999999999999999999999776665555553333 222 3568899999999
Q ss_pred HHcccCCCCCCCHHHHHHH
Q 013214 391 ECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 391 ~cl~~dp~~Rps~~~~l~~ 409 (447)
+|+.+||.+|.|+.+|++|
T Consensus 245 ~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 245 RMLDVDPSTRITTEEILKH 263 (786)
T ss_pred HHhccCccccccHHHHhhC
Confidence 9999999999999999987
No 14
>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=7.5e-44 Score=345.70 Aligned_cols=253 Identities=28% Similarity=0.458 Sum_probs=215.0
Q ss_pred CcCcccceeeecceEEEEE-----EcCeEEEEEEcCcccCC-C-HHHHHHHHHHHHHHhcCC-CCcccceeEEEEeCCce
Q 013214 154 ELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVIS-D-DDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPM 225 (447)
Q Consensus 154 ~~~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~-~-~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~ 225 (447)
...|...+.||+|+||.|+ .+|+.||+|++...... . ....+.+.+|+.+++++. ||||+++++++.....+
T Consensus 16 ~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~ 95 (370)
T KOG0583|consen 16 IGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKI 95 (370)
T ss_pred cCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeE
Confidence 3478888999999999986 36899999987664222 1 134456678999999998 99999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCC-CCEEEeecccccccc
Q 013214 226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS-GNLKVADFGVSKLLT 304 (447)
Q Consensus 226 ~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~-~~vkl~Dfg~~~~~~ 304 (447)
++||||+.||+|.+++.+.+++.+..+..+++|+++|++|||++| |+||||||+|+|++.+ +++||+|||++....
T Consensus 96 ~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~ 172 (370)
T KOG0583|consen 96 YIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGLSAISP 172 (370)
T ss_pred EEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEeccccccccC
Confidence 999999999999999999999999999999999999999999999 9999999999999999 999999999998764
Q ss_pred cCCCCCcccCCCCCcccCCcccCCCC-CC-CchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhh-
Q 013214 305 VKEDRPLTCQDTSCRYVAPEVFKNEE-YD-TKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLY- 381 (447)
Q Consensus 305 ~~~~~~~~~~~~t~~y~aPE~~~~~~-~~-~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 381 (447)
..........||+.|+|||++.+.. |+ .++||||+|++||.|++|+.||.+.+...+...+ ..+...++ ..+
T Consensus 173 -~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki-~~~~~~~p---~~~~ 247 (370)
T KOG0583|consen 173 -GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKI-RKGEFKIP---SYLL 247 (370)
T ss_pred -CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHH-hcCCccCC---CCcC
Confidence 2334456678999999999999877 76 6899999999999999999999997666665554 33333332 233
Q ss_pred HHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHh
Q 013214 382 ARGLKELIEECWNEKPAKRPTFRQIITRLESINN 415 (447)
Q Consensus 382 ~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~ 415 (447)
|++++.++++||..||.+|+++.+++ .-..++.
T Consensus 248 S~~~~~Li~~mL~~~P~~R~t~~~i~-~h~w~~~ 280 (370)
T KOG0583|consen 248 SPEARSLIEKMLVPDPSTRITLLEIL-EHPWFQK 280 (370)
T ss_pred CHHHHHHHHHHcCCCcccCCCHHHHh-hChhhcc
Confidence 89999999999999999999999999 4455554
No 15
>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]
Probab=100.00 E-value=1.5e-44 Score=321.96 Aligned_cols=248 Identities=21% Similarity=0.399 Sum_probs=205.0
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
.|.....+|+|+||+|++ +|+.||||++.... .++...+-..+|+++|++++|||+|.++++|...+.+++|+|
T Consensus 3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Ese-dd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESE-DDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred HHhhhhccccCcceEEEEeccCCcccEEEEEeeccCC-ccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 466677899999999974 79999999997543 234444555889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 013214 231 YLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (447)
Q Consensus 231 ~~~~g~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~ 309 (447)
||+. ++.+-|.+. ..++.+.+.+++.|++.|+.|+|+++ ++||||||+|||++.+|.+||||||+|+.+.. +..
T Consensus 82 ~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~-pgd 156 (396)
T KOG0593|consen 82 YCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSA-PGD 156 (396)
T ss_pred ecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcC-Ccc
Confidence 9965 555566654 45999999999999999999999999 99999999999999999999999999998774 334
Q ss_pred CcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcC-------------CCC--
Q 013214 310 PLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-------------RPP-- 373 (447)
Q Consensus 310 ~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~-------------~~~-- 373 (447)
..+.+..|.+|.|||.+.+ .+|++.+||||+||++.||++|.+.|++.++-+....+...- .+-
T Consensus 157 ~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~ 236 (396)
T KOG0593|consen 157 NYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFH 236 (396)
T ss_pred hhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCcee
Confidence 5566778999999999988 489999999999999999999999999988765443332211 000
Q ss_pred ---CCC---------ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 374 ---FKA---------PAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 374 ---~~~---------~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
++. ..+..+.-+.++++.||..||.+|++.++++.+
T Consensus 237 Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 237 GVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred eeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 110 123456678999999999999999999999854
No 16
>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=3.9e-43 Score=327.88 Aligned_cols=258 Identities=28% Similarity=0.461 Sum_probs=217.2
Q ss_pred CCcccCCCCcCcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEE
Q 013214 146 PEYEIDPHELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVT 220 (447)
Q Consensus 146 ~~~~i~~~~~~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 220 (447)
+..++.+.-..|+...+||.|.-+.|+ -+++.||||++..+...+ .+..+++|+..++.++||||++++..|.
T Consensus 17 ~~~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~--~ld~l~kE~~~msl~~HPNIv~~~~sFv 94 (516)
T KOG0582|consen 17 SEKEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNN--DLDALRKEVQTMSLIDHPNIVTYHCSFV 94 (516)
T ss_pred ccccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhh--hHHHHHHHHHHhhhcCCCCcceEEEEEE
Confidence 344555666789999999999887765 368999999999876533 3788999999999999999999999999
Q ss_pred eCCceEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecc
Q 013214 221 QSSPMMIVTEYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298 (447)
Q Consensus 221 ~~~~~~lv~e~~~~g~L~~~l~~~--~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg 298 (447)
.+..+|+||.||.+|++.+.++.. ..+++..+..+++++++||.|||++| .||||||+.||||+.+|.|||+|||
T Consensus 95 v~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFg 171 (516)
T KOG0582|consen 95 VDSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFG 171 (516)
T ss_pred ecceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCce
Confidence 999999999999999999999864 34999999999999999999999999 9999999999999999999999999
Q ss_pred cccccccCCCCC--c-ccCCCCCcccCCcccCCC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCC
Q 013214 299 VSKLLTVKEDRP--L-TCQDTSCRYVAPEVFKNE--EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPP 373 (447)
Q Consensus 299 ~~~~~~~~~~~~--~-~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~ 373 (447)
.+..+.....+. . ....||+.|||||++... .|+.|+||||||++..||.+|..||....+....... ..+.|+
T Consensus 172 vsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~t-Lqn~pp 250 (516)
T KOG0582|consen 172 VSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLT-LQNDPP 250 (516)
T ss_pred eeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHH-hcCCCC
Confidence 776543322211 1 456799999999996554 7899999999999999999999999998887766555 333333
Q ss_pred CC-------CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 374 FK-------APAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 374 ~~-------~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
.. .....++.+++.+|..||+.||.+|||+++++++
T Consensus 251 ~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 251 TLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred CcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 11 1234577899999999999999999999999975
No 17
>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]
Probab=100.00 E-value=3.2e-44 Score=330.79 Aligned_cols=245 Identities=27% Similarity=0.481 Sum_probs=221.7
Q ss_pred CcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|.+.+.||+|+||.|. ..|+.||||.++++.+.++..+-.+++|+++|..++||||+++|++|+..+.+.||||
T Consensus 54 RyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivME 133 (668)
T KOG0611|consen 54 RYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVME 133 (668)
T ss_pred HHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEE
Confidence 67778899999999885 5799999999999999888888899999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCC
Q 013214 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (447)
Q Consensus 231 ~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~ 310 (447)
|..+|.|++|+.+++.+++.++..+++||.+|+.|||.++ ++|||||.+|||+|.++++||+|||++..+... ..
T Consensus 134 YaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~~--kf 208 (668)
T KOG0611|consen 134 YASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYADK--KF 208 (668)
T ss_pred ecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhccc--cH
Confidence 9999999999999999999999999999999999999999 999999999999999999999999999877643 45
Q ss_pred cccCCCCCcccCCcccCCCCCC-CchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcC-CCCCCCChhhhHHHHHHH
Q 013214 311 LTCQDTSCRYVAPEVFKNEEYD-TKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RPPFKAPAKLYARGLKEL 388 (447)
Q Consensus 311 ~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~l 388 (447)
...++|+|.|.+||++.+.+|. +.+|.||||++||.|..|..||++.+...+.+++..+. +.+ .-+....-|
T Consensus 209 LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP------~~PSdA~gL 282 (668)
T KOG0611|consen 209 LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREP------ETPSDASGL 282 (668)
T ss_pred HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCC------CCCchHHHH
Confidence 5678899999999999998775 68999999999999999999999999888888875444 222 123567789
Q ss_pred HHHHcccCCCCCCCHHHHHHHHH
Q 013214 389 IEECWNEKPAKRPTFRQIITRLE 411 (447)
Q Consensus 389 i~~cl~~dp~~Rps~~~~l~~l~ 411 (447)
|+.||.+||++|.|..++..++.
T Consensus 283 IRwmLmVNP~RRATieDiAsHWW 305 (668)
T KOG0611|consen 283 IRWMLMVNPERRATIEDIASHWW 305 (668)
T ss_pred HHHHHhcCcccchhHHHHhhhhe
Confidence 99999999999999999999873
No 18
>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]
Probab=100.00 E-value=2.6e-44 Score=343.61 Aligned_cols=244 Identities=27% Similarity=0.505 Sum_probs=216.1
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|...+.||+|+||+||+ +.+.||+|.+.+... .++....+++|+++++.++||||+.+++.|+...++|+|+|
T Consensus 3 ~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr-~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 3 QYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGR-NEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred chhHHHHhcCCccceeeecccccceeEEEEEEehhcCC-chHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 567778899999999984 678999999987654 55677889999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCC
Q 013214 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (447)
Q Consensus 231 ~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~ 310 (447)
|+.| +|..++...+.++++.+..++.+++.||.|||+.+ |+|||+||+|||++..|.+|+||||+++.++.. ...
T Consensus 82 ~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~-t~v 156 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN-TSV 156 (808)
T ss_pred hhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcccC-cee
Confidence 9965 99999999999999999999999999999999999 999999999999999999999999999987653 233
Q ss_pred cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHHH
Q 013214 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIE 390 (447)
Q Consensus 311 ~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 390 (447)
.+...|||.|||||.+.++.|+..+|+||+||++||+++|++||....-.++.+.+....-. .+...+..+.++++
T Consensus 157 ltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~----~p~~~S~~f~nfl~ 232 (808)
T KOG0597|consen 157 LTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVK----PPSTASSSFVNFLQ 232 (808)
T ss_pred eeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCC----CcccccHHHHHHHH
Confidence 46678999999999999999999999999999999999999999977766666665333311 23467899999999
Q ss_pred HHcccCCCCCCCHHHHHHH
Q 013214 391 ECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 391 ~cl~~dp~~Rps~~~~l~~ 409 (447)
.+|.+||.+|.+..+++.+
T Consensus 233 gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 233 GLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred HHhhcChhhcccHHHHhcC
Confidence 9999999999999999864
No 19
>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=3.6e-44 Score=344.93 Aligned_cols=245 Identities=23% Similarity=0.457 Sum_probs=218.1
Q ss_pred CcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
.|..-.+||+|.-|.|+ .+++.||+|++..... ...+-+.+|+.+|+..+|+|||.+++.|...+.+|.|||
T Consensus 274 ~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q---~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVME 350 (550)
T KOG0578|consen 274 KYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQ---PKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVME 350 (550)
T ss_pred hhcchhhhccccccceeeeeeccCCceEEEEEEEeccC---CchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEe
Confidence 46667789999888776 4788999999976533 234567899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCC
Q 013214 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (447)
Q Consensus 231 ~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~ 310 (447)
|++||+|.+.+.. ..+++.++..++.++++||+|||.+| |+|||||.+|||++.+|.+||+|||++..+..... .
T Consensus 351 ym~ggsLTDvVt~-~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~-K 425 (550)
T KOG0578|consen 351 YMEGGSLTDVVTK-TRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS-K 425 (550)
T ss_pred ecCCCchhhhhhc-ccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccC-c
Confidence 9999999998865 44999999999999999999999999 99999999999999999999999999988765443 3
Q ss_pred cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHHH
Q 013214 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIE 390 (447)
Q Consensus 311 ~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 390 (447)
.....|||.|||||++....|+++.||||||++++||+-|++||-..++-.....+...+.|.+.. +..+|+.+++++.
T Consensus 426 R~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~-~~klS~~~kdFL~ 504 (550)
T KOG0578|consen 426 RSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKN-PEKLSPELKDFLD 504 (550)
T ss_pred cccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCC-ccccCHHHHHHHH
Confidence 345678999999999999999999999999999999999999999988888888888888888754 5668999999999
Q ss_pred HHcccCCCCCCCHHHHHHH
Q 013214 391 ECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 391 ~cl~~dp~~Rps~~~~l~~ 409 (447)
+||+.|+++|++++++|++
T Consensus 505 ~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 505 RCLVVDVEQRASAKELLEH 523 (550)
T ss_pred HHhhcchhcCCCHHHHhcC
Confidence 9999999999999999975
No 20
>PHA02988 hypothetical protein; Provisional
Probab=100.00 E-value=1.4e-42 Score=329.51 Aligned_cols=256 Identities=20% Similarity=0.316 Sum_probs=213.5
Q ss_pred cCCCCcCcccceeeecceEEEE---EEcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEe----C
Q 013214 150 IDPHELDFTNSVEITKGTFILA---FWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ----S 222 (447)
Q Consensus 150 i~~~~~~~~~~~~lg~G~~~~~---~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----~ 222 (447)
+++.+++......||+|+++.+ .++|+.||+|.++..........+.+.+|+.++++++||||+++++++.+ .
T Consensus 15 i~~~~i~~~~~~~i~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~ 94 (283)
T PHA02988 15 IESDDIDKYTSVLIKENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94 (283)
T ss_pred cCHHHcCCCCCeEEeeCCceEEEEEEECCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCC
Confidence 4445555555567888888765 47899999999987654455556788899999999999999999999876 3
Q ss_pred CceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEeCCCCCCCEEEcCCCCEEEeeccccc
Q 013214 223 SPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHEN-KPVPIIHRDLEPSNILRDDSGNLKVADFGVSK 301 (447)
Q Consensus 223 ~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~-~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~ 301 (447)
..++++|||+++|+|.+++.+...+++.....++.|++.|+.|||+. + ++||||||+||++++++.+||+|||++.
T Consensus 95 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~ 171 (283)
T PHA02988 95 PRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEK 171 (283)
T ss_pred CceEEEEEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHh
Confidence 56899999999999999999888899999999999999999999985 6 8899999999999999999999999987
Q ss_pred ccccCCCCCcccCCCCCcccCCcccCC--CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcC-CCCCCCCh
Q 013214 302 LLTVKEDRPLTCQDTSCRYVAPEVFKN--EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RPPFKAPA 378 (447)
Q Consensus 302 ~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~ 378 (447)
...... ....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...+..+....+.... ++++ +
T Consensus 172 ~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~---~ 244 (283)
T PHA02988 172 ILSSPP----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKL---P 244 (283)
T ss_pred hhcccc----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCC---C
Confidence 654221 22356889999999876 578999999999999999999999999877666555543333 3332 2
Q ss_pred hhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHh
Q 013214 379 KLYARGLKELIEECWNEKPAKRPTFRQIITRLESINN 415 (447)
Q Consensus 379 ~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~ 415 (447)
..+++.+.+++.+||+.||++|||++++++.|+.++.
T Consensus 245 ~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 245 LDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred CcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 3567899999999999999999999999999998764
No 21
>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]
Probab=100.00 E-value=3.2e-43 Score=335.94 Aligned_cols=249 Identities=28% Similarity=0.401 Sum_probs=216.3
Q ss_pred cCcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEE
Q 013214 155 LDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 229 (447)
.+|.....||+|+||.|+ .+|..+|+|++++...-..+++...+.|-++|....+|+||++|-.|++...+||||
T Consensus 141 ~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiM 220 (550)
T KOG0605|consen 141 DDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIM 220 (550)
T ss_pred ccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEE
Confidence 368888899999999886 489999999999988878888899999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeeccccccccc----
Q 013214 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV---- 305 (447)
Q Consensus 230 e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~---- 305 (447)
||++||++..+|.+.+.|+++.+..++.+++-|+..+|+.| ++||||||+|+|||..|++||+|||++.-+..
T Consensus 221 EylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~ 297 (550)
T KOG0605|consen 221 EYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRI 297 (550)
T ss_pred EecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchhhhhhhh
Confidence 99999999999999999999999999999999999999999 99999999999999999999999999853211
Q ss_pred -----------------CCCCC-----c--------------------ccCCCCCcccCCcccCCCCCCCchhHHHHHHH
Q 013214 306 -----------------KEDRP-----L--------------------TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALI 343 (447)
Q Consensus 306 -----------------~~~~~-----~--------------------~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~ 343 (447)
..... . .+..|||.|+|||++.+.+|+..+|+|||||+
T Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~I 377 (550)
T KOG0605|consen 298 ESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCI 377 (550)
T ss_pred hhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHH
Confidence 00000 0 13468999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCCCCchHHHHHhcC-CCCCCCChhhhHHHHHHHHHHHcccCCCCCCC---HHHHHH
Q 013214 344 LQEMIEGCPPFTMKHDNEVPKAYAARQ-RPPFKAPAKLYARGLKELIEECWNEKPAKRPT---FRQIIT 408 (447)
Q Consensus 344 l~~l~tg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps---~~~~l~ 408 (447)
+|||+.|.+||...++.++.+.+.... .-.++. ....+++..+||.+|+. ||++|.. +.||-+
T Consensus 378 myEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~-~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~ 444 (550)
T KOG0605|consen 378 MYEMLVGYPPFCSETPQETYRKIVNWRETLKFPE-EVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKK 444 (550)
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCC-cCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhc
Confidence 999999999999999999888875444 233332 33467999999999999 9999975 444443
No 22
>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=3e-44 Score=335.12 Aligned_cols=247 Identities=29% Similarity=0.499 Sum_probs=219.2
Q ss_pred CcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEE
Q 013214 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 228 (447)
Q Consensus 154 ~~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 228 (447)
...|+....||+|.||.||. +++.||+|++..+. ..+..+++++|+.++.+++++||.++|+.+.....++++
T Consensus 12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~--~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~Lwii 89 (467)
T KOG0201|consen 12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEE--AEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWII 89 (467)
T ss_pred ccccccchhccccccceeeeeeeccccceEEEEEechhh--cchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHH
Confidence 44677778999999999873 68899999998764 445678899999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 013214 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (447)
Q Consensus 229 ~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~ 308 (447)
||||.||++.+.++..+.+++..+..++++++.|+.|+|+++ .+|||||+.|||+..+|.+||+|||.+..+.....
T Consensus 90 Mey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~ 166 (467)
T KOG0201|consen 90 MEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK 166 (467)
T ss_pred HHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhh
Confidence 999999999999988887899999999999999999999999 99999999999999999999999999988776544
Q ss_pred CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHH
Q 013214 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKEL 388 (447)
Q Consensus 309 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 388 (447)
.. ....|||.|||||++.+..|+.++||||||++.+||.+|.+||....+......+.....|.+ ...+++.++++
T Consensus 167 rr-~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L---~~~~S~~~kEF 242 (467)
T KOG0201|consen 167 RR-KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRL---DGDFSPPFKEF 242 (467)
T ss_pred cc-ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCcc---ccccCHHHHHH
Confidence 44 567899999999999988999999999999999999999999999998776655533333333 34789999999
Q ss_pred HHHHcccCCCCCCCHHHHHHH
Q 013214 389 IEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 389 i~~cl~~dp~~Rps~~~~l~~ 409 (447)
|..||..||+.||++.+++++
T Consensus 243 V~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 243 VEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred HHHHhhcCcccCcCHHHHhhh
Confidence 999999999999999999975
No 23
>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]
Probab=100.00 E-value=1.5e-44 Score=313.05 Aligned_cols=247 Identities=23% Similarity=0.402 Sum_probs=217.9
Q ss_pred CcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|+...+||+|.|+.|+ -+|+.+|+|++....+... ..+++.+|+.+-+.++||||+++.+.+.+....|+|+|
T Consensus 12 ~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~-~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe 90 (355)
T KOG0033|consen 12 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 90 (355)
T ss_pred hhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc-cHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEe
Confidence 67777899999998764 5899999999876655443 56889999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCC---CEEEeecccccccccCC
Q 013214 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG---NLKVADFGVSKLLTVKE 307 (447)
Q Consensus 231 ~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~---~vkl~Dfg~~~~~~~~~ 307 (447)
+++|++|..-+..+..+++..+..+++||++||.|+|.++ |+|||+||.|+++.+.. -+||+|||++..++ .
T Consensus 91 ~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~--~ 165 (355)
T KOG0033|consen 91 LVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN--D 165 (355)
T ss_pred cccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEEeC--C
Confidence 9999999877776667899999999999999999999999 99999999999997543 49999999999877 3
Q ss_pred CCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCC-CChhhhHHHHH
Q 013214 308 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFK-APAKLYARGLK 386 (447)
Q Consensus 308 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~ 386 (447)
........|||+|||||++...+|+..+|||+.|+++|-|+.|++||.+.++..+.+.+..+. ..++ ..+.+++++.+
T Consensus 166 g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~-yd~~~~~w~~is~~Ak 244 (355)
T KOG0033|consen 166 GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGA-YDYPSPEWDTVTPEAK 244 (355)
T ss_pred ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccc-cCCCCcccCcCCHHHH
Confidence 455567789999999999999999999999999999999999999999999888888884443 3333 36778999999
Q ss_pred HHHHHHcccCCCCCCCHHHHHHH
Q 013214 387 ELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 387 ~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
+|+++||..||.+|.|+.|.+++
T Consensus 245 ~LvrrML~~dP~kRIta~EAL~H 267 (355)
T KOG0033|consen 245 SLIRRMLTVNPKKRITADEALKH 267 (355)
T ss_pred HHHHHHhccChhhhccHHHHhCC
Confidence 99999999999999999998865
No 24
>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=9.3e-44 Score=334.47 Aligned_cols=247 Identities=25% Similarity=0.383 Sum_probs=207.3
Q ss_pred cCcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC-CCcccceeEEEEeCC-ceEE
Q 013214 155 LDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSS-PMMI 227 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~-~~~l 227 (447)
.+|...++||.|+||.|+ .+|+.||||+++......++... .+|++.|++++ ||||+++.+++.+++ .+++
T Consensus 10 ~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~n--LREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 10 DRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMN--LREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHH--HHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 368888999999999987 36889999999887665443332 46999999998 999999999998887 8999
Q ss_pred EEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccC
Q 013214 228 VTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306 (447)
Q Consensus 228 v~e~~~~g~L~~~l~~~~-~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~ 306 (447)
||||| ..+|+++++.++ .+++..+..|+.||++||+|+|.+| +.|||+||+|||+..+..+||+|||+|+.+.
T Consensus 88 VfE~M-d~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev~-- 161 (538)
T KOG0661|consen 88 VFEFM-DCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREVR-- 161 (538)
T ss_pred eHHhh-hhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEecccccccccc--
Confidence 99999 579999998764 5999999999999999999999999 9999999999999988999999999999765
Q ss_pred CCCCcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHh-cCCC------------
Q 013214 307 EDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA-RQRP------------ 372 (447)
Q Consensus 307 ~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~-~~~~------------ 372 (447)
...+.+.+..|.+|.|||++.. +.|+.+.|+|++||+++|+.+-++.|++.+..+....+.. -+.|
T Consensus 162 SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La 241 (538)
T KOG0661|consen 162 SKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLA 241 (538)
T ss_pred cCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHH
Confidence 3456788889999999998754 5789999999999999999999999998876544333311 1121
Q ss_pred --------CCC-----CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 373 --------PFK-----APAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 373 --------~~~-----~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
.+. ...++.+.++.++|.+|++.||.+|||+.+++++
T Consensus 242 ~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 242 SAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 111 1123477899999999999999999999999875
No 25
>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]
Probab=100.00 E-value=4.2e-43 Score=332.32 Aligned_cols=249 Identities=26% Similarity=0.412 Sum_probs=210.9
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeC--CceEE
Q 013214 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--SPMMI 227 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~~l 227 (447)
-.|.....||+|+||.||. +|..||+|++..+...++ ...-..+|+.+|++++||||+++.+...+. ..+|+
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~-~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEG-FPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCc-chHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 3578888999999999884 789999999987654333 334456799999999999999999998876 68999
Q ss_pred EEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccC
Q 013214 228 VTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306 (447)
Q Consensus 228 v~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~ 306 (447)
|+|||+ -||.-++... -.+++.++..++.||+.||.|||++| |+|||||.+|||||.+|.+||+|||+|+++...
T Consensus 196 VFeYMd-hDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~ 271 (560)
T KOG0600|consen 196 VFEYMD-HDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYTPS 271 (560)
T ss_pred EEeccc-chhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeeccCC
Confidence 999995 5898888764 36999999999999999999999999 999999999999999999999999999988877
Q ss_pred CCCCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcC-CC--CCCC------
Q 013214 307 EDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RP--PFKA------ 376 (447)
Q Consensus 307 ~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~-~~--~~~~------ 376 (447)
.....+....|.+|.|||.+.+. .|+...|+||.||+|.||++|++.|++.+..+....|.... .| .++.
T Consensus 272 ~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~ 351 (560)
T KOG0600|consen 272 GSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPH 351 (560)
T ss_pred CCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCc
Confidence 66677888889999999999876 79999999999999999999999999998877666653322 11 1110
Q ss_pred ----------------ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHH
Q 013214 377 ----------------PAKLYARGLKELIEECWNEKPAKRPTFRQIIT 408 (447)
Q Consensus 377 ----------------~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~ 408 (447)
.....+....+|+..+|..||.+|.|+.++++
T Consensus 352 ~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 352 ATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred ccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 01235677889999999999999999999886
No 26
>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=2e-42 Score=335.09 Aligned_cols=267 Identities=34% Similarity=0.533 Sum_probs=211.8
Q ss_pred CCCcccCCCCcCcccceeeecceEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEE
Q 013214 145 VPEYEIDPHELDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVT 220 (447)
Q Consensus 145 ~~~~~i~~~~~~~~~~~~lg~G~~~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 220 (447)
.+..++..++.+|.....||+|+||.||. +|..||||++....... ..+|.+|+.++.+++|||+++++|+|.
T Consensus 65 fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l~H~Nlv~LlGyC~ 141 (361)
T KOG1187|consen 65 FSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG---EREFLNEVEILSRLRHPNLVKLLGYCL 141 (361)
T ss_pred eeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc---hhHHHHHHHHHhcCCCcCcccEEEEEe
Confidence 34456667777999999999999999883 56899999887543221 456999999999999999999999999
Q ss_pred eCC-ceEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeec
Q 013214 221 QSS-PMMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297 (447)
Q Consensus 221 ~~~-~~~lv~e~~~~g~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Df 297 (447)
+.+ ..+||+||+++|+|.++|.... +++|.++.+|+.++++||+|||+..+.+|+||||||+|||+|++.+.||+||
T Consensus 142 e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDF 221 (361)
T KOG1187|consen 142 EGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDF 221 (361)
T ss_pred cCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCc
Confidence 988 4999999999999999998754 8999999999999999999999988778999999999999999999999999
Q ss_pred ccccccccCCCCCcccC-CCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCC-Cc--hHH----HHHhc
Q 013214 298 GVSKLLTVKEDRPLTCQ-DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHD-NE--VPK----AYAAR 369 (447)
Q Consensus 298 g~~~~~~~~~~~~~~~~-~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~-~~--~~~----~~~~~ 369 (447)
|++...... ....... .||.+|+|||+...+..+.++||||||+++.|++||+.|.+.... .+ ... .+...
T Consensus 222 GLa~~~~~~-~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~ 300 (361)
T KOG1187|consen 222 GLAKLGPEG-DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEG 300 (361)
T ss_pred cCcccCCcc-ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCc
Confidence 999765431 1111222 789999999999989999999999999999999999988875431 11 111 11111
Q ss_pred C-----CCCCC--CChh-hhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHh
Q 013214 370 Q-----RPPFK--APAK-LYARGLKELIEECWNEKPAKRPTFRQIITRLESINN 415 (447)
Q Consensus 370 ~-----~~~~~--~~~~-~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~ 415 (447)
. .+.+. .... ..-..+..+..+|++.+|.+||+|.++++.|+.+..
T Consensus 301 ~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~ 354 (361)
T KOG1187|consen 301 KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS 354 (361)
T ss_pred chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence 1 12221 1111 122336677789999999999999999999866543
No 27
>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]
Probab=100.00 E-value=3e-43 Score=353.57 Aligned_cols=260 Identities=31% Similarity=0.539 Sum_probs=220.5
Q ss_pred cccCCCCcCcccceeeecceEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeE
Q 013214 148 YEIDPHELDFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLG 217 (447)
Q Consensus 148 ~~i~~~~~~~~~~~~lg~G~~~~~~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~ 217 (447)
.++...++ ...++||+|.||.|+. ..+-||||.++.. .+....++|++|+.++..++|||||+++|
T Consensus 481 ~~i~r~~i--~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~--a~~~~~~dF~REaeLla~l~H~nIVrLlG 556 (774)
T KOG1026|consen 481 LEIPRSDI--VFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDK--AENQARQDFRREAELLAELQHPNIVRLLG 556 (774)
T ss_pred eEechhhe--eehhhhcCchhhhhhhhhccCCCCCccceehhHhhhccc--ccHHHHHHHHHHHHHHHhccCCCeEEEEE
Confidence 34444433 4456899999999873 3468999999865 35567899999999999999999999999
Q ss_pred EEEeCCceEEEEeccCCCCHHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCC
Q 013214 218 AVTQSSPMMIVTEYLPKGDLRAFLKRKG--------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSN 283 (447)
Q Consensus 218 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~--------------~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~N 283 (447)
+|...+.+|+|+|||..|||.++|.... +++..+.+.++.||+.|+.||-++. +|||||-.+|
T Consensus 557 VC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRN 633 (774)
T KOG1026|consen 557 VCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRN 633 (774)
T ss_pred EEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhh
Confidence 9999999999999999999999997421 2788899999999999999999999 9999999999
Q ss_pred EEEcCCCCEEEeeccccccc-ccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCc
Q 013214 284 ILRDDSGNLKVADFGVSKLL-TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNE 361 (447)
Q Consensus 284 ill~~~~~vkl~Dfg~~~~~-~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~ 361 (447)
+||+++..|||+|||+++.. +.+..+......-+.+|||||.+..+++++++||||+||+|||+++ |+.||.+..+.|
T Consensus 634 CLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E 713 (774)
T KOG1026|consen 634 CLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE 713 (774)
T ss_pred ceeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHH
Confidence 99999999999999999853 2111111112234789999999999999999999999999999999 999999999999
Q ss_pred hHHHHHhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhh
Q 013214 362 VPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSI 417 (447)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~~ 417 (447)
+.+.+..+.-- .-+.++|.++.+||..||+.+|++||++++|-..|++.-..-
T Consensus 714 VIe~i~~g~lL---~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s 766 (774)
T KOG1026|consen 714 VIECIRAGQLL---SCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQAS 766 (774)
T ss_pred HHHHHHcCCcc---cCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcC
Confidence 99988555432 236678999999999999999999999999999999876543
No 28
>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]
Probab=100.00 E-value=1.2e-42 Score=304.68 Aligned_cols=248 Identities=27% Similarity=0.453 Sum_probs=206.5
Q ss_pred CcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|...+.+|+|+||.|+ .+|+.||||+++.....+.-.. ...+|++.|+.++||||+.++++|.....+.+|+|
T Consensus 3 rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~-talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 3 RYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINR-TALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred hhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccH-HHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 57777899999999987 4799999999987655433333 34569999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 013214 231 YLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (447)
Q Consensus 231 ~~~~g~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~ 309 (447)
|++ .+|+..++.. ..++..++..++.++++|++|||++. |+||||||.|+|++++|.+||+|||+++.+.... .
T Consensus 82 fm~-tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~-~ 156 (318)
T KOG0659|consen 82 FMP-TDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN-R 156 (318)
T ss_pred ecc-ccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCC-c
Confidence 995 6999999765 46999999999999999999999999 9999999999999999999999999999887543 3
Q ss_pred CcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhc-CCCC--------------
Q 013214 310 PLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR-QRPP-------------- 373 (447)
Q Consensus 310 ~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~-~~~~-------------- 373 (447)
..+....|.+|.|||.+.+. .|+...||||.||++.||+.|.+.|.+.++-+....+... +.|.
T Consensus 157 ~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~ 236 (318)
T KOG0659|consen 157 IQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYV 236 (318)
T ss_pred ccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHH
Confidence 33334678999999988764 7999999999999999999999999988876655554222 1211
Q ss_pred ----CCC-----ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 374 ----FKA-----PAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 374 ----~~~-----~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
++. ..+..+....+++.+||..||.+|+++++++++
T Consensus 237 ~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 237 KIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred HHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 110 112346678999999999999999999999985
No 29
>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]
Probab=100.00 E-value=1.8e-42 Score=337.40 Aligned_cols=292 Identities=27% Similarity=0.506 Sum_probs=244.3
Q ss_pred HHHHHHHHHhCCCCCCCcccccccCCCCCcccCCCCcCcccceeeecceEEEEEE-----c-C---eEEEEEEcCcccCC
Q 013214 119 HEVIKLLEKHGAKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFW-----R-G---IQVAVKKLGEEVIS 189 (447)
Q Consensus 119 ~~~~~~L~~~~a~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~lg~G~~~~~~~-----~-g---~~vavK~~~~~~~~ 189 (447)
.+++.+.......+.-......+|..-+.|++.-.++.+. +.||+|+||.|+. . + ..||+|..+.+...
T Consensus 123 ~~li~~~~~~~~~~~~~~~~L~~PI~r~~Wel~H~~v~l~--kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~ 200 (474)
T KOG0194|consen 123 SELVNYYKFSKLEITGKNFFLKRPIPRQKWELSHSDIELG--KKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSEL 200 (474)
T ss_pred HHHHHHHHhcccceeccceeecccccccccEEeccCcccc--ceeecccccEEEEEEEEecCCceeeeeEEEeecccccc
Confidence 3455555555555444444555666667888888877776 7999999998862 1 2 23899998865556
Q ss_pred CHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEeccCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHh
Q 013214 190 DDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGA-LKPSTAVRFALDIARGMNYLHE 268 (447)
Q Consensus 190 ~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~-l~~~~~~~i~~ql~~~l~~lH~ 268 (447)
..+...++.+|++++++++||||+++||+...+..+++|||+|.||+|.++|++++. ++..+...++.+.+.||+|||+
T Consensus 201 ~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~ 280 (474)
T KOG0194|consen 201 TKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHS 280 (474)
T ss_pred cHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHH
Confidence 788899999999999999999999999999999999999999999999999998875 9999999999999999999999
Q ss_pred CCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHH
Q 013214 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMI 348 (447)
Q Consensus 269 ~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~ 348 (447)
++ ++||||-.+|+|++.++.+||+|||+++...... .......-+.+|+|||.+..+.++.++|||||||++||++
T Consensus 281 k~---~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~~-~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif 356 (474)
T KOG0194|consen 281 KN---CIHRDIAARNCLYSKKGVVKISDFGLSRAGSQYV-MKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIF 356 (474)
T ss_pred CC---CcchhHhHHHheecCCCeEEeCccccccCCccee-eccccccCcceecChhhhccCccccccchhheeeeEEeee
Confidence 99 9999999999999999999999999998654211 1111224578999999999999999999999999999999
Q ss_pred h-CCCCCCCCCCCchHHHHHhcC-CCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhhc
Q 013214 349 E-GCPPFTMKHDNEVPKAYAARQ-RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINH 419 (447)
Q Consensus 349 t-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~~~~ 419 (447)
+ |..||.+....++...+...+ +.+.+. ..+..+..++.+||..||++||+|.++.+.++.+......
T Consensus 357 ~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~---~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 357 ENGAEPYPGMKNYEVKAKIVKNGYRMPIPS---KTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred ccCCCCCCCCCHHHHHHHHHhcCccCCCCC---CCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 9 899999999988888884444 555433 5578899999999999999999999999999998877654
No 30
>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]
Probab=100.00 E-value=5.4e-43 Score=337.99 Aligned_cols=267 Identities=28% Similarity=0.552 Sum_probs=221.4
Q ss_pred CcccCCCCcCcccceeeecceEEEEE---EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCC
Q 013214 147 EYEIDPHELDFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS 223 (447)
Q Consensus 147 ~~~i~~~~~~~~~~~~lg~G~~~~~~---~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 223 (447)
+|+|.+. ++.....||+|.||+|+ |-| +||||++..+.. .++..+.|++|+.++++-+|.||+-+.|+|..+.
T Consensus 386 ~WeIp~~--ev~l~~rIGsGsFGtV~Rg~whG-dVAVK~Lnv~~p-t~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~ 461 (678)
T KOG0193|consen 386 EWEIPPE--EVLLGERIGSGSFGTVYRGRWHG-DVAVKLLNVDDP-TPEQLQAFKNEVAVLKKTRHENILLFMGACMNPP 461 (678)
T ss_pred ccccCHH--Hhhccceeccccccceeeccccc-ceEEEEEecCCC-CHHHHHHHHHHHHHHhhcchhhheeeehhhcCCc
Confidence 4555544 45566789999999987 444 799999998765 5568999999999999999999999999999877
Q ss_pred ceEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccc
Q 013214 224 PMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 302 (447)
Q Consensus 224 ~~~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~ 302 (447)
. .||+.+|+|.+|+.+++.. .++...+.+.|++|+++|+.|||.++ |||+|||..||++.+++.|||+|||++..
T Consensus 462 ~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLatv 537 (678)
T KOG0193|consen 462 L-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLATV 537 (678)
T ss_pred e-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccceee
Confidence 6 9999999999999999854 45899999999999999999999999 99999999999999999999999999875
Q ss_pred cccCC-CCCcccCCCCCcccCCcccCCC---CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcC-CCCCCCC
Q 013214 303 LTVKE-DRPLTCQDTSCRYVAPEVFKNE---EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RPPFKAP 377 (447)
Q Consensus 303 ~~~~~-~~~~~~~~~t~~y~aPE~~~~~---~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~-~~~~~~~ 377 (447)
..... ........+...|||||+++.+ +|++.+||||||+++|||++|..||.....+++.-.+..+. .+.....
T Consensus 538 k~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~ 617 (678)
T KOG0193|consen 538 KTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKI 617 (678)
T ss_pred eeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhh
Confidence 54332 1222334567889999998754 68899999999999999999999999555554443332222 5566666
Q ss_pred hhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhhccc
Q 013214 378 AKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINHKR 421 (447)
Q Consensus 378 ~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~~~~~~ 421 (447)
..++++++++|+..||..++++||.+.+|+..|+.+..+..+.+
T Consensus 618 ~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~pki~ 661 (678)
T KOG0193|consen 618 RSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSLPKIN 661 (678)
T ss_pred hccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhcccccc
Confidence 67788999999999999999999999999999988877654333
No 31
>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3. Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V
Probab=100.00 E-value=2.6e-41 Score=329.15 Aligned_cols=253 Identities=29% Similarity=0.474 Sum_probs=203.9
Q ss_pred cCcccceeeecceEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeEEEEeC-
Q 013214 155 LDFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQS- 222 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~- 222 (447)
.+|+..+.||+|+||.|+. ++..||+|++.... .......+.+|+.+++.+ +||||+++++++...
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 7 DRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA--TASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred hHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc--chHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 3677788999999998863 24679999987532 334456788999999999 899999999988764
Q ss_pred CceEEEEeccCCCCHHHHHHhc----------------------------------------------------------
Q 013214 223 SPMMIVTEYLPKGDLRAFLKRK---------------------------------------------------------- 244 (447)
Q Consensus 223 ~~~~lv~e~~~~g~L~~~l~~~---------------------------------------------------------- 244 (447)
..++++|||+++|+|.+++...
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 4589999999999999999753
Q ss_pred ----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCC-CcccCCCCCc
Q 013214 245 ----GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR-PLTCQDTSCR 319 (447)
Q Consensus 245 ----~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~-~~~~~~~t~~ 319 (447)
.++++.++..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++........ ......+++.
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~ 241 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence 23677888899999999999999998 999999999999999999999999999765322111 1122345678
Q ss_pred ccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcC-CCCCCCChhhhHHHHHHHHHHHcccCC
Q 013214 320 YVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQ-RPPFKAPAKLYARGLKELIEECWNEKP 397 (447)
Q Consensus 320 y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dp 397 (447)
|+|||.+.+..++.++||||||+++|+|++ |..||.+....+......... .+. .+..+++.+.+++.+||+.||
T Consensus 242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dp 318 (338)
T cd05102 242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMR---APENATPEIYRIMLACWQGDP 318 (338)
T ss_pred ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCC---CCCCCCHHHHHHHHHHccCCh
Confidence 999999988889999999999999999997 999998766544332222222 222 234567889999999999999
Q ss_pred CCCCCHHHHHHHHHHHHh
Q 013214 398 AKRPTFRQIITRLESINN 415 (447)
Q Consensus 398 ~~Rps~~~~l~~l~~~~~ 415 (447)
++|||+.++++.|+++..
T Consensus 319 ~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 319 KERPTFSALVEILGDLLQ 336 (338)
T ss_pred hhCcCHHHHHHHHHHHHh
Confidence 999999999999998765
No 32
>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=2.2e-42 Score=338.84 Aligned_cols=242 Identities=26% Similarity=0.402 Sum_probs=214.9
Q ss_pred CCcCcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeEEEEeCCceE
Q 013214 153 HELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMM 226 (447)
Q Consensus 153 ~~~~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~ 226 (447)
...+|...+.||+|.||+|. .+++.+|||++++..+-..+.++..+.|.+++... +||+++.++.+|+.+.++|
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~ 445 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF 445 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence 33478888999999999986 37889999999999888888889999999999998 5999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccC
Q 013214 227 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306 (447)
Q Consensus 227 lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~ 306 (447)
+||||+.||++..+ ...+.+++..+..++..++.||+|||++| ||+||||.+|||+|.+|++||+|||+++.....
T Consensus 446 fvmey~~Ggdm~~~-~~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~ 521 (694)
T KOG0694|consen 446 FVMEYVAGGDLMHH-IHTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQ 521 (694)
T ss_pred EEEEecCCCcEEEE-EecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEecccccccccCCC
Confidence 99999999995543 34467999999999999999999999999 999999999999999999999999999875433
Q ss_pred CCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHH
Q 013214 307 EDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLK 386 (447)
Q Consensus 307 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 386 (447)
.+ .....+|||.|||||++.+..|+..+|+|||||+||||+.|..||.+.+.+++...+... .+.+ |..+|.+..
T Consensus 522 g~-~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d-~~~y---P~~ls~ea~ 596 (694)
T KOG0694|consen 522 GD-RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVND-EVRY---PRFLSKEAI 596 (694)
T ss_pred CC-ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC-CCCC---CCcccHHHH
Confidence 33 445688999999999999999999999999999999999999999999999988887333 3333 456789999
Q ss_pred HHHHHHcccCCCCCCCH
Q 013214 387 ELIEECWNEKPAKRPTF 403 (447)
Q Consensus 387 ~li~~cl~~dp~~Rps~ 403 (447)
++|+++|..||++|..+
T Consensus 597 ~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 597 AIMRRLLRKNPEKRLGS 613 (694)
T ss_pred HHHHHHhccCcccccCC
Confidence 99999999999999866
No 33
>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt
Probab=100.00 E-value=4.5e-42 Score=327.41 Aligned_cols=243 Identities=24% Similarity=0.409 Sum_probs=207.3
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|+..+.||+|+||.|+. +|+.||+|.+...........+.+.+|+.+++.++||||+++++++.+....+++||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 81 (291)
T cd05612 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLME 81 (291)
T ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEe
Confidence 577788999999998862 588999999875433334455678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCC
Q 013214 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (447)
Q Consensus 231 ~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~ 310 (447)
|+++|+|.+++.+.+.+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++......
T Consensus 82 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~---- 154 (291)
T cd05612 82 YVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR---- 154 (291)
T ss_pred CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCC----
Confidence 9999999999998888999999999999999999999999 999999999999999999999999998765321
Q ss_pred cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHHH
Q 013214 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIE 390 (447)
Q Consensus 311 ~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 390 (447)
.....|++.|+|||.+.+..++.++|||||||++|+|++|+.||...+..+....+.. ....+ +..+++.+.++|+
T Consensus 155 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~-~~~~~---~~~~~~~~~~li~ 230 (291)
T cd05612 155 TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILA-GKLEF---PRHLDLYAKDLIK 230 (291)
T ss_pred cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-CCcCC---CccCCHHHHHHHH
Confidence 1234578999999999888899999999999999999999999988776555555432 23333 3345788999999
Q ss_pred HHcccCCCCCCC-----HHHHHHH
Q 013214 391 ECWNEKPAKRPT-----FRQIITR 409 (447)
Q Consensus 391 ~cl~~dp~~Rps-----~~~~l~~ 409 (447)
+||+.||.+||+ +++++++
T Consensus 231 ~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 231 KLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred HHcCCCHHHccCCccCCHHHHhcC
Confidence 999999999995 8888765
No 34
>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i
Probab=100.00 E-value=1.6e-41 Score=322.62 Aligned_cols=248 Identities=23% Similarity=0.359 Sum_probs=203.7
Q ss_pred cccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEec
Q 013214 157 FTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (447)
Q Consensus 157 ~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 231 (447)
|+..+.||+|+||.|+ .+|+.||+|.+.............+.+|+.+++.++|++|+++++++..++..+++|||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 5667889999999885 36899999998755433333445677899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 013214 232 LPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (447)
Q Consensus 232 ~~~g~L~~~l~~~--~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~ 309 (447)
+++|+|.+++... ..+++..+..++.|++.||.|||+.+ ++||||||+||++++++.++|+|||++...... .
T Consensus 82 ~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~--~ 156 (285)
T cd05631 82 MNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEG--E 156 (285)
T ss_pred cCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC--C
Confidence 9999999888643 35899999999999999999999999 999999999999999999999999998765322 1
Q ss_pred CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHH
Q 013214 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELI 389 (447)
Q Consensus 310 ~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 389 (447)
......||+.|+|||.+.+..++.++|||||||++|+|++|+.||...........+...........+..++..+.+++
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li 236 (285)
T cd05631 157 TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSIC 236 (285)
T ss_pred eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHH
Confidence 22344679999999999988999999999999999999999999987665433333322222222223445788999999
Q ss_pred HHHcccCCCCCCC-----HHHHHHH
Q 013214 390 EECWNEKPAKRPT-----FRQIITR 409 (447)
Q Consensus 390 ~~cl~~dp~~Rps-----~~~~l~~ 409 (447)
++||+.||.+||+ +++++++
T Consensus 237 ~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 237 RMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred HHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 9999999999997 7888864
No 35
>PTZ00263 protein kinase A catalytic subunit; Provisional
Probab=100.00 E-value=6.5e-42 Score=331.93 Aligned_cols=244 Identities=24% Similarity=0.410 Sum_probs=208.4
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEE
Q 013214 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 229 (447)
.+|...+.||+|+||.|+. +|+.||+|.+...........+.+.+|+.++++++||||+++++++..++..+++|
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 3688889999999998862 57899999987654334445677889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 013214 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (447)
Q Consensus 230 e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~ 309 (447)
||+.+|+|.+++.+.+.+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++......
T Consensus 98 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--- 171 (329)
T PTZ00263 98 EFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR--- 171 (329)
T ss_pred cCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCCC---
Confidence 99999999999998888999999999999999999999999 999999999999999999999999998765322
Q ss_pred CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHH
Q 013214 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELI 389 (447)
Q Consensus 310 ~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 389 (447)
.....||+.|+|||.+.+..++.++|||||||++|+|++|+.||.+....+....+. .....+ +..++..+.++|
T Consensus 172 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~-~~~~~~---p~~~~~~~~~li 246 (329)
T PTZ00263 172 -TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKIL-AGRLKF---PNWFDGRARDLV 246 (329)
T ss_pred -cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHh-cCCcCC---CCCCCHHHHHHH
Confidence 123467999999999998889999999999999999999999998766555544442 233333 234678899999
Q ss_pred HHHcccCCCCCCC-----HHHHHHH
Q 013214 390 EECWNEKPAKRPT-----FRQIITR 409 (447)
Q Consensus 390 ~~cl~~dp~~Rps-----~~~~l~~ 409 (447)
++||+.||.+||+ +.+++++
T Consensus 247 ~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 247 KGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred HHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 9999999999987 6887765
No 36
>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B. Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be
Probab=100.00 E-value=8.3e-42 Score=330.39 Aligned_cols=240 Identities=25% Similarity=0.400 Sum_probs=203.9
Q ss_pred eeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEeccCCCC
Q 013214 162 EITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236 (447)
Q Consensus 162 ~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g~ 236 (447)
.||+|+||.|+ .+|+.||+|++.............+.+|+.+++.++||||+++++.+...+..++||||+++|+
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~ 81 (323)
T cd05571 2 LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGE 81 (323)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCCc
Confidence 68999999887 3688999999976544344555677889999999999999999999999999999999999999
Q ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCCcccCCC
Q 013214 237 LRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT 316 (447)
Q Consensus 237 L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~ 316 (447)
|.+++..++.+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++...... ........|
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~-~~~~~~~~g 157 (323)
T cd05571 82 LFFHLSRERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISD-GATMKTFCG 157 (323)
T ss_pred HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccC-CCcccceec
Confidence 9999998888999999999999999999999999 999999999999999999999999998753221 112234568
Q ss_pred CCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHHHHHcccC
Q 013214 317 SCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEK 396 (447)
Q Consensus 317 t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 396 (447)
|+.|+|||.+.+..++.++|||||||++|+|++|+.||...+.......+. .....+ +..+++++.++|++||+.|
T Consensus 158 t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~-~~~~~~---p~~~~~~~~~li~~~L~~d 233 (323)
T cd05571 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL-MEEIRF---PRTLSPEAKSLLAGLLKKD 233 (323)
T ss_pred CccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHH-cCCCCC---CCCCCHHHHHHHHHHccCC
Confidence 999999999998889999999999999999999999998766555444442 222232 3457889999999999999
Q ss_pred CCCCC-----CHHHHHHH
Q 013214 397 PAKRP-----TFRQIITR 409 (447)
Q Consensus 397 p~~Rp-----s~~~~l~~ 409 (447)
|++|| ++.+++++
T Consensus 234 P~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 234 PKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred HHHcCCCCCCCHHHHHcC
Confidence 99999 79988764
No 37
>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]
Probab=100.00 E-value=1.3e-42 Score=300.38 Aligned_cols=245 Identities=26% Similarity=0.442 Sum_probs=217.9
Q ss_pred CcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|..++.||+|-||.|| .++-.||+|++.++.+......+++++|+++...++||||+++|++|.++.++|+++|
T Consensus 23 dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilE 102 (281)
T KOG0580|consen 23 DFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILE 102 (281)
T ss_pred hccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEEE
Confidence 67788899999999887 3678899999988777666777889999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 013214 231 YLPKGDLRAFLK--RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (447)
Q Consensus 231 ~~~~g~L~~~l~--~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~ 308 (447)
|..+|+|...|. ...++++...+.++.|++.|+.|+|..+ ++||||||+|+|++..+.+|++|||-+..-+ .
T Consensus 103 ya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p---~ 176 (281)
T KOG0580|consen 103 YAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP---S 176 (281)
T ss_pred ecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecC---C
Confidence 999999999998 5567999999999999999999999999 9999999999999999999999999886543 2
Q ss_pred CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHH
Q 013214 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKEL 388 (447)
Q Consensus 309 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 388 (447)
......+||..|++||...+..++..+|+|++|++.||++.|.+||......+....+... +..+ +..++.+++++
T Consensus 177 ~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~-~~~~---p~~is~~a~dl 252 (281)
T KOG0580|consen 177 NKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKV-DLKF---PSTISGGAADL 252 (281)
T ss_pred CCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHc-cccC---CcccChhHHHH
Confidence 2335567899999999999999999999999999999999999999999877776666332 2232 35688999999
Q ss_pred HHHHcccCCCCCCCHHHHHHHH
Q 013214 389 IEECWNEKPAKRPTFRQIITRL 410 (447)
Q Consensus 389 i~~cl~~dp~~Rps~~~~l~~l 410 (447)
|.+|+..+|.+|.+..+++++-
T Consensus 253 I~~ll~~~p~~r~~l~~v~~hp 274 (281)
T KOG0580|consen 253 ISRLLVKNPIERLALTEVMDHP 274 (281)
T ss_pred HHHHhccCccccccHHHHhhhH
Confidence 9999999999999999998874
No 38
>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]
Probab=100.00 E-value=1.1e-42 Score=332.35 Aligned_cols=250 Identities=35% Similarity=0.546 Sum_probs=208.1
Q ss_pred CcccCCCCcCcccceeeecceEEEEE---EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCC
Q 013214 147 EYEIDPHELDFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS 223 (447)
Q Consensus 147 ~~~i~~~~~~~~~~~~lg~G~~~~~~---~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 223 (447)
.|+|.++. +....-||+|+-|-|+ ..++.||||+++.- -..+++.|++++||||+.|.|+|....
T Consensus 118 ~WeiPFe~--IsELeWlGSGaQGAVF~Grl~netVAVKKV~el----------kETdIKHLRkLkH~NII~FkGVCtqsP 185 (904)
T KOG4721|consen 118 LWEIPFEE--ISELEWLGSGAQGAVFLGRLHNETVAVKKVREL----------KETDIKHLRKLKHPNIITFKGVCTQSP 185 (904)
T ss_pred hccCCHHH--hhhhhhhccCcccceeeeeccCceehhHHHhhh----------hhhhHHHHHhccCcceeeEeeeecCCc
Confidence 44555443 2334457888777665 67899999988521 235889999999999999999999999
Q ss_pred ceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeeccccccc
Q 013214 224 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (447)
Q Consensus 224 ~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~ 303 (447)
..|||||||..|-|...|+....+.......|..+|+.|+.|||.++ |||||||..||||..+..|||+|||-++..
T Consensus 186 cyCIiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~ 262 (904)
T KOG4721|consen 186 CYCIIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKEL 262 (904)
T ss_pred eeEEeeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhh
Confidence 99999999999999999999999999999999999999999999999 999999999999999999999999999876
Q ss_pred ccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCC-CCChhhhH
Q 013214 304 TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPF-KAPAKLYA 382 (447)
Q Consensus 304 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 382 (447)
.... ..-.+.||..|||||++...+++.|+|||||||+||||+||..||.+-+..-+.--+ +...+ -..+..+|
T Consensus 263 ~~~S--TkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGV---GsNsL~LpvPstcP 337 (904)
T KOG4721|consen 263 SDKS--TKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGV---GSNSLHLPVPSTCP 337 (904)
T ss_pred hhhh--hhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEec---cCCcccccCcccCc
Confidence 5442 223567999999999999999999999999999999999999999976654332111 11111 12356788
Q ss_pred HHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhh
Q 013214 383 RGLKELIEECWNEKPAKRPTFRQIITRLESINNS 416 (447)
Q Consensus 383 ~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~ 416 (447)
+.+.-||+.||+..|.+|||+.+++.+|+-....
T Consensus 338 ~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pe 371 (904)
T KOG4721|consen 338 DGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPE 371 (904)
T ss_pred hHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHH
Confidence 9999999999999999999999999999754433
No 39
>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10. Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor
Probab=100.00 E-value=9.6e-41 Score=314.03 Aligned_cols=251 Identities=26% Similarity=0.437 Sum_probs=208.8
Q ss_pred cCcccceeeecceEEEEEE--------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceE
Q 013214 155 LDFTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM 226 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 226 (447)
.+|+..+.||+|+||.|+. .+..||+|.++... .......+.+|+..+++++||||+++++++..++..+
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 82 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC--SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMM 82 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcE
Confidence 4677888999999998852 35789999997642 3444567889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeeccccccccc
Q 013214 227 IVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305 (447)
Q Consensus 227 lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~ 305 (447)
+||||+++|+|.+++... ..+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.++++|||.+.....
T Consensus 83 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~~ 159 (266)
T cd05064 83 IVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS 159 (266)
T ss_pred EEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence 999999999999999774 56899999999999999999999999 99999999999999999999999998765322
Q ss_pred CCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHH
Q 013214 306 KEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARG 384 (447)
Q Consensus 306 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (447)
..........++..|+|||.+.+..++.++||||||+++|++++ |+.||......+....+......+ .+..++..
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~ 236 (266)
T cd05064 160 EAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLP---APRNCPNL 236 (266)
T ss_pred cchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCC---CCCCCCHH
Confidence 11111122334678999999988899999999999999999875 999998877666555553333333 24557788
Q ss_pred HHHHHHHHcccCCCCCCCHHHHHHHHHHH
Q 013214 385 LKELIEECWNEKPAKRPTFRQIITRLESI 413 (447)
Q Consensus 385 l~~li~~cl~~dp~~Rps~~~~l~~l~~~ 413 (447)
+.+++.+||+.+|.+||++.++++.|.++
T Consensus 237 ~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 237 LHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred HHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 99999999999999999999999988764
No 40
>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]
Probab=100.00 E-value=3.4e-42 Score=302.64 Aligned_cols=249 Identities=25% Similarity=0.417 Sum_probs=212.8
Q ss_pred CcccceeeecceEEEEE-----EcCeEEEEEEcCccc-----CCCHHHHHHHHHHHHHHhcC-CCCcccceeEEEEeCCc
Q 013214 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEV-----ISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSP 224 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~-----~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~ 224 (447)
.|...+.+|.|..+.+. .+|..+|+|++.... .......++...|+.+|+++ .||+|+++.++++++..
T Consensus 18 ~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF 97 (411)
T KOG0599|consen 18 KYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAF 97 (411)
T ss_pred hcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcch
Confidence 35566788998887653 578899999885422 11334456678899999999 79999999999999999
Q ss_pred eEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccc
Q 013214 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304 (447)
Q Consensus 225 ~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~ 304 (447)
+++|+|.|+.|.|.|+|.+.-.+++....++++|+.+|+.|||.++ |+||||||+|||++++.++||+|||+++.+.
T Consensus 98 ~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDFGFa~~l~ 174 (411)
T KOG0599|consen 98 VFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDFGFACQLE 174 (411)
T ss_pred hhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEeccceeeccC
Confidence 9999999999999999998888999999999999999999999998 9999999999999999999999999999876
Q ss_pred cCCCCCcccCCCCCcccCCcccCC------CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCCh
Q 013214 305 VKEDRPLTCQDTSCRYVAPEVFKN------EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPA 378 (447)
Q Consensus 305 ~~~~~~~~~~~~t~~y~aPE~~~~------~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 378 (447)
.+ ......+|||+|+|||.+.. ..|+...|+|++|++||.|+.|++||....+.-..+.+-.+...--++.+
T Consensus 175 ~G--ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~speW 252 (411)
T KOG0599|consen 175 PG--EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPEW 252 (411)
T ss_pred Cc--hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcch
Confidence 44 44566789999999998753 46888999999999999999999999977766666666343333334567
Q ss_pred hhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 379 KLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 379 ~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
.++|.+.++||.+||+.||.+|.|++|++.+
T Consensus 253 adis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 253 ADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred hhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 8899999999999999999999999999865
No 41
>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.
Probab=100.00 E-value=2.5e-41 Score=328.53 Aligned_cols=247 Identities=29% Similarity=0.453 Sum_probs=209.9
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|+..+.||+|+||.|+. +|+.||+|++.............+.+|+.++..++||||+++++++......+++||
T Consensus 2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e 81 (333)
T cd05600 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAME 81 (333)
T ss_pred CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEe
Confidence 577888999999998862 578999999976544344456678889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCC
Q 013214 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (447)
Q Consensus 231 ~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~ 310 (447)
|+++|+|.+++...+.+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++..... .
T Consensus 82 ~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~----~ 154 (333)
T cd05600 82 YVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT----Y 154 (333)
T ss_pred CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc----c
Confidence 9999999999998888999999999999999999999999 99999999999999999999999999876432 2
Q ss_pred cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcC----CCCCCCChhhhHHHHH
Q 013214 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ----RPPFKAPAKLYARGLK 386 (447)
Q Consensus 311 ~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~l~ 386 (447)
.....||+.|+|||.+.+..++.++|||||||++|+|++|+.||...+..+....+.... .+........+++++.
T Consensus 155 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~ 234 (333)
T cd05600 155 ANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAW 234 (333)
T ss_pred cCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHH
Confidence 234467999999999998899999999999999999999999998877655544442221 1222111235678999
Q ss_pred HHHHHHcccCCCCCCCHHHHHHH
Q 013214 387 ELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 387 ~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
++|.+||..+|.+||++.+++++
T Consensus 235 ~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 235 DLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred HHHHHHhhChhhhcCCHHHHHhC
Confidence 99999999999999999999976
No 42
>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]
Probab=100.00 E-value=5e-41 Score=311.39 Aligned_cols=248 Identities=24% Similarity=0.391 Sum_probs=214.6
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
.|+..+.||+|..|.||. ++..+|+|++.++.....+...+.+.|.+||+.++||+++++|..|+.+...|++||
T Consensus 78 ~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~me 157 (459)
T KOG0610|consen 78 HFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVME 157 (459)
T ss_pred HHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEe
Confidence 467778899999999873 458999999998877777778888999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccC--
Q 013214 231 YLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK-- 306 (447)
Q Consensus 231 ~~~~g~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~-- 306 (447)
||+||+|...++++. .++++.+..++.+++-||+|||..| ||.|||||+|||+.++|+|-|+||.++......
T Consensus 158 yCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt 234 (459)
T KOG0610|consen 158 YCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPT 234 (459)
T ss_pred cCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCCCCe
Confidence 999999999998764 4999999999999999999999999 999999999999999999999999987543110
Q ss_pred ------------------------------CCC-----------------------CcccCCCCCcccCCcccCCCCCCC
Q 013214 307 ------------------------------EDR-----------------------PLTCQDTSCRYVAPEVFKNEEYDT 333 (447)
Q Consensus 307 ------------------------------~~~-----------------------~~~~~~~t~~y~aPE~~~~~~~~~ 333 (447)
... ...+..||-.|+|||++.+...+.
T Consensus 235 ~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgs 314 (459)
T KOG0610|consen 235 LVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGS 314 (459)
T ss_pred eeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCc
Confidence 000 012345889999999999999999
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCC----HHHHHH
Q 013214 334 KVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPT----FRQIIT 408 (447)
Q Consensus 334 ~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps----~~~~l~ 408 (447)
.+|+|+||+++|||+.|.-||.+.+..+....+ ....+.++..+ .++..+++||+++|.+||.+|.. +.||-+
T Consensus 315 AVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NI-v~~~l~Fp~~~-~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 315 AVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNI-VGQPLKFPEEP-EVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKR 391 (459)
T ss_pred hhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHH-hcCCCcCCCCC-cchhHHHHHHHHHhccChhhhhccccchHHhhc
Confidence 999999999999999999999999999988887 34444454433 67899999999999999999988 666554
No 43
>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta. Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in
Probab=100.00 E-value=3.4e-41 Score=326.03 Aligned_cols=240 Identities=25% Similarity=0.400 Sum_probs=203.5
Q ss_pred eeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEeccCCCC
Q 013214 162 EITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236 (447)
Q Consensus 162 ~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g~ 236 (447)
.||+|+||.|+ .+|..||+|.+.............+.+|+.+++.++||||+++++++...+..|+||||+++|+
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~ 81 (323)
T cd05595 2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGE 81 (323)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCCc
Confidence 68999999887 3688999999976544344556677889999999999999999999999999999999999999
Q ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCCcccCCC
Q 013214 237 LRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT 316 (447)
Q Consensus 237 L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~ 316 (447)
|..++...+.+++..++.++.|++.||.|||+++ ++||||||+|||++.++.+||+|||++...... ........|
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~-~~~~~~~~g 157 (323)
T cd05595 82 LFFHLSRERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD-GATMKTFCG 157 (323)
T ss_pred HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCC-CCccccccC
Confidence 9999988888999999999999999999999999 999999999999999999999999998753221 112233568
Q ss_pred CCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHHHHHcccC
Q 013214 317 SCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEK 396 (447)
Q Consensus 317 t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 396 (447)
|+.|+|||.+.+..++.++|+|||||++|+|++|+.||...+..+....+... ...+ +..+++++.++|.+||+.|
T Consensus 158 t~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~-~~~~---p~~~~~~~~~li~~~L~~d 233 (323)
T cd05595 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME-EIRF---PRTLSPEAKSLLAGLLKKD 233 (323)
T ss_pred CcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcC-CCCC---CCCCCHHHHHHHHHHccCC
Confidence 99999999998888999999999999999999999999877665555444222 2222 3457889999999999999
Q ss_pred CCCCC-----CHHHHHHH
Q 013214 397 PAKRP-----TFRQIITR 409 (447)
Q Consensus 397 p~~Rp-----s~~~~l~~ 409 (447)
|++|| ++.+++++
T Consensus 234 P~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 234 PKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred HHHhCCCCCCCHHHHHcC
Confidence 99998 88888764
No 44
>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]
Probab=100.00 E-value=1.1e-41 Score=326.03 Aligned_cols=247 Identities=25% Similarity=0.461 Sum_probs=217.5
Q ss_pred cCcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCc-eEEE
Q 013214 155 LDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP-MMIV 228 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~-~~lv 228 (447)
.+|...+.+|+|+||.++ .++..+++|.+........ ..+...+|+.+++++.||||+.+.+.|..++. ++|+
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~-~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEP-ERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCch-hhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 357778899999999764 4678999999987765444 44567889999999999999999999999988 9999
Q ss_pred EeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccC
Q 013214 229 TEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306 (447)
Q Consensus 229 ~e~~~~g~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~ 306 (447)
|+||+||+|.+.+.+.+ .++++.+..|+.|++.|+.|||+++ |+|||||++|||++.++.|+|+|||+|+.+...
T Consensus 83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence 99999999999998654 4899999999999999999999988 999999999999999999999999999987754
Q ss_pred CCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHH
Q 013214 307 EDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLK 386 (447)
Q Consensus 307 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 386 (447)
. .......||+.|++||++.+.+|+.|+|||||||++|||++-+++|...+-..+...+.... +.+.+..++.+++
T Consensus 160 ~-~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~---~~Plp~~ys~el~ 235 (426)
T KOG0589|consen 160 D-SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGL---YSPLPSMYSSELR 235 (426)
T ss_pred h-hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhcc---CCCCCccccHHHH
Confidence 3 23456789999999999999999999999999999999999999999888777766664444 3344678999999
Q ss_pred HHHHHHcccCCCCCCCHHHHHHH
Q 013214 387 ELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 387 ~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
.+|+.|++.+|..||++.+++.+
T Consensus 236 ~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 236 SLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred HHHHHHhhcCCccCCCHHHHhhC
Confidence 99999999999999999999976
No 45
>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional
Probab=100.00 E-value=4.4e-41 Score=327.14 Aligned_cols=245 Identities=24% Similarity=0.391 Sum_probs=207.3
Q ss_pred CcCcccceeeecceEEEEEE---c---CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEE
Q 013214 154 ELDFTNSVEITKGTFILAFW---R---GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227 (447)
Q Consensus 154 ~~~~~~~~~lg~G~~~~~~~---~---g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 227 (447)
..+|...+.||+|+||.|+. . +..||+|.+...........+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 34688889999999998762 1 25899999875544344556778899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCC
Q 013214 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307 (447)
Q Consensus 228 v~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~ 307 (447)
+|||+++|+|.+++.+++.+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++......
T Consensus 109 v~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~- 184 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR- 184 (340)
T ss_pred EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecCCC-
Confidence 9999999999999998888999999999999999999999999 999999999999999999999999998765321
Q ss_pred CCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHH
Q 013214 308 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKE 387 (447)
Q Consensus 308 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 387 (447)
.....||+.|+|||++.+..++.++|+|||||++|+|++|+.||...+.......+.. ....+ +..+++.+.+
T Consensus 185 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~-~~~~~---p~~~~~~~~~ 257 (340)
T PTZ00426 185 ---TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILE-GIIYF---PKFLDNNCKH 257 (340)
T ss_pred ---cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhc-CCCCC---CCCCCHHHHH
Confidence 2334689999999999888899999999999999999999999987665544444422 22222 3446788999
Q ss_pred HHHHHcccCCCCCC-----CHHHHHHH
Q 013214 388 LIEECWNEKPAKRP-----TFRQIITR 409 (447)
Q Consensus 388 li~~cl~~dp~~Rp-----s~~~~l~~ 409 (447)
+|++||+.||.+|+ ++++++++
T Consensus 258 li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 258 LMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred HHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 99999999999995 88888765
No 46
>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma. Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate
Probab=100.00 E-value=4.7e-41 Score=325.70 Aligned_cols=240 Identities=26% Similarity=0.411 Sum_probs=203.9
Q ss_pred eeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEeccCCCC
Q 013214 162 EITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236 (447)
Q Consensus 162 ~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g~ 236 (447)
.||+|+||.|+ .+|+.||+|++.............+.+|+.+++.++||||+++++.+...+..++||||+++|+
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~ 81 (328)
T cd05593 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGE 81 (328)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCC
Confidence 58999999887 3688999999976544444556778889999999999999999999999999999999999999
Q ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCCcccCCC
Q 013214 237 LRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT 316 (447)
Q Consensus 237 L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~ 316 (447)
|.+++...+.+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++...... ........|
T Consensus 82 L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~-~~~~~~~~g 157 (328)
T cd05593 82 LFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITD-AATMKTFCG 157 (328)
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCc-ccccccccC
Confidence 9999988888999999999999999999999999 999999999999999999999999998753221 112233568
Q ss_pred CCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHHHHHcccC
Q 013214 317 SCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEK 396 (447)
Q Consensus 317 t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 396 (447)
|+.|+|||.+.+..++.++|||||||++|+|++|+.||...+..+....+. .....+ +..+++.+.++|++||+.|
T Consensus 158 t~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~-~~~~~~---p~~~~~~~~~li~~~L~~d 233 (328)
T cd05593 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL-MEDIKF---PRTLSADAKSLLSGLLIKD 233 (328)
T ss_pred CcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhc-cCCccC---CCCCCHHHHHHHHHHcCCC
Confidence 999999999988889999999999999999999999998766555444442 222222 3457789999999999999
Q ss_pred CCCCC-----CHHHHHHH
Q 013214 397 PAKRP-----TFRQIITR 409 (447)
Q Consensus 397 p~~Rp-----s~~~~l~~ 409 (447)
|.+|| ++.+++++
T Consensus 234 P~~R~~~~~~~~~~il~h 251 (328)
T cd05593 234 PNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred HHHcCCCCCCCHHHHhcC
Confidence 99997 89998875
No 47
>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]
Probab=100.00 E-value=2.1e-41 Score=318.27 Aligned_cols=251 Identities=26% Similarity=0.404 Sum_probs=203.7
Q ss_pred CcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCC-----------HHHHHHHHHHHHHHhcCCCCcccceeEEE
Q 013214 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISD-----------DDRVRAFRDELALLQKIRHPNVVQFLGAV 219 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~-----------~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 219 (447)
+|...+.||+|.||.|. .+++.||+|++.+..... ....+..++|+.+|++++|||||+++++.
T Consensus 98 qy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvL 177 (576)
T KOG0585|consen 98 QYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVL 177 (576)
T ss_pred heehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEee
Confidence 68889999999999886 368999999997643211 11235788899999999999999999998
Q ss_pred Ee--CCceEEEEeccCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEee
Q 013214 220 TQ--SSPMMIVTEYLPKGDLRAFLKRKGA-LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296 (447)
Q Consensus 220 ~~--~~~~~lv~e~~~~g~L~~~l~~~~~-l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~D 296 (447)
.+ .+.+|||+|||..|.+...- ..++ +++.+++.++++++.||.|||.+| |+||||||+|+|++++|++||+|
T Consensus 178 DDP~s~~~YlVley~s~G~v~w~p-~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~g~VKIsD 253 (576)
T KOG0585|consen 178 DDPESDKLYLVLEYCSKGEVKWCP-PDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSDGTVKISD 253 (576)
T ss_pred cCcccCceEEEEEeccCCccccCC-CCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCCCcEEeec
Confidence 65 46799999999988876432 2334 999999999999999999999999 99999999999999999999999
Q ss_pred cccccccccCCCCC----cccCCCCCcccCCcccCCCC----CCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHh
Q 013214 297 FGVSKLLTVKEDRP----LTCQDTSCRYVAPEVFKNEE----YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA 368 (447)
Q Consensus 297 fg~~~~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~----~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~ 368 (447)
||.+.......... .....|||.|+|||...++. .+.+.||||+||+||+|+.|+.||-+....++...+..
T Consensus 254 FGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIvn 333 (576)
T KOG0585|consen 254 FGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKIVN 333 (576)
T ss_pred cceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHHhc
Confidence 99998764332211 13357899999999987742 34689999999999999999999998877777666633
Q ss_pred cCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHH
Q 013214 369 RQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLES 412 (447)
Q Consensus 369 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~ 412 (447)
. ...++. .+...+.+++||.+||..||++|.+..++..+...
T Consensus 334 ~-pL~fP~-~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwv 375 (576)
T KOG0585|consen 334 D-PLEFPE-NPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWV 375 (576)
T ss_pred C-cccCCC-cccccHHHHHHHHHHhhcChhheeehhhheeccee
Confidence 2 233332 23467899999999999999999999999877543
No 48
>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1. Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus
Probab=100.00 E-value=1.1e-40 Score=327.70 Aligned_cols=250 Identities=26% Similarity=0.391 Sum_probs=205.3
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|+..+.||+|+||.|+. +++.||+|++.............+.+|..++..++||||+++++.+.+...+|+|||
T Consensus 2 ~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E 81 (363)
T cd05628 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIME 81 (363)
T ss_pred CceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEc
Confidence 577788999999998863 578999999976543344556778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCC--
Q 013214 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED-- 308 (447)
Q Consensus 231 ~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~-- 308 (447)
|+++|+|.+++.+.+.+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 82 ~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~ 158 (363)
T cd05628 82 FLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTE 158 (363)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccccccccc
Confidence 9999999999998889999999999999999999999999 99999999999999999999999999875432100
Q ss_pred --------------------------------CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 013214 309 --------------------------------RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTM 356 (447)
Q Consensus 309 --------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~ 356 (447)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~ 238 (363)
T cd05628 159 FYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS 238 (363)
T ss_pred ccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCC
Confidence 001234689999999999988999999999999999999999999988
Q ss_pred CCCCchHHHHHhcC-CCCCCCChhhhHHHHHHHHHHHcc--cCCCCCCCHHHHHHH
Q 013214 357 KHDNEVPKAYAARQ-RPPFKAPAKLYARGLKELIEECWN--EKPAKRPTFRQIITR 409 (447)
Q Consensus 357 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~--~dp~~Rps~~~~l~~ 409 (447)
.+..+....+.... ...++. ...+++++.++|.+++. .++..||++.+++++
T Consensus 239 ~~~~~~~~~i~~~~~~~~~p~-~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 239 ETPQETYKKVMNWKETLIFPP-EVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN 293 (363)
T ss_pred CCHHHHHHHHHcCcCcccCCC-cCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence 77666555553322 222322 22367889999988664 233346899999987
No 49
>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl
Probab=100.00 E-value=6.3e-41 Score=322.72 Aligned_cols=239 Identities=25% Similarity=0.401 Sum_probs=200.3
Q ss_pred eecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEeccCCCCH
Q 013214 163 ITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237 (447)
Q Consensus 163 lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L 237 (447)
||+|+||.|+. +++.||+|.+.............+.+|+.++++++||||+++++.+...+..+++|||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 68999998862 5788999998754433445566788899999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCCcccCCCC
Q 013214 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS 317 (447)
Q Consensus 238 ~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~t 317 (447)
.+++.+.+.+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++....... .......||
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt 156 (312)
T cd05585 81 FHHLQREGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNTFCGT 156 (312)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCC-CccccccCC
Confidence 999988888999999999999999999999999 9999999999999999999999999987533221 122345689
Q ss_pred CcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHHHHHcccCC
Q 013214 318 CRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKP 397 (447)
Q Consensus 318 ~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp 397 (447)
+.|+|||.+.+..++.++|||||||++|+|++|+.||...+..+....+. .....+ +..+++.+.++|.+||+.||
T Consensus 157 ~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~-~~~~~~---~~~~~~~~~~li~~~L~~dp 232 (312)
T cd05585 157 PEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKIL-QEPLRF---PDGFDRDAKDLLIGLLSRDP 232 (312)
T ss_pred cccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHH-cCCCCC---CCcCCHHHHHHHHHHcCCCH
Confidence 99999999998889999999999999999999999998766555444432 222222 34577899999999999999
Q ss_pred CCCCC---HHHHHHH
Q 013214 398 AKRPT---FRQIITR 409 (447)
Q Consensus 398 ~~Rps---~~~~l~~ 409 (447)
.+||+ +.+++.+
T Consensus 233 ~~R~~~~~~~e~l~h 247 (312)
T cd05585 233 TRRLGYNGAQEIKNH 247 (312)
T ss_pred HHcCCCCCHHHHHcC
Confidence 99975 5666654
No 50
>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2. Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po
Probab=100.00 E-value=1e-40 Score=330.00 Aligned_cols=250 Identities=23% Similarity=0.333 Sum_probs=205.6
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
.|...+.||+|+||.|+. +++.||+|++...........+.+.+|+.+++.++||||+++++++.+.+.+++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 467778999999999873 678999999976554455566788999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCC--
Q 013214 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED-- 308 (447)
Q Consensus 231 ~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~-- 308 (447)
|+++|+|.+++.+.+.+++..+..++.|++.||.|||+.+ |+||||||+|||++.++++||+|||++........
T Consensus 82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~ 158 (381)
T cd05626 82 YIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSK 158 (381)
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCcccccccccc
Confidence 9999999999998888999999999999999999999999 99999999999999999999999998753311000
Q ss_pred --------------------------------------------CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHH
Q 013214 309 --------------------------------------------RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALIL 344 (447)
Q Consensus 309 --------------------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l 344 (447)
.......||+.|+|||.+.+..++.++|||||||++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il 238 (381)
T cd05626 159 YYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVIL 238 (381)
T ss_pred cccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHH
Confidence 001134689999999999888899999999999999
Q ss_pred HHHHhCCCCCCCCCCCchHHHHHhcC-CCCCCCChhhhHHHHHHHHHHHc--ccCCCCCCCHHHHHHH
Q 013214 345 QEMIEGCPPFTMKHDNEVPKAYAARQ-RPPFKAPAKLYARGLKELIEECW--NEKPAKRPTFRQIITR 409 (447)
Q Consensus 345 ~~l~tg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl--~~dp~~Rps~~~~l~~ 409 (447)
|+|++|+.||...+..+....+.... ...++ ....+++++.++|.+|+ ..+|..||++.+++++
T Consensus 239 ~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~-~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~h 305 (381)
T cd05626 239 FEMLVGQPPFLAPTPTETQLKVINWENTLHIP-PQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAH 305 (381)
T ss_pred HHHHhCCCCCcCCCHHHHHHHHHccccccCCC-CCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 99999999998877655444442222 22221 22346789999999854 5566669999999875
No 51
>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2. Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph
Probab=100.00 E-value=1.1e-40 Score=323.75 Aligned_cols=248 Identities=22% Similarity=0.395 Sum_probs=202.3
Q ss_pred CcccceeeecceEEEEEE--------cCeEEEEEEcCcccC-CCHHHHHHHHHHHHHHhcC-CCCcccceeEEEEeCCce
Q 013214 156 DFTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVI-SDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPM 225 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~--------~g~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~ 225 (447)
+|+..+.||+|+||.|+. +|+.||+|++.+... ......+.+..|..+++.+ +||+|+++++++..++..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 467788999999998872 578999999865322 1223445678899999999 599999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeeccccccccc
Q 013214 226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305 (447)
Q Consensus 226 ~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~ 305 (447)
+++|||+++|+|.+++.++..+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++.....
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~ 157 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEFLS 157 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCccccc
Confidence 999999999999999988888999999999999999999999999 99999999999999999999999999876543
Q ss_pred CCCCCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHH---HhcCCCCCCCChhhh
Q 013214 306 KEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAY---AARQRPPFKAPAKLY 381 (447)
Q Consensus 306 ~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~---~~~~~~~~~~~~~~~ 381 (447)
..........||+.|+|||.+.+. .++.++|||||||++|+|++|+.||...........+ .....+.+ +..+
T Consensus 158 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~---~~~~ 234 (332)
T cd05614 158 EEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPF---PSFI 234 (332)
T ss_pred cCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCC---CCCC
Confidence 322223345689999999998765 4788999999999999999999999755433222222 12223332 3456
Q ss_pred HHHHHHHHHHHcccCCCCCC-----CHHHHHHH
Q 013214 382 ARGLKELIEECWNEKPAKRP-----TFRQIITR 409 (447)
Q Consensus 382 ~~~l~~li~~cl~~dp~~Rp-----s~~~~l~~ 409 (447)
++.+.+++.+||+.||++|| ++++++++
T Consensus 235 ~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 235 GPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred CHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 78899999999999999999 77788765
No 52
>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica
Probab=100.00 E-value=6.9e-41 Score=329.45 Aligned_cols=249 Identities=25% Similarity=0.420 Sum_probs=206.4
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|+..+.||+|+||.|+. +|+.||+|++.............+.+|+.+++.++||||+++++.+.++...++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (364)
T cd05599 2 DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIME 81 (364)
T ss_pred CceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEEC
Confidence 577788999999998862 688999999976543344556678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCC-
Q 013214 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR- 309 (447)
Q Consensus 231 ~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~- 309 (447)
|+++|+|.+++.+.+.+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.++|+|||++..+......
T Consensus 82 ~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~ 158 (364)
T cd05599 82 YLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTE 158 (364)
T ss_pred CCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecccccccc
Confidence 9999999999998888999999999999999999999999 999999999999999999999999998654321100
Q ss_pred ------------------------------------CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCC
Q 013214 310 ------------------------------------PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPP 353 (447)
Q Consensus 310 ------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p 353 (447)
......||+.|+|||++.+..++.++|||||||++|+|++|..|
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~P 238 (364)
T cd05599 159 FYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPP 238 (364)
T ss_pred ccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCC
Confidence 00123589999999999888999999999999999999999999
Q ss_pred CCCCCCCchHHHHHhcC-CCCCCCChhhhHHHHHHHHHHHcccCCCCCCC---HHHHHHH
Q 013214 354 FTMKHDNEVPKAYAARQ-RPPFKAPAKLYARGLKELIEECWNEKPAKRPT---FRQIITR 409 (447)
Q Consensus 354 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps---~~~~l~~ 409 (447)
|...+..+....+.... ...++. ...+++.+.++|++|+. +|.+|++ +.+++++
T Consensus 239 f~~~~~~~~~~~i~~~~~~~~~~~-~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 239 FCSDNPQETYRKIINWKETLQFPD-EVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred CCCCCHHHHHHHHHcCCCccCCCC-CCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 98777655444442222 122221 22467899999999996 9999998 8888774
No 53
>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the
Probab=100.00 E-value=4.3e-41 Score=329.12 Aligned_cols=249 Identities=27% Similarity=0.424 Sum_probs=209.7
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|...+.||+|+||.|+. +|+.||+|++.............+.+|..++..++||||+++++++.+.+..++|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (350)
T cd05573 2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVME 81 (350)
T ss_pred CceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEc
Confidence 577888999999998862 589999999976544343456778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCC---
Q 013214 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE--- 307 (447)
Q Consensus 231 ~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~--- 307 (447)
|+++++|.+++.+.+.+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 82 ~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~ 158 (350)
T cd05573 82 YMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDRE 158 (350)
T ss_pred CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCcccCccc
Confidence 9999999999988888999999999999999999999998 9999999999999999999999999987654332
Q ss_pred -------------------------CCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCch
Q 013214 308 -------------------------DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV 362 (447)
Q Consensus 308 -------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~ 362 (447)
........||+.|+|||.+.+..++.++|||||||++|+|++|+.||......+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~ 238 (350)
T cd05573 159 YYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQET 238 (350)
T ss_pred ccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHHH
Confidence 0112334589999999999998999999999999999999999999998776555
Q ss_pred HHHHHhcC-CCCCCCChhhhHHHHHHHHHHHcccCCCCCCC-HHHHHHH
Q 013214 363 PKAYAARQ-RPPFKAPAKLYARGLKELIEECWNEKPAKRPT-FRQIITR 409 (447)
Q Consensus 363 ~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps-~~~~l~~ 409 (447)
...+.... ...++. ...+++.+.++|.+||. ||.+||+ +.+++++
T Consensus 239 ~~~i~~~~~~~~~p~-~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 239 YNKIINWKESLRFPP-DPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred HHHHhccCCcccCCC-CCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 44443311 112221 22368899999999997 9999999 9999975
No 54
>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes
Probab=100.00 E-value=1.7e-40 Score=315.68 Aligned_cols=250 Identities=22% Similarity=0.366 Sum_probs=200.8
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|+..+.||+|+||.++. +++.||+|++..... .....+.+.+|+.+++.++||||+++++++..++..++|||
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEE-NEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccc-cccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 577788999999998762 578999999875432 23345667889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCC
Q 013214 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (447)
Q Consensus 231 ~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~ 310 (447)
|++++++..+......+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++..........
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 157 (287)
T cd07848 81 YVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNAN 157 (287)
T ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCccccccccccc
Confidence 9988777665555567999999999999999999999999 9999999999999999999999999998764333333
Q ss_pred cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcC-------------CC-----
Q 013214 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-------------RP----- 372 (447)
Q Consensus 311 ~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~-------------~~----- 372 (447)
.....+++.|+|||++.+..++.++|+|||||++|+|++|+.||...+..+....+.... .+
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07848 158 YTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGL 237 (287)
T ss_pred ccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhccc
Confidence 334567899999999988889999999999999999999999998765433221111100 00
Q ss_pred CCCC----------ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 373 PFKA----------PAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 373 ~~~~----------~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
..+. ....+|..+.++|++||+.||++|||+++++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 238 RFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred ccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0000 012357789999999999999999999999864
No 55
>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]
Probab=100.00 E-value=2.6e-40 Score=320.82 Aligned_cols=249 Identities=28% Similarity=0.433 Sum_probs=220.9
Q ss_pred cCcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC-CCcccceeEEEEeCCceEEE
Q 013214 155 LDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIV 228 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~lv 228 (447)
..|...+.||.|.||.++ .+|+.+|+|.+.+.............+|+.+|+++. ||||+++++.|++...+++|
T Consensus 35 ~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lv 114 (382)
T KOG0032|consen 35 EKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLV 114 (382)
T ss_pred ccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEE
Confidence 367788899999999887 369999999998876655556678899999999998 99999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCC----CCEEEeecccccccc
Q 013214 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS----GNLKVADFGVSKLLT 304 (447)
Q Consensus 229 ~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~----~~vkl~Dfg~~~~~~ 304 (447)
||+|.||.|.+.+... .+++..+..++.|++.++.|||+.| ++|||+||+|+|+... +.+|++|||++....
T Consensus 115 mEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~ 190 (382)
T KOG0032|consen 115 MELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIK 190 (382)
T ss_pred EEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCCceEcc
Confidence 9999999999999876 4999999999999999999999999 9999999999999743 479999999999876
Q ss_pred cCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHH
Q 013214 305 VKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARG 384 (447)
Q Consensus 305 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (447)
. ........||+.|+|||++....|+..+||||+|+++|.|++|..||.+.+..+....+......--...+..++..
T Consensus 191 ~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~~ 268 (382)
T KOG0032|consen 191 P--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDISES 268 (382)
T ss_pred C--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccCHH
Confidence 5 34456678999999999999899999999999999999999999999999988877777444432334557788999
Q ss_pred HHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 385 LKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 385 l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
+.++|+.|+..||.+|+|+.++++|
T Consensus 269 akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 269 AKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred HHHHHHHhcccCcccCCCHHHHhcC
Confidence 9999999999999999999999997
No 56
>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]
Probab=100.00 E-value=3e-41 Score=293.13 Aligned_cols=259 Identities=22% Similarity=0.391 Sum_probs=208.0
Q ss_pred cCCCCcCcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCC-
Q 013214 150 IDPHELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS- 223 (447)
Q Consensus 150 i~~~~~~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~- 223 (447)
+...+.+|++.+.+|+|||..|+ .++..+|+|++.-. ..+..+..++|++..++++|||+++++++...+.
T Consensus 16 v~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~---~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~ 92 (302)
T KOG2345|consen 16 VIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCH---SQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEK 92 (302)
T ss_pred EEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeecc---chHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhc
Confidence 34456789999999999998775 47889999998643 4566778889999999999999999998875443
Q ss_pred ----ceEEEEeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEe
Q 013214 224 ----PMMIVTEYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVA 295 (447)
Q Consensus 224 ----~~~lv~e~~~~g~L~~~l~~----~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~ 295 (447)
..|++++|...|+|.+.+.. +..+++.+.+.|+.++++||++||+..| ++.||||||.|||+++.+.+++.
T Consensus 93 D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~-~yAH~DiKP~NILls~~~~~vl~ 171 (302)
T KOG2345|consen 93 DGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEP-PYAHRDIKPANILLSDSGLPVLM 171 (302)
T ss_pred cCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCC-cccccCCCcceeEecCCCceEEE
Confidence 38999999999999999964 2359999999999999999999999985 79999999999999999999999
Q ss_pred ecccccccccCCCC--------CcccCCCCCcccCCcccCCC---CCCCchhHHHHHHHHHHHHhCCCCCCCCCC--Cch
Q 013214 296 DFGVSKLLTVKEDR--------PLTCQDTSCRYVAPEVFKNE---EYDTKVDVFSFALILQEMIEGCPPFTMKHD--NEV 362 (447)
Q Consensus 296 Dfg~~~~~~~~~~~--------~~~~~~~t~~y~aPE~~~~~---~~~~~~Di~slG~~l~~l~tg~~p~~~~~~--~~~ 362 (447)
|||++......... .+....+|..|.|||.+.-. ..++++|||||||++|+|+.|..||...-. ..+
T Consensus 172 D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSl 251 (302)
T KOG2345|consen 172 DLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSL 251 (302)
T ss_pred eccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeE
Confidence 99998765432111 12334578999999998543 567899999999999999999999974322 111
Q ss_pred HHHHHhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHH
Q 013214 363 PKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESIN 414 (447)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~ 414 (447)
...+ ......++...+ +|+.+.++|+.||+.||.+||+..+++..++++.
T Consensus 252 aLAv-~n~q~s~P~~~~-yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 252 ALAV-QNAQISIPNSSR-YSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred EEee-eccccccCCCCC-ccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 1111 122233333333 8999999999999999999999999999998764
No 57
>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase. Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor
Probab=100.00 E-value=5.2e-41 Score=325.89 Aligned_cols=249 Identities=25% Similarity=0.372 Sum_probs=207.4
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|...+.||+|+||.|+. +|+.||+|++........+..+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (330)
T cd05601 2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVME 81 (330)
T ss_pred CceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEEC
Confidence 577888999999998873 688999999986544444556778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 013214 231 YLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (447)
Q Consensus 231 ~~~~g~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~ 309 (447)
|+++|+|.+++.+. ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.........
T Consensus 82 ~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~ 158 (330)
T cd05601 82 YQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV 158 (330)
T ss_pred CCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCCCce
Confidence 99999999999876 67999999999999999999999999 999999999999999999999999999765433222
Q ss_pred CcccCCCCCcccCCcccC------CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCC-CCCCCChhhhH
Q 013214 310 PLTCQDTSCRYVAPEVFK------NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQR-PPFKAPAKLYA 382 (447)
Q Consensus 310 ~~~~~~~t~~y~aPE~~~------~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 382 (447)
......+|+.|+|||++. ...++.++|||||||++|+|++|+.||......+....+..... ..++ ....++
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~-~~~~~~ 237 (330)
T cd05601 159 NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFP-EDPKVS 237 (330)
T ss_pred eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCC-CCCCCC
Confidence 223346799999999986 44677899999999999999999999987766555444433221 2222 223577
Q ss_pred HHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 383 RGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 383 ~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
+.+.+++..||+ +|.+||++.+++++
T Consensus 238 ~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 238 SDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred HHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 899999999997 99999999999864
No 58
>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha. Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien
Probab=100.00 E-value=7.1e-41 Score=324.19 Aligned_cols=240 Identities=25% Similarity=0.404 Sum_probs=203.0
Q ss_pred eeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEeccCCCC
Q 013214 162 EITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236 (447)
Q Consensus 162 ~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g~ 236 (447)
.||+|+||.|+ .+|+.||+|++.............+.+|..+++.++||||+++++++..++..++||||+++|+
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~ 81 (325)
T cd05594 2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGE 81 (325)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCCc
Confidence 68999999887 3688999999976544444556677889999999999999999999999999999999999999
Q ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCCcccCC
Q 013214 237 LRAFLKRKGALKPSTAVRFALDIARGMNYLHE-NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD 315 (447)
Q Consensus 237 L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~-~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~ 315 (447)
|.+++...+.+++..+..++.|++.||.|||+ .+ ++||||||+||+++.++.+||+|||++...... ........
T Consensus 82 L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~-~~~~~~~~ 157 (325)
T cd05594 82 LFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD-GATMKTFC 157 (325)
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCC-Cccccccc
Confidence 99999888889999999999999999999997 67 999999999999999999999999998753221 11223346
Q ss_pred CCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHHHHHccc
Q 013214 316 TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNE 395 (447)
Q Consensus 316 ~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 395 (447)
||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+. .....+ +..+++++.++|++||+.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~-~~~~~~---p~~~~~~~~~li~~~L~~ 233 (325)
T cd05594 158 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL-MEEIRF---PRTLSPEAKSLLSGLLKK 233 (325)
T ss_pred CCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHh-cCCCCC---CCCCCHHHHHHHHHHhhc
Confidence 8999999999988889999999999999999999999998776655544442 222222 345678999999999999
Q ss_pred CCCCCC-----CHHHHHHH
Q 013214 396 KPAKRP-----TFRQIITR 409 (447)
Q Consensus 396 dp~~Rp-----s~~~~l~~ 409 (447)
||++|+ ++.+++++
T Consensus 234 dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 234 DPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred CHHHhCCCCCCCHHHHhcC
Confidence 999996 89999865
No 59
>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1. Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k
Probab=100.00 E-value=7.5e-40 Score=314.04 Aligned_cols=252 Identities=28% Similarity=0.463 Sum_probs=201.8
Q ss_pred cCcccceeeecceEEEEEE---------------------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCccc
Q 013214 155 LDFTNSVEITKGTFILAFW---------------------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVV 213 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~---------------------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv 213 (447)
.+|...+.||+|+||.|+. ++..||+|.+.... .......+.+|+.++.+++||||+
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv 82 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA--NKNARNDFLKEVKILSRLKDPNII 82 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC--CHHHHHHHHHHHHHHhhcCCCCee
Confidence 3577788999999998863 23479999987542 345567889999999999999999
Q ss_pred ceeEEEEeCCceEEEEeccCCCCHHHHHHhcC-------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 013214 214 QFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG-------------------ALKPSTAVRFALDIARGMNYLHENKPVPI 274 (447)
Q Consensus 214 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-------------------~l~~~~~~~i~~ql~~~l~~lH~~~~~~i 274 (447)
++++++......+++|||+++|+|.+++.... .+++..++.++.|++.||.|||+.+ +
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i 159 (304)
T cd05096 83 RLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---F 159 (304)
T ss_pred EEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---c
Confidence 99999999999999999999999999986532 3567788999999999999999999 9
Q ss_pred EeCCCCCCCEEEcCCCCEEEeecccccccccCCCC-CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh--CC
Q 013214 275 IHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE--GC 351 (447)
Q Consensus 275 ~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t--g~ 351 (447)
+|+||||+||+++.++.+||+|||++......... ......++..|+|||.+.+..++.++||||||+++|+|++ +.
T Consensus 160 vH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~ 239 (304)
T cd05096 160 VHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKE 239 (304)
T ss_pred cccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCC
Confidence 99999999999999999999999998765332111 1122334778999999988889999999999999999986 56
Q ss_pred CCCCCCCCCchHHHHHhc----CCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHH
Q 013214 352 PPFTMKHDNEVPKAYAAR----QRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLE 411 (447)
Q Consensus 352 ~p~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~ 411 (447)
.||...+..+........ ........++.++..+.+++.+||+.||++|||+.++.+.|+
T Consensus 240 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 240 QPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 788776655443332111 111112223456788999999999999999999999988875
No 60
>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2. Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst
Probab=100.00 E-value=1e-39 Score=316.80 Aligned_cols=248 Identities=25% Similarity=0.449 Sum_probs=205.1
Q ss_pred CcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEE
Q 013214 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 228 (447)
Q Consensus 154 ~~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 228 (447)
..+|+..+.||+|+||.|+. +|..+|+|.+.... .....+.+.+|+++++.++||||+++++++..++..+++
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 81 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 81 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 34788888999999998863 57889999987542 344567789999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 013214 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (447)
Q Consensus 229 ~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~ 308 (447)
|||+++++|.+++.....+++..+..++.|++.||.|||+.+ .++|+||||+||+++.++.+||+|||++......
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 157 (331)
T cd06649 82 MEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 157 (331)
T ss_pred eecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc--
Confidence 999999999999998888999999999999999999999863 2999999999999999999999999998755322
Q ss_pred CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHH---------------------
Q 013214 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYA--------------------- 367 (447)
Q Consensus 309 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~--------------------- 367 (447)
......+++.|+|||.+.+..++.++|+|||||++|+|++|+.||...+..+....+.
T Consensus 158 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (331)
T cd06649 158 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPP 236 (331)
T ss_pred -ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccccc
Confidence 2233467899999999998889999999999999999999999997554332221110
Q ss_pred -------------------------hcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHH
Q 013214 368 -------------------------ARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRL 410 (447)
Q Consensus 368 -------------------------~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l 410 (447)
....+.. ....+++++.++|.+||+.||++|||+.+++++-
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~ 302 (331)
T cd06649 237 GRPVSGHGMDSRPAMAIFELLDYIVNEPPPKL--PNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT 302 (331)
T ss_pred cccccccccccccchhHHHHHHHHHhCCCcCC--CCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 0001111 1224678899999999999999999999999863
No 61
>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]
Probab=100.00 E-value=1.6e-40 Score=299.89 Aligned_cols=251 Identities=28% Similarity=0.407 Sum_probs=206.3
Q ss_pred CCcCcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeC--Cce
Q 013214 153 HELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--SPM 225 (447)
Q Consensus 153 ~~~~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~ 225 (447)
...+|+....|++|+||.|| .+++.||+|+++.+.-...-.... .+|+.+|.+.+|||||.+-.+.... +.+
T Consensus 74 sv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPIts-LREIniLl~~~H~NIV~vkEVVvG~~~d~i 152 (419)
T KOG0663|consen 74 SVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITS-LREINILLKARHPNIVEVKEVVVGSNMDKI 152 (419)
T ss_pred cHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchh-HHHHHHHHhcCCCCeeeeEEEEecccccee
Confidence 33467888899999999998 368899999998765333333333 4699999999999999999887643 569
Q ss_pred EEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccc
Q 013214 226 MIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304 (447)
Q Consensus 226 ~lv~e~~~~g~L~~~l~~~~-~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~ 304 (447)
|+|||||+ .+|...+..-+ +++..++..++.|++.|++|||.++ |+||||||+|+|++..|.+|++|||+|+.++
T Consensus 153 y~VMe~~E-hDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg 228 (419)
T KOG0663|consen 153 YIVMEYVE-HDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYG 228 (419)
T ss_pred eeeHHHHH-hhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhc
Confidence 99999995 59999998765 7999999999999999999999999 9999999999999999999999999999887
Q ss_pred cCCCCCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcC-CC------CCCC
Q 013214 305 VKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RP------PFKA 376 (447)
Q Consensus 305 ~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~-~~------~~~~ 376 (447)
.+ ..+.+....|.+|.|||.+.+. .|++..|+||+||++.||+++++.|.+....+....+...- .| .+..
T Consensus 229 sp-~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~ 307 (419)
T KOG0663|consen 229 SP-LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSE 307 (419)
T ss_pred CC-cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccc
Confidence 54 4556667789999999998875 68999999999999999999999999887765554442211 11 1111
Q ss_pred C---------------------hhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 377 P---------------------AKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 377 ~---------------------~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
. ....+..-.+|+..+|..||.+|.|+++.+++
T Consensus 308 lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 308 LPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred cchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 0 01145778899999999999999999998875
No 62
>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of
Probab=100.00 E-value=1.3e-40 Score=329.04 Aligned_cols=249 Identities=24% Similarity=0.379 Sum_probs=204.2
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|...+.||+|+||.|+. +|+.||+|++........+..+.+.+|+.+++.++||||+++++++.+....|+|||
T Consensus 2 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E 81 (377)
T cd05629 2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIME 81 (377)
T ss_pred CceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEe
Confidence 577788999999998873 688999999875433344556778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCC--
Q 013214 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED-- 308 (447)
Q Consensus 231 ~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~-- 308 (447)
|+++|+|.+++...+.+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++..+.....
T Consensus 82 ~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 158 (377)
T cd05629 82 FLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSA 158 (377)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccccccccccccc
Confidence 9999999999988888999999999999999999999999 99999999999999999999999999863211000
Q ss_pred -----------C---------------------------------CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHH
Q 013214 309 -----------R---------------------------------PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALIL 344 (447)
Q Consensus 309 -----------~---------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l 344 (447)
. ......||+.|+|||++.+..++.++|||||||++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 238 (377)
T cd05629 159 YYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIM 238 (377)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhh
Confidence 0 00123589999999999888899999999999999
Q ss_pred HHHHhCCCCCCCCCCCchHHHHHhcC-CCCCCCChhhhHHHHHHHHHHHcccCCCCC---CCHHHHHHH
Q 013214 345 QEMIEGCPPFTMKHDNEVPKAYAARQ-RPPFKAPAKLYARGLKELIEECWNEKPAKR---PTFRQIITR 409 (447)
Q Consensus 345 ~~l~tg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dp~~R---ps~~~~l~~ 409 (447)
|+|++|+.||......+....+.... ...++ ....++.++.++|.+|+. +|.+| +++.+++.+
T Consensus 239 ~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p-~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~h 305 (377)
T cd05629 239 FECLIGWPPFCSENSHETYRKIINWRETLYFP-DDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSH 305 (377)
T ss_pred hhhhcCCCCCCCCCHHHHHHHHHccCCccCCC-CCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcC
Confidence 99999999998776555444442221 22222 223467899999999997 77765 599998876
No 63
>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=6e-41 Score=306.94 Aligned_cols=248 Identities=28% Similarity=0.430 Sum_probs=204.0
Q ss_pred cccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEe-----CCceE
Q 013214 157 FTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ-----SSPMM 226 (447)
Q Consensus 157 ~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~~~~~ 226 (447)
|...+.||+|++|.|. .+|+.||+|++... +...-..++..+|+++|+.++|+||+.+.+.+.. -+.+|
T Consensus 24 y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~-F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvY 102 (359)
T KOG0660|consen 24 YVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNP-FENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVY 102 (359)
T ss_pred ecccccccCcceeeEEEEEEcCCCCEeehhhhhhh-hhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeE
Confidence 4445789999999874 47899999999743 3455556677789999999999999999998865 24689
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccC
Q 013214 227 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306 (447)
Q Consensus 227 lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~ 306 (447)
+|+|+| +.+|...++++..++++.+..++.|++.||+|+||.+ ++|||+||+|++++.+..+||||||+|+.....
T Consensus 103 iV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~ 178 (359)
T KOG0660|consen 103 LVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLARYLDKF 178 (359)
T ss_pred EehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccceeecccc
Confidence 999999 6799999999888999999999999999999999999 999999999999999999999999999977533
Q ss_pred C-CCCcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHh----------------
Q 013214 307 E-DRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA---------------- 368 (447)
Q Consensus 307 ~-~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~---------------- 368 (447)
. ....+.+..|.+|.|||++.. ..|+...||||+||++.||++|++.|.+.+.......+..
T Consensus 179 ~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~ 258 (359)
T KOG0660|consen 179 FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSE 258 (359)
T ss_pred CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccH
Confidence 1 233467788999999998755 4899999999999999999999999998875433222211
Q ss_pred ------cC-----CCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 369 ------RQ-----RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 369 ------~~-----~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
.. +.++....++.++...+|+++||..||.+|+|+++++++
T Consensus 259 ~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 259 KARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred HHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 00 112222234677899999999999999999999999875
No 64
>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta. Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp
Probab=100.00 E-value=2.1e-40 Score=319.54 Aligned_cols=239 Identities=29% Similarity=0.485 Sum_probs=197.7
Q ss_pred eeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeEEEEeCCceEEEEeccCCC
Q 013214 162 EITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKG 235 (447)
Q Consensus 162 ~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~g 235 (447)
.||+|+||.|+. +++.||+|.++..........+.+..|..++... +||||+++++++......++||||+++|
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg 81 (316)
T cd05592 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGG 81 (316)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence 689999998862 5788999999765433334445556677777654 8999999999999999999999999999
Q ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCCcccCC
Q 013214 236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD 315 (447)
Q Consensus 236 ~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~ 315 (447)
+|.+++...+.+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++....... .......
T Consensus 82 ~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~~~~~ 157 (316)
T cd05592 82 DLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKASTFC 157 (316)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Ccccccc
Confidence 99999988888999999999999999999999998 9999999999999999999999999987543222 2223456
Q ss_pred CCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHHHHHccc
Q 013214 316 TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNE 395 (447)
Q Consensus 316 ~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 395 (447)
||+.|+|||.+.+..++.++|||||||++|+|++|+.||.+.+..+....+ ....+.+ +..++.++.+++.+||+.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i-~~~~~~~---~~~~~~~~~~ll~~~l~~ 233 (316)
T cd05592 158 GTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSI-LNDRPHF---PRWISKEAKDCLSKLFER 233 (316)
T ss_pred CCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHH-HcCCCCC---CCCCCHHHHHHHHHHccC
Confidence 899999999998888999999999999999999999999987765555444 2233333 345678899999999999
Q ss_pred CCCCCCCHH-HHHH
Q 013214 396 KPAKRPTFR-QIIT 408 (447)
Q Consensus 396 dp~~Rps~~-~~l~ 408 (447)
||.+||++. ++++
T Consensus 234 ~P~~R~~~~~~l~~ 247 (316)
T cd05592 234 DPTKRLGVDGDIRQ 247 (316)
T ss_pred CHHHcCCChHHHHc
Confidence 999999875 5544
No 65
>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor. Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti
Probab=100.00 E-value=7.4e-40 Score=322.66 Aligned_cols=253 Identities=28% Similarity=0.466 Sum_probs=205.1
Q ss_pred CcCcccceeeecceEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeEEEEeC
Q 013214 154 ELDFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQS 222 (447)
Q Consensus 154 ~~~~~~~~~lg~G~~~~~~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~ 222 (447)
..+|+..+.||+|+||.|+. ++..||+|+++... ..+..+.+.+|+.+++.+ +||||+++++++...
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~ 114 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA--HTDEREALMSELKILSHLGQHKNIVNLLGACTHG 114 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC--CHHHHHHHHHHHHHHHhhccCCceeeEeeEecCC
Confidence 34688889999999998862 22479999997543 334456788999999999 899999999999999
Q ss_pred CceEEEEeccCCCCHHHHHHhc----------------------------------------------------------
Q 013214 223 SPMMIVTEYLPKGDLRAFLKRK---------------------------------------------------------- 244 (447)
Q Consensus 223 ~~~~lv~e~~~~g~L~~~l~~~---------------------------------------------------------- 244 (447)
+..+++|||+++|+|.+++...
T Consensus 115 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (374)
T cd05106 115 GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS 194 (374)
T ss_pred CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence 9999999999999999998642
Q ss_pred ------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCC-c
Q 013214 245 ------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP-L 311 (447)
Q Consensus 245 ------------~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~-~ 311 (447)
.++++..++.++.|++.||.|||+.+ ++||||||+||++++++.+||+|||++.......... .
T Consensus 195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~ 271 (374)
T cd05106 195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVK 271 (374)
T ss_pred ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeec
Confidence 13677888999999999999999998 9999999999999999999999999987654322111 1
Q ss_pred ccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcC-CCCCCCChhhhHHHHHHHH
Q 013214 312 TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQ-RPPFKAPAKLYARGLKELI 389 (447)
Q Consensus 312 ~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li 389 (447)
....++..|+|||++.+..++.++||||||+++|+|++ |+.||................ .+.. +..+++++.+++
T Consensus 272 ~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li 348 (374)
T cd05106 272 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSR---PDFAPPEIYSIM 348 (374)
T ss_pred cCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccC---CCCCCHHHHHHH
Confidence 12234567999999988889999999999999999997 999998766544333332222 2222 233578899999
Q ss_pred HHHcccCCCCCCCHHHHHHHHHHHH
Q 013214 390 EECWNEKPAKRPTFRQIITRLESIN 414 (447)
Q Consensus 390 ~~cl~~dp~~Rps~~~~l~~l~~~~ 414 (447)
.+||+.||++|||+.++++.|+++.
T Consensus 349 ~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 349 KMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred HHHcCCChhhCcCHHHHHHHHHHHh
Confidence 9999999999999999999998863
No 66
>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta. Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal
Probab=100.00 E-value=1.8e-40 Score=320.52 Aligned_cols=234 Identities=25% Similarity=0.417 Sum_probs=197.2
Q ss_pred eeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeEEEEeCCceEEEEeccCCC
Q 013214 162 EITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKG 235 (447)
Q Consensus 162 ~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~g 235 (447)
.||+|+||.|+ .+++.||+|++...........+.+..|..++... +||||+++++++...+.+++||||+++|
T Consensus 2 ~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g 81 (320)
T cd05590 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGG 81 (320)
T ss_pred eeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCCc
Confidence 68999999886 25789999998765433344556677788888876 7999999999999999999999999999
Q ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCCcccCC
Q 013214 236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD 315 (447)
Q Consensus 236 ~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~ 315 (447)
+|.+++.+.+.+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++...... ........
T Consensus 82 ~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~-~~~~~~~~ 157 (320)
T cd05590 82 DLMFHIQKSRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN-GKTTSTFC 157 (320)
T ss_pred hHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC-CCcccccc
Confidence 99999988888999999999999999999999999 999999999999999999999999998753221 11223456
Q ss_pred CCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHHHHHccc
Q 013214 316 TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNE 395 (447)
Q Consensus 316 ~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 395 (447)
||+.|+|||.+.+..++.++|+|||||++|+|++|+.||...+..+....+.. ....+ +..++.++.++|++||+.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~-~~~~~---~~~~~~~~~~li~~~L~~ 233 (320)
T cd05590 158 GTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN-DEVVY---PTWLSQDAVDILKAFMTK 233 (320)
T ss_pred cCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhc-CCCCC---CCCCCHHHHHHHHHHccc
Confidence 89999999999888899999999999999999999999998776665555532 22222 334678899999999999
Q ss_pred CCCCCCCH
Q 013214 396 KPAKRPTF 403 (447)
Q Consensus 396 dp~~Rps~ 403 (447)
||.+||++
T Consensus 234 dP~~R~~~ 241 (320)
T cd05590 234 NPTMRLGS 241 (320)
T ss_pred CHHHCCCC
Confidence 99999998
No 67
>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors. Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer
Probab=100.00 E-value=9.3e-40 Score=309.98 Aligned_cols=249 Identities=33% Similarity=0.557 Sum_probs=207.9
Q ss_pred CcccceeeecceEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCce
Q 013214 156 DFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 225 (447)
+|+..+.||+|+||.|+. ....||+|.+.... .......+.+|+.+++.++||||+++++++......
T Consensus 6 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T cd05048 6 AVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA--EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPT 83 (283)
T ss_pred HcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC--CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCce
Confidence 567778899999998762 12579999987542 445567789999999999999999999999998999
Q ss_pred EEEEeccCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCC
Q 013214 226 MIVTEYLPKGDLRAFLKRK----------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289 (447)
Q Consensus 226 ~lv~e~~~~g~L~~~l~~~----------------~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~ 289 (447)
+++|||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++++
T Consensus 84 ~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~ 160 (283)
T cd05048 84 CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEG 160 (283)
T ss_pred EEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCC
Confidence 9999999999999999764 34778889999999999999999999 9999999999999999
Q ss_pred CCEEEeecccccccccCCC-CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHH
Q 013214 290 GNLKVADFGVSKLLTVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYA 367 (447)
Q Consensus 290 ~~vkl~Dfg~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~ 367 (447)
+.++|+|||++........ .......+++.|+|||.+.+..++.++|+|||||++|+|++ |..||.+....+....+.
T Consensus 161 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~ 240 (283)
T cd05048 161 LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIR 240 (283)
T ss_pred CcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 9999999999875432211 11223345788999999988889999999999999999998 999998877766655554
Q ss_pred hcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHH
Q 013214 368 ARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLES 412 (447)
Q Consensus 368 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~ 412 (447)
....+. .+..+++++.+++.+||+.||.+||++.+++++|+.
T Consensus 241 ~~~~~~---~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 241 SRQLLP---CPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred cCCcCC---CcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 333332 245678999999999999999999999999999875
No 68
>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase. Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in
Probab=100.00 E-value=2.3e-40 Score=325.88 Aligned_cols=250 Identities=23% Similarity=0.321 Sum_probs=206.0
Q ss_pred cCcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEE
Q 013214 155 LDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 229 (447)
.+|+..+.||+|+||.|+ .+++.||+|.+.............+.+|+.+++.++||||+++++++.++...++||
T Consensus 43 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~ 122 (370)
T cd05596 43 EDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVM 122 (370)
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEE
Confidence 468888899999999887 368899999987543333344456788999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 013214 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (447)
Q Consensus 230 e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~ 309 (447)
||+++|+|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.........
T Consensus 123 Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~~ 198 (370)
T cd05596 123 EYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMV 198 (370)
T ss_pred cCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeeccCCCcc
Confidence 99999999998865 45889999999999999999999999 999999999999999999999999998765432222
Q ss_pred CcccCCCCCcccCCcccCCC----CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcC-CCCCCCChhhhHHH
Q 013214 310 PLTCQDTSCRYVAPEVFKNE----EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RPPFKAPAKLYARG 384 (447)
Q Consensus 310 ~~~~~~~t~~y~aPE~~~~~----~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 384 (447)
......||+.|+|||.+.+. .++.++|+|||||++|+|++|+.||...+.......+.... ...++ ....+|.+
T Consensus 199 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~-~~~~~s~~ 277 (370)
T cd05596 199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFP-DDIEISKQ 277 (370)
T ss_pred cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCC-CcCCCCHH
Confidence 22345689999999998653 47889999999999999999999999877655555553322 22222 23357889
Q ss_pred HHHHHHHHcccCCCC--CCCHHHHHHH
Q 013214 385 LKELIEECWNEKPAK--RPTFRQIITR 409 (447)
Q Consensus 385 l~~li~~cl~~dp~~--Rps~~~~l~~ 409 (447)
+.++|.+||+.+|.+ |+++.+++++
T Consensus 278 ~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 278 AKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred HHHHHHHHccChhhccCCCCHHHHhcC
Confidence 999999999999988 9999999876
No 69
>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit. Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce
Probab=100.00 E-value=1e-39 Score=321.97 Aligned_cols=249 Identities=29% Similarity=0.477 Sum_probs=202.0
Q ss_pred CcccceeeecceEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeEEEEeCCc
Q 013214 156 DFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSP 224 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~ 224 (447)
+|+..+.||+|+||.|+. ++..||+|+++... .....+.+.+|+.+++.+ +||||+++++++.....
T Consensus 36 ~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 36 RLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred HeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc--CcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 677788999999998852 35689999987543 223446788899999999 89999999999999999
Q ss_pred eEEEEeccCCCCHHHHHHhcC-----------------------------------------------------------
Q 013214 225 MMIVTEYLPKGDLRAFLKRKG----------------------------------------------------------- 245 (447)
Q Consensus 225 ~~lv~e~~~~g~L~~~l~~~~----------------------------------------------------------- 245 (447)
.+++|||+++|+|.+++.+..
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 999999999999999986432
Q ss_pred ----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 013214 246 ----------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (447)
Q Consensus 246 ----------------~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~ 309 (447)
.+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 3677888999999999999999998 999999999999999999999999998765432211
Q ss_pred C-cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcC-CCCCCCChhhhHHHHH
Q 013214 310 P-LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQ-RPPFKAPAKLYARGLK 386 (447)
Q Consensus 310 ~-~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~ 386 (447)
. .....++..|+|||.+.+..++.++||||||+++|+|++ |..||................ ++.. +...+.++.
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~ 347 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLS---PECAPSEMY 347 (375)
T ss_pred cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCC---CCCCCHHHH
Confidence 1 112234667999999998899999999999999999998 899998765443322222222 2221 234567899
Q ss_pred HHHHHHcccCCCCCCCHHHHHHHHHH
Q 013214 387 ELIEECWNEKPAKRPTFRQIITRLES 412 (447)
Q Consensus 387 ~li~~cl~~dp~~Rps~~~~l~~l~~ 412 (447)
+++.+||+.||++|||+.++++.|++
T Consensus 348 ~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 348 DIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred HHHHHHccCChhHCcCHHHHHHHHHh
Confidence 99999999999999999999999886
No 70
>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase. Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in
Probab=100.00 E-value=3.4e-40 Score=319.12 Aligned_cols=241 Identities=24% Similarity=0.424 Sum_probs=200.9
Q ss_pred eeeecceEEEEEE--------cCeEEEEEEcCcccC-CCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEec
Q 013214 161 VEITKGTFILAFW--------RGIQVAVKKLGEEVI-SDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (447)
Q Consensus 161 ~~lg~G~~~~~~~--------~g~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 231 (447)
+.||+|+||.|+. .++.||+|.+..... ........+.+|+.+++.++||||+++++.+..++..+++|||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 4799999998862 578899999875432 1223345678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCCc
Q 013214 232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPL 311 (447)
Q Consensus 232 ~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~ 311 (447)
+++++|.+++.+.+.+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++...... ....
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~ 157 (323)
T cd05584 82 LSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHE-GTVT 157 (323)
T ss_pred CCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccC-CCcc
Confidence 999999999998888999999999999999999999999 999999999999999999999999998643221 1122
Q ss_pred ccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHHHH
Q 013214 312 TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEE 391 (447)
Q Consensus 312 ~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 391 (447)
....||+.|+|||++.+..++.++||||||+++|+|++|+.||...+.......+.. ....+ +..+++.+.++|.+
T Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~-~~~~~---~~~~~~~~~~li~~ 233 (323)
T cd05584 158 HTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILK-GKLNL---PPYLTPEARDLLKK 233 (323)
T ss_pred cccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHc-CCCCC---CCCCCHHHHHHHHH
Confidence 345689999999999888889999999999999999999999987765554444422 22222 34467889999999
Q ss_pred HcccCCCCCC-----CHHHHHHH
Q 013214 392 CWNEKPAKRP-----TFRQIITR 409 (447)
Q Consensus 392 cl~~dp~~Rp-----s~~~~l~~ 409 (447)
||+.||++|| ++.+++++
T Consensus 234 ~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 234 LLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred HcccCHhHcCCCCCCCHHHHhcC
Confidence 9999999999 78888764
No 71
>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1. Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an
Probab=100.00 E-value=2.4e-40 Score=327.68 Aligned_cols=249 Identities=24% Similarity=0.345 Sum_probs=204.0
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
.|...+.||+|+||.|+. +++.||+|++...........+.+.+|+.+++.++||||+++++.+.+...+++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 467788999999998863 678999999876543344556788899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCC---
Q 013214 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE--- 307 (447)
Q Consensus 231 ~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~--- 307 (447)
|+++|+|.+++.+.+.+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~ 158 (382)
T cd05625 82 YIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 158 (382)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCcccccccccc
Confidence 9999999999988888999999999999999999999999 9999999999999999999999999975321000
Q ss_pred -------------------------------------------CCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHH
Q 013214 308 -------------------------------------------DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALIL 344 (447)
Q Consensus 308 -------------------------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l 344 (447)
........||+.|+|||++.+..++.++|||||||++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil 238 (382)
T cd05625 159 YYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 238 (382)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHH
Confidence 0001124589999999999988999999999999999
Q ss_pred HHHHhCCCCCCCCCCCchHHHHHhcC-CCCCCCChhhhHHHHHHHHHHHcccCCCCCCC---HHHHHHH
Q 013214 345 QEMIEGCPPFTMKHDNEVPKAYAARQ-RPPFKAPAKLYARGLKELIEECWNEKPAKRPT---FRQIITR 409 (447)
Q Consensus 345 ~~l~tg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps---~~~~l~~ 409 (447)
|+|++|+.||...+..+....+.... ...++ ....+++++.++|.+|+ .+|.+|++ +.+++++
T Consensus 239 ~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p-~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h 305 (382)
T cd05625 239 YEMLVGQPPFLAQTPLETQMKVINWQTSLHIP-PQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAH 305 (382)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHccCCCcCCC-CcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcC
Confidence 99999999999876655444443322 22221 23456788999998876 59999987 8877754
No 72
>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=2.8e-40 Score=312.73 Aligned_cols=243 Identities=24% Similarity=0.460 Sum_probs=211.5
Q ss_pred cccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEec
Q 013214 157 FTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (447)
Q Consensus 157 ~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 231 (447)
|...+-||+|-|..|. .+|+.||||++.+....+ -....+.+|+++|+.++|||||++|++...+..+|||+|+
T Consensus 20 YDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~-~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLEL 98 (864)
T KOG4717|consen 20 YDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDT-LSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILEL 98 (864)
T ss_pred ehhhhhhcCCceehhhhhhhhcccceeEEEEecccccch-hhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEe
Confidence 5556679999998774 699999999998876543 3446677899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEc-CCCCEEEeecccccccccCCCC
Q 013214 232 LPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVADFGVSKLLTVKEDR 309 (447)
Q Consensus 232 ~~~g~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~-~~~~vkl~Dfg~~~~~~~~~~~ 309 (447)
-++|+|++|+-+. ..+.++.+.+++.||+.|+.|||+.. +|||||||+|+.+- .-|-|||.|||++..+..+ .
T Consensus 99 GD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG--~ 173 (864)
T KOG4717|consen 99 GDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG--K 173 (864)
T ss_pred cCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCCc--c
Confidence 9999999999765 45999999999999999999999998 99999999999876 6789999999999766543 3
Q ss_pred CcccCCCCCcccCCcccCCCCCCC-chhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHH
Q 013214 310 PLTCQDTSCRYVAPEVFKNEEYDT-KVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKEL 388 (447)
Q Consensus 310 ~~~~~~~t~~y~aPE~~~~~~~~~-~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 388 (447)
.....+|+..|-|||++.+..|+. .+||||||++||.|.+|++||+..++.+..-.+ ....... +..++.++++|
T Consensus 174 kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmI-mDCKYtv---PshvS~eCrdL 249 (864)
T KOG4717|consen 174 KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMI-MDCKYTV---PSHVSKECRDL 249 (864)
T ss_pred hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhh-hcccccC---chhhhHHHHHH
Confidence 445678899999999999998884 799999999999999999999999998877666 3333332 56789999999
Q ss_pred HHHHcccCCCCCCCHHHHHHH
Q 013214 389 IEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 389 i~~cl~~dp~~Rps~~~~l~~ 409 (447)
|..||..||++|.+.++|...
T Consensus 250 I~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 250 IQSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred HHHHHhcCchhhccHHHHhcc
Confidence 999999999999999998864
No 73
>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor. Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.
Probab=100.00 E-value=1.2e-40 Score=329.08 Aligned_cols=249 Identities=23% Similarity=0.331 Sum_probs=204.7
Q ss_pred CcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|+..+.||+|+||.|+ .+++.||+|++.............+.+|+.+++.++||||+++++.+.+++.+++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 57788899999999887 3578999999875433333445678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCC--
Q 013214 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED-- 308 (447)
Q Consensus 231 ~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~-- 308 (447)
|+++|+|.+++.+.+.+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++..+.....
T Consensus 82 ~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~ 158 (376)
T cd05598 82 YIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 158 (376)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccc
Confidence 9999999999988888999999999999999999999999 99999999999999999999999999753211000
Q ss_pred ----------------------------------------CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHH
Q 013214 309 ----------------------------------------RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMI 348 (447)
Q Consensus 309 ----------------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~ 348 (447)
.......||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell 238 (376)
T cd05598 159 YYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 238 (376)
T ss_pred ccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehh
Confidence 0011246899999999999889999999999999999999
Q ss_pred hCCCCCCCCCCCchHHHHHhcC-CCCCCCChhhhHHHHHHHHHHHcccCCCCCC---CHHHHHHH
Q 013214 349 EGCPPFTMKHDNEVPKAYAARQ-RPPFKAPAKLYARGLKELIEECWNEKPAKRP---TFRQIITR 409 (447)
Q Consensus 349 tg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp---s~~~~l~~ 409 (447)
+|+.||......+....+.... ...+ .....+++.+.++|.+|+ .+|.+|+ ++.+++++
T Consensus 239 ~G~~Pf~~~~~~~~~~~i~~~~~~~~~-~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 239 VGQPPFLADTPAETQLKVINWETTLHI-PSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred hCCCCCCCCCHHHHHHHHhccCccccC-CCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 9999999877655544442222 1111 122356788999999976 5999999 88998876
No 74
>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase. Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays
Probab=100.00 E-value=1.8e-39 Score=304.71 Aligned_cols=248 Identities=29% Similarity=0.516 Sum_probs=206.2
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|...+.||+|++|.++. .++.||+|.+... ......+.+|+++++.++||||+++++++..+...+++||
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (263)
T cd05052 7 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 82 (263)
T ss_pred HeEEeeecCCcccceEEEEEEecCCceEEEEEecCC----chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEE
Confidence 466678899999987752 5789999998643 2234678889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 013214 231 YLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (447)
Q Consensus 231 ~~~~g~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~ 308 (447)
|+++++|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||++........
T Consensus 83 ~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~ 159 (263)
T cd05052 83 FMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 159 (263)
T ss_pred eCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCcccccccccee
Confidence 999999999997643 4889999999999999999999998 99999999999999999999999999886543322
Q ss_pred CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHH
Q 013214 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKE 387 (447)
Q Consensus 309 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 387 (447)
........+..|+|||.+.+..++.++||||||+++|+|++ |..||......+....+.....+. .+..++.++.+
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~ 236 (263)
T cd05052 160 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRME---RPEGCPPKVYE 236 (263)
T ss_pred eccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCC---CCCCCCHHHHH
Confidence 22222234667999999988889999999999999999998 999998766655544443322332 23457789999
Q ss_pred HHHHHcccCCCCCCCHHHHHHHHHHH
Q 013214 388 LIEECWNEKPAKRPTFRQIITRLESI 413 (447)
Q Consensus 388 li~~cl~~dp~~Rps~~~~l~~l~~~ 413 (447)
++.+||+.||++||++.++++.|+.+
T Consensus 237 li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 237 LMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred HHHHHccCCcccCCCHHHHHHHHHhh
Confidence 99999999999999999999999875
No 75
>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g
Probab=100.00 E-value=6.6e-40 Score=310.74 Aligned_cols=243 Identities=25% Similarity=0.362 Sum_probs=197.2
Q ss_pred eecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEeccCCCCH
Q 013214 163 ITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237 (447)
Q Consensus 163 lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L 237 (447)
||+|+||.|+ .+|+.||+|.+...........+.+..|+.+++.++||||+++.+++..+...+++|||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 6899999886 36889999998765444444456678899999999999999999999999999999999999999
Q ss_pred HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCCccc
Q 013214 238 RAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTC 313 (447)
Q Consensus 238 ~~~l~~----~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~ 313 (447)
.+++.. +..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++........ ....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~ 156 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTKG 156 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-cccc
Confidence 988743 345899999999999999999999999 99999999999999999999999999876543221 2233
Q ss_pred CCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHHHHHc
Q 013214 314 QDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECW 393 (447)
Q Consensus 314 ~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 393 (447)
..+|+.|+|||.+.+..++.++|+||||+++|+|++|+.||.......................+..++..+.+++.+||
T Consensus 157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 236 (280)
T cd05608 157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALL 236 (280)
T ss_pred cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHHHHh
Confidence 46789999999999989999999999999999999999999865543222222111111111223457889999999999
Q ss_pred ccCCCCCC-----CHHHHHHH
Q 013214 394 NEKPAKRP-----TFRQIITR 409 (447)
Q Consensus 394 ~~dp~~Rp-----s~~~~l~~ 409 (447)
+.||++|| ++++++++
T Consensus 237 ~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 237 AKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred cCCHHHhcCCCCCCHHHHhcC
Confidence 99999999 67777764
No 76
>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,
Probab=100.00 E-value=5.9e-40 Score=311.87 Aligned_cols=249 Identities=24% Similarity=0.379 Sum_probs=203.3
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|+..+.||+|+||.|+. +++.||+|.+.............+.+|+.+++.++||||+++++.+..+...+++||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 366778999999998863 578999999875443333344567789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 013214 231 YLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (447)
Q Consensus 231 ~~~~g~L~~~l~~~--~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~ 308 (447)
|+++|+|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~- 156 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE- 156 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCC-
Confidence 99999999888654 45899999999999999999999999 9999999999999999999999999987654221
Q ss_pred CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHH
Q 013214 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKEL 388 (447)
Q Consensus 309 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 388 (447)
......+++.|+|||.+.+..++.++|+||+|+++|+|++|+.||.+.........+...........+..++..+.++
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 235 (285)
T cd05605 157 -TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSI 235 (285)
T ss_pred -ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHH
Confidence 1223457899999999988889999999999999999999999998766544333322211111112234578889999
Q ss_pred HHHHcccCCCCCC-----CHHHHHHH
Q 013214 389 IEECWNEKPAKRP-----TFRQIITR 409 (447)
Q Consensus 389 i~~cl~~dp~~Rp-----s~~~~l~~ 409 (447)
+.+||+.||.+|| ++++++++
T Consensus 236 i~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 236 CRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred HHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 9999999999999 88888765
No 77
>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C. Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl
Probab=100.00 E-value=5.2e-40 Score=318.63 Aligned_cols=241 Identities=24% Similarity=0.416 Sum_probs=198.5
Q ss_pred eeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeEEEEeCCceEEEEeccCCC
Q 013214 162 EITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKG 235 (447)
Q Consensus 162 ~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~g 235 (447)
.||+|+||.|+ .+++.||+|+++............+..|..+++.+ +||||+++++++.....++++|||+++|
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~g 81 (329)
T cd05588 2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGG 81 (329)
T ss_pred eEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 68999999886 25789999999876554555567788999999988 7999999999999999999999999999
Q ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCCcccCC
Q 013214 236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD 315 (447)
Q Consensus 236 ~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~ 315 (447)
+|.+++.+.+.+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++...... ........
T Consensus 82 ~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-~~~~~~~~ 157 (329)
T cd05588 82 DLMFHMQRQRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP-GDTTSTFC 157 (329)
T ss_pred CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccC-CCcccccc
Confidence 99999988888999999999999999999999999 999999999999999999999999998642211 11223456
Q ss_pred CCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCc--------hHHHHHhcCCCCCCCChhhhHHHHHH
Q 013214 316 TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNE--------VPKAYAARQRPPFKAPAKLYARGLKE 387 (447)
Q Consensus 316 ~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~l~~ 387 (447)
||+.|+|||.+.+..++.++|+|||||++|+|++|+.||......+ ............+ +..++..+.+
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~---p~~~~~~~~~ 234 (329)
T cd05588 158 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRI---PRSLSVKASS 234 (329)
T ss_pred CCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCC---CCCCCHHHHH
Confidence 8999999999999899999999999999999999999996432111 1111112222222 3456788999
Q ss_pred HHHHHcccCCCCCCC------HHHHHHH
Q 013214 388 LIEECWNEKPAKRPT------FRQIITR 409 (447)
Q Consensus 388 li~~cl~~dp~~Rps------~~~~l~~ 409 (447)
+|.+||+.||.+||+ +.+++++
T Consensus 235 li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 235 VLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred HHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 999999999999997 5677654
No 78
>PTZ00267 NIMA-related protein kinase; Provisional
Probab=100.00 E-value=3.3e-39 Score=327.74 Aligned_cols=248 Identities=24% Similarity=0.369 Sum_probs=206.7
Q ss_pred CCcCcccceeeecceEEEEEE-----c-CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceE
Q 013214 153 HELDFTNSVEITKGTFILAFW-----R-GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM 226 (447)
Q Consensus 153 ~~~~~~~~~~lg~G~~~~~~~-----~-g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 226 (447)
....|...+.||+|++|.++. + ++.||+|.+... .......+.+|+.+++.++||||+++++++...+..+
T Consensus 65 ~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~---~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~ 141 (478)
T PTZ00267 65 REHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN---DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLL 141 (478)
T ss_pred cceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEE
Confidence 344588889999999998762 3 678999977533 3445567788999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccc
Q 013214 227 IVTEYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 302 (447)
Q Consensus 227 lv~e~~~~g~L~~~l~~----~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~ 302 (447)
+||||+++|+|.+++.. ..++++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 142 lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~ 218 (478)
T PTZ00267 142 LIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQ 218 (478)
T ss_pred EEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCcee
Confidence 99999999999988754 346899999999999999999999998 99999999999999999999999999986
Q ss_pred cccCCC-CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhh
Q 013214 303 LTVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLY 381 (447)
Q Consensus 303 ~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 381 (447)
...... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+......++ +..+
T Consensus 219 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~---~~~~ 295 (478)
T PTZ00267 219 YSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPF---PCPV 295 (478)
T ss_pred cCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC---CccC
Confidence 543221 112345689999999999988899999999999999999999999987766555555433333332 3456
Q ss_pred HHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 382 ARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 382 ~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
+.++.++|.+||+.||++||++.+++.+
T Consensus 296 s~~~~~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 296 SSGMKALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred CHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence 7899999999999999999999998753
No 79
>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon. Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to
Probab=100.00 E-value=3.3e-40 Score=319.00 Aligned_cols=240 Identities=25% Similarity=0.399 Sum_probs=201.5
Q ss_pred eeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeEEEEeCCceEEEEeccCCC
Q 013214 162 EITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKG 235 (447)
Q Consensus 162 ~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~g 235 (447)
.||+|+||.|+. +++.||+|++........+..+.+..|..++..+ +||||+++++++...+..|+||||+++|
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 81 (321)
T cd05591 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGG 81 (321)
T ss_pred ccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCCC
Confidence 589999998862 4789999999765444445556677888988866 8999999999999999999999999999
Q ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCCcccCC
Q 013214 236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD 315 (447)
Q Consensus 236 ~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~ 315 (447)
+|..++.+.+.+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++...... ........
T Consensus 82 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~-~~~~~~~~ 157 (321)
T cd05591 82 DLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILN-GVTTTTFC 157 (321)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccC-Cccccccc
Confidence 99999988888999999999999999999999999 999999999999999999999999998753322 12223445
Q ss_pred CCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHHHHHccc
Q 013214 316 TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNE 395 (447)
Q Consensus 316 ~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 395 (447)
||+.|+|||.+.+..++.++||||||+++|+|++|+.||...+..+....+... ...+ +..++.++.+++.+||+.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~-~~~~---p~~~~~~~~~ll~~~L~~ 233 (321)
T cd05591 158 GTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHD-DVLY---PVWLSKEAVSILKAFMTK 233 (321)
T ss_pred cCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcC-CCCC---CCCCCHHHHHHHHHHhcc
Confidence 799999999998888999999999999999999999999987766655554322 2222 234678899999999999
Q ss_pred CCCCCC-------CHHHHHHH
Q 013214 396 KPAKRP-------TFRQIITR 409 (447)
Q Consensus 396 dp~~Rp-------s~~~~l~~ 409 (447)
||++|| ++.+++++
T Consensus 234 dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 234 NPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred CHHHcCCCCCCCCCHHHHhcC
Confidence 999999 77877765
No 80
>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]
Probab=100.00 E-value=4.9e-40 Score=341.75 Aligned_cols=255 Identities=33% Similarity=0.562 Sum_probs=219.1
Q ss_pred CcccceeeecceEEEEEE------cC----eEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCce
Q 013214 156 DFTNSVEITKGTFILAFW------RG----IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~------~g----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 225 (447)
+.+..+.||+|.||.||. .| ..||+|.+++. .+.....+|.+|..+|+.++|||||+++|++.+....
T Consensus 693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~--~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL--SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP 770 (1025)
T ss_pred heEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc--CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence 445567899999999873 23 35899988754 5677788999999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecc
Q 013214 226 MIVTEYLPKGDLRAFLKRK-------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298 (447)
Q Consensus 226 ~lv~e~~~~g~L~~~l~~~-------~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg 298 (447)
++++|||+||+|..+|++. ..++..+.+.++.|+++|+.||++++ +|||||..+|+|++....+||+|||
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFG 847 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFG 847 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccc
Confidence 9999999999999999875 23889999999999999999999999 9999999999999999999999999
Q ss_pred cccccccCC-CCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCCCC
Q 013214 299 VSKLLTVKE-DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKA 376 (447)
Q Consensus 299 ~~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 376 (447)
+|+.+-... .+......-+..|||||.+..+.++.|+|||||||++||++| |..||...++.++...+..+++.+.
T Consensus 848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL~~-- 925 (1025)
T KOG1095|consen 848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRLDP-- 925 (1025)
T ss_pred hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCccCC--
Confidence 999432221 111112234678999999999999999999999999999999 9999999999998887767775553
Q ss_pred ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhh
Q 013214 377 PAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSIN 418 (447)
Q Consensus 377 ~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~~~ 418 (447)
+..++..+.++|..||+.+|++||++..+++.+..+.+..-
T Consensus 926 -P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~ 966 (1025)
T KOG1095|consen 926 -PSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAAL 966 (1025)
T ss_pred -CCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhc
Confidence 55678889999999999999999999999998888776653
No 81
>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase. Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h
Probab=100.00 E-value=2.2e-39 Score=302.88 Aligned_cols=245 Identities=32% Similarity=0.580 Sum_probs=202.7
Q ss_pred CcccceeeecceEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEec
Q 013214 156 DFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 231 (447)
+|+..+.||+|+||.++. ++..+|+|.+..... ....+.+|+.+++.++||||+++++++......+++|||
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~ 80 (256)
T cd05114 5 ELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAM----SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEF 80 (256)
T ss_pred HcEEeeEecCCcCceEEEEEeccCceEEEEecccCCc----cHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEc
Confidence 456677899999997762 456899998764432 235678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCC
Q 013214 232 LPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (447)
Q Consensus 232 ~~~g~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~ 310 (447)
+++|+|.+++... +.+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||.+..........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05114 81 MENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS 157 (256)
T ss_pred CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCceec
Confidence 9999999999753 46899999999999999999999999 9999999999999999999999999987654322222
Q ss_pred cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHH
Q 013214 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELI 389 (447)
Q Consensus 311 ~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 389 (447)
.....++..|+|||.+.+..++.++|+||||+++|+|++ |+.||...+..+....+....++.. +...+..+.+++
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~---~~~~~~~~~~li 234 (256)
T cd05114 158 SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYR---PKLASMTVYEVM 234 (256)
T ss_pred cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCC---CCCCCHHHHHHH
Confidence 223334668999999988889999999999999999999 9999987776665555544333322 233567899999
Q ss_pred HHHcccCCCCCCCHHHHHHHH
Q 013214 390 EECWNEKPAKRPTFRQIITRL 410 (447)
Q Consensus 390 ~~cl~~dp~~Rps~~~~l~~l 410 (447)
.+||+.+|++||++.++++.|
T Consensus 235 ~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 235 YSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred HHHccCCcccCcCHHHHHHhh
Confidence 999999999999999999876
No 82
>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C. Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory
Probab=100.00 E-value=7.1e-40 Score=317.06 Aligned_cols=246 Identities=28% Similarity=0.442 Sum_probs=203.6
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCC-cccceeEEEEeCCceEEEE
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP-NVVQFLGAVTQSSPMMIVT 229 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp-~iv~~~~~~~~~~~~~lv~ 229 (447)
+|+..+.||+|+||.|+. +++.||+|++...........+.+..|..++..++|+ +|+++++++...+.+|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 467778999999998863 5678999999765443445566778899999999764 6888999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 013214 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (447)
Q Consensus 230 e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~ 309 (447)
||+++|+|.+++...+.+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++...... ..
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~-~~ 156 (324)
T cd05587 81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG-GK 156 (324)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCC-CC
Confidence 99999999999988888999999999999999999999999 999999999999999999999999998643221 11
Q ss_pred CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHH
Q 013214 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELI 389 (447)
Q Consensus 310 ~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 389 (447)
......||+.|+|||++.+..++.++|+||+||++|+|++|+.||...+..+....+. .....+ +..+++++.+++
T Consensus 157 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~-~~~~~~---~~~~~~~~~~li 232 (324)
T cd05587 157 TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIM-EHNVSY---PKSLSKEAVSIC 232 (324)
T ss_pred ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH-cCCCCC---CCCCCHHHHHHH
Confidence 2234567999999999998889999999999999999999999998776655554442 223333 345678899999
Q ss_pred HHHcccCCCCCCCH-----HHHHHH
Q 013214 390 EECWNEKPAKRPTF-----RQIITR 409 (447)
Q Consensus 390 ~~cl~~dp~~Rps~-----~~~l~~ 409 (447)
.+||..||.+|++. .+++++
T Consensus 233 ~~~l~~~P~~R~~~~~~~~~~~~~h 257 (324)
T cd05587 233 KGLLTKHPAKRLGCGPTGERDIREH 257 (324)
T ss_pred HHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 99999999999976 555543
No 83
>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase. Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio
Probab=100.00 E-value=3.1e-39 Score=302.09 Aligned_cols=244 Identities=26% Similarity=0.435 Sum_probs=204.1
Q ss_pred eeecceEEEEEE-------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEeccCC
Q 013214 162 EITKGTFILAFW-------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234 (447)
Q Consensus 162 ~lg~G~~~~~~~-------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 234 (447)
+||+|+||.|+. ++..+|+|++.... ......+.+.+|+.+++.++||||+++++++.. ...+++|||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~ 79 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN-NDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAEL 79 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCC-CcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCC
Confidence 589999988762 46889999987543 244556788999999999999999999998764 567899999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCC--cc
Q 013214 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP--LT 312 (447)
Q Consensus 235 g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~--~~ 312 (447)
++|.+++.....+++..+..++.|++.|+.|||+.+ ++|+||||+||+++.++.+||+|||++.......... ..
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 156 (257)
T cd05116 80 GPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKT 156 (257)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecC
Confidence 999999988788999999999999999999999999 9999999999999999999999999998654332211 12
Q ss_pred cCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHHHH
Q 013214 313 CQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEE 391 (447)
Q Consensus 313 ~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 391 (447)
...++..|+|||.+....++.++|+||||+++|+|++ |..||......+....+.....++. +..+++++.++|.+
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~---~~~~~~~l~~li~~ 233 (257)
T cd05116 157 HGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMEC---PQRCPPEMYDLMKL 233 (257)
T ss_pred CCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCC---CCCCCHHHHHHHHH
Confidence 2233578999999988888999999999999999998 9999987776666666544444333 34577899999999
Q ss_pred HcccCCCCCCCHHHHHHHHHHH
Q 013214 392 CWNEKPAKRPTFRQIITRLESI 413 (447)
Q Consensus 392 cl~~dp~~Rps~~~~l~~l~~~ 413 (447)
||+.||++||++.+|.+.|++.
T Consensus 234 ~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 234 CWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred HhccCchhCcCHHHHHHHHhcc
Confidence 9999999999999999999864
No 84
>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase
Probab=100.00 E-value=4.3e-39 Score=302.70 Aligned_cols=253 Identities=24% Similarity=0.463 Sum_probs=208.1
Q ss_pred CcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|+..+.||+|+||.++ .+++.||+|.+........+....+.+|+.+++.++||||+++++++...+..++++|
T Consensus 3 ~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 82 (267)
T cd08228 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLE 82 (267)
T ss_pred ceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEE
Confidence 57778899999998775 3689999998865444456666788999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccC
Q 013214 231 YLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306 (447)
Q Consensus 231 ~~~~g~L~~~l~~----~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~ 306 (447)
|+++++|.+++.. ...+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++......
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~ 159 (267)
T cd08228 83 LADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred ecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccch
Confidence 9999999988853 344889999999999999999999998 999999999999999999999999998765432
Q ss_pred CCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCC--chHHHHHhcCCCCCCCChhhhHHH
Q 013214 307 EDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDN--EVPKAYAARQRPPFKAPAKLYARG 384 (447)
Q Consensus 307 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 384 (447)
. .......+++.|+|||.+.+..++.++|+||||+++|+|++|+.||...... +....+.....++. ....++..
T Consensus 160 ~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 236 (267)
T cd08228 160 T-TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPL--PTEHYSEK 236 (267)
T ss_pred h-HHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCC--ChhhcCHH
Confidence 1 1112345788899999998888899999999999999999999999755432 22222222222222 23356788
Q ss_pred HHHHHHHHcccCCCCCCCHHHHHHHHHHHH
Q 013214 385 LKELIEECWNEKPAKRPTFRQIITRLESIN 414 (447)
Q Consensus 385 l~~li~~cl~~dp~~Rps~~~~l~~l~~~~ 414 (447)
+.++|.+||+.+|++||++.++++.++.++
T Consensus 237 ~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 237 LRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred HHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 999999999999999999999999998864
No 85
>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta. Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I
Probab=100.00 E-value=5.9e-40 Score=316.42 Aligned_cols=240 Identities=28% Similarity=0.450 Sum_probs=197.5
Q ss_pred eeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeEEEEeCCceEEEEeccCC
Q 013214 161 VEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPK 234 (447)
Q Consensus 161 ~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~ 234 (447)
+.||+|+||.|+ .+|+.||+|.++..........+.+..|..++... +||||+++++++...+..++||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 368999999886 26789999998764332223345566777777654 899999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCCcccC
Q 013214 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQ 314 (447)
Q Consensus 235 g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~ 314 (447)
|+|.+++.+.+.+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++...... .......
T Consensus 81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~ 156 (316)
T cd05620 81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG-DNRASTF 156 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccC-CCceecc
Confidence 999999988888999999999999999999999999 999999999999999999999999998643221 1222345
Q ss_pred CCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHHHHHcc
Q 013214 315 DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWN 394 (447)
Q Consensus 315 ~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 394 (447)
.||+.|+|||.+.+..++.++||||||+++|+|++|+.||...+..+..+.+. ...+.+ +..++.++.++|.+||+
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~-~~~~~~---~~~~~~~~~~li~~~l~ 232 (316)
T cd05620 157 CGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIR-VDTPHY---PRWITKESKDILEKLFE 232 (316)
T ss_pred CCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH-hCCCCC---CCCCCHHHHHHHHHHcc
Confidence 67999999999998899999999999999999999999998776655544442 223332 33467889999999999
Q ss_pred cCCCCCCCHH-HHHH
Q 013214 395 EKPAKRPTFR-QIIT 408 (447)
Q Consensus 395 ~dp~~Rps~~-~~l~ 408 (447)
.||++||++. ++++
T Consensus 233 ~dP~~R~~~~~~~~~ 247 (316)
T cd05620 233 RDPTRRLGVVGNIRG 247 (316)
T ss_pred CCHHHcCCChHHHHc
Confidence 9999999984 5553
No 86
>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants. Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos
Probab=100.00 E-value=1e-39 Score=317.82 Aligned_cols=249 Identities=25% Similarity=0.403 Sum_probs=196.2
Q ss_pred CcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeC-----Cce
Q 013214 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS-----SPM 225 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~~ 225 (447)
+|+..+.||+|+||.|+ .+|+.||+|++..... .......+.+|+.+++.++||||+++++++... ...
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 79 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 79 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhc-cchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceE
Confidence 46778899999999876 3689999999864322 223345678899999999999999999988543 247
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeeccccccccc
Q 013214 226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305 (447)
Q Consensus 226 ~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~ 305 (447)
|++|||+ +++|.+++.....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.....
T Consensus 80 ~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 155 (338)
T cd07859 80 YVVFELM-ESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFN 155 (338)
T ss_pred EEEEecC-CCCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccccc
Confidence 9999999 5799999988888999999999999999999999999 99999999999999999999999999875432
Q ss_pred CCC--CCcccCCCCCcccCCcccCC--CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHh-------------
Q 013214 306 KED--RPLTCQDTSCRYVAPEVFKN--EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA------------- 368 (447)
Q Consensus 306 ~~~--~~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~------------- 368 (447)
... .......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+.......+..
T Consensus 156 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i 235 (338)
T cd07859 156 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRV 235 (338)
T ss_pred ccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHh
Confidence 211 11234568999999999865 5788999999999999999999999976553221111100
Q ss_pred --------------cCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 369 --------------RQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 369 --------------~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
....++....+.+++.+.+++.+||+.||++|||+++++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 236 RNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred hhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 00011111112356788999999999999999999999975
No 87
>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C. Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re
Probab=100.00 E-value=6.7e-40 Score=316.38 Aligned_cols=240 Identities=28% Similarity=0.453 Sum_probs=201.0
Q ss_pred eeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeEEEEeCCceEEEEeccCCC
Q 013214 162 EITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKG 235 (447)
Q Consensus 162 ~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~g 235 (447)
.||+|+||.|+. +++.||+|++++...........+..|..+++.+ +||||+++++++...+..+++|||+++|
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 81 (318)
T cd05570 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGG 81 (318)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence 689999998863 5789999999765433444556677888998888 7999999999999999999999999999
Q ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCCcccCC
Q 013214 236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD 315 (447)
Q Consensus 236 ~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~ 315 (447)
+|.+++.+.+.+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||++....... .......
T Consensus 82 ~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~ 157 (318)
T cd05570 82 DLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG-VTTSTFC 157 (318)
T ss_pred CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCC-Cccccee
Confidence 99999988888999999999999999999999999 9999999999999999999999999986432211 1223345
Q ss_pred CCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHHHHHccc
Q 013214 316 TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNE 395 (447)
Q Consensus 316 ~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 395 (447)
+++.|+|||.+.+..++.++|+|||||++|+|++|+.||...+..+....+. .....+ +..++..+.++|++||+.
T Consensus 158 g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~-~~~~~~---~~~~~~~~~~li~~~l~~ 233 (318)
T cd05570 158 GTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSIL-EDEVRY---PRWLSKEAKSILKSFLTK 233 (318)
T ss_pred cCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHH-cCCCCC---CCcCCHHHHHHHHHHccC
Confidence 7899999999998899999999999999999999999998776555544442 222222 345678999999999999
Q ss_pred CCCCCCCH-----HHHHHH
Q 013214 396 KPAKRPTF-----RQIITR 409 (447)
Q Consensus 396 dp~~Rps~-----~~~l~~ 409 (447)
||.+||++ .+++++
T Consensus 234 dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 234 NPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred CHHHcCCCCCCCHHHHhcC
Confidence 99999999 777764
No 88
>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2. Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found
Probab=100.00 E-value=6.1e-40 Score=322.67 Aligned_cols=250 Identities=23% Similarity=0.325 Sum_probs=203.7
Q ss_pred cCcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEE
Q 013214 155 LDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 229 (447)
.+|+..+.||+|+||.|+ .+++.+|+|.+.+...........+.+|..+++.++||||+++++++..+...++||
T Consensus 43 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~ 122 (370)
T cd05621 43 EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVM 122 (370)
T ss_pred HHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 468888899999999886 257899999987543333344566788999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 013214 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (447)
Q Consensus 230 e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~ 309 (447)
||+++|+|.+++... .+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||++.........
T Consensus 123 Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~~ 198 (370)
T cd05621 123 EYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMV 198 (370)
T ss_pred cCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccceecccCCce
Confidence 999999999998654 5889999999999999999999999 999999999999999999999999999865432222
Q ss_pred CcccCCCCCcccCCcccCCC----CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcC-CCCCCCChhhhHHH
Q 013214 310 PLTCQDTSCRYVAPEVFKNE----EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RPPFKAPAKLYARG 384 (447)
Q Consensus 310 ~~~~~~~t~~y~aPE~~~~~----~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 384 (447)
......||+.|+|||++.+. .++.++|+||+||++|+|++|+.||...+.......+.... ...++ ....++..
T Consensus 199 ~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p-~~~~~s~~ 277 (370)
T cd05621 199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFP-EDVEISKH 277 (370)
T ss_pred ecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCC-CcccCCHH
Confidence 22345689999999998654 37789999999999999999999998776655555543322 22222 22346788
Q ss_pred HHHHHHHHcccCCCC--CCCHHHHHHH
Q 013214 385 LKELIEECWNEKPAK--RPTFRQIITR 409 (447)
Q Consensus 385 l~~li~~cl~~dp~~--Rps~~~~l~~ 409 (447)
+++++..|+..++.+ |+++.+++++
T Consensus 278 ~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 278 AKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred HHHHHHHHccCchhccCCCCHHHHhcC
Confidence 999999999855543 8899999886
No 89
>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B. Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly
Probab=100.00 E-value=5.8e-39 Score=305.49 Aligned_cols=253 Identities=28% Similarity=0.501 Sum_probs=209.7
Q ss_pred cCcccceeeecceEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCc
Q 013214 155 LDFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 224 (447)
.+|...+.||+|+||.++. ++..+|+|.+... .......+.+|+.++++++||||+++++++.....
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 81 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDP 81 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc---CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCc
Confidence 3677888999999998863 2356899988643 34456778999999999999999999999999999
Q ss_pred eEEEEeccCCCCHHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCC
Q 013214 225 MMIVTEYLPKGDLRAFLKRKG-------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291 (447)
Q Consensus 225 ~~lv~e~~~~g~L~~~l~~~~-------------~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~ 291 (447)
.++++||+++++|.+++...+ .+++..+..++.|++.||.|||+.+ ++||||||+||++++++.
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~ 158 (288)
T cd05093 82 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLL 158 (288)
T ss_pred cEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence 999999999999999997543 3899999999999999999999999 999999999999999999
Q ss_pred EEEeecccccccccCCC-CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhc
Q 013214 292 LKVADFGVSKLLTVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAAR 369 (447)
Q Consensus 292 vkl~Dfg~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~ 369 (447)
++|+|||++........ .......++..|+|||.+.+..++.++|+||||+++|+|++ |..||......+....+...
T Consensus 159 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~ 238 (288)
T cd05093 159 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQG 238 (288)
T ss_pred EEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence 99999999875432211 11122334678999999988889999999999999999998 99999877665555555333
Q ss_pred CCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhh
Q 013214 370 QRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS 416 (447)
Q Consensus 370 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~ 416 (447)
..... +..++.++.+++.+||+.||.+|||+.++++.|+++.+.
T Consensus 239 ~~~~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 239 RVLQR---PRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred CcCCC---CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 32222 334678899999999999999999999999999998865
No 90
>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N. Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved
Probab=100.00 E-value=1e-39 Score=315.93 Aligned_cols=244 Identities=25% Similarity=0.407 Sum_probs=198.9
Q ss_pred cccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHH---hcCCCCcccceeEEEEeCCceEEE
Q 013214 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALL---QKIRHPNVVQFLGAVTQSSPMMIV 228 (447)
Q Consensus 157 ~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l---~~l~hp~iv~~~~~~~~~~~~~lv 228 (447)
|...+.||+|+||.|+. +|+.||+|+++..........+.+..|..++ +.++||||+++++++...+..|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 45667899999998863 5889999999765433344455666676655 566899999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 013214 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (447)
Q Consensus 229 ~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~ 308 (447)
|||+++++|..++.. +.+++..+..++.|++.||.|||+.+ ++||||||+||++++++.+||+|||++.......
T Consensus 81 ~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~- 155 (324)
T cd05589 81 MEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG- 155 (324)
T ss_pred EcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCCCC-
Confidence 999999999988854 56999999999999999999999999 9999999999999999999999999987532221
Q ss_pred CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHH
Q 013214 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKEL 388 (447)
Q Consensus 309 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 388 (447)
.......|++.|+|||.+.+..++.++|+|||||++|+|++|+.||...+..+....+.. ..+.+ +..+++.+.++
T Consensus 156 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~-~~~~~---p~~~~~~~~~l 231 (324)
T cd05589 156 DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVN-DEVRY---PRFLSREAISI 231 (324)
T ss_pred CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-CCCCC---CCCCCHHHHHH
Confidence 122345689999999999988899999999999999999999999987766555544422 22222 34567889999
Q ss_pred HHHHcccCCCCCC-----CHHHHHHH
Q 013214 389 IEECWNEKPAKRP-----TFRQIITR 409 (447)
Q Consensus 389 i~~cl~~dp~~Rp-----s~~~~l~~ 409 (447)
|.+||+.||.+|| ++.+++++
T Consensus 232 i~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 232 MRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred HHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 9999999999999 56666654
No 91
>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment
Probab=100.00 E-value=6.2e-39 Score=301.60 Aligned_cols=250 Identities=32% Similarity=0.529 Sum_probs=208.7
Q ss_pred CcccceeeecceEEEEEE--------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEE
Q 013214 156 DFTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 227 (447)
+|+..+.||+|+||.|+. +...||+|.++... .......+.+|+.+++.++||||+++++.+...+..++
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 5 YVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS--SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred HceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 577788999999998863 23579999987543 34456778899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccC
Q 013214 228 VTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306 (447)
Q Consensus 228 v~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~ 306 (447)
+|||+++++|.+++... +.+++..+..++.|++.|+.|||+.+ ++|+||||+||++++++.++|+|||++......
T Consensus 83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd05033 83 ITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS 159 (266)
T ss_pred EEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence 99999999999999764 46899999999999999999999998 999999999999999999999999999876421
Q ss_pred CCC-CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHH
Q 013214 307 EDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARG 384 (447)
Q Consensus 307 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (447)
... ......++..|+|||.+.+..++.++|+||||+++|+|++ |..||......+....+......+. +..++..
T Consensus 160 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~ 236 (266)
T cd05033 160 EATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPP---PMDCPSA 236 (266)
T ss_pred ccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCC---CCCCCHH
Confidence 111 1122334678999999988889999999999999999998 9999987766655555533323222 3456789
Q ss_pred HHHHHHHHcccCCCCCCCHHHHHHHHHHH
Q 013214 385 LKELIEECWNEKPAKRPTFRQIITRLESI 413 (447)
Q Consensus 385 l~~li~~cl~~dp~~Rps~~~~l~~l~~~ 413 (447)
+.+++.+||+.+|++||++.+++++|+++
T Consensus 237 l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 237 LYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred HHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 99999999999999999999999999875
No 92
>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a
Probab=100.00 E-value=4.2e-39 Score=301.84 Aligned_cols=248 Identities=29% Similarity=0.499 Sum_probs=205.9
Q ss_pred CcccceeeecceEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEec
Q 013214 156 DFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 231 (447)
+|+..+.||+|++|.++. +++.||+|.++.... ..+.+.+|+.++++++||||+++++++...+..+++|||
T Consensus 7 ~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05068 7 SIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM----DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL 82 (261)
T ss_pred heeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcc----cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence 577778999999987752 567899999875432 235688899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 013214 232 LPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (447)
Q Consensus 232 ~~~g~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~ 309 (447)
+++++|.+++.... .+++..+..++.|++.|+.+||+.+ ++|+||||+||++++++.++|+|||++.........
T Consensus 83 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05068 83 MKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE 159 (261)
T ss_pred ccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCccc
Confidence 99999999997654 6899999999999999999999998 999999999999999999999999999866532211
Q ss_pred CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHH
Q 013214 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKEL 388 (447)
Q Consensus 310 ~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 388 (447)
.......+..|+|||.+.+..++.++|+||||+++|+|++ |+.||.+.........+......+. +..++..+.++
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l 236 (261)
T cd05068 160 AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPC---PPGCPKELYDI 236 (261)
T ss_pred ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC---CCcCCHHHHHH
Confidence 1122223457999999988889999999999999999999 9999987766555555433323222 34567889999
Q ss_pred HHHHcccCCCCCCCHHHHHHHHHHH
Q 013214 389 IEECWNEKPAKRPTFRQIITRLESI 413 (447)
Q Consensus 389 i~~cl~~dp~~Rps~~~~l~~l~~~ 413 (447)
+.+||+.+|++||++.++++.|+++
T Consensus 237 i~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 237 MLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred HHHHhhcCcccCCCHHHHHHHHhcC
Confidence 9999999999999999999998763
No 93
>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn. Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa
Probab=100.00 E-value=2.6e-39 Score=303.16 Aligned_cols=248 Identities=30% Similarity=0.528 Sum_probs=206.6
Q ss_pred CcccceeeecceEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEec
Q 013214 156 DFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 231 (447)
+|+..+.||+|++|.++. ++..||+|.+.... ...+.+.+|+.+++.++||||+++++.+...+..++++||
T Consensus 7 ~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05072 7 SIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT----MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEY 82 (261)
T ss_pred HeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc----hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEec
Confidence 577778999999998763 56789999886432 2346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 013214 232 LPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (447)
Q Consensus 232 ~~~g~L~~~l~~~--~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~ 309 (447)
+++++|.+++.+. ..++......++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.........
T Consensus 83 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05072 83 MAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT 159 (261)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCcee
Confidence 9999999999753 45888899999999999999999998 999999999999999999999999999865432222
Q ss_pred CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHH
Q 013214 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKEL 388 (447)
Q Consensus 310 ~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 388 (447)
......++..|+|||.+.+..++.++|+||||+++|+|++ |+.||...........+......+. ...++.++.++
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l 236 (261)
T cd05072 160 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPR---MENCPDELYDI 236 (261)
T ss_pred ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCC---CCCCCHHHHHH
Confidence 2223345678999999988888999999999999999998 9999987766555555533322222 23567889999
Q ss_pred HHHHcccCCCCCCCHHHHHHHHHHH
Q 013214 389 IEECWNEKPAKRPTFRQIITRLESI 413 (447)
Q Consensus 389 i~~cl~~dp~~Rps~~~~l~~l~~~ 413 (447)
+.+||..+|++||+++++++.|+++
T Consensus 237 i~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 237 MKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred HHHHccCCcccCcCHHHHHHHHhcC
Confidence 9999999999999999999998763
No 94
>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota. Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o
Probab=100.00 E-value=1.1e-39 Score=316.24 Aligned_cols=242 Identities=24% Similarity=0.411 Sum_probs=197.3
Q ss_pred eeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeEEEEeCCceEEEEeccCC
Q 013214 161 VEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPK 234 (447)
Q Consensus 161 ~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~ 234 (447)
+.||+|+||.|+ .+++.||+|++.+...........+.+|..++.++ +||||+++++++......++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 368999999886 25789999999876544555566788899988877 899999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCCcccC
Q 013214 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQ 314 (447)
Q Consensus 235 g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~ 314 (447)
|+|..++.+.+.+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++...... .......
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~-~~~~~~~ 156 (329)
T cd05618 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP-GDTTSTF 156 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCC-CCccccc
Confidence 999999988888999999999999999999999999 999999999999999999999999998753221 1122345
Q ss_pred CCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCC-----c---hHHHHHhcCCCCCCCChhhhHHHHH
Q 013214 315 DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDN-----E---VPKAYAARQRPPFKAPAKLYARGLK 386 (447)
Q Consensus 315 ~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~-----~---~~~~~~~~~~~~~~~~~~~~~~~l~ 386 (447)
.||+.|+|||++.+..++.++|+||||+++|+|++|+.||...... . ............+ +..++..+.
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~---p~~~~~~~~ 233 (329)
T cd05618 157 CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRI---PRSLSVKAA 233 (329)
T ss_pred cCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCC---CCCCCHHHH
Confidence 6799999999999888999999999999999999999999632111 1 1111112222222 345678899
Q ss_pred HHHHHHcccCCCCCCC------HHHHHHH
Q 013214 387 ELIEECWNEKPAKRPT------FRQIITR 409 (447)
Q Consensus 387 ~li~~cl~~dp~~Rps------~~~~l~~ 409 (447)
++|.+||+.||++||+ +.+++++
T Consensus 234 ~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 234 SVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred HHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 9999999999999998 4566554
No 95
>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity. Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....
Probab=100.00 E-value=4e-40 Score=308.56 Aligned_cols=244 Identities=37% Similarity=0.707 Sum_probs=198.6
Q ss_pred cceeeecceEEEEE---Ec------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEE
Q 013214 159 NSVEITKGTFILAF---WR------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (447)
Q Consensus 159 ~~~~lg~G~~~~~~---~~------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 229 (447)
..+.||.|.||.|+ +. +..|+||.++.. ...+....+.+|++.+++++||||++++|++...+..++|+
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~ 80 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS--SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVM 80 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT--SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEE
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc--cccccceeeeecccccccccccccccccccccccccccccc
Confidence 45689999999876 34 688999999643 34555788999999999999999999999999888899999
Q ss_pred eccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCC
Q 013214 230 EYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307 (447)
Q Consensus 230 e~~~~g~L~~~l~~~--~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~ 307 (447)
||+++|+|.+++... ..+++..++.++.|++.||.|||+.+ ++|++|+++||++++++.+||+|||++.......
T Consensus 81 e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~ 157 (259)
T PF07714_consen 81 EYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS 157 (259)
T ss_dssp E--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred ccccccccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc
Confidence 999999999999886 67999999999999999999999998 9999999999999999999999999988662211
Q ss_pred C-CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHH
Q 013214 308 D-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGL 385 (447)
Q Consensus 308 ~-~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 385 (447)
. ........+..|+|||.+....++.++||||||+++||+++ |+.||...+..+....+....+++. +..++..+
T Consensus 158 ~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~ 234 (259)
T PF07714_consen 158 KYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPI---PDNCPKDI 234 (259)
T ss_dssp SEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTS---BTTSBHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccee---ccchhHHH
Confidence 1 11122345678999999988889999999999999999999 7899988876666666644444333 44567889
Q ss_pred HHHHHHHcccCCCCCCCHHHHHHHH
Q 013214 386 KELIEECWNEKPAKRPTFRQIITRL 410 (447)
Q Consensus 386 ~~li~~cl~~dp~~Rps~~~~l~~l 410 (447)
.++|..||+.||++|||+.++++.|
T Consensus 235 ~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 235 YSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp HHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred HHHHHHHcCCChhhCcCHHHHHhcC
Confidence 9999999999999999999999876
No 96
>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta. Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and
Probab=100.00 E-value=9.7e-40 Score=315.98 Aligned_cols=245 Identities=27% Similarity=0.420 Sum_probs=203.5
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeEEEEeCCceEEEE
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVT 229 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~ 229 (447)
+|...+.||+|+||.|+. +++.||+|.+.............+..|..++... +||+|+++++++...+.+++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 466778999999998873 5679999998765433444455667788888777 6899999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 013214 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (447)
Q Consensus 230 e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~ 309 (447)
||+++|+|.+++...+.+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++....... .
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~-~ 156 (323)
T cd05616 81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG-V 156 (323)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCCC-C
Confidence 99999999999988888999999999999999999999999 9999999999999999999999999987533211 1
Q ss_pred CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHH
Q 013214 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELI 389 (447)
Q Consensus 310 ~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 389 (447)
......||+.|+|||.+.+..++.++|+|||||++|+|++|+.||...+..+....+.. ....+ +..++.++.+++
T Consensus 157 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~-~~~~~---p~~~s~~~~~li 232 (323)
T cd05616 157 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME-HNVAY---PKSMSKEAVAIC 232 (323)
T ss_pred ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHh-CCCCC---CCcCCHHHHHHH
Confidence 22345679999999999998999999999999999999999999988776655555432 22222 345778999999
Q ss_pred HHHcccCCCCCCCH-----HHHHH
Q 013214 390 EECWNEKPAKRPTF-----RQIIT 408 (447)
Q Consensus 390 ~~cl~~dp~~Rps~-----~~~l~ 408 (447)
.+||+.||.+|++. .++.+
T Consensus 233 ~~~l~~~p~~R~~~~~~~~~~i~~ 256 (323)
T cd05616 233 KGLMTKHPGKRLGCGPEGERDIKE 256 (323)
T ss_pred HHHcccCHHhcCCCCCCCHHHHhc
Confidence 99999999999984 55554
No 97
>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1. Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst
Probab=100.00 E-value=6.4e-39 Score=311.45 Aligned_cols=245 Identities=27% Similarity=0.486 Sum_probs=202.1
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEE
Q 013214 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 229 (447)
.+|+..+.||+|+||.|+. +|..+|+|.+.... .......+.+|+++++.++||||+++++++..++..+++|
T Consensus 5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (333)
T cd06650 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (333)
T ss_pred hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEE
Confidence 4788888999999998873 67889999887542 3445577889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 013214 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHEN-KPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (447)
Q Consensus 230 e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~-~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~ 308 (447)
||+.+|+|.+++...+.+++..+..++.|++.||.|||+. + ++|+||||+||+++.++.+||+|||++......
T Consensus 83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-- 157 (333)
T cd06650 83 EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 157 (333)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChhhEEEcCCCCEEEeeCCcchhhhhh--
Confidence 9999999999999888899999999999999999999985 5 999999999999999999999999998754321
Q ss_pred CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHH---------------------
Q 013214 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYA--------------------- 367 (447)
Q Consensus 309 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~--------------------- 367 (447)
......++..|+|||.+.+..++.++|+|||||++|+|++|+.||......+......
T Consensus 158 -~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (333)
T cd06650 158 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGR 236 (333)
T ss_pred -ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccc
Confidence 1233457889999999988889999999999999999999999997654332211110
Q ss_pred -----------------------hcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 368 -----------------------ARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 368 -----------------------~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
....+.+ ....++.++.++|.+||+.||++|||+.+++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h 299 (333)
T cd06650 237 PLSSYGPDSRPPMAIFELLDYIVNEPPPKL--PSGVFGAEFQDFVNKCLIKNPAERADLKQLMVH 299 (333)
T ss_pred hhhhhcccccccccHHHHHHHHhcCCCccC--CCCCcCHHHHHHHHHhccCCcccCcCHHHHhhC
Confidence 0000111 011356789999999999999999999999865
No 98
>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta. Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in
Probab=100.00 E-value=1.1e-39 Score=314.46 Aligned_cols=239 Identities=28% Similarity=0.451 Sum_probs=197.0
Q ss_pred eeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeEEEEeCCceEEEEeccCCC
Q 013214 162 EITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKG 235 (447)
Q Consensus 162 ~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~g 235 (447)
.||+|+||.|+ .+++.||+|.++..........+.+..|..++... +||||+++++++.+.+..+++|||+++|
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~g 81 (316)
T cd05619 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGG 81 (316)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCCC
Confidence 68999999886 25788999998765332233345566677777764 8999999999999999999999999999
Q ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCCcccCC
Q 013214 236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD 315 (447)
Q Consensus 236 ~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~ 315 (447)
+|.+++.+...+++.++..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++....... .......
T Consensus 82 ~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~ 157 (316)
T cd05619 82 DLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD-AKTCTFC 157 (316)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCC-Cceeeec
Confidence 99999988888999999999999999999999999 9999999999999999999999999987532211 1223345
Q ss_pred CCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHHHHHccc
Q 013214 316 TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNE 395 (447)
Q Consensus 316 ~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 395 (447)
||+.|+|||.+.+..++.++|+|||||++|+|++|+.||...+..+....+.. ..+.+ +..++.++.+++.+||+.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~-~~~~~---~~~~~~~~~~li~~~l~~ 233 (316)
T cd05619 158 GTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRM-DNPCY---PRWLTREAKDILVKLFVR 233 (316)
T ss_pred CCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-CCCCC---CccCCHHHHHHHHHHhcc
Confidence 79999999999888899999999999999999999999987766555544422 22332 334678899999999999
Q ss_pred CCCCCCCHH-HHHH
Q 013214 396 KPAKRPTFR-QIIT 408 (447)
Q Consensus 396 dp~~Rps~~-~~l~ 408 (447)
||++||++. ++.+
T Consensus 234 ~P~~R~~~~~~l~~ 247 (316)
T cd05619 234 EPERRLGVKGDIRQ 247 (316)
T ss_pred CHhhcCCChHHHHc
Confidence 999999997 5554
No 99
>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase. Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament
Probab=100.00 E-value=1.6e-39 Score=309.40 Aligned_cols=247 Identities=25% Similarity=0.417 Sum_probs=196.9
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|...+.||.|+||.|+. +++.||+|.++.... ......+.+|+.++++++||||+++++++...+..+++||
T Consensus 6 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (288)
T cd07871 6 TYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE--EGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE 83 (288)
T ss_pred cceEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc--CCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence 578888999999998873 678999999875432 1223456789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 013214 231 YLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (447)
Q Consensus 231 ~~~~g~L~~~l~~~~-~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~ 309 (447)
|++ ++|.+++...+ .+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++....... .
T Consensus 84 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~-~ 158 (288)
T cd07871 84 YLD-SDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPT-K 158 (288)
T ss_pred CCC-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCC-c
Confidence 996 59999887654 4789999999999999999999999 9999999999999999999999999987543221 1
Q ss_pred CcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcC-C----------------
Q 013214 310 PLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-R---------------- 371 (447)
Q Consensus 310 ~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~-~---------------- 371 (447)
......+++.|+|||.+.+ ..++.++||||+||++|+|++|+.||...+..+....+.... .
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd07871 159 TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFR 238 (288)
T ss_pred cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhh
Confidence 2233456889999998865 468899999999999999999999998766544332221110 0
Q ss_pred ----CCCC-----CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 372 ----PPFK-----APAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 372 ----~~~~-----~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
+... ...+..++++.++|++||+.||.+|||+++++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 239 SYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred ccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0000 0112356789999999999999999999999864
No 100
>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]
Probab=100.00 E-value=7.5e-41 Score=330.53 Aligned_cols=260 Identities=32% Similarity=0.541 Sum_probs=229.2
Q ss_pred ccCCCCcCcccceeeecceEEEEEE--------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEE
Q 013214 149 EIDPHELDFTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVT 220 (447)
Q Consensus 149 ~i~~~~~~~~~~~~lg~G~~~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 220 (447)
||++. ...+.+.||.|.||.|.. ....||||.++... .+++..+|..|..+|-+++||||+++.|+..
T Consensus 625 EId~s--~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy--tekqrrdFL~EAsIMGQFdHPNIIrLEGVVT 700 (996)
T KOG0196|consen 625 EIDPS--CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY--TEKQRRDFLSEASIMGQFDHPNIIRLEGVVT 700 (996)
T ss_pred hcChh--heEEEEEEecccccceecccccCCCCcceeEEEeeeccCc--cHHHHhhhhhhhhhcccCCCCcEEEEEEEEe
Confidence 44443 455667899999998863 34789999998764 6778899999999999999999999999999
Q ss_pred eCCceEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeeccc
Q 013214 221 QSSPMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGV 299 (447)
Q Consensus 221 ~~~~~~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~ 299 (447)
....+.||+|||++|+|+.+|+++ ++++..+...+++.|+.|++||-+.+ +|||||..+|||++.+-..|++|||+
T Consensus 701 ks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGL 777 (996)
T KOG0196|consen 701 KSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGL 777 (996)
T ss_pred cCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccc
Confidence 999999999999999999999875 67999999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCCCCcccCC--CCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCCCC
Q 013214 300 SKLLTVKEDRPLTCQD--TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKA 376 (447)
Q Consensus 300 ~~~~~~~~~~~~~~~~--~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 376 (447)
++.+..+.....+..+ -+.+|.|||.+..++++.++||||+|++|||.++ |+.||.++.+.++...+..+.+.+.
T Consensus 778 SRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPp-- 855 (996)
T KOG0196|consen 778 SRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPP-- 855 (996)
T ss_pred eeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCC--
Confidence 9987655433333333 3688999999999999999999999999999998 9999999999999999877776653
Q ss_pred ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhh
Q 013214 377 PAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSIN 418 (447)
Q Consensus 377 ~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~~~ 418 (447)
+.++|..+.+||..||++|-.+||.+.+|+..|+++....+
T Consensus 856 -PmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~ 896 (996)
T KOG0196|consen 856 -PMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPN 896 (996)
T ss_pred -CCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCch
Confidence 55788999999999999999999999999999999876653
No 101
>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase. Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr
Probab=100.00 E-value=9.5e-40 Score=316.05 Aligned_cols=235 Identities=28% Similarity=0.422 Sum_probs=193.5
Q ss_pred eeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHH-HHhcCCCCcccceeEEEEeCCceEEEEeccCCC
Q 013214 162 EITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELA-LLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235 (447)
Q Consensus 162 ~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~-~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g 235 (447)
.||+|+||.|+ .+|+.||+|++.............+..|.. +++.++||||+++++.+...+..+++|||+++|
T Consensus 2 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g 81 (323)
T cd05575 2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGG 81 (323)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCCC
Confidence 68999999886 268999999987543323333344445544 567889999999999999999999999999999
Q ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCCcccCC
Q 013214 236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD 315 (447)
Q Consensus 236 ~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~ 315 (447)
+|.+++.+++.+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++...... ........
T Consensus 82 ~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~ 157 (323)
T cd05575 82 ELFFHLQRERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH-SKTTSTFC 157 (323)
T ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccC-CCcccccc
Confidence 99999998888999999999999999999999999 999999999999999999999999998753221 12223446
Q ss_pred CCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHHHHHccc
Q 013214 316 TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNE 395 (447)
Q Consensus 316 ~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 395 (447)
||+.|+|||.+.+..++.++|||||||++|+|++|+.||...+..+....+... ...+ .+.++..+.++|.+||+.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~-~~~~---~~~~~~~~~~li~~~l~~ 233 (323)
T cd05575 158 GTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNK-PLRL---KPNISVSARHLLEGLLQK 233 (323)
T ss_pred CChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcC-CCCC---CCCCCHHHHHHHHHHhhc
Confidence 799999999999888999999999999999999999999877655554444222 2222 234678899999999999
Q ss_pred CCCCCCCHH
Q 013214 396 KPAKRPTFR 404 (447)
Q Consensus 396 dp~~Rps~~ 404 (447)
||.+||++.
T Consensus 234 ~p~~R~~~~ 242 (323)
T cd05575 234 DRTKRLGAK 242 (323)
T ss_pred CHHhCCCCC
Confidence 999999985
No 102
>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1. Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an
Probab=100.00 E-value=1.5e-39 Score=320.09 Aligned_cols=252 Identities=24% Similarity=0.332 Sum_probs=204.0
Q ss_pred CcCcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEE
Q 013214 154 ELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 228 (447)
Q Consensus 154 ~~~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 228 (447)
..+|+..+.||+|+||.|+ .+++.+|+|++...........+.+.+|..+++.++||||+++++.+..+...++|
T Consensus 42 ~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv 121 (371)
T cd05622 42 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMV 121 (371)
T ss_pred hhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 3578888999999999886 26789999998654333334456678899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 013214 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (447)
Q Consensus 229 ~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~ 308 (447)
|||+++|+|.+++... .+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++........
T Consensus 122 ~Ey~~gg~L~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~ 197 (371)
T cd05622 122 MEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM 197 (371)
T ss_pred EcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCc
Confidence 9999999999998654 5889999999999999999999999 99999999999999999999999999986543222
Q ss_pred CCcccCCCCCcccCCcccCCC----CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcC-CCCCCCChhhhHH
Q 013214 309 RPLTCQDTSCRYVAPEVFKNE----EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RPPFKAPAKLYAR 383 (447)
Q Consensus 309 ~~~~~~~~t~~y~aPE~~~~~----~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 383 (447)
.......||+.|+|||++.+. .++.++|||||||++|+|++|+.||...+.......+.... ...++ ....++.
T Consensus 198 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~-~~~~~s~ 276 (371)
T cd05622 198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFP-DDNDISK 276 (371)
T ss_pred ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCC-CcCCCCH
Confidence 222345689999999998654 37789999999999999999999998776655555543322 22222 2345788
Q ss_pred HHHHHHHHHcccCCCC--CCCHHHHHHHH
Q 013214 384 GLKELIEECWNEKPAK--RPTFRQIITRL 410 (447)
Q Consensus 384 ~l~~li~~cl~~dp~~--Rps~~~~l~~l 410 (447)
.+.++|..|+..++.+ |+++.+++++.
T Consensus 277 ~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 277 EAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred HHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 9999999999844433 78999988764
No 103
>PHA03212 serine/threonine kinase US3; Provisional
Probab=100.00 E-value=2.7e-39 Score=319.92 Aligned_cols=244 Identities=23% Similarity=0.304 Sum_probs=195.5
Q ss_pred CCcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEE
Q 013214 153 HELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227 (447)
Q Consensus 153 ~~~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 227 (447)
...+|+..+.||+|+||.|+. +++.||+|.... ..+.+|+.++++++||||+++++++......++
T Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~---------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~l 160 (391)
T PHA03212 90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR---------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCL 160 (391)
T ss_pred ccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh---------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEE
Confidence 345799999999999998863 688999996532 245789999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCC
Q 013214 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307 (447)
Q Consensus 228 v~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~ 307 (447)
++|++ +++|.+++.....+++.+++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 161 v~e~~-~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~ 236 (391)
T PHA03212 161 ILPRY-KTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN 236 (391)
T ss_pred EEecC-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCccccccccc
Confidence 99999 5799999988888999999999999999999999999 9999999999999999999999999987543222
Q ss_pred CCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCC-------chHHHH-HhcC---------
Q 013214 308 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDN-------EVPKAY-AARQ--------- 370 (447)
Q Consensus 308 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~-------~~~~~~-~~~~--------- 370 (447)
........||+.|+|||++.+..++.++|||||||++|+|++|+.||...... .....+ ...+
T Consensus 237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~ 316 (391)
T PHA03212 237 ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPID 316 (391)
T ss_pred ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcc
Confidence 22223456899999999998889999999999999999999999876533210 000000 0000
Q ss_pred ------------------CCCCCC---ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 371 ------------------RPPFKA---PAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 371 ------------------~~~~~~---~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
.+.... .....+.++.++|.+||+.||.+|||+++++++
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h 376 (391)
T PHA03212 317 AQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF 376 (391)
T ss_pred hhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 000000 111346789999999999999999999999964
No 104
>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,
Probab=100.00 E-value=2.1e-39 Score=314.63 Aligned_cols=251 Identities=21% Similarity=0.317 Sum_probs=203.4
Q ss_pred CcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|+..+.||+|+||.|+ .+++.||+|++.+.........+.+.+|..+++.++||||+++++++..++.+|+|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (331)
T cd05597 2 DFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMD 81 (331)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEe
Confidence 57778899999999886 2578999999875433334445668899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 013214 231 YLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (447)
Q Consensus 231 ~~~~g~L~~~l~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~ 309 (447)
|+++|+|.+++.+ ...+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++.........
T Consensus 82 ~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 158 (331)
T cd05597 82 YYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTV 158 (331)
T ss_pred cCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCCCCc
Confidence 9999999999976 456899999999999999999999999 999999999999999999999999998765432222
Q ss_pred CcccCCCCCcccCCcccCC-----CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcC-CCCCCCChhhhHH
Q 013214 310 PLTCQDTSCRYVAPEVFKN-----EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RPPFKAPAKLYAR 383 (447)
Q Consensus 310 ~~~~~~~t~~y~aPE~~~~-----~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 383 (447)
......||+.|+|||++.. ..++.++|||||||++|+|++|+.||......+....+.... ...++.....+++
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 238 (331)
T cd05597 159 QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSE 238 (331)
T ss_pred cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCCCH
Confidence 2223458999999999863 356789999999999999999999998766555444443222 2333333445788
Q ss_pred HHHHHHHHHcccCCCC--CCCHHHHHHH
Q 013214 384 GLKELIEECWNEKPAK--RPTFRQIITR 409 (447)
Q Consensus 384 ~l~~li~~cl~~dp~~--Rps~~~~l~~ 409 (447)
.++++|++|+..++++ |+++.+++++
T Consensus 239 ~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 239 EAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred HHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 9999999988654443 7899999887
No 105
>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr
Probab=100.00 E-value=3.9e-39 Score=304.93 Aligned_cols=242 Identities=25% Similarity=0.390 Sum_probs=193.7
Q ss_pred eecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEeccCCCCH
Q 013214 163 ITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237 (447)
Q Consensus 163 lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L 237 (447)
||+|+||.|+ .+|+.+|+|.+.............+..|+++++.++||||+++++.+..+...+++|||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 6899999886 35899999998754333333334556799999999999999999999999999999999999999
Q ss_pred HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCCcccCC
Q 013214 238 RAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD 315 (447)
Q Consensus 238 ~~~l~~~~--~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~ 315 (447)
.+++.... .+++..+..++.|++.||.|||+.+ ++||||||+||++++++.++|+|||++...... .......
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~--~~~~~~~ 155 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG--KTITQRA 155 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCC--ceeeccC
Confidence 98886543 4888899999999999999999999 999999999999999999999999998765432 1223345
Q ss_pred CCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcC-CCCCCCChhhhHHHHHHHHHHHcc
Q 013214 316 TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RPPFKAPAKLYARGLKELIEECWN 394 (447)
Q Consensus 316 ~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~ 394 (447)
++..|+|||++.+..++.++|+||+||++|+|++|+.||...........+.... ..........+++++.+++.+||+
T Consensus 156 ~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 235 (277)
T cd05607 156 GTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLA 235 (277)
T ss_pred CCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHHHHHHhc
Confidence 7889999999988889999999999999999999999997654322211211111 111222234578899999999999
Q ss_pred cCCCCCCCHHHHHHH
Q 013214 395 EKPAKRPTFRQIITR 409 (447)
Q Consensus 395 ~dp~~Rps~~~~l~~ 409 (447)
.||++||++.++++.
T Consensus 236 ~~P~~R~~~~~~~~~ 250 (277)
T cd05607 236 KKPEDRLGSREKNDD 250 (277)
T ss_pred cCHhhCCCCccchhh
Confidence 999999999776543
No 106
>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]
Probab=100.00 E-value=2e-39 Score=327.52 Aligned_cols=261 Identities=21% Similarity=0.374 Sum_probs=211.7
Q ss_pred CcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC-CCcccceeEE-EEe-----
Q 013214 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGA-VTQ----- 221 (447)
Q Consensus 154 ~~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~-~~~----- 221 (447)
..++++.+.|.+|||+.||. .|..||+|++-. .++...+...+|+++|++++ |||||.+++. ...
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~---~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~ 112 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYV---NDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNN 112 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeec---CCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCC
Confidence 44677788999999999883 348999999854 37788899999999999995 9999999993 221
Q ss_pred -CCceEEEEeccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecc
Q 013214 222 -SSPMMIVTEYLPKGDLRAFLKR--KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298 (447)
Q Consensus 222 -~~~~~lv~e~~~~g~L~~~l~~--~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg 298 (447)
...++|+||||.||.|-+++.+ +..|++.++++|+.|+|+|+.+||... .||||||||.+||||+.+|+.||||||
T Consensus 113 ~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDFG 191 (738)
T KOG1989|consen 113 GVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDFG 191 (738)
T ss_pred ceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCccc
Confidence 1347899999999999999975 345999999999999999999999998 479999999999999999999999999
Q ss_pred cccccccCCCCCc--------ccCCCCCcccCCccc---CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHH
Q 013214 299 VSKLLTVKEDRPL--------TCQDTSCRYVAPEVF---KNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYA 367 (447)
Q Consensus 299 ~~~~~~~~~~~~~--------~~~~~t~~y~aPE~~---~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~ 367 (447)
++........... -....|+.|+|||++ .+...++|+|||+|||+||-|+....||+......+
T Consensus 192 Satt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laI----- 266 (738)
T KOG1989|consen 192 SATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAI----- 266 (738)
T ss_pred ccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeE-----
Confidence 9875432221110 112358999999976 466889999999999999999999999997644322
Q ss_pred hcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhhcccchh
Q 013214 368 ARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINHKRRWK 424 (447)
Q Consensus 368 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~~~~~~~~~ 424 (447)
..+...++. .+.|+..+.+||+.||+.||.+||+..+++.++-.+...-.+.....
T Consensus 267 lng~Y~~P~-~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~~~~~~ 322 (738)
T KOG1989|consen 267 LNGNYSFPP-FPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCPIPDIY 322 (738)
T ss_pred EeccccCCC-CccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCCccccc
Confidence 222223332 25689999999999999999999999999999999887776554433
No 107
>PTZ00283 serine/threonine protein kinase; Provisional
Probab=100.00 E-value=5e-39 Score=326.81 Aligned_cols=251 Identities=22% Similarity=0.342 Sum_probs=207.8
Q ss_pred CCCcCcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCC---
Q 013214 152 PHELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS--- 223 (447)
Q Consensus 152 ~~~~~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~--- 223 (447)
....+|...+.||+|+||.|+ .+|+.||+|++..... .......+.+|+.++..++|+|++++++.+....
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~ 107 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGM-SEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN 107 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence 344589999999999999886 2689999999876544 3455667888999999999999999988765432
Q ss_pred -----ceEEEEeccCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEE
Q 013214 224 -----PMMIVTEYLPKGDLRAFLKRK----GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294 (447)
Q Consensus 224 -----~~~lv~e~~~~g~L~~~l~~~----~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl 294 (447)
.++++|||+++|+|.++++.. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||
T Consensus 108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vkL 184 (496)
T PTZ00283 108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVKL 184 (496)
T ss_pred cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEEE
Confidence 368999999999999998653 45899999999999999999999998 999999999999999999999
Q ss_pred eecccccccccCC-CCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCC
Q 013214 295 ADFGVSKLLTVKE-DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPP 373 (447)
Q Consensus 295 ~Dfg~~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~ 373 (447)
+|||+++.+.... ........||+.|+|||.+.+..++.++||||||+++|+|++|+.||...+..+....+......+
T Consensus 185 ~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~~ 264 (496)
T PTZ00283 185 GDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDP 264 (496)
T ss_pred EecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCC
Confidence 9999987654321 112234568999999999998889999999999999999999999998776555544443333333
Q ss_pred CCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 374 FKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 374 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
.+..+++++.+++.+||+.||.+||++.+++++
T Consensus 265 ---~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 265 ---LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred ---CCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 345678899999999999999999999999865
No 108
>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases. Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt
Probab=100.00 E-value=7e-39 Score=303.40 Aligned_cols=248 Identities=29% Similarity=0.497 Sum_probs=205.8
Q ss_pred CcccceeeecceEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCce
Q 013214 156 DFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 225 (447)
+|...+.||+|+||.++. ++..||+|.+.... ..+..+.+.+|+++++.++||||+++++++......
T Consensus 6 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 6 TIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA--SNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred HhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC--CHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 567778899999998863 23689999987542 344567899999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCC
Q 013214 226 MIVTEYLPKGDLRAFLKRKG--------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291 (447)
Q Consensus 226 ~lv~e~~~~g~L~~~l~~~~--------------~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~ 291 (447)
+++|||+++++|.+++...+ .+++..+..++.|++.|+.|||+.+ ++|+||||+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCe
Confidence 99999999999999997643 3778889999999999999999999 999999999999999999
Q ss_pred EEEeecccccccccCCC-CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhc
Q 013214 292 LKVADFGVSKLLTVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAAR 369 (447)
Q Consensus 292 vkl~Dfg~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~ 369 (447)
++|+|||++........ .......+++.|+|||.+.+..++.++||||||+++|+|++ |..||......+....+...
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~ 240 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQG 240 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC
Confidence 99999999875432211 11122334678999999998899999999999999999998 99999877766655555322
Q ss_pred CCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHH
Q 013214 370 QRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLE 411 (447)
Q Consensus 370 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~ 411 (447)
..+. .+..++..+.+++.+||+.||++||++.++++.|+
T Consensus 241 ~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 241 RLLQ---RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred CcCC---CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 2222 23457789999999999999999999999999885
No 109
>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2. Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul
Probab=100.00 E-value=9e-40 Score=320.98 Aligned_cols=249 Identities=24% Similarity=0.393 Sum_probs=204.7
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|+..+.||+|+||.|+. +++.||+|++........+....+.+|..++..++||+|+++++.+.+.+.+++|||
T Consensus 2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E 81 (360)
T cd05627 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIME 81 (360)
T ss_pred CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence 467778999999998863 688999999975443344556778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCC--
Q 013214 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED-- 308 (447)
Q Consensus 231 ~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~-- 308 (447)
|+++|+|.+++.+.+.+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++........
T Consensus 82 ~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~ 158 (360)
T cd05627 82 FLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTE 158 (360)
T ss_pred CCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccccccccc
Confidence 9999999999998888999999999999999999999999 99999999999999999999999999864421100
Q ss_pred --------------------------------CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 013214 309 --------------------------------RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTM 356 (447)
Q Consensus 309 --------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~ 356 (447)
.......||+.|+|||++.+..++.++|+|||||++|+|++|+.||..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~ 238 (360)
T cd05627 159 FYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS 238 (360)
T ss_pred cccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCC
Confidence 001134589999999999998999999999999999999999999988
Q ss_pred CCCCchHHHHHhcC-CCCCCCChhhhHHHHHHHHHHHcccCCCCCCC---HHHHHHH
Q 013214 357 KHDNEVPKAYAARQ-RPPFKAPAKLYARGLKELIEECWNEKPAKRPT---FRQIITR 409 (447)
Q Consensus 357 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps---~~~~l~~ 409 (447)
.+..+....+.... ...++. ...+++++.++|.+|+ .||.+|++ +.+++++
T Consensus 239 ~~~~~~~~~i~~~~~~~~~p~-~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 239 ETPQETYRKVMNWKETLVFPP-EVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSH 293 (360)
T ss_pred CCHHHHHHHHHcCCCceecCC-CCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcC
Confidence 77666555543322 222222 2236788999999877 49999985 6666655
No 110
>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor. Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh
Probab=100.00 E-value=7.6e-39 Score=302.85 Aligned_cols=250 Identities=26% Similarity=0.448 Sum_probs=203.2
Q ss_pred CcCcccceeeecceEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCC
Q 013214 154 ELDFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS 223 (447)
Q Consensus 154 ~~~~~~~~~lg~G~~~~~~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 223 (447)
..+|+..+.||+|++|.++. .+..||+|.+.... ......++.+|+.+++.++||||+++++++....
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~ 82 (277)
T cd05062 5 REKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 82 (277)
T ss_pred HHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 34688889999999998762 24679999886432 3344567889999999999999999999999999
Q ss_pred ceEEEEeccCCCCHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEE
Q 013214 224 PMMIVTEYLPKGDLRAFLKRKG----------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK 293 (447)
Q Consensus 224 ~~~lv~e~~~~g~L~~~l~~~~----------~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vk 293 (447)
..+++|||+++++|.+++.+.. .++...+..++.|++.||.|||+.+ ++|+||||+||++++++.++
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~ 159 (277)
T cd05062 83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVK 159 (277)
T ss_pred CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEE
Confidence 9999999999999999997532 2467788899999999999999998 99999999999999999999
Q ss_pred EeecccccccccCCCC-CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCC
Q 013214 294 VADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQR 371 (447)
Q Consensus 294 l~Dfg~~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~ 371 (447)
|+|||++......... ......+++.|+|||.+.+..++.++|+||||+++|+|++ |..||......+....+.....
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~ 239 (277)
T cd05062 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGL 239 (277)
T ss_pred ECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCc
Confidence 9999998754322111 1112234678999999988889999999999999999999 7899987766555544433333
Q ss_pred CCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHH
Q 013214 372 PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLE 411 (447)
Q Consensus 372 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~ 411 (447)
+.. +...+..+.+++.+||+.||++|||+.++++.|+
T Consensus 240 ~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 240 LDK---PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred CCC---CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 332 3446778999999999999999999999998875
No 111
>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha. Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a
Probab=100.00 E-value=2.8e-39 Score=312.68 Aligned_cols=239 Identities=27% Similarity=0.431 Sum_probs=199.3
Q ss_pred cccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC-CCcccceeEEEEeCCceEEEEe
Q 013214 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 157 ~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~lv~e 230 (447)
|...+.||+|+||.|+. +|+.||+|++...........+.+..|..+++.+. ||+|+++++++...+..++|||
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (323)
T cd05615 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVME 81 (323)
T ss_pred ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEc
Confidence 56678999999998863 58899999987654333445566778889988885 6778889999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCC
Q 013214 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (447)
Q Consensus 231 ~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~ 310 (447)
|+++|+|.+++.+.+.+++.++..++.|++.||.|||+.+ ++||||||+||++++++.+||+|||++....... ..
T Consensus 82 y~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~-~~ 157 (323)
T cd05615 82 YVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG-VT 157 (323)
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCCC-cc
Confidence 9999999999988888999999999999999999999999 9999999999999999999999999987533221 12
Q ss_pred cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHHH
Q 013214 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIE 390 (447)
Q Consensus 311 ~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 390 (447)
.....||+.|+|||.+.+..++.++|+||+|+++|+|++|+.||...........+.. ....+ +..++..+.+++.
T Consensus 158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~-~~~~~---p~~~~~~~~~li~ 233 (323)
T cd05615 158 TRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIME-HNVSY---PKSLSKEAVSICK 233 (323)
T ss_pred ccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh-CCCCC---CccCCHHHHHHHH
Confidence 2334579999999999888899999999999999999999999987766555544422 22222 3456788999999
Q ss_pred HHcccCCCCCCCH
Q 013214 391 ECWNEKPAKRPTF 403 (447)
Q Consensus 391 ~cl~~dp~~Rps~ 403 (447)
+||+.||.+|++.
T Consensus 234 ~~l~~~p~~R~~~ 246 (323)
T cd05615 234 GLMTKHPSKRLGC 246 (323)
T ss_pred HHcccCHhhCCCC
Confidence 9999999999984
No 112
>PLN00034 mitogen-activated protein kinase kinase; Provisional
Probab=100.00 E-value=4.3e-39 Score=315.34 Aligned_cols=244 Identities=24% Similarity=0.388 Sum_probs=196.2
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|...+.||+|+||.|+. +|+.||+|++.... .......+.+|+.+++.++|+||+++++++...+.++++||
T Consensus 75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 152 (353)
T PLN00034 75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH--EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLE 152 (353)
T ss_pred HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC--cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEe
Confidence 567778899999998873 58899999986442 34456778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCC
Q 013214 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (447)
Q Consensus 231 ~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~ 310 (447)
|+++|+|.+. ...++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++....... ..
T Consensus 153 ~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~-~~ 224 (353)
T PLN00034 153 FMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM-DP 224 (353)
T ss_pred cCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceeccccc-cc
Confidence 9999998653 33567788899999999999999999 9999999999999999999999999987654321 12
Q ss_pred cccCCCCCcccCCcccCCC-----CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHH
Q 013214 311 LTCQDTSCRYVAPEVFKNE-----EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGL 385 (447)
Q Consensus 311 ~~~~~~t~~y~aPE~~~~~-----~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 385 (447)
.....||..|+|||.+... ..+.++|||||||++|+|++|+.||......+................+..++.++
T Consensus 225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 304 (353)
T PLN00034 225 CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASREF 304 (353)
T ss_pred ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccCHHH
Confidence 2334679999999987432 33468999999999999999999998555444333322221111122344577899
Q ss_pred HHHHHHHcccCCCCCCCHHHHHHH
Q 013214 386 KELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 386 ~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
.++|.+||+.||++||++.+++++
T Consensus 305 ~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 305 RHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred HHHHHHHccCChhhCcCHHHHhcC
Confidence 999999999999999999999986
No 113
>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase. Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate
Probab=100.00 E-value=5.8e-40 Score=316.88 Aligned_cols=236 Identities=25% Similarity=0.372 Sum_probs=197.4
Q ss_pred eeeecceEEEEE--------EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEecc
Q 013214 161 VEITKGTFILAF--------WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYL 232 (447)
Q Consensus 161 ~~lg~G~~~~~~--------~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 232 (447)
+.||+|+||.|+ .+|+.||+|++...... ......+.+|+.++++++||||+++++++..++..|+||||+
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 80 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLK-VRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL 80 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence 468999999876 25789999998754322 223345678999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCCcc
Q 013214 233 PKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLT 312 (447)
Q Consensus 233 ~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~ 312 (447)
++|+|.+++.+...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++....... ....
T Consensus 81 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-~~~~ 156 (318)
T cd05582 81 RGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE-KKAY 156 (318)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCC-Ccee
Confidence 99999999988888999999999999999999999999 9999999999999999999999999987643321 1223
Q ss_pred cCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHHHHH
Q 013214 313 CQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEEC 392 (447)
Q Consensus 313 ~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 392 (447)
...|++.|+|||.+.+..++.++||||||+++|+|++|+.||...+..+....+.. ....+ +..+++.+.++|++|
T Consensus 157 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~-~~~~~---p~~~~~~~~~li~~~ 232 (318)
T cd05582 157 SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILK-AKLGM---PQFLSPEAQSLLRAL 232 (318)
T ss_pred cccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHc-CCCCC---CCCCCHHHHHHHHHH
Confidence 45679999999999888889999999999999999999999987765555444422 22222 344678899999999
Q ss_pred cccCCCCCCCHHH
Q 013214 393 WNEKPAKRPTFRQ 405 (447)
Q Consensus 393 l~~dp~~Rps~~~ 405 (447)
|+.||++||++.+
T Consensus 233 l~~~P~~R~~a~~ 245 (318)
T cd05582 233 FKRNPANRLGAGP 245 (318)
T ss_pred hhcCHhHcCCCCC
Confidence 9999999999544
No 114
>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C. Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n
Probab=100.00 E-value=1.4e-38 Score=303.28 Aligned_cols=252 Identities=28% Similarity=0.492 Sum_probs=207.9
Q ss_pred CcccceeeecceEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCce
Q 013214 156 DFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 225 (447)
+|...+.||+|+||.++. ++..+++|.+... .....+.+.+|+.++++++||||+++++++......
T Consensus 6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (291)
T cd05094 6 DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP---TLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPL 82 (291)
T ss_pred HeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCc---cHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCce
Confidence 466678899999987762 2456899988643 334456788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCC
Q 013214 226 MIVTEYLPKGDLRAFLKRKG----------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289 (447)
Q Consensus 226 ~lv~e~~~~g~L~~~l~~~~----------------~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~ 289 (447)
+++|||+++++|.+++...+ .+++..++.++.|++.|+.|||+++ ++|+||||+||+++.+
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~ 159 (291)
T cd05094 83 IMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGAN 159 (291)
T ss_pred EEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccC
Confidence 99999999999999997542 3788999999999999999999999 9999999999999999
Q ss_pred CCEEEeecccccccccCCC-CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHH
Q 013214 290 GNLKVADFGVSKLLTVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYA 367 (447)
Q Consensus 290 ~~vkl~Dfg~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~ 367 (447)
+.++|+|||++........ .......++..|+|||.+.+..++.++||||||+++|+|++ |+.||...+..+....+.
T Consensus 160 ~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~ 239 (291)
T cd05094 160 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECIT 239 (291)
T ss_pred CcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh
Confidence 9999999999875432211 11123345778999999988889999999999999999998 999998777655555443
Q ss_pred hcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhh
Q 013214 368 ARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS 416 (447)
Q Consensus 368 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~ 416 (447)
....+. .+...+..+.+++.+||+.||++||++.++++.|+++...
T Consensus 240 ~~~~~~---~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 240 QGRVLE---RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred CCCCCC---CCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 332222 2344678899999999999999999999999999998764
No 115
>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor. Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor
Probab=100.00 E-value=1.1e-38 Score=307.76 Aligned_cols=255 Identities=24% Similarity=0.483 Sum_probs=208.2
Q ss_pred cCcccceeeecceEEEEEE-----cCe----EEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCce
Q 013214 155 LDFTNSVEITKGTFILAFW-----RGI----QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~-----~g~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 225 (447)
.+|+..+.||+|+||.|+. +|+ .||+|.+... ......+.+.+|+.+++.++||||+++++++... ..
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~ 83 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV 83 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cc
Confidence 4688889999999998863 333 4899998643 2345567788999999999999999999998764 57
Q ss_pred EEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccc
Q 013214 226 MIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304 (447)
Q Consensus 226 ~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~ 304 (447)
++++||+++|+|.+++.+. ..+++.....++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++....
T Consensus 84 ~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 160 (316)
T cd05108 84 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 160 (316)
T ss_pred eeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEcccccccccc
Confidence 8999999999999999875 35888999999999999999999999 9999999999999999999999999998765
Q ss_pred cCCCCC-cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCCCCChhhhH
Q 013214 305 VKEDRP-LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYA 382 (447)
Q Consensus 305 ~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 382 (447)
...... ......+..|+|||.+.+..++.++||||||+++|+|++ |+.||.+....+...........+. +..++
T Consensus 161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~ 237 (316)
T cd05108 161 ADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ---PPICT 237 (316)
T ss_pred CCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCCCCCC---CCCCC
Confidence 332211 122234678999999988899999999999999999998 9999987665554444433333332 34467
Q ss_pred HHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhh
Q 013214 383 RGLKELIEECWNEKPAKRPTFRQIITRLESINNSIN 418 (447)
Q Consensus 383 ~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~~~ 418 (447)
..+.+++.+||..||.+||++.+++..+..+.....
T Consensus 238 ~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~~ 273 (316)
T cd05108 238 IDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQ 273 (316)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCCc
Confidence 789999999999999999999999999988876553
No 116
>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1. Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly
Probab=100.00 E-value=1.3e-38 Score=302.34 Aligned_cols=249 Identities=30% Similarity=0.525 Sum_probs=204.6
Q ss_pred CcccceeeecceEEEEEE---------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceE
Q 013214 156 DFTNSVEITKGTFILAFW---------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM 226 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~---------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 226 (447)
+|+..+.||+|+||.++. .+..||+|.+... ........+.+|+.+++.++||||+++++++......+
T Consensus 6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 83 (283)
T cd05090 6 AVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDI--NNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVC 83 (283)
T ss_pred hceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCC--CCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceE
Confidence 466678899999998863 4478999998743 23445577889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhcC-----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCC
Q 013214 227 IVTEYLPKGDLRAFLKRKG-----------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289 (447)
Q Consensus 227 lv~e~~~~g~L~~~l~~~~-----------------~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~ 289 (447)
++|||+++++|.+++.... .+++.....++.|++.||.|||+.+ ++|+||||+||+++++
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~ 160 (283)
T cd05090 84 MLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQ 160 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCC
Confidence 9999999999999985322 3678888999999999999999999 9999999999999999
Q ss_pred CCEEEeecccccccccCCC-CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHH
Q 013214 290 GNLKVADFGVSKLLTVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYA 367 (447)
Q Consensus 290 ~~vkl~Dfg~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~ 367 (447)
+.+||+|||++........ .......++..|+|||.+.+..++.++|+||||+++|+|++ |..||......+....+.
T Consensus 161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~ 240 (283)
T cd05090 161 LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVR 240 (283)
T ss_pred CcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 9999999999876532211 11223334677999999988889999999999999999998 999998766555555543
Q ss_pred hcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHH
Q 013214 368 ARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLES 412 (447)
Q Consensus 368 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~ 412 (447)
....++ .+..+++.+.+++.+||+.||.+||++.+++++|+.
T Consensus 241 ~~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 241 KRQLLP---CSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred cCCcCC---CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 333333 234567899999999999999999999999998864
No 117
>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome. Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds
Probab=100.00 E-value=8.1e-39 Score=299.19 Aligned_cols=246 Identities=30% Similarity=0.556 Sum_probs=201.9
Q ss_pred CcccceeeecceEEEEE---E-cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEec
Q 013214 156 DFTNSVEITKGTFILAF---W-RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~---~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 231 (447)
+|...+.||+|+||.++ + .+..+|+|.+..... ....+.+|+.++++++||||+++++++......+++|||
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd05113 5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM----SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEY 80 (256)
T ss_pred HeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc----cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEc
Confidence 46677889999998875 2 234699998875432 235688899999999999999999999998999999999
Q ss_pred cCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCC
Q 013214 232 LPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (447)
Q Consensus 232 ~~~g~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~ 310 (447)
+.+|+|.+++... ..+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||.+..........
T Consensus 81 ~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05113 81 MSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS 157 (256)
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCceee
Confidence 9999999999764 46899999999999999999999999 9999999999999999999999999987654322111
Q ss_pred cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHH
Q 013214 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELI 389 (447)
Q Consensus 311 ~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 389 (447)
.....++..|+|||.+.+..++.++|+||||+++|+|++ |..||...+..+....+....++.. +...+..+.+++
T Consensus 158 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li 234 (256)
T cd05113 158 SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYR---PHLASEKVYAIM 234 (256)
T ss_pred cCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCC---CCCCCHHHHHHH
Confidence 122335677999999988888999999999999999998 9999987766555555433333322 234578899999
Q ss_pred HHHcccCCCCCCCHHHHHHHHH
Q 013214 390 EECWNEKPAKRPTFRQIITRLE 411 (447)
Q Consensus 390 ~~cl~~dp~~Rps~~~~l~~l~ 411 (447)
.+||+.||.+||++.++++.++
T Consensus 235 ~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 235 YSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred HHHcCCCcccCCCHHHHHHhhC
Confidence 9999999999999999998763
No 118
>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows
Probab=100.00 E-value=9.8e-39 Score=298.54 Aligned_cols=245 Identities=31% Similarity=0.562 Sum_probs=202.1
Q ss_pred CcccceeeecceEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEec
Q 013214 156 DFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 231 (447)
+|+..+.||+|+||.++. .+..+|+|.+...... ...+.+|+.++++++||||+++++++......+++|||
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMS----EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEY 80 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCC----HHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEec
Confidence 466778899999998763 4568999988654322 24577899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCC
Q 013214 232 LPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (447)
Q Consensus 232 ~~~g~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~ 310 (447)
+++++|.+++..+ ..+++..+..++.|++.|+.|||+.+ ++|+||||+||++++++.+||+|||++..........
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~ 157 (256)
T cd05059 81 MANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS 157 (256)
T ss_pred CCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceecccccccc
Confidence 9999999999764 46899999999999999999999999 9999999999999999999999999987654221111
Q ss_pred cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHH
Q 013214 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELI 389 (447)
Q Consensus 311 ~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 389 (447)
.....++..|+|||.+.+..++.++|+||||+++|+|++ |+.||...+..+....+....+... +..++..+.+++
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li 234 (256)
T cd05059 158 SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYR---PKLAPTEVYTIM 234 (256)
T ss_pred cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCCC---CCCCCHHHHHHH
Confidence 112223467999999988889999999999999999999 8999987766665555533333332 234688999999
Q ss_pred HHHcccCCCCCCCHHHHHHHH
Q 013214 390 EECWNEKPAKRPTFRQIITRL 410 (447)
Q Consensus 390 ~~cl~~dp~~Rps~~~~l~~l 410 (447)
.+||..+|++|||+.++++.|
T Consensus 235 ~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 235 YSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred HHHhcCChhhCcCHHHHHHHh
Confidence 999999999999999999876
No 119
>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.
Probab=100.00 E-value=1.4e-38 Score=299.28 Aligned_cols=253 Identities=25% Similarity=0.488 Sum_probs=207.6
Q ss_pred CcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|+..+.||.|++|.++ .+|..+|+|.+......+.....++.+|+.+++.++||||+++++++..++..+++||
T Consensus 3 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 82 (267)
T cd08229 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLE 82 (267)
T ss_pred hhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEE
Confidence 56777889999998775 3788999998876544455566788899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccC
Q 013214 231 YLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306 (447)
Q Consensus 231 ~~~~g~L~~~l~~----~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~ 306 (447)
|+++++|.+++.. ...+++..++.++.|++.|+.|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd08229 83 LADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred ecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhccccC
Confidence 9999999998864 345899999999999999999999999 999999999999999999999999998765432
Q ss_pred CCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCC--chHHHHHhcCCCCCCCChhhhHHH
Q 013214 307 EDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDN--EVPKAYAARQRPPFKAPAKLYARG 384 (447)
Q Consensus 307 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 384 (447)
.. ......++..|+|||.+.+..++.++|+||||+++|+|++|..||...... +....+.....++. ....+++.
T Consensus 160 ~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 236 (267)
T cd08229 160 TT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPL--PSDHYSEE 236 (267)
T ss_pred Cc-ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCC--CcccccHH
Confidence 21 122345788999999998888899999999999999999999999754432 11122211112221 23357789
Q ss_pred HHHHHHHHcccCCCCCCCHHHHHHHHHHHH
Q 013214 385 LKELIEECWNEKPAKRPTFRQIITRLESIN 414 (447)
Q Consensus 385 l~~li~~cl~~dp~~Rps~~~~l~~l~~~~ 414 (447)
+.+++.+||+.||++|||+.++++.++++.
T Consensus 237 ~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 237 LRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred HHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 999999999999999999999999988763
No 120
>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes. Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular
Probab=100.00 E-value=1.7e-38 Score=296.15 Aligned_cols=242 Identities=31% Similarity=0.545 Sum_probs=199.2
Q ss_pred eeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEeccCCCC
Q 013214 162 EITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236 (447)
Q Consensus 162 ~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g~ 236 (447)
.||+|+||.++. +++.+|+|...... ..+....+.+|+.+++.++||||+++++++......+++|||+++++
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (252)
T cd05084 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGD 79 (252)
T ss_pred ccCcccCccEEEEEEecCCceEEEEecCccC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCc
Confidence 589999988763 68899999876432 44556778999999999999999999999999999999999999999
Q ss_pred HHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCCc-ccC
Q 013214 237 LRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPL-TCQ 314 (447)
Q Consensus 237 L~~~l~~~~-~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~-~~~ 314 (447)
|.+++.+.+ .+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++........... ...
T Consensus 80 L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 156 (252)
T cd05084 80 FLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMK 156 (252)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCCCC
Confidence 999997644 5899999999999999999999999 99999999999999999999999999875432111110 111
Q ss_pred CCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHHHHHc
Q 013214 315 DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECW 393 (447)
Q Consensus 315 ~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 393 (447)
..+..|+|||.+.++.++.++|+||||+++|+|++ |..||...........+........ +..++..+.+++.+||
T Consensus 157 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l 233 (252)
T cd05084 157 QIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPC---PELCPDAVYRLMERCW 233 (252)
T ss_pred CCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCC---cccCCHHHHHHHHHHc
Confidence 23456999999988889999999999999999998 9999987665444444433323332 3456788999999999
Q ss_pred ccCCCCCCCHHHHHHHHH
Q 013214 394 NEKPAKRPTFRQIITRLE 411 (447)
Q Consensus 394 ~~dp~~Rps~~~~l~~l~ 411 (447)
+.+|++|||+.++++.|+
T Consensus 234 ~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 234 EYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred CCChhhCcCHHHHHHHHh
Confidence 999999999999998875
No 121
>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t
Probab=100.00 E-value=1.7e-38 Score=297.83 Aligned_cols=249 Identities=27% Similarity=0.466 Sum_probs=205.1
Q ss_pred CcccceeeecceEEEEE-----EcCeEEEEEEcCcccCC--CHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEE
Q 013214 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVIS--DDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 228 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 228 (447)
+|...+.||+|++|.++ .+++.||+|.+...... .......+.+|+.++++++||||+++++++..+...+++
T Consensus 3 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 82 (263)
T cd06625 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIF 82 (263)
T ss_pred cccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEE
Confidence 57778899999998776 25789999988654322 122346788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 013214 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (447)
Q Consensus 229 ~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~ 308 (447)
+||+++++|.+++.+.+.+++..+..++.|++.|+.|||+.+ ++|+||+|+||++++++.++|+|||++........
T Consensus 83 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~ 159 (263)
T cd06625 83 MEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICS 159 (263)
T ss_pred EEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecccccc
Confidence 999999999999988888999999999999999999999999 99999999999999999999999999876533211
Q ss_pred CCc--ccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHH
Q 013214 309 RPL--TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLK 386 (447)
Q Consensus 309 ~~~--~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 386 (447)
... ....++..|+|||.+.+..++.++|+||||+++|+|++|+.||......+......... .....+..++..+.
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~ 237 (263)
T cd06625 160 SGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQP--TNPQLPSHVSPDAR 237 (263)
T ss_pred ccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccC--CCCCCCccCCHHHH
Confidence 111 23456788999999998889999999999999999999999998665443333322221 11223445778999
Q ss_pred HHHHHHcccCCCCCCCHHHHHHH
Q 013214 387 ELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 387 ~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
++|.+||..+|++||++.+++++
T Consensus 238 ~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 238 NFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred HHHHHHhhcCcccCCCHHHHhhC
Confidence 99999999999999999999875
No 122
>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1. Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt
Probab=100.00 E-value=1.7e-39 Score=314.54 Aligned_cols=237 Identities=27% Similarity=0.402 Sum_probs=193.5
Q ss_pred eeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHH-HHHhcCCCCcccceeEEEEeCCceEEEEeccCCC
Q 013214 162 EITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDEL-ALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235 (447)
Q Consensus 162 ~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~-~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g 235 (447)
.||+|+||.|+. +++.||+|++.............+..|. .+++.++||||+++++.+...+..+++|||+++|
T Consensus 2 ~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~ 81 (325)
T cd05602 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGG 81 (325)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCCC
Confidence 689999998862 5688999998754322222333444444 4567889999999999999999999999999999
Q ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCCcccCC
Q 013214 236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD 315 (447)
Q Consensus 236 ~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~ 315 (447)
+|.+++...+.+++..+..++.|++.||.|||+.| ++||||||+||+++.++.+||+|||++...... ........
T Consensus 82 ~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~-~~~~~~~~ 157 (325)
T cd05602 82 ELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEH-NGTTSTFC 157 (325)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccC-CCCccccc
Confidence 99999988888999999999999999999999999 999999999999999999999999998753221 12223456
Q ss_pred CCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHHHHHccc
Q 013214 316 TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNE 395 (447)
Q Consensus 316 ~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 395 (447)
||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+... ... ..+.++..+.+++++||+.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~-~~~---~~~~~~~~~~~li~~~l~~ 233 (325)
T cd05602 158 GTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK-PLQ---LKPNITNSARHLLEGLLQK 233 (325)
T ss_pred CCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhC-CcC---CCCCCCHHHHHHHHHHccc
Confidence 899999999999989999999999999999999999999877665554444222 112 2335678899999999999
Q ss_pred CCCCCCCHHHH
Q 013214 396 KPAKRPTFRQI 406 (447)
Q Consensus 396 dp~~Rps~~~~ 406 (447)
||.+||++.+.
T Consensus 234 ~p~~R~~~~~~ 244 (325)
T cd05602 234 DRTKRLGAKDD 244 (325)
T ss_pred CHHHCCCCCCC
Confidence 99999988743
No 123
>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase. Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an
Probab=100.00 E-value=6.2e-39 Score=307.59 Aligned_cols=248 Identities=25% Similarity=0.449 Sum_probs=194.0
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEE
Q 013214 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 229 (447)
.+|...+.||+|+||.|+. +|+.||+|++..... ......+.+|+.+++.++||||+++++++.++...++||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 82 (303)
T cd07869 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE--EGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVF 82 (303)
T ss_pred ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc--cccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEE
Confidence 3688889999999998862 688999999875432 122345678999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 013214 230 EYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (447)
Q Consensus 230 e~~~~g~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~ 308 (447)
||+. ++|.+++.+. +.+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~- 157 (303)
T cd07869 83 EYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS- 157 (303)
T ss_pred ECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCC-
Confidence 9995 6888887654 56899999999999999999999999 9999999999999999999999999987543221
Q ss_pred CCcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCch-HHHH-HhcCCC------------C
Q 013214 309 RPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV-PKAY-AARQRP------------P 373 (447)
Q Consensus 309 ~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~-~~~~-~~~~~~------------~ 373 (447)
.......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+...... ...+ .....+ .
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (303)
T cd07869 158 HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPH 237 (303)
T ss_pred ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccc
Confidence 22233457899999999865 4578899999999999999999999986543211 1111 000000 0
Q ss_pred CC---------CC------hhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 374 FK---------AP------AKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 374 ~~---------~~------~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
+. .. ...+++.+.+++.+||+.||.+|||+.+++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h 288 (303)
T cd07869 238 FKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH 288 (303)
T ss_pred cccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence 00 00 01234678899999999999999999999864
No 124
>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla
Probab=100.00 E-value=6.4e-39 Score=305.39 Aligned_cols=247 Identities=28% Similarity=0.450 Sum_probs=193.4
Q ss_pred CcccceeeecceEEEEEE------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC---CCCcccceeEEEE-----e
Q 013214 156 DFTNSVEITKGTFILAFW------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI---RHPNVVQFLGAVT-----Q 221 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~hp~iv~~~~~~~-----~ 221 (447)
+|+..+.||+|+||.|+. +|+.||+|.+....... .....+.+|+.+++.+ +||||+++++++. .
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCC-CchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 577888999999998862 36789999886543222 2223445577666655 6999999999885 2
Q ss_pred CCceEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeeccc
Q 013214 222 SSPMMIVTEYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGV 299 (447)
Q Consensus 222 ~~~~~lv~e~~~~g~L~~~l~~~--~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~ 299 (447)
....+++|||+. ++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGL 156 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEccccc
Confidence 456899999995 6999998754 34899999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCC------
Q 013214 300 SKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPP------ 373 (447)
Q Consensus 300 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~------ 373 (447)
+...... .......+|+.|+|||.+.+..++.++||||||+++|+|++|++||.+.+..+....+......+
T Consensus 157 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~ 234 (290)
T cd07862 157 ARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 234 (290)
T ss_pred eEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhch
Confidence 8765432 22234567899999999988889999999999999999999999998776554433332211100
Q ss_pred ---------C--------CCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 374 ---------F--------KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 374 ---------~--------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
+ ....+.+++.+.+++.+||+.||++|||+.+++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h 287 (290)
T cd07862 235 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 287 (290)
T ss_pred hhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 0 00112456788999999999999999999999863
No 125
>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk. Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom
Probab=100.00 E-value=8.4e-39 Score=299.67 Aligned_cols=249 Identities=30% Similarity=0.535 Sum_probs=209.4
Q ss_pred cCcccceeeecceEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 155 LDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
.+|+..+.||.|+||.++. .+..+|+|.+... .......+.+|+.+++.++||||+++++++......+++||
T Consensus 6 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 82 (261)
T cd05148 6 EEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSD---DLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE 82 (261)
T ss_pred HHHHHhhhhccCCCccEEEeEecCCCcEEEEecccc---chhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence 4677888999999988762 4788999998754 23345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 013214 231 YLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (447)
Q Consensus 231 ~~~~g~L~~~l~~~--~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~ 308 (447)
|+++++|.+++.+. ..+++..+..++.|++.|+.|||+.+ ++|+||||+||+++.++.+||+|||.+........
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~ 159 (261)
T cd05148 83 LMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY 159 (261)
T ss_pred ecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence 99999999999753 45899999999999999999999999 99999999999999999999999999876543221
Q ss_pred CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHH
Q 013214 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKE 387 (447)
Q Consensus 309 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 387 (447)
.. ....++..|+|||.+.+..++.++|+||||+++|+|++ |+.||...+..+....+....+++. +..+++.+.+
T Consensus 160 ~~-~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~ 235 (261)
T cd05148 160 LS-SDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPC---PAKCPQEIYK 235 (261)
T ss_pred cc-cCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCCC---CCCCCHHHHH
Confidence 11 23345678999999988889999999999999999998 8999988776666555543333332 3456788999
Q ss_pred HHHHHcccCCCCCCCHHHHHHHHHHH
Q 013214 388 LIEECWNEKPAKRPTFRQIITRLESI 413 (447)
Q Consensus 388 li~~cl~~dp~~Rps~~~~l~~l~~~ 413 (447)
++.+||+.||++|||+.++++.|+.+
T Consensus 236 ~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 236 IMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred HHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 99999999999999999999999863
No 126
>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein. Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi
Probab=100.00 E-value=2.3e-38 Score=301.67 Aligned_cols=252 Identities=29% Similarity=0.522 Sum_probs=206.3
Q ss_pred CcccceeeecceEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCce
Q 013214 156 DFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 225 (447)
+|+..+.||+|+||.++. ....+++|.+.... .......+.+|+.+++.++||||+++++.+..++..
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 78 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA--SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPL 78 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC--CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCc
Confidence 356678899999998863 12468999887543 334457788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCC
Q 013214 226 MIVTEYLPKGDLRAFLKRK------------------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEP 281 (447)
Q Consensus 226 ~lv~e~~~~g~L~~~l~~~------------------------~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp 281 (447)
++++||+.+++|.+++... ..+++..++.++.|++.||.|||+.+ ++||||||
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp 155 (290)
T cd05045 79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAA 155 (290)
T ss_pred EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhh
Confidence 9999999999999998642 23778889999999999999999998 99999999
Q ss_pred CCEEEcCCCCEEEeecccccccccCCCC-CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCC
Q 013214 282 SNILRDDSGNLKVADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHD 359 (447)
Q Consensus 282 ~Nill~~~~~vkl~Dfg~~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~ 359 (447)
+||++++++.+||+|||++......... ......++..|+|||.+.+..++.++||||||+++|+|++ |+.||.+...
T Consensus 156 ~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~ 235 (290)
T cd05045 156 RNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP 235 (290)
T ss_pred heEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCH
Confidence 9999999999999999998754322111 1122234678999999988889999999999999999998 9999987776
Q ss_pred CchHHHHHhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHh
Q 013214 360 NEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINN 415 (447)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~ 415 (447)
.+...........+. +..++.++.+++.+||+.+|++||++.++++.|+++..
T Consensus 236 ~~~~~~~~~~~~~~~---~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 236 ERLFNLLKTGYRMER---PENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred HHHHHHHhCCCCCCC---CCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 665555433333322 34567899999999999999999999999999998764
No 127
>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa. Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho
Probab=100.00 E-value=2.2e-38 Score=296.43 Aligned_cols=244 Identities=25% Similarity=0.444 Sum_probs=201.1
Q ss_pred eeecceEEEEEE-------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEeccCC
Q 013214 162 EITKGTFILAFW-------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234 (447)
Q Consensus 162 ~lg~G~~~~~~~-------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 234 (447)
.||+|+||.++. .+..||+|++.... .....+.+.+|+.++++++||||+++++++.. ...+++|||+++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~ 78 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASG 78 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc--ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCC
Confidence 489999988752 34579999987542 34455778899999999999999999998864 578999999999
Q ss_pred CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCC--Cc
Q 013214 235 GDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR--PL 311 (447)
Q Consensus 235 g~L~~~l~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~--~~ 311 (447)
++|.+++.. ...+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++......... ..
T Consensus 79 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05115 79 GPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR 155 (257)
T ss_pred CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence 999999975 456899999999999999999999998 999999999999999999999999998755432211 11
Q ss_pred ccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHHH
Q 013214 312 TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIE 390 (447)
Q Consensus 312 ~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 390 (447)
....++..|+|||.+....++.++|+||||+++|++++ |..||......+....+.....+.. +...++++.++|.
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~ 232 (257)
T cd05115 156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDC---PAECPPEMYALMK 232 (257)
T ss_pred CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCC---CCCCCHHHHHHHH
Confidence 22233578999999988888999999999999999996 9999988776666555544444443 3456789999999
Q ss_pred HHcccCCCCCCCHHHHHHHHHHHH
Q 013214 391 ECWNEKPAKRPTFRQIITRLESIN 414 (447)
Q Consensus 391 ~cl~~dp~~Rps~~~~l~~l~~~~ 414 (447)
+||..||++||++.++.+.|+.+.
T Consensus 233 ~c~~~~~~~Rp~~~~i~~~l~~~~ 256 (257)
T cd05115 233 DCWIYKWEDRPNFAKVEERMRTYY 256 (257)
T ss_pred HHcCCChhhCcCHHHHHHHHhhhc
Confidence 999999999999999999988753
No 128
>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors. Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke
Probab=100.00 E-value=1.7e-38 Score=303.24 Aligned_cols=253 Identities=29% Similarity=0.467 Sum_probs=206.0
Q ss_pred CcCcccceeeecceEEEEEE---------------------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcc
Q 013214 154 ELDFTNSVEITKGTFILAFW---------------------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNV 212 (447)
Q Consensus 154 ~~~~~~~~~lg~G~~~~~~~---------------------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i 212 (447)
..+|...+.||+|+||.++. .+..||+|.+.... .......+.+|++++++++||||
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i 81 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA--SDNAREDFLKEVKILSRLSDPNI 81 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhcCCCCE
Confidence 44678888999999998763 23568999987543 33556788999999999999999
Q ss_pred cceeEEEEeCCceEEEEeccCCCCHHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCC
Q 013214 213 VQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG-----------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEP 281 (447)
Q Consensus 213 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-----------~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp 281 (447)
+++++++..++..++++||+++++|.+++.+.. .+++..++.++.|++.||.|||+.+ ++|+||||
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp 158 (296)
T cd05051 82 ARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLAT 158 (296)
T ss_pred eEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccch
Confidence 999999999999999999999999999998765 6899999999999999999999998 99999999
Q ss_pred CCEEEcCCCCEEEeecccccccccCCC-CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh--CCCCCCCCC
Q 013214 282 SNILRDDSGNLKVADFGVSKLLTVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE--GCPPFTMKH 358 (447)
Q Consensus 282 ~Nill~~~~~vkl~Dfg~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t--g~~p~~~~~ 358 (447)
+||+++.++.++|+|||++........ .......++..|+|||.+.+..++.++||||||+++|+|++ |..||...+
T Consensus 159 ~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~ 238 (296)
T cd05051 159 RNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT 238 (296)
T ss_pred hceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcC
Confidence 999999999999999999875432211 11122345678999999988889999999999999999998 778887666
Q ss_pred CCchHHHHHhc----CCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHH
Q 013214 359 DNEVPKAYAAR----QRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLE 411 (447)
Q Consensus 359 ~~~~~~~~~~~----~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~ 411 (447)
..+........ ........+..++.++.+++.+||+.||.+|||+.++++.|+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 239 DQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred hHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 55544433222 111112223456789999999999999999999999998875
No 129
>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as
Probab=100.00 E-value=1.1e-38 Score=303.26 Aligned_cols=248 Identities=25% Similarity=0.381 Sum_probs=200.9
Q ss_pred cccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEec
Q 013214 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (447)
Q Consensus 157 ~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 231 (447)
|+..+.||+|+||.++. +++.||+|.+.............+.+|+.++++++|++++++++.+...+..+++|||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 55667899999998863 6789999998765444444445677899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 013214 232 LPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (447)
Q Consensus 232 ~~~g~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~ 309 (447)
+++++|.+++...+ .+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||++.......
T Consensus 82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-- 156 (285)
T cd05630 82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-- 156 (285)
T ss_pred cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCc--
Confidence 99999999986543 5899999999999999999999998 9999999999999999999999999987543221
Q ss_pred CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHH
Q 013214 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELI 389 (447)
Q Consensus 310 ~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 389 (447)
......++..|+|||.+.+..++.++|+||+|+++|+|++|+.||.......................+..+++++.+++
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 236 (285)
T cd05630 157 TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLC 236 (285)
T ss_pred cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCccCCHHHHHHH
Confidence 12234678999999999888899999999999999999999999987554322222111111001112345678899999
Q ss_pred HHHcccCCCCCCC-----HHHHHHH
Q 013214 390 EECWNEKPAKRPT-----FRQIITR 409 (447)
Q Consensus 390 ~~cl~~dp~~Rps-----~~~~l~~ 409 (447)
++||+.||++||| +.+++++
T Consensus 237 ~~~l~~~p~~R~s~~~~~~~~~~~h 261 (285)
T cd05630 237 KMLLCKDPKERLGCQGGGAREVKEH 261 (285)
T ss_pred HHHhhcCHHHccCCCCCchHHHHcC
Confidence 9999999999999 8888874
No 130
>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha. Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-
Probab=100.00 E-value=1.8e-38 Score=314.43 Aligned_cols=254 Identities=26% Similarity=0.452 Sum_probs=205.0
Q ss_pred CcCcccceeeecceEEEEEEc----------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC-CCcccceeEEEEeC
Q 013214 154 ELDFTNSVEITKGTFILAFWR----------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQS 222 (447)
Q Consensus 154 ~~~~~~~~~lg~G~~~~~~~~----------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~ 222 (447)
..+|.+.+.||+|+||.|+.. +..||+|++.... .....+.+.+|+++++++. ||||+++++++...
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~ 113 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA--RSSEKQALMSELKIMTHLGPHLNIVNLLGACTKS 113 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccC
Confidence 346778889999999988631 2469999997542 3344567899999999995 99999999999999
Q ss_pred CceEEEEeccCCCCHHHHHHhc----------------------------------------------------------
Q 013214 223 SPMMIVTEYLPKGDLRAFLKRK---------------------------------------------------------- 244 (447)
Q Consensus 223 ~~~~lv~e~~~~g~L~~~l~~~---------------------------------------------------------- 244 (447)
...++|||||++|+|.+++.++
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (400)
T cd05105 114 GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLE 193 (400)
T ss_pred CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhh
Confidence 9999999999999999988643
Q ss_pred --------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEE
Q 013214 245 --------------------------------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR 286 (447)
Q Consensus 245 --------------------------------------~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill 286 (447)
..+++..+..++.|++.||.|||+.+ ++|+||||+||++
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill 270 (400)
T cd05105 194 IKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLL 270 (400)
T ss_pred hhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEE
Confidence 13667778899999999999999998 9999999999999
Q ss_pred cCCCCEEEeecccccccccCCCC-CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchH-
Q 013214 287 DDSGNLKVADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVP- 363 (447)
Q Consensus 287 ~~~~~vkl~Dfg~~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~- 363 (447)
+.++.+||+|||++......... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||.........
T Consensus 271 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~ 350 (400)
T cd05105 271 AQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFY 350 (400)
T ss_pred eCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHH
Confidence 99999999999998765332211 1122345678999999988889999999999999999997 99999876544332
Q ss_pred HHHHhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHh
Q 013214 364 KAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINN 415 (447)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~ 415 (447)
..+....+++ .+..++..+.+++.+||+.||++||++.++.+.|+++..
T Consensus 351 ~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 351 NKIKSGYRMA---KPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred HHHhcCCCCC---CCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 2222222222 234567889999999999999999999999999988653
No 131
>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=4.2e-40 Score=316.01 Aligned_cols=244 Identities=25% Similarity=0.469 Sum_probs=215.2
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEE
Q 013214 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 229 (447)
.-|...+.||.|+||-||+ +.+.||||++.-......+.-+++..|+.+|+++.|||++.+-|+|..+...|+||
T Consensus 26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVM 105 (948)
T KOG0577|consen 26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVM 105 (948)
T ss_pred HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHH
Confidence 3567778999999999874 67899999998665556666688999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 013214 230 EYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (447)
Q Consensus 230 e~~~~g~L~~~l~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~ 308 (447)
||| -|+-.|.+.- ..++.+-++..|+.+.++||.|||+.+ .||||||..|||+++.|.|||+|||++.....
T Consensus 106 EYC-lGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P--- 178 (948)
T KOG0577|consen 106 EYC-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAP--- 178 (948)
T ss_pred HHH-hccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCc---
Confidence 999 5788888864 357899999999999999999999999 99999999999999999999999999986543
Q ss_pred CCcccCCCCCcccCCcccC---CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHH
Q 013214 309 RPLTCQDTSCRYVAPEVFK---NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGL 385 (447)
Q Consensus 309 ~~~~~~~~t~~y~aPE~~~---~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 385 (447)
-.++.|||.|||||++. .+.|+-++||||||+++.+|...++|+..++-.....-+..+..|.+. .+.+|..+
T Consensus 179 --AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLq--s~eWS~~F 254 (948)
T KOG0577|consen 179 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQ--SNEWSDYF 254 (948)
T ss_pred --hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCC--CchhHHHH
Confidence 35678999999999875 458999999999999999999999999999887777777666666664 46789999
Q ss_pred HHHHHHHcccCCCCCCCHHHHHHH
Q 013214 386 KELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 386 ~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
++++..||+.-|.+|||..+++.+
T Consensus 255 ~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 255 RNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred HHHHHHHHhhCcccCCcHHHHhhc
Confidence 999999999999999999988875
No 132
>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta. Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways
Probab=100.00 E-value=4.3e-39 Score=311.91 Aligned_cols=235 Identities=25% Similarity=0.421 Sum_probs=194.6
Q ss_pred eeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeEEEEeCCceEEEEeccCCC
Q 013214 162 EITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKG 235 (447)
Q Consensus 162 ~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~g 235 (447)
.||+|+||.|+ .+++.||+|++...........+.+.+|..++.++ +||+|+++++++.....+++||||+++|
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 81 (327)
T cd05617 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGG 81 (327)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCCC
Confidence 68999999886 35789999999876554555667788999999888 6999999999999999999999999999
Q ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCCcccCC
Q 013214 236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD 315 (447)
Q Consensus 236 ~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~ 315 (447)
+|..++...+.+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++...... ........
T Consensus 82 ~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~ 157 (327)
T cd05617 82 DLMFHMQRQRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP-GDTTSTFC 157 (327)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCC-CCceeccc
Confidence 99999988888999999999999999999999999 999999999999999999999999998753221 12223456
Q ss_pred CCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCC------chHHHHHhcCCCCCCCChhhhHHHHHHHH
Q 013214 316 TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDN------EVPKAYAARQRPPFKAPAKLYARGLKELI 389 (447)
Q Consensus 316 ~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~l~~li 389 (447)
||+.|+|||.+.+..++.++|+||||+++|+|++|+.||...... +............+ +..++..+.+++
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~---p~~~~~~~~~li 234 (327)
T cd05617 158 GTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRI---PRFLSVKASHVL 234 (327)
T ss_pred CCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCC---CCCCCHHHHHHH
Confidence 899999999999889999999999999999999999999643221 11112212222222 345678899999
Q ss_pred HHHcccCCCCCCCH
Q 013214 390 EECWNEKPAKRPTF 403 (447)
Q Consensus 390 ~~cl~~dp~~Rps~ 403 (447)
.+||+.||.+|+++
T Consensus 235 ~~~L~~dP~~R~~~ 248 (327)
T cd05617 235 KGFLNKDPKERLGC 248 (327)
T ss_pred HHHhccCHHHcCCC
Confidence 99999999999984
No 133
>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha. Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw
Probab=100.00 E-value=3.9e-39 Score=312.92 Aligned_cols=251 Identities=22% Similarity=0.319 Sum_probs=204.4
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|...+.||+|+||.|+. +++.+|+|++.+...........+.+|..++..++||+|+++++.+.+....++|||
T Consensus 2 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (332)
T cd05623 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMD 81 (332)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEe
Confidence 577788999999998762 567899999865333333445568889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 013214 231 YLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (447)
Q Consensus 231 ~~~~g~L~~~l~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~ 309 (447)
|+++|+|.+++.+ ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.........
T Consensus 82 y~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~ 158 (332)
T cd05623 82 YYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV 158 (332)
T ss_pred ccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccCCcc
Confidence 9999999999987 467899999999999999999999999 999999999999999999999999998754332222
Q ss_pred CcccCCCCCcccCCcccC-----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcC-CCCCCCChhhhHH
Q 013214 310 PLTCQDTSCRYVAPEVFK-----NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RPPFKAPAKLYAR 383 (447)
Q Consensus 310 ~~~~~~~t~~y~aPE~~~-----~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 383 (447)
......||+.|+|||++. ...++.++|||||||++|+|++|+.||...+..+....+.... +..++.....+++
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~ 238 (332)
T cd05623 159 QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSE 238 (332)
T ss_pred eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccCCH
Confidence 223356899999999986 3467889999999999999999999998776655555543322 3334444456788
Q ss_pred HHHHHHHHHcccCCCC--CCCHHHHHHH
Q 013214 384 GLKELIEECWNEKPAK--RPTFRQIITR 409 (447)
Q Consensus 384 ~l~~li~~cl~~dp~~--Rps~~~~l~~ 409 (447)
++.+++++|+..++.+ |+++.+++++
T Consensus 239 ~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 239 DAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred HHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 9999999999665544 6899999877
No 134
>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5. Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated
Probab=100.00 E-value=8.4e-39 Score=300.77 Aligned_cols=249 Identities=24% Similarity=0.397 Sum_probs=201.4
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEE
Q 013214 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 229 (447)
.+|+..+.||+|+||.++. +++.||+|++.... ......+.+|+.+++.++||||+++++.+......+++|
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~ 85 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP---GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICM 85 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc---cchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEE
Confidence 3688889999999998762 67899999986432 233456788999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 013214 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (447)
Q Consensus 230 e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~ 309 (447)
||+++++|.+++.+++++++..+..++.|++.|+.|||+.+ ++|+|+||+||+++.++.++|+|||++....... .
T Consensus 86 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~-~ 161 (267)
T cd06646 86 EYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATI-A 161 (267)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeecccc-c
Confidence 99999999999988888999999999999999999999998 9999999999999999999999999987653221 1
Q ss_pred CcccCCCCCcccCCcccC---CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcC-CCCCCCChhhhHHHH
Q 013214 310 PLTCQDTSCRYVAPEVFK---NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RPPFKAPAKLYARGL 385 (447)
Q Consensus 310 ~~~~~~~t~~y~aPE~~~---~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l 385 (447)
......++..|+|||.+. ...++.++|+||+|+++|+|++|+.||......+......... .++.......++..+
T Consensus 162 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (267)
T cd06646 162 KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTF 241 (267)
T ss_pred ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHHH
Confidence 122345788999999874 3457789999999999999999999997554333222111111 222112233567899
Q ss_pred HHHHHHHcccCCCCCCCHHHHHHHH
Q 013214 386 KELIEECWNEKPAKRPTFRQIITRL 410 (447)
Q Consensus 386 ~~li~~cl~~dp~~Rps~~~~l~~l 410 (447)
.++|++||+.+|++||+++++++++
T Consensus 242 ~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 242 HNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred HHHHHHHhhCChhhCcCHHHHhcCC
Confidence 9999999999999999999998754
No 135
>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1. Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to
Probab=100.00 E-value=2.3e-38 Score=304.14 Aligned_cols=256 Identities=29% Similarity=0.518 Sum_probs=209.1
Q ss_pred cCcccceeeecceEEEEEE------------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeEEEEe
Q 013214 155 LDFTNSVEITKGTFILAFW------------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQ 221 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~------------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~ 221 (447)
.+|.+.+.||+|+||.|+. ++..+|+|.+.... .......+.+|+.+++.+ +||||+++++++..
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 95 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC--ChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec
Confidence 3688889999999998862 12469999987542 334456788899999999 79999999999999
Q ss_pred CCceEEEEeccCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEE
Q 013214 222 SSPMMIVTEYLPKGDLRAFLKRKG----------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL 285 (447)
Q Consensus 222 ~~~~~lv~e~~~~g~L~~~l~~~~----------------~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nil 285 (447)
....+++|||+++|+|.+++.... .++..++..++.|++.||+|||+.+ ++|+||||+||+
T Consensus 96 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nil 172 (307)
T cd05098 96 DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVL 172 (307)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheE
Confidence 999999999999999999997642 3788899999999999999999998 999999999999
Q ss_pred EcCCCCEEEeecccccccccCCCC-CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchH
Q 013214 286 RDDSGNLKVADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVP 363 (447)
Q Consensus 286 l~~~~~vkl~Dfg~~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~ 363 (447)
++.++.+||+|||.+......... ......+++.|+|||.+.+..++.++|+||||+++|+|++ |..||...+..+..
T Consensus 173 l~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~ 252 (307)
T cd05098 173 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 252 (307)
T ss_pred EcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHH
Confidence 999999999999998765422111 1122234568999999988889999999999999999998 89999876655544
Q ss_pred HHHHhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhh
Q 013214 364 KAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSIN 418 (447)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~~~ 418 (447)
..+....... .+...+.++.+++.+||..+|++||++.++++.|+.+.....
T Consensus 253 ~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~~ 304 (307)
T cd05098 253 KLLKEGHRMD---KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALTS 304 (307)
T ss_pred HHHHcCCCCC---CCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHhh
Confidence 4443332322 234567899999999999999999999999999999877643
No 136
>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi
Probab=100.00 E-value=2.7e-38 Score=295.68 Aligned_cols=245 Identities=28% Similarity=0.506 Sum_probs=202.3
Q ss_pred eeeecceEEEEEE--------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEecc
Q 013214 161 VEITKGTFILAFW--------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYL 232 (447)
Q Consensus 161 ~~lg~G~~~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 232 (447)
+.||+|+||.++. .+..+|+|.+...... ...+.+.+|+.+++.++||||+++++++.. ...+++|||+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~ 77 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELA 77 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEEeC
Confidence 3689999998752 2368999998765432 445678899999999999999999998764 4679999999
Q ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCCc-
Q 013214 233 PKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPL- 311 (447)
Q Consensus 233 ~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~- 311 (447)
++++|.+++.....+++..+..++.|++.|+.|||+.+ ++|+||||+||+++.++.+||+|||++...........
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~ 154 (257)
T cd05060 78 PLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRA 154 (257)
T ss_pred CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCccccc
Confidence 99999999988888999999999999999999999999 99999999999999999999999999886543322111
Q ss_pred -ccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHH
Q 013214 312 -TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELI 389 (447)
Q Consensus 312 -~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 389 (447)
....++..|+|||.+.+..++.++|+||||+++|++++ |..||...+..+....+......+ .+..++..+.++|
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li 231 (257)
T cd05060 155 TTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLP---RPEECPQEIYSIM 231 (257)
T ss_pred ccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCC---CCCCCCHHHHHHH
Confidence 11223467999999988889999999999999999998 999998776655555543333222 2345678899999
Q ss_pred HHHcccCCCCCCCHHHHHHHHHHHH
Q 013214 390 EECWNEKPAKRPTFRQIITRLESIN 414 (447)
Q Consensus 390 ~~cl~~dp~~Rps~~~~l~~l~~~~ 414 (447)
.+||..+|++||++.++++.|+++.
T Consensus 232 ~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 232 LSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred HHHhcCChhhCcCHHHHHHHHHhcc
Confidence 9999999999999999999998753
No 137
>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2. Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign
Probab=100.00 E-value=4.8e-38 Score=298.36 Aligned_cols=249 Identities=27% Similarity=0.487 Sum_probs=199.1
Q ss_pred cccceeeecceEEEEEE---------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeC--Cce
Q 013214 157 FTNSVEITKGTFILAFW---------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--SPM 225 (447)
Q Consensus 157 ~~~~~~lg~G~~~~~~~---------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~ 225 (447)
|+..+.||+|+||.|+. ++..||+|.+.... .......+.+|+.+++.++||||+++++++... ...
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC--GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGL 83 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceE
Confidence 37778999999998842 56789999987542 233456788899999999999999999987653 458
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeeccccccccc
Q 013214 226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305 (447)
Q Consensus 226 ~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~ 305 (447)
+++|||+++++|.+++... .+++..++.++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||++.....
T Consensus 84 ~lv~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 159 (283)
T cd05080 84 QLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 159 (283)
T ss_pred EEEecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccCC
Confidence 9999999999999999764 5999999999999999999999999 99999999999999999999999999886543
Q ss_pred CCCC--CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCch---------------HHHHHh
Q 013214 306 KEDR--PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV---------------PKAYAA 368 (447)
Q Consensus 306 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~---------------~~~~~~ 368 (447)
.... ......++..|+|||.+.+..++.++||||||+++|+|++|+.||........ ......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (283)
T cd05080 160 GHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLER 239 (283)
T ss_pred cchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhc
Confidence 2211 11223456679999999888899999999999999999999999865432110 000000
Q ss_pred cCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHH
Q 013214 369 RQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESIN 414 (447)
Q Consensus 369 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~ 414 (447)
....+ .+..++..+.+++.+||+.||++|||++++++.|+++.
T Consensus 240 ~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 240 GMRLP---CPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred CCCCC---CCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 11111 23456789999999999999999999999999998864
No 138
>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with
Probab=100.00 E-value=1.3e-38 Score=302.71 Aligned_cols=248 Identities=23% Similarity=0.350 Sum_probs=202.4
Q ss_pred cccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEec
Q 013214 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (447)
Q Consensus 157 ~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 231 (447)
|+..+.||+|+||.++. +++.||+|.+.............+.+|+.+++.++|+||+++++.+..++..+++|||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 55667899999998863 5789999998765444444445677899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 013214 232 LPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (447)
Q Consensus 232 ~~~g~L~~~l~~~--~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~ 309 (447)
+.+++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||++...... .
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~--~ 156 (285)
T cd05632 82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEG--E 156 (285)
T ss_pred ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCC--C
Confidence 9999999888653 35999999999999999999999999 999999999999999999999999998754322 1
Q ss_pred CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHH
Q 013214 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELI 389 (447)
Q Consensus 310 ~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 389 (447)
......++..|+|||.+.+..++.++|+||||+++|+|++|..||...........+..............++..+.+++
T Consensus 157 ~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 236 (285)
T cd05632 157 SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSIC 236 (285)
T ss_pred cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHH
Confidence 22334678999999999888899999999999999999999999987655433333322221111122345678899999
Q ss_pred HHHcccCCCCCCC-----HHHHHHH
Q 013214 390 EECWNEKPAKRPT-----FRQIITR 409 (447)
Q Consensus 390 ~~cl~~dp~~Rps-----~~~~l~~ 409 (447)
..||+.||++||+ +.+++.+
T Consensus 237 ~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 237 KMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred HHHccCCHhHcCCCcccChHHHHcC
Confidence 9999999999999 6677664
No 139
>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta. Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.
Probab=100.00 E-value=3.6e-39 Score=313.02 Aligned_cols=251 Identities=20% Similarity=0.307 Sum_probs=204.1
Q ss_pred CcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|...+.||+|+||.|+ .+++.||+|.+.............+.+|..++..++||+|+++++++.+.+..|+|||
T Consensus 2 ~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~E 81 (331)
T cd05624 2 DFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMD 81 (331)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence 57778899999999875 3578899999875333333445668889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 013214 231 YLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (447)
Q Consensus 231 ~~~~g~L~~~l~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~ 309 (447)
|+++|+|.+++.+ ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.........
T Consensus 82 y~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 158 (331)
T cd05624 82 YYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV 158 (331)
T ss_pred CCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCCCce
Confidence 9999999999987 467899999999999999999999999 999999999999999999999999998765433222
Q ss_pred CcccCCCCCcccCCcccCC-----CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcC-CCCCCCChhhhHH
Q 013214 310 PLTCQDTSCRYVAPEVFKN-----EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RPPFKAPAKLYAR 383 (447)
Q Consensus 310 ~~~~~~~t~~y~aPE~~~~-----~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 383 (447)
......||+.|+|||++.+ +.++.++|+||||+++|+|++|+.||...+..+....+.... +.+++.....+++
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~ 238 (331)
T cd05624 159 QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSE 238 (331)
T ss_pred eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccCCH
Confidence 2233468999999999865 467889999999999999999999998776655544443322 3344444445788
Q ss_pred HHHHHHHHHcccCCCC--CCCHHHHHHH
Q 013214 384 GLKELIEECWNEKPAK--RPTFRQIITR 409 (447)
Q Consensus 384 ~l~~li~~cl~~dp~~--Rps~~~~l~~ 409 (447)
.+.+++.+|+..++.+ |+++.+++++
T Consensus 239 ~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 239 EAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred HHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 9999999999866544 4678888765
No 140
>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src. Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo
Probab=100.00 E-value=2.9e-38 Score=296.51 Aligned_cols=248 Identities=32% Similarity=0.518 Sum_probs=203.3
Q ss_pred CcccceeeecceEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEec
Q 013214 156 DFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 231 (447)
+|+..+.||+|+||.++. ++..||+|++...... ...+.+|+.+++.++||||+++++.+.. ...+++|||
T Consensus 7 ~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~----~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~ 81 (262)
T cd05071 7 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 81 (262)
T ss_pred HeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccC----HHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEc
Confidence 578888999999987752 3457999998754321 2467889999999999999999998754 568999999
Q ss_pred cCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 013214 232 LPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (447)
Q Consensus 232 ~~~g~L~~~l~~~--~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~ 309 (447)
+++|+|.+++.+. ..+++..+..++.|++.||.|+|+.+ ++|+||||+||++++++.++|+|||.+.........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~ 158 (262)
T cd05071 82 MSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 158 (262)
T ss_pred CCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeeccccccc
Confidence 9999999999763 34789999999999999999999998 999999999999999999999999999765433222
Q ss_pred CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHH
Q 013214 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKEL 388 (447)
Q Consensus 310 ~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 388 (447)
......++..|+|||...+..++.++|+||||+++|+|++ |..||......+....+......+. ...++..+.++
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~l 235 (262)
T cd05071 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC---PPECPESLHDL 235 (262)
T ss_pred cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCCCC---ccccCHHHHHH
Confidence 2223345678999999988889999999999999999999 8999987766555544433322222 34567889999
Q ss_pred HHHHcccCCCCCCCHHHHHHHHHHHH
Q 013214 389 IEECWNEKPAKRPTFRQIITRLESIN 414 (447)
Q Consensus 389 i~~cl~~dp~~Rps~~~~l~~l~~~~ 414 (447)
+.+||+.||++||++.++++.|+.+.
T Consensus 236 i~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 236 MCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred HHHHccCCcccCCCHHHHHHHHHHhc
Confidence 99999999999999999999998864
No 141
>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3. Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,
Probab=100.00 E-value=2.5e-39 Score=313.37 Aligned_cols=236 Identities=26% Similarity=0.410 Sum_probs=194.4
Q ss_pred eeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHH-HHhcCCCCcccceeEEEEeCCceEEEEeccCCC
Q 013214 162 EITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELA-LLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235 (447)
Q Consensus 162 ~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~-~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g 235 (447)
.||+|+||.|+. +|+.||+|++.............+..|.. +++.++||||+++++.+...+..+++|||+++|
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~~ 81 (325)
T cd05604 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGG 81 (325)
T ss_pred ceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCCC
Confidence 589999998862 68899999987543333333445555554 567789999999999999999999999999999
Q ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCCcccCC
Q 013214 236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD 315 (447)
Q Consensus 236 ~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~ 315 (447)
+|..++.+.+.+++..+..++.|++.||.|||+.| ++||||||+||+++.++.+||+|||++...... ........
T Consensus 82 ~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~-~~~~~~~~ 157 (325)
T cd05604 82 ELFFHLQRERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ-SDTTTTFC 157 (325)
T ss_pred CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCC-CCCccccc
Confidence 99999988888999999999999999999999999 999999999999999999999999998753221 11223456
Q ss_pred CCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHHHHHccc
Q 013214 316 TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNE 395 (447)
Q Consensus 316 ~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 395 (447)
||+.|+|||.+.+..++.++|||||||++|+|++|+.||...+..+....+... ...+ .+..+..+.+++++|++.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~-~~~~---~~~~~~~~~~ll~~ll~~ 233 (325)
T cd05604 158 GTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHK-PLVL---RPGASLTAWSILEELLEK 233 (325)
T ss_pred CChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcC-CccC---CCCCCHHHHHHHHHHhcc
Confidence 899999999999988999999999999999999999999877665554444222 2222 234678899999999999
Q ss_pred CCCCCCCHHH
Q 013214 396 KPAKRPTFRQ 405 (447)
Q Consensus 396 dp~~Rps~~~ 405 (447)
||.+||++.+
T Consensus 234 ~p~~R~~~~~ 243 (325)
T cd05604 234 DRQRRLGAKE 243 (325)
T ss_pred CHHhcCCCCC
Confidence 9999998853
No 142
>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2. Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to
Probab=100.00 E-value=3.6e-38 Score=302.39 Aligned_cols=257 Identities=28% Similarity=0.516 Sum_probs=210.9
Q ss_pred CcCcccceeeecceEEEEEE------------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeEEEE
Q 013214 154 ELDFTNSVEITKGTFILAFW------------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVT 220 (447)
Q Consensus 154 ~~~~~~~~~lg~G~~~~~~~------------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~ 220 (447)
..+|...+.||+|+||.|+. ++..||+|...... .....+.+.+|+.+++.+ +||||+++++++.
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc--chHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 44677888999999998862 23479999887442 344567788999999999 8999999999999
Q ss_pred eCCceEEEEeccCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCE
Q 013214 221 QSSPMMIVTEYLPKGDLRAFLKRKG----------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI 284 (447)
Q Consensus 221 ~~~~~~lv~e~~~~g~L~~~l~~~~----------------~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Ni 284 (447)
.....+++|||+++|+|.+++.+.. .++..++..++.|++.||.|||+++ ++|+||||+||
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Ni 168 (304)
T cd05101 92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNV 168 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceE
Confidence 9999999999999999999997642 3677788999999999999999999 99999999999
Q ss_pred EEcCCCCEEEeecccccccccCCCC-CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCch
Q 013214 285 LRDDSGNLKVADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEV 362 (447)
Q Consensus 285 ll~~~~~vkl~Dfg~~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~ 362 (447)
+++.++.+||+|||++......... ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||...+..+.
T Consensus 169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~ 248 (304)
T cd05101 169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 248 (304)
T ss_pred EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHH
Confidence 9999999999999999865432211 1222345678999999988889999999999999999998 8899987766665
Q ss_pred HHHHHhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhh
Q 013214 363 PKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSIN 418 (447)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~~~ 418 (447)
...+....+... +..++..+.+++.+||+.+|.+|||+.++++.|+++.+...
T Consensus 249 ~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~~ 301 (304)
T cd05101 249 FKLLKEGHRMDK---PANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLTT 301 (304)
T ss_pred HHHHHcCCcCCC---CCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhhh
Confidence 555533333222 34567889999999999999999999999999999876543
No 143
>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains. Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc
Probab=100.00 E-value=2.6e-38 Score=295.31 Aligned_cols=246 Identities=27% Similarity=0.464 Sum_probs=206.2
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|...+.||+|++|.++. +|+.|++|.+..... .......+.+|+.+++.++||||+++++++...+..+++||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKM-NRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVME 79 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhC-CHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEE
Confidence 356678899999987752 678999999875443 34456778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 013214 231 YLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (447)
Q Consensus 231 ~~~~g~L~~~l~~~--~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~ 308 (447)
|+++++|.+++... ..+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++........
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~ 156 (256)
T cd08529 80 YAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN 156 (256)
T ss_pred eCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence 99999999999774 46899999999999999999999998 99999999999999999999999999876543221
Q ss_pred CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHH
Q 013214 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKEL 388 (447)
Q Consensus 309 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 388 (447)
......+++.|+|||++.+..++.++|+||||+++++|++|+.||...+..+....+.....+.+ +..++..+.++
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~ 232 (256)
T cd08529 157 -FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPV---SQMYSQQLAQL 232 (256)
T ss_pred -hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC---ccccCHHHHHH
Confidence 22334578899999999888889999999999999999999999987765544444433333333 33577899999
Q ss_pred HHHHcccCCCCCCCHHHHHHH
Q 013214 389 IEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 389 i~~cl~~dp~~Rps~~~~l~~ 409 (447)
+.+||+.+|++||++.+++++
T Consensus 233 i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 233 IDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred HHHHccCCcccCcCHHHHhhC
Confidence 999999999999999999864
No 144
>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A. Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory
Probab=100.00 E-value=3.3e-38 Score=299.09 Aligned_cols=248 Identities=28% Similarity=0.495 Sum_probs=203.9
Q ss_pred cCcccceeeecceEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCc
Q 013214 155 LDFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 224 (447)
.++...++||+|+||.++. ++..+|+|.+... .......+.+|+++++.++||||+++++++.....
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 81 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTVLQHQHIVRFYGVCTEGRP 81 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC---CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCc
Confidence 3566778999999998863 3568999987643 34556788999999999999999999999999999
Q ss_pred eEEEEeccCCCCHHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCC
Q 013214 225 MMIVTEYLPKGDLRAFLKRKG---------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289 (447)
Q Consensus 225 ~~lv~e~~~~g~L~~~l~~~~---------------~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~ 289 (447)
.+++|||+++++|.+++...+ .+++..+..++.|++.|+.|||+.+ ++|+||||+||+++++
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~ 158 (280)
T cd05092 82 LLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQG 158 (280)
T ss_pred eEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCC
Confidence 999999999999999997643 3788999999999999999999999 9999999999999999
Q ss_pred CCEEEeecccccccccCCC-CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHH
Q 013214 290 GNLKVADFGVSKLLTVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYA 367 (447)
Q Consensus 290 ~~vkl~Dfg~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~ 367 (447)
+.+||+|||++........ .......+++.|+|||.+.+..++.++||||||+++|+|++ |.+||......+....+.
T Consensus 159 ~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~ 238 (280)
T cd05092 159 LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECIT 238 (280)
T ss_pred CCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHH
Confidence 9999999999875432211 11112234678999999988889999999999999999998 999998766555544443
Q ss_pred hcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHH
Q 013214 368 ARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLE 411 (447)
Q Consensus 368 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~ 411 (447)
...... .+..+++.+.+++.+||+.||.+||++.++++.|+
T Consensus 239 ~~~~~~---~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 239 QGRELE---RPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred cCccCC---CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 332222 23456788999999999999999999999998875
No 145
>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors. Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto
Probab=100.00 E-value=4.7e-38 Score=305.71 Aligned_cols=252 Identities=29% Similarity=0.494 Sum_probs=202.9
Q ss_pred CcccceeeecceEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeEEEEeC-C
Q 013214 156 DFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQS-S 223 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~-~ 223 (447)
+|+..+.||+|+||.|+. +++.||+|++.... .....+.+..|+.+++++ +||||+++++++... .
T Consensus 8 ~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 8 RLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA--TASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC--CHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 677888999999999873 23689999987542 334456678899999999 899999999988644 5
Q ss_pred ceEEEEeccCCCCHHHHHHhc-----------------------------------------------------------
Q 013214 224 PMMIVTEYLPKGDLRAFLKRK----------------------------------------------------------- 244 (447)
Q Consensus 224 ~~~lv~e~~~~g~L~~~l~~~----------------------------------------------------------- 244 (447)
.+++++||+++++|.+++...
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 688999999999999998642
Q ss_pred --CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCC-CCcccCCCCCccc
Q 013214 245 --GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED-RPLTCQDTSCRYV 321 (447)
Q Consensus 245 --~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~-~~~~~~~~t~~y~ 321 (447)
.++++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++..+..... .......++..|+
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 242 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 242 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence 25788889999999999999999998 99999999999999999999999999986533221 1122334567899
Q ss_pred CCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcC-CCCCCCChhhhHHHHHHHHHHHcccCCCC
Q 013214 322 APEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQ-RPPFKAPAKLYARGLKELIEECWNEKPAK 399 (447)
Q Consensus 322 aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dp~~ 399 (447)
|||.+.+..++.++|||||||++|+|++ |..||.+....+......... ++.. +..+++++.+++.+||+.+|++
T Consensus 243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~~cl~~~p~~ 319 (337)
T cd05054 243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRA---PEYATPEIYSIMLDCWHNNPED 319 (337)
T ss_pred CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCC---CccCCHHHHHHHHHHccCChhh
Confidence 9999989899999999999999999998 999998755444322222222 2221 3346788999999999999999
Q ss_pred CCCHHHHHHHHHHHHh
Q 013214 400 RPTFRQIITRLESINN 415 (447)
Q Consensus 400 Rps~~~~l~~l~~~~~ 415 (447)
||++.+++++|+++..
T Consensus 320 RPs~~ell~~l~~~~~ 335 (337)
T cd05054 320 RPTFSELVEILGDLLQ 335 (337)
T ss_pred CcCHHHHHHHHHHHHh
Confidence 9999999999998654
No 146
>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]
Probab=100.00 E-value=5.1e-39 Score=310.27 Aligned_cols=249 Identities=28% Similarity=0.515 Sum_probs=216.9
Q ss_pred ccceeeecceEEEEEE-------cC--eEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEE
Q 013214 158 TNSVEITKGTFILAFW-------RG--IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 228 (447)
Q Consensus 158 ~~~~~lg~G~~~~~~~-------~g--~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 228 (447)
...+.||.|.||-||. .| --||||.-+.+. +.+..+.|..|..+|+.++||||++++|+|.+. ..|||
T Consensus 392 tl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~--t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~Wiv 468 (974)
T KOG4257|consen 392 TLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC--TPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWIV 468 (974)
T ss_pred cHHHhhcCCcccceeeeEecccccCcceeeeeehhccCC--ChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeEE
Confidence 3456789999998762 23 358899887653 445578999999999999999999999999864 78999
Q ss_pred EeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCC
Q 013214 229 TEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307 (447)
Q Consensus 229 ~e~~~~g~L~~~l~~~~-~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~ 307 (447)
||.++-|.|.++|+.+. .++......++.||+.||.|||+.+ +|||||..+|||+.+...+||+|||+++.+....
T Consensus 469 mEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~ 545 (974)
T KOG4257|consen 469 MELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRYLEDDA 545 (974)
T ss_pred EecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhhccccc
Confidence 99999999999998765 4889999999999999999999999 9999999999999999999999999999887554
Q ss_pred CCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHH
Q 013214 308 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLK 386 (447)
Q Consensus 308 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 386 (447)
....+...-+..|||||-+.-+.++..+|||.||+++||+++ |..||.+-.+.++...+..+.+.+. ++++|+.+.
T Consensus 546 yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~---P~nCPp~LY 622 (974)
T KOG4257|consen 546 YYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPC---PPNCPPALY 622 (974)
T ss_pred hhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCC---CCCCChHHH
Confidence 333333445778999999998999999999999999999987 9999999998888877777778876 567789999
Q ss_pred HHHHHHcccCCCCCCCHHHHHHHHHHHHh
Q 013214 387 ELIEECWNEKPAKRPTFRQIITRLESINN 415 (447)
Q Consensus 387 ~li~~cl~~dp~~Rps~~~~l~~l~~~~~ 415 (447)
.++.+||+.+|.+||.+.++...|.++..
T Consensus 623 slmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 623 SLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred HHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 99999999999999999999999998776
No 147
>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1. Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.
Probab=100.00 E-value=4.8e-38 Score=300.54 Aligned_cols=254 Identities=32% Similarity=0.527 Sum_probs=206.3
Q ss_pred CcccceeeecceEEEEEE-----cC--eEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeEEEEeCCceEE
Q 013214 156 DFTNSVEITKGTFILAFW-----RG--IQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMI 227 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g--~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~l 227 (447)
+|+..+.||+|+||.++. ++ ..+++|.++.. ......+.+.+|+.+++++ +||||+++++++......++
T Consensus 3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 80 (297)
T cd05089 3 DIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF--ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYI 80 (297)
T ss_pred cceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc--CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceE
Confidence 577778999999998762 23 34788887632 2344556788999999999 79999999999999999999
Q ss_pred EEeccCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCC
Q 013214 228 VTEYLPKGDLRAFLKRKG----------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291 (447)
Q Consensus 228 v~e~~~~g~L~~~l~~~~----------------~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~ 291 (447)
++||+++++|.+++.+.. .+++..++.++.|++.|+.|||+.+ ++|+||||+||+++.++.
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~ 157 (297)
T cd05089 81 AIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLA 157 (297)
T ss_pred EEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCe
Confidence 999999999999997542 3778899999999999999999998 999999999999999999
Q ss_pred EEEeecccccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcC
Q 013214 292 LKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQ 370 (447)
Q Consensus 292 vkl~Dfg~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~ 370 (447)
+||+|||++...... ........+..|+|||.+.+..++.++||||||+++|+|++ |..||......+....+....
T Consensus 158 ~kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~ 235 (297)
T cd05089 158 SKIADFGLSRGEEVY--VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY 235 (297)
T ss_pred EEECCcCCCccccce--eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC
Confidence 999999998643211 11111223557999999988889999999999999999997 999998777665555443332
Q ss_pred CCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhhc
Q 013214 371 RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINH 419 (447)
Q Consensus 371 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~~~~ 419 (447)
.+. .+..++..+.+++.+||+.+|.+||++.++++.|+.+......
T Consensus 236 ~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~ 281 (297)
T cd05089 236 RME---KPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKA 281 (297)
T ss_pred CCC---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 222 2345778999999999999999999999999999988876543
No 148
>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4. Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to
Probab=100.00 E-value=5.5e-38 Score=302.54 Aligned_cols=257 Identities=28% Similarity=0.528 Sum_probs=210.1
Q ss_pred cCcccceeeecceEEEEEE------------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeEEEEe
Q 013214 155 LDFTNSVEITKGTFILAFW------------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQ 221 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~------------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~ 221 (447)
.+|...+.||+|+||.++. ....+|+|.+.... .......+.+|+.+++++ +||||+++++++..
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA--TDKDLADLISEMELMKLIGKHKNIINLLGVCTQ 89 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC--ChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc
Confidence 3677888999999998763 13569999987542 344566788999999999 69999999999999
Q ss_pred CCceEEEEeccCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEE
Q 013214 222 SSPMMIVTEYLPKGDLRAFLKRK----------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL 285 (447)
Q Consensus 222 ~~~~~lv~e~~~~g~L~~~l~~~----------------~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nil 285 (447)
+...+++|||+++|+|.+++... ..++..++..++.|++.||.|||+++ ++|+||||+||+
T Consensus 90 ~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nil 166 (314)
T cd05099 90 EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVL 166 (314)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEE
Confidence 99999999999999999999753 23788889999999999999999998 999999999999
Q ss_pred EcCCCCEEEeecccccccccCCC-CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchH
Q 013214 286 RDDSGNLKVADFGVSKLLTVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVP 363 (447)
Q Consensus 286 l~~~~~vkl~Dfg~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~ 363 (447)
++.++.+||+|||.+........ .......++..|+|||.+.+..++.++|+||||+++|+|++ |..||......+..
T Consensus 167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~ 246 (314)
T cd05099 167 VTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELF 246 (314)
T ss_pred EcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 99999999999999976542211 11122233467999999988889999999999999999999 89999877665555
Q ss_pred HHHHhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhhc
Q 013214 364 KAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINH 419 (447)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~~~~ 419 (447)
..+........ +..++.++.+++.+||+.||++||++.++++.|+.+....+.
T Consensus 247 ~~~~~~~~~~~---~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~~ 299 (314)
T cd05099 247 KLLREGHRMDK---PSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAVSE 299 (314)
T ss_pred HHHHcCCCCCC---CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHhcC
Confidence 55533332222 345677899999999999999999999999999998876654
No 149
>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase. Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription
Probab=100.00 E-value=1.2e-38 Score=314.37 Aligned_cols=249 Identities=24% Similarity=0.376 Sum_probs=200.0
Q ss_pred CcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCC-----ce
Q 013214 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS-----PM 225 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-----~~ 225 (447)
+|+..+.||+|+||.|+ .+|+.||+|.+.... ........+.+|+.+++.++||||+++++++.... ..
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 79 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVF-QNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEI 79 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccc-cchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceE
Confidence 36677899999999886 368999999986532 23344567888999999999999999999998776 78
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeeccccccccc
Q 013214 226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305 (447)
Q Consensus 226 ~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~ 305 (447)
++++||+. ++|.+.+.....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.....
T Consensus 80 ~lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~ 155 (372)
T cd07853 80 YVVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEEP 155 (372)
T ss_pred EEEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeeccc
Confidence 99999995 689998888888999999999999999999999999 99999999999999999999999999986543
Q ss_pred CCCCCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhc---------------
Q 013214 306 KEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR--------------- 369 (447)
Q Consensus 306 ~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~--------------- 369 (447)
..........+++.|+|||.+.+. .++.++|||||||++|+|++|+.||...+..+....+...
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 235 (372)
T cd07853 156 DESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEG 235 (372)
T ss_pred CccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHH
Confidence 322233344578899999998764 4788999999999999999999999876654332222110
Q ss_pred --------C-CCCC----CCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 370 --------Q-RPPF----KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 370 --------~-~~~~----~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
. .++. .......++++.++|.+||+.||++|||+.+++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 236 ARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 0 1110 00112346789999999999999999999999875
No 150
>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2. Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.
Probab=100.00 E-value=4.1e-39 Score=311.36 Aligned_cols=235 Identities=26% Similarity=0.396 Sum_probs=192.4
Q ss_pred eeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHH-HHhcCCCCcccceeEEEEeCCceEEEEeccCCC
Q 013214 162 EITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELA-LLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235 (447)
Q Consensus 162 ~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~-~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g 235 (447)
.||+|+||.|+. +|+.||+|++.............+..|.. +++.++||||+++++.+.+.+..++||||+++|
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 81 (321)
T cd05603 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGG 81 (321)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence 689999998872 57899999987543323333444555554 678889999999999999999999999999999
Q ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCCcccCC
Q 013214 236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD 315 (447)
Q Consensus 236 ~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~ 315 (447)
+|...+.....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++...... ........
T Consensus 82 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~ 157 (321)
T cd05603 82 ELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP-EETTSTFC 157 (321)
T ss_pred CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCC-CCcccccc
Confidence 99999988888999999999999999999999999 999999999999999999999999998753221 12223456
Q ss_pred CCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHHHHHccc
Q 013214 316 TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNE 395 (447)
Q Consensus 316 ~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 395 (447)
+|+.|+|||.+.+..++.++|||||||++|+|++|+.||...+..+....+.. ....+ +...+..+.+++.+||+.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~-~~~~~---~~~~~~~~~~li~~~l~~ 233 (321)
T cd05603 158 GTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILH-KPLQL---PGGKTVAACDLLVGLLHK 233 (321)
T ss_pred CCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhc-CCCCC---CCCCCHHHHHHHHHHccC
Confidence 79999999999888899999999999999999999999987765444444422 22222 334677899999999999
Q ss_pred CCCCCCCHH
Q 013214 396 KPAKRPTFR 404 (447)
Q Consensus 396 dp~~Rps~~ 404 (447)
||.+||++.
T Consensus 234 ~p~~R~~~~ 242 (321)
T cd05603 234 DQRRRLGAK 242 (321)
T ss_pred CHhhcCCCC
Confidence 999999764
No 151
>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer. Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c
Probab=100.00 E-value=5.8e-38 Score=292.05 Aligned_cols=242 Identities=31% Similarity=0.541 Sum_probs=200.3
Q ss_pred eeecceEEEEE----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEeccCCCCH
Q 013214 162 EITKGTFILAF----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237 (447)
Q Consensus 162 ~lg~G~~~~~~----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L 237 (447)
.||+|+||.++ .++..+|+|.+.... ..+....+.+|+.+++.++||||+++++++......+++|||+++++|
T Consensus 2 ~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (250)
T cd05085 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDL--PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF 79 (250)
T ss_pred ccCCCCCceEEEEEecCCcEEEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence 58999999876 357789999987542 344556788999999999999999999999999999999999999999
Q ss_pred HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCCcccCCC
Q 013214 238 RAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT 316 (447)
Q Consensus 238 ~~~l~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~ 316 (447)
.+++... ..+++..+..++.|++.+|.|+|+.+ ++|+||||+||+++.++.+||+|||++...............+
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~ 156 (250)
T cd05085 80 LSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI 156 (250)
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCC
Confidence 9998754 45789999999999999999999999 9999999999999999999999999987543222111122234
Q ss_pred CCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHHHHHccc
Q 013214 317 SCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNE 395 (447)
Q Consensus 317 t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 395 (447)
+..|+|||.+.+..++.++|+||||+++|++++ |..||...........+....+... +..++..+.+++.+||+.
T Consensus 157 ~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~ 233 (250)
T cd05085 157 PIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSC---PQKCPDDVYKVMQRCWDY 233 (250)
T ss_pred cccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCCCC---CCCCCHHHHHHHHHHccc
Confidence 567999999988888999999999999999998 9999987766555544433323322 334678899999999999
Q ss_pred CCCCCCCHHHHHHHHH
Q 013214 396 KPAKRPTFRQIITRLE 411 (447)
Q Consensus 396 dp~~Rps~~~~l~~l~ 411 (447)
+|++||++.++++.|.
T Consensus 234 ~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 234 KPENRPKFSELQKELA 249 (250)
T ss_pred CcccCCCHHHHHHHhc
Confidence 9999999999998874
No 152
>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a
Probab=100.00 E-value=8.4e-38 Score=293.71 Aligned_cols=253 Identities=26% Similarity=0.502 Sum_probs=207.8
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|+..+.||+|++|.++. +|+.||+|.++.....+......+.+|+.++++++|+|++++++.+...+..+++||
T Consensus 3 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 82 (267)
T cd08224 3 NFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLE 82 (267)
T ss_pred ceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEe
Confidence 577888999999987752 689999998875444455556788999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccC
Q 013214 231 YLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306 (447)
Q Consensus 231 ~~~~g~L~~~l~~----~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~ 306 (447)
|+++++|.+++.. ...+++.++..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 83 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~ 159 (267)
T cd08224 83 LADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred cCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccCC
Confidence 9999999999864 244889999999999999999999999 999999999999999999999999998765432
Q ss_pred CCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCC--chHHHHHhcCCCCCCCChhhhHHH
Q 013214 307 EDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDN--EVPKAYAARQRPPFKAPAKLYARG 384 (447)
Q Consensus 307 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 384 (447)
.. ......+++.|+|||.+.+..++.++|+||||+++|+|++|+.||...... +..........++. ....++..
T Consensus 160 ~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 236 (267)
T cd08224 160 TT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPL--PADHYSEE 236 (267)
T ss_pred Cc-ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCC--ChhhcCHH
Confidence 11 112334678899999998888999999999999999999999999654422 12222222222222 12357788
Q ss_pred HHHHHHHHcccCCCCCCCHHHHHHHHHHHH
Q 013214 385 LKELIEECWNEKPAKRPTFRQIITRLESIN 414 (447)
Q Consensus 385 l~~li~~cl~~dp~~Rps~~~~l~~l~~~~ 414 (447)
+.++|.+||..+|++||++.++++.|+.+.
T Consensus 237 ~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 237 LRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred HHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 999999999999999999999999998864
No 153
>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]
Probab=100.00 E-value=6.8e-40 Score=300.58 Aligned_cols=250 Identities=26% Similarity=0.435 Sum_probs=200.7
Q ss_pred CCcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCC----
Q 013214 153 HELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS---- 223 (447)
Q Consensus 153 ~~~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~---- 223 (447)
..+.|...+.+|.|+||.|+. +++.||||+.-.+.. .-.+|+.+|+.+.|||||++.-+|....
T Consensus 22 ~~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r-------~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~ 94 (364)
T KOG0658|consen 22 VEISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR-------YKNRELQIMRKLDHPNIVRLLYFFSSSTESDE 94 (364)
T ss_pred eEEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC-------cCcHHHHHHHhcCCcCeeeEEEEEEecCCCch
Confidence 455788889999999999873 578999998854421 1246999999999999999988886432
Q ss_pred -ceEEEEeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcC-CCCEEEeec
Q 013214 224 -PMMIVTEYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD-SGNLKVADF 297 (447)
Q Consensus 224 -~~~lv~e~~~~g~L~~~l~~----~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~-~~~vkl~Df 297 (447)
.+.+||||++ .+|.++++. +.+++.-.+.-+.+||++||.|||+.+ |+||||||+|+|+|. .|.+|||||
T Consensus 95 ~~lnlVleymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDF 170 (364)
T KOG0658|consen 95 VYLNLVLEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDF 170 (364)
T ss_pred hHHHHHHHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccC
Confidence 4578999996 599999974 566888899999999999999999998 999999999999995 499999999
Q ss_pred ccccccccCCCCCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHh-cCCC---
Q 013214 298 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA-RQRP--- 372 (447)
Q Consensus 298 g~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~-~~~~--- 372 (447)
|+|+.+... .+..++.+|..|.|||.+.+. .|+.+.||||.||++.||+-|++.|.+.+.......+.. -+.|
T Consensus 171 GSAK~L~~~--epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e 248 (364)
T KOG0658|consen 171 GSAKVLVKG--EPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTRE 248 (364)
T ss_pred CcceeeccC--CCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHH
Confidence 999987643 445667789999999998775 799999999999999999999999999876554443322 1111
Q ss_pred ---------------CCCC------ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH--HHHHHh
Q 013214 373 ---------------PFKA------PAKLYARGLKELIEECWNEKPAKRPTFRQIITR--LESINN 415 (447)
Q Consensus 373 ---------------~~~~------~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~--l~~~~~ 415 (447)
.+.. .....+++..+++.++|..+|.+|.++.+++.+ ++.++.
T Consensus 249 ~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~ 314 (364)
T KOG0658|consen 249 DIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRD 314 (364)
T ss_pred HHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhC
Confidence 1111 223567889999999999999999999999853 444443
No 154
>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2. Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly
Probab=100.00 E-value=2.1e-38 Score=300.80 Aligned_cols=249 Identities=27% Similarity=0.501 Sum_probs=204.9
Q ss_pred CcccceeeecceEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCce
Q 013214 156 DFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 225 (447)
+|...+.||+|+||.|+. .+..||+|.+.... .....+.+.+|..++..++||||+++++++......
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~ 83 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA--EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPL 83 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCce
Confidence 466677899999998763 24789999997542 334456788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCC
Q 013214 226 MIVTEYLPKGDLRAFLKRK----------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289 (447)
Q Consensus 226 ~lv~e~~~~g~L~~~l~~~----------------~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~ 289 (447)
++++||+.+++|.+++... ..+++..+..++.|++.||.|+|+.+ ++||||||+||+++++
T Consensus 84 ~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~ 160 (283)
T cd05091 84 SMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDK 160 (283)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCC
Confidence 9999999999999998532 24778889999999999999999999 9999999999999999
Q ss_pred CCEEEeecccccccccCCC-CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHH
Q 013214 290 GNLKVADFGVSKLLTVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYA 367 (447)
Q Consensus 290 ~~vkl~Dfg~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~ 367 (447)
+.+||+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|+|++ |..||.+....+....+.
T Consensus 161 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~ 240 (283)
T cd05091 161 LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIR 240 (283)
T ss_pred CceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 9999999999876532211 11122335678999999988889999999999999999998 889998776665555554
Q ss_pred hcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHH
Q 013214 368 ARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLES 412 (447)
Q Consensus 368 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~ 412 (447)
.....++ +..++..+.+++..||+.+|.+||++++++..|+.
T Consensus 241 ~~~~~~~---~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 241 NRQVLPC---PDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred cCCcCCC---CCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 4333332 44678889999999999999999999999998864
No 155
>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk
Probab=100.00 E-value=4.7e-38 Score=293.84 Aligned_cols=243 Identities=34% Similarity=0.617 Sum_probs=205.8
Q ss_pred CcccceeeecceEEEEE---EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEecc
Q 013214 156 DFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYL 232 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~---~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 232 (447)
+|+..+.||.|++|.|+ ..|+.||+|.+.... ...+.+.+|+.+++.++||||+++++++......+++|||+
T Consensus 7 ~~~~~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 7 ELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDS----TAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hccceeeeecCCCceEEEEEecCcEEEEEEeccch----hHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 56777899999998876 578999999997542 14577889999999999999999999999889999999999
Q ss_pred CCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCC
Q 013214 233 PKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (447)
Q Consensus 233 ~~g~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~ 310 (447)
++++|.+++.... .+++..+..++.|++.|+.|||+.+ ++|+||||+||+++.++.++|+|||.+........
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~-- 157 (256)
T cd05039 83 AKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-- 157 (256)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccccccc--
Confidence 9999999998765 6899999999999999999999999 99999999999999999999999999886532211
Q ss_pred cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHH
Q 013214 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELI 389 (447)
Q Consensus 311 ~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 389 (447)
....+..|+|||.+....++.++|+||||+++|++++ |..||...+..+....+....... .+..+++.+.++|
T Consensus 158 --~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li 232 (256)
T cd05039 158 --SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRME---APEGCPPEVYKVM 232 (256)
T ss_pred --cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCC---CccCCCHHHHHHH
Confidence 2234567999999988888999999999999999997 999998776555544443332222 2345678899999
Q ss_pred HHHcccCCCCCCCHHHHHHHHHH
Q 013214 390 EECWNEKPAKRPTFRQIITRLES 412 (447)
Q Consensus 390 ~~cl~~dp~~Rps~~~~l~~l~~ 412 (447)
.+||..+|++||++.++++.|+.
T Consensus 233 ~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 233 KDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred HHHhccChhhCcCHHHHHHHHhc
Confidence 99999999999999999999875
No 156
>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors. Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,
Probab=100.00 E-value=2.2e-38 Score=302.08 Aligned_cols=253 Identities=30% Similarity=0.536 Sum_probs=207.7
Q ss_pred CcCcccceeeecceEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeEEEEeC
Q 013214 154 ELDFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQS 222 (447)
Q Consensus 154 ~~~~~~~~~lg~G~~~~~~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~ 222 (447)
..+|+..+.||+|+||.++. ....+|+|.+.... .......+.+|+.+++++ +||||+++++++..+
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 88 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE 88 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence 34677778999999998763 12679999987542 334456788999999999 899999999999999
Q ss_pred CceEEEEeccCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEE
Q 013214 223 SPMMIVTEYLPKGDLRAFLKRK----------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR 286 (447)
Q Consensus 223 ~~~~lv~e~~~~g~L~~~l~~~----------------~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill 286 (447)
+..+++|||+++|+|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||||+||++
T Consensus 89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~ 165 (293)
T cd05053 89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLV 165 (293)
T ss_pred CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEE
Confidence 9999999999999999999642 35788899999999999999999998 9999999999999
Q ss_pred cCCCCEEEeecccccccccCCCC-CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHH
Q 013214 287 DDSGNLKVADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPK 364 (447)
Q Consensus 287 ~~~~~vkl~Dfg~~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~ 364 (447)
+.++.+||+|||++......... ......++..|+|||.+.+..++.++|||||||++|+|++ |..||......+...
T Consensus 166 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~ 245 (293)
T cd05053 166 TEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFK 245 (293)
T ss_pred cCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHH
Confidence 99999999999999865432211 1122234567999999988889999999999999999997 999998777666555
Q ss_pred HHHhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHH
Q 013214 365 AYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESIN 414 (447)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~ 414 (447)
.......+.. +...+..+.+++.+||..||++|||+.++++.|+++.
T Consensus 246 ~~~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 246 LLKEGYRMEK---PQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred HHHcCCcCCC---CCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 5533333332 3345778999999999999999999999999998864
No 157
>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]
Probab=100.00 E-value=1.3e-40 Score=296.35 Aligned_cols=244 Identities=27% Similarity=0.446 Sum_probs=212.6
Q ss_pred CcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
-|.+..+||+|+||.|+ .+|+.+|+|.++.+ ..++++.+|+.++++.+.|++|++||.+.....+|+|||
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~-----sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVME 108 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD-----TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVME 108 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc-----chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehh
Confidence 36677889999999875 58999999998744 346889999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 013214 231 YLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (447)
Q Consensus 231 ~~~~g~L~~~l~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~ 309 (447)
||..|+..+.++- +.++++.++..+++..+.||+|||... -+|||||..|||++.+|..||+|||.+-.+...-.
T Consensus 109 YCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA- 184 (502)
T KOG0574|consen 109 YCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA- 184 (502)
T ss_pred hcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhhHH-
Confidence 9999999999974 567999999999999999999999988 79999999999999999999999999976653321
Q ss_pred CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHH
Q 013214 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELI 389 (447)
Q Consensus 310 ~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 389 (447)
......|||.|||||++..-.|+.++||||||++..||..|++||.+..+....-.+.....|.|. .+..+|.++.+++
T Consensus 185 KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~-KPE~WS~~F~DFi 263 (502)
T KOG0574|consen 185 KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFK-KPEEWSSEFNDFI 263 (502)
T ss_pred hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCC-ChHhhhhHHHHHH
Confidence 124567899999999999989999999999999999999999999988876655555344344444 4667899999999
Q ss_pred HHHcccCCCCCCCHHHHHHH
Q 013214 390 EECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 390 ~~cl~~dp~~Rps~~~~l~~ 409 (447)
++||..+|++|.|+.+++++
T Consensus 264 ~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 264 RSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred HHHhcCCHHHHHHHHHHhhh
Confidence 99999999999999998876
No 158
>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk. Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr
Probab=100.00 E-value=3.7e-38 Score=295.31 Aligned_cols=246 Identities=31% Similarity=0.526 Sum_probs=203.5
Q ss_pred CcccceeeecceEEEEE----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEec
Q 013214 156 DFTNSVEITKGTFILAF----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 231 (447)
+|+..+.||+|+||.++ .+++.||+|.+...... ...+.+|+.++++++||||+++++++. .+..+++|||
T Consensus 7 ~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 81 (260)
T cd05067 7 TLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS----PEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEY 81 (260)
T ss_pred HceeeeeeccCccceEEeeecCCCceEEEEEecCCCCc----HHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEc
Confidence 56777899999999876 36789999998754432 356888999999999999999999874 4578999999
Q ss_pred cCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 013214 232 LPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (447)
Q Consensus 232 ~~~g~L~~~l~~~--~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~ 309 (447)
+.+++|.+++.+. ..+++.++..++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||++.........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05067 82 MENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCcc
Confidence 9999999998753 35889999999999999999999998 999999999999999999999999998765422222
Q ss_pred CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHH
Q 013214 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKEL 388 (447)
Q Consensus 310 ~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 388 (447)
......++..|+|||.+.+..++.++|+||||+++|++++ |+.||...+..+...........+. +...+.++.++
T Consensus 159 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l 235 (260)
T cd05067 159 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPR---PDNCPEELYEL 235 (260)
T ss_pred cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCC---CCCCCHHHHHH
Confidence 2223345678999999988888999999999999999999 9999987776655555433323322 33467889999
Q ss_pred HHHHcccCCCCCCCHHHHHHHHHH
Q 013214 389 IEECWNEKPAKRPTFRQIITRLES 412 (447)
Q Consensus 389 i~~cl~~dp~~Rps~~~~l~~l~~ 412 (447)
+.+||+.+|++||++++++..|++
T Consensus 236 i~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 236 MRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred HHHHccCChhhCCCHHHHHHHhhc
Confidence 999999999999999999999875
No 159
>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]
Probab=100.00 E-value=6.1e-39 Score=294.68 Aligned_cols=248 Identities=29% Similarity=0.468 Sum_probs=201.7
Q ss_pred CcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCc-ccceeEEEEeCC------
Q 013214 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPN-VVQFLGAVTQSS------ 223 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~-iv~~~~~~~~~~------ 223 (447)
.|...++||+|+||.|| .+|+.||+|+++.+... +-.-....+|+.+++.++|+| |+++++++....
T Consensus 12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~-EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE-EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc-cCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 46666789999999987 47899999999865432 112234567999999999999 999999998877
Q ss_pred ceEEEEeccCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeeccc
Q 013214 224 PMMIVTEYLPKGDLRAFLKRKG----ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGV 299 (447)
Q Consensus 224 ~~~lv~e~~~~g~L~~~l~~~~----~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~ 299 (447)
.+++|+||+ .-+|..++...+ .++...+..++.||+.||.|||+++ |+||||||+||+++++|.+||+|||+
T Consensus 91 ~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 91 KLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred eEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccch
Confidence 789999999 569999998765 4778899999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCCCCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhc-CCC-----
Q 013214 300 SKLLTVKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR-QRP----- 372 (447)
Q Consensus 300 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~-~~~----- 372 (447)
|+....+. ...+...+|.+|.|||++.+. .|++..||||+||++.||+++++.|++....+....+... +.|
T Consensus 167 Ara~~ip~-~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~W 245 (323)
T KOG0594|consen 167 ARAFSIPM-RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDW 245 (323)
T ss_pred HHHhcCCc-ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCC
Confidence 99765432 334556679999999999886 7899999999999999999999999988775544444221 111
Q ss_pred -----------CCCCC--h-------hhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 373 -----------PFKAP--A-------KLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 373 -----------~~~~~--~-------~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
.++.. + +..++...+++.+|++.+|.+|.|++.++.+
T Consensus 246 p~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 246 PGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 11111 1 1122478899999999999999999999987
No 160
>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological
Probab=100.00 E-value=3.4e-38 Score=298.24 Aligned_cols=248 Identities=29% Similarity=0.491 Sum_probs=205.0
Q ss_pred CcccceeeecceEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCce
Q 013214 156 DFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 225 (447)
+|.....||+|+||.|+. .+..||+|.+.... .......+.+|+.+++.++||||+++++++......
T Consensus 7 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 7 KITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred HeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 567778999999998762 23689999986442 334456788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEe
Q 013214 226 MIVTEYLPKGDLRAFLKRKG----------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVA 295 (447)
Q Consensus 226 ~lv~e~~~~g~L~~~l~~~~----------~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~ 295 (447)
+++|||+++|+|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence 99999999999999996532 3677889999999999999999998 9999999999999999999999
Q ss_pred ecccccccccCCC-CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCC
Q 013214 296 DFGVSKLLTVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPP 373 (447)
Q Consensus 296 Dfg~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~ 373 (447)
|||+++....... .......++..|+|||.+.+..++.++|+||||+++|++++ |..||...+..+....+.....+.
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~ 241 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHLD 241 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCCCCC
Confidence 9999876543221 11223345778999999988889999999999999999998 999998777666665554333333
Q ss_pred CCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHH
Q 013214 374 FKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLE 411 (447)
Q Consensus 374 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~ 411 (447)
. +..++..+.+++.+||+.+|++|||+.++++.|+
T Consensus 242 ~---~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 242 L---PENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred C---CCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 3 3345789999999999999999999999999875
No 161
>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk. Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r
Probab=100.00 E-value=4e-38 Score=295.07 Aligned_cols=246 Identities=33% Similarity=0.535 Sum_probs=203.2
Q ss_pred CcccceeeecceEEEEE----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEec
Q 013214 156 DFTNSVEITKGTFILAF----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 231 (447)
+|+..+.||+|++|.++ ..+..+|+|.+...... .+.+.+|+.++++++|||++++++++. ....+++|||
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~----~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~ 81 (260)
T cd05070 7 SLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMS----PESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEY 81 (260)
T ss_pred HhhhhheeccccCceEEEEEecCCceeEEEEecCCCCC----HHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEe
Confidence 57778899999999876 35678999998754332 246888999999999999999999875 4568999999
Q ss_pred cCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 013214 232 LPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (447)
Q Consensus 232 ~~~g~L~~~l~~~--~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~ 309 (447)
+++++|.+++.+. ..+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||++.........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05070 82 MSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCcccc
Confidence 9999999999764 35899999999999999999999999 999999999999999999999999999765432222
Q ss_pred CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHH
Q 013214 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKEL 388 (447)
Q Consensus 310 ~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 388 (447)
......++..|+|||...+..++.++|+||||+++|+|++ |..||...+..+....+.....++. +...+..+.++
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l 235 (260)
T cd05070 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPC---PQDCPISLHEL 235 (260)
T ss_pred cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC---CCcCCHHHHHH
Confidence 2222334667999999988889999999999999999999 9999987776665555543333332 34567889999
Q ss_pred HHHHcccCCCCCCCHHHHHHHHHH
Q 013214 389 IEECWNEKPAKRPTFRQIITRLES 412 (447)
Q Consensus 389 i~~cl~~dp~~Rps~~~~l~~l~~ 412 (447)
+.+||..+|++|||+.++.+.|++
T Consensus 236 i~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 236 MLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred HHHHcccCcccCcCHHHHHHHHhc
Confidence 999999999999999999998875
No 162
>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl. Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor
Probab=100.00 E-value=6.2e-38 Score=295.64 Aligned_cols=249 Identities=27% Similarity=0.463 Sum_probs=200.5
Q ss_pred ccceeeecceEEEEEE-----cC--eEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeC------Cc
Q 013214 158 TNSVEITKGTFILAFW-----RG--IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS------SP 224 (447)
Q Consensus 158 ~~~~~lg~G~~~~~~~-----~g--~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~------~~ 224 (447)
...+.||+|+||.|+. .+ ..+|+|.++... ......+.+.+|+.+++.++||||+++++++... ..
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAI-CTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCc-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3457899999998863 22 269999887643 2445567888999999999999999999987432 24
Q ss_pred eEEEEeccCCCCHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecc
Q 013214 225 MMIVTEYLPKGDLRAFLKR------KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298 (447)
Q Consensus 225 ~~lv~e~~~~g~L~~~l~~------~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg 298 (447)
.++++||+.+|+|.+++.. ...+++..+..++.|++.||.|||+++ ++|+||||+||++++++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCC
Confidence 6899999999999988742 134789999999999999999999998 9999999999999999999999999
Q ss_pred cccccccCCCC-CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCCCC
Q 013214 299 VSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKA 376 (447)
Q Consensus 299 ~~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 376 (447)
++......... .......++.|+|||...+..++.++|+||||+++|+|++ |+.||......+....+........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~-- 235 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQ-- 235 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCC--
Confidence 98865432211 1122345678999999988889999999999999999999 8999987666555555544333332
Q ss_pred ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHH
Q 013214 377 PAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 413 (447)
Q Consensus 377 ~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~ 413 (447)
+..++..+.++|.+||+.||++|||+.++++.|+++
T Consensus 236 -~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 236 -PPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred -CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 345678899999999999999999999999999874
No 163
>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors. Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul
Probab=100.00 E-value=7.3e-38 Score=294.50 Aligned_cols=250 Identities=31% Similarity=0.538 Sum_probs=205.9
Q ss_pred CcccceeeecceEEEEEE--------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEE
Q 013214 156 DFTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 227 (447)
+|+..+.||+|+||.++. .+..+|+|.+.... .......+.+|+.++++++||||+++++++..++..++
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (267)
T cd05066 5 CIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI 82 (267)
T ss_pred HeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 566778999999987752 23379999987543 34456788999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccC
Q 013214 228 VTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306 (447)
Q Consensus 228 v~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~ 306 (447)
+|||+++++|.+++.+. +.+++.++..++.|++.|+.|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd05066 83 VTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 159 (267)
T ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence 99999999999999765 45899999999999999999999999 999999999999999999999999998865432
Q ss_pred CCCCc--ccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHH
Q 013214 307 EDRPL--TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYAR 383 (447)
Q Consensus 307 ~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (447)
..... ....++..|+|||.+.+..++.++|+||||+++|++++ |..||......+....+....+.+. +..+++
T Consensus 160 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~ 236 (267)
T cd05066 160 PEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPA---PMDCPA 236 (267)
T ss_pred cceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcCCC---CCCCCH
Confidence 22111 11223567999999988889999999999999999887 9999987766555444433323222 234678
Q ss_pred HHHHHHHHHcccCCCCCCCHHHHHHHHHHH
Q 013214 384 GLKELIEECWNEKPAKRPTFRQIITRLESI 413 (447)
Q Consensus 384 ~l~~li~~cl~~dp~~Rps~~~~l~~l~~~ 413 (447)
.+.+++.+||+.+|.+||++.++++.|+++
T Consensus 237 ~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 237 ALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred HHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 899999999999999999999999998874
No 164
>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu
Probab=100.00 E-value=7.4e-38 Score=295.06 Aligned_cols=250 Identities=27% Similarity=0.468 Sum_probs=203.4
Q ss_pred cccceeeecceEEEEEE--------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCc----
Q 013214 157 FTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP---- 224 (447)
Q Consensus 157 ~~~~~~lg~G~~~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~---- 224 (447)
|+..+.||+|+||.++. .+..||+|.++.+.. .......+.+|+..++.++||||+++++.+.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 79 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIH-TYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKI 79 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcC-CHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccC
Confidence 45667899999998862 236799999875432 34456778999999999999999999998865544
Q ss_pred --eEEEEeccCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEee
Q 013214 225 --MMIVTEYLPKGDLRAFLKRK------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296 (447)
Q Consensus 225 --~~lv~e~~~~g~L~~~l~~~------~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~D 296 (447)
.++++||+++|+|..++... ..+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.+||+|
T Consensus 80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~d 156 (273)
T cd05035 80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVAD 156 (273)
T ss_pred cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECC
Confidence 79999999999999998542 25889999999999999999999998 99999999999999999999999
Q ss_pred cccccccccCCCC-CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCC
Q 013214 297 FGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPF 374 (447)
Q Consensus 297 fg~~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~ 374 (447)
||+++........ .......+..|+|||.+.+..++.++||||||+++|+|++ |..||......+....+.......
T Consensus 157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~- 235 (273)
T cd05035 157 FGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLK- 235 (273)
T ss_pred ccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC-
Confidence 9998765432211 1112234678999999988889999999999999999999 999998776666555553333332
Q ss_pred CCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHH
Q 013214 375 KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 413 (447)
Q Consensus 375 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~ 413 (447)
.+..++..+.+++.+||+.||++||++.++++.|+++
T Consensus 236 --~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 236 --QPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred --CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 2445778999999999999999999999999999875
No 165
>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including
Probab=100.00 E-value=8.5e-38 Score=298.51 Aligned_cols=252 Identities=27% Similarity=0.475 Sum_probs=202.3
Q ss_pred cCcccceeeecceEEEEEE-----------------c--CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccce
Q 013214 155 LDFTNSVEITKGTFILAFW-----------------R--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQF 215 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~-----------------~--g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~ 215 (447)
.+|+..+.||+|+||.|+. + ...||+|.+.... .......+.+|++++++++|||++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~ 82 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV--TKTARNDFLKEIKIMSRLKNPNIIRL 82 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCcCeE
Confidence 3677788999999998863 1 2358999987542 34556778999999999999999999
Q ss_pred eEEEEeCCceEEEEeccCCCCHHHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCC
Q 013214 216 LGAVTQSSPMMIVTEYLPKGDLRAFLKRKG------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSN 283 (447)
Q Consensus 216 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~------------~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~N 283 (447)
++++......+++|||+.+++|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||||+|
T Consensus 83 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~N 159 (295)
T cd05097 83 LGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRN 159 (295)
T ss_pred EEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhh
Confidence 999999999999999999999999996532 3678888999999999999999999 9999999999
Q ss_pred EEEcCCCCEEEeecccccccccCCC-CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh--CCCCCCCCCCC
Q 013214 284 ILRDDSGNLKVADFGVSKLLTVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE--GCPPFTMKHDN 360 (447)
Q Consensus 284 ill~~~~~vkl~Dfg~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t--g~~p~~~~~~~ 360 (447)
|+++.++.+||+|||++........ .......++..|+|||.+.++.++.++|+||||+++|+|++ |..||......
T Consensus 160 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~ 239 (295)
T cd05097 160 CLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE 239 (295)
T ss_pred EEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChH
Confidence 9999999999999999875432211 11122234678999999988889999999999999999988 67788776654
Q ss_pred chHHHHHh----cCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHH
Q 013214 361 EVPKAYAA----RQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLE 411 (447)
Q Consensus 361 ~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~ 411 (447)
+....... .....+...++.+++.+.+++.+||+.||++|||+.++++.|+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 240 QVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred HHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 44333211 1122222334456789999999999999999999999999875
No 166
>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase. Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re
Probab=100.00 E-value=4.7e-38 Score=293.88 Aligned_cols=243 Identities=30% Similarity=0.565 Sum_probs=201.1
Q ss_pred CcccceeeecceEEEEE---EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEE-eCCceEEEEec
Q 013214 156 DFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVT-QSSPMMIVTEY 231 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~---~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-~~~~~~lv~e~ 231 (447)
+|+..+.||+|+||.++ ..|..||+|..... ...+.+.+|+.++++++|||++++++++. .....++++||
T Consensus 7 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~k~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (256)
T cd05082 7 ELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKND-----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 81 (256)
T ss_pred hCeeeeeecccCCCeEEEEEEcCCcEEEEEeCCC-----chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEEC
Confidence 57777899999998765 57889999988643 22456888999999999999999999764 45678999999
Q ss_pred cCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 013214 232 LPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (447)
Q Consensus 232 ~~~g~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~ 309 (447)
+++++|.+++.+.. .+++..+..++.|++.||.|||+++ ++|+||||+||++++++.+||+|||++.......
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-- 156 (256)
T cd05082 82 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 156 (256)
T ss_pred CCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence 99999999997654 3788999999999999999999999 9999999999999999999999999987543221
Q ss_pred CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHH
Q 013214 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKEL 388 (447)
Q Consensus 310 ~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 388 (447)
.....+..|+|||++.+..++.++||||||+++|+|++ |+.||......+....+.....+. .+..+++.+.++
T Consensus 157 --~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l 231 (256)
T cd05082 157 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMD---APDGCPPVVYDV 231 (256)
T ss_pred --CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCC---CCCCCCHHHHHH
Confidence 22234567999999988889999999999999999997 999998766555544443332222 234567899999
Q ss_pred HHHHcccCCCCCCCHHHHHHHHHHH
Q 013214 389 IEECWNEKPAKRPTFRQIITRLESI 413 (447)
Q Consensus 389 i~~cl~~dp~~Rps~~~~l~~l~~~ 413 (447)
+.+||+.+|++|||+.++++.|+.+
T Consensus 232 i~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 232 MKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred HHHHhcCChhhCcCHHHHHHHHhcC
Confidence 9999999999999999999988753
No 167
>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2. Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A
Probab=100.00 E-value=4.1e-38 Score=301.90 Aligned_cols=253 Identities=32% Similarity=0.537 Sum_probs=203.7
Q ss_pred CcccceeeecceEEEEEE-----cCe--EEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeEEEEeCCceEE
Q 013214 156 DFTNSVEITKGTFILAFW-----RGI--QVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMI 227 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~l 227 (447)
+|+..+.||+|+||.++. ++. .+|+|.+... ........+.+|+.++.++ +||||+++++++..++..++
T Consensus 8 ~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 8 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc--CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 567778999999998763 343 4677776532 2345567788899999999 89999999999999999999
Q ss_pred EEeccCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCC
Q 013214 228 VTEYLPKGDLRAFLKRKG----------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291 (447)
Q Consensus 228 v~e~~~~g~L~~~l~~~~----------------~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~ 291 (447)
+|||+++++|.+++.+.+ .+++.++..++.|++.|+.|||+.+ ++||||||+||++++++.
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV 162 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCc
Confidence 999999999999997542 4788899999999999999999999 999999999999999999
Q ss_pred EEEeecccccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcC
Q 013214 292 LKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQ 370 (447)
Q Consensus 292 vkl~Dfg~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~ 370 (447)
+||+|||++....... .......+..|+|||.+.+..++.++||||||+++|+|++ |..||...+..+.........
T Consensus 163 ~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~ 240 (303)
T cd05088 163 AKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY 240 (303)
T ss_pred EEeCccccCcccchhh--hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCC
Confidence 9999999986432111 1111223567999999988888999999999999999998 999998766655444442222
Q ss_pred CCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhh
Q 013214 371 RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSIN 418 (447)
Q Consensus 371 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~~~ 418 (447)
.... +...++.+.+++.+||+.+|++||++.++++.++++.....
T Consensus 241 ~~~~---~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~ 285 (303)
T cd05088 241 RLEK---PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 285 (303)
T ss_pred cCCC---CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhh
Confidence 2222 23456789999999999999999999999999988755543
No 168
>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati
Probab=100.00 E-value=4.1e-38 Score=294.08 Aligned_cols=245 Identities=27% Similarity=0.452 Sum_probs=203.8
Q ss_pred CcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|+..+.||.|+||.++ .+++.+|+|.+.... .....+.+.+|+.+++.++||||+++++.+..++.+++++|
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK--SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVME 78 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc--chHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 46677899999998775 368899999886442 23455678889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 013214 231 YLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (447)
Q Consensus 231 ~~~~g~L~~~l~~~--~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~ 308 (447)
|+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.++++|||++.......
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~- 154 (255)
T cd08219 79 YCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG- 154 (255)
T ss_pred eCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeecccc-
Confidence 99999999988653 35889999999999999999999999 9999999999999999999999999987654321
Q ss_pred CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHH
Q 013214 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKEL 388 (447)
Q Consensus 309 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 388 (447)
.......+++.|+|||.+.+..++.++|+||||+++|+|++|..||...+.......+......+. +..++..+.++
T Consensus 155 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l 231 (255)
T cd08219 155 AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPL---PSHYSYELRSL 231 (255)
T ss_pred cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCC---CcccCHHHHHH
Confidence 112234578889999999888899999999999999999999999987665444444433333332 34567889999
Q ss_pred HHHHcccCCCCCCCHHHHHHH
Q 013214 389 IEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 389 i~~cl~~dp~~Rps~~~~l~~ 409 (447)
|.+||+.||++||++.+++..
T Consensus 232 i~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 232 IKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred HHHHHhCCcccCCCHHHHhhc
Confidence 999999999999999999864
No 169
>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4. Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.
Probab=100.00 E-value=6.1e-38 Score=294.58 Aligned_cols=249 Identities=24% Similarity=0.468 Sum_probs=204.5
Q ss_pred CcccceeeecceEEEEEE----cCeEEEEEEcCcccCC---CHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEE
Q 013214 156 DFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVIS---DDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 228 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~----~g~~vavK~~~~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 228 (447)
+|+..+.||.|+||.++. +|+.+|+|.+...... .......+.+|+.+++.++|+||+++++++.+.+..+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 466778899999998763 6788999988654221 233446688999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCC-
Q 013214 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE- 307 (447)
Q Consensus 229 ~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~- 307 (447)
+||+++++|.+++.+..++++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 157 (265)
T cd06631 81 MEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGL 157 (265)
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhhccc
Confidence 999999999999988888999999999999999999999998 9999999999999999999999999987543211
Q ss_pred ----CCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHH
Q 013214 308 ----DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYAR 383 (447)
Q Consensus 308 ----~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (447)
........++..|+|||.+.+..++.++|+||||+++|+|++|+.||...+.......+.. .....+..+..++.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 236 (265)
T cd06631 158 HGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGA-HRGLMPRLPDSFSA 236 (265)
T ss_pred cccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhh-ccCCCCCCCCCCCH
Confidence 1112234578899999999888889999999999999999999999986654433222211 11222233456788
Q ss_pred HHHHHHHHHcccCCCCCCCHHHHHH
Q 013214 384 GLKELIEECWNEKPAKRPTFRQIIT 408 (447)
Q Consensus 384 ~l~~li~~cl~~dp~~Rps~~~~l~ 408 (447)
++.++|++||+.+|.+||++.++++
T Consensus 237 ~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 237 AAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred HHHHHHHHHhcCCcccCCCHHHHhc
Confidence 9999999999999999999999886
No 170
>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase). Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It
Probab=100.00 E-value=1.1e-37 Score=295.28 Aligned_cols=256 Identities=26% Similarity=0.422 Sum_probs=209.0
Q ss_pred CCcCcccceeeecceEEEEEE----c-----CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEe-C
Q 013214 153 HELDFTNSVEITKGTFILAFW----R-----GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ-S 222 (447)
Q Consensus 153 ~~~~~~~~~~lg~G~~~~~~~----~-----g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~ 222 (447)
...+|+..+.||+|+||.|+. . +..|++|.+... ........+.+|+.+++.++||||+++++++.. +
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~ 81 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH--ASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDG 81 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence 345677888999999998752 2 588999988643 345566778899999999999999999998765 4
Q ss_pred CceEEEEeccCCCCHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEE
Q 013214 223 SPMMIVTEYLPKGDLRAFLKRK--------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294 (447)
Q Consensus 223 ~~~~lv~e~~~~g~L~~~l~~~--------~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl 294 (447)
...++++||+++++|.+++... ..+++.++..++.|++.||.|||+.+ ++|+||||+||++++++.+||
T Consensus 82 ~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl 158 (280)
T cd05043 82 EPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKI 158 (280)
T ss_pred CCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEE
Confidence 6789999999999999999753 34889999999999999999999998 999999999999999999999
Q ss_pred eecccccccccCCCC-CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCC
Q 013214 295 ADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRP 372 (447)
Q Consensus 295 ~Dfg~~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~ 372 (447)
+|||+++.+...... ......++..|+|||.+.+..++.++||||||+++|++++ |+.||...+..+....+......
T Consensus 159 ~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~ 238 (280)
T cd05043 159 TDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYRL 238 (280)
T ss_pred CCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCCCC
Confidence 999999765322111 1122345677999999988889999999999999999999 99999876655544444333222
Q ss_pred CCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhh
Q 013214 373 PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS 416 (447)
Q Consensus 373 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~ 416 (447)
.. ...+++++.+++.+||..||++|||+.++++.|+++.+.
T Consensus 239 ~~---~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 279 (280)
T cd05043 239 AQ---PINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ 279 (280)
T ss_pred CC---CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence 22 234678899999999999999999999999999998764
No 171
>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes. Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an
Probab=100.00 E-value=8.2e-38 Score=293.00 Aligned_cols=246 Identities=33% Similarity=0.527 Sum_probs=201.3
Q ss_pred CcccceeeecceEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEec
Q 013214 156 DFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 231 (447)
+|...+.||+|++|.++. .+..+|+|.+..... ..+.+.+|+.+++.++|||++++++++. ....+++|||
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 81 (260)
T cd05069 7 SLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM----MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEF 81 (260)
T ss_pred HeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc----cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEc
Confidence 467778899999988762 345799998865432 2356788999999999999999999875 4568999999
Q ss_pred cCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 013214 232 LPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (447)
Q Consensus 232 ~~~g~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~ 309 (447)
+.+++|.+++.+.. .+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||.+.........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05069 82 MGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCccc
Confidence 99999999997643 4788999999999999999999998 999999999999999999999999999765432222
Q ss_pred CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHH
Q 013214 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKEL 388 (447)
Q Consensus 310 ~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 388 (447)
......++..|+|||...+..++.++|+||||+++|+|++ |+.||......+....+.....++. +...+..+.++
T Consensus 159 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l 235 (260)
T cd05069 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPC---PQGCPESLHEL 235 (260)
T ss_pred ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC---CcccCHHHHHH
Confidence 2222345678999999988889999999999999999999 9999987766555555433333332 34567899999
Q ss_pred HHHHcccCCCCCCCHHHHHHHHHH
Q 013214 389 IEECWNEKPAKRPTFRQIITRLES 412 (447)
Q Consensus 389 i~~cl~~dp~~Rps~~~~l~~l~~ 412 (447)
+.+||+.||++||++.++++.|++
T Consensus 236 i~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 236 MKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred HHHHccCCcccCcCHHHHHHHHhc
Confidence 999999999999999999999875
No 172
>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase. Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well
Probab=100.00 E-value=8.2e-38 Score=295.84 Aligned_cols=249 Identities=28% Similarity=0.483 Sum_probs=202.7
Q ss_pred cCcccceeeecceEEEEE---E-------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCc
Q 013214 155 LDFTNSVEITKGTFILAF---W-------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~---~-------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 224 (447)
.+|...+.||+|++|.++ . .+..||+|..... ........+.+|+.+++.++||||+++++++.+...
T Consensus 6 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPES--CSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred HHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCC--CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 357777899999998775 2 4578999988643 234445678889999999999999999999998889
Q ss_pred eEEEEeccCCCCHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCC---CEEE
Q 013214 225 MMIVTEYLPKGDLRAFLKRKG-------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG---NLKV 294 (447)
Q Consensus 225 ~~lv~e~~~~g~L~~~l~~~~-------~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~---~vkl 294 (447)
.+++|||+++++|.+++.+.+ .+++..+..++.|++.|+.|||+.+ ++|+||||+||+++.++ .+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEe
Confidence 999999999999999997653 4788999999999999999999999 99999999999998755 5999
Q ss_pred eecccccccccCCCC-CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCC
Q 013214 295 ADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRP 372 (447)
Q Consensus 295 ~Dfg~~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~ 372 (447)
+|||++......... .......+..|+|||.+.+..++.++|||||||++|+|++ |+.||...+..+....+......
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~ 240 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRL 240 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcC
Confidence 999998865321111 1111223567999999988889999999999999999997 99999877766655554333333
Q ss_pred CCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHH
Q 013214 373 PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLE 411 (447)
Q Consensus 373 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~ 411 (447)
.. +..++..+.+++.+||+.+|++||++.+++++|+
T Consensus 241 ~~---~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 241 DP---PKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred CC---CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 32 3456788999999999999999999999999885
No 173
>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors. Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept
Probab=100.00 E-value=1.1e-37 Score=298.78 Aligned_cols=253 Identities=27% Similarity=0.462 Sum_probs=205.8
Q ss_pred CcCcccceeeecceEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeEEEEeC
Q 013214 154 ELDFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQS 222 (447)
Q Consensus 154 ~~~~~~~~~lg~G~~~~~~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~ 222 (447)
..+|...+.||+|+||.++. .+..||+|.++... .....+.+.+|+.+++++ +||||+++++++...
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 111 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA--HSSEREALMSELKIMSHLGNHENIVNLLGACTIG 111 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC--ChHHHHHHHHHHHHHHhccCCCCcceEEEEEecC
Confidence 34678888999999998752 23579999887542 234456788999999999 799999999999999
Q ss_pred CceEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccc
Q 013214 223 SPMMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS 300 (447)
Q Consensus 223 ~~~~lv~e~~~~g~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~ 300 (447)
+..+++|||+.+|+|.+++.+.. .+++.++..++.|++.||.|||+.+ ++|+||||+||+++.++.++++|||++
T Consensus 112 ~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~ 188 (302)
T cd05055 112 GPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLA 188 (302)
T ss_pred CceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCccc
Confidence 99999999999999999997643 3899999999999999999999998 999999999999999999999999998
Q ss_pred cccccCCCC-CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCCCCCh
Q 013214 301 KLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPA 378 (447)
Q Consensus 301 ~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 378 (447)
......... ......++..|+|||.+.+..++.++||||+|+++|+|++ |..||......+............ ..+
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~--~~~ 266 (302)
T cd05055 189 RDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRM--AQP 266 (302)
T ss_pred ccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcC--CCC
Confidence 765432211 1122345678999999988889999999999999999998 999998766544333332222111 122
Q ss_pred hhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHH
Q 013214 379 KLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 413 (447)
Q Consensus 379 ~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~ 413 (447)
...++.+.+++.+||+.+|++||++.++++.|+++
T Consensus 267 ~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 267 EHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 34578899999999999999999999999999874
No 174
>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2. Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve
Probab=100.00 E-value=1e-37 Score=295.40 Aligned_cols=254 Identities=23% Similarity=0.477 Sum_probs=206.5
Q ss_pred cCcccceeeecceEEEEEE-----cCe----EEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCce
Q 013214 155 LDFTNSVEITKGTFILAFW-----RGI----QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~-----~g~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 225 (447)
.+|+..+.||+|+||.++. +|+ .||+|.+.... .......+.+|..+++.++||||+++++++.. ...
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~ 83 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT--SPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STV 83 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC--CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCc
Confidence 3577778999999998863 344 48999987542 34455778899999999999999999999875 457
Q ss_pred EEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccc
Q 013214 226 MIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304 (447)
Q Consensus 226 ~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~ 304 (447)
++++||+++|+|.+++.++ +.+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||++....
T Consensus 84 ~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~ 160 (279)
T cd05109 84 QLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLD 160 (279)
T ss_pred EEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeecc
Confidence 8999999999999999774 56899999999999999999999999 9999999999999999999999999988654
Q ss_pred cCCCC-CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCCCCChhhhH
Q 013214 305 VKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYA 382 (447)
Q Consensus 305 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 382 (447)
..... ......+++.|+|||...+..++.++||||||+++|+|++ |..||...........+.....++. +..++
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~ 237 (279)
T cd05109 161 IDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQ---PPICT 237 (279)
T ss_pred cccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCC---CccCC
Confidence 32211 1112234678999999988889999999999999999998 9999987665555444433333332 34567
Q ss_pred HHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhh
Q 013214 383 RGLKELIEECWNEKPAKRPTFRQIITRLESINNSI 417 (447)
Q Consensus 383 ~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~~ 417 (447)
..+.+++.+||+.||++||++.++++.|+.+....
T Consensus 238 ~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 238 IDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 88999999999999999999999999988875544
No 175
>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2. Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored
Probab=100.00 E-value=1.3e-37 Score=292.95 Aligned_cols=250 Identities=30% Similarity=0.531 Sum_probs=206.3
Q ss_pred CcccceeeecceEEEEEE-----cC---eEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEE
Q 013214 156 DFTNSVEITKGTFILAFW-----RG---IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g---~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 227 (447)
+|+..+.||+|+||.++. ++ ..+|+|.+.... .....+.+.+|+.+++.++|||++++.+++...+..++
T Consensus 6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 6 HITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY--TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred HceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 566778999999998762 22 379999987542 34456778899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccC
Q 013214 228 VTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306 (447)
Q Consensus 228 v~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~ 306 (447)
+|||+++++|.+++.+. +.+++.++..++.|++.|+.|||+.+ ++|+||||+||+++.++.+||+|||++......
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 160 (268)
T cd05063 84 ITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLEDD 160 (268)
T ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceecccc
Confidence 99999999999999764 56899999999999999999999998 999999999999999999999999998765432
Q ss_pred CCCCc--ccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHH
Q 013214 307 EDRPL--TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYAR 383 (447)
Q Consensus 307 ~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (447)
..... .....+..|+|||.+.+..++.++|+||||+++|++++ |+.||...+..+....+......+. +..++.
T Consensus 161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~---~~~~~~ 237 (268)
T cd05063 161 PEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPA---PMDCPS 237 (268)
T ss_pred cccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCCC---CCCCCH
Confidence 22111 11223457999999988888999999999999999997 9999987766555555543332222 234678
Q ss_pred HHHHHHHHHcccCCCCCCCHHHHHHHHHHH
Q 013214 384 GLKELIEECWNEKPAKRPTFRQIITRLESI 413 (447)
Q Consensus 384 ~l~~li~~cl~~dp~~Rps~~~~l~~l~~~ 413 (447)
.+.+++.+||+.+|++||++.++++.|+++
T Consensus 238 ~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 238 AVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred HHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 899999999999999999999999999875
No 176
>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases. Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate
Probab=100.00 E-value=9.4e-38 Score=293.57 Aligned_cols=247 Identities=30% Similarity=0.499 Sum_probs=203.1
Q ss_pred cccceeeecceEEEEE-----EcCeEEEEEEcCcccCCC------HHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCce
Q 013214 157 FTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISD------DDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225 (447)
Q Consensus 157 ~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~------~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 225 (447)
|.....||+|++|.++ .+++.+|+|.+....... .+..+.+.+|+.+++.++||||+++++++......
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL 81 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence 5566789999998775 257899999886543322 12346788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeeccccccccc
Q 013214 226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305 (447)
Q Consensus 226 ~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~ 305 (447)
++++||+++++|.+++.+.+.+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||.+.....
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06628 82 NIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKKLEA 158 (267)
T ss_pred EEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCccccc
Confidence 999999999999999988888999999999999999999999998 99999999999999999999999999876542
Q ss_pred CCC-----CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhh
Q 013214 306 KED-----RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKL 380 (447)
Q Consensus 306 ~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 380 (447)
... .......++..|+|||.+.+..++.++|+||||+++|+|++|+.||...+.......+.....+. .+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~ 235 (267)
T cd06628 159 NSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPE---IPSN 235 (267)
T ss_pred ccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCCCc---CCcc
Confidence 111 11122346788999999988888999999999999999999999998765443333332222333 2345
Q ss_pred hHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 381 YARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 381 ~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
++..+.++|++||+.||.+||++.+++++
T Consensus 236 ~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 236 ISSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred cCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 67899999999999999999999998863
No 177
>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan
Probab=100.00 E-value=7.2e-38 Score=292.76 Aligned_cols=242 Identities=33% Similarity=0.611 Sum_probs=204.8
Q ss_pred eeecceEEEEEE-----c---CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEeccC
Q 013214 162 EITKGTFILAFW-----R---GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 233 (447)
Q Consensus 162 ~lg~G~~~~~~~-----~---g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 233 (447)
.||+|+||.++. . +..|++|.+..... ....+.+.+|+..++.++|||++++++++......+++|||++
T Consensus 2 ~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 79 (262)
T cd00192 2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDAS--EEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYME 79 (262)
T ss_pred ccccCCceEEEEEEEecCCCCCceEEeEeeccccc--hhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEecc
Confidence 589999987752 2 78899999976532 2256788999999999999999999999999999999999999
Q ss_pred CCCHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccc
Q 013214 234 KGDLRAFLKRK---------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304 (447)
Q Consensus 234 ~g~L~~~l~~~---------~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~ 304 (447)
+++|.+++... ..+++..++.++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||.+....
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 156 (262)
T cd00192 80 GGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVY 156 (262)
T ss_pred CCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEcccccccccc
Confidence 99999999875 67999999999999999999999998 9999999999999999999999999998765
Q ss_pred cCCC-CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCCCCChhhhH
Q 013214 305 VKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYA 382 (447)
Q Consensus 305 ~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 382 (447)
.... .......++..|+|||.+....++.++|+||||+++|+|++ |..||......+....+....... .+..++
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~ 233 (262)
T cd00192 157 DDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLP---KPEYCP 233 (262)
T ss_pred cccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC---CCccCC
Confidence 3321 11233446788999999988888999999999999999999 699999887666655554433333 244568
Q ss_pred HHHHHHHHHHcccCCCCCCCHHHHHHHHH
Q 013214 383 RGLKELIEECWNEKPAKRPTFRQIITRLE 411 (447)
Q Consensus 383 ~~l~~li~~cl~~dp~~Rps~~~~l~~l~ 411 (447)
..+.+++.+||..+|.+|||+.+++++|+
T Consensus 234 ~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 234 DELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred hHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 89999999999999999999999998873
No 178
>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase. Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions
Probab=100.00 E-value=1.8e-37 Score=292.28 Aligned_cols=252 Identities=26% Similarity=0.497 Sum_probs=206.7
Q ss_pred CcccceeeecceEEEEEE----c----CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEE
Q 013214 156 DFTNSVEITKGTFILAFW----R----GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~----~----g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 227 (447)
+|...+.||+|+||.++. + ...||+|..... ...+..+.+.+|+.+++.++||||+++++++.+ ...++
T Consensus 7 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~--~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l 83 (270)
T cd05056 7 DITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNC--TSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI 83 (270)
T ss_pred hceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCc--CCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence 566778999999998763 1 236899988644 234556788999999999999999999998875 45789
Q ss_pred EEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccC
Q 013214 228 VTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306 (447)
Q Consensus 228 v~e~~~~g~L~~~l~~~~-~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~ 306 (447)
+|||+++++|.+++.+.. .+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 84 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 160 (270)
T cd05056 84 VMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE 160 (270)
T ss_pred EEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeecccc
Confidence 999999999999998754 5899999999999999999999998 999999999999999999999999998765433
Q ss_pred CCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHH
Q 013214 307 EDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGL 385 (447)
Q Consensus 307 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 385 (447)
.........++..|+|||.+....++.++|+||||+++|++++ |..||......+....+....+.+. +..++..+
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~---~~~~~~~~ 237 (270)
T cd05056 161 SYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPM---PPNCPPTL 237 (270)
T ss_pred cceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCCC---CCCCCHHH
Confidence 2111222334567999999988888999999999999999986 9999987776655544433333332 34567899
Q ss_pred HHHHHHHcccCCCCCCCHHHHHHHHHHHHhh
Q 013214 386 KELIEECWNEKPAKRPTFRQIITRLESINNS 416 (447)
Q Consensus 386 ~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~ 416 (447)
.++|.+|+..+|.+|||+.++++.|+.+...
T Consensus 238 ~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 238 YSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred HHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 9999999999999999999999999987654
No 179
>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3. Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated
Probab=100.00 E-value=4.5e-38 Score=295.79 Aligned_cols=247 Identities=24% Similarity=0.403 Sum_probs=201.4
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|...+.||+|+||.++. +++.||+|.++... ......+.+|+.+++.++||||+++++.+...+..++++|
T Consensus 10 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e 86 (267)
T cd06645 10 DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP---GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICME 86 (267)
T ss_pred HHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEe
Confidence 677888999999998762 68899999986542 2334567889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCC
Q 013214 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (447)
Q Consensus 231 ~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~ 310 (447)
|+++++|.+++...+.+++.++..++.|++.|+.|||+.+ ++|+||||+||+++.++.++|+|||++....... ..
T Consensus 87 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~-~~ 162 (267)
T cd06645 87 FCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITATI-AK 162 (267)
T ss_pred ccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCcc-cc
Confidence 9999999999988888999999999999999999999999 9999999999999999999999999987554221 12
Q ss_pred cccCCCCCcccCCcccC---CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcC-CCCCCCChhhhHHHHH
Q 013214 311 LTCQDTSCRYVAPEVFK---NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RPPFKAPAKLYARGLK 386 (447)
Q Consensus 311 ~~~~~~t~~y~aPE~~~---~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~ 386 (447)
.....++..|+|||.+. ...++.++|+|||||++|+|++|..||................ .++.......++..+.
T Consensus 163 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (267)
T cd06645 163 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFH 242 (267)
T ss_pred cccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHHHH
Confidence 23345788999999874 4467889999999999999999999997655433322221111 2221112224677899
Q ss_pred HHHHHHcccCCCCCCCHHHHHHH
Q 013214 387 ELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 387 ~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
++|.+||+.+|++||++.+++++
T Consensus 243 ~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 243 HFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred HHHHHHccCCchhCcCHHHHhcC
Confidence 99999999999999999998864
No 180
>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3. Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r
Probab=100.00 E-value=1.5e-37 Score=294.37 Aligned_cols=252 Identities=24% Similarity=0.470 Sum_probs=203.4
Q ss_pred CcccceeeecceEEEEEE-----cCe----EEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceE
Q 013214 156 DFTNSVEITKGTFILAFW-----RGI----QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM 226 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 226 (447)
+|+..+.||+|+||.++. +|+ .+++|.+... .......++..|+..++.+.||||+++++++.. ...+
T Consensus 8 ~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~ 84 (279)
T cd05111 8 ELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR--SGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQ 84 (279)
T ss_pred hceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc--cchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccE
Confidence 566778899999998762 344 4788887532 233445678888989999999999999998764 4578
Q ss_pred EEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeeccccccccc
Q 013214 227 IVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305 (447)
Q Consensus 227 lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~ 305 (447)
+++||+++|+|.+++... +.+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++....
T Consensus 85 ~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~ 161 (279)
T cd05111 85 LVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYP 161 (279)
T ss_pred EEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence 899999999999999764 56899999999999999999999998 99999999999999999999999999976543
Q ss_pred CCC-CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHH
Q 013214 306 KED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYAR 383 (447)
Q Consensus 306 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (447)
... .......++..|+|||.+.+..++.++||||||+++|++++ |+.||.+....+....+.....+.. +..++.
T Consensus 162 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~ 238 (279)
T cd05111 162 DDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQ---PQICTI 238 (279)
T ss_pred CCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCC---CCCCCH
Confidence 221 11223446778999999988889999999999999999998 9999987765555444433333332 223567
Q ss_pred HHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhh
Q 013214 384 GLKELIEECWNEKPAKRPTFRQIITRLESINNS 416 (447)
Q Consensus 384 ~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~ 416 (447)
.+.+++.+||..||.+|||+.++++.|..+...
T Consensus 239 ~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~ 271 (279)
T cd05111 239 DVYMVMVKCWMIDENVRPTFKELANEFTRMARD 271 (279)
T ss_pred HHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhC
Confidence 789999999999999999999999999887653
No 181
>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of
Probab=100.00 E-value=6.2e-39 Score=311.30 Aligned_cols=239 Identities=25% Similarity=0.404 Sum_probs=193.4
Q ss_pred eecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC---CCCcccceeEEEEeCCceEEEEeccCC
Q 013214 163 ITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI---RHPNVVQFLGAVTQSSPMMIVTEYLPK 234 (447)
Q Consensus 163 lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~hp~iv~~~~~~~~~~~~~lv~e~~~~ 234 (447)
||+|+||.|+. +|+.||+|++................|..++... +||||+++++.+......+++|||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 68999998862 5889999998754333333344455566776655 699999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCCcccC
Q 013214 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQ 314 (447)
Q Consensus 235 g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~ 314 (447)
|+|.+++.+.+.+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++...... .......
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~-~~~~~~~ 156 (330)
T cd05586 81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTD-NKTTNTF 156 (330)
T ss_pred ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCC-CCCccCc
Confidence 999999988888999999999999999999999999 999999999999999999999999998753221 1222345
Q ss_pred CCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHHHHHc
Q 013214 315 DTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECW 393 (447)
Q Consensus 315 ~~t~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 393 (447)
.||+.|+|||.+.+. .++.++|||||||++|+|++|+.||...+..+....+... ...++ ...+++.+.+++++||
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~-~~~~~--~~~~~~~~~~li~~~L 233 (330)
T cd05586 157 CGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFG-KVRFP--KNVLSDEGRQFVKGLL 233 (330)
T ss_pred cCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcC-CCCCC--CccCCHHHHHHHHHHc
Confidence 689999999998754 4788999999999999999999999877665554444222 22222 2346788999999999
Q ss_pred ccCCCCCC----CHHHHHH
Q 013214 394 NEKPAKRP----TFRQIIT 408 (447)
Q Consensus 394 ~~dp~~Rp----s~~~~l~ 408 (447)
+.||.+|| ++.++++
T Consensus 234 ~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 234 NRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred CCCHHHCCCCCCCHHHHhc
Confidence 99999998 5666665
No 182
>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor. Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta
Probab=100.00 E-value=1.5e-37 Score=295.82 Aligned_cols=252 Identities=25% Similarity=0.423 Sum_probs=203.5
Q ss_pred cCcccceeeecceEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCc
Q 013214 155 LDFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 224 (447)
.+|++.+.||+|+||.|+. .+..||+|.+.... .......+.+|+.+++.++||||+++++++.....
T Consensus 6 ~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 6 EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA--SLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred HHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4677888999999998873 13479999886442 33344567889999999999999999999999999
Q ss_pred eEEEEeccCCCCHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEE
Q 013214 225 MMIVTEYLPKGDLRAFLKRKG----------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294 (447)
Q Consensus 225 ~~lv~e~~~~g~L~~~l~~~~----------~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl 294 (447)
.+++|||+++|+|.+++.+.. ..+...+..++.|++.||.|||+.+ ++||||||+||++++++.++|
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEE
Confidence 999999999999999997532 2456678889999999999999999 999999999999999999999
Q ss_pred eecccccccccCCCC-CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCC
Q 013214 295 ADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRP 372 (447)
Q Consensus 295 ~Dfg~~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~ 372 (447)
+|||+++........ ......++..|+|||.+.+..++.++|+||||+++|+|++ |..||......+....+......
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~ 240 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYL 240 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC
Confidence 999998754322111 1112234677999999988889999999999999999998 78999876655554444333333
Q ss_pred CCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHH
Q 013214 373 PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESIN 414 (447)
Q Consensus 373 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~ 414 (447)
.. +...++.+.+++.+||+.||++|||+.++++.|++..
T Consensus 241 ~~---~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 241 DQ---PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred CC---CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 32 3345688999999999999999999999999888753
No 183
>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase. Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M
Probab=100.00 E-value=9.8e-38 Score=296.98 Aligned_cols=250 Identities=30% Similarity=0.492 Sum_probs=204.6
Q ss_pred cCcccceeeecceEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCc
Q 013214 155 LDFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 224 (447)
.+|+..+.||+|+||.++. ++..||+|.+.... .......+.+|+.+++.++||||+++++++.....
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~ 82 (288)
T cd05050 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP 82 (288)
T ss_pred HhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc--CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence 3577788999999998763 46789999987542 34455778899999999999999999999999999
Q ss_pred eEEEEeccCCCCHHHHHHhcC----------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCC
Q 013214 225 MMIVTEYLPKGDLRAFLKRKG----------------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS 282 (447)
Q Consensus 225 ~~lv~e~~~~g~L~~~l~~~~----------------------~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~ 282 (447)
.++++||+++|+|.+++.... .+++..++.++.|++.||.|||+.+ ++|+||||+
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~ 159 (288)
T cd05050 83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATR 159 (288)
T ss_pred cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHh
Confidence 999999999999999997432 3677888999999999999999998 999999999
Q ss_pred CEEEcCCCCEEEeecccccccccCCC-CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCC
Q 013214 283 NILRDDSGNLKVADFGVSKLLTVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDN 360 (447)
Q Consensus 283 Nill~~~~~vkl~Dfg~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~ 360 (447)
||+++.++.++|+|||++........ ........+..|+|||.+.+..++.++|+||||+++|+|++ |..||.+....
T Consensus 160 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~ 239 (288)
T cd05050 160 NCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE 239 (288)
T ss_pred heEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999875432211 11112234667999999988889999999999999999997 88899877666
Q ss_pred chHHHHHhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHH
Q 013214 361 EVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLES 412 (447)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~ 412 (447)
+....+......+. +..++.++.+++.+||+.||++|||+.++++.|++
T Consensus 240 ~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 240 EVIYYVRDGNVLSC---PDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred HHHHHHhcCCCCCC---CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 65555433332222 33567889999999999999999999999998863
No 184
>PRK13184 pknD serine/threonine-protein kinase; Reviewed
Probab=100.00 E-value=1.1e-37 Score=326.36 Aligned_cols=257 Identities=20% Similarity=0.299 Sum_probs=205.8
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|...+.||+|+||.|+. +|+.||+|++...........+++.+|+.+++.++||||+++++++.+++..+++||
T Consensus 3 rYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVME 82 (932)
T PRK13184 3 RYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMP 82 (932)
T ss_pred CeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEE
Confidence 677888999999998873 588999999976554455566788999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeeccc
Q 013214 231 YLPKGDLRAFLKRK-----------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGV 299 (447)
Q Consensus 231 ~~~~g~L~~~l~~~-----------~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~ 299 (447)
|++||+|.+++... ...+...+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||+
T Consensus 83 Y~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFGL 159 (932)
T PRK13184 83 YIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWGA 159 (932)
T ss_pred cCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecCc
Confidence 99999999998642 23456678899999999999999999 99999999999999999999999999
Q ss_pred ccccccCCC-----------------CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCch
Q 013214 300 SKLLTVKED-----------------RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV 362 (447)
Q Consensus 300 ~~~~~~~~~-----------------~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~ 362 (447)
+........ .......||+.|+|||.+.+..++.++|||||||++|+|++|+.||........
T Consensus 160 Ak~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki 239 (932)
T PRK13184 160 AIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKI 239 (932)
T ss_pred ceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhh
Confidence 976521110 001123589999999999988999999999999999999999999987554333
Q ss_pred HHHHHhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCC-CHHHHHHHHHHHHhh
Q 013214 363 PKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRP-TFRQIITRLESINNS 416 (447)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-s~~~~l~~l~~~~~~ 416 (447)
.... ....+.-......+++.+.+++.+||+.||++|| +++++++.|+.+.+.
T Consensus 240 ~~~~-~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~ 293 (932)
T PRK13184 240 SYRD-VILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG 293 (932)
T ss_pred hhhh-hccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 2221 1111111112345678899999999999999995 667777888776553
No 185
>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase. Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a
Probab=100.00 E-value=8.1e-38 Score=300.10 Aligned_cols=253 Identities=24% Similarity=0.370 Sum_probs=205.3
Q ss_pred CcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|...+.||+|+||.++ .+++.|++|.+.............+.+|+.+++.++||||+++++.+..++..+++||
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (305)
T cd05609 2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVME 81 (305)
T ss_pred CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEe
Confidence 56777899999999876 3578999999876543344455678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCC--
Q 013214 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED-- 308 (447)
Q Consensus 231 ~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~-- 308 (447)
|+++++|.+++...+.+++..+..++.|++.|+.|||+.+ ++|+||||+||+++.++.++|+|||++........
T Consensus 82 ~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~ 158 (305)
T cd05609 82 YVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTN 158 (305)
T ss_pred cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcCcccc
Confidence 9999999999988888999999999999999999999998 99999999999999999999999998864211100
Q ss_pred ------------CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCC
Q 013214 309 ------------RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKA 376 (447)
Q Consensus 309 ------------~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 376 (447)
.......++..|+|||.+.+..++.++|+||||+++|+|++|..||.+....+......... ...+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~-~~~~~ 237 (305)
T cd05609 159 LYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDD-IEWPE 237 (305)
T ss_pred ccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc-cCCCC
Confidence 00112346788999999988889999999999999999999999998776655554443322 22222
Q ss_pred ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHH
Q 013214 377 PAKLYARGLKELIEECWNEKPAKRPTFRQIITRLES 412 (447)
Q Consensus 377 ~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~ 412 (447)
....++..+.++|.+||+.||++||++.++.+.++.
T Consensus 238 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 238 GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred ccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 233577889999999999999999996555554443
No 186
>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2. Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit
Probab=100.00 E-value=1.7e-37 Score=296.60 Aligned_cols=252 Identities=28% Similarity=0.482 Sum_probs=201.9
Q ss_pred cCcccceeeecceEEEEEE---------------------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCccc
Q 013214 155 LDFTNSVEITKGTFILAFW---------------------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVV 213 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~---------------------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv 213 (447)
.+|+..+.||+|+||.++. ++..+|+|.+.... .......+.+|+.+++.++||||+
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~E~~~l~~l~~~~i~ 82 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA--NKNARNDFLKEIKIMSRLKDPNII 82 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCcc
Confidence 3578888999999998874 23469999987542 344567889999999999999999
Q ss_pred ceeEEEEeCCceEEEEeccCCCCHHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCC
Q 013214 214 QFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG-----------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS 282 (447)
Q Consensus 214 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-----------~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~ 282 (447)
++++++...+..+++|||+++++|.+++.+.. .+++.++..++.|++.|+.|||+.+ ++|+||||+
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~ 159 (296)
T cd05095 83 RLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATR 159 (296)
T ss_pred eEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChh
Confidence 99999999999999999999999999997642 2567789999999999999999999 999999999
Q ss_pred CEEEcCCCCEEEeecccccccccCCC-CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh--CCCCCCCCCC
Q 013214 283 NILRDDSGNLKVADFGVSKLLTVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE--GCPPFTMKHD 359 (447)
Q Consensus 283 Nill~~~~~vkl~Dfg~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t--g~~p~~~~~~ 359 (447)
||+++.++.++|+|||++..+..... ........++.|++||...++.++.++|+||||+++|+|++ |..||...+.
T Consensus 160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~ 239 (296)
T cd05095 160 NCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSD 239 (296)
T ss_pred eEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccCh
Confidence 99999999999999999876532211 11112233578999999888889999999999999999998 7788876655
Q ss_pred CchHHHHHh----cCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHH
Q 013214 360 NEVPKAYAA----RQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLE 411 (447)
Q Consensus 360 ~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~ 411 (447)
.+....... .......+.+..+++.+.+++.+||+.||.+||++.++++.|+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 240 EQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred HHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 444332211 1111122223456788999999999999999999999999886
No 187
>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=1.5e-39 Score=292.37 Aligned_cols=238 Identities=27% Similarity=0.397 Sum_probs=212.6
Q ss_pred CcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|...+.||+|+||.|. .+|+.+|+|+++++.+-..+.+..-..|-++|+..+||++..+--.|+.++++|+|||
T Consensus 169 dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMe 248 (516)
T KOG0690|consen 169 DFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVME 248 (516)
T ss_pred hhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEE
Confidence 46667789999999875 4789999999999988888888888899999999999999999989999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCC
Q 013214 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (447)
Q Consensus 231 ~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~ 310 (447)
|..||.|.-+|.+.+.+++..+..+...|+.||.|||+++ |+.||+|.+|.|+|.+|++||+|||+.+..-.. ...
T Consensus 249 yanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~-g~t 324 (516)
T KOG0690|consen 249 YANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEIKY-GDT 324 (516)
T ss_pred EccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhcccc-cce
Confidence 9999999999998888999999999999999999999998 999999999999999999999999998753211 223
Q ss_pred cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHHH
Q 013214 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIE 390 (447)
Q Consensus 311 ~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 390 (447)
....+|||.|+|||++....|+..+|+|.+|+++|||++|+.||...+.+.+.+.+... ...| ++.++++.+.|+.
T Consensus 325 ~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~e-d~kF---Pr~ls~eAktLLs 400 (516)
T KOG0690|consen 325 TKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILME-DLKF---PRTLSPEAKTLLS 400 (516)
T ss_pred eccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhh-hccC---CccCCHHHHHHHH
Confidence 45678999999999999999999999999999999999999999999988887777333 2333 5678899999999
Q ss_pred HHcccCCCCCC
Q 013214 391 ECWNEKPAKRP 401 (447)
Q Consensus 391 ~cl~~dp~~Rp 401 (447)
.+|..||.+|.
T Consensus 401 GLL~kdP~kRL 411 (516)
T KOG0690|consen 401 GLLKKDPKKRL 411 (516)
T ss_pred HHhhcChHhhc
Confidence 99999999995
No 188
>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2. Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn
Probab=100.00 E-value=6.5e-38 Score=307.73 Aligned_cols=246 Identities=25% Similarity=0.378 Sum_probs=194.2
Q ss_pred cCcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCC------
Q 013214 155 LDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS------ 223 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~------ 223 (447)
.+|+..+.||+|+||.|+ .+|..||+|++..... .......+.+|+.+++.++||||+++++++....
T Consensus 21 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 99 (359)
T cd07876 21 KRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQ-NQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ 99 (359)
T ss_pred hceEEEEEeecCCCEEEEEEEEcCCCceeEEEEeccccc-chhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence 478888999999999886 3588999999875432 3344566778999999999999999999986543
Q ss_pred ceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeeccccccc
Q 013214 224 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (447)
Q Consensus 224 ~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~ 303 (447)
..|++|||++ ++|.+.+. ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++...
T Consensus 100 ~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~ 173 (359)
T cd07876 100 DVYLVMELMD-ANLCQVIH--MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA 173 (359)
T ss_pred eeEEEEeCCC-cCHHHHHh--ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCCcccc
Confidence 4799999995 56766664 34888999999999999999999999 999999999999999999999999998754
Q ss_pred ccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHh---------------
Q 013214 304 TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA--------------- 368 (447)
Q Consensus 304 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~--------------- 368 (447)
... .......+|+.|+|||.+.+..++.++||||||+++|+|++|+.||.+.+.......+..
T Consensus 174 ~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (359)
T cd07876 174 CTN--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQP 251 (359)
T ss_pred ccC--ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHH
Confidence 321 222345678999999999988999999999999999999999999986653221111100
Q ss_pred ------cCCCCCC-----------------CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 369 ------RQRPPFK-----------------APAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 369 ------~~~~~~~-----------------~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
...+.++ ......++.++++|.+||+.||++|||+.+++++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 252 TVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0011110 0011235678999999999999999999999986
No 189
>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa
Probab=100.00 E-value=1.3e-37 Score=290.69 Aligned_cols=246 Identities=22% Similarity=0.395 Sum_probs=206.9
Q ss_pred CcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|+..+.||.|+||.++ .+++.+++|.+..... ......++.+|+.++++++|+||+++++++.+.+..+++||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e 79 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRL-SEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEME 79 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeeccc-chhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEE
Confidence 46778899999998654 3688999999865443 33455678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 013214 231 YLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (447)
Q Consensus 231 ~~~~g~L~~~l~~~--~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~ 308 (447)
|+++++|.+++.+. ..+++..+..++.|++.++.|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 80 YANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS 156 (256)
T ss_pred ecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence 99999999999765 45899999999999999999999998 99999999999999999999999999876543321
Q ss_pred CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHH
Q 013214 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKEL 388 (447)
Q Consensus 309 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 388 (447)
......+++.|+|||.+.+..++.++|+||||+++|+|++|..||......+....+......+ ....++..+.++
T Consensus 157 -~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~ 232 (256)
T cd08221 157 -MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTP---VVSVYSSELISL 232 (256)
T ss_pred -cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCC---CccccCHHHHHH
Confidence 2233457889999999988888899999999999999999999998776655555553333222 235567889999
Q ss_pred HHHHcccCCCCCCCHHHHHHH
Q 013214 389 IEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 389 i~~cl~~dp~~Rps~~~~l~~ 409 (447)
+.+||..+|.+||++.+++++
T Consensus 233 i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 233 VHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred HHHHcccCcccCCCHHHHhhC
Confidence 999999999999999999875
No 190
>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase. Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa
Probab=100.00 E-value=1.8e-37 Score=290.62 Aligned_cols=248 Identities=29% Similarity=0.504 Sum_probs=204.1
Q ss_pred cCcccceeeecceEEEEE----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 155 LDFTNSVEITKGTFILAF----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
.+|+..+.||+|+||.++ ..+..+|+|.+... ....+.+.+|+.+++.++|+||+++++.+.. ...+++||
T Consensus 6 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e 80 (260)
T cd05073 6 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG----SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITE 80 (260)
T ss_pred cceeEEeEecCccceEEEEEEecCCccEEEEecCCC----hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEE
Confidence 367788899999999886 24567999988643 2345678889999999999999999999887 77899999
Q ss_pred ccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 013214 231 YLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (447)
Q Consensus 231 ~~~~g~L~~~l~~~--~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~ 308 (447)
|+++++|.+++.+. ..++...+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||.+........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 157 (260)
T cd05073 81 FMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEY 157 (260)
T ss_pred eCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCCc
Confidence 99999999999763 34788889999999999999999998 99999999999999999999999999876543222
Q ss_pred CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHH
Q 013214 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKE 387 (447)
Q Consensus 309 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 387 (447)
.......++..|+|||.+....++.++|+||||+++|++++ |+.||...+.......+......+ .....+.++.+
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~ 234 (260)
T cd05073 158 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMP---RPENCPEELYN 234 (260)
T ss_pred ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCC---CcccCCHHHHH
Confidence 22222345677999999988888999999999999999998 999998776655554443332222 23456788999
Q ss_pred HHHHHcccCCCCCCCHHHHHHHHHHH
Q 013214 388 LIEECWNEKPAKRPTFRQIITRLESI 413 (447)
Q Consensus 388 li~~cl~~dp~~Rps~~~~l~~l~~~ 413 (447)
++.+||+.+|++||++.++.+.|+.+
T Consensus 235 ~i~~~l~~~p~~Rp~~~~l~~~L~~~ 260 (260)
T cd05073 235 IMMRCWKNRPEERPTFEYIQSVLDDF 260 (260)
T ss_pred HHHHHcccCcccCcCHHHHHHHHhcC
Confidence 99999999999999999999998763
No 191
>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta. Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D
Probab=100.00 E-value=1.4e-37 Score=307.96 Aligned_cols=251 Identities=29% Similarity=0.464 Sum_probs=203.2
Q ss_pred CcccceeeecceEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC-CCcccceeEEEEeCCc
Q 013214 156 DFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSP 224 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~ 224 (447)
++...+.||+|+||.|+. .+..||+|++.... .....+.+.+|+.++.++. ||||+++++++..+..
T Consensus 38 ~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~ 115 (401)
T cd05107 38 NLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA--RSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGP 115 (401)
T ss_pred HeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC--ChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCC
Confidence 566678999999998862 23579999997543 2334457889999999997 9999999999999999
Q ss_pred eEEEEeccCCCCHHHHHHhcC-----------------------------------------------------------
Q 013214 225 MMIVTEYLPKGDLRAFLKRKG----------------------------------------------------------- 245 (447)
Q Consensus 225 ~~lv~e~~~~g~L~~~l~~~~----------------------------------------------------------- 245 (447)
.++|+||+.+|+|.+++++++
T Consensus 116 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (401)
T cd05107 116 IYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDM 195 (401)
T ss_pred cEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcc
Confidence 999999999999999996532
Q ss_pred ---------------------------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEE
Q 013214 246 ---------------------------------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR 286 (447)
Q Consensus 246 ---------------------------------------~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill 286 (447)
.+++.....++.|++.||.|||+.+ ++||||||+||++
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiLl 272 (401)
T cd05107 196 KGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVLI 272 (401)
T ss_pred hhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceEEE
Confidence 2456677889999999999999998 9999999999999
Q ss_pred cCCCCEEEeecccccccccCCC-CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHH
Q 013214 287 DDSGNLKVADFGVSKLLTVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPK 364 (447)
Q Consensus 287 ~~~~~vkl~Dfg~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~ 364 (447)
++++.+||+|||++........ .......++..|+|||.+.+..++.++|+||||+++|+|++ |..||......+...
T Consensus 273 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~ 352 (401)
T cd05107 273 CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFY 352 (401)
T ss_pred eCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHH
Confidence 9999999999999876432211 11122345788999999988889999999999999999998 899998766554433
Q ss_pred HHHhcC-CCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHH
Q 013214 365 AYAARQ-RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESIN 414 (447)
Q Consensus 365 ~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~ 414 (447)
.....+ ++.. +..++.++.+++.+||..+|.+||+++++++.|+++.
T Consensus 353 ~~~~~~~~~~~---p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 353 NAIKRGYRMAK---PAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred HHHHcCCCCCC---CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 332222 3322 3456789999999999999999999999999998864
No 192
>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1. Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a
Probab=100.00 E-value=2.4e-37 Score=293.74 Aligned_cols=252 Identities=26% Similarity=0.515 Sum_probs=201.0
Q ss_pred CcCcccceeeecceEEEEEE---------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeC--
Q 013214 154 ELDFTNSVEITKGTFILAFW---------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS-- 222 (447)
Q Consensus 154 ~~~~~~~~~lg~G~~~~~~~---------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-- 222 (447)
...|+..+.||+|+||.++. ++..||+|.++.. ........+.+|+.+++.++|||++++++++...
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (284)
T cd05079 3 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPE--SGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGG 80 (284)
T ss_pred hhhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCcc--ccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCC
Confidence 34567888999999998852 4788999998754 2345567789999999999999999999998775
Q ss_pred CceEEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeeccccc
Q 013214 223 SPMMIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK 301 (447)
Q Consensus 223 ~~~~lv~e~~~~g~L~~~l~~~~-~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~ 301 (447)
...+++|||+++++|.+++.+.. .+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++.
T Consensus 81 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05079 81 NGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTK 157 (284)
T ss_pred CceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCcccc
Confidence 56899999999999999997653 5899999999999999999999999 9999999999999999999999999988
Q ss_pred ccccCCCC--CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCC----------Cc-----hHH
Q 013214 302 LLTVKEDR--PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHD----------NE-----VPK 364 (447)
Q Consensus 302 ~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~----------~~-----~~~ 364 (447)
........ ......++..|+|||.+.+..++.++|+||||+++|+|++++.|+..... .+ ...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05079 158 AIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVR 237 (284)
T ss_pred ccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHH
Confidence 65432211 11234466789999999888899999999999999999998766432111 00 001
Q ss_pred HHHhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHH
Q 013214 365 AYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 413 (447)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~ 413 (447)
........ ..+..++..+.+++.+||+.||++||++.++++.++.+
T Consensus 238 ~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 238 VLEEGKRL---PRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHHcCccC---CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 11111111 12345788999999999999999999999999999875
No 193
>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t
Probab=100.00 E-value=1.1e-37 Score=292.04 Aligned_cols=248 Identities=31% Similarity=0.517 Sum_probs=204.5
Q ss_pred cCcccceeeecceEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 155 LDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
.+|...+.||+|++|.++. +++.||+|.+..... ...++.+|+.+++.++||||+++++++......+++||
T Consensus 6 ~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (261)
T cd05034 6 ESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM----SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTE 81 (261)
T ss_pred hheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc----CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEe
Confidence 3677788999999998762 457799999875432 23568889999999999999999999998889999999
Q ss_pred ccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 013214 231 YLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (447)
Q Consensus 231 ~~~~g~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~ 308 (447)
|+++++|.+++.+.. .+++..+..++.|++.|+.|||+++ ++|+||||+||++++++.++|+|||++........
T Consensus 82 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (261)
T cd05034 82 YMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDEY 158 (261)
T ss_pred ccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchhh
Confidence 999999999997653 5899999999999999999999999 99999999999999999999999999876543211
Q ss_pred CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHH
Q 013214 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKE 387 (447)
Q Consensus 309 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 387 (447)
........+..|+|||.+.+..++.++|+||||+++|++++ |+.||...........+......+. +...+..+.+
T Consensus 159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~ 235 (261)
T cd05034 159 TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPR---PPNCPEELYD 235 (261)
T ss_pred hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC---CCCCCHHHHH
Confidence 11122234567999999988889999999999999999998 9999987665555544433322222 2334778999
Q ss_pred HHHHHcccCCCCCCCHHHHHHHHHH
Q 013214 388 LIEECWNEKPAKRPTFRQIITRLES 412 (447)
Q Consensus 388 li~~cl~~dp~~Rps~~~~l~~l~~ 412 (447)
++.+||+.+|++||+++++++.|+.
T Consensus 236 ~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 236 LMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred HHHHHcccCcccCCCHHHHHHHHhc
Confidence 9999999999999999999998875
No 194
>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3. Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to
Probab=100.00 E-value=1.6e-37 Score=301.91 Aligned_cols=262 Identities=29% Similarity=0.541 Sum_probs=211.4
Q ss_pred CCcccCCCCcCcccceeeecceEEEEEE------------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcc
Q 013214 146 PEYEIDPHELDFTNSVEITKGTFILAFW------------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNV 212 (447)
Q Consensus 146 ~~~~i~~~~~~~~~~~~lg~G~~~~~~~------------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~i 212 (447)
|.+++.. .+|.+.+.||+|+||.++. .+..||+|.+... ......+.+.+|+.+++++ +||||
T Consensus 5 ~~~~~~~--~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~i 80 (334)
T cd05100 5 PKWELSR--TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD--ATDKDLSDLVSEMEMMKMIGKHKNI 80 (334)
T ss_pred cccccCH--hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc--cCHHHHHHHHHHHHHHHhhcCCCCe
Confidence 4444443 3678888999999998752 1236899988743 2345567888999999999 79999
Q ss_pred cceeEEEEeCCceEEEEeccCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEe
Q 013214 213 VQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG----------------ALKPSTAVRFALDIARGMNYLHENKPVPIIH 276 (447)
Q Consensus 213 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------------~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H 276 (447)
+++++++......++++||+++|+|.+++.+.. .++..++..++.|++.||.|||+.+ ++|
T Consensus 81 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH 157 (334)
T cd05100 81 INLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIH 157 (334)
T ss_pred eeeeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eec
Confidence 999999999999999999999999999997532 3677888999999999999999999 999
Q ss_pred CCCCCCCEEEcCCCCEEEeecccccccccCCCC-CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCC
Q 013214 277 RDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPF 354 (447)
Q Consensus 277 ~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~ 354 (447)
+||||+||+++.++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|+|++ |..||
T Consensus 158 ~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~ 237 (334)
T cd05100 158 RDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPY 237 (334)
T ss_pred cccccceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCC
Confidence 999999999999999999999998765432111 1122334567999999988889999999999999999998 89999
Q ss_pred CCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhh
Q 013214 355 TMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSI 417 (447)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~~ 417 (447)
...+..+....+........ +..++.++.+++.+||+.+|.+||++.++++.|+.+.+.-
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~ 297 (334)
T cd05100 238 PGIPVEELFKLLKEGHRMDK---PANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT 297 (334)
T ss_pred CCCCHHHHHHHHHcCCCCCC---CCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence 87766555555433333332 3346778999999999999999999999999999988544
No 195
>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ
Probab=100.00 E-value=2.2e-37 Score=290.08 Aligned_cols=248 Identities=29% Similarity=0.462 Sum_probs=204.7
Q ss_pred cCcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEE
Q 013214 155 LDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 229 (447)
.+|...+.||.|++|.++ .+++.+++|.+.... ....+.+.+|+.++++++||||+++++++.+....+++|
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~ 79 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP---GDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVM 79 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCc---hhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEE
Confidence 367778899999998775 256789999987542 235577889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 013214 230 EYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (447)
Q Consensus 230 e~~~~g~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~ 308 (447)
||+++++|.+++... ..+++..+..++.|++.|+.|||+.+ ++|+||||+||+++.++.++|+|||++........
T Consensus 80 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 156 (262)
T cd06613 80 EYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA 156 (262)
T ss_pred eCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhhh
Confidence 999999999999876 77999999999999999999999998 99999999999999999999999999876543211
Q ss_pred CCcccCCCCCcccCCcccCCC---CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcC-CCCCCCChhhhHHH
Q 013214 309 RPLTCQDTSCRYVAPEVFKNE---EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RPPFKAPAKLYARG 384 (447)
Q Consensus 309 ~~~~~~~~t~~y~aPE~~~~~---~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 384 (447)
......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||......+......... .+........++.+
T Consensus 157 -~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (262)
T cd06613 157 -KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPV 235 (262)
T ss_pred -ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHH
Confidence 11234567889999998776 78889999999999999999999998766544433332221 22222234567889
Q ss_pred HHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 385 LKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 385 l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
+.+++++||..+|.+||++.+++.+
T Consensus 236 ~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 236 FHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred HHHHHHHHcCCChhhCCCHHHHhcC
Confidence 9999999999999999999998863
No 196
>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase. Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down
Probab=100.00 E-value=1.9e-37 Score=297.95 Aligned_cols=244 Identities=26% Similarity=0.477 Sum_probs=200.8
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|+..+.||+|+||.|+. +|..+|+|.+.... .......+.+|++++++++||||+++++++..++..+++||
T Consensus 2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 79 (308)
T cd06615 2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI--KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICME 79 (308)
T ss_pred CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEee
Confidence 577888999999998763 57889999887542 34455678889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 013214 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHE-NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (447)
Q Consensus 231 ~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~-~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~ 309 (447)
|+++++|.+++.+.+.+++..+..++.|++.||.|||+ .+ ++|+||||+||+++.++.++|+|||++......
T Consensus 80 y~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--- 153 (308)
T cd06615 80 HMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--- 153 (308)
T ss_pred ccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCccccccc---
Confidence 99999999999888889999999999999999999998 46 999999999999999999999999998754321
Q ss_pred CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhc--------------------
Q 013214 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR-------------------- 369 (447)
Q Consensus 310 ~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~-------------------- 369 (447)
......++..|+|||.+.+..++.++|+||||+++|+|++|+.||...+...........
T Consensus 154 ~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (308)
T cd06615 154 MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDS 233 (308)
T ss_pred ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCc
Confidence 123345788999999998888899999999999999999999999755433222111100
Q ss_pred ----------------CCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 370 ----------------QRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 370 ----------------~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
..+.. ....++.++.+++.+||..||++||++.+++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 234 PRPMAIFELLDYIVNEPPPKL--PSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred cchhhHHHHHHHHhcCCCccC--cCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00110 112367789999999999999999999999976
No 197
>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity. Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....
Probab=100.00 E-value=1.5e-38 Score=297.38 Aligned_cols=248 Identities=28% Similarity=0.547 Sum_probs=200.0
Q ss_pred cccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEec
Q 013214 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (447)
Q Consensus 157 ~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 231 (447)
|+..+.||+|+||.|+. +++.+|+|.+..... .........+|+.++++++||||+++++++......+++|||
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~ 79 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEI-EEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEY 79 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTH-HHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccc-cccccchhhhhhhccccccccccccccccccccccccccccc
Confidence 56678999999999873 577899999986542 222233445699999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCCc
Q 013214 232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPL 311 (447)
Q Consensus 232 ~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~ 311 (447)
+++++|.+++...+.+++..+..++.|+++||.+||+.+ ++|+||||+||++++++.++|+|||.+..... .....
T Consensus 80 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~-~~~~~ 155 (260)
T PF00069_consen 80 CPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLSE-NNENF 155 (260)
T ss_dssp ETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEESTS-TTSEB
T ss_pred ccccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccc-ccccc
Confidence 998899999998888999999999999999999999999 99999999999999999999999999875411 12233
Q ss_pred ccCCCCCcccCCcccC-CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCC---CCChhhhHHHHHH
Q 013214 312 TCQDTSCRYVAPEVFK-NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPF---KAPAKLYARGLKE 387 (447)
Q Consensus 312 ~~~~~t~~y~aPE~~~-~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~ 387 (447)
....++..|+|||.+. +..++.++|+||+|+++|+|++|..||.................... .......++.+.+
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 235 (260)
T PF00069_consen 156 NPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRD 235 (260)
T ss_dssp SSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHH
Confidence 4556789999999998 77889999999999999999999999997732222222211111110 0011122478999
Q ss_pred HHHHHcccCCCCCCCHHHHHHH
Q 013214 388 LIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 388 li~~cl~~dp~~Rps~~~~l~~ 409 (447)
+|.+||+.||++||++.+++++
T Consensus 236 li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 236 LIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp HHHHHSSSSGGGSTTHHHHHTS
T ss_pred HHHHHccCChhHCcCHHHHhcC
Confidence 9999999999999999999863
No 198
>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3. Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th
Probab=100.00 E-value=2.9e-37 Score=293.05 Aligned_cols=251 Identities=27% Similarity=0.504 Sum_probs=198.9
Q ss_pred CcCcccceeeecceEEEEEE---------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEe--C
Q 013214 154 ELDFTNSVEITKGTFILAFW---------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ--S 222 (447)
Q Consensus 154 ~~~~~~~~~lg~G~~~~~~~---------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~ 222 (447)
+..|+..+.||+|+||.++. ++..||+|.+... .....+.+.+|+++++.++||||+++++++.. .
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 79 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS---TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR 79 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCC
Confidence 44677788999999998863 4778999998643 34556788999999999999999999998754 3
Q ss_pred CceEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeeccccc
Q 013214 223 SPMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK 301 (447)
Q Consensus 223 ~~~~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~ 301 (447)
...++++||+++++|.+++.+. ..+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||++.
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~ 156 (284)
T cd05081 80 RNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTK 156 (284)
T ss_pred CceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccc
Confidence 4689999999999999999764 45899999999999999999999999 9999999999999999999999999998
Q ss_pred ccccCCCC--CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCch----------------H
Q 013214 302 LLTVKEDR--PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV----------------P 363 (447)
Q Consensus 302 ~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~----------------~ 363 (447)
........ ......++..|+|||.+.+..++.++|+||||+++|+|++|..|+........ .
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05081 157 VLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLI 236 (284)
T ss_pred cccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHH
Confidence 65432211 11122334569999999888899999999999999999998777543321100 0
Q ss_pred HHHHhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHH
Q 013214 364 KAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 413 (447)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~ 413 (447)
......... ..+..++..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus 237 ~~~~~~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 237 ELLKNNGRL---PAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHHhcCCcC---CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 011111111 12345678899999999999999999999999999875
No 199
>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase. Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi
Probab=100.00 E-value=1.1e-37 Score=296.98 Aligned_cols=243 Identities=28% Similarity=0.471 Sum_probs=205.7
Q ss_pred CcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|+..+.||+|++|.++ .+++.||+|.+.............+.+|++++++++||||+++++++...+..+++||
T Consensus 2 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (290)
T cd05580 2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVME 81 (290)
T ss_pred ceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEe
Confidence 56778899999998775 2579999999876544444556778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCC
Q 013214 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (447)
Q Consensus 231 ~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~ 310 (447)
|+++++|.+++...+.+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++......
T Consensus 82 ~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~---- 154 (290)
T cd05580 82 YVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR---- 154 (290)
T ss_pred cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC----
Confidence 9999999999998888999999999999999999999998 999999999999999999999999998765432
Q ss_pred cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHHH
Q 013214 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIE 390 (447)
Q Consensus 311 ~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 390 (447)
.....+++.|+|||.+.+...+.++|+||||+++|+|++|+.||......+....+. .....+ +..++..+++++.
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~---~~~~~~~l~~li~ 230 (290)
T cd05580 155 TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKIL-EGKVRF---PSFFSPDAKDLIR 230 (290)
T ss_pred CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh-cCCccC---CccCCHHHHHHHH
Confidence 223457889999999988888899999999999999999999998766444444332 333333 3345788999999
Q ss_pred HHcccCCCCCC-----CHHHHHHH
Q 013214 391 ECWNEKPAKRP-----TFRQIITR 409 (447)
Q Consensus 391 ~cl~~dp~~Rp-----s~~~~l~~ 409 (447)
+||..||.+|+ ++++++++
T Consensus 231 ~~l~~~p~~R~~~~~~~~~~l~~~ 254 (290)
T cd05580 231 NLLQVDLTKRLGNLKNGVNDIKNH 254 (290)
T ss_pred HHccCCHHHccCcccCCHHHHHcC
Confidence 99999999998 77777654
No 200
>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors. Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr
Probab=100.00 E-value=2.7e-37 Score=290.95 Aligned_cols=250 Identities=30% Similarity=0.537 Sum_probs=204.0
Q ss_pred CcccceeeecceEEEEEE-----cC---eEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEE
Q 013214 156 DFTNSVEITKGTFILAFW-----RG---IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g---~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 227 (447)
.|+..+.||+|+||.++. ++ ..||+|.+.... .......+..|+.+++.++||||+++++++..+...++
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l 82 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMI 82 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEE
Confidence 456778999999998762 22 369999987542 45556789999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccC
Q 013214 228 VTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306 (447)
Q Consensus 228 v~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~ 306 (447)
+|||+++++|.+++... +.+++.++..++.|++.|+.|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 159 (269)
T cd05065 83 ITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 159 (269)
T ss_pred EEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCccccccccC
Confidence 99999999999999764 56899999999999999999999999 999999999999999999999999998765432
Q ss_pred CCCCc--ccC--CCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCCCCChhhh
Q 013214 307 EDRPL--TCQ--DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLY 381 (447)
Q Consensus 307 ~~~~~--~~~--~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 381 (447)
..... ... ..+..|+|||.+.+..++.++||||||+++|++++ |..||......+....+......+. +..+
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~~---~~~~ 236 (269)
T cd05065 160 TSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPP---PMDC 236 (269)
T ss_pred ccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCC---cccC
Confidence 21111 111 12457999999988889999999999999999886 9999987665555444432222222 2356
Q ss_pred HHHHHHHHHHHcccCCCCCCCHHHHHHHHHHH
Q 013214 382 ARGLKELIEECWNEKPAKRPTFRQIITRLESI 413 (447)
Q Consensus 382 ~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~ 413 (447)
+..+.+++.+||+.+|.+||++.+++..|+.+
T Consensus 237 ~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 237 PTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 78899999999999999999999999988764
No 201
>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]
Probab=100.00 E-value=1.4e-38 Score=305.47 Aligned_cols=253 Identities=29% Similarity=0.468 Sum_probs=211.6
Q ss_pred CcccceeeecceEEEEE----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEec
Q 013214 156 DFTNSVEITKGTFILAF----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 231 (447)
.....++||+|.||.+. ..+..||+|+++.+. ......+|..|+++|.+++||||++++|+|..++.+++++||
T Consensus 539 ~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a--~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EY 616 (807)
T KOG1094|consen 539 RLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDA--TKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEY 616 (807)
T ss_pred heehhhhhcCcccceeEEEEecCceEEEEeecCccc--chhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHH
Confidence 44566789999999875 345999999998764 455578999999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCC-C
Q 013214 232 LPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE-D 308 (447)
Q Consensus 232 ~~~g~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~-~ 308 (447)
+++|+|.+++.++. .+......+++.||++|++||.+.+ ++||||.+.|+|++.++++||+|||+++.+=... .
T Consensus 617 mEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy 693 (807)
T KOG1094|consen 617 MENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYY 693 (807)
T ss_pred HhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccCCce
Confidence 99999999998763 3456677789999999999999998 9999999999999999999999999998542221 1
Q ss_pred CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh--CCCCCCCCCCCchHHHHHhc----CCCCCCCChhhhH
Q 013214 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE--GCPPFTMKHDNEVPKAYAAR----QRPPFKAPAKLYA 382 (447)
Q Consensus 309 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t--g~~p~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~ 382 (447)
+......-+.+|||||.+.-+++++++|+|+||+++||+++ ...||....++++.+..... ++..+..-++-++
T Consensus 694 ~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~~cp 773 (807)
T KOG1094|consen 694 RVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPPACP 773 (807)
T ss_pred eeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCCcCc
Confidence 11122234789999999999999999999999999999876 78999988887766554222 2333444566788
Q ss_pred HHHHHHHHHHcccCCCCCCCHHHHHHHHHHH
Q 013214 383 RGLKELIEECWNEKPAKRPTFRQIITRLESI 413 (447)
Q Consensus 383 ~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~ 413 (447)
.++-++|.+||..|-++||+++++...|++.
T Consensus 774 ~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 774 QGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred HHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 9999999999999999999999999988764
No 202
>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2. Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp
Probab=100.00 E-value=3.6e-37 Score=300.47 Aligned_cols=253 Identities=28% Similarity=0.487 Sum_probs=201.4
Q ss_pred cCcccceeeecceEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeEEEEeC-
Q 013214 155 LDFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQS- 222 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~- 222 (447)
.+|+..+.||+|+||.|+. +++.||+|+++... .......+.+|+.++.++ +||||+++++++...
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 84 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC--ChHHHHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence 3688889999999998862 46789999997543 334456788899999999 689999999988654
Q ss_pred CceEEEEeccCCCCHHHHHHhcC---------------------------------------------------------
Q 013214 223 SPMMIVTEYLPKGDLRAFLKRKG--------------------------------------------------------- 245 (447)
Q Consensus 223 ~~~~lv~e~~~~g~L~~~l~~~~--------------------------------------------------------- 245 (447)
...+++|||+++|+|.+++....
T Consensus 85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (343)
T cd05103 85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 164 (343)
T ss_pred CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence 46799999999999999986431
Q ss_pred ----------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCC-CcccC
Q 013214 246 ----------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR-PLTCQ 314 (447)
Q Consensus 246 ----------~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~-~~~~~ 314 (447)
.++...+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++......... .....
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 241 (343)
T cd05103 165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 241 (343)
T ss_pred hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCC
Confidence 2567778889999999999999998 999999999999999999999999998764322111 11122
Q ss_pred CCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchH-HHHHhcCCCCCCCChhhhHHHHHHHHHHH
Q 013214 315 DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVP-KAYAARQRPPFKAPAKLYARGLKELIEEC 392 (447)
Q Consensus 315 ~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~c 392 (447)
.++..|+|||.+.+..++.++|+||||+++|+|++ |..||......+.. ..+....+... +...++.+.+++..|
T Consensus 242 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~c 318 (343)
T cd05103 242 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA---PDYTTPEMYQTMLDC 318 (343)
T ss_pred CCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCC---CCCCCHHHHHHHHHH
Confidence 34677999999988889999999999999999997 99999876544322 22222222222 223567899999999
Q ss_pred cccCCCCCCCHHHHHHHHHHHHh
Q 013214 393 WNEKPAKRPTFRQIITRLESINN 415 (447)
Q Consensus 393 l~~dp~~Rps~~~~l~~l~~~~~ 415 (447)
|+.||++|||+.+++++|+.+.+
T Consensus 319 l~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 319 WHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred ccCChhhCcCHHHHHHHHHHHHh
Confidence 99999999999999999998765
No 203
>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase. Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ
Probab=100.00 E-value=2.4e-37 Score=288.96 Aligned_cols=245 Identities=31% Similarity=0.595 Sum_probs=201.9
Q ss_pred CcccceeeecceEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEec
Q 013214 156 DFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 231 (447)
+|+..+.||.|+||.++. .+..+|+|.+...... ...+.+|++++++++|||++++++++......++++||
T Consensus 5 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd05112 5 ELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMS----EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEF 80 (256)
T ss_pred HeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCC----HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEc
Confidence 456678899999998763 4788999998754432 24678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCC
Q 013214 232 LPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (447)
Q Consensus 232 ~~~g~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~ 310 (447)
+++++|.+++... +.+++..++.++.|++.++.+||+.+ ++|+||||+||+++.++.++|+|||.+..........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~ 157 (256)
T cd05112 81 MEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS 157 (256)
T ss_pred CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCcccc
Confidence 9999999999764 46899999999999999999999998 9999999999999999999999999987553222111
Q ss_pred cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHH
Q 013214 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELI 389 (447)
Q Consensus 311 ~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 389 (447)
.....++..|+|||.+.+..++.++|+||||+++|+|++ |+.||......+....+....++.. +...+..+.+++
T Consensus 158 ~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~ 234 (256)
T cd05112 158 STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYK---PRLASQSVYELM 234 (256)
T ss_pred cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCC---CCCCCHHHHHHH
Confidence 222334678999999988889999999999999999998 9999987666555555433322221 233568899999
Q ss_pred HHHcccCCCCCCCHHHHHHHH
Q 013214 390 EECWNEKPAKRPTFRQIITRL 410 (447)
Q Consensus 390 ~~cl~~dp~~Rps~~~~l~~l 410 (447)
.+||+.+|++||++.++++.|
T Consensus 235 ~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 235 QHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred HHHcccChhhCCCHHHHHHhh
Confidence 999999999999999999876
No 204
>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron. Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca
Probab=100.00 E-value=4.3e-37 Score=288.27 Aligned_cols=246 Identities=31% Similarity=0.558 Sum_probs=195.8
Q ss_pred eeecceEEEEEE--------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEE-eCCceEEEEecc
Q 013214 162 EITKGTFILAFW--------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVT-QSSPMMIVTEYL 232 (447)
Q Consensus 162 ~lg~G~~~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-~~~~~~lv~e~~ 232 (447)
.||+|+||.++. .+..||+|.+... ......+.+.+|..+++.++||||+++++++. .++..++++||+
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~ 79 (262)
T cd05058 2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI--TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYM 79 (262)
T ss_pred cccccCCceEEEEEEecCCCceEEEEEEecCcc--CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecC
Confidence 589999998762 2357999988532 23445677888999999999999999999775 455689999999
Q ss_pred CCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCC---
Q 013214 233 PKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED--- 308 (447)
Q Consensus 233 ~~g~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~--- 308 (447)
.+|+|.+++.+. ...++.....++.|++.|+.|||+.+ ++|+||||+||++++++.+||+|||++........
T Consensus 80 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~ 156 (262)
T cd05058 80 KHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSV 156 (262)
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCcceee
Confidence 999999999764 34677788899999999999999998 99999999999999999999999999875432111
Q ss_pred CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHH
Q 013214 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKE 387 (447)
Q Consensus 309 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 387 (447)
.......+++.|+|||.+.+..++.++||||||+++|+|++ |.+||...+..+....+.....+.. +...++.+.+
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~ 233 (262)
T cd05058 157 HNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQ---PEYCPDPLYE 233 (262)
T ss_pred cccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCC---CCcCCHHHHH
Confidence 11122345678999999988889999999999999999999 5677776555444444433222222 3345778999
Q ss_pred HHHHHcccCCCCCCCHHHHHHHHHHHHh
Q 013214 388 LIEECWNEKPAKRPTFRQIITRLESINN 415 (447)
Q Consensus 388 li~~cl~~dp~~Rps~~~~l~~l~~~~~ 415 (447)
++.+||+.+|++||++.++++.|+++..
T Consensus 234 li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 234 VMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred HHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 9999999999999999999999998754
No 205
>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]
Probab=100.00 E-value=4.3e-38 Score=308.52 Aligned_cols=242 Identities=29% Similarity=0.383 Sum_probs=198.0
Q ss_pred CcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC-CC-----cccceeEEEEeCCc
Q 013214 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HP-----NVVQFLGAVTQSSP 224 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp-----~iv~~~~~~~~~~~ 224 (447)
+|.+.+.||+|+||.|. .+++.||||+++. ......+...|+.+|..++ |. |+|+++++|...++
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN----~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~H 262 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKN----KKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNH 262 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeecc----ChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccc
Confidence 67888999999999875 4789999999974 3455566778999999996 43 79999999999999
Q ss_pred eEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCC--CEEEeecccc
Q 013214 225 MMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG--NLKVADFGVS 300 (447)
Q Consensus 225 ~~lv~e~~~~g~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~--~vkl~Dfg~~ 300 (447)
+|||+|.+ +-+|+++++.+. .++...+..++.||+.||..||+.+ |||+||||+|||+...+ .|||+|||+|
T Consensus 263 lciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSS 338 (586)
T KOG0667|consen 263 LCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSS 338 (586)
T ss_pred eeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecccc
Confidence 99999999 579999999875 4899999999999999999999999 99999999999998544 6999999999
Q ss_pred cccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhc-CCCC------
Q 013214 301 KLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR-QRPP------ 373 (447)
Q Consensus 301 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~-~~~~------ 373 (447)
++..... ..+..+..|.|||++.+.+|+.+.|||||||++.||++|.+.|.+.+..+....+... +.|+
T Consensus 339 c~~~q~v----ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~ 414 (586)
T KOG0667|consen 339 CFESQRV----YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDT 414 (586)
T ss_pred cccCCcc----eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 9765432 2456678899999999999999999999999999999999999877654432222110 0000
Q ss_pred --------------------------------------------CC----C----ChhhhHHHHHHHHHHHcccCCCCCC
Q 013214 374 --------------------------------------------FK----A----PAKLYARGLKELIEECWNEKPAKRP 401 (447)
Q Consensus 374 --------------------------------------------~~----~----~~~~~~~~l~~li~~cl~~dp~~Rp 401 (447)
.+ . ........+.+++++||..||.+|+
T Consensus 415 ~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~ 494 (586)
T KOG0667|consen 415 AKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERI 494 (586)
T ss_pred ccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcC
Confidence 00 0 0012235689999999999999999
Q ss_pred CHHHHHHH
Q 013214 402 TFRQIITR 409 (447)
Q Consensus 402 s~~~~l~~ 409 (447)
|..++++|
T Consensus 495 tp~qal~H 502 (586)
T KOG0667|consen 495 TPAQALNH 502 (586)
T ss_pred CHHHHhcC
Confidence 99999876
No 206
>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]
Probab=100.00 E-value=4.2e-38 Score=305.70 Aligned_cols=251 Identities=27% Similarity=0.469 Sum_probs=218.8
Q ss_pred ccCCCCcCcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCC
Q 013214 149 EIDPHELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS 223 (447)
Q Consensus 149 ~i~~~~~~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 223 (447)
........|.....||+|.|+.|. .++..||+|.+.+... +...++.+.+|+++|+.++||||++++.+.+.+.
T Consensus 50 ~~~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~l-n~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~ 128 (596)
T KOG0586|consen 50 DDSNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQL-NPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEA 128 (596)
T ss_pred cccccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhccc-ChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecc
Confidence 334455578888899999999886 4789999999988765 3444556889999999999999999999999999
Q ss_pred ceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeeccccccc
Q 013214 224 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (447)
Q Consensus 224 ~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~ 303 (447)
.+|+||||+.+|.+.+++.++++..+.++..++.|+.+|++|||+++ |+|||||.+|+|++.+.++||+|||++.++
T Consensus 129 ~lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~ 205 (596)
T KOG0586|consen 129 TLYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFF 205 (596)
T ss_pred eeEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceee
Confidence 99999999999999999999999999999999999999999999999 999999999999999999999999999987
Q ss_pred ccCCCCCcccCCCCCcccCCcccCCCCCC-CchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcC-CCCCCCChhhh
Q 013214 304 TVKEDRPLTCQDTSCRYVAPEVFKNEEYD-TKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RPPFKAPAKLY 381 (447)
Q Consensus 304 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 381 (447)
... .......|++.|.|||++.+..++ +.+|+||+|+++|.|+.|..||++.+..+......... +.++ -+
T Consensus 206 ~~~--~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~-----~m 278 (596)
T KOG0586|consen 206 DYG--LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPF-----YM 278 (596)
T ss_pred ccc--ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecccc-----ee
Confidence 743 344567889999999999988665 68999999999999999999999998877766653333 4443 35
Q ss_pred HHHHHHHHHHHcccCCCCCCCHHHHHHHH
Q 013214 382 ARGLKELIEECWNEKPAKRPTFRQIITRL 410 (447)
Q Consensus 382 ~~~l~~li~~cl~~dp~~Rps~~~~l~~l 410 (447)
+.++.++|++++..+|.+|++.+++.++-
T Consensus 279 s~dce~lLrk~lvl~Pskr~~~dqim~~~ 307 (596)
T KOG0586|consen 279 SCDCEDLLRKFLVLNPSKRGPCDQIMKDR 307 (596)
T ss_pred echhHHHHHHhhccCccccCCHHHhhhhc
Confidence 67899999999999999999999998753
No 207
>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase. Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play
Probab=100.00 E-value=1e-37 Score=299.91 Aligned_cols=247 Identities=26% Similarity=0.419 Sum_probs=196.4
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|...+.||+|+||.|+. +++.||+|.+..... ......+.+|+.++++++||||+++++++..++..+++||
T Consensus 7 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 84 (309)
T cd07872 7 TYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFE 84 (309)
T ss_pred ceEEEEEecccCCEEEEEEEecCCCCeEEEEEeecccc--CCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEe
Confidence 578888999999998873 578899999875432 1223456789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 013214 231 YLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (447)
Q Consensus 231 ~~~~g~L~~~l~~~~-~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~ 309 (447)
|++ ++|.+++...+ .+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++........
T Consensus 85 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~- 159 (309)
T cd07872 85 YLD-KDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPTK- 159 (309)
T ss_pred CCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCcc-
Confidence 996 58888886654 4889999999999999999999999 99999999999999999999999999875433221
Q ss_pred CcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcC------------------
Q 013214 310 PLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ------------------ 370 (447)
Q Consensus 310 ~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~------------------ 370 (447)
......+++.|+|||.+.+ ..++.++||||||+++|+|++|+.||...+..+....+....
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (309)
T cd07872 160 TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFK 239 (309)
T ss_pred ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhh
Confidence 1223456889999998865 467889999999999999999999998776544332221110
Q ss_pred ---CCCCC-----CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 371 ---RPPFK-----APAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 371 ---~~~~~-----~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
.+.+. ...+.+++++.++|.+||+.||.+|||+.+++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 286 (309)
T cd07872 240 NYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH 286 (309)
T ss_pred hhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence 01110 0112457789999999999999999999999873
No 208
>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2. Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding
Probab=100.00 E-value=2.1e-37 Score=295.87 Aligned_cols=251 Identities=22% Similarity=0.450 Sum_probs=207.2
Q ss_pred cCCCCcCcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCc
Q 013214 150 IDPHELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224 (447)
Q Consensus 150 i~~~~~~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 224 (447)
+.....+|+..+.||.|++|.++ .+|+.|++|.+.... ....+.+.+|+.+++.++|||++++++.+.....
T Consensus 14 ~~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 90 (296)
T cd06655 14 IGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK---QPKKELIINEILVMKELKNPNIVNFLDSFLVGDE 90 (296)
T ss_pred cCCCcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEeccc---CchHHHHHHHHHHHHhcCCCceeeeeeeEecCce
Confidence 34445678888999999999876 368999999886542 2234667889999999999999999999999999
Q ss_pred eEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccc
Q 013214 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304 (447)
Q Consensus 225 ~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~ 304 (447)
.++++||+++++|.+++.+ ..+++.++..++.|++.|+.|||+.+ ++|+||||+||+++.++.++|+|||++....
T Consensus 91 ~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~ 166 (296)
T cd06655 91 LFVVMEYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQIT 166 (296)
T ss_pred EEEEEEecCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhcc
Confidence 9999999999999998865 45899999999999999999999999 9999999999999999999999999987654
Q ss_pred cCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHH
Q 013214 305 VKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARG 384 (447)
Q Consensus 305 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (447)
.... ......++..|+|||.+.+..++.++|+||||+++|+|++|+.||...+..+....+.....+.. ..+..+++.
T Consensus 167 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 244 (296)
T cd06655 167 PEQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPEL-QNPEKLSPI 244 (296)
T ss_pred cccc-cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCccc-CCcccCCHH
Confidence 3221 12234578899999999888889999999999999999999999987765444333322222222 234457788
Q ss_pred HHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 385 LKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 385 l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
+.++|++||..||++||++.+++++
T Consensus 245 ~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 245 FRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred HHHHHHHHhhcChhhCCCHHHHhhC
Confidence 9999999999999999999999864
No 209
>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4. Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4
Probab=100.00 E-value=4.3e-37 Score=288.38 Aligned_cols=248 Identities=25% Similarity=0.466 Sum_probs=204.0
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|+..+.||+|+++.++. +++.|++|.+...... ....+.+.+|+.+++.++||||+++++.+......++++|
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND-PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFME 79 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc-hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEe
Confidence 467788999999987752 6789999998765432 4567889999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCC
Q 013214 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (447)
Q Consensus 231 ~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~ 310 (447)
|+++++|.+++.+...+++..+..++.|++.|+.|||+.+ ++|+||+|+||++++++.+||+|||++..........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~ 156 (264)
T cd06626 80 YCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTM 156 (264)
T ss_pred cCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCCcc
Confidence 9999999999988777899999999999999999999999 9999999999999999999999999988764332211
Q ss_pred c---ccCCCCCcccCCcccCCCC---CCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHH-HHhcCCCCCCCChhhhHH
Q 013214 311 L---TCQDTSCRYVAPEVFKNEE---YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKA-YAARQRPPFKAPAKLYAR 383 (447)
Q Consensus 311 ~---~~~~~t~~y~aPE~~~~~~---~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 383 (447)
. ....++..|+|||.+.+.. .+.++|+||||+++|++++|+.||........... +.....+.++ ....+++
T Consensus 157 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 235 (264)
T cd06626 157 GEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIP-DSLQLSP 235 (264)
T ss_pred cccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCC-cccccCH
Confidence 1 1345688999999987765 78899999999999999999999976543322222 2222233332 2233578
Q ss_pred HHHHHHHHHcccCCCCCCCHHHHHH
Q 013214 384 GLKELIEECWNEKPAKRPTFRQIIT 408 (447)
Q Consensus 384 ~l~~li~~cl~~dp~~Rps~~~~l~ 408 (447)
.+.+++.+||+.+|++||++.+++.
T Consensus 236 ~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 236 EGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred HHHHHHHHHccCCcccCCCHHHHhc
Confidence 8999999999999999999999875
No 210
>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.
Probab=100.00 E-value=3.4e-37 Score=288.01 Aligned_cols=246 Identities=28% Similarity=0.428 Sum_probs=201.5
Q ss_pred CcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEe-CCceEEEE
Q 013214 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ-SSPMMIVT 229 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~lv~ 229 (447)
+|+..+.||+|++|.++ .+++.||+|.+..... .....+.+.+|+.++++++|||++++++.+.. +..+++++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~ 79 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNA-SRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVM 79 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhc-CHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEe
Confidence 46778899999998775 2578899999875432 33445678889999999999999999998764 44679999
Q ss_pred eccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCC
Q 013214 230 EYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307 (447)
Q Consensus 230 e~~~~g~L~~~l~~~--~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~ 307 (447)
||+++++|.+++... ..+++.++..++.|++.|+.+||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 80 e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 80 GFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156 (257)
T ss_pred cccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence 999999999999763 45899999999999999999999999 9999999999999999999999999987654322
Q ss_pred CCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHH
Q 013214 308 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKE 387 (447)
Q Consensus 308 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 387 (447)
.......+++.|+|||.+.+..++.++|+||||+++++|++|+.||...+.......+.....+. .+..+++.+.+
T Consensus 157 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~ 232 (257)
T cd08223 157 -DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPP---MPKDYSPELGE 232 (257)
T ss_pred -CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCC---CccccCHHHHH
Confidence 12233457889999999988888999999999999999999999998665444333332222222 24567789999
Q ss_pred HHHHHcccCCCCCCCHHHHHHH
Q 013214 388 LIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 388 li~~cl~~dp~~Rps~~~~l~~ 409 (447)
++.+||+.||++||++.+++.+
T Consensus 233 li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 233 LIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred HHHHHhccCcccCCCHHHHhcC
Confidence 9999999999999999999864
No 211
>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase. Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.
Probab=100.00 E-value=3e-37 Score=292.75 Aligned_cols=245 Identities=28% Similarity=0.425 Sum_probs=199.8
Q ss_pred cccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEec
Q 013214 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (447)
Q Consensus 157 ~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 231 (447)
|+..+.||.|+||.++. ++..+++|.+... .....+.+.+|+.+++.++|||++++++.+......++++||
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~ 83 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK---SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 83 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC---CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEe
Confidence 45667899999998763 5788899988643 345567788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCC
Q 013214 232 LPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (447)
Q Consensus 232 ~~~g~L~~~l~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~ 310 (447)
+++++|..++.+ ..++++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++....... ..
T Consensus 84 ~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~-~~ 159 (282)
T cd06643 84 CAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QR 159 (282)
T ss_pred cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccccccccccc-cc
Confidence 999999998765 456899999999999999999999999 9999999999999999999999999987543221 12
Q ss_pred cccCCCCCcccCCcccC-----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHH
Q 013214 311 LTCQDTSCRYVAPEVFK-----NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGL 385 (447)
Q Consensus 311 ~~~~~~t~~y~aPE~~~-----~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 385 (447)
.....+++.|+|||.+. +..++.++|+|||||++|+|++|+.||...+..+..........+.. ..+..++.++
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 238 (282)
T cd06643 160 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTL-AQPSRWSSEF 238 (282)
T ss_pred cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCC-CCccccCHHH
Confidence 23345788999999874 33567899999999999999999999987665444333322222222 2234577899
Q ss_pred HHHHHHHcccCCCCCCCHHHHHHH
Q 013214 386 KELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 386 ~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
.++|.+||+.||.+||++.+++++
T Consensus 239 ~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 239 KDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred HHHHHHHccCChhhCcCHHHHhcC
Confidence 999999999999999999998764
No 212
>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=2.6e-38 Score=308.42 Aligned_cols=241 Identities=31% Similarity=0.533 Sum_probs=202.6
Q ss_pred ceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEeccCC
Q 013214 160 SVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234 (447)
Q Consensus 160 ~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 234 (447)
...||+|+||+||. +...+|||.++.. +....+-+.+|+.+.++++|.|||+++|.+.+++.+-|.||-++|
T Consensus 580 rvVLGKGTYG~VYA~RD~~tqvrIaIKEIpek---dsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPG 656 (1226)
T KOG4279|consen 580 RVVLGKGTYGTVYAARDMDTQVRIAIKEIPEK---DSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPG 656 (1226)
T ss_pred eEEeecCceeEEEeeccccceeEEEeeecccc---cchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCC
Confidence 44799999999983 5678999999754 233456788999999999999999999999999999999999999
Q ss_pred CCHHHHHHh-cCCC--CHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEc-CCCCEEEeecccccccccCCCCC
Q 013214 235 GDLRAFLKR-KGAL--KPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVADFGVSKLLTVKEDRP 310 (447)
Q Consensus 235 g~L~~~l~~-~~~l--~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~-~~~~vkl~Dfg~~~~~~~~~~~~ 310 (447)
|+|.+.++. .+++ .+.+...+..||++||.|||++. |||||||-+|+|++ -.|.+||+|||-++.+..- +..
T Consensus 657 GSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi-nP~ 732 (1226)
T KOG4279|consen 657 GSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI-NPC 732 (1226)
T ss_pred CcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccC-Ccc
Confidence 999999975 4777 78888899999999999999999 99999999999998 6789999999999876532 233
Q ss_pred cccCCCCCcccCCcccCCC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHH
Q 013214 311 LTCQDTSCRYVAPEVFKNE--EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKEL 388 (447)
Q Consensus 311 ~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 388 (447)
...+.||..|||||++..+ .|+..+|||||||++.||.||++||......+...-. .+....-++.+...+.+.+++
T Consensus 733 TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFk-VGmyKvHP~iPeelsaeak~F 811 (1226)
T KOG4279|consen 733 TETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFK-VGMYKVHPPIPEELSAEAKNF 811 (1226)
T ss_pred ccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhh-hcceecCCCCcHHHHHHHHHH
Confidence 4556799999999999776 6889999999999999999999999876655432221 121222233467789999999
Q ss_pred HHHHcccCCCCCCCHHHHHH
Q 013214 389 IEECWNEKPAKRPTFRQIIT 408 (447)
Q Consensus 389 i~~cl~~dp~~Rps~~~~l~ 408 (447)
|.+|+..||.+||++++++.
T Consensus 812 ilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 812 ILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred HHHHcCCCcccCccHHHhcc
Confidence 99999999999999999985
No 213
>PTZ00036 glycogen synthase kinase; Provisional
Probab=100.00 E-value=1.2e-37 Score=312.85 Aligned_cols=243 Identities=24% Similarity=0.362 Sum_probs=189.5
Q ss_pred CcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeC------
Q 013214 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS------ 222 (447)
Q Consensus 154 ~~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~------ 222 (447)
..+|+..+.||+|+||.|+. +++.||+|++.... ....+|+.+++.++||||+++++++...
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~ 137 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNE 137 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-------chHHHHHHHHHhcCCCCCcceeeeEeecccccCC
Confidence 34688899999999998873 67899999885431 1234699999999999999998876432
Q ss_pred --CceEEEEeccCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCC-CEEEe
Q 013214 223 --SPMMIVTEYLPKGDLRAFLK----RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG-NLKVA 295 (447)
Q Consensus 223 --~~~~lv~e~~~~g~L~~~l~----~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~-~vkl~ 295 (447)
..++++|||++ ++|.+++. ....+++..++.++.|++.||.|||+.+ |+||||||+|||++.++ .+||+
T Consensus 138 ~~~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~ 213 (440)
T PTZ00036 138 KNIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLC 213 (440)
T ss_pred CceEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeee
Confidence 24679999996 57777664 3456899999999999999999999999 99999999999999665 69999
Q ss_pred ecccccccccCCCCCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhc-CCC-
Q 013214 296 DFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR-QRP- 372 (447)
Q Consensus 296 Dfg~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~-~~~- 372 (447)
|||+++...... ......+|+.|+|||++.+. .++.++|||||||++|+|++|.+||.+....+....+... +.+
T Consensus 214 DFGla~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~ 291 (440)
T PTZ00036 214 DFGSAKNLLAGQ--RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPT 291 (440)
T ss_pred ccccchhccCCC--CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 999998654322 22345678999999988654 6899999999999999999999999877654433332111 011
Q ss_pred --------------CCCC---------ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 373 --------------PFKA---------PAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 373 --------------~~~~---------~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
.++. .+...++++.+||.+||+.||.+|||+.+++++
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 292 EDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred HHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 0000 112356789999999999999999999999954
No 214
>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4. Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter
Probab=100.00 E-value=5.1e-37 Score=290.38 Aligned_cols=244 Identities=29% Similarity=0.503 Sum_probs=203.9
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
.|+..+.||.|+||.++. +++.||+|.+.... .......+.+|+.+++.+.||||+++++.+.++...+++||
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIME 82 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccc--cHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEe
Confidence 466677899999987752 57899999887542 23456788899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCC
Q 013214 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (447)
Q Consensus 231 ~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~ 310 (447)
|+++++|.+++.. +++++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++++|||++....... ..
T Consensus 83 ~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~-~~ 157 (277)
T cd06640 83 YLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-IK 157 (277)
T ss_pred cCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCc-cc
Confidence 9999999999865 56899999999999999999999998 9999999999999999999999999987654322 12
Q ss_pred cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHHH
Q 013214 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIE 390 (447)
Q Consensus 311 ~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 390 (447)
.....++..|+|||.+.+..++.++|+||||+++|+|++|..||...........+.....+. ....++..+.+++.
T Consensus 158 ~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~ 234 (277)
T cd06640 158 RNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPT---LTGEFSKPFKEFID 234 (277)
T ss_pred cccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCCCC---CchhhhHHHHHHHH
Confidence 223456788999999988888999999999999999999999998766554444332222222 34567889999999
Q ss_pred HHcccCCCCCCCHHHHHHH
Q 013214 391 ECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 391 ~cl~~dp~~Rps~~~~l~~ 409 (447)
+||+.+|++||++.+++++
T Consensus 235 ~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 235 ACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred HHcccCcccCcCHHHHHhC
Confidence 9999999999999999876
No 215
>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1. Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn
Probab=100.00 E-value=1.8e-37 Score=305.07 Aligned_cols=246 Identities=25% Similarity=0.358 Sum_probs=195.5
Q ss_pred cCcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeC------C
Q 013214 155 LDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS------S 223 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~------~ 223 (447)
.+|+..+.||+|+||.|+ ..++.||+|++..... .......+.+|+.+++.++||||+++++++... .
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 24 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred cceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCcccc-CchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 478888999999999885 3578999999875432 334456678899999999999999999987543 3
Q ss_pred ceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeeccccccc
Q 013214 224 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (447)
Q Consensus 224 ~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~ 303 (447)
..|+||||++ ++|.+.+.. .+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++...
T Consensus 103 ~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~ 176 (364)
T cd07875 103 DVYIVMELMD-ANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA 176 (364)
T ss_pred eEEEEEeCCC-CCHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCCcccc
Confidence 5799999995 578777753 4788899999999999999999999 999999999999999999999999999765
Q ss_pred ccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcC-------------
Q 013214 304 TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ------------- 370 (447)
Q Consensus 304 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~------------- 370 (447)
... .......+|+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+....
T Consensus 177 ~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (364)
T cd07875 177 GTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP 254 (364)
T ss_pred CCC--CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhH
Confidence 422 22234567899999999999899999999999999999999999998766433322221110
Q ss_pred --------CCCCC-----------------CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 371 --------RPPFK-----------------APAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 371 --------~~~~~-----------------~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
++.+. ......+..++++|.+||+.||.+|||+.+++++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 255 TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 11110 0011134578999999999999999999999986
No 216
>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1. Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding
Probab=100.00 E-value=3.4e-37 Score=294.49 Aligned_cols=248 Identities=22% Similarity=0.431 Sum_probs=203.5
Q ss_pred CCcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEE
Q 013214 153 HELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227 (447)
Q Consensus 153 ~~~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 227 (447)
...+|+..+.||.|++|.++. +++.||+|.+..... ...+.+.+|+.+++.++||||+++++.+......++
T Consensus 18 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~---~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~l 94 (296)
T cd06654 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWV 94 (296)
T ss_pred cccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCc---chHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEE
Confidence 345788888999999988762 578999998875432 223667889999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCC
Q 013214 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307 (447)
Q Consensus 228 v~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~ 307 (447)
||||+++++|.+++.+ ..+++.++..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 95 v~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~ 170 (296)
T cd06654 95 VMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (296)
T ss_pred eecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhccccc
Confidence 9999999999999865 45889999999999999999999999 9999999999999999999999999987543221
Q ss_pred CCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHH
Q 013214 308 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKE 387 (447)
Q Consensus 308 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 387 (447)
. ......+++.|+|||.+.+..++.++|+||||+++|+|++|+.||.................+.. ..+..++..+.+
T Consensus 171 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~ 248 (296)
T cd06654 171 S-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPEL-QNPEKLSAIFRD 248 (296)
T ss_pred c-ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCC-CCccccCHHHHH
Confidence 1 12234578899999999888889999999999999999999999986654333222222222222 223457788999
Q ss_pred HHHHHcccCCCCCCCHHHHHHH
Q 013214 388 LIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 388 li~~cl~~dp~~Rps~~~~l~~ 409 (447)
++.+||..||++||++.+++++
T Consensus 249 li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 249 FLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred HHHHHCcCCcccCcCHHHHhhC
Confidence 9999999999999999999974
No 217
>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha. Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype
Probab=100.00 E-value=3.9e-37 Score=298.29 Aligned_cols=246 Identities=17% Similarity=0.358 Sum_probs=190.9
Q ss_pred ceeeecc--eEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEecc
Q 013214 160 SVEITKG--TFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYL 232 (447)
Q Consensus 160 ~~~lg~G--~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 232 (447)
...||+| +|+.++ .+|+.||+|.+..... .....+.+.+|+.+++.++||||+++++++..++..++||||+
T Consensus 3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEAC-TNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhccccccceEEEEEEeecccCcEEEEEEechhhc-cHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 3578998 556554 3689999999876543 3445567888999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCC-
Q 013214 233 PKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR- 309 (447)
Q Consensus 233 ~~g~L~~~l~~~--~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~- 309 (447)
++|+|.+++... ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++++||+...........
T Consensus 82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~ 158 (327)
T cd08227 82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL 158 (327)
T ss_pred CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence 999999999653 45899999999999999999999999 999999999999999999999999865432211100
Q ss_pred -----CcccCCCCCcccCCcccCC--CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCC----------
Q 013214 310 -----PLTCQDTSCRYVAPEVFKN--EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRP---------- 372 (447)
Q Consensus 310 -----~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~---------- 372 (447)
......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.................+
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (327)
T cd08227 159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPA 238 (327)
T ss_pred cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhh
Confidence 0112245677999999876 35889999999999999999999999765433221111110000
Q ss_pred --------------------------------CCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 373 --------------------------------PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 373 --------------------------------~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
........+++.+.+++.+||+.||++|||+.+++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~ 307 (327)
T cd08227 239 EELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 307 (327)
T ss_pred hhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence 0001122356789999999999999999999999974
No 218
>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea
Probab=100.00 E-value=7.9e-37 Score=289.37 Aligned_cols=255 Identities=26% Similarity=0.508 Sum_probs=209.1
Q ss_pred cCcccceeeecceEEEEEE-----cC----eEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCce
Q 013214 155 LDFTNSVEITKGTFILAFW-----RG----IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~-----~g----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 225 (447)
.+|+..+.||+|+||.++. +| ..+|+|...... .......+.+|+.+++.++||||+++++++.. ...
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 83 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET--SPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQV 83 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-Cce
Confidence 3567778999999998763 23 268999887553 34556778899999999999999999999987 788
Q ss_pred EEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccc
Q 013214 226 MIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304 (447)
Q Consensus 226 ~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~ 304 (447)
++++||+++|+|.+++.++ ..+++..+..++.|++.|+.|||+.+ ++|+||||+||+++.++.+||+|||.+....
T Consensus 84 ~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~ 160 (279)
T cd05057 84 QLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLD 160 (279)
T ss_pred EEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCccccccc
Confidence 9999999999999999874 46899999999999999999999998 9999999999999999999999999998654
Q ss_pred cCCCCC-cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCCCCChhhhH
Q 013214 305 VKEDRP-LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYA 382 (447)
Q Consensus 305 ~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 382 (447)
...... .....++..|+|||.+....++.++|+||||+++|++++ |+.||......+....+......+. +...+
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~ 237 (279)
T cd05057 161 VDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQ---PPICT 237 (279)
T ss_pred CcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCCC---CCCCC
Confidence 322111 112223567999999988888999999999999999998 9999988776665555533322222 33456
Q ss_pred HHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhh
Q 013214 383 RGLKELIEECWNEKPAKRPTFRQIITRLESINNSIN 418 (447)
Q Consensus 383 ~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~~~ 418 (447)
..+.+++.+||..||.+||++.++++.|+++.+...
T Consensus 238 ~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~~ 273 (279)
T cd05057 238 IDVYMVLVKCWMIDAESRPTFKELINEFSKMARDPQ 273 (279)
T ss_pred HHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhCCc
Confidence 789999999999999999999999999999866443
No 219
>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase. Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki
Probab=100.00 E-value=3.4e-37 Score=287.71 Aligned_cols=241 Identities=32% Similarity=0.611 Sum_probs=200.7
Q ss_pred CcccceeeecceEEEEE---EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEecc
Q 013214 156 DFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYL 232 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~---~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 232 (447)
+|+..+.||+|+||.++ .+++.||+|...... ..+.+.+|+.+++.++|||++++++++..+ ..+++|||+
T Consensus 7 ~~~~~~~lg~g~~g~v~~~~~~~~~~~iK~~~~~~-----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~ 80 (254)
T cd05083 7 KLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDV-----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELM 80 (254)
T ss_pred HceeeeeeccCCCCceEecccCCCceEEEeecCcc-----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECC
Confidence 57778899999999876 478899999986432 235788899999999999999999998765 479999999
Q ss_pred CCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCC
Q 013214 233 PKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (447)
Q Consensus 233 ~~g~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~ 310 (447)
.+++|.+++.... .+++..+..++.|++.|+.|||+.+ ++||||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~---- 153 (254)
T cd05083 81 SKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMG---- 153 (254)
T ss_pred CCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceecccc----
Confidence 9999999997643 4789999999999999999999998 999999999999999999999999998754321
Q ss_pred cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHH
Q 013214 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELI 389 (447)
Q Consensus 311 ~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 389 (447)
......+..|+|||.+.+..++.++|+||||+++|+|++ |+.||...+..+....+....++. .+..++..+.+++
T Consensus 154 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li 230 (254)
T cd05083 154 VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRME---PPEGCPADVYVLM 230 (254)
T ss_pred CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCC---CCCcCCHHHHHHH
Confidence 112234567999999988889999999999999999997 999998777655555543333332 2345678999999
Q ss_pred HHHcccCCCCCCCHHHHHHHHHH
Q 013214 390 EECWNEKPAKRPTFRQIITRLES 412 (447)
Q Consensus 390 ~~cl~~dp~~Rps~~~~l~~l~~ 412 (447)
.+||+.+|++||+++++++.|++
T Consensus 231 ~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 231 TSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred HHHcCCChhhCcCHHHHHHHHcc
Confidence 99999999999999999998763
No 220
>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou
Probab=100.00 E-value=1.4e-37 Score=295.82 Aligned_cols=247 Identities=28% Similarity=0.416 Sum_probs=190.5
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC---CCCcccceeEEEEeC-----
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI---RHPNVVQFLGAVTQS----- 222 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~hp~iv~~~~~~~~~----- 222 (447)
+|+..+.||+|+||.|+. +|+.||+|.++...... .....+.+|+.+++.+ +||||+++++++...
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~ 79 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNED-GLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE 79 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCC-CCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence 467778999999998863 68899999887543221 1122344566666655 799999999988642
Q ss_pred CceEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccc
Q 013214 223 SPMMIVTEYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS 300 (447)
Q Consensus 223 ~~~~lv~e~~~~g~L~~~l~~~--~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~ 300 (447)
...++++||+. ++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++
T Consensus 80 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~ 155 (288)
T cd07863 80 TKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLA 155 (288)
T ss_pred ceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcc
Confidence 45799999996 5899888764 34899999999999999999999999 999999999999999999999999998
Q ss_pred cccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcC-C--------
Q 013214 301 KLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-R-------- 371 (447)
Q Consensus 301 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~-~-------- 371 (447)
...... .......+|..|+|||.+.+..++.++||||+||++|+|++|++||...........+.... .
T Consensus 156 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07863 156 RIYSCQ--MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPR 233 (288)
T ss_pred ccccCc--ccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcc
Confidence 765422 12233457889999999988889999999999999999999999997665443322221100 0
Q ss_pred ------CCC--------CCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 372 ------PPF--------KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 372 ------~~~--------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
..+ ....+.++..+.+++.+||+.||++|||+.+++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 234 DVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred cccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 000 00112456788999999999999999999999864
No 221
>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k
Probab=100.00 E-value=6.1e-37 Score=285.36 Aligned_cols=242 Identities=30% Similarity=0.539 Sum_probs=199.3
Q ss_pred eeecceEEEEE---E-cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEeccCCCCH
Q 013214 162 EITKGTFILAF---W-RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237 (447)
Q Consensus 162 ~lg~G~~~~~~---~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L 237 (447)
.||.|++|.++ . .++.||+|.+..... .+....+.+|++++++++||||+++++++......++++||+++++|
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l 79 (251)
T cd05041 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLP--PDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL 79 (251)
T ss_pred ccccCCCceEEEEEEeCCCcEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence 58899888765 2 389999999876532 24567789999999999999999999999999999999999999999
Q ss_pred HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCCc-ccCC
Q 013214 238 RAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPL-TCQD 315 (447)
Q Consensus 238 ~~~l~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~-~~~~ 315 (447)
.+++.+. ..++......++.+++.|+.|||+++ ++|+||||+||+++.++.++|+|||++........... ....
T Consensus 80 ~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~ 156 (251)
T cd05041 80 LTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQ 156 (251)
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCc
Confidence 9999764 46889999999999999999999999 99999999999999999999999999875442111111 1122
Q ss_pred CCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHHHHHcc
Q 013214 316 TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWN 394 (447)
Q Consensus 316 ~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 394 (447)
.+..|+|||.+.++.++.++|+||||+++|+|++ |..||...........+........ +...+..+.+++.+||.
T Consensus 157 ~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~ 233 (251)
T cd05041 157 IPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPA---PQLCPEEIYRLMLQCWA 233 (251)
T ss_pred ceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCCC---CccCCHHHHHHHHHHhc
Confidence 3567999999988889999999999999999999 8999987776555554433222222 34567889999999999
Q ss_pred cCCCCCCCHHHHHHHHH
Q 013214 395 EKPAKRPTFRQIITRLE 411 (447)
Q Consensus 395 ~dp~~Rps~~~~l~~l~ 411 (447)
.+|++||++.++++.|+
T Consensus 234 ~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 234 YDPENRPSFSEIYNELQ 250 (251)
T ss_pred cChhhCcCHHHHHHHhh
Confidence 99999999999999875
No 222
>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l
Probab=100.00 E-value=4.7e-37 Score=289.54 Aligned_cols=243 Identities=33% Similarity=0.559 Sum_probs=196.8
Q ss_pred eeecceEEEEEE-----cC--eEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeEEEEeCCceEEEEeccC
Q 013214 162 EITKGTFILAFW-----RG--IQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLP 233 (447)
Q Consensus 162 ~lg~G~~~~~~~-----~g--~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~ 233 (447)
.||+|+||.++. ++ ..+++|.++.. ......+.+.+|+.+++++ +||||+++++++...+..+++|||++
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~ 79 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP 79 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEcccc--CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCC
Confidence 589999987752 23 35788888643 2345556788999999999 89999999999999999999999999
Q ss_pred CCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeec
Q 013214 234 KGDLRAFLKRKG----------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297 (447)
Q Consensus 234 ~g~L~~~l~~~~----------------~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Df 297 (447)
+|+|.+++..+. .+++.++..++.|++.|++|||+.+ ++|+||||+||++++++.+||+||
T Consensus 80 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~df 156 (270)
T cd05047 80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADF 156 (270)
T ss_pred CCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCC
Confidence 999999997543 3778899999999999999999998 999999999999999999999999
Q ss_pred ccccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCCCC
Q 013214 298 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKA 376 (447)
Q Consensus 298 g~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 376 (447)
|++....... .......+..|+|||.+.+..++.++|+||||+++|+|++ |..||...+..+....+........
T Consensus 157 gl~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~-- 232 (270)
T cd05047 157 GLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEK-- 232 (270)
T ss_pred CCccccchhh--hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCCCCC--
Confidence 9986322111 1111223567999999988889999999999999999997 9999987665555444433222222
Q ss_pred ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHH
Q 013214 377 PAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESIN 414 (447)
Q Consensus 377 ~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~ 414 (447)
+...+..+.+++.+||+.||.+|||+.++++.|+.+.
T Consensus 233 -~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 233 -PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred -CCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 2345678999999999999999999999999998864
No 223
>smart00219 TyrKc Tyrosine kinase, catalytic domain. Phosphotransferases. Tyrosine-specific kinase subfamily.
Probab=100.00 E-value=5.2e-37 Score=286.59 Aligned_cols=245 Identities=34% Similarity=0.612 Sum_probs=203.2
Q ss_pred ccceeeecceEEEEE---Ec------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEE
Q 013214 158 TNSVEITKGTFILAF---WR------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 228 (447)
Q Consensus 158 ~~~~~lg~G~~~~~~---~~------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 228 (447)
+..+.||.|+||.++ +. +..||+|.+.... ..+....+..|+.+++.++||||+++++.+...+..+++
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i 79 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDA--DEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIV 79 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCC--ChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEE
Confidence 345689999998775 22 3889999997543 233567889999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccC
Q 013214 229 TEYLPKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306 (447)
Q Consensus 229 ~e~~~~g~L~~~l~~~~~--l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~ 306 (447)
|||+++++|.+++..... +++..+..++.|++.|+.+||+.+ ++|+||||+||++++++.++|+|||++......
T Consensus 80 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 156 (258)
T smart00219 80 MEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD 156 (258)
T ss_pred EeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecccc
Confidence 999999999999976554 899999999999999999999998 999999999999999999999999998765533
Q ss_pred CCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHH
Q 013214 307 EDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGL 385 (447)
Q Consensus 307 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 385 (447)
.........+++.|+|||.+.+..++.++|+||+|+++++|++ |+.||...+.......+.....+.. +..++..+
T Consensus 157 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~ 233 (258)
T smart00219 157 DYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPK---PENCPPEI 233 (258)
T ss_pred cccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCC---CCcCCHHH
Confidence 2211112336788999999988889999999999999999998 8899987666555555544333332 34478899
Q ss_pred HHHHHHHcccCCCCCCCHHHHHHHH
Q 013214 386 KELIEECWNEKPAKRPTFRQIITRL 410 (447)
Q Consensus 386 ~~li~~cl~~dp~~Rps~~~~l~~l 410 (447)
.+++.+||..||++|||+.++++.|
T Consensus 234 ~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 234 YKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred HHHHHHHCcCChhhCcCHHHHHhhC
Confidence 9999999999999999999998754
No 224
>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4. Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s
Probab=100.00 E-value=5.2e-37 Score=289.85 Aligned_cols=250 Identities=29% Similarity=0.493 Sum_probs=204.7
Q ss_pred cCcccceeeecceEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCc
Q 013214 155 LDFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 224 (447)
.+|+....||+|+||.++. ....|++|.+... ......+.+.+|+.++++++||||+++++++.....
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 82 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKT--KDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEP 82 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCc--cchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCc
Confidence 4677788899999998862 2467999988643 233456778999999999999999999999999899
Q ss_pred eEEEEeccCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEe
Q 013214 225 MMIVTEYLPKGDLRAFLKRKG---------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVA 295 (447)
Q Consensus 225 ~~lv~e~~~~g~L~~~l~~~~---------~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~ 295 (447)
.+++|||+++|+|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++++
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~ 159 (275)
T cd05046 83 HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVS 159 (275)
T ss_pred ceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEc
Confidence 999999999999999998655 6899999999999999999999999 9999999999999999999999
Q ss_pred ecccccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCC
Q 013214 296 DFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPF 374 (447)
Q Consensus 296 Dfg~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~ 374 (447)
|||++...............++..|+|||.+.+..++.++|+||||+++|++++ |..||................ ...
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~-~~~ 238 (275)
T cd05046 160 LLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGK-LEL 238 (275)
T ss_pred ccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCC-cCC
Confidence 999986543222222233345677999999988888899999999999999998 889997666555444442222 111
Q ss_pred CCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHH
Q 013214 375 KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLE 411 (447)
Q Consensus 375 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~ 411 (447)
. .+..++..+.+++.+||+.+|.+||++.++++.|.
T Consensus 239 ~-~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 239 P-VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred C-CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 1 23346789999999999999999999999999875
No 225
>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases. Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include
Probab=100.00 E-value=3.1e-37 Score=293.14 Aligned_cols=246 Identities=26% Similarity=0.468 Sum_probs=199.8
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|+..+.||+|+||.++. +|..||+|.+.... .......+.+|+.++++++||||+++++.+..++..+++||
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL--DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCME 79 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEe
Confidence 466778899999998752 58999999886532 34445678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccC
Q 013214 231 YLPKGDLRAFLKRK---GALKPSTAVRFALDIARGMNYLHEN-KPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306 (447)
Q Consensus 231 ~~~~g~L~~~l~~~---~~l~~~~~~~i~~ql~~~l~~lH~~-~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~ 306 (447)
|+++++|.+++... ..+++..+..++.|++.|+.|||+. + ++|+||||+||+++.++.++|+|||++......
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 156 (286)
T cd06622 80 YMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS 156 (286)
T ss_pred ecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccccCC
Confidence 99999999988763 3689999999999999999999974 6 999999999999999999999999998755322
Q ss_pred CCCCcccCCCCCcccCCcccCCCC------CCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhh
Q 013214 307 EDRPLTCQDTSCRYVAPEVFKNEE------YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKL 380 (447)
Q Consensus 307 ~~~~~~~~~~t~~y~aPE~~~~~~------~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 380 (447)
......+++.|+|||.+.+.. ++.++|+|||||++|+|++|+.||.......................+..
T Consensus 157 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd06622 157 ---LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSG 233 (286)
T ss_pred ---ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCcc
Confidence 122334678899999986543 47899999999999999999999976655444333222111112223445
Q ss_pred hHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 381 YARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 381 ~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
++.++.++|.+||+.+|++||++.+++++
T Consensus 234 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 234 YSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred cCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 78899999999999999999999999975
No 226
>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3. Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok
Probab=100.00 E-value=2.1e-37 Score=303.59 Aligned_cols=246 Identities=25% Similarity=0.357 Sum_probs=194.3
Q ss_pred cCcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeC------C
Q 013214 155 LDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS------S 223 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~------~ 223 (447)
.+|+..+.||+|+||.|+ ..++.||+|.+..... .......+.+|+.+++.++||||+++++++... .
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 95 (355)
T cd07874 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQ 95 (355)
T ss_pred hceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCccc-ChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccc
Confidence 478888999999999886 3588999999875432 334456777899999999999999999988643 3
Q ss_pred ceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeeccccccc
Q 013214 224 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (447)
Q Consensus 224 ~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~ 303 (447)
..+++|||++ ++|.+.+.. .+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++...
T Consensus 96 ~~~lv~e~~~-~~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~~~~~ 169 (355)
T cd07874 96 DVYLVMELMD-ANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA 169 (355)
T ss_pred eeEEEhhhhc-ccHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcccccC
Confidence 4799999995 577776653 4888999999999999999999999 999999999999999999999999999764
Q ss_pred ccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhc--------------
Q 013214 304 TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR-------------- 369 (447)
Q Consensus 304 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~-------------- 369 (447)
... .......+|+.|+|||.+.+..++.++|+|||||++|+|++|+.||.+.+..+........
T Consensus 170 ~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (355)
T cd07874 170 GTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 247 (355)
T ss_pred CCc--cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcH
Confidence 422 2223456789999999998888999999999999999999999999866532221111000
Q ss_pred -------CCCCC-----------------CCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 370 -------QRPPF-----------------KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 370 -------~~~~~-----------------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
..+.+ .......+..+.++|.+||+.||++|||+.+++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 00000 00112235678999999999999999999999986
No 227
>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1. Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their
Probab=100.00 E-value=4.7e-37 Score=288.88 Aligned_cols=251 Identities=26% Similarity=0.517 Sum_probs=203.6
Q ss_pred CcccceeeecceEEEEE-----EcCeEEEEEEcCcccCC---CHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEE
Q 013214 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVIS---DDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 227 (447)
+|+..+.||+|++|.++ .+++.||+|.+...... .....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 36677889999999876 36889999998654321 12345788999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCC-CEEEeecccccccccC
Q 013214 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG-NLKVADFGVSKLLTVK 306 (447)
Q Consensus 228 v~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~-~vkl~Dfg~~~~~~~~ 306 (447)
++||+++++|.+++.+.+++++..+..++.|++.||.|||+.+ ++|+||||+||+++.++ .++|+|||++......
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~ 157 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAK 157 (268)
T ss_pred EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEcccccccccccc
Confidence 9999999999999988888999999999999999999999999 99999999999998776 5999999998765432
Q ss_pred CCC---CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhc-CCCCCCCChhhhH
Q 013214 307 EDR---PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR-QRPPFKAPAKLYA 382 (447)
Q Consensus 307 ~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 382 (447)
... ......++..|+|||.+.+..++.++|+||+|+++|+|++|+.||...........+... .....+..+..++
T Consensus 158 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (268)
T cd06630 158 GTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLS 237 (268)
T ss_pred cccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhC
Confidence 111 112335688999999998888899999999999999999999999765543322222111 1111222345577
Q ss_pred HHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 383 RGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 383 ~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
+.+.+++.+||..+|.+||++.+++++
T Consensus 238 ~~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 238 PGLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred HHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 899999999999999999999999863
No 228
>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1. Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.
Probab=100.00 E-value=1.3e-37 Score=291.26 Aligned_cols=247 Identities=25% Similarity=0.361 Sum_probs=205.2
Q ss_pred CcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|+..+.||.|+|+.++ .+++.||+|.+...........+.+.+|++++++++||||+++++.+......++++|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 46778899999998765 2589999999986554454566788999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCC
Q 013214 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (447)
Q Consensus 231 ~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~ 310 (447)
|+.+++|.+++.+..++++..+..++.|+++||.|||+.+ ++|+||+|+||++++++.++|+|||.+....... .
T Consensus 81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--~ 155 (258)
T cd05578 81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--L 155 (258)
T ss_pred CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc--c
Confidence 9999999999988778999999999999999999999998 9999999999999999999999999987654321 2
Q ss_pred cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHHH
Q 013214 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIE 390 (447)
Q Consensus 311 ~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 390 (447)
.....++..|+|||.+.+..++.++|+||||+++|+|++|+.||...+........ ..........+..++..+.++|.
T Consensus 156 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~i~ 234 (258)
T cd05578 156 TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIR-AKQETADVLYPATWSTEAIDAIN 234 (258)
T ss_pred ccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHH-HHhccccccCcccCcHHHHHHHH
Confidence 23345678899999998888899999999999999999999999877653221111 11111222234457789999999
Q ss_pred HHcccCCCCCCCH--HHHHH
Q 013214 391 ECWNEKPAKRPTF--RQIIT 408 (447)
Q Consensus 391 ~cl~~dp~~Rps~--~~~l~ 408 (447)
+||+.||.+||++ +++++
T Consensus 235 ~~l~~~p~~R~~~~~~~l~~ 254 (258)
T cd05578 235 KLLERDPQKRLGDNLKDLKN 254 (258)
T ss_pred HHccCChhHcCCccHHHHhc
Confidence 9999999999999 66553
No 229
>PHA03207 serine/threonine kinase US3; Provisional
Probab=100.00 E-value=2.7e-37 Score=306.62 Aligned_cols=243 Identities=23% Similarity=0.330 Sum_probs=196.6
Q ss_pred cCcccceeeecceEEEEEE-------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEE
Q 013214 155 LDFTNSVEITKGTFILAFW-------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~-------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 227 (447)
.+|...+.||+|+||.|+. .+..||+|.+... ....+|+.+++.++||||+++++.+......++
T Consensus 92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~--------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l 163 (392)
T PHA03207 92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG--------KTPGREIDILKTISHRAIINLIHAYRWKSTVCM 163 (392)
T ss_pred CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc--------ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEE
Confidence 4688899999999998863 3478999987643 134579999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCC
Q 013214 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307 (447)
Q Consensus 228 v~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~ 307 (447)
+||++ +++|.+++...+.+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++.......
T Consensus 164 v~e~~-~~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~ 239 (392)
T PHA03207 164 VMPKY-KCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP 239 (392)
T ss_pred Eehhc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCccc
Confidence 99999 4799999977788999999999999999999999999 9999999999999999999999999987654332
Q ss_pred CC-CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchH----HHHH---------------
Q 013214 308 DR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVP----KAYA--------------- 367 (447)
Q Consensus 308 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~----~~~~--------------- 367 (447)
.. ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+....... ..+.
T Consensus 240 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~ 319 (392)
T PHA03207 240 DTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGST 319 (392)
T ss_pred ccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccch
Confidence 21 122456899999999999888999999999999999999999999765432211 1000
Q ss_pred ----------hcCCCCCCCC----hhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 368 ----------ARQRPPFKAP----AKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 368 ----------~~~~~~~~~~----~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
...++++... ...++.+++++|.+||..||++|||+.+++.+
T Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 320 NLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred hHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0011111110 01346678999999999999999999999986
No 230
>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase. Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and
Probab=100.00 E-value=4.1e-37 Score=287.53 Aligned_cols=242 Identities=30% Similarity=0.525 Sum_probs=199.8
Q ss_pred eeecceEEEEEE------cC--eEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEeccC
Q 013214 162 EITKGTFILAFW------RG--IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 233 (447)
Q Consensus 162 ~lg~G~~~~~~~------~g--~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 233 (447)
.||+|++|.++. .+ ..||+|.+...... ...+.+.+|+.++++++||||+++++.+.. ...++++||++
T Consensus 2 ~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~ 78 (257)
T cd05040 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAP 78 (257)
T ss_pred cCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecC
Confidence 579999987752 22 36999999876432 567789999999999999999999999988 88999999999
Q ss_pred CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCC--
Q 013214 234 KGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR-- 309 (447)
Q Consensus 234 ~g~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~-- 309 (447)
+++|.+++.++. .+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++.........
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 155 (257)
T cd05040 79 LGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV 155 (257)
T ss_pred CCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEecccccccccccccccee
Confidence 999999998764 5899999999999999999999999 999999999999999999999999998876432111
Q ss_pred CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHH
Q 013214 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKEL 388 (447)
Q Consensus 310 ~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 388 (447)
......++..|+|||.+.+..++.++|+||||+++|+|++ |+.||...+..+....+.... ... ..+..++..+.++
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~-~~~-~~~~~~~~~~~~l 233 (257)
T cd05040 156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEG-ERL-ERPEACPQDIYNV 233 (257)
T ss_pred cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcC-CcC-CCCccCCHHHHHH
Confidence 1122345778999999988889999999999999999998 999998766655544443222 111 1233467889999
Q ss_pred HHHHcccCCCCCCCHHHHHHHHH
Q 013214 389 IEECWNEKPAKRPTFRQIITRLE 411 (447)
Q Consensus 389 i~~cl~~dp~~Rps~~~~l~~l~ 411 (447)
+.+||+.+|++||++.++++.|.
T Consensus 234 i~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 234 MLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred HHHHCCCCcccCCCHHHHHHHhc
Confidence 99999999999999999998874
No 231
>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)
Probab=100.00 E-value=3.6e-37 Score=290.89 Aligned_cols=245 Identities=28% Similarity=0.484 Sum_probs=204.6
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|+..+.||.|++|.++. +++.||+|.+.... .......+.+|+.+++.++||||+++++++.++...++++|
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE--AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIME 79 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc--cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEE
Confidence 466778899999988762 68899999987543 23445678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCC
Q 013214 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (447)
Q Consensus 231 ~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~ 310 (447)
|+++++|.+++..+ ++++..+..++.|++.|+.|||+.+ ++|+||+|+||++++++.++|+|||++........ .
T Consensus 80 ~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~ 154 (274)
T cd06609 80 YCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS-K 154 (274)
T ss_pred eeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeeccccc-c
Confidence 99999999999765 7899999999999999999999998 99999999999999999999999999987654321 1
Q ss_pred cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHHH
Q 013214 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIE 390 (447)
Q Consensus 311 ~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 390 (447)
.....+++.|+|||.+.+..++.++|+||||+++|+|++|+.||...+.......+.....+... ...++..+.+++.
T Consensus 155 ~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~ 232 (274)
T cd06609 155 RNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLE--GNKFSKPFKDFVS 232 (274)
T ss_pred cccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCc--ccccCHHHHHHHH
Confidence 22345678899999998888999999999999999999999999876654444443333233322 1127788999999
Q ss_pred HHcccCCCCCCCHHHHHHH
Q 013214 391 ECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 391 ~cl~~dp~~Rps~~~~l~~ 409 (447)
+||..+|++||++++++++
T Consensus 233 ~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 233 LCLNKDPKERPSAKELLKH 251 (274)
T ss_pred HHhhCChhhCcCHHHHhhC
Confidence 9999999999999999874
No 232
>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase. Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1
Probab=100.00 E-value=5.3e-37 Score=288.15 Aligned_cols=249 Identities=29% Similarity=0.503 Sum_probs=205.9
Q ss_pred CcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|+..+.||.|++|.++ .++..+|+|++...... .....+.+|+..++.++|||++++++.+......++++|
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 79 (267)
T cd06610 2 DYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQ--TSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMP 79 (267)
T ss_pred cceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcc--hHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEe
Confidence 57778899999998775 26788999998754332 256778999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCC
Q 013214 231 YLPKGDLRAFLKRK---GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307 (447)
Q Consensus 231 ~~~~g~L~~~l~~~---~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~ 307 (447)
++++++|.+++... ..+++..+..++.|++.|+.+||+.+ ++|+||||+||++++++.++|+|||++.......
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~ 156 (267)
T cd06610 80 YLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGG 156 (267)
T ss_pred ccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence 99999999999764 35899999999999999999999999 9999999999999999999999999987655432
Q ss_pred CC---CcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCCh--hhh
Q 013214 308 DR---PLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPA--KLY 381 (447)
Q Consensus 308 ~~---~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~ 381 (447)
.. ......++..|+|||.+... .++.++|+||||+++|+|++|+.||...+..+..........+.+.... ..+
T Consensus 157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (267)
T cd06610 157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKY 236 (267)
T ss_pred cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCccccccc
Confidence 22 11233578899999998776 7888999999999999999999999877665544444333333332222 367
Q ss_pred HHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 382 ARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 382 ~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
++.+.+++.+||..||++||++.+++++
T Consensus 237 ~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 237 SKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred cHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 8899999999999999999999999874
No 233
>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2. Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt
Probab=100.00 E-value=6e-37 Score=289.48 Aligned_cols=233 Identities=24% Similarity=0.423 Sum_probs=187.2
Q ss_pred eeecceEEEEEEc-----------------------------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcc
Q 013214 162 EITKGTFILAFWR-----------------------------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNV 212 (447)
Q Consensus 162 ~lg~G~~~~~~~~-----------------------------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i 212 (447)
.||+|+||.||.. ...|++|.+... .......+.+|+.+++.++||||
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~---~~~~~~~~~~~~~~~~~l~h~ni 78 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPS---HRDIALAFFETASLMSQVSHIHL 78 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChH---HHHHHHHHHHHHHHHhcCCCCCe
Confidence 5899999887732 135899988643 23345678889999999999999
Q ss_pred cceeEEEEeCCceEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCC-
Q 013214 213 VQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG- 290 (447)
Q Consensus 213 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~- 290 (447)
+++++++..+...++||||+++|+|..++.+ .+.+++..+..++.|++.||.|||+.+ ++||||||+||+++..+
T Consensus 79 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~ 155 (274)
T cd05076 79 AFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGL 155 (274)
T ss_pred eeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCc
Confidence 9999999999999999999999999999875 456899999999999999999999998 99999999999998644
Q ss_pred ------CEEEeecccccccccCCCCCcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHH-hCCCCCCCCCCCch
Q 013214 291 ------NLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEV 362 (447)
Q Consensus 291 ------~vkl~Dfg~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~-tg~~p~~~~~~~~~ 362 (447)
.+|++|||.+...... ....++..|+|||.+.+ ..++.++|+||||+++|+++ +|+.||......+.
T Consensus 156 ~~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~ 230 (274)
T cd05076 156 AEGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK 230 (274)
T ss_pred ccCccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH
Confidence 3899999987643211 22345778999998865 46789999999999999995 69999987665544
Q ss_pred HHHHHhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHH
Q 013214 363 PKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRL 410 (447)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l 410 (447)
....... ..++ ...++.+.++|.+||+.+|++|||+.++++.|
T Consensus 231 ~~~~~~~--~~~~---~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 231 ERFYEKK--HRLP---EPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred HHHHHhc--cCCC---CCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 3332211 1111 12346789999999999999999999999876
No 234
>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3. Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells
Probab=100.00 E-value=7.5e-37 Score=287.97 Aligned_cols=244 Identities=27% Similarity=0.419 Sum_probs=190.2
Q ss_pred eeecceEEEEEE-------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEeccCC
Q 013214 162 EITKGTFILAFW-------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234 (447)
Q Consensus 162 ~lg~G~~~~~~~-------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 234 (447)
.||+|+||.|+. ++..+|+|.+.... .......+.+|+.++++++||||+++++.+.+....+++|||+++
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 79 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSA--SVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPL 79 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCC
Confidence 589999998763 23579999887543 233345688899999999999999999999999999999999999
Q ss_pred CCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCC-
Q 013214 235 GDLRAFLKRKG-----ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED- 308 (447)
Q Consensus 235 g~L~~~l~~~~-----~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~- 308 (447)
|+|.+++.... ..++..+..++.|++.|+.|||+.+ ++|+||||+||+++.++.++|+|||.+........
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~ 156 (269)
T cd05087 80 GDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYY 156 (269)
T ss_pred CcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCccee
Confidence 99999997532 3566778889999999999999999 99999999999999999999999999865332111
Q ss_pred CCcccCCCCCcccCCcccCCC-------CCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCCC--CCh
Q 013214 309 RPLTCQDTSCRYVAPEVFKNE-------EYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFK--APA 378 (447)
Q Consensus 309 ~~~~~~~~t~~y~aPE~~~~~-------~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~ 378 (447)
.......++..|+|||.+.+. .++.++|+||||+++|+|++ |+.||......+............+. ...
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (269)
T cd05087 157 VTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLK 236 (269)
T ss_pred ecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccC
Confidence 111223467889999988542 35779999999999999996 99999876655543333222222221 122
Q ss_pred hhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHH
Q 013214 379 KLYARGLKELIEECWNEKPAKRPTFRQIITRLE 411 (447)
Q Consensus 379 ~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~ 411 (447)
...++.+.++++.|| .+|++|||+.+++..|.
T Consensus 237 ~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 237 LPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 345678999999999 68999999999998763
No 235
>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti
Probab=100.00 E-value=4.2e-37 Score=287.31 Aligned_cols=246 Identities=23% Similarity=0.462 Sum_probs=205.2
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|+..+.||+|+||.++. +|+.||+|.+..... ......++.+|+.+++.++||||+++++++...+..++++|
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKM-SPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMD 79 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhC-ChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEe
Confidence 467788999999997763 688999999875433 23345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 013214 231 YLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (447)
Q Consensus 231 ~~~~g~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~ 308 (447)
|+.+++|.+++.... .+++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 156 (256)
T cd08218 80 YCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE 156 (256)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence 999999999997643 4789999999999999999999998 99999999999999999999999999876543211
Q ss_pred CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHH
Q 013214 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKEL 388 (447)
Q Consensus 309 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 388 (447)
......+++.|+|||.+.+..++.++|+||||+++++|++|+.||......+....+.....++. +..++..+.++
T Consensus 157 -~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l 232 (256)
T cd08218 157 -LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPV---SSHYSYDLRNL 232 (256)
T ss_pred -hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCC---cccCCHHHHHH
Confidence 11223467889999999888888999999999999999999999987665555444433333332 44567889999
Q ss_pred HHHHcccCCCCCCCHHHHHHH
Q 013214 389 IEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 389 i~~cl~~dp~~Rps~~~~l~~ 409 (447)
|.+||+.+|.+||++.+++++
T Consensus 233 i~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 233 VSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred HHHHhhCChhhCcCHHHHhhC
Confidence 999999999999999999874
No 236
>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase. Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.
Probab=100.00 E-value=8.5e-37 Score=291.13 Aligned_cols=246 Identities=25% Similarity=0.419 Sum_probs=200.9
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
.|+..+.||.|+||.++. ++..+++|.+... .....+.+.+|+.+++.++||||+++++.+..+...+++||
T Consensus 13 ~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 89 (292)
T cd06644 13 VWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK---SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIE 89 (292)
T ss_pred hhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEe
Confidence 577888999999998872 5789999998643 45566778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 013214 231 YLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (447)
Q Consensus 231 ~~~~g~L~~~l~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~ 309 (447)
|+++++|..++.+ ...+++..+..++.|++.++.|||+.+ ++|+||||+||+++.++.++|+|||++....... .
T Consensus 90 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~-~ 165 (292)
T cd06644 90 FCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL-Q 165 (292)
T ss_pred cCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceeccccc-c
Confidence 9999999988765 456899999999999999999999998 9999999999999999999999999886533211 1
Q ss_pred CcccCCCCCcccCCcccC-----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHH
Q 013214 310 PLTCQDTSCRYVAPEVFK-----NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARG 384 (447)
Q Consensus 310 ~~~~~~~t~~y~aPE~~~-----~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (447)
......+++.|+|||.+. ...++.++|+||||+++|+|++|+.||...+..+..........+.. ..+..++.+
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 244 (292)
T cd06644 166 RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTL-SQPSKWSME 244 (292)
T ss_pred ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccC-CCCcccCHH
Confidence 112345678899999884 33467799999999999999999999987665443333322222222 223456788
Q ss_pred HHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 385 LKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 385 l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
+.++|.+||..||++||++.+++++
T Consensus 245 ~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 245 FRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred HHHHHHHHhcCCcccCcCHHHHhcC
Confidence 9999999999999999999999874
No 237
>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases. Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina
Probab=100.00 E-value=8.3e-37 Score=287.59 Aligned_cols=243 Identities=26% Similarity=0.446 Sum_probs=191.2
Q ss_pred eeecceEEEEEE-------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEeccCC
Q 013214 162 EITKGTFILAFW-------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234 (447)
Q Consensus 162 ~lg~G~~~~~~~-------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 234 (447)
+||+|+||.|+. ....+|+|.+.... .......+.+|+..++.++||||+++++.+......+++|||+++
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~ 79 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASA--TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPL 79 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccC--ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCC
Confidence 589999998762 23578888876432 344456788899999999999999999999999999999999999
Q ss_pred CCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCC-
Q 013214 235 GDLRAFLKRKG-----ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED- 308 (447)
Q Consensus 235 g~L~~~l~~~~-----~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~- 308 (447)
|+|.+++.+.. ..++.....++.|++.|+.|||+.+ ++||||||+||+++.++.+||+|||++........
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~ 156 (269)
T cd05042 80 GDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYY 156 (269)
T ss_pred CcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchhe
Confidence 99999997643 2467788899999999999999999 99999999999999999999999999865322111
Q ss_pred CCcccCCCCCcccCCcccCC-------CCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCC--CCCh
Q 013214 309 RPLTCQDTSCRYVAPEVFKN-------EEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPF--KAPA 378 (447)
Q Consensus 309 ~~~~~~~~t~~y~aPE~~~~-------~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~ 378 (447)
.......++..|+|||++.. ..++.++||||||+++|+|++ |..||......+............+ +...
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (269)
T cd05042 157 ITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLD 236 (269)
T ss_pred eccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCccc
Confidence 11122335677999998643 356779999999999999999 8899987765554444433333222 2223
Q ss_pred hhhHHHHHHHHHHHcccCCCCCCCHHHHHHHH
Q 013214 379 KLYARGLKELIEECWNEKPAKRPTFRQIITRL 410 (447)
Q Consensus 379 ~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l 410 (447)
..+++.+.+++..|| .||++|||++++++.|
T Consensus 237 ~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 237 LKYSDRWYEVMQFCW-LDPETRPTAEEVHELL 267 (269)
T ss_pred ccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence 457788899999999 5999999999999876
No 238
>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5. Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p
Probab=100.00 E-value=8.5e-37 Score=289.22 Aligned_cols=240 Identities=25% Similarity=0.453 Sum_probs=196.0
Q ss_pred CcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|+..+.||+|+||.++ .+++.||+|.+.... .....+.+.+|++++++++||||+++++.+...+..++++|
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 79 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI--TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTE 79 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC--ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEe
Confidence 45667789999998876 367899999986542 34455678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCC
Q 013214 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (447)
Q Consensus 231 ~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~ 310 (447)
|+++++|..+ ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++...... .
T Consensus 80 ~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~---~ 149 (279)
T cd06619 80 FMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS---I 149 (279)
T ss_pred cCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceecccc---c
Confidence 9999999754 35788899999999999999999999 999999999999999999999999998754322 2
Q ss_pred cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCc-------hHHHHHhcCCCCCCCChhhhHH
Q 013214 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNE-------VPKAYAARQRPPFKAPAKLYAR 383 (447)
Q Consensus 311 ~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~ 383 (447)
.....++..|+|||.+.+..++.++|+||||+++|+|++|+.||......+ ....+.....+.. ....+++
T Consensus 150 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 227 (279)
T cd06619 150 AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVL--PVGQFSE 227 (279)
T ss_pred ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCC--CCCcCCH
Confidence 233467889999999988889999999999999999999999997543221 1111111111111 1234678
Q ss_pred HHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 384 GLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 384 ~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
++.+++.+||+.||++||++.+++++
T Consensus 228 ~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 228 KFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred HHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 89999999999999999999999876
No 239
>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1. Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops
Probab=100.00 E-value=7.9e-37 Score=285.49 Aligned_cols=247 Identities=27% Similarity=0.462 Sum_probs=204.2
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccC--CCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEE
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVI--SDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 228 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 228 (447)
+|+..+.||+|++|.++. +++.|++|.+..... ...+..+.+.+|+.+++.++||||+++++++......+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 356677899999988752 688999998864321 2344567889999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 013214 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (447)
Q Consensus 229 ~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~ 308 (447)
+||+++++|.+++.+.+.+++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.+||+|||++.......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~- 156 (258)
T cd06632 81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS- 156 (258)
T ss_pred EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccccc-
Confidence 999999999999988888999999999999999999999999 9999999999999999999999999987654322
Q ss_pred CCcccCCCCCcccCCcccCCCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHH
Q 013214 309 RPLTCQDTSCRYVAPEVFKNEE-YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKE 387 (447)
Q Consensus 309 ~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 387 (447)
......++..|++||.+.... ++.++|+||||+++|+|++|+.||.............. ....+..+..+++.+.+
T Consensus 157 -~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~ 233 (258)
T cd06632 157 -FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGR--SKELPPIPDHLSDEAKD 233 (258)
T ss_pred -cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHh--cccCCCcCCCcCHHHHH
Confidence 223455788899999987765 88999999999999999999999986654333333222 12222234557789999
Q ss_pred HHHHHcccCCCCCCCHHHHHHH
Q 013214 388 LIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 388 li~~cl~~dp~~Rps~~~~l~~ 409 (447)
++.+||+.+|.+||++.+++.+
T Consensus 234 li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 234 FILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred HHHHHhhcCcccCcCHHHHhcC
Confidence 9999999999999999999863
No 240
>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of
Probab=100.00 E-value=4.1e-37 Score=291.04 Aligned_cols=241 Identities=26% Similarity=0.405 Sum_probs=195.6
Q ss_pred eecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEeccCCCCH
Q 013214 163 ITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237 (447)
Q Consensus 163 lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L 237 (447)
||+|+||.++ .+|+.||+|.+...........+.+.+|+.++++++||||+++++.+...+..|++|||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 5889998876 25889999998754433334455667899999999999999999999999999999999999999
Q ss_pred HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCCcccCC
Q 013214 238 RAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD 315 (447)
Q Consensus 238 ~~~l~~~~--~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~ 315 (447)
.+++.+.. .+++..+..++.|++.|+.|||+.+ ++|+||+|+||++++++.++|+|||.+...... .......
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~--~~~~~~~ 155 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGG--KKIKGRA 155 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccC--Ccccccc
Confidence 99997765 6899999999999999999999999 999999999999999999999999998765431 2223345
Q ss_pred CCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHHHHHccc
Q 013214 316 TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNE 395 (447)
Q Consensus 316 ~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 395 (447)
++..|+|||.+.+..++.++|+||||+++|+|++|+.||...........+...........+..+++.+.++|.+||+.
T Consensus 156 ~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 235 (277)
T cd05577 156 GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQK 235 (277)
T ss_pred CCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccC
Confidence 67889999999888889999999999999999999999987654322222222221111122345688999999999999
Q ss_pred CCCCCC-----CHHHHHH
Q 013214 396 KPAKRP-----TFRQIIT 408 (447)
Q Consensus 396 dp~~Rp-----s~~~~l~ 408 (447)
||.+|| ++.++++
T Consensus 236 ~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 236 DPEKRLGCRGGSADEVRE 253 (277)
T ss_pred ChhHccCCCcccHHHHHh
Confidence 999999 6666765
No 241
>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin
Probab=100.00 E-value=7e-37 Score=295.07 Aligned_cols=249 Identities=25% Similarity=0.407 Sum_probs=204.2
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|+..+.||+|++|.++. +++.||+|.+...........+.+.+|+.+++.++||||+++++.+......+++||
T Consensus 2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (316)
T cd05574 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMD 81 (316)
T ss_pred ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEE
Confidence 577788999999998762 578999999987654444566778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 013214 231 YLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (447)
Q Consensus 231 ~~~~g~L~~~l~~~--~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~ 308 (447)
|+.+++|.+++.+. ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++........
T Consensus 82 ~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~ 158 (316)
T cd05574 82 YCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPP 158 (316)
T ss_pred ecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccccccc
Confidence 99999999999764 46899999999999999999999998 99999999999999999999999999875432111
Q ss_pred C----------------------------CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCC
Q 013214 309 R----------------------------PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDN 360 (447)
Q Consensus 309 ~----------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~ 360 (447)
. ......|+..|+|||.+.+..++.++||||||+++|+|++|+.||...+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~ 238 (316)
T cd05574 159 PVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRD 238 (316)
T ss_pred ccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchH
Confidence 0 011234688899999998888899999999999999999999999877655
Q ss_pred chHHHHHhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCC----HHHHHHH
Q 013214 361 EVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPT----FRQIITR 409 (447)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps----~~~~l~~ 409 (447)
.....+. .....++. ...++..+.+++.+||..||++||+ +.+++++
T Consensus 239 ~~~~~~~-~~~~~~~~-~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~ 289 (316)
T cd05574 239 ETFSNIL-KKEVTFPG-SPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH 289 (316)
T ss_pred HHHHHHh-cCCccCCC-ccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence 4444332 22222222 2226789999999999999999999 7776664
No 242
>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3. Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development
Probab=100.00 E-value=8.9e-37 Score=286.98 Aligned_cols=249 Identities=27% Similarity=0.484 Sum_probs=200.2
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCC--CHHHHHHHHHHHHHHhcCCCCcccceeEEEEe--CCce
Q 013214 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVIS--DDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ--SSPM 225 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~ 225 (447)
.+|+..+.||+|+||.++. ++..||+|.+...... .......+.+|+.++++++||||+++++++.. ....
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 3678888999999998763 5789999988654321 23345678899999999999999999998875 3568
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeeccccccccc
Q 013214 226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305 (447)
Q Consensus 226 ~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~ 305 (447)
++++||+++++|.+++...+.+++...+.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQT 158 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCcccccc
Confidence 899999999999999988888999999999999999999999998 99999999999999999999999999875532
Q ss_pred CC--CCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHH
Q 013214 306 KE--DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYAR 383 (447)
Q Consensus 306 ~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (447)
.. ........++..|+|||.+.+..++.++|+||||+++|+|++|+.||......+......... ..+..+..+++
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 236 (266)
T cd06651 159 ICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQP--TNPQLPSHISE 236 (266)
T ss_pred ccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCC--CCCCCchhcCH
Confidence 11 111123457889999999988888999999999999999999999998665443333222211 11222445677
Q ss_pred HHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 384 GLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 384 ~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
.+.+++ +||..+|++||++++++.+
T Consensus 237 ~~~~li-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 237 HARDFL-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred HHHHHH-HHhcCChhhCcCHHHHhcC
Confidence 888888 6888999999999999863
No 243
>PTZ00284 protein kinase; Provisional
Probab=100.00 E-value=3.6e-37 Score=312.58 Aligned_cols=246 Identities=20% Similarity=0.245 Sum_probs=189.8
Q ss_pred CCCcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC------CCcccceeEEEE
Q 013214 152 PHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR------HPNVVQFLGAVT 220 (447)
Q Consensus 152 ~~~~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~------hp~iv~~~~~~~ 220 (447)
....+|+..+.||+|+||.|+. +++.||||+++.. .........|+.+++.+. |++++++++++.
T Consensus 126 ~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~ 201 (467)
T PTZ00284 126 VSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNV----PKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ 201 (467)
T ss_pred cCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecc----hhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence 3456789999999999999863 5788999998632 122334555676666664 456888888887
Q ss_pred eC-CceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeCCCCCCCEEEcCCC--------
Q 013214 221 QS-SPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHE-NKPVPIIHRDLEPSNILRDDSG-------- 290 (447)
Q Consensus 221 ~~-~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~-~~~~~i~H~Dikp~Nill~~~~-------- 290 (447)
.. ...|++||++ +++|.+++.+.+.+++..+..++.|++.||.|||+ .+ |+||||||+|||++.++
T Consensus 202 ~~~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~~~~ 277 (467)
T PTZ00284 202 NETGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDPVTN 277 (467)
T ss_pred cCCceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCcccccccc
Confidence 54 5689999998 78999999888889999999999999999999998 47 99999999999998765
Q ss_pred --------CEEEeecccccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCch
Q 013214 291 --------NLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV 362 (447)
Q Consensus 291 --------~vkl~Dfg~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~ 362 (447)
.+||+|||.+.... .......+|+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.
T Consensus 278 ~~~~~~~~~vkl~DfG~~~~~~----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~ 353 (467)
T PTZ00284 278 RALPPDPCRVRICDLGGCCDER----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEH 353 (467)
T ss_pred cccCCCCceEEECCCCccccCc----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 49999999876432 222345689999999999998999999999999999999999999987665433
Q ss_pred HHHHHhcC-C-------------------------CCCCC------------ChhhhHHHHHHHHHHHcccCCCCCCCHH
Q 013214 363 PKAYAARQ-R-------------------------PPFKA------------PAKLYARGLKELIEECWNEKPAKRPTFR 404 (447)
Q Consensus 363 ~~~~~~~~-~-------------------------~~~~~------------~~~~~~~~l~~li~~cl~~dp~~Rps~~ 404 (447)
...+.... . +.... .....++.+.+||.+||+.||++|||++
T Consensus 354 ~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~ 433 (467)
T PTZ00284 354 LHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNAR 433 (467)
T ss_pred HHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHH
Confidence 22221110 0 00000 0001235678999999999999999999
Q ss_pred HHHHH
Q 013214 405 QIITR 409 (447)
Q Consensus 405 ~~l~~ 409 (447)
++++|
T Consensus 434 e~L~H 438 (467)
T PTZ00284 434 QMTTH 438 (467)
T ss_pred HHhcC
Confidence 99974
No 244
>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1. Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom
Probab=100.00 E-value=1.2e-36 Score=285.44 Aligned_cols=233 Identities=24% Similarity=0.416 Sum_probs=186.9
Q ss_pred eeecceEEEEEEc-----------------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCc
Q 013214 162 EITKGTFILAFWR-----------------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224 (447)
Q Consensus 162 ~lg~G~~~~~~~~-----------------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 224 (447)
.||+|+||.++.. ...|++|.+... .......+.+|+.+++.++||||+++++++..+..
T Consensus 2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~---~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~ 78 (262)
T cd05077 2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS---HRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVE 78 (262)
T ss_pred ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh---hhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 5899999877632 235899987643 23445678889999999999999999999999999
Q ss_pred eEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCC-------EEEee
Q 013214 225 MMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN-------LKVAD 296 (447)
Q Consensus 225 ~~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~-------vkl~D 296 (447)
.+++|||+++|+|..++.+. ..+++..++.++.|++.||.|||+.+ ++||||||+||+++.++. ++++|
T Consensus 79 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d 155 (262)
T cd05077 79 NIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSD 155 (262)
T ss_pred CEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCC
Confidence 99999999999999998754 56899999999999999999999999 999999999999987664 89999
Q ss_pred cccccccccCCCCCcccCCCCCcccCCcccC-CCCCCCchhHHHHHHHHHHHH-hCCCCCCCCCCCchHHHHHhcCCCCC
Q 013214 297 FGVSKLLTVKEDRPLTCQDTSCRYVAPEVFK-NEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQRPPF 374 (447)
Q Consensus 297 fg~~~~~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~Di~slG~~l~~l~-tg~~p~~~~~~~~~~~~~~~~~~~~~ 374 (447)
||++...... ....++..|+|||.+. +..++.++||||||+++|+|+ +|..||......+..... ..... .
T Consensus 156 ~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~-~~~~~-~ 228 (262)
T cd05077 156 PGIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFY-EGQCM-L 228 (262)
T ss_pred CCCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHHH-hcCcc-C
Confidence 9998654321 2234678899999886 456888999999999999998 588898765544432221 11111 1
Q ss_pred CCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHH
Q 013214 375 KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRL 410 (447)
Q Consensus 375 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l 410 (447)
....++++.++|.+||+.||.+||++.++++++
T Consensus 229 ---~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 229 ---VTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred ---CCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 122357899999999999999999999999876
No 245
>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2. Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a
Probab=100.00 E-value=6e-37 Score=286.07 Aligned_cols=245 Identities=26% Similarity=0.463 Sum_probs=202.9
Q ss_pred cCcccceeeecceEEEEE---E--cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEE
Q 013214 155 LDFTNSVEITKGTFILAF---W--RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~---~--~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 229 (447)
.+|+..+.||+|++|.++ + +++.+++|.+... ...+++.+|+.+++.++||||+++++.+......++++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~-----~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~ 77 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVE-----EDLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVM 77 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecH-----HHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEE
Confidence 367778889999998765 2 3789999998643 22578899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 013214 230 EYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (447)
Q Consensus 230 e~~~~g~L~~~l~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~ 308 (447)
||+++++|.+++.. ...+++..+..++.|++.|+.|||+.+ ++|+||+|+||++++++.++|+|||++........
T Consensus 78 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (256)
T cd06612 78 EYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA 154 (256)
T ss_pred ecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc
Confidence 99999999999976 456899999999999999999999998 99999999999999999999999999886543321
Q ss_pred CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHH
Q 013214 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKEL 388 (447)
Q Consensus 309 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 388 (447)
......++..|+|||.+.+..++.++||||||+++|+|++|+.||......+....+.....+. ...+..++..+.++
T Consensus 155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 232 (256)
T cd06612 155 -KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPT-LSDPEKWSPEFNDF 232 (256)
T ss_pred -ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCC-CCchhhcCHHHHHH
Confidence 2223446888999999988889999999999999999999999998765544333332211222 22344577889999
Q ss_pred HHHHcccCCCCCCCHHHHHHH
Q 013214 389 IEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 389 i~~cl~~dp~~Rps~~~~l~~ 409 (447)
|.+||+.||++|||+.+++++
T Consensus 233 i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 233 VKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred HHHHHhcChhhCcCHHHHhcC
Confidence 999999999999999999863
No 246
>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2. Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re
Probab=100.00 E-value=1.7e-36 Score=284.84 Aligned_cols=248 Identities=26% Similarity=0.439 Sum_probs=200.2
Q ss_pred CcccceeeecceEEEEE-----EcCeEEEEEEcCccc--CCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeC--CceE
Q 013214 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEV--ISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--SPMM 226 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~--~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~~ 226 (447)
+|+..+.||+|+||.++ .+|..||+|.+.... .......+.+.+|+.++++++||||+++++++.+. ..++
T Consensus 3 ~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (265)
T cd06652 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLS 82 (265)
T ss_pred cceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEE
Confidence 57778899999999876 257899999875432 12334567888999999999999999999988764 4678
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccC
Q 013214 227 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306 (447)
Q Consensus 227 lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~ 306 (447)
++|||+++++|.+++.+...+++.....++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 83 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~ 159 (265)
T cd06652 83 IFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTI 159 (265)
T ss_pred EEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccccccc
Confidence 99999999999999988778899999999999999999999999 999999999999999999999999998754321
Q ss_pred CC--CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHH
Q 013214 307 ED--RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARG 384 (447)
Q Consensus 307 ~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (447)
.. .......++..|+|||.+.+..++.++|+||||+++|+|++|+.||............. ..+..+..+..++..
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~ 237 (265)
T cd06652 160 CLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIA--TQPTNPVLPPHVSDH 237 (265)
T ss_pred cccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHh--cCCCCCCCchhhCHH
Confidence 11 11223447888999999988888999999999999999999999998664433332221 122222334567788
Q ss_pred HHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 385 LKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 385 l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
+.+++.+|+. +|++||++++++++
T Consensus 238 ~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 238 CRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred HHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 9999999994 99999999998864
No 247
>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti
Probab=100.00 E-value=4.5e-37 Score=291.14 Aligned_cols=246 Identities=24% Similarity=0.411 Sum_probs=203.1
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|++.+.||.|++|.++. ++..+|+|..... .....+.+.+|+.++++++||||+++++.+..+...+++||
T Consensus 6 ~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (280)
T cd06611 6 IWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE---SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIE 82 (280)
T ss_pred HHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC---CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEee
Confidence 577888899999987752 5789999998643 44556778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 013214 231 YLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (447)
Q Consensus 231 ~~~~g~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~ 309 (447)
|+++++|.+++.+. ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++....... .
T Consensus 83 ~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-~ 158 (280)
T cd06611 83 FCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL-Q 158 (280)
T ss_pred ccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhcccc-c
Confidence 99999999998764 56999999999999999999999999 9999999999999999999999999886543221 1
Q ss_pred CcccCCCCCcccCCcccC-----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHH
Q 013214 310 PLTCQDTSCRYVAPEVFK-----NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARG 384 (447)
Q Consensus 310 ~~~~~~~t~~y~aPE~~~-----~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (447)
......+++.|+|||.+. ...++.++|+||||+++|+|++|+.||......+....+.....+.+ ..+..++.+
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 237 (280)
T cd06611 159 KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTL-DQPSKWSSS 237 (280)
T ss_pred ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCc-CCcccCCHH
Confidence 122345788999999874 23467799999999999999999999987765554444422222222 224457889
Q ss_pred HHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 385 LKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 385 l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
+.++|.+||+.+|.+||++.+++++
T Consensus 238 ~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 238 FNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred HHHHHHHHhccChhhCcCHHHHhcC
Confidence 9999999999999999999999875
No 248
>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with
Probab=100.00 E-value=1.1e-36 Score=284.27 Aligned_cols=245 Identities=26% Similarity=0.464 Sum_probs=204.2
Q ss_pred CcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|+..+.||+|++|.++ .+++.+|+|.+...... ......+.+|+.+++.++|||++++++.+...+..+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMT-KDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVME 79 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccc-cHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEe
Confidence 46778899999998776 36889999998765433 3446778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCC-CEEEeecccccccccCC
Q 013214 231 YLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG-NLKVADFGVSKLLTVKE 307 (447)
Q Consensus 231 ~~~~g~L~~~l~~~--~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~-~vkl~Dfg~~~~~~~~~ 307 (447)
|+++++|.+++.+. ..+++..+..++.|++.++.|||+++ ++|+||||+||++++++ .++|+|||.+.......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (256)
T cd08220 80 YAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS 156 (256)
T ss_pred cCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence 99999999999764 34889999999999999999999998 99999999999998654 57999999988654322
Q ss_pred CCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHH
Q 013214 308 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKE 387 (447)
Q Consensus 308 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 387 (447)
......++..|+|||.+.+..++.++|+||||+++|+|++|+.||...+.......+......++ +..+++.+.+
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~ 231 (256)
T cd08220 157 --KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPI---SDRYSPDLRQ 231 (256)
T ss_pred --cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCCC---CCCcCHHHHH
Confidence 22234568899999999888889999999999999999999999987766555444433333332 3346788999
Q ss_pred HHHHHcccCCCCCCCHHHHHHH
Q 013214 388 LIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 388 li~~cl~~dp~~Rps~~~~l~~ 409 (447)
++.+||+.||.+|||+.+++++
T Consensus 232 li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 232 LILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred HHHHHccCChhhCCCHHHHhhC
Confidence 9999999999999999999864
No 249
>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases. Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte
Probab=100.00 E-value=1.1e-36 Score=287.23 Aligned_cols=251 Identities=28% Similarity=0.485 Sum_probs=201.3
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCC-------CHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCC
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVIS-------DDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS 223 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~-------~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 223 (447)
+|...+.||.|++|.++. +|+.||+|.+...... .....+.+.+|+.+++.++|||++++++++....
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 466778999999998863 6889999987542211 1123456788999999999999999999999999
Q ss_pred ceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeeccccccc
Q 013214 224 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (447)
Q Consensus 224 ~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~ 303 (447)
..++++||+++++|.+++.+.+.+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++...
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~~~~ 158 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKS 158 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeeccccccc
Confidence 99999999999999999988888999999999999999999999998 999999999999999999999999998754
Q ss_pred ccCCC-CCcccCCCCCcccCCcccCCCC--CCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcC-CCCCCC-Ch
Q 013214 304 TVKED-RPLTCQDTSCRYVAPEVFKNEE--YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RPPFKA-PA 378 (447)
Q Consensus 304 ~~~~~-~~~~~~~~t~~y~aPE~~~~~~--~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~-~~~~~~-~~ 378 (447)
..... .......++..|+|||.+.... ++.++|+||||+++|++++|..||......+......... .+.++. ..
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (272)
T cd06629 159 DDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVS 238 (272)
T ss_pred cccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCcccc
Confidence 32211 1122345788999999987654 7889999999999999999999997554433222221111 222221 22
Q ss_pred hhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 379 KLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 379 ~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
..++..+.++|.+||..+|++||++.+++++
T Consensus 239 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 239 MNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred ccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 4567899999999999999999999999874
No 250
>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase. Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi
Probab=100.00 E-value=1e-36 Score=285.85 Aligned_cols=238 Identities=26% Similarity=0.430 Sum_probs=197.7
Q ss_pred eecceEEEEE---E--cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEeccCCCCH
Q 013214 163 ITKGTFILAF---W--RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237 (447)
Q Consensus 163 lg~G~~~~~~---~--~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L 237 (447)
||.|++|.++ . +++.+|+|.+...........+.+.+|+.+++.++||||+++++.+.+....++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 5778887654 3 4889999999765544455567889999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCCcccCCCC
Q 013214 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS 317 (447)
Q Consensus 238 ~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~t 317 (447)
.+++.+...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+....... ......++
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~~~~ 155 (262)
T cd05572 81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTFCGT 155 (262)
T ss_pred HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--ccccccCC
Confidence 999988878999999999999999999999998 9999999999999999999999999988664332 12234568
Q ss_pred CcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCC--CchHHHHHh-cCCCCCCCChhhhHHHHHHHHHHHcc
Q 013214 318 CRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHD--NEVPKAYAA-RQRPPFKAPAKLYARGLKELIEECWN 394 (447)
Q Consensus 318 ~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~--~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~ 394 (447)
..|++||.+.+..++.++|+||+|+++|+|++|..||..... .+....+.. .....+ +...++++.++|.+||+
T Consensus 156 ~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~i~~~l~ 232 (262)
T cd05572 156 PEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEF---PNYIDKAAKDLIKQLLR 232 (262)
T ss_pred cCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCC---CcccCHHHHHHHHHHcc
Confidence 889999999888889999999999999999999999987763 223333321 112222 33347899999999999
Q ss_pred cCCCCCCC-----HHHHHH
Q 013214 395 EKPAKRPT-----FRQIIT 408 (447)
Q Consensus 395 ~dp~~Rps-----~~~~l~ 408 (447)
.||++||+ ++++++
T Consensus 233 ~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 233 RNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred CChhhCcCCcccCHHHHhc
Confidence 99999999 777776
No 251
>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros. Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male
Probab=100.00 E-value=6.7e-37 Score=288.07 Aligned_cols=242 Identities=29% Similarity=0.527 Sum_probs=196.8
Q ss_pred eeecceEEEEEEc-----------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 162 EITKGTFILAFWR-----------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 162 ~lg~G~~~~~~~~-----------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
.||+|+||.|+.. +..+|+|.+.... .......+.+|+.+++.++||||+++++++......+++||
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA--TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIME 79 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhccc--chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEe
Confidence 5899999987621 2578999886432 23445678889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCC-----CEEEeecc
Q 013214 231 YLPKGDLRAFLKRK-------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG-----NLKVADFG 298 (447)
Q Consensus 231 ~~~~g~L~~~l~~~-------~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~-----~vkl~Dfg 298 (447)
|+++++|.+++.+. ..+++.++..++.|++.|+.|||+.+ ++|+||||+||+++.++ .++|+|||
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg 156 (269)
T cd05044 80 LMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFG 156 (269)
T ss_pred ccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCcc
Confidence 99999999999642 23788899999999999999999998 99999999999999877 89999999
Q ss_pred cccccccCCC-CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCCCC
Q 013214 299 VSKLLTVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKA 376 (447)
Q Consensus 299 ~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 376 (447)
++........ .......++..|+|||.+.+..++.++||||||+++|+|++ |+.||...+..+....+.......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~--- 233 (269)
T cd05044 157 LARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQ--- 233 (269)
T ss_pred cccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCccC---
Confidence 9875532211 11112234678999999988889999999999999999998 999998766555544443332222
Q ss_pred ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHH
Q 013214 377 PAKLYARGLKELIEECWNEKPAKRPTFRQIITRLE 411 (447)
Q Consensus 377 ~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~ 411 (447)
.+..+|..+.++|.+||+.+|.+||++.++++.|+
T Consensus 234 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 234 KPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred CcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 23456789999999999999999999999999876
No 252
>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1. Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25
Probab=100.00 E-value=5.5e-37 Score=290.16 Aligned_cols=244 Identities=29% Similarity=0.502 Sum_probs=201.7
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
.|+..+.||+|+||.++. +++.||+|.+.... .....+.+.+|+.+++.++||||+++++.+..+...++|+|
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIME 82 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEecccc--chHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEE
Confidence 355667899999988762 57899999887542 23455778999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCC
Q 013214 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (447)
Q Consensus 231 ~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~ 310 (447)
|+++++|.+++.. ..+++..+..++.|++.|+.|||+.+ ++|+||+|+||++++++.++|+|||++....... ..
T Consensus 83 ~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~-~~ 157 (277)
T cd06642 83 YLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-IK 157 (277)
T ss_pred ccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcc-hh
Confidence 9999999998864 56899999999999999999999998 9999999999999999999999999987654321 11
Q ss_pred cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHHH
Q 013214 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIE 390 (447)
Q Consensus 311 ~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 390 (447)
.....++..|+|||.+.+..++.++|+||||+++|+|++|+.||...........+.....+. ....++.++.+++.
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~ 234 (277)
T cd06642 158 RNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPT---LEGQYSKPFKEFVE 234 (277)
T ss_pred hhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCCC---CCcccCHHHHHHHH
Confidence 223356788999999988888999999999999999999999998665544433332222222 23356788999999
Q ss_pred HHcccCCCCCCCHHHHHHH
Q 013214 391 ECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 391 ~cl~~dp~~Rps~~~~l~~ 409 (447)
+||+.+|++||++.+++++
T Consensus 235 ~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 235 ACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred HHccCCcccCcCHHHHHHh
Confidence 9999999999999999985
No 253
>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase. Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina
Probab=100.00 E-value=2.5e-36 Score=284.16 Aligned_cols=246 Identities=28% Similarity=0.504 Sum_probs=195.1
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
++.....||+|+||.++. ++..||+|.+... .....+.+.+|+.+++.++||||+++++++..++..++++|
T Consensus 9 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 85 (268)
T cd06624 9 ENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPER---DSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFME 85 (268)
T ss_pred cCCceEEEecCCceEEEEeEecCCCcEEEEEEecCC---CHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEe
Confidence 444556899999998762 4678999988654 33455678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc-CCC--CHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcC-CCCEEEeecccccccccC
Q 013214 231 YLPKGDLRAFLKRK-GAL--KPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD-SGNLKVADFGVSKLLTVK 306 (447)
Q Consensus 231 ~~~~g~L~~~l~~~-~~l--~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~-~~~vkl~Dfg~~~~~~~~ 306 (447)
|+++++|.+++... ..+ ++..+..++.|++.|+.|||+.+ ++|+||||+||+++. ++.++|+|||++......
T Consensus 86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~ 162 (268)
T cd06624 86 QVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGI 162 (268)
T ss_pred cCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheecccC
Confidence 99999999999764 445 78888899999999999999998 999999999999986 679999999998755322
Q ss_pred CCCCcccCCCCCcccCCcccCCC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHH
Q 013214 307 EDRPLTCQDTSCRYVAPEVFKNE--EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARG 384 (447)
Q Consensus 307 ~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (447)
........+++.|+|||.+.+. .++.++|+||||+++|+|++|+.||............ .......+..+..++++
T Consensus 163 -~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 240 (268)
T cd06624 163 -NPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFK-VGMFKIHPEIPESLSAE 240 (268)
T ss_pred -CCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhh-hhhhccCCCCCcccCHH
Confidence 1222334578899999998654 3778999999999999999999999754432221111 11111111223456788
Q ss_pred HHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 385 LKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 385 l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
+.+++.+||+.+|.+|||+.+++.+
T Consensus 241 ~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 241 AKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred HHHHHHHHcCCCchhCCCHHHHHhC
Confidence 9999999999999999999999864
No 254
>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase. Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl
Probab=100.00 E-value=6.5e-37 Score=293.28 Aligned_cols=247 Identities=23% Similarity=0.416 Sum_probs=195.6
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|...+.||+|+||.++. +++.||+|.+...... .....+.+|+.+++.++||||+++++++..++..+++||
T Consensus 7 ~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 84 (301)
T cd07873 7 TYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEE--GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 84 (301)
T ss_pred ceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEeccccc--CchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence 578888999999998863 5789999998654321 223456789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 013214 231 YLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (447)
Q Consensus 231 ~~~~g~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~ 309 (447)
|++ ++|.+++.+. ..+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||++....... .
T Consensus 85 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~-~ 159 (301)
T cd07873 85 YLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT-K 159 (301)
T ss_pred ccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCC-C
Confidence 996 6899888764 45889999999999999999999999 9999999999999999999999999987543321 1
Q ss_pred CcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcC------------------
Q 013214 310 PLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ------------------ 370 (447)
Q Consensus 310 ~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~------------------ 370 (447)
......+++.|+|||.+.+. .++.++||||||+++|+|++|++||...+..+....+....
T Consensus 160 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (301)
T cd07873 160 TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFK 239 (301)
T ss_pred cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccccc
Confidence 12233468899999988654 57789999999999999999999998765433322211100
Q ss_pred ---CCCCC-----CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 371 ---RPPFK-----APAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 371 ---~~~~~-----~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
.+.+. .....+++.+.++|.+||+.||.+|||+++++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h 286 (301)
T cd07873 240 SYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH 286 (301)
T ss_pred ccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 00000 0112457789999999999999999999999873
No 255
>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4. Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin
Probab=100.00 E-value=1.4e-36 Score=291.28 Aligned_cols=255 Identities=23% Similarity=0.482 Sum_probs=205.1
Q ss_pred cCcccceeeecceEEEEEE-----cCe----EEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCce
Q 013214 155 LDFTNSVEITKGTFILAFW-----RGI----QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~-----~g~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 225 (447)
.+|+..+.||+|+||.++. +|. .||+|.+.... .......+.+|+.+++.++||||+++++++... ..
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~ 83 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT--GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TI 83 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cc
Confidence 4567778899999998763 343 57999886542 334445688999999999999999999998754 46
Q ss_pred EEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccc
Q 013214 226 MIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304 (447)
Q Consensus 226 ~lv~e~~~~g~L~~~l~~~~-~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~ 304 (447)
++++||+++|+|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++....
T Consensus 84 ~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~ 160 (303)
T cd05110 84 QLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLE 160 (303)
T ss_pred eeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEcccccccccc
Confidence 78999999999999997654 5889999999999999999999998 9999999999999999999999999998654
Q ss_pred cCCCC-CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCCCCChhhhH
Q 013214 305 VKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYA 382 (447)
Q Consensus 305 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 382 (447)
..... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||.+....+....+......+. +..++
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~ 237 (303)
T cd05110 161 GDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQ---PPICT 237 (303)
T ss_pred CcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCC---CCCCC
Confidence 32211 1122334678999999988889999999999999999997 9999987665444444433333322 23456
Q ss_pred HHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhh
Q 013214 383 RGLKELIEECWNEKPAKRPTFRQIITRLESINNSIN 418 (447)
Q Consensus 383 ~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~~~ 418 (447)
..+.+++.+||..+|++||++.++++.|+.+.....
T Consensus 238 ~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~~ 273 (303)
T cd05110 238 IDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDPQ 273 (303)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhchh
Confidence 789999999999999999999999999998765543
No 256
>PTZ00266 NIMA-related protein kinase; Provisional
Probab=100.00 E-value=6.7e-37 Score=321.71 Aligned_cols=249 Identities=22% Similarity=0.370 Sum_probs=197.7
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEe--CCceEE
Q 013214 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ--SSPMMI 227 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~l 227 (447)
.+|.+.+.||+|+||.|+. ++..||+|.+..... .......+..|+.+++.++||||++++++|.. ...+|+
T Consensus 13 ~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l-~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyI 91 (1021)
T PTZ00266 13 NEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGL-KEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYI 91 (1021)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEecccc-CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEE
Confidence 3788899999999998873 578899999876543 34455778899999999999999999998854 356899
Q ss_pred EEeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCC----CCeEeCCCCCCCEEEcC-----------
Q 013214 228 VTEYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKP----VPIIHRDLEPSNILRDD----------- 288 (447)
Q Consensus 228 v~e~~~~g~L~~~l~~----~~~l~~~~~~~i~~ql~~~l~~lH~~~~----~~i~H~Dikp~Nill~~----------- 288 (447)
||||+++|+|.+++.. .+.+++..++.|+.||+.||.|||+.+. .+|+|+||||+|||++.
T Consensus 92 VMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~ 171 (1021)
T PTZ00266 92 LMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQ 171 (1021)
T ss_pred EEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccccc
Confidence 9999999999999975 2569999999999999999999998531 23999999999999964
Q ss_pred ------CCCEEEeecccccccccCCCCCcccCCCCCcccCCcccCC--CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCC
Q 013214 289 ------SGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN--EEYDTKVDVFSFALILQEMIEGCPPFTMKHDN 360 (447)
Q Consensus 289 ------~~~vkl~Dfg~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~ 360 (447)
.+.+||+|||++....... ......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||......
T Consensus 172 ~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~ 249 (1021)
T PTZ00266 172 ANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNF 249 (1021)
T ss_pred ccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcH
Confidence 2348999999998654321 2233467999999999854 35788999999999999999999999865543
Q ss_pred chHHHHHhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 361 EVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
......... .+.+ ....++..+.+||..||+.+|.+||++.+++.+
T Consensus 250 ~qli~~lk~-~p~l--pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h 295 (1021)
T PTZ00266 250 SQLISELKR-GPDL--PIKGKSKELNILIKNLLNLSAKERPSALQCLGY 295 (1021)
T ss_pred HHHHHHHhc-CCCC--CcCCCCHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence 322222111 2222 123467889999999999999999999999953
No 257
>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]
Probab=100.00 E-value=1.4e-37 Score=299.95 Aligned_cols=252 Identities=30% Similarity=0.521 Sum_probs=220.8
Q ss_pred CcccceeeecceEEEEE---Ec--CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAF---WR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~---~~--g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
++.-..+||-|.||.|| |. ...||||.++.+. -.+++|..|..+|+.++|||+|+++|+|..+..+|||+|
T Consensus 268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt----MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTE 343 (1157)
T KOG4278|consen 268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITE 343 (1157)
T ss_pred heeeeeccCCCcccceeeeeeeccceeeehhhhhhcc----hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEe
Confidence 45556789999998775 43 4679999998543 346889999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 013214 231 YLPKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (447)
Q Consensus 231 ~~~~g~L~~~l~~~~~--l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~ 308 (447)
||..|+|.+||++..+ ++.-..+.++.||.+|+.||..++ +|||||..+|+|+.++..+|++|||+++.+..+..
T Consensus 344 fM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTY 420 (1157)
T KOG4278|consen 344 FMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTY 420 (1157)
T ss_pred cccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhhhcCCce
Confidence 9999999999987543 677777889999999999999998 99999999999999999999999999999876655
Q ss_pred CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHH
Q 013214 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKE 387 (447)
Q Consensus 309 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 387 (447)
........+..|.|||-+....++.|+|||+||++|||+.| |-.||.+.+..++...+....+..- +..+++.+.+
T Consensus 421 TAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~~---PeGCPpkVYe 497 (1157)
T KOG4278|consen 421 TAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMDG---PEGCPPKVYE 497 (1157)
T ss_pred ecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccccC---CCCCCHHHHH
Confidence 55555566888999999999899999999999999999998 9999999988877777766666553 5568899999
Q ss_pred HHHHHcccCCCCCCCHHHHHHHHHHHHhhh
Q 013214 388 LIEECWNEKPAKRPTFRQIITRLESINNSI 417 (447)
Q Consensus 388 li~~cl~~dp~~Rps~~~~l~~l~~~~~~~ 417 (447)
||+.||+.+|.+||++.++-+.++.+..+-
T Consensus 498 LMraCW~WsPsDRPsFaeiHqafEtmf~~s 527 (1157)
T KOG4278|consen 498 LMRACWNWSPSDRPSFAEIHQAFETMFSSS 527 (1157)
T ss_pred HHHHHhcCCcccCccHHHHHHHHHHHhccc
Confidence 999999999999999999999999987654
No 258
>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases. Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut
Probab=100.00 E-value=1.7e-36 Score=287.37 Aligned_cols=253 Identities=25% Similarity=0.481 Sum_probs=201.7
Q ss_pred cCcccceeeecceEEEEEE---------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEe--CC
Q 013214 155 LDFTNSVEITKGTFILAFW---------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ--SS 223 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~---------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~ 223 (447)
..|+..+.||+|+||.++. ++..||+|.+..... ....+.+.+|+.+++.++||||+++++++.. ..
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~ 81 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGE--EQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGR 81 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccc--hHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCC
Confidence 3566778899999998762 267899999975532 2456789999999999999999999999877 55
Q ss_pred ceEEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccc
Q 013214 224 PMMIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 302 (447)
Q Consensus 224 ~~~lv~e~~~~g~L~~~l~~~~-~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~ 302 (447)
..+++|||+++++|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||.+..
T Consensus 82 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05038 82 SLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKV 158 (284)
T ss_pred ceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccc
Confidence 7899999999999999997754 5899999999999999999999999 99999999999999999999999999987
Q ss_pred cccCCCC--CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCch-----------HHHHH--
Q 013214 303 LTVKEDR--PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV-----------PKAYA-- 367 (447)
Q Consensus 303 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~-----------~~~~~-- 367 (447)
....... ......++..|+|||.+.+..++.++|+||||+++|+|++|+.|+........ .....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05038 159 LPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLEL 238 (284)
T ss_pred cccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHH
Confidence 6522111 11123345679999999888899999999999999999999999865432210 11110
Q ss_pred hcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHH
Q 013214 368 ARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 413 (447)
Q Consensus 368 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~ 413 (447)
.......+ .+..++.++.+++.+||+.+|++||++.++++.|+.+
T Consensus 239 ~~~~~~~~-~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 239 LKEGERLP-RPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHcCCcCC-CCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 01111111 1334568899999999999999999999999999875
No 259
>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi
Probab=100.00 E-value=1.6e-36 Score=284.21 Aligned_cols=246 Identities=24% Similarity=0.447 Sum_probs=203.4
Q ss_pred CcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEe--CCceEEE
Q 013214 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ--SSPMMIV 228 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~lv 228 (447)
+|+..+.||.|+||.++ .+|+.||+|.+..... .....+.+.+|+.+++.++||||+++++.+.. ....+++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM-TEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIV 79 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEE
Confidence 36667889999999876 3678999999876543 34556778899999999999999999998764 3457999
Q ss_pred EeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH-----hCCCCCeEeCCCCCCCEEEcCCCCEEEeeccc
Q 013214 229 TEYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLH-----ENKPVPIIHRDLEPSNILRDDSGNLKVADFGV 299 (447)
Q Consensus 229 ~e~~~~g~L~~~l~~----~~~l~~~~~~~i~~ql~~~l~~lH-----~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~ 299 (447)
+||+++++|.+++.. ..++++..++.++.|++.||.||| +.+ ++|+||||+||+++.++.+||+|||+
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~~kl~d~g~ 156 (265)
T cd08217 80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNNVKLGDFGL 156 (265)
T ss_pred ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCCEEEecccc
Confidence 999999999999975 356899999999999999999999 776 99999999999999999999999999
Q ss_pred ccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChh
Q 013214 300 SKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAK 379 (447)
Q Consensus 300 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (447)
+........ ......+++.|+|||.+.+..++.++|+||||+++|+|++|+.||...+..+....+..... +..+.
T Consensus 157 ~~~~~~~~~-~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~ 232 (265)
T cd08217 157 AKILGHDSS-FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKF---RRIPY 232 (265)
T ss_pred cccccCCcc-cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCC---CCCcc
Confidence 887653321 12234578899999999888889999999999999999999999998765444444433222 23345
Q ss_pred hhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 380 LYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 380 ~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
.++..+.+++.+||+.+|++||++.+++++
T Consensus 233 ~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 233 RYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred ccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 678899999999999999999999999874
No 260
>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3. Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding
Probab=100.00 E-value=7.6e-37 Score=292.23 Aligned_cols=248 Identities=21% Similarity=0.430 Sum_probs=203.8
Q ss_pred CCcCcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEE
Q 013214 153 HELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227 (447)
Q Consensus 153 ~~~~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 227 (447)
...+|+..+.||.|++|.++ .+++.||+|.+..... ...+.+.+|+.+++.++||||+++++++......++
T Consensus 17 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l 93 (297)
T cd06656 17 PKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWV 93 (297)
T ss_pred hhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc---chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEE
Confidence 34578888999999999876 3689999999865432 233567889999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCC
Q 013214 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307 (447)
Q Consensus 228 v~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~ 307 (447)
+|||+++++|.+++.+ ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 94 v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~ 169 (297)
T cd06656 94 VMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (297)
T ss_pred eecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCc
Confidence 9999999999999865 45888999999999999999999998 9999999999999999999999999987543321
Q ss_pred CCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHH
Q 013214 308 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKE 387 (447)
Q Consensus 308 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 387 (447)
.......+++.|+|||.+.+..++.++|+||||+++|++++|+.||...+.............+.. ..+..++..+.+
T Consensus 170 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 247 (297)
T cd06656 170 -SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPEL-QNPERLSAVFRD 247 (297)
T ss_pred -cCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCC-CCccccCHHHHH
Confidence 112234578899999999888889999999999999999999999976654333222222222222 224456788999
Q ss_pred HHHHHcccCCCCCCCHHHHHHH
Q 013214 388 LIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 388 li~~cl~~dp~~Rps~~~~l~~ 409 (447)
++.+||..||++||++.+++++
T Consensus 248 li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 248 FLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred HHHHHccCChhhCcCHHHHhcC
Confidence 9999999999999999999984
No 261
>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases. Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include
Probab=100.00 E-value=7.5e-37 Score=290.32 Aligned_cols=247 Identities=24% Similarity=0.443 Sum_probs=202.6
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEE
Q 013214 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 229 (447)
.+|+..+.||+|+||.++. +|+.||+|++.... .......+.+|+.+++.++||||+++++++......++++
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA--KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCM 82 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC--cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEE
Confidence 3677788999999998862 48899999886542 3344577889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 013214 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHE-NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (447)
Q Consensus 230 e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~-~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~ 308 (447)
||+++++|.+++.+.+.+++..+..++.+++.|+.|||+ .+ ++|+||||+||++++++.++|+|||++......
T Consensus 83 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~-- 157 (284)
T cd06620 83 EFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGELINS-- 157 (284)
T ss_pred ecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccchhhh--
Confidence 999999999999888889999999999999999999997 46 999999999999999999999999998654321
Q ss_pred CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCC-----------chHHHHHhcCCCCCCCC
Q 013214 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDN-----------EVPKAYAARQRPPFKAP 377 (447)
Q Consensus 309 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~-----------~~~~~~~~~~~~~~~~~ 377 (447)
......++..|+|||.+.+..++.++|+|||||++|++++|+.||...... +..........+.+ .
T Consensus 158 -~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~ 234 (284)
T cd06620 158 -IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRL--P 234 (284)
T ss_pred -ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCC--C
Confidence 112345788999999998888899999999999999999999999865542 11111111112222 1
Q ss_pred hhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHH
Q 013214 378 AKLYARGLKELIEECWNEKPAKRPTFRQIITRLE 411 (447)
Q Consensus 378 ~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~ 411 (447)
...++..+.+++.+||+.||++||++.+++++..
T Consensus 235 ~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~ 268 (284)
T cd06620 235 SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPP 268 (284)
T ss_pred chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence 2236778999999999999999999999998743
No 262
>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins. Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of
Probab=100.00 E-value=2.2e-36 Score=283.45 Aligned_cols=248 Identities=28% Similarity=0.459 Sum_probs=205.1
Q ss_pred CcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|...+.||+|++|.++ .+++.|++|++..... ......+.+|+..+..++|||++++++++......++++|
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGD--EEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLE 79 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcc--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEE
Confidence 46677889999998765 2589999999876532 2556788999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 013214 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHE-NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (447)
Q Consensus 231 ~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~-~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~ 309 (447)
|+++++|.+++.....+++...+.++.|++.|+.|||+ .+ ++|+||+|+||+++.++.++|+|||++.........
T Consensus 80 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~ 156 (264)
T cd06623 80 YMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ 156 (264)
T ss_pred ecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCCCc
Confidence 99999999999888889999999999999999999999 98 999999999999999999999999998865433221
Q ss_pred CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhh-hHHHHHHH
Q 013214 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKL-YARGLKEL 388 (447)
Q Consensus 310 ~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~l 388 (447)
.....++..|+|||.+.+..++.++|+||||+++|+|++|+.||.......................... ++..+.++
T Consensus 157 -~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 235 (264)
T cd06623 157 -CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDF 235 (264)
T ss_pred -ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCCHHHHHH
Confidence 1234567889999999888889999999999999999999999987753222222211112222222334 78899999
Q ss_pred HHHHcccCCCCCCCHHHHHHH
Q 013214 389 IEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 389 i~~cl~~dp~~Rps~~~~l~~ 409 (447)
|.+||..+|++||++.+++++
T Consensus 236 i~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 236 ISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred HHHHccCChhhCCCHHHHHhC
Confidence 999999999999999999975
No 263
>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2
Probab=100.00 E-value=7.8e-37 Score=290.11 Aligned_cols=248 Identities=27% Similarity=0.441 Sum_probs=194.1
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|+..+.||+|++|.++. +++.||+|.+..... .......+.+|+.++++++||||+++++++..+...++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESE-EEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFE 79 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccc-cCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEe
Confidence 466778899999987763 588999999875432 22233567789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCC
Q 013214 231 YLPKGDLRAFLKRK---GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307 (447)
Q Consensus 231 ~~~~g~L~~~l~~~---~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~ 307 (447)
|++ ++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 155 (285)
T cd07861 80 FLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV 155 (285)
T ss_pred cCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence 996 6898888643 45899999999999999999999999 9999999999999999999999999987554321
Q ss_pred CCCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHh-cC---------------
Q 013214 308 DRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA-RQ--------------- 370 (447)
Q Consensus 308 ~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~-~~--------------- 370 (447)
.......+++.|+|||.+.+. .++.++|+||||+++|+|++|+.||.............. ..
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (285)
T cd07861 156 -RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPD 234 (285)
T ss_pred -ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHH
Confidence 122233457889999987654 568899999999999999999999986543221111100 00
Q ss_pred ---------CCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 371 ---------RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 371 ---------~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
..........+++++.++|++||+.||.+|||+.+++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 235 YKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred HHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 000001123467889999999999999999999999864
No 264
>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio
Probab=100.00 E-value=8.1e-37 Score=290.07 Aligned_cols=249 Identities=23% Similarity=0.391 Sum_probs=198.5
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|+....||+|++|.++. +|+.||+|++..... .....+.+.+|+.++++++|||++++++++......+++||
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESED-DPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred ceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeeccc-CccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 467778899999987753 588999998865432 22233557889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCC
Q 013214 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (447)
Q Consensus 231 ~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~ 310 (447)
|+++++|..+......+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||++........ .
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-~ 156 (286)
T cd07847 81 YCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPGD-D 156 (286)
T ss_pred ccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCcc-c
Confidence 9999888888777677999999999999999999999998 99999999999999999999999999986543221 2
Q ss_pred cccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcC-------------------
Q 013214 311 LTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ------------------- 370 (447)
Q Consensus 311 ~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~------------------- 370 (447)
.....++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||.+....+....+....
T Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (286)
T cd07847 157 YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKG 236 (286)
T ss_pred ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccccc
Confidence 223456788999999866 457889999999999999999999998766543322221100
Q ss_pred --CCCCC------CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 371 --RPPFK------APAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 371 --~~~~~------~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
.+... .....++..+.+++.+||+.+|++||++.+++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 237 LSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred ccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 00000 0012456789999999999999999999998864
No 265
>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase. Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea
Probab=100.00 E-value=2e-36 Score=287.43 Aligned_cols=249 Identities=27% Similarity=0.436 Sum_probs=199.9
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|+..+.||+|++|.++. +|+.||+|++...... ......+.+|+.++++++||||+++++++......++|+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e 79 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLE-GGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVME 79 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEccccc-chhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEec
Confidence 467778999999987763 6889999998765432 3345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 013214 231 YLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (447)
Q Consensus 231 ~~~~g~L~~~l~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~ 309 (447)
|+ +++|.+++.. ...+++.+++.++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||++.........
T Consensus 80 ~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~ 155 (286)
T cd07832 80 YM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPR 155 (286)
T ss_pred cc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCC
Confidence 99 9999999865 456899999999999999999999999 999999999999999999999999998866543322
Q ss_pred CcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcC-CC---------------
Q 013214 310 PLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RP--------------- 372 (447)
Q Consensus 310 ~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~-~~--------------- 372 (447)
......++..|+|||.+.+. .++.++||||+|+++|+|++|.+||......+....+.... .+
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T cd07832 156 LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYN 235 (286)
T ss_pred ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhh
Confidence 33445678899999998654 46889999999999999999988887655433322221110 00
Q ss_pred --CC--------CCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 373 --PF--------KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 373 --~~--------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
.+ ....+..+..+.+++.+||+.||++||++++++.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 236 KITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred cccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00 00112356889999999999999999999999875
No 266
>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=4.6e-38 Score=303.88 Aligned_cols=245 Identities=24% Similarity=0.413 Sum_probs=208.7
Q ss_pred cccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEec
Q 013214 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (447)
Q Consensus 157 ~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 231 (447)
+.+...||.|+||.||. ++...|.|++. ..+++.+++|.-|+.+|..+.||+|+++++.|..++.+|++.||
T Consensus 34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIe---tkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEF 110 (1187)
T KOG0579|consen 34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIE---TKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEF 110 (1187)
T ss_pred HHHHhhhcCccchhhhhhhcccchhhhhhhhhc---ccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEee
Confidence 44556899999999874 34455667663 34677889999999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCC
Q 013214 232 LPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (447)
Q Consensus 232 ~~~g~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~ 310 (447)
|.||.+...+-+- ..+.+.++..++.|++.||.|||+++ |||||||..|||++-+|.++|+|||.+...... ...
T Consensus 111 C~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t-~qk 186 (1187)
T KOG0579|consen 111 CGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKST-RQK 186 (1187)
T ss_pred cCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccchhH-Hhh
Confidence 9999998888664 56999999999999999999999999 999999999999999999999999987643221 122
Q ss_pred cccCCCCCcccCCcccC-----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHH
Q 013214 311 LTCQDTSCRYVAPEVFK-----NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGL 385 (447)
Q Consensus 311 ~~~~~~t~~y~aPE~~~-----~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 385 (447)
..++.|||.|||||+.. ..+|+.++||||||++|.+|..+.+|....++..+...+.. ..|+.-..+..++..+
T Consensus 187 RDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaK-SePPTLlqPS~Ws~~F 265 (1187)
T KOG0579|consen 187 RDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAK-SEPPTLLQPSHWSRSF 265 (1187)
T ss_pred hccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhh-cCCCcccCcchhhhHH
Confidence 35678999999999864 45899999999999999999999999998888877776633 3444445577899999
Q ss_pred HHHHHHHcccCCCCCCCHHHHHHH
Q 013214 386 KELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 386 ~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
.+++.+||..||..||++.+++++
T Consensus 266 ~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 266 SDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred HHHHHHHHhcCCccCCCHHHHhhC
Confidence 999999999999999999999876
No 267
>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p
Probab=100.00 E-value=2.2e-36 Score=291.74 Aligned_cols=241 Identities=23% Similarity=0.388 Sum_probs=181.7
Q ss_pred ceeeecceEEEEEE-------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEe--CCceEEEEe
Q 013214 160 SVEITKGTFILAFW-------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ--SSPMMIVTE 230 (447)
Q Consensus 160 ~~~lg~G~~~~~~~-------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~lv~e 230 (447)
...||+|+||.|+. +++.||+|.+..... ...+.+|+.++++++||||+++++.+.. +...++++|
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD 80 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-----cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEe
Confidence 35799999998863 457899999865432 1346789999999999999999998854 456899999
Q ss_pred ccCCCCHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEE----cCCCCEEEeec
Q 013214 231 YLPKGDLRAFLKRK---------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR----DDSGNLKVADF 297 (447)
Q Consensus 231 ~~~~g~L~~~l~~~---------~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill----~~~~~vkl~Df 297 (447)
|+ +++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||||+|||+ +..+.+||+||
T Consensus 81 ~~-~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~Df 156 (317)
T cd07868 81 YA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADM 156 (317)
T ss_pred cc-CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeec
Confidence 99 56898887532 24889999999999999999999999 9999999999999 45678999999
Q ss_pred ccccccccCCC--CCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCc---------hHHH
Q 013214 298 GVSKLLTVKED--RPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNE---------VPKA 365 (447)
Q Consensus 298 g~~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~---------~~~~ 365 (447)
|++........ .......+|+.|+|||++.+. .++.++||||+||++|+|++|++||....... ....
T Consensus 157 G~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~ 236 (317)
T cd07868 157 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDR 236 (317)
T ss_pred CceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHH
Confidence 99986543211 122345678999999998764 57889999999999999999999997543210 0000
Q ss_pred H-HhcCCCC------------------------CC---------CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 366 Y-AARQRPP------------------------FK---------APAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 366 ~-~~~~~~~------------------------~~---------~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
+ ...+.+. .. ......+..+.++|.+||+.||.+|||+++++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~h 314 (317)
T cd07868 237 IFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD 314 (317)
T ss_pred HHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0 0000000 00 0000123467899999999999999999999864
No 268
>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase. Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is
Probab=100.00 E-value=6.8e-37 Score=298.65 Aligned_cols=244 Identities=25% Similarity=0.365 Sum_probs=192.6
Q ss_pred CcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeC------Cc
Q 013214 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS------SP 224 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~------~~ 224 (447)
+|+..+.||+|+||.|+ .+++.||+|.+..... .......+.+|+.+++.++||||+++++++... ..
T Consensus 16 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 94 (343)
T cd07878 16 RYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQ-SLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNE 94 (343)
T ss_pred hhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhh-hhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCc
Confidence 67888899999999886 3578999999875432 223345677899999999999999999887533 34
Q ss_pred eEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccc
Q 013214 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304 (447)
Q Consensus 225 ~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~ 304 (447)
.++++|++ +++|.+++. ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++....
T Consensus 95 ~~~~~~~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~ 169 (343)
T cd07878 95 VYLVTNLM-GADLNNIVK-CQKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQAD 169 (343)
T ss_pred EEEEeecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCccceecC
Confidence 78999998 789988775 456999999999999999999999999 9999999999999999999999999988654
Q ss_pred cCCCCCcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcC-C-----------
Q 013214 305 VKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-R----------- 371 (447)
Q Consensus 305 ~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~-~----------- 371 (447)
.. .....+|+.|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+..+....+.... .
T Consensus 170 ~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (343)
T cd07878 170 DE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISS 245 (343)
T ss_pred CC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcch
Confidence 22 233467899999999876 468889999999999999999999998655433222211100 0
Q ss_pred ----------CCCCC-----ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 372 ----------PPFKA-----PAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 372 ----------~~~~~-----~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
+..+. .....++.+.+++.+||..||.+|||+.+++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 246 EHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred hhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000 011245568899999999999999999999975
No 269
>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase. Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun
Probab=100.00 E-value=2.7e-36 Score=286.72 Aligned_cols=245 Identities=24% Similarity=0.432 Sum_probs=201.3
Q ss_pred CcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
.|...+.||+|++|.++ .+++.+++|.+... .....+.+.+|+.+++.++||||+++++++...+..++++|
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e 96 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR---KQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVME 96 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEecc---chhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEe
Confidence 34455689999998775 25788999988533 33344667889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCC
Q 013214 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (447)
Q Consensus 231 ~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~ 310 (447)
|+++++|.+++.. +++++..+..++.|++.|+.|||+.+ ++||||+|+||+++.++.++|+|||.+........ .
T Consensus 97 ~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-~ 171 (285)
T cd06648 97 FLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-R 171 (285)
T ss_pred ccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCc-c
Confidence 9999999999877 67899999999999999999999999 99999999999999999999999998765432211 1
Q ss_pred cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHHH
Q 013214 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIE 390 (447)
Q Consensus 311 ~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 390 (447)
.....+++.|+|||.+.+..++.++|+||||+++|+|++|+.||...+..+....+... .++.......++..+.+++.
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~ 250 (285)
T cd06648 172 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDN-LPPKLKNLHKVSPRLRSFLD 250 (285)
T ss_pred cccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhc-CCCCCcccccCCHHHHHHHH
Confidence 12345788999999998888899999999999999999999999876655444444322 22222223346788999999
Q ss_pred HHcccCCCCCCCHHHHHHH
Q 013214 391 ECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 391 ~cl~~dp~~Rps~~~~l~~ 409 (447)
+||+.+|++||++.+++++
T Consensus 251 ~~l~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 251 RMLVRDPAQRATAAELLNH 269 (285)
T ss_pred HHcccChhhCcCHHHHccC
Confidence 9999999999999999863
No 270
>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi
Probab=100.00 E-value=1.9e-36 Score=286.79 Aligned_cols=240 Identities=23% Similarity=0.352 Sum_probs=189.1
Q ss_pred eecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHh---cCCCCcccceeEEEEeCCceEEEEeccCC
Q 013214 163 ITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQ---KIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234 (447)
Q Consensus 163 lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~---~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 234 (447)
||+|+||.|+ .+|+.+|+|.+.............+.+|..+++ ..+||+|+.+++.+...+..++||||+++
T Consensus 2 lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (279)
T cd05633 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMNG 81 (279)
T ss_pred cccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCCC
Confidence 7999999886 257899999887654332222233344444433 34799999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCCcccC
Q 013214 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQ 314 (447)
Q Consensus 235 g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~ 314 (447)
++|.+++..++.+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||++...... .....
T Consensus 82 ~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~---~~~~~ 155 (279)
T cd05633 82 GDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK---KPHAS 155 (279)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceecccc---CccCc
Confidence 999999988888999999999999999999999999 999999999999999999999999998754322 11234
Q ss_pred CCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHHHHHc
Q 013214 315 DTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECW 393 (447)
Q Consensus 315 ~~t~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 393 (447)
.++..|+|||.+.+ ..++.++|+||+|+++|+|++|..||................... ...+..++..+.++|.+||
T Consensus 156 ~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l 234 (279)
T cd05633 156 VGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVN-VELPDSFSPELKSLLEGLL 234 (279)
T ss_pred CCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCC-cCCccccCHHHHHHHHHHh
Confidence 57899999999864 467899999999999999999999997655433222111111111 1123457789999999999
Q ss_pred ccCCCCCC-----CHHHHHHH
Q 013214 394 NEKPAKRP-----TFRQIITR 409 (447)
Q Consensus 394 ~~dp~~Rp-----s~~~~l~~ 409 (447)
..||.+|| ++++++++
T Consensus 235 ~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 235 QRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred cCCHHHhcCCCCCCHHHHHhC
Confidence 99999999 58888775
No 271
>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin. Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear
Probab=100.00 E-value=2.5e-36 Score=286.90 Aligned_cols=249 Identities=27% Similarity=0.416 Sum_probs=196.3
Q ss_pred CCcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeEEEE-----e
Q 013214 153 HELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVT-----Q 221 (447)
Q Consensus 153 ~~~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~-----~ 221 (447)
...+|+..+.||+|+||.++. +++.+|+|...... .....+.+|+.+++.+ +||||+++++++. .
T Consensus 16 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~ 91 (286)
T cd06638 16 PSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH----DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKN 91 (286)
T ss_pred cccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc----chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCC
Confidence 455788889999999998763 67899999875421 2235677899999999 6999999999874 3
Q ss_pred CCceEEEEeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeec
Q 013214 222 SSPMMIVTEYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297 (447)
Q Consensus 222 ~~~~~lv~e~~~~g~L~~~l~~----~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Df 297 (447)
....+++|||+++++|.+++.. ...+++..+..++.|++.|+.|||+.+ ++|+||||+||++++++.++|+||
T Consensus 92 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~kl~df 168 (286)
T cd06638 92 GDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKLVDF 168 (286)
T ss_pred CCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEEEccC
Confidence 4568999999999999998753 345888999999999999999999998 999999999999999999999999
Q ss_pred ccccccccCCCCCcccCCCCCcccCCcccCC-----CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCC
Q 013214 298 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-----EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRP 372 (447)
Q Consensus 298 g~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-----~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~ 372 (447)
|++....... .......+++.|+|||.+.. ..++.++|+||+||++|+|++|+.||.................+
T Consensus 169 g~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~ 247 (286)
T cd06638 169 GVSAQLTSTR-LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPP 247 (286)
T ss_pred CceeecccCC-CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccCCC
Confidence 9987654321 12223457899999998753 34788999999999999999999999876543332222111111
Q ss_pred CCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHH
Q 013214 373 PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRL 410 (447)
Q Consensus 373 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l 410 (447)
.. ..+..++..+.++|.+||+.||++|||+.+++++.
T Consensus 248 ~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 248 TL-HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred cc-cCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 11 12334567899999999999999999999998763
No 272
>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase. Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ
Probab=100.00 E-value=1.2e-36 Score=286.73 Aligned_cols=246 Identities=26% Similarity=0.429 Sum_probs=195.5
Q ss_pred CcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeEEEEeC-----
Q 013214 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQS----- 222 (447)
Q Consensus 154 ~~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~----- 222 (447)
+..|...+.||+|+||.++. +++.||+|.+.... .....+..|+.+++++ +||||+++++++...
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (272)
T cd06637 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM 80 (272)
T ss_pred hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC----ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCC
Confidence 44577778899999998763 57899999986432 2235677899999998 799999999998753
Q ss_pred -CceEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeeccc
Q 013214 223 -SPMMIVTEYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGV 299 (447)
Q Consensus 223 -~~~~lv~e~~~~g~L~~~l~~~--~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~ 299 (447)
...+++|||+.+++|.+++... ..+++..+..++.|++.|+.|||+.+ ++|+||||+||++++++.++|+|||+
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~ 157 (272)
T cd06637 81 DDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGV 157 (272)
T ss_pred CcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCC
Confidence 4589999999999999999864 35889999999999999999999998 99999999999999999999999999
Q ss_pred ccccccCCCCCcccCCCCCcccCCcccCC-----CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCC
Q 013214 300 SKLLTVKEDRPLTCQDTSCRYVAPEVFKN-----EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPF 374 (447)
Q Consensus 300 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-----~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~ 374 (447)
+....... .......++..|+|||.+.+ ..++.++|+|||||++|+|++|..||...................
T Consensus 158 ~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~- 235 (272)
T cd06637 158 SAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPR- 235 (272)
T ss_pred ceeccccc-ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCC-
Confidence 87653221 12233457889999999862 357789999999999999999999997655433332222211111
Q ss_pred CCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 375 KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 375 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
.....++..+.+++.+||..||.+|||+.+++++
T Consensus 236 -~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 236 -LKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred -CCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 1233567889999999999999999999998864
No 273
>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3. Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac
Probab=100.00 E-value=4.2e-36 Score=283.25 Aligned_cols=250 Identities=29% Similarity=0.476 Sum_probs=199.1
Q ss_pred cccceeeecceEEEEEE--------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCC-----
Q 013214 157 FTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS----- 223 (447)
Q Consensus 157 ~~~~~~lg~G~~~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~----- 223 (447)
|...+.||+|+||.++. +++.||+|.+..+.. .....+++.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 79 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIF-SSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRL 79 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccC-ChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcc
Confidence 44566899999987762 368899999876543 3445677889999999999999999999886532
Q ss_pred -ceEEEEeccCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEee
Q 013214 224 -PMMIVTEYLPKGDLRAFLKRK------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296 (447)
Q Consensus 224 -~~~lv~e~~~~g~L~~~l~~~------~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~D 296 (447)
..++++||+.+|+|.+++... ..++......++.|++.|+.|||+.+ ++|+||||+||+++.++.+||+|
T Consensus 80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~d 156 (273)
T cd05074 80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVAD 156 (273)
T ss_pred cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECc
Confidence 247889999999999887532 14788899999999999999999998 99999999999999999999999
Q ss_pred cccccccccCCCC-CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCC
Q 013214 297 FGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPF 374 (447)
Q Consensus 297 fg~~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~ 374 (447)
||.+......... ......+++.|++||.+....++.++||||||+++|+|++ |+.||...+..+....+........
T Consensus 157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~ 236 (273)
T cd05074 157 FGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQ 236 (273)
T ss_pred ccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcCCC
Confidence 9998865322111 1122334678999999988888999999999999999999 8999987665544444433322221
Q ss_pred CCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHH
Q 013214 375 KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 413 (447)
Q Consensus 375 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~ 413 (447)
+...++.+.+++.+||+.+|++|||+.++++.|+.+
T Consensus 237 ---~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 237 ---PPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred ---CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 234667899999999999999999999999999875
No 274
>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]
Probab=100.00 E-value=1.5e-37 Score=302.18 Aligned_cols=252 Identities=25% Similarity=0.511 Sum_probs=203.8
Q ss_pred ccCCCCcCcccceeeecceEEEEEE-----cCeEEEEEEcCc-ccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeC
Q 013214 149 EIDPHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGE-EVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS 222 (447)
Q Consensus 149 ~i~~~~~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~-~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 222 (447)
+.++...-.+....||+|+|-+||. +|..||=-.++. +....+...++|..|+.+|+.++||||+++|.+|.+.
T Consensus 34 e~~p~gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~ 113 (632)
T KOG0584|consen 34 EKDPTGRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDT 113 (632)
T ss_pred ccCCCCceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecC
Confidence 4444443445566899999988874 566665222211 1234566778999999999999999999999999876
Q ss_pred Cc--eEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEc-CCCCEEEeeccc
Q 013214 223 SP--MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVADFGV 299 (447)
Q Consensus 223 ~~--~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~-~~~~vkl~Dfg~ 299 (447)
.. +.+|+|.+..|+|..|+++.+..+......|++||+.||.|||++.| ||+|||||.+||+|+ ..|.|||+|+|+
T Consensus 114 ~n~~in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~P-PIIHRDLKCDNIFinG~~G~VKIGDLGL 192 (632)
T KOG0584|consen 114 DNKTINFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDP-PIIHRDLKCDNIFVNGNLGEVKIGDLGL 192 (632)
T ss_pred CCceeeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCC-CccccccccceEEEcCCcCceeecchhH
Confidence 55 88999999999999999999999999999999999999999999995 899999999999998 678999999999
Q ss_pred ccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCC-chHHHHHhcCCCCCCCCh
Q 013214 300 SKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDN-EVPKAYAARQRPPFKAPA 378 (447)
Q Consensus 300 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~ 378 (447)
|...... ......|||.|||||++. ..|+..+||||||++++||.|+..||.--... ++.+.+..+..|.-- .
T Consensus 193 Atl~r~s---~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl--~ 266 (632)
T KOG0584|consen 193 ATLLRKS---HAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAAL--S 266 (632)
T ss_pred HHHhhcc---ccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHh--h
Confidence 9876532 223468999999999986 68999999999999999999999999866554 444555344344321 1
Q ss_pred hhhHHHHHHHHHHHcccCCCCCCCHHHHHH
Q 013214 379 KLYARGLKELIEECWNEKPAKRPTFRQIIT 408 (447)
Q Consensus 379 ~~~~~~l~~li~~cl~~dp~~Rps~~~~l~ 408 (447)
..-.++++++|.+|+.. ..+|||+.++++
T Consensus 267 kV~dPevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 267 KVKDPEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred ccCCHHHHHHHHHHhcC-chhccCHHHHhh
Confidence 12247899999999999 899999999996
No 275
>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do
Probab=100.00 E-value=1.9e-36 Score=283.62 Aligned_cols=240 Identities=26% Similarity=0.365 Sum_probs=191.8
Q ss_pred eeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHH-hcCCCCcccceeEEEEeCCceEEEEeccCC
Q 013214 161 VEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALL-QKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234 (447)
Q Consensus 161 ~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l-~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 234 (447)
+.||.|++|.++. +|+.||+|.+.............+..|..++ ...+|||++++++.+...+..++++||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 4589999988763 5789999998754332333334445555544 455899999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCCcccC
Q 013214 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQ 314 (447)
Q Consensus 235 g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~ 314 (447)
++|.+++...+.+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++..... ....
T Consensus 82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~~~~ 153 (260)
T cd05611 82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----NKKF 153 (260)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc-----cccC
Confidence 999999988888999999999999999999999998 99999999999999999999999998875432 1223
Q ss_pred CCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHHHHHcc
Q 013214 315 DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWN 394 (447)
Q Consensus 315 ~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 394 (447)
.++..|+|||.+.+..++.++|+||||+++|+|++|..||...+..+....+..............+++.+.+++.+||+
T Consensus 154 ~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 233 (260)
T cd05611 154 VGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLC 233 (260)
T ss_pred CCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHcc
Confidence 46788999999988778899999999999999999999998766655444442222111111233578899999999999
Q ss_pred cCCCCCCCHHHHHH
Q 013214 395 EKPAKRPTFRQIIT 408 (447)
Q Consensus 395 ~dp~~Rps~~~~l~ 408 (447)
.||++||++.++.+
T Consensus 234 ~~p~~R~~~~~~~~ 247 (260)
T cd05611 234 MDPAKRLGANGYQE 247 (260)
T ss_pred CCHHHccCCCcHHH
Confidence 99999997754444
No 276
>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins. Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily
Probab=100.00 E-value=3.8e-36 Score=288.80 Aligned_cols=244 Identities=26% Similarity=0.470 Sum_probs=200.8
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEE
Q 013214 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 229 (447)
..|...+.||+|+||.++. +|+.||+|.+........+..+.+.+|+.+++.++||||+++++++......++++
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 4577888999999998763 68999999987554445566677889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 013214 230 EYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (447)
Q Consensus 230 e~~~~g~L~~~l~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~ 308 (447)
||+. |++.+.+.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 95 e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~-- 168 (307)
T cd06607 95 EYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSPA-- 168 (307)
T ss_pred HhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCCC--
Confidence 9996 677777754 456899999999999999999999999 999999999999999999999999998754322
Q ss_pred CCcccCCCCCcccCCcccC---CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHH
Q 013214 309 RPLTCQDTSCRYVAPEVFK---NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGL 385 (447)
Q Consensus 309 ~~~~~~~~t~~y~aPE~~~---~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 385 (447)
....+++.|+|||.+. ...++.++||||||+++|+|++|+.||...+.......+.....+.. ....++..+
T Consensus 169 ---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 243 (307)
T cd06607 169 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTL--SSNDWSDYF 243 (307)
T ss_pred ---CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCC--CchhhCHHH
Confidence 2345678899999874 34678899999999999999999999986654443333322222222 233467889
Q ss_pred HHHHHHHcccCCCCCCCHHHHHHH
Q 013214 386 KELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 386 ~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
.++|.+||+.||++||++.+++.+
T Consensus 244 ~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 244 RNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred HHHHHHHhcCChhhCcCHHHHhcC
Confidence 999999999999999999999875
No 277
>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5. Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express
Probab=100.00 E-value=9.7e-37 Score=290.77 Aligned_cols=243 Identities=23% Similarity=0.427 Sum_probs=198.4
Q ss_pred ccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEecc
Q 013214 158 TNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYL 232 (447)
Q Consensus 158 ~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 232 (447)
.....||+|+||.++ .++..||+|.+... .....+.+.+|+.+++.++||||+++++.+...+..+++|||+
T Consensus 25 ~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 101 (292)
T cd06658 25 DSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLR---KQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFL 101 (292)
T ss_pred hhhhcccCCCCeEEEEEEECCCCCEEEEEEEecc---hHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCC
Confidence 334568999998776 25789999988643 2344567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCCcc
Q 013214 233 PKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLT 312 (447)
Q Consensus 233 ~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~ 312 (447)
++++|.+++.. +.+++..+..++.|++.|+.|||+.+ ++|+||||+||++++++.++|+|||++........ ...
T Consensus 102 ~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~ 176 (292)
T cd06658 102 EGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP-KRK 176 (292)
T ss_pred CCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-cCc
Confidence 99999998754 56899999999999999999999998 99999999999999999999999999875432211 122
Q ss_pred cCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHHHHH
Q 013214 313 CQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEEC 392 (447)
Q Consensus 313 ~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 392 (447)
...++..|+|||.+.+..++.++|+||||+++|+|++|+.||...........+.....+.+ .....++..+.+++.+|
T Consensus 177 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~ 255 (292)
T cd06658 177 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRV-KDSHKVSSVLRGFLDLM 255 (292)
T ss_pred eeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCcc-ccccccCHHHHHHHHHH
Confidence 34578899999999888889999999999999999999999987655443333322212222 22334677899999999
Q ss_pred cccCCCCCCCHHHHHHH
Q 013214 393 WNEKPAKRPTFRQIITR 409 (447)
Q Consensus 393 l~~dp~~Rps~~~~l~~ 409 (447)
|..||.+|||+.+++++
T Consensus 256 l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 256 LVREPSQRATAQELLQH 272 (292)
T ss_pred ccCChhHCcCHHHHhhC
Confidence 99999999999999975
No 278
>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]
Probab=100.00 E-value=4.4e-38 Score=294.20 Aligned_cols=244 Identities=28% Similarity=0.425 Sum_probs=206.5
Q ss_pred CcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
.|+.-+.||+|+||.|+ .+|..+|.|.+.+..+.......-..+|-.+|.+++.++||.+--.|+..+.+|+|+.
T Consensus 186 ~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLt 265 (591)
T KOG0986|consen 186 TFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLT 265 (591)
T ss_pred ceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEE
Confidence 46777899999998764 6899999998876655444444556789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 013214 231 YLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (447)
Q Consensus 231 ~~~~g~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~ 308 (447)
.|+||+|.-++.+.+ .+++..+..++.+|+.||.+||+.+ ||.||+||+|||+|+.|+++|+|+|+|..+...
T Consensus 266 lMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g-- 340 (591)
T KOG0986|consen 266 LMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIPEG-- 340 (591)
T ss_pred eecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecCCC--
Confidence 999999999997755 6999999999999999999999999 999999999999999999999999999977643
Q ss_pred CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHH
Q 013214 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKEL 388 (447)
Q Consensus 309 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 388 (447)
.+.....||.+|||||++.++.|+.+.|+|||||++|+|+.|+.||.........+.+.......-...+...|++++++
T Consensus 341 ~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~kFS~eaksl 420 (591)
T KOG0986|consen 341 KPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSDKFSEEAKSL 420 (591)
T ss_pred CccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcccccCHHHHHH
Confidence 45566689999999999999999999999999999999999999998665433333332222222223346788999999
Q ss_pred HHHHcccCCCCCCCHH
Q 013214 389 IEECWNEKPAKRPTFR 404 (447)
Q Consensus 389 i~~cl~~dp~~Rps~~ 404 (447)
.+.+|+.||.+|....
T Consensus 421 c~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 421 CEGLLTKDPEKRLGCR 436 (591)
T ss_pred HHHHHccCHHHhccCC
Confidence 9999999999997554
No 279
>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6. Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i
Probab=100.00 E-value=1.1e-36 Score=291.19 Aligned_cols=244 Identities=23% Similarity=0.425 Sum_probs=199.1
Q ss_pred cccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEec
Q 013214 157 FTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (447)
Q Consensus 157 ~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 231 (447)
|.....||+|+||.++ .+++.||+|.+.... ....+.+.+|+.+++.++|||++++++.+..+...++++||
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~ 99 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRK---QQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEF 99 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecc---cchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEec
Confidence 3344578999998775 258899999986432 22345678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCCc
Q 013214 232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPL 311 (447)
Q Consensus 232 ~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~ 311 (447)
+++++|.+++.. ..+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++....... ...
T Consensus 100 ~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~-~~~ 174 (297)
T cd06659 100 LQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-PKR 174 (297)
T ss_pred CCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhccccc-ccc
Confidence 999999997754 56899999999999999999999999 9999999999999999999999999986543221 112
Q ss_pred ccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHHHH
Q 013214 312 TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEE 391 (447)
Q Consensus 312 ~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 391 (447)
....++..|+|||.+.+..++.++|+||||+++|+|++|+.||......+....+.. ..+........++..+.++|++
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~~i~~ 253 (297)
T cd06659 175 KSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRD-SPPPKLKNAHKISPVLRDFLER 253 (297)
T ss_pred cceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc-cCCCCccccCCCCHHHHHHHHH
Confidence 334578899999999888889999999999999999999999986655444333322 2222222334567889999999
Q ss_pred HcccCCCCCCCHHHHHHH
Q 013214 392 CWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 392 cl~~dp~~Rps~~~~l~~ 409 (447)
||+.+|++||++.+++++
T Consensus 254 ~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 254 MLTREPQERATAQELLDH 271 (297)
T ss_pred HhcCCcccCcCHHHHhhC
Confidence 999999999999999985
No 280
>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2. Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage
Probab=100.00 E-value=6.8e-36 Score=281.36 Aligned_cols=243 Identities=25% Similarity=0.406 Sum_probs=187.4
Q ss_pred eeecceEEEEEE----cC---eEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEeccCC
Q 013214 162 EITKGTFILAFW----RG---IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234 (447)
Q Consensus 162 ~lg~G~~~~~~~----~g---~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 234 (447)
.||+|+||.++. ++ ..+++|.+.... .....+.+.+|+.+++.++||||+++++.+......+++|||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 79 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANA--SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCEL 79 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCC--ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCC
Confidence 589999998863 22 345677665432 234457789999999999999999999999999999999999999
Q ss_pred CCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCC-CC
Q 013214 235 GDLRAFLKRK----GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE-DR 309 (447)
Q Consensus 235 g~L~~~l~~~----~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~-~~ 309 (447)
|+|.+++.+. ...+...+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++....... ..
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 156 (268)
T cd05086 80 GDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIE 156 (268)
T ss_pred CcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhh
Confidence 9999999764 23566778889999999999999998 9999999999999999999999999875422111 11
Q ss_pred CcccCCCCCcccCCcccCC-------CCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCC--CCChh
Q 013214 310 PLTCQDTSCRYVAPEVFKN-------EEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPF--KAPAK 379 (447)
Q Consensus 310 ~~~~~~~t~~y~aPE~~~~-------~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~ 379 (447)
......++..|+|||++.. ..++.++||||||+++|+|++ |..||......+....+........ +....
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (268)
T cd05086 157 TEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLEL 236 (268)
T ss_pred cccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCC
Confidence 1123456788999998743 235678999999999999997 6778876665444444323322211 12233
Q ss_pred hhHHHHHHHHHHHcccCCCCCCCHHHHHHHH
Q 013214 380 LYARGLKELIEECWNEKPAKRPTFRQIITRL 410 (447)
Q Consensus 380 ~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l 410 (447)
.+++.+.+++..|| .+|++||+++++++.|
T Consensus 237 ~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l 266 (268)
T cd05086 237 PYSERWYEVLQFCW-LSPEKRATAEEVHRLL 266 (268)
T ss_pred CCcHHHHHHHHHHh-hCcccCCCHHHHHHHh
Confidence 47788999999999 6899999999998876
No 281
>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase. Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity
Probab=100.00 E-value=1.7e-36 Score=284.58 Aligned_cols=244 Identities=28% Similarity=0.515 Sum_probs=199.7
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|...+.||.|++|.++. +++.+|+|.+.... .......+.+|+.+++.++||||+++++.+......++++|
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEI--NEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICME 79 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEeccc--ChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEE
Confidence 456667899999987752 58899999987643 23555778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 013214 231 YLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHE-NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (447)
Q Consensus 231 ~~~~g~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~lH~-~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~ 308 (447)
|+++++|.+++... ..+++.....++.|++.|+.|||+ .+ ++|+||||+||++++++.++|+|||.+........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 156 (265)
T cd06605 80 YMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA 156 (265)
T ss_pred ecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHHh
Confidence 99999999999876 778999999999999999999999 88 99999999999999999999999999875532211
Q ss_pred CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCC--CchHH---HHHhcCCCCCCCChhhhHH
Q 013214 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHD--NEVPK---AYAARQRPPFKAPAKLYAR 383 (447)
Q Consensus 309 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~--~~~~~---~~~~~~~~~~~~~~~~~~~ 383 (447)
....++..|+|||.+.+..++.++|+||||+++|+|++|+.||..... ..... .......+..+ ...++.
T Consensus 157 ---~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~ 231 (265)
T cd06605 157 ---KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLP--SGKFSP 231 (265)
T ss_pred ---hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCC--hhhcCH
Confidence 115568889999999888899999999999999999999999976531 11111 11111122221 222788
Q ss_pred HHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 384 GLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 384 ~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
++.++|.+||..||++|||+.+++.+
T Consensus 232 ~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 232 DFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred HHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 89999999999999999999999864
No 282
>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases. Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki
Probab=100.00 E-value=4.4e-36 Score=280.69 Aligned_cols=231 Identities=27% Similarity=0.497 Sum_probs=186.4
Q ss_pred eeecceEEEEE---E--cC----------eEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceE
Q 013214 162 EITKGTFILAF---W--RG----------IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM 226 (447)
Q Consensus 162 ~lg~G~~~~~~---~--~g----------~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 226 (447)
.||+|+||.++ . ++ ..+++|.+.... .....+.+|+.+++.++||||+++++++.. ...+
T Consensus 2 ~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 76 (259)
T cd05037 2 HLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH----RDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENI 76 (259)
T ss_pred cccccccceEEEEEEeccCCccccCCccceeeeeeccccch----hhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcE
Confidence 58999998775 2 22 247888775432 115778899999999999999999999988 7789
Q ss_pred EEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCC-------CEEEeecc
Q 013214 227 IVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG-------NLKVADFG 298 (447)
Q Consensus 227 lv~e~~~~g~L~~~l~~~~-~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~-------~vkl~Dfg 298 (447)
++|||+++|+|.+++...+ .++...+..++.|++.||.|||+.+ ++|+||||+||+++.++ .+||+|||
T Consensus 77 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg 153 (259)
T cd05037 77 MVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153 (259)
T ss_pred EEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCC
Confidence 9999999999999998766 6899999999999999999999998 99999999999999887 79999999
Q ss_pred cccccccCCCCCcccCCCCCcccCCcccCCC--CCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCCC
Q 013214 299 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE--EYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFK 375 (447)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~ 375 (447)
++..... .....++..|+|||.+.+. .++.++|+||||+++|+|++ |..||...+..+...........+.
T Consensus 154 ~a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~- 227 (259)
T cd05037 154 IPITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQHRLPM- 227 (259)
T ss_pred ccccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhcCCCCCC-
Confidence 9876443 1223456779999998776 78889999999999999999 6888877654433333221111111
Q ss_pred CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHH
Q 013214 376 APAKLYARGLKELIEECWNEKPAKRPTFRQIITRL 410 (447)
Q Consensus 376 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l 410 (447)
.....+.+++.+||..+|.+||++.++++.|
T Consensus 228 ----~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 228 ----PDCAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred ----CCchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 1127889999999999999999999999876
No 283
>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]
Probab=100.00 E-value=2.4e-38 Score=327.86 Aligned_cols=251 Identities=24% Similarity=0.410 Sum_probs=211.9
Q ss_pred CCCcCcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceE
Q 013214 152 PHELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM 226 (447)
Q Consensus 152 ~~~~~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 226 (447)
....+.+.+..||.|.||.|| .+|+--|+|.++..... ......+.+|..++..++|||+|++||+-.+++..+
T Consensus 1232 nV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~ 1310 (1509)
T KOG4645|consen 1232 NVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVY 1310 (1509)
T ss_pred cceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc-cccCcchHHHHHHHHhccCccccccCceeecHHHHH
Confidence 344567778899999999998 47899999988754432 455677889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccC
Q 013214 227 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306 (447)
Q Consensus 227 lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~ 306 (447)
|.||||++|+|.+.+...+-.++.....+..|++.|+.|||++| ||||||||+||+++.+|.+|++|||.|..+...
T Consensus 1311 IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~ 1387 (1509)
T KOG4645|consen 1311 IFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIKNN 1387 (1509)
T ss_pred HHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEecCc
Confidence 99999999999999988777888888889999999999999999 999999999999999999999999999876543
Q ss_pred CC---CCcccCCCCCcccCCcccCCC---CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCc-hHHHHHhcCCCCCCCChh
Q 013214 307 ED---RPLTCQDTSCRYVAPEVFKNE---EYDTKVDVFSFALILQEMIEGCPPFTMKHDNE-VPKAYAARQRPPFKAPAK 379 (447)
Q Consensus 307 ~~---~~~~~~~~t~~y~aPE~~~~~---~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~ 379 (447)
.. .......||+.|||||++.+. +...++|||||||++.||+||+.||...+.+= +...+..+..|++ |.
T Consensus 1388 ~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~---P~ 1464 (1509)
T KOG4645|consen 1388 AQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQI---PE 1464 (1509)
T ss_pred hhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCC---ch
Confidence 21 112466799999999999764 45568999999999999999999999777653 3344445556666 44
Q ss_pred hhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 380 LYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 380 ~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
.+|.+-+++|++||..||++|=++.+++++
T Consensus 1465 ~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1465 RLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred hhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 589999999999999999999888877764
No 284
>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI
Probab=100.00 E-value=1.2e-36 Score=288.93 Aligned_cols=249 Identities=25% Similarity=0.419 Sum_probs=197.9
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|+..+.||+|+||.++. +++.||+|.+....... ...+.+.+|+++++.++||||+++++++..++..++++|
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDK-MVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcc-hhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 466778999999988752 57899999887543322 344567889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCC
Q 013214 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (447)
Q Consensus 231 ~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~ 310 (447)
|+++++|..+......+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++....... ..
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~-~~ 156 (286)
T cd07846 81 FVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-EV 156 (286)
T ss_pred cCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc-cc
Confidence 9999999888776667999999999999999999999998 9999999999999999999999999987654322 22
Q ss_pred cccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhc--------------------
Q 013214 311 LTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR-------------------- 369 (447)
Q Consensus 311 ~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~-------------------- 369 (447)
.....++..|+|||.+.+. .++.++||||||+++|+|++|+.||......+....+...
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (286)
T cd07846 157 YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAG 236 (286)
T ss_pred cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhc
Confidence 2334568889999998653 5678999999999999999999999765432221111100
Q ss_pred -CCCCCC------CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 370 -QRPPFK------APAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 370 -~~~~~~------~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
..+... ...+.++..+.+++.+||+.+|++||++.+++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 237 MRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred cccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 000000 0122457789999999999999999999998864
No 285
>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3. Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int
Probab=100.00 E-value=6.2e-36 Score=283.00 Aligned_cols=243 Identities=30% Similarity=0.531 Sum_probs=202.0
Q ss_pred cccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEec
Q 013214 157 FTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (447)
Q Consensus 157 ~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 231 (447)
|+..+.||+|+||.++ .+++.||+|...... .......+.+|+.+++.++||||+++++++..+...+++|||
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence 5566789999999886 257899999886442 234456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCCc
Q 013214 232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPL 311 (447)
Q Consensus 232 ~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~ 311 (447)
+++++|.+++.. ..+++..+..++.|++.++.+||+.+ ++|+||||+||+++.++.++|+|||++....... ...
T Consensus 84 ~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~-~~~ 158 (277)
T cd06641 84 LGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-IKR 158 (277)
T ss_pred CCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccch-hhh
Confidence 999999998864 56899999999999999999999998 9999999999999999999999999987654321 112
Q ss_pred ccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHHHH
Q 013214 312 TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEE 391 (447)
Q Consensus 312 ~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 391 (447)
....++..|+|||.+.+..++.++|+||||+++|+|++|..||...........+.....+. ....++.++.+++.+
T Consensus 159 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~i~~ 235 (277)
T cd06641 159 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPT---LEGNYSKPLKEFVEA 235 (277)
T ss_pred ccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCCC---CCcccCHHHHHHHHH
Confidence 23456788999999988888899999999999999999999998766544444432222222 234567889999999
Q ss_pred HcccCCCCCCCHHHHHHH
Q 013214 392 CWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 392 cl~~dp~~Rps~~~~l~~ 409 (447)
||+.+|.+||++.+++++
T Consensus 236 ~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 236 CLNKEPSFRPTAKELLKH 253 (277)
T ss_pred HccCChhhCcCHHHHHhC
Confidence 999999999999999985
No 286
>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]
Probab=100.00 E-value=5.5e-37 Score=299.65 Aligned_cols=246 Identities=28% Similarity=0.527 Sum_probs=212.1
Q ss_pred CcccceeeecceEEEEE---Ec-----CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEE
Q 013214 156 DFTNSVEITKGTFILAF---WR-----GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~---~~-----g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 227 (447)
++...+.||+|.||.|. |+ ...||||.++..... ....+|.+|+.+|.+++|||++++||+..+ ..+.+
T Consensus 111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~--~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mM 187 (1039)
T KOG0199|consen 111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLN--AIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMM 187 (1039)
T ss_pred HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccc--hhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhH
Confidence 45566789999999875 42 357999999876432 267899999999999999999999999987 67899
Q ss_pred EEeccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeeccccccccc
Q 013214 228 VTEYLPKGDLRAFLKR--KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305 (447)
Q Consensus 228 v~e~~~~g~L~~~l~~--~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~ 305 (447)
|||+++.|+|.+.|++ ...|.......++.||+.|+.||.+++ +|||||-.+|+++-....|||+|||+.+.++.
T Consensus 188 V~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ 264 (1039)
T KOG0199|consen 188 VFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGE 264 (1039)
T ss_pred HhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCC
Confidence 9999999999999987 345888999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCC--cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCCCCChhhhH
Q 013214 306 KEDRP--LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYA 382 (447)
Q Consensus 306 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 382 (447)
..+.- .....-+..|+|||.+...+++.++|+|++||++|||+| |+.||.+....++.+.+..+.+.+- ++.++
T Consensus 265 ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erLpR---Pk~cs 341 (1039)
T KOG0199|consen 265 NEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERLPR---PKYCS 341 (1039)
T ss_pred CCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccCCC---CCCCh
Confidence 43321 223345677999999999999999999999999999999 9999999999999998876555553 45578
Q ss_pred HHHHHHHHHHcccCCCCCCCHHHHHHHH
Q 013214 383 RGLKELIEECWNEKPAKRPTFRQIITRL 410 (447)
Q Consensus 383 ~~l~~li~~cl~~dp~~Rps~~~~l~~l 410 (447)
+.+.++++.||..+|++||++..|.+.+
T Consensus 342 edIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 342 EDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred HHHHHHHHHhccCCccccccHHHHHHhH
Confidence 9999999999999999999999998543
No 287
>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]
Probab=100.00 E-value=4.7e-37 Score=270.45 Aligned_cols=245 Identities=26% Similarity=0.473 Sum_probs=199.4
Q ss_pred cccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeEEEEeCCceEEEEe
Q 013214 157 FTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 157 ~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
.+....||.|+-|.|. .+|...|||.+... .+.+...++...++++..- ..|+||+.+|+|..+..+++.||
T Consensus 94 l~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt--~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe 171 (391)
T KOG0983|consen 94 LENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRT--GNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME 171 (391)
T ss_pred hhhHHhhcCCCccceEEEEEcccceEEEEEeeccc--CCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence 4455678999888664 46899999999865 4666677888888887766 49999999999999999999999
Q ss_pred ccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 013214 231 YLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (447)
Q Consensus 231 ~~~~g~L~~~l~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~ 309 (447)
.| ...++.++++ .+++++..+=++...+..||.||.+++ +|+|||+||+|||+|+.|++||||||.+-++-. +.
T Consensus 172 lM-s~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvd--Sk 246 (391)
T KOG0983|consen 172 LM-STCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVD--SK 246 (391)
T ss_pred HH-HHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeec--cc
Confidence 98 4566666655 356888888889999999999999877 499999999999999999999999999977643 23
Q ss_pred CcccCCCCCcccCCcccCC---CCCCCchhHHHHHHHHHHHHhCCCCCCCCCC-CchHHHHHhcCCCCCCCChhhhHHHH
Q 013214 310 PLTCQDTSCRYVAPEVFKN---EEYDTKVDVFSFALILQEMIEGCPPFTMKHD-NEVPKAYAARQRPPFKAPAKLYARGL 385 (447)
Q Consensus 310 ~~~~~~~t~~y~aPE~~~~---~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l 385 (447)
..+-..|-+.|||||.+.- .+|+.++||||||++++||.||+.||.+.+. .+....+.. ..|+.-.....+|+.+
T Consensus 247 AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln-~ePP~L~~~~gFSp~F 325 (391)
T KOG0983|consen 247 AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLN-EEPPLLPGHMGFSPDF 325 (391)
T ss_pred ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHh-cCCCCCCcccCcCHHH
Confidence 3444556778999999854 3788899999999999999999999998654 344444433 4444433444589999
Q ss_pred HHHHHHHcccCCCCCCCHHHHHHH
Q 013214 386 KELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 386 ~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
++++..||+.|+.+||.+.+++++
T Consensus 326 ~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 326 QSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred HHHHHHHhhcCcccCcchHHHhcC
Confidence 999999999999999999999875
No 288
>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is
Probab=100.00 E-value=3.9e-36 Score=287.30 Aligned_cols=249 Identities=29% Similarity=0.453 Sum_probs=197.4
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCC--CHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEE
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVIS--DDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 228 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 228 (447)
+|...+.||+|++|.++. +|+.||+|.+...... .......+..|+.+++.++||||+++++++.+....++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 356677899999987762 5789999999765432 123345667899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCC
Q 013214 229 TEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307 (447)
Q Consensus 229 ~e~~~~g~L~~~l~~~~-~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~ 307 (447)
|||+ +++|.+++.... .+++..+..++.|+++||.|||+++ ++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 156 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN 156 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccCCC
Confidence 9999 899999998766 7999999999999999999999999 9999999999999999999999999998654332
Q ss_pred CCCcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcC-CC-------------
Q 013214 308 DRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RP------------- 372 (447)
Q Consensus 308 ~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~-~~------------- 372 (447)
. ......+++.|+|||.+.+ ..++.++|+||||+++|+|++|.+||......+....+.... .+
T Consensus 157 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (298)
T cd07841 157 R-KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPD 235 (298)
T ss_pred c-cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccc
Confidence 1 2222345778999998855 357889999999999999999988887655433322221110 00
Q ss_pred --------C--CCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 373 --------P--FKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 373 --------~--~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
+ ........+..+.++|.+||+.||++|||+++++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 236 YVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred cccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 0 000112346789999999999999999999999974
No 289
>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3. Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity
Probab=100.00 E-value=1.7e-36 Score=283.74 Aligned_cols=234 Identities=23% Similarity=0.390 Sum_probs=186.6
Q ss_pred eeecceEEEEEEc------------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEE
Q 013214 162 EITKGTFILAFWR------------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (447)
Q Consensus 162 ~lg~G~~~~~~~~------------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 229 (447)
.||+|+||.|+.. ...||+|.+... .....+.+.+|..+++.++||||+++++++......++||
T Consensus 2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 78 (258)
T cd05078 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS---HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQ 78 (258)
T ss_pred CCCcccchhheeeeecccccccccccchhhHHhhcch---hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEE
Confidence 5899999887631 234888877533 2344567888999999999999999999999989999999
Q ss_pred eccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCC--------EEEeecccc
Q 013214 230 EYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN--------LKVADFGVS 300 (447)
Q Consensus 230 e~~~~g~L~~~l~~~~-~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~--------vkl~Dfg~~ 300 (447)
||+++|+|.+++..++ .+++..+..++.|++.||.|||+.+ ++||||||+||+++.++. ++++|||.+
T Consensus 79 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~ 155 (258)
T cd05078 79 EYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155 (258)
T ss_pred ecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccc
Confidence 9999999999997654 4899999999999999999999999 999999999999987765 699999988
Q ss_pred cccccCCCCCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhC-CCCCCCCCCCchHHHHHhcCCCCCCCCh
Q 013214 301 KLLTVKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEG-CPPFTMKHDNEVPKAYAARQRPPFKAPA 378 (447)
Q Consensus 301 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 378 (447)
..... .....++..|+|||.+.+. .++.++|+||||+++|+|++| ..||...+........ .....+ +
T Consensus 156 ~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~--~~~~~~---~ 225 (258)
T cd05078 156 ITVLP-----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFY--EDRHQL---P 225 (258)
T ss_pred cccCC-----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHH--HccccC---C
Confidence 65432 1223467889999998764 578899999999999999998 4666654443322222 222222 2
Q ss_pred hhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHH
Q 013214 379 KLYARGLKELIEECWNEKPAKRPTFRQIITRLE 411 (447)
Q Consensus 379 ~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~ 411 (447)
...+.++.+++.+||+.||++|||++++++.|+
T Consensus 226 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 226 APKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred CCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 234578999999999999999999999998763
No 290
>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning
Probab=100.00 E-value=3e-36 Score=286.47 Aligned_cols=250 Identities=26% Similarity=0.438 Sum_probs=199.5
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|+..+.||+|++|.++. +++.||+|.+..... .......+.+|++++++++||||+++++++...+..++++|
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED-DEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc-cccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 577788999999987753 578999998875432 33345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCC
Q 013214 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (447)
Q Consensus 231 ~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~ 310 (447)
|++++.+..+..+...+++..+..++.|++.|+.|||+.+ ++|+||+|+||++++++.+||+|||.+..........
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~ 157 (288)
T cd07833 81 YVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARPASP 157 (288)
T ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCcccc
Confidence 9988777776666667999999999999999999999999 9999999999999999999999999988765443223
Q ss_pred cccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhc--------------------
Q 013214 311 LTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR-------------------- 369 (447)
Q Consensus 311 ~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~-------------------- 369 (447)
.....++..|+|||.+.+. .++.++|+||||+++|+|++|+.||......+........
T Consensus 158 ~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd07833 158 LTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAG 237 (288)
T ss_pred ccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccc
Confidence 3345568889999999887 7889999999999999999999999865432221111000
Q ss_pred -CCCCCCC-------ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 370 -QRPPFKA-------PAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 370 -~~~~~~~-------~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
..+.... .+..++.++.++|++||..+|++||++++++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 238 VAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred cccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 0000000 112247889999999999999999999998753
No 291
>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.
Probab=100.00 E-value=6.2e-36 Score=281.60 Aligned_cols=249 Identities=23% Similarity=0.452 Sum_probs=201.3
Q ss_pred CcccceeeecceEEEEEE------cCeEEEEEEcCccc-------CCCHHHHHHHHHHHHHHhc-CCCCcccceeEEEEe
Q 013214 156 DFTNSVEITKGTFILAFW------RGIQVAVKKLGEEV-------ISDDDRVRAFRDELALLQK-IRHPNVVQFLGAVTQ 221 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~------~g~~vavK~~~~~~-------~~~~~~~~~~~~E~~~l~~-l~hp~iv~~~~~~~~ 221 (447)
+|+..+.||+|+||.++. .++.+|+|.+.... ........++.+|+.++.. ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 366778899999987752 35889999875422 1233455667788888865 699999999999999
Q ss_pred CCceEEEEeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeCCCCCCCEEEcCCCCEEEee
Q 013214 222 SSPMMIVTEYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHE-NKPVPIIHRDLEPSNILRDDSGNLKVAD 296 (447)
Q Consensus 222 ~~~~~lv~e~~~~g~L~~~l~~----~~~l~~~~~~~i~~ql~~~l~~lH~-~~~~~i~H~Dikp~Nill~~~~~vkl~D 296 (447)
++..+++|||+++++|.+++.. ...+++..++.++.|++.+|.|||+ .+ ++|+||+|+||++++++.++|+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEec
Confidence 9999999999999999988743 3458999999999999999999996 56 99999999999999999999999
Q ss_pred cccccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCC
Q 013214 297 FGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKA 376 (447)
Q Consensus 297 fg~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 376 (447)
||.+....... ......++..|+|||.+.+..++.++|+||||+++|+|++|+.||...........+......+.
T Consensus 158 fg~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-- 233 (269)
T cd08528 158 FGLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPL-- 233 (269)
T ss_pred ccceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcC--
Confidence 99987654332 22344578889999999888899999999999999999999999976655444444323222222
Q ss_pred ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHH
Q 013214 377 PAKLYARGLKELIEECWNEKPAKRPTFRQIITRLE 411 (447)
Q Consensus 377 ~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~ 411 (447)
....+++.+.++|++||+.||++||++.++.++++
T Consensus 234 ~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 234 PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 12346788999999999999999999999998875
No 292
>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent
Probab=100.00 E-value=4.4e-36 Score=283.81 Aligned_cols=245 Identities=27% Similarity=0.503 Sum_probs=199.0
Q ss_pred CcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC---CCcccceeEEEEeCCceEE
Q 013214 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR---HPNVVQFLGAVTQSSPMMI 227 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~---hp~iv~~~~~~~~~~~~~l 227 (447)
.|+..+.||.|+||.++ .+++.||+|.+.... .......+.+|+.+++.++ |||++++++++......++
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l 79 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT--PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI 79 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC--CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence 35667789999998776 368899999987542 3344567888999999996 9999999999999999999
Q ss_pred EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCC
Q 013214 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307 (447)
Q Consensus 228 v~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~ 307 (447)
+|||+++++|.+++.. +.+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 80 v~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06917 80 IMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS 155 (277)
T ss_pred EEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCCc
Confidence 9999999999999865 47899999999999999999999999 9999999999999999999999999987665332
Q ss_pred CCCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHH
Q 013214 308 DRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLK 386 (447)
Q Consensus 308 ~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 386 (447)
.......++..|+|||.+.++ .++.++|+||||+++|+|++|+.||...........+.....+.+. ...++.++.
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 232 (277)
T cd06917 156 -SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLE--DNGYSKLLR 232 (277)
T ss_pred -cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCCCCCCC--cccCCHHHH
Confidence 122334578889999988654 4688999999999999999999999876544333222111122221 122678899
Q ss_pred HHHHHHcccCCCCCCCHHHHHHH
Q 013214 387 ELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 387 ~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
+++.+||+.||++||++.+++.+
T Consensus 233 ~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 233 EFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred HHHHHHcCCCcccCcCHHHHhhC
Confidence 99999999999999999999874
No 293
>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin. Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre
Probab=100.00 E-value=8.8e-36 Score=283.95 Aligned_cols=252 Identities=27% Similarity=0.410 Sum_probs=199.2
Q ss_pred ccCCCCcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeEEEEeC
Q 013214 149 EIDPHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQS 222 (447)
Q Consensus 149 ~i~~~~~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~ 222 (447)
++.....+|.....||+|+||.++. +++.+|+|.+.... .....+.+|+.+++++ +|||++++++++...
T Consensus 16 ~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~ 91 (291)
T cd06639 16 SLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS----DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKA 91 (291)
T ss_pred cCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc----cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEec
Confidence 3444566788999999999998763 68899999886432 2235567899999998 899999999998753
Q ss_pred -----CceEEEEeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEE
Q 013214 223 -----SPMMIVTEYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK 293 (447)
Q Consensus 223 -----~~~~lv~e~~~~g~L~~~l~~----~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vk 293 (447)
...++++||+++++|.++++. ...+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+|
T Consensus 92 ~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~k 168 (291)
T cd06639 92 DKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVK 168 (291)
T ss_pred cccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEE
Confidence 358999999999999998863 356899999999999999999999998 99999999999999999999
Q ss_pred EeecccccccccCCCCCcccCCCCCcccCCcccCCC-----CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHh
Q 013214 294 VADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE-----EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA 368 (447)
Q Consensus 294 l~Dfg~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-----~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~ 368 (447)
|+|||++......... .....++..|+|||.+... .++.++|+||||+++|+|++|+.||......+....+..
T Consensus 169 l~dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~ 247 (291)
T cd06639 169 LVDFGVSAQLTSTRLR-RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPR 247 (291)
T ss_pred Eeecccchhccccccc-ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhc
Confidence 9999998765432111 1223568889999987543 367899999999999999999999987655443333322
Q ss_pred cCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 369 RQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 369 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
...+.+. .+..++..+.++|.+||+.+|++||++.+++++
T Consensus 248 ~~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 248 NPPPTLL-HPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred CCCCCCC-cccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 2222221 233466789999999999999999999999875
No 294
>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I
Probab=100.00 E-value=5.6e-36 Score=282.33 Aligned_cols=247 Identities=27% Similarity=0.430 Sum_probs=197.8
Q ss_pred CcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeEEEEeCC----
Q 013214 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSS---- 223 (447)
Q Consensus 154 ~~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~---- 223 (447)
..+|+..+.||.|++|.++. +++.+++|++.... ...+.+.+|+.+++++ +||||+++++++....
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE----DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN 80 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc----hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence 45788889999999987652 57889999986442 2346788999999999 7999999999997654
Q ss_pred --ceEEEEeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeec
Q 013214 224 --PMMIVTEYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297 (447)
Q Consensus 224 --~~~lv~e~~~~g~L~~~l~~----~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Df 297 (447)
..+++|||+++++|.+++.. +..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+||
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~ 157 (275)
T cd06608 81 DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDF 157 (275)
T ss_pred ceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCC
Confidence 48999999999999998865 356899999999999999999999999 999999999999999999999999
Q ss_pred ccccccccCCCCCcccCCCCCcccCCcccCC-----CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCC
Q 013214 298 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-----EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRP 372 (447)
Q Consensus 298 g~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-----~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~ 372 (447)
|++....... .......++..|+|||.+.. ..++.++||||||+++|+|++|+.||...........+.....+
T Consensus 158 ~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 236 (275)
T cd06608 158 GVSAQLDSTL-GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPP 236 (275)
T ss_pred ccceecccch-hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCC
Confidence 9987643221 11233457888999998753 24677899999999999999999999865544443333222222
Q ss_pred CCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 373 PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 373 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
.. ..+..++..+.++|.+||..||++|||+.+++++
T Consensus 237 ~~-~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 237 TL-KSPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred CC-CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 22 2233467899999999999999999999999863
No 295
>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1. Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph
Probab=100.00 E-value=5.9e-36 Score=284.99 Aligned_cols=248 Identities=23% Similarity=0.395 Sum_probs=198.6
Q ss_pred CcccceeeecceEEEEEE--------cCeEEEEEEcCcccCC-CHHHHHHHHHHHHHHhcC-CCCcccceeEEEEeCCce
Q 013214 156 DFTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVIS-DDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPM 225 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~--------~g~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~ 225 (447)
+|+..+.||.|+||.++. +|..||+|.+...... .....+.+.+|+.+++++ +||||+++++.+..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 366778899999997762 6789999998753221 223346678899999999 699999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeeccccccccc
Q 013214 226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305 (447)
Q Consensus 226 ~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~ 305 (447)
++++||+++++|.+++.....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++.....
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 157 (290)
T cd05613 81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFHE 157 (290)
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCccceeccc
Confidence 999999999999999988888999999999999999999999998 99999999999999999999999999876543
Q ss_pred CCCCCcccCCCCCcccCCcccCCC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHh---cCCCCCCCChhh
Q 013214 306 KEDRPLTCQDTSCRYVAPEVFKNE--EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA---RQRPPFKAPAKL 380 (447)
Q Consensus 306 ~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~ 380 (447)
..........++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...........+.. ...+++ +..
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~ 234 (290)
T cd05613 158 DEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPY---PQE 234 (290)
T ss_pred ccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCC---Ccc
Confidence 222222334578899999998653 467899999999999999999999975443322222211 122222 344
Q ss_pred hHHHHHHHHHHHcccCCCCCC-----CHHHHHHH
Q 013214 381 YARGLKELIEECWNEKPAKRP-----TFRQIITR 409 (447)
Q Consensus 381 ~~~~l~~li~~cl~~dp~~Rp-----s~~~~l~~ 409 (447)
+++.+.+++++||+.||++|| ++.+++++
T Consensus 235 ~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 235 MSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred CCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 678899999999999999997 67777654
No 296
>PHA03211 serine/threonine kinase US3; Provisional
Probab=100.00 E-value=4.4e-36 Score=300.95 Aligned_cols=243 Identities=20% Similarity=0.260 Sum_probs=191.1
Q ss_pred CcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEE
Q 013214 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 228 (447)
Q Consensus 154 ~~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 228 (447)
...|.+.+.||+|+||.|+. .++.||+|.... ..+.+|++++++++||||+++++++...+..+++
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~---------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv 238 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY---------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLV 238 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc---------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence 44788889999999998873 578899996431 2356799999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCC
Q 013214 229 TEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307 (447)
Q Consensus 229 ~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~ 307 (447)
||++ .++|.+++... ..+++.++..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 239 ~e~~-~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~ 314 (461)
T PHA03211 239 LPKY-RSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSW 314 (461)
T ss_pred EEcc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceeccccc
Confidence 9999 57898888764 46999999999999999999999999 9999999999999999999999999997654322
Q ss_pred CC-CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCC--------CchHHHHHhcCC--CCCCC
Q 013214 308 DR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHD--------NEVPKAYAARQR--PPFKA 376 (447)
Q Consensus 308 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~--------~~~~~~~~~~~~--~~~~~ 376 (447)
.. ......||+.|+|||++.+..++.++|||||||++|||++|..|+..... .++...+..... ..++.
T Consensus 315 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~ 394 (461)
T PHA03211 315 STPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQ 394 (461)
T ss_pred ccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCC
Confidence 11 12234689999999999988999999999999999999998765432211 111111111110 00000
Q ss_pred -------------------------Ch---hhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 377 -------------------------PA---KLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 377 -------------------------~~---~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
.+ ...+..+.+||.+||+.||.+|||+.|++++
T Consensus 395 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 395 HAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred CcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 00 1234578999999999999999999999975
No 297
>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also
Probab=100.00 E-value=1.4e-36 Score=288.32 Aligned_cols=248 Identities=22% Similarity=0.420 Sum_probs=193.2
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|+..+.||+|++|.++. +|+.||+|.++.... .......+.+|+.++++++||||+++++++.+....++++|
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFE 79 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccc-cccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEe
Confidence 366778899999988763 688999999875432 22233556789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 013214 231 YLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (447)
Q Consensus 231 ~~~~g~L~~~l~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~ 309 (447)
|++ ++|.+++.+ .+.+++..+..++.|+++||.|||+.+ ++|+||||+||+++.++.++|+|||++....... .
T Consensus 80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~-~ 154 (284)
T cd07839 80 YCD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPV-R 154 (284)
T ss_pred cCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCC-C
Confidence 996 688888765 467999999999999999999999999 9999999999999999999999999987654322 1
Q ss_pred CcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCC-chHHHHHhc----------------C-
Q 013214 310 PLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDN-EVPKAYAAR----------------Q- 370 (447)
Q Consensus 310 ~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~-~~~~~~~~~----------------~- 370 (447)
......+++.|+|||.+.+. .++.++|+||||+++|+|++|..|+...... +....+... .
T Consensus 155 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07839 155 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDY 234 (284)
T ss_pred CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccc
Confidence 22334568889999988664 4688999999999999999998886433322 111111000 0
Q ss_pred --CCCCC------CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 371 --RPPFK------APAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 371 --~~~~~------~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
.+.+. ...+.+++++.++|.+||+.||.+|||+++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 235 KPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred cccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 00000 0112467889999999999999999999999864
No 298
>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase. Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines
Probab=100.00 E-value=4.6e-36 Score=285.48 Aligned_cols=253 Identities=23% Similarity=0.342 Sum_probs=199.5
Q ss_pred cccceeeecceEEEEEE--------cCeEEEEEEcCcccCC-CHHHHHHHHHHHHHHhcC-CCCcccceeEEEEeCCceE
Q 013214 157 FTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVIS-DDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMM 226 (447)
Q Consensus 157 ~~~~~~lg~G~~~~~~~--------~g~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~ 226 (447)
|+..+.||+|++|.++. +++.||+|.++..... .......+.+|+.++.++ +||||+++++.+......+
T Consensus 2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~ 81 (288)
T cd05583 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLH 81 (288)
T ss_pred ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEE
Confidence 56678899999998763 4678999988653221 223345678899999999 6999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccC
Q 013214 227 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306 (447)
Q Consensus 227 lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~ 306 (447)
+||||+++++|.+++..+..+++..+..++.|++.+|.|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 82 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 158 (288)
T cd05583 82 LILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAE 158 (288)
T ss_pred EEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccccccc
Confidence 99999999999999988778999999999999999999999998 999999999999999999999999998765432
Q ss_pred CCCCcccCCCCCcccCCcccCCCC--CCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHH
Q 013214 307 EDRPLTCQDTSCRYVAPEVFKNEE--YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARG 384 (447)
Q Consensus 307 ~~~~~~~~~~t~~y~aPE~~~~~~--~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (447)
.........++..|+|||.+.+.. .+.++|+||||+++|+|++|..||...........+...........+..++..
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd05583 159 EEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAE 238 (288)
T ss_pred cccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCCCCcccCHH
Confidence 222222345688999999987654 678999999999999999999999754332221121111111111223456788
Q ss_pred HHHHHHHHcccCCCCCCCHHHHHHHHHH
Q 013214 385 LKELIEECWNEKPAKRPTFRQIITRLES 412 (447)
Q Consensus 385 l~~li~~cl~~dp~~Rps~~~~l~~l~~ 412 (447)
+.+++.+||+.||++|||+.++.+.|+.
T Consensus 239 l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 239 ARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred HHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 9999999999999999998877766554
No 299
>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins. Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re
Probab=100.00 E-value=3.2e-36 Score=282.22 Aligned_cols=243 Identities=30% Similarity=0.441 Sum_probs=199.4
Q ss_pred eecceEEEEE---E--cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEeccCCCCH
Q 013214 163 ITKGTFILAF---W--RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237 (447)
Q Consensus 163 lg~G~~~~~~---~--~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L 237 (447)
||.|+||.++ . +|+.+++|.+...........+.+.+|+.++++++||||+++++.+......++++||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 5778887765 2 4899999999765544445667889999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCC-------CC
Q 013214 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED-------RP 310 (447)
Q Consensus 238 ~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~-------~~ 310 (447)
.+++.+.+.+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++........ ..
T Consensus 81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~ 157 (265)
T cd05579 81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKE 157 (265)
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccccc
Confidence 999988778999999999999999999999999 99999999999999999999999999875433211 12
Q ss_pred cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHHH
Q 013214 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIE 390 (447)
Q Consensus 311 ~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 390 (447)
.....++..|+|||...+...+.++|+||||+++|++++|..||......+....+.. .....+. ...++..+.+++.
T Consensus 158 ~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~-~~~~~~~~~~~i~ 235 (265)
T cd05579 158 DKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILN-GKIEWPE-DVEVSDEAIDLIS 235 (265)
T ss_pred ccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc-CCcCCCc-cccCCHHHHHHHH
Confidence 2334567889999999888888999999999999999999999987776555544433 2222221 1124788999999
Q ss_pred HHcccCCCCCCCHHHHHHHH
Q 013214 391 ECWNEKPAKRPTFRQIITRL 410 (447)
Q Consensus 391 ~cl~~dp~~Rps~~~~l~~l 410 (447)
+||+.+|.+||++..+.+.|
T Consensus 236 ~~l~~~p~~Rpt~~~~~~~l 255 (265)
T cd05579 236 KLLVPDPEKRLGAKSIEEIK 255 (265)
T ss_pred HHhcCCHhhcCCCccHHHHh
Confidence 99999999999995544443
No 300
>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6. Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea
Probab=100.00 E-value=6.3e-36 Score=283.57 Aligned_cols=251 Identities=26% Similarity=0.429 Sum_probs=197.6
Q ss_pred ccCCCCcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeEEEEe-
Q 013214 149 EIDPHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQ- 221 (447)
Q Consensus 149 ~i~~~~~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~- 221 (447)
+.......|+..+.||.|+||.++. +++.+|+|..... ......+..|+.+++++ +||||+++++++..
T Consensus 10 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~----~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 10 ALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT----EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC----hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 3334445788888999999998763 6789999987543 23345678899999998 79999999999853
Q ss_pred -----CCceEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEE
Q 013214 222 -----SSPMMIVTEYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294 (447)
Q Consensus 222 -----~~~~~lv~e~~~~g~L~~~l~~~--~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl 294 (447)
....+++|||+++|+|.+++... ..+++..+..++.|++.|+.|||+.+ ++|+||||+||+++.++.++|
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~l 162 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKL 162 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEE
Confidence 45689999999999999999753 34788889999999999999999999 999999999999999999999
Q ss_pred eecccccccccCCCCCcccCCCCCcccCCcccC-----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhc
Q 013214 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFK-----NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR 369 (447)
Q Consensus 295 ~Dfg~~~~~~~~~~~~~~~~~~t~~y~aPE~~~-----~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~ 369 (447)
+|||++....... .......++..|+|||.+. ...++.++|+||||+++|+|++|..||...........+..
T Consensus 163 ~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~- 240 (282)
T cd06636 163 VDFGVSAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPR- 240 (282)
T ss_pred eeCcchhhhhccc-cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhh-
Confidence 9999987543221 1123345788999999875 34577899999999999999999999976554332222211
Q ss_pred CCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 370 QRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 370 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
..........++..+.++|.+||+.||.+||++.+++++
T Consensus 241 -~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 241 -NPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH 279 (282)
T ss_pred -CCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence 111122234578899999999999999999999999763
No 301
>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase. Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou
Probab=100.00 E-value=1.1e-35 Score=282.63 Aligned_cols=247 Identities=25% Similarity=0.486 Sum_probs=204.6
Q ss_pred CcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEE
Q 013214 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 228 (447)
Q Consensus 154 ~~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 228 (447)
...|.....||+|++|.++. ++..|++|.+..... ..+.+.+|+..++.++|||++++++.+......+++
T Consensus 18 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 93 (286)
T cd06614 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVV 93 (286)
T ss_pred cccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEE
Confidence 34577778899999987652 588999999875422 456788899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCC
Q 013214 229 TEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307 (447)
Q Consensus 229 ~e~~~~g~L~~~l~~~~-~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~ 307 (447)
+||+++++|.+++.... .++...+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 94 ~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 170 (286)
T cd06614 94 MEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK 170 (286)
T ss_pred EeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccch
Confidence 99999999999998876 7999999999999999999999998 9999999999999999999999999886544321
Q ss_pred CCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHH
Q 013214 308 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKE 387 (447)
Q Consensus 308 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 387 (447)
. ......++..|+|||.+.+..++.++|+||||+++|+|++|+.||...........+.....+... ....++..+.+
T Consensus 171 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~ 248 (286)
T cd06614 171 S-KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLK-NPEKWSPEFKD 248 (286)
T ss_pred h-hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCc-chhhCCHHHHH
Confidence 1 112334678899999998888899999999999999999999999876654444443333333222 23347789999
Q ss_pred HHHHHcccCCCCCCCHHHHHHH
Q 013214 388 LIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 388 li~~cl~~dp~~Rps~~~~l~~ 409 (447)
+|.+||+.+|.+||++.+++.+
T Consensus 249 li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 249 FLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred HHHHHhccChhhCcCHHHHhhC
Confidence 9999999999999999999863
No 302
>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1. Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron
Probab=100.00 E-value=1.7e-35 Score=285.57 Aligned_cols=244 Identities=26% Similarity=0.473 Sum_probs=201.6
Q ss_pred cccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEec
Q 013214 157 FTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (447)
Q Consensus 157 ~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 231 (447)
|...+.||+|+||.++ .+|..||+|.+........+....+.+|+.+++.++|||++++++++..+...+++|||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 7778889999998775 26789999998765444555667788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCC
Q 013214 232 LPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (447)
Q Consensus 232 ~~~g~L~~~l~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~ 310 (447)
+. |+|.+.+.. ..++++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 107 ~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~----- 177 (317)
T cd06635 107 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASP----- 177 (317)
T ss_pred CC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCC-----
Confidence 96 578777754 456899999999999999999999999 99999999999999999999999998865432
Q ss_pred cccCCCCCcccCCcccC---CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHH
Q 013214 311 LTCQDTSCRYVAPEVFK---NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKE 387 (447)
Q Consensus 311 ~~~~~~t~~y~aPE~~~---~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 387 (447)
.....+++.|+|||.+. ++.++.++|+||||+++|+|++|+.||...........+.....+.. ....+++.+.+
T Consensus 178 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~ 255 (317)
T cd06635 178 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTL--QSNEWSDYFRN 255 (317)
T ss_pred cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCC--CCccccHHHHH
Confidence 12345688899999874 35678899999999999999999999987655544444433333332 23356788999
Q ss_pred HHHHHcccCCCCCCCHHHHHHHHH
Q 013214 388 LIEECWNEKPAKRPTFRQIITRLE 411 (447)
Q Consensus 388 li~~cl~~dp~~Rps~~~~l~~l~ 411 (447)
++.+||+.+|.+||++.+++++.-
T Consensus 256 li~~~l~~~p~~Rpt~~~il~~~~ 279 (317)
T cd06635 256 FVDSCLQKIPQDRPTSEELLKHMF 279 (317)
T ss_pred HHHHHccCCcccCcCHHHHHhChh
Confidence 999999999999999999998754
No 303
>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase. Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi
Probab=100.00 E-value=6.6e-36 Score=285.19 Aligned_cols=247 Identities=22% Similarity=0.450 Sum_probs=202.2
Q ss_pred CcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEE
Q 013214 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 228 (447)
Q Consensus 154 ~~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 228 (447)
..+|...+.||+|+||.++. ++..||+|.+... .....+.+.+|+.+++.++||||+++++.+......++|
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv 94 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQ---QQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVV 94 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccc---cchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEE
Confidence 35788888999999998762 5788999998643 223346678899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 013214 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (447)
Q Consensus 229 ~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~ 308 (447)
+||+++++|.+++.+. .+++..+..++.|++.|+.|||+.+ ++|+||||+||+++.++.++|+|||++........
T Consensus 95 ~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~ 170 (293)
T cd06647 95 MEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (293)
T ss_pred EecCCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccccccc
Confidence 9999999999998653 5788999999999999999999999 99999999999999999999999998875443221
Q ss_pred CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHH
Q 013214 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKEL 388 (447)
Q Consensus 309 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 388 (447)
......+++.|+|||.+.+..++.++|+||||+++|++++|+.||...+..+....+.....+.+. .+..++..+.++
T Consensus 171 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~l 248 (293)
T cd06647 171 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQ-NPEKLSAIFRDF 248 (293)
T ss_pred -ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCC-CccccCHHHHHH
Confidence 222345788899999998888899999999999999999999999876544332222222222222 233467789999
Q ss_pred HHHHcccCCCCCCCHHHHHHH
Q 013214 389 IEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 389 i~~cl~~dp~~Rps~~~~l~~ 409 (447)
|++||+.+|++||++.+++.+
T Consensus 249 i~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 249 LNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred HHHHccCChhhCcCHHHHhcC
Confidence 999999999999999999975
No 304
>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho
Probab=100.00 E-value=1.7e-35 Score=277.91 Aligned_cols=248 Identities=28% Similarity=0.477 Sum_probs=201.2
Q ss_pred CcccceeeecceEEEEE-----EcCeEEEEEEcCccc--CCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeC--CceE
Q 013214 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEV--ISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--SPMM 226 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~--~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~~ 226 (447)
+|...+.||+|+||.++ .+|..||+|.+.... .........+.+|+.++++++||||+++++++.+. ...+
T Consensus 3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (264)
T cd06653 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLS 82 (264)
T ss_pred ceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEE
Confidence 67788899999998775 368899999875322 12234556788999999999999999999998764 4588
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccC
Q 013214 227 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306 (447)
Q Consensus 227 lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~ 306 (447)
+++||+++++|.+++.+.+.+++.....++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 83 ~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 159 (264)
T cd06653 83 IFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTI 159 (264)
T ss_pred EEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccccccc
Confidence 99999999999999988778999999999999999999999999 999999999999999999999999998765321
Q ss_pred CC--CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHH
Q 013214 307 ED--RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARG 384 (447)
Q Consensus 307 ~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (447)
.. .......++..|+|||.+.+..++.++|+||||+++|+|++|+.||.............. .+..+..+..+++.
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~~p~~~~~~ 237 (264)
T cd06653 160 CMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIAT--QPTKPMLPDGVSDA 237 (264)
T ss_pred cccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHc--CCCCCCCCcccCHH
Confidence 11 111234578899999999888889999999999999999999999986654443333221 22222335567889
Q ss_pred HHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 385 LKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 385 l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
+.+++++||+ +|.+||++.+++.+
T Consensus 238 ~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 238 CRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred HHHHHHHHhc-CcccCccHHHHhcC
Confidence 9999999998 57999999988764
No 305
>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast
Probab=100.00 E-value=1.8e-35 Score=275.52 Aligned_cols=245 Identities=28% Similarity=0.535 Sum_probs=206.3
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|+..+.||+|++|.++. +++.|++|.+...... ......+.+|++++++++|||++++++++.+....++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK-EEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILE 79 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccC-HHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Confidence 466778999999987763 6789999999765432 3556789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCC
Q 013214 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (447)
Q Consensus 231 ~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~ 310 (447)
|+++++|.+++.....+++..++.++.|++.|+.+||+.+ ++|+||||+||+++.++.++|+|||.+.........
T Consensus 80 ~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~- 155 (254)
T cd06627 80 YAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD- 155 (254)
T ss_pred cCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCccc-
Confidence 9999999999988888999999999999999999999999 999999999999999999999999998866543221
Q ss_pred cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHHH
Q 013214 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIE 390 (447)
Q Consensus 311 ~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 390 (447)
.....++..|+|||...+..++.++|+||+|+++|+|++|+.||.................+. .+..++..+.+++.
T Consensus 156 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~i~ 232 (254)
T cd06627 156 DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPP---LPEGISPELKDFLM 232 (254)
T ss_pred ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCCC---CCCCCCHHHHHHHH
Confidence 223456888999999888788899999999999999999999998665433333332233333 34456789999999
Q ss_pred HHcccCCCCCCCHHHHHH
Q 013214 391 ECWNEKPAKRPTFRQIIT 408 (447)
Q Consensus 391 ~cl~~dp~~Rps~~~~l~ 408 (447)
+||..+|++||++.+++.
T Consensus 233 ~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 233 QCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred HHHhCChhhCcCHHHHhc
Confidence 999999999999999875
No 306
>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases. Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core
Probab=100.00 E-value=1.6e-35 Score=275.02 Aligned_cols=244 Identities=29% Similarity=0.529 Sum_probs=203.3
Q ss_pred cccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEec
Q 013214 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (447)
Q Consensus 157 ~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 231 (447)
|...+.||+|++|.++. ++..+++|++..... .....+.+|+..++.++|||++++++.+......++++||
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~ 78 (253)
T cd05122 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEF 78 (253)
T ss_pred ceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEec
Confidence 56678899999987652 488999999975432 3557788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCC
Q 013214 232 LPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (447)
Q Consensus 232 ~~~g~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~ 310 (447)
+++++|.+++... ..+++..+..++.|++.|+.+||+.+ ++|+||+|+||+++.++.++|+|||.+........
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 153 (253)
T cd05122 79 CSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-- 153 (253)
T ss_pred CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc--
Confidence 9999999999776 57899999999999999999999998 99999999999999999999999999876654321
Q ss_pred cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHHH
Q 013214 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIE 390 (447)
Q Consensus 311 ~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 390 (447)
.....++..|+|||.+.+..++.++|+||||+++|+|++|+.||...+..+..........+... ....++..+.++|.
T Consensus 154 ~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~ 232 (253)
T cd05122 154 RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLR-NPEKWSDEFKDFLK 232 (253)
T ss_pred ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcC-cccccCHHHHHHHH
Confidence 23345788899999998888889999999999999999999999876554444333332222222 22234788999999
Q ss_pred HHcccCCCCCCCHHHHHHH
Q 013214 391 ECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 391 ~cl~~dp~~Rps~~~~l~~ 409 (447)
+||+.||++|||+.+++++
T Consensus 233 ~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 233 KCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred HHccCChhhCCCHHHHhcC
Confidence 9999999999999999864
No 307
>PHA03209 serine/threonine kinase US3; Provisional
Probab=100.00 E-value=7.1e-36 Score=292.81 Aligned_cols=240 Identities=23% Similarity=0.329 Sum_probs=187.0
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEE
Q 013214 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 229 (447)
.+|...+.||+|+||.|+. +++.||+|...... ...|+.++++++||||+++++++......++++
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~---------~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 136 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGT---------TLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL 136 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccc---------cHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence 4688899999999998863 56789999864321 245899999999999999999999999999999
Q ss_pred eccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 013214 230 EYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (447)
Q Consensus 230 e~~~~g~L~~~l~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~ 308 (447)
||+ .++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 137 e~~-~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-- 210 (357)
T PHA03209 137 PHY-SSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA-- 210 (357)
T ss_pred Ecc-CCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccC--
Confidence 999 5688888865 456899999999999999999999999 999999999999999999999999998753321
Q ss_pred CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCC-CCCCCCC----------chHHHHHhcC-C-CCCC
Q 013214 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPP-FTMKHDN----------EVPKAYAARQ-R-PPFK 375 (447)
Q Consensus 309 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p-~~~~~~~----------~~~~~~~~~~-~-~~~~ 375 (447)
.......||+.|+|||++.+..++.++|||||||++|+|+++..| |...... .....+...+ . ..++
T Consensus 211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 290 (357)
T PHA03209 211 PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFP 290 (357)
T ss_pred cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcC
Confidence 122334679999999999988999999999999999999985444 4432221 0000010000 0 0000
Q ss_pred -----------------------C----ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 376 -----------------------A----PAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 376 -----------------------~----~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
. ....++..+.++|.+||+.||.+|||+.+++++
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~h 351 (357)
T PHA03209 291 RDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNY 351 (357)
T ss_pred CCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcC
Confidence 0 011345567789999999999999999999875
No 308
>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases. Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include
Probab=100.00 E-value=2.4e-35 Score=280.50 Aligned_cols=246 Identities=27% Similarity=0.452 Sum_probs=196.5
Q ss_pred CcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeC--CceEEE
Q 013214 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--SPMMIV 228 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~~lv 228 (447)
+|...+.||.|++|.++ .+++.+|+|.+.... .......+.+|++++++++||||+++++++... ..++++
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 79 (287)
T cd06621 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDP--NPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIA 79 (287)
T ss_pred ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCC--chHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEE
Confidence 46667889999998775 367899999987542 234557788999999999999999999988653 468999
Q ss_pred EeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccc
Q 013214 229 TEYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304 (447)
Q Consensus 229 ~e~~~~g~L~~~l~~----~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~ 304 (447)
|||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~ 156 (287)
T cd06621 80 MEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELV 156 (287)
T ss_pred EEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeecccccccc
Confidence 999999999988753 345889999999999999999999999 9999999999999999999999999987543
Q ss_pred cCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCC-----CchHHHHHhcCCCCCCCC--
Q 013214 305 VKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHD-----NEVPKAYAARQRPPFKAP-- 377 (447)
Q Consensus 305 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~-----~~~~~~~~~~~~~~~~~~-- 377 (447)
.... ....++..|+|||.+.+..++.++|+||||+++|+|++|+.||..... .+....+.....+.+...
T Consensus 157 ~~~~---~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd06621 157 NSLA---GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPG 233 (287)
T ss_pred cccc---ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCC
Confidence 2211 233467889999999888899999999999999999999999986632 122222211112222111
Q ss_pred -hhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 378 -AKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 378 -~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
...+++.+.+++.+||..+|.+|||+.+++.+
T Consensus 234 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 234 NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred CCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 12467889999999999999999999999985
No 309
>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains. Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an
Probab=100.00 E-value=9.4e-36 Score=277.87 Aligned_cols=244 Identities=28% Similarity=0.485 Sum_probs=205.2
Q ss_pred CcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|+..+.||.|+++.++ .+++.+|+|.+..... .......+.+|+.+++.++||||+++++.+......++++|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSM-SQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVME 79 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhc-cHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEeh
Confidence 36677889999998765 2678999999876543 33445677889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccC
Q 013214 231 YLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306 (447)
Q Consensus 231 ~~~~g~L~~~l~~----~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~ 306 (447)
|+++++|.+++.+ ...+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~ 156 (256)
T cd08530 80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN 156 (256)
T ss_pred hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC
Confidence 9999999999866 356899999999999999999999999 999999999999999999999999998766533
Q ss_pred CCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHH
Q 013214 307 EDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLK 386 (447)
Q Consensus 307 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 386 (447)
......+++.|+|||.+.+..++.++|+||||+++|+|++|+.||...+..+....+.....++ .+..++.++.
T Consensus 157 ---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~ 230 (256)
T cd08530 157 ---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPP---IPPIYSQDLQ 230 (256)
T ss_pred ---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCC---CchhhCHHHH
Confidence 2223456889999999988888999999999999999999999998776655544443333333 3346788999
Q ss_pred HHHHHHcccCCCCCCCHHHHHHH
Q 013214 387 ELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 387 ~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
+++.+||+.+|++||++.+++++
T Consensus 231 ~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 231 NFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred HHHHHHcCCCcccCCCHHHHhcC
Confidence 99999999999999999999864
No 310
>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.
Probab=100.00 E-value=6.2e-36 Score=279.36 Aligned_cols=246 Identities=24% Similarity=0.450 Sum_probs=201.2
Q ss_pred CcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|+..+.||+|+||.++ .+|..+|+|.+...... ....+.+.+|+.+++.++||||+++++.+......++++|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 79 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMP-VKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVME 79 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhcc-chhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEe
Confidence 46677889999998776 26788999998754332 2334567889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCC-EEEeecccccccccCC
Q 013214 231 YLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN-LKVADFGVSKLLTVKE 307 (447)
Q Consensus 231 ~~~~g~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~-vkl~Dfg~~~~~~~~~ 307 (447)
|+++++|.+++.+.. .+++..+..++.|++.|+.|||+.+ ++|+||||+||++++++. ++|+|||.+.......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (257)
T cd08225 80 YCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM 156 (257)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence 999999999997643 4789999999999999999999998 999999999999998764 6999999987654322
Q ss_pred CCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHH
Q 013214 308 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKE 387 (447)
Q Consensus 308 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 387 (447)
. ......+++.|+|||.+.+..++.++|+||||+++++|++|..||...+..+............ ..+.++..+.+
T Consensus 157 ~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~ 232 (257)
T cd08225 157 E-LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAP---ISPNFSRDLRS 232 (257)
T ss_pred c-cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCC---CCCCCCHHHHH
Confidence 1 1123457888999999988888999999999999999999999998666544444332222222 23456788999
Q ss_pred HHHHHcccCCCCCCCHHHHHHH
Q 013214 388 LIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 388 li~~cl~~dp~~Rps~~~~l~~ 409 (447)
++.+||..+|++|||+.+++++
T Consensus 233 ~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 233 LISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred HHHHHhccChhhCcCHHHHhhC
Confidence 9999999999999999999864
No 311
>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=3.1e-37 Score=285.29 Aligned_cols=240 Identities=29% Similarity=0.445 Sum_probs=210.9
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeEEEEeCCceEEEE
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVT 229 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~ 229 (447)
+|.....||+|+||.|.. +.+.+|||+++++.+-..+.++--..|-++|... +-|+++++..+|+..+++|+||
T Consensus 350 DFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFVM 429 (683)
T KOG0696|consen 350 DFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVM 429 (683)
T ss_pred ccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeEE
Confidence 566677899999999863 4578999999998877666677777888999888 5778999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 013214 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (447)
Q Consensus 230 e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~ 309 (447)
||+.||+|--++++-+++.+..+..++..|+-||.+||++| |+.||||.+|||++.+|++||+|||++..-- ....
T Consensus 430 EyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni-~~~~ 505 (683)
T KOG0696|consen 430 EYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENI-FDGV 505 (683)
T ss_pred EEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeecccccccc-cCCc
Confidence 99999999999999999999999999999999999999999 9999999999999999999999999987522 2234
Q ss_pred CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHH
Q 013214 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELI 389 (447)
Q Consensus 310 ~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 389 (447)
......|||.|+|||++..++|+.++|+||+|++||||+.|++||++.+..++...+ ......+ +...|.+..++.
T Consensus 506 TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI-~ehnvsy---PKslSkEAv~ic 581 (683)
T KOG0696|consen 506 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAI-MEHNVSY---PKSLSKEAVAIC 581 (683)
T ss_pred ceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH-HHccCcC---cccccHHHHHHH
Confidence 456788999999999999999999999999999999999999999999998888877 3333333 566789999999
Q ss_pred HHHcccCCCCCCCH
Q 013214 390 EECWNEKPAKRPTF 403 (447)
Q Consensus 390 ~~cl~~dp~~Rps~ 403 (447)
+..|...|.+|...
T Consensus 582 kg~ltK~P~kRLGc 595 (683)
T KOG0696|consen 582 KGLLTKHPGKRLGC 595 (683)
T ss_pred HHHhhcCCccccCC
Confidence 99999999999643
No 312
>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase. Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK
Probab=100.00 E-value=2.7e-35 Score=274.74 Aligned_cols=249 Identities=28% Similarity=0.500 Sum_probs=205.4
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeC--CceEEE
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--SPMMIV 228 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~~lv 228 (447)
+|+..+.||+|++|.++. ++..|++|++..... .....+.+.+|+..+++++||||+++++.+... ...+++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 79 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGD-SEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIF 79 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeecccc-chHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEE
Confidence 366678899999987763 588999999876543 245667889999999999999999999999988 889999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 013214 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (447)
Q Consensus 229 ~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~ 308 (447)
+||+++++|.+++.+...+++..++.++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||.+........
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 156 (260)
T cd06606 80 LEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIET 156 (260)
T ss_pred EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccccc
Confidence 999999999999988878999999999999999999999998 99999999999999999999999999887654322
Q ss_pred C-CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHH
Q 013214 309 R-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKE 387 (447)
Q Consensus 309 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 387 (447)
. ......++..|+|||.+.+...+.++|+||||+++|+|++|..||....... ...............+...+..+.+
T Consensus 157 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~ 235 (260)
T cd06606 157 GEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPM-AALYKIGSSGEPPEIPEHLSEEAKD 235 (260)
T ss_pred cccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH-HHHHhccccCCCcCCCcccCHHHHH
Confidence 1 1233457889999999988888999999999999999999999998766211 1111111112222334456789999
Q ss_pred HHHHHcccCCCCCCCHHHHHHH
Q 013214 388 LIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 388 li~~cl~~dp~~Rps~~~~l~~ 409 (447)
++.+|++.||++||++.+++.+
T Consensus 236 ~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 236 FLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred HHHHhCcCChhhCCCHHHHhhC
Confidence 9999999999999999999864
No 313
>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6. Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs
Probab=100.00 E-value=1.7e-35 Score=280.72 Aligned_cols=244 Identities=25% Similarity=0.482 Sum_probs=190.9
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHH-HhcCCCCcccceeEEEEeCCceEEEE
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELAL-LQKIRHPNVVQFLGAVTQSSPMMIVT 229 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~-l~~l~hp~iv~~~~~~~~~~~~~lv~ 229 (447)
+|+..+.||+|+||.++. +|+.||+|.+..... .... ..+..|... ++..+||||+++++++..+...+++|
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~-~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~ 79 (283)
T cd06617 2 DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVN-SQEQ-KRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICM 79 (283)
T ss_pred CceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCC-cHHH-HHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEh
Confidence 567778999999998863 689999999876532 2222 334445554 66679999999999999999999999
Q ss_pred eccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEeCCCCCCCEEEcCCCCEEEeecccccccc
Q 013214 230 EYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHEN-KPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304 (447)
Q Consensus 230 e~~~~g~L~~~l~~----~~~l~~~~~~~i~~ql~~~l~~lH~~-~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~ 304 (447)
||++ |+|.+++.. +..+++..++.++.|++.|+.|||++ + ++|+||||+||+++.++.+||+|||++....
T Consensus 80 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~ 155 (283)
T cd06617 80 EVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLV 155 (283)
T ss_pred hhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecccccccc
Confidence 9995 788888754 24589999999999999999999997 7 9999999999999999999999999987653
Q ss_pred cCCCCCcccCCCCCcccCCcccCC----CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCC-chHHHHHhcCCCCCCCChh
Q 013214 305 VKEDRPLTCQDTSCRYVAPEVFKN----EEYDTKVDVFSFALILQEMIEGCPPFTMKHDN-EVPKAYAARQRPPFKAPAK 379 (447)
Q Consensus 305 ~~~~~~~~~~~~t~~y~aPE~~~~----~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~ 379 (447)
.. .......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||...... +..........+.+ ...
T Consensus 156 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~ 231 (283)
T cd06617 156 DS--VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQL--PAE 231 (283)
T ss_pred cc--cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCC--Ccc
Confidence 22 11122346788999998865 34678999999999999999999999754322 22222222222222 223
Q ss_pred hhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 380 LYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 380 ~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
.+|.++.++|.+||..+|++||++.+++++
T Consensus 232 ~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 232 KFSPEFQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 477899999999999999999999999874
No 314
>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1. Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto
Probab=100.00 E-value=4.9e-36 Score=283.57 Aligned_cols=247 Identities=25% Similarity=0.472 Sum_probs=205.9
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC-CCcccceeEEEEeCCceEEEE
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVT 229 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~lv~ 229 (447)
+|...+.||.|++|.++. +|+.||+|++.............+.+|..+++++. ||||+++++.+...+..+++|
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~ 81 (280)
T cd05581 2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVL 81 (280)
T ss_pred CceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEE
Confidence 577778999999988762 68999999987654444555677889999999998 999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCC-
Q 013214 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED- 308 (447)
Q Consensus 230 e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~- 308 (447)
||+++++|.+++.+.+.+++..++.++.|++.||.+||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 82 e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~ 158 (280)
T cd05581 82 EYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSP 158 (280)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCCcccc
Confidence 99999999999998888999999999999999999999999 99999999999999999999999999876543221
Q ss_pred ------------------CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcC
Q 013214 309 ------------------RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (447)
Q Consensus 309 ------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~ 370 (447)
.......++..|+|||.+....++.++|+||||++++++++|+.||............. ..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~-~~ 237 (280)
T cd05581 159 ESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKIL-KL 237 (280)
T ss_pred ccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHH-hc
Confidence 11123346788999999988888899999999999999999999999776444333332 22
Q ss_pred CCCCCCChhhhHHHHHHHHHHHcccCCCCCCCH----HHHHHH
Q 013214 371 RPPFKAPAKLYARGLKELIEECWNEKPAKRPTF----RQIITR 409 (447)
Q Consensus 371 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~----~~~l~~ 409 (447)
...+ +..+++.+.+++++||+.+|.+||++ .+++++
T Consensus 238 ~~~~---~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~ 277 (280)
T cd05581 238 EYSF---PPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH 277 (280)
T ss_pred CCCC---CCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence 2222 33457889999999999999999999 777653
No 315
>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6. Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as
Probab=100.00 E-value=1.7e-35 Score=285.50 Aligned_cols=241 Identities=24% Similarity=0.404 Sum_probs=180.8
Q ss_pred ceeeecceEEEEEE-------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEe--CCceEEEEe
Q 013214 160 SVEITKGTFILAFW-------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ--SSPMMIVTE 230 (447)
Q Consensus 160 ~~~lg~G~~~~~~~-------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~lv~e 230 (447)
...||+|+||.|+. ++..||+|.+..... ...+.+|+.+++.++||||+++++++.. +...++++|
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI-----SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFD 80 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC-----cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEe
Confidence 35799999998863 346899998865422 2356789999999999999999998853 567899999
Q ss_pred ccCCCCHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEE----cCCCCEEEeec
Q 013214 231 YLPKGDLRAFLKRK---------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR----DDSGNLKVADF 297 (447)
Q Consensus 231 ~~~~g~L~~~l~~~---------~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill----~~~~~vkl~Df 297 (447)
|+. ++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||||+||++ +.++.+||+||
T Consensus 81 ~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~Df 156 (317)
T cd07867 81 YAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADM 156 (317)
T ss_pred eeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeec
Confidence 995 6888877521 24788899999999999999999999 9999999999999 46678999999
Q ss_pred ccccccccCCC--CCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCch----------HH
Q 013214 298 GVSKLLTVKED--RPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV----------PK 364 (447)
Q Consensus 298 g~~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~----------~~ 364 (447)
|++........ .......+|+.|+|||.+.+. .++.++||||||+++|+|++|++||........ ..
T Consensus 157 G~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~ 236 (317)
T cd07867 157 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDR 236 (317)
T ss_pred cceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHH
Confidence 99986543211 122344678999999998764 578899999999999999999999975432110 00
Q ss_pred HHHhcC------------CCCCC---------------------CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 365 AYAARQ------------RPPFK---------------------APAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 365 ~~~~~~------------~~~~~---------------------~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
.....+ .+.+. ......+..+.+++.+||+.||.+|||+.+++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~h 314 (317)
T cd07867 237 IFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQD 314 (317)
T ss_pred HHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcC
Confidence 000000 00000 0001124568889999999999999999999864
No 316
>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They
Probab=100.00 E-value=2.3e-35 Score=275.22 Aligned_cols=246 Identities=26% Similarity=0.476 Sum_probs=206.2
Q ss_pred CcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|...+.||.|++|.++ .++..|++|++..... .......+.+|+++++.++|||++++.+.+......++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e 79 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNM-SEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVME 79 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccC-ChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEE
Confidence 46677889999998765 2588999999876543 33556678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccC
Q 013214 231 YLPKGDLRAFLKRK----GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306 (447)
Q Consensus 231 ~~~~g~L~~~l~~~----~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~ 306 (447)
|+++++|.+++.+. ..+++..+..++.+++.|+.+||+.+ ++|+||+|+||+++.++.++|+|||.+......
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 156 (258)
T cd08215 80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST 156 (258)
T ss_pred ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccC
Confidence 99999999999764 66999999999999999999999998 999999999999999999999999998765433
Q ss_pred CCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHH
Q 013214 307 EDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLK 386 (447)
Q Consensus 307 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 386 (447)
. .......+++.|+|||...+..++.++|+||+|+++++|++|+.||......+..........++ .+..++..+.
T Consensus 157 ~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~ 232 (258)
T cd08215 157 V-DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPP---IPSQYSSELR 232 (258)
T ss_pred c-ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCC---CCCCCCHHHH
Confidence 2 11223456888999999988888999999999999999999999998776555544443333333 2346778999
Q ss_pred HHHHHHcccCCCCCCCHHHHHHH
Q 013214 387 ELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 387 ~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
+++.+||..+|++||++.+++++
T Consensus 233 ~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 233 NLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred HHHHHHcCCChhhCcCHHHHhcC
Confidence 99999999999999999999864
No 317
>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex
Probab=100.00 E-value=9.7e-36 Score=282.52 Aligned_cols=248 Identities=24% Similarity=0.455 Sum_probs=194.5
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|+..+.||.|++|.++. +|+.||+|.+..... .......+.+|++++++++||||+++++++.+.+..+++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 79 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccc-ccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEee
Confidence 367778899999987752 688999999875432 22334568889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 013214 231 YLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (447)
Q Consensus 231 ~~~~g~L~~~l~~~--~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~ 308 (447)
|+. ++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++.......
T Consensus 80 ~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~- 154 (284)
T cd07860 80 FLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV- 154 (284)
T ss_pred ccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCc-
Confidence 995 6899888653 45899999999999999999999998 9999999999999999999999999987654321
Q ss_pred CCcccCCCCCcccCCcccCCCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhc-CCC--------------
Q 013214 309 RPLTCQDTSCRYVAPEVFKNEE-YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR-QRP-------------- 372 (447)
Q Consensus 309 ~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~-~~~-------------- 372 (447)
.......+++.|+|||.+.+.. ++.++|+||||+++|+|++|+.||............... ..+
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07860 155 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDY 234 (284)
T ss_pred cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHH
Confidence 1222334578899999886643 578899999999999999999999765533222111111 000
Q ss_pred --CC--------CCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 373 --PF--------KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 373 --~~--------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
.+ ....+.+++++.++|.+||+.||.+||++.+++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 235 KPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred HhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 00 00112356788999999999999999999999864
No 318
>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional
Probab=100.00 E-value=1.7e-35 Score=278.58 Aligned_cols=230 Identities=23% Similarity=0.407 Sum_probs=184.8
Q ss_pred eecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeEEEEeCCceEEEEeccCCCC
Q 013214 163 ITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236 (447)
Q Consensus 163 lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~g~ 236 (447)
+|+|+||.++ .++..+|+|.......... |......+ +||||+++++.+..++..+++|||+++++
T Consensus 24 lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--------e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~~~ 95 (267)
T PHA03390 24 LIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI--------EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGD 95 (267)
T ss_pred ecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh--------hHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCCCc
Confidence 6999999876 3678899999865432211 22222222 79999999999999999999999999999
Q ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCC-CEEEeecccccccccCCCCCcccCC
Q 013214 237 LRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG-NLKVADFGVSKLLTVKEDRPLTCQD 315 (447)
Q Consensus 237 L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~-~vkl~Dfg~~~~~~~~~~~~~~~~~ 315 (447)
|.+++.++..+++.++..++.|+++|+.|||+.+ ++|+||||+||+++.++ .++|+|||++...... ....
T Consensus 96 L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~-----~~~~ 167 (267)
T PHA03390 96 LFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP-----SCYD 167 (267)
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccceecCCC-----ccCC
Confidence 9999988888999999999999999999999999 99999999999999988 9999999998765422 2235
Q ss_pred CCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchH-HHHHhcCCCCCCCChhhhHHHHHHHHHHHcc
Q 013214 316 TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVP-KAYAARQRPPFKAPAKLYARGLKELIEECWN 394 (447)
Q Consensus 316 ~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 394 (447)
++..|+|||.+.+..++.++|+||+|+++|+|++|+.||......... .......... ...+..+++.+.++|.+||+
T Consensus 168 ~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~ 246 (267)
T PHA03390 168 GTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKK-LPFIKNVSKNANDFVQSMLK 246 (267)
T ss_pred CCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhccc-CCcccccCHHHHHHHHHHhc
Confidence 788999999998888999999999999999999999999865543321 1111111111 12234678899999999999
Q ss_pred cCCCCCCC-HHHHHHH
Q 013214 395 EKPAKRPT-FRQIITR 409 (447)
Q Consensus 395 ~dp~~Rps-~~~~l~~ 409 (447)
.+|.+||+ +++++++
T Consensus 247 ~~p~~R~~~~~~~l~h 262 (267)
T PHA03390 247 YNINYRLTNYNEIIKH 262 (267)
T ss_pred cChhhCCchHHHHhcC
Confidence 99999996 6888753
No 319
>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]
Probab=100.00 E-value=6.6e-37 Score=272.70 Aligned_cols=240 Identities=26% Similarity=0.400 Sum_probs=195.8
Q ss_pred Ccccc-eeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeEEEEe----CCc
Q 013214 156 DFTNS-VEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQ----SSP 224 (447)
Q Consensus 156 ~~~~~-~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~----~~~ 224 (447)
+|++. ..||-|--|.|. .+|+.+|+|++... +..++|+++--+. .|||||+++++|+. ...
T Consensus 62 dY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds--------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 62 DYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS--------PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred hheehhhhhccccCCceEEEEeccchhhhHHHHHhcC--------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 34443 357888777663 58999999998632 3456688775555 69999999998864 356
Q ss_pred eEEEEeccCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcC---CCCEEEeeccc
Q 013214 225 MMIVTEYLPKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD---SGNLKVADFGV 299 (447)
Q Consensus 225 ~~lv~e~~~~g~L~~~l~~~~~--l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~---~~~vkl~Dfg~ 299 (447)
+.+|||.++||.|.+.+++++. +++.++..|+.||+.|+.|||+.+ |.||||||+|+|... +..+||+|||+
T Consensus 134 LLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfGF 210 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFGF 210 (400)
T ss_pred eEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEeccccc
Confidence 7899999999999999998765 999999999999999999999999 999999999999974 45699999999
Q ss_pred ccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCC----chHHHHHhcCCCCCC
Q 013214 300 SKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDN----EVPKAYAARQRPPFK 375 (447)
Q Consensus 300 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~----~~~~~~~~~~~~~~~ 375 (447)
++.-.. .........||.|.|||++...+|+...|+||+||++|-|++|.+||...... .....+ ..+...|+
T Consensus 211 AK~t~~--~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI-~~gqy~FP 287 (400)
T KOG0604|consen 211 AKETQE--PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRI-RTGQYEFP 287 (400)
T ss_pred ccccCC--CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHh-hccCccCC
Confidence 986442 23334456799999999999999999999999999999999999999876542 334444 33344443
Q ss_pred -CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 376 -APAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 376 -~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
+.+..+|+..+++|+.+|..+|.+|.|..+++++
T Consensus 288 ~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 288 EPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred ChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 4567889999999999999999999999999876
No 320
>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co
Probab=100.00 E-value=1.9e-35 Score=279.88 Aligned_cols=238 Identities=22% Similarity=0.374 Sum_probs=188.6
Q ss_pred eecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHH---HHHHhcCCCCcccceeEEEEeCCceEEEEeccCC
Q 013214 163 ITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDE---LALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234 (447)
Q Consensus 163 lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E---~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 234 (447)
||+|+||.|+ .+++.||+|.+.............+..| ...++...||+|+++++++...+..+++|||+.|
T Consensus 2 ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~g 81 (278)
T cd05606 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNG 81 (278)
T ss_pred cccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCCC
Confidence 7899999876 3578999999876443322222223333 3445556899999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCCcccC
Q 013214 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQ 314 (447)
Q Consensus 235 g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~ 314 (447)
++|.+++...+.+++..+..++.|++.|+.|||+.+ ++|+||||+||+++.++.++|+|||++...... .....
T Consensus 82 ~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~---~~~~~ 155 (278)
T cd05606 82 GDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK---KPHAS 155 (278)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCcc---CCcCc
Confidence 999999988888999999999999999999999998 999999999999999999999999998754322 11234
Q ss_pred CCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHH--HHhcCCCCCCCChhhhHHHHHHHHHH
Q 013214 315 DTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKA--YAARQRPPFKAPAKLYARGLKELIEE 391 (447)
Q Consensus 315 ~~t~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~l~~li~~ 391 (447)
.++..|+|||.+.++ .++.++|+||+|+++|+|++|+.||........... ......+.+ +..++..+.+++.+
T Consensus 156 ~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~s~~~~~li~~ 232 (278)
T cd05606 156 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVEL---PDSFSPELRSLLEG 232 (278)
T ss_pred CCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCC---CCcCCHHHHHHHHH
Confidence 578999999998754 578999999999999999999999987643222111 111112222 33467899999999
Q ss_pred HcccCCCCCC-----CHHHHHHH
Q 013214 392 CWNEKPAKRP-----TFRQIITR 409 (447)
Q Consensus 392 cl~~dp~~Rp-----s~~~~l~~ 409 (447)
||..+|.+|| ++.+++++
T Consensus 233 ~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 233 LLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred HhhcCHHhccCCCCCCHHHHHhC
Confidence 9999999999 99998863
No 321
>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase. Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK
Probab=100.00 E-value=1.4e-35 Score=290.44 Aligned_cols=246 Identities=26% Similarity=0.377 Sum_probs=194.6
Q ss_pred cCcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeC------C
Q 013214 155 LDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS------S 223 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~------~ 223 (447)
.+|+..+.||+|+||.++ .+|+.||+|.+..... .......+.+|+.++++++||||+++++++... .
T Consensus 16 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 94 (353)
T cd07850 16 KRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQ-NVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ 94 (353)
T ss_pred cceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCcccc-ChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence 468888999999999875 3789999999875432 334445677899999999999999999988644 3
Q ss_pred ceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeeccccccc
Q 013214 224 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (447)
Q Consensus 224 ~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~ 303 (447)
..+++|||+. ++|.+.+... ++...+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++...
T Consensus 95 ~~~lv~e~~~-~~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~ 168 (353)
T cd07850 95 DVYLVMELMD-ANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA 168 (353)
T ss_pred cEEEEEeccC-CCHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCccceeC
Confidence 5799999995 6888888654 889999999999999999999999 999999999999999999999999999865
Q ss_pred ccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhc--------------
Q 013214 304 TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR-------------- 369 (447)
Q Consensus 304 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~-------------- 369 (447)
.... ......++..|+|||.+.+..++.++|+||||+++|+|++|+.||...+.......+...
T Consensus 169 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (353)
T cd07850 169 GTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQP 246 (353)
T ss_pred CCCC--CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhh
Confidence 4321 122345688899999999889999999999999999999999999765532221111000
Q ss_pred -------CCCCC--------------C----CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 370 -------QRPPF--------------K----APAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 370 -------~~~~~--------------~----~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
.++.. + ......++.+.++|.+||+.||++|||+.+++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 247 TVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred hhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00000 0 0012346678999999999999999999999965
No 322
>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3. Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co
Probab=100.00 E-value=7.4e-35 Score=280.60 Aligned_cols=242 Identities=26% Similarity=0.464 Sum_probs=198.2
Q ss_pred cccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEec
Q 013214 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (447)
Q Consensus 157 ~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 231 (447)
|.....||+|+||.++. +|+.|++|.+...........+.+.+|+.+++.++|||++++++++.+....+++|||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 44456799999988763 6889999998765444555667788899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCC
Q 013214 232 LPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (447)
Q Consensus 232 ~~~g~L~~~l~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~ 310 (447)
+. |++.+++.. ..++++.++..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 103 ~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~----- 173 (313)
T cd06633 103 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSP----- 173 (313)
T ss_pred CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCC-----
Confidence 95 688887765 456899999999999999999999999 99999999999999999999999998864321
Q ss_pred cccCCCCCcccCCcccC---CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHH
Q 013214 311 LTCQDTSCRYVAPEVFK---NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKE 387 (447)
Q Consensus 311 ~~~~~~t~~y~aPE~~~---~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 387 (447)
.....++..|+|||.+. ...++.++|+||||+++|+|++|..||...+.......+.....+.. ....++..+.+
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~ 251 (313)
T cd06633 174 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTL--QSNEWTDSFRG 251 (313)
T ss_pred CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC--CccccCHHHHH
Confidence 12345688899999974 35678899999999999999999999987765444444323322222 12346678999
Q ss_pred HHHHHcccCCCCCCCHHHHHHH
Q 013214 388 LIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 388 li~~cl~~dp~~Rps~~~~l~~ 409 (447)
++.+||+.+|.+||++.+++.+
T Consensus 252 li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 252 FVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred HHHHHccCChhhCcCHHHHhcC
Confidence 9999999999999999999975
No 323
>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]
Probab=100.00 E-value=2.3e-36 Score=288.96 Aligned_cols=249 Identities=23% Similarity=0.343 Sum_probs=198.1
Q ss_pred CCcCcccceeeecceEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeEEEEeCCceEE
Q 013214 153 HELDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMI 227 (447)
Q Consensus 153 ~~~~~~~~~~lg~G~~~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~l 227 (447)
....|++.+.||+||-..|+. +.+-+|+|++.... .+......|.+|+..|.++ .|.+|+++|+|-..++.+|+
T Consensus 359 kg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~-~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYm 437 (677)
T KOG0596|consen 359 KGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLE-ADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYM 437 (677)
T ss_pred CcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhh-cCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEE
Confidence 344788999999999988873 44778888877654 3667889999999999999 59999999999999999999
Q ss_pred EEeccCCCCHHHHHHhcCCC-CHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccC
Q 013214 228 VTEYLPKGDLRAFLKRKGAL-KPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306 (447)
Q Consensus 228 v~e~~~~g~L~~~l~~~~~l-~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~ 306 (447)
||||= ..+|.++|++.... +.-.+..+..|++.|+.++|..| |||.||||.|+|+- .|.+||+|||.|..+..+
T Consensus 438 vmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~D 512 (677)
T KOG0596|consen 438 VMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLV-KGRLKLIDFGIANAIQPD 512 (677)
T ss_pred Eeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEE-eeeEEeeeechhcccCcc
Confidence 99986 57999999876553 33577889999999999999999 99999999999986 579999999999877654
Q ss_pred CCC-CcccCCCCCcccCCcccCCC-----------CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCch-HHHHHhc-CCC
Q 013214 307 EDR-PLTCQDTSCRYVAPEVFKNE-----------EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV-PKAYAAR-QRP 372 (447)
Q Consensus 307 ~~~-~~~~~~~t~~y~aPE~~~~~-----------~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~-~~~~~~~-~~~ 372 (447)
... ......||+.||+||.+... +.++++|||||||+||+|+.|+.||........ ...+..- ...
T Consensus 513 TTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~I 592 (677)
T KOG0596|consen 513 TTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHEI 592 (677)
T ss_pred ccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCccc
Confidence 322 22456799999999988532 366899999999999999999999985442211 1111111 122
Q ss_pred CCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 373 PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 373 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
+|+..+..+ ++.++++.||+.||++||+..+++++
T Consensus 593 efp~~~~~~--~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 593 EFPDIPEND--ELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred cccCCCCch--HHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 454444433 38999999999999999999999975
No 324
>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1. Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the
Probab=100.00 E-value=1.5e-35 Score=282.72 Aligned_cols=248 Identities=27% Similarity=0.407 Sum_probs=195.2
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeC--CceEEE
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--SPMMIV 228 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~~lv 228 (447)
+|+..+.||.|++|.++. +++.+|+|.++..... ......+.+|+.++++++||||+++++++... ...+++
T Consensus 6 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 6 EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK-EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc-ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 677788999999988763 5789999998754332 22334566799999999999999999998877 889999
Q ss_pred EeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCC
Q 013214 229 TEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307 (447)
Q Consensus 229 ~e~~~~g~L~~~l~~~~-~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~ 307 (447)
+||+. ++|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 85 ~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 160 (293)
T cd07843 85 MEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL 160 (293)
T ss_pred ehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccCCc
Confidence 99996 59999887644 5899999999999999999999999 9999999999999999999999999988655432
Q ss_pred CCCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCC---------------
Q 013214 308 DRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQR--------------- 371 (447)
Q Consensus 308 ~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~--------------- 371 (447)
.......+++.|+|||.+.+. .++.++|+||||+++|+|++|..||...........+.....
T Consensus 161 -~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (293)
T cd07843 161 -KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPG 239 (293)
T ss_pred -cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccch
Confidence 122334467889999998764 468899999999999999999999987654433222211100
Q ss_pred --------CCC---CCChhh--hHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 372 --------PPF---KAPAKL--YARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 372 --------~~~---~~~~~~--~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
... ....+. +++.+.++|++||+.||++|||+.+++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 240 AKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred hcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 000 000111 47789999999999999999999999864
No 325
>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4. Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates
Probab=100.00 E-value=1.8e-35 Score=281.39 Aligned_cols=244 Identities=28% Similarity=0.465 Sum_probs=192.2
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC-CCcccceeEEEEeCCceEEEE
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVT 229 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~lv~ 229 (447)
+|...+.||+|+||.|+. +|+.||+|.+..... ......+.+|+.++.++. ||||+++++++..+...+++|
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~ 82 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVD--EKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICM 82 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccC--hHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEE
Confidence 445567899999998862 678999999875432 244567888999999995 999999999999989999999
Q ss_pred eccCCCCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEeCCCCCCCEEEcCCCCEEEeeccccccc
Q 013214 230 EYLPKGDLRAFLK-----RKGALKPSTAVRFALDIARGMNYLHEN-KPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (447)
Q Consensus 230 e~~~~g~L~~~l~-----~~~~l~~~~~~~i~~ql~~~l~~lH~~-~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~ 303 (447)
||+. +++.++.. ....+++..+..++.|++.||.|||+. + ++||||||+||+++.++.++|+|||++...
T Consensus 83 e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~ 158 (288)
T cd06616 83 ELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQL 158 (288)
T ss_pred eccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHh
Confidence 9985 56655432 235689999999999999999999985 6 999999999999999999999999998754
Q ss_pred ccCCCCCcccCCCCCcccCCcccCCC---CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHh---cCCCCCC-C
Q 013214 304 TVKEDRPLTCQDTSCRYVAPEVFKNE---EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA---RQRPPFK-A 376 (447)
Q Consensus 304 ~~~~~~~~~~~~~t~~y~aPE~~~~~---~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~---~~~~~~~-~ 376 (447)
... .......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||..... ....+.. ...+.+. .
T Consensus 159 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd06616 159 VDS--IAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS--VFDQLTQVVKGDPPILSNS 234 (288)
T ss_pred ccC--CccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch--HHHHHhhhcCCCCCcCCCc
Confidence 322 111233568889999998765 688899999999999999999999986542 2222211 1112221 1
Q ss_pred ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 377 PAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 377 ~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
....++..+.++|.+||+.||++|||+.+++.+
T Consensus 235 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 235 EEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred CCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 123478899999999999999999999999875
No 326
>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc
Probab=100.00 E-value=2e-35 Score=280.16 Aligned_cols=247 Identities=27% Similarity=0.465 Sum_probs=195.1
Q ss_pred cccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEec
Q 013214 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (447)
Q Consensus 157 ~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 231 (447)
|+..+.||.|++|.++. +|..||+|++..+.. .......+.+|+.+++.++|||++++++++.+.+..++++||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~ 79 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETE-DEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEF 79 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccc-cccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEec
Confidence 45667899999987763 689999999875532 222335677899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 013214 232 LPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (447)
Q Consensus 232 ~~~g~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~ 309 (447)
+ +++|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... .
T Consensus 80 ~-~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~-~ 154 (283)
T cd07835 80 L-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPV-R 154 (283)
T ss_pred c-CcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCc-c
Confidence 9 479999998765 6899999999999999999999998 9999999999999999999999999987654321 1
Q ss_pred CcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcC------------------
Q 013214 310 PLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ------------------ 370 (447)
Q Consensus 310 ~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~------------------ 370 (447)
......+++.|+|||.+.+. .++.++|+||||+++|+|++|+.||...+.......+....
T Consensus 155 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07835 155 TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYK 234 (283)
T ss_pred ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhh
Confidence 12223457889999987654 56889999999999999999999997654322211111100
Q ss_pred -------CCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 371 -------RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 371 -------~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
.+......+.++..+.++|.+||+.||.+||++++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 235 PTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 011111223466789999999999999999999999864
No 327
>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po
Probab=100.00 E-value=2.3e-35 Score=279.97 Aligned_cols=248 Identities=29% Similarity=0.421 Sum_probs=196.5
Q ss_pred cccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeC--CceEEEE
Q 013214 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--SPMMIVT 229 (447)
Q Consensus 157 ~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~~lv~ 229 (447)
|+..+.||.|++|.++. +|+.+|+|.+.... ........+.+|+.+++.++|||++++++++... +..++++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 79 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVF 79 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc-ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEe
Confidence 45667899999987763 57899999998653 2333446678899999999999999999999888 8899999
Q ss_pred eccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 013214 230 EYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (447)
Q Consensus 230 e~~~~g~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~ 308 (447)
||++ ++|.+++... ..+++..++.++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||++........
T Consensus 80 e~~~-~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~ 155 (287)
T cd07840 80 EYMD-HDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS 155 (287)
T ss_pred cccc-ccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCCc
Confidence 9996 5899888765 57999999999999999999999998 99999999999999999999999999987654332
Q ss_pred CCcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCC-C------CCCC----
Q 013214 309 RPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQR-P------PFKA---- 376 (447)
Q Consensus 309 ~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~-~------~~~~---- 376 (447)
.......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...+.......+..... + .+..
T Consensus 156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd07840 156 ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWF 235 (287)
T ss_pred ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhh
Confidence 22333456788999998765 3578899999999999999999999987665433333211110 0 0000
Q ss_pred ---------------Chhh-hHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 377 ---------------PAKL-YARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 377 ---------------~~~~-~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
.... +++.+.+++++||+.+|.+||++.+++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 236 ENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred hhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 0011 26788999999999999999999998863
No 328
>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein. Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc
Probab=100.00 E-value=4.9e-35 Score=281.89 Aligned_cols=249 Identities=18% Similarity=0.330 Sum_probs=194.1
Q ss_pred cccceeeecceEEEEE---EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEeccC
Q 013214 157 FTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 233 (447)
Q Consensus 157 ~~~~~~lg~G~~~~~~---~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 233 (447)
+...+.+|.|+++.++ .+|+.||+|++..... .......+.+|+.+++.++||||+++++++..+...+++|||++
T Consensus 4 ~~i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~ 82 (314)
T cd08216 4 TLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSC-SKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMA 82 (314)
T ss_pred hhhhHhhcCCceEEEEEecCCCCEEEEEEEecccc-chhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccC
Confidence 3344555666665443 4789999999876532 34566789999999999999999999999999999999999999
Q ss_pred CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCC---
Q 013214 234 KGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED--- 308 (447)
Q Consensus 234 ~g~L~~~l~~~--~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~--- 308 (447)
+|+|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+|++|||.+........
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~ 159 (314)
T cd08216 83 YGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQR 159 (314)
T ss_pred CCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeecccccccc
Confidence 99999999763 45889999999999999999999999 99999999999999999999999998865432111
Q ss_pred ---CCcccCCCCCcccCCcccCCC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCC-----------
Q 013214 309 ---RPLTCQDTSCRYVAPEVFKNE--EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRP----------- 372 (447)
Q Consensus 309 ---~~~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~----------- 372 (447)
.......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||.................+
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (314)
T cd08216 160 VVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLY 239 (314)
T ss_pred ccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhh
Confidence 011233467789999998663 5788999999999999999999999865433221111110000
Q ss_pred -------------------CCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 373 -------------------PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 373 -------------------~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
.-......++..+.+++.+||+.||++|||+++++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 240 EDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred cCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 0011123456789999999999999999999999974
No 329
>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4. Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo
Probab=100.00 E-value=3.2e-35 Score=280.26 Aligned_cols=241 Identities=22% Similarity=0.406 Sum_probs=197.3
Q ss_pred ceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEeccCC
Q 013214 160 SVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234 (447)
Q Consensus 160 ~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 234 (447)
...||+|+||.++ .+|+.||+|.+... .......+.+|+.+++.++|||++++++.+...+..+++|||+++
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 101 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR---KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 101 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc---chhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCC
Confidence 3568999998775 26889999987533 233456688899999999999999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCCcccC
Q 013214 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQ 314 (447)
Q Consensus 235 g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~ 314 (447)
++|.+++. .+.+++..+..++.|++.|+.|||+.+ ++|+||+|+||++++++.++|+|||++....... ......
T Consensus 102 ~~L~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~-~~~~~~ 176 (292)
T cd06657 102 GALTDIVT-HTRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRRKSL 176 (292)
T ss_pred CcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceeccccc-cccccc
Confidence 99999775 456899999999999999999999999 9999999999999999999999999887554321 112334
Q ss_pred CCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHHHHHcc
Q 013214 315 DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWN 394 (447)
Q Consensus 315 ~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 394 (447)
.+++.|+|||.+.+..++.++|+||+|+++|+|++|..||......+....+.....+.+. ....++..+.+++.+||+
T Consensus 177 ~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~ 255 (292)
T cd06657 177 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLK-NLHKVSPSLKGFLDRLLV 255 (292)
T ss_pred ccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccC-CcccCCHHHHHHHHHHHh
Confidence 5788899999998888899999999999999999999999876554443333222222221 233467789999999999
Q ss_pred cCCCCCCCHHHHHHH
Q 013214 395 EKPAKRPTFRQIITR 409 (447)
Q Consensus 395 ~dp~~Rps~~~~l~~ 409 (447)
.||.+||++.+++.+
T Consensus 256 ~~P~~R~~~~~ll~~ 270 (292)
T cd06657 256 RDPAQRATAAELLKH 270 (292)
T ss_pred CCcccCcCHHHHhcC
Confidence 999999999999874
No 330
>PHA03210 serine/threonine kinase US3; Provisional
Probab=100.00 E-value=1.4e-35 Score=302.37 Aligned_cols=251 Identities=16% Similarity=0.225 Sum_probs=184.4
Q ss_pred cCcccceeeecceEEEEEE------cCeEEEEE--------------EcCcccCCCHHHHHHHHHHHHHHhcCCCCcccc
Q 013214 155 LDFTNSVEITKGTFILAFW------RGIQVAVK--------------KLGEEVISDDDRVRAFRDELALLQKIRHPNVVQ 214 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~------~g~~vavK--------------~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~ 214 (447)
.+|+..+.||+|+||.|+. .+..++.| .+.+...........+.+|+.++++++||||++
T Consensus 148 ~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~ 227 (501)
T PHA03210 148 AHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILK 227 (501)
T ss_pred hccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCc
Confidence 3688899999999998873 11112222 111111122334566889999999999999999
Q ss_pred eeEEEEeCCceEEEEeccCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCC
Q 013214 215 FLGAVTQSSPMMIVTEYLPKGDLRAFLKRK-----GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289 (447)
Q Consensus 215 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-----~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~ 289 (447)
+++++...+..++++|++ +++|.+++... .......+..++.|++.||.|||+++ |+||||||+|||++.+
T Consensus 228 l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl~~~ 303 (501)
T PHA03210 228 IEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFLNCD 303 (501)
T ss_pred EeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCC
Confidence 999999999999999999 56888777542 22345677889999999999999999 9999999999999999
Q ss_pred CCEEEeecccccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCC-CCCCCCCc---hHHH
Q 013214 290 GNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPP-FTMKHDNE---VPKA 365 (447)
Q Consensus 290 ~~vkl~Dfg~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p-~~~~~~~~---~~~~ 365 (447)
+.+||+|||++..+............||..|+|||++.+..++.++|||||||++|+|++|..+ |....... ....
T Consensus 304 ~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~ 383 (501)
T PHA03210 304 GKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKI 383 (501)
T ss_pred CCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHH
Confidence 9999999999987653322222345689999999999998999999999999999999998754 44332221 1111
Q ss_pred HHhcC--CCCCCCC-------------------------hhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 366 YAARQ--RPPFKAP-------------------------AKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 366 ~~~~~--~~~~~~~-------------------------~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
+.... ...++.. ....+..+.++|.+||+.||.+|||+.+++++
T Consensus 384 ~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 384 IDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 11000 0000000 01234567788999999999999999999874
No 331
>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10. Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing
Probab=100.00 E-value=2.1e-35 Score=283.85 Aligned_cols=249 Identities=29% Similarity=0.421 Sum_probs=194.9
Q ss_pred cCcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeC--CceEE
Q 013214 155 LDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--SPMMI 227 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~~l 227 (447)
.+|+..+.||.|+||.++ .+|+.||+|.++...... .....+.+|+.++++++||||+++++++... +..++
T Consensus 7 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 7 TEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERD-GIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred cceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCC-CCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 367888899999999876 258899999986543222 2223456799999999999999999998755 46899
Q ss_pred EEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccC
Q 013214 228 VTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306 (447)
Q Consensus 228 v~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~ 306 (447)
+|||+. ++|.+++... ..+++.++..++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||++......
T Consensus 86 v~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~ 161 (309)
T cd07845 86 VMEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP 161 (309)
T ss_pred EEecCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecCCc
Confidence 999995 5898888753 56899999999999999999999999 999999999999999999999999998865432
Q ss_pred CCCCcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCC-------------
Q 013214 307 EDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRP------------- 372 (447)
Q Consensus 307 ~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~------------- 372 (447)
. .......+++.|+|||.+.+ ..++.++|+||||+++|+|++|+.||...+..+....+......
T Consensus 162 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (309)
T cd07845 162 A-KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLP 240 (309)
T ss_pred c-CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhccc
Confidence 2 12222334778999999865 45788999999999999999999999877655444333221100
Q ss_pred -----CCCC--------ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 373 -----PFKA--------PAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 373 -----~~~~--------~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
.... .....++.+.++|.+||+.||++|||+.+++.+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 241 LVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred ccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0000 011247788999999999999999999999864
No 332
>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85. Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.
Probab=100.00 E-value=3.2e-35 Score=278.94 Aligned_cols=247 Identities=25% Similarity=0.481 Sum_probs=195.4
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|+..+.||.|++|.++. +|+.||+|.+..... ......+.+|+.++++++||||+++++++.+.+..+++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE--EGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFE 78 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc--ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEe
Confidence 467788999999987762 588999999875432 2223556789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCC
Q 013214 231 YLPKGDLRAFLKRKG---ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307 (447)
Q Consensus 231 ~~~~g~L~~~l~~~~---~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~ 307 (447)
|++ ++|.+++...+ .+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||++.......
T Consensus 79 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~ 154 (284)
T cd07836 79 YMD-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPV 154 (284)
T ss_pred cCC-ccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc
Confidence 997 58988886543 5899999999999999999999999 9999999999999999999999999987554321
Q ss_pred CCCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCC---------------
Q 013214 308 DRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQR--------------- 371 (447)
Q Consensus 308 ~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~--------------- 371 (447)
. ......++..|++||.+.+. .++.++|+||||+++|+|++|+.||...+..+....+.....
T Consensus 155 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07836 155 N-TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPE 233 (284)
T ss_pred c-ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCch
Confidence 1 12233467889999988654 568899999999999999999999987765443332211110
Q ss_pred --CCCCC--------ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 372 --PPFKA--------PAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 372 --~~~~~--------~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
..++. ..+..+..+.+++.+||+.||.+||++.+++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 234 YKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred hcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 00000 012346788999999999999999999998863
No 333
>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]
Probab=100.00 E-value=3.2e-36 Score=270.37 Aligned_cols=242 Identities=24% Similarity=0.389 Sum_probs=199.0
Q ss_pred ceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeEEEEeCCceEEEEeccC
Q 013214 160 SVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLP 233 (447)
Q Consensus 160 ~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~ 233 (447)
...||+|+++.|. .+|..+|||++.+. +.-.+.+..+|++++.+. .|+||++++++|+++.++|||||-|.
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq---~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~ 159 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ---PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMR 159 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcC---CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEeccc
Confidence 4578999998763 68999999999764 334456677899999999 59999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCC---EEEeecccccccccCC--C
Q 013214 234 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN---LKVADFGVSKLLTVKE--D 308 (447)
Q Consensus 234 ~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~---vkl~Dfg~~~~~~~~~--~ 308 (447)
||+|..+++++..+++.++..+..+|+.||.+||.+| |.|||+||+|||-.+... +|||||.+...+.... .
T Consensus 160 GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~s 236 (463)
T KOG0607|consen 160 GGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCS 236 (463)
T ss_pred CchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeeccccccccccCCCCC
Confidence 9999999999999999999999999999999999999 999999999999875543 8999998765432111 1
Q ss_pred ----CCcccCCCCCcccCCcccC-----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCC-------Cc--------hHH
Q 013214 309 ----RPLTCQDTSCRYVAPEVFK-----NEEYDTKVDVFSFALILQEMIEGCPPFTMKHD-------NE--------VPK 364 (447)
Q Consensus 309 ----~~~~~~~~t~~y~aPE~~~-----~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~-------~~--------~~~ 364 (447)
.......|+..|||||+.. ...|+.+.|.||||+++|-|++|.+||.+.-. .+ +.+
T Consensus 237 pastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFe 316 (463)
T KOG0607|consen 237 PASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFE 316 (463)
T ss_pred CCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHH
Confidence 1123456788999999753 23688999999999999999999999976533 22 122
Q ss_pred HHHhcCCCCCC-CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHH
Q 013214 365 AYAARQRPPFK-APAKLYARGLKELIEECWNEKPAKRPTFRQIIT 408 (447)
Q Consensus 365 ~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~ 408 (447)
.+ ..+...|+ +.+..+|.+..+++..++..|+.+|.++.++++
T Consensus 317 sI-QEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 317 SI-QEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred HH-hccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 23 33444443 467789999999999999999999999999987
No 334
>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2. Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin
Probab=100.00 E-value=4.3e-35 Score=281.59 Aligned_cols=245 Identities=26% Similarity=0.454 Sum_probs=200.0
Q ss_pred CcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
.|+..+.||+|++|.++ .+++.+|+|.+...........+++.+|+.+++.++|||++++++++......++++|
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 95 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence 46677789999998775 2578899998865433444556678889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 013214 231 YLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (447)
Q Consensus 231 ~~~~g~L~~~l~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~ 309 (447)
|+. |+|.+.+.. ..++++.++..++.|++.|+.|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 96 ~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~--- 168 (308)
T cd06634 96 YCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--- 168 (308)
T ss_pred ccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecCc---
Confidence 995 688887754 456899999999999999999999998 999999999999999999999999998754321
Q ss_pred CcccCCCCCcccCCcccC---CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHH
Q 013214 310 PLTCQDTSCRYVAPEVFK---NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLK 386 (447)
Q Consensus 310 ~~~~~~~t~~y~aPE~~~---~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 386 (447)
....+++.|+|||.+. ...++.++||||||+++|+|++|..||......+....+.....+.. ....++..+.
T Consensus 169 --~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 244 (308)
T cd06634 169 --NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPAL--QSGHWSEYFR 244 (308)
T ss_pred --ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCc--CcccccHHHH
Confidence 2335688899999874 34578899999999999999999999987655444444433333332 2335778899
Q ss_pred HHHHHHcccCCCCCCCHHHHHHHHH
Q 013214 387 ELIEECWNEKPAKRPTFRQIITRLE 411 (447)
Q Consensus 387 ~li~~cl~~dp~~Rps~~~~l~~l~ 411 (447)
++|++||+.+|++||++.+++.+-.
T Consensus 245 ~li~~cl~~~P~~Rp~~~~ll~~~~ 269 (308)
T cd06634 245 NFVDSCLQKIPQDRPTSEVLLKHRF 269 (308)
T ss_pred HHHHHHhhCCcccCCCHHHHhhCcc
Confidence 9999999999999999999987643
No 335
>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the
Probab=100.00 E-value=3.8e-35 Score=272.87 Aligned_cols=235 Identities=30% Similarity=0.467 Sum_probs=197.2
Q ss_pred eecceEEEEE---E--cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEeccCCCCH
Q 013214 163 ITKGTFILAF---W--RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237 (447)
Q Consensus 163 lg~G~~~~~~---~--~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L 237 (447)
||.|++|.++ . +++.+|+|.+.............+.+|+.++++++||||+++++.+..+...+++|||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 5788888665 2 4889999998876555555677889999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCCcccCCCC
Q 013214 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS 317 (447)
Q Consensus 238 ~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~t 317 (447)
.+++.....+++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++....... .......++
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~ 156 (250)
T cd05123 81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNTFCGT 156 (250)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccCCcCC
Confidence 999988888999999999999999999999998 9999999999999999999999999987654321 122334568
Q ss_pred CcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHHHHHcccCC
Q 013214 318 CRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKP 397 (447)
Q Consensus 318 ~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp 397 (447)
..|+|||.+.+...+.++|+||||+++|++++|..||...+..+....+.. ....+ +...+..+.+++++||..||
T Consensus 157 ~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~---~~~~~~~l~~~i~~~l~~~p 232 (250)
T cd05123 157 PEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK-DPLRF---PEFLSPEARDLISGLLQKDP 232 (250)
T ss_pred ccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc-CCCCC---CCCCCHHHHHHHHHHhcCCH
Confidence 889999999888888999999999999999999999976665443333322 22222 33447889999999999999
Q ss_pred CCCCCHHH
Q 013214 398 AKRPTFRQ 405 (447)
Q Consensus 398 ~~Rps~~~ 405 (447)
++||++.+
T Consensus 233 ~~R~~~~~ 240 (250)
T cd05123 233 TKRLGSGG 240 (250)
T ss_pred hhCCCccc
Confidence 99999943
No 336
>PLN00009 cyclin-dependent kinase A; Provisional
Probab=100.00 E-value=5e-35 Score=279.20 Aligned_cols=248 Identities=26% Similarity=0.431 Sum_probs=192.9
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|+..+.||+|++|.++. +|+.||+|.+..... .......+.+|++++++++||||+++++++.+....++|||
T Consensus 3 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 3 QYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQE-DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred ceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccc-cccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 577788999999987752 678999999865432 22334567889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcC-CCCEEEeecccccccccCC
Q 013214 231 YLPKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD-SGNLKVADFGVSKLLTVKE 307 (447)
Q Consensus 231 ~~~~g~L~~~l~~~~~--l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~-~~~vkl~Dfg~~~~~~~~~ 307 (447)
|++ ++|.+++..... +++..+..++.|++.||.|||+++ ++|+||+|+||+++. ++.+||+|||++.......
T Consensus 82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~ 157 (294)
T PLN00009 82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (294)
T ss_pred ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence 995 688888865443 577888899999999999999998 999999999999985 5579999999987654321
Q ss_pred CCCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhc-CCC-------------
Q 013214 308 DRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR-QRP------------- 372 (447)
Q Consensus 308 ~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~-~~~------------- 372 (447)
.......+++.|+|||.+.+. .++.++|+||+|+++|+|++|+.||...+..+....+... ..+
T Consensus 158 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (294)
T PLN00009 158 -RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPD 236 (294)
T ss_pred -cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchh
Confidence 112233467889999988664 5788999999999999999999999876543322221110 000
Q ss_pred ------CCC-----CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 373 ------PFK-----APAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 373 ------~~~-----~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
.+. ...+.+++.+.+++.+||+.+|++||++.+++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 237 YKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred hhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 0113456789999999999999999999999874
No 337
>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase. Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess
Probab=100.00 E-value=5.6e-35 Score=278.40 Aligned_cols=248 Identities=23% Similarity=0.402 Sum_probs=190.2
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEE
Q 013214 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 229 (447)
.+|...+.||+|+||.|+. +|+.||+|.+...... .....+.+|+.+++.++|+||+++++++..+...++++
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEE--GVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcC--CCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 4688888999999998863 5889999998654321 22235668999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 013214 230 EYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (447)
Q Consensus 230 e~~~~g~L~~~l~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~ 308 (447)
||+. ++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++........
T Consensus 83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 158 (291)
T cd07870 83 EYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ 158 (291)
T ss_pred eccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCCCC
Confidence 9995 677777654 355788889999999999999999998 99999999999999999999999999875432211
Q ss_pred CCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCc-hHHHHHh-cC------------CCC
Q 013214 309 RPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNE-VPKAYAA-RQ------------RPP 373 (447)
Q Consensus 309 ~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~-~~~~~~~-~~------------~~~ 373 (447)
......+++.|+|||.+.+. .++.++|+||||+++|+|++|+.||....... ....... .+ .+.
T Consensus 159 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (291)
T cd07870 159 -TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPN 237 (291)
T ss_pred -CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhccc
Confidence 11233468889999998654 57889999999999999999999997654321 1111000 00 000
Q ss_pred C---------CCC------hhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 374 F---------KAP------AKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 374 ~---------~~~------~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
+ ... ....+..+.+++.+|+..||.+|||+.+++.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h 288 (291)
T cd07870 238 YKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH 288 (291)
T ss_pred ccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence 0 000 00124678999999999999999999998753
No 338
>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the
Probab=100.00 E-value=3.8e-35 Score=279.54 Aligned_cols=247 Identities=25% Similarity=0.422 Sum_probs=190.4
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|+..+.||+|++|.++. +++.||+|.+...... .....+.+|+.++++++||||+++++++......++|||
T Consensus 6 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (291)
T cd07844 6 TYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE--GAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE 83 (291)
T ss_pred ceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc--CCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence 577888999999998762 6789999998654321 122345679999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 013214 231 YLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (447)
Q Consensus 231 ~~~~g~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~ 309 (447)
|+. ++|.+++.+. ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++........
T Consensus 84 ~~~-~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~- 158 (291)
T cd07844 84 YLD-TDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSK- 158 (291)
T ss_pred cCC-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCCc-
Confidence 996 5999988764 46899999999999999999999999 99999999999999999999999999875432211
Q ss_pred CcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCC-chHHHHHhc-CCC--------------
Q 013214 310 PLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDN-EVPKAYAAR-QRP-------------- 372 (447)
Q Consensus 310 ~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~-~~~~~~~~~-~~~-------------- 372 (447)
......++..|+|||.+.+ ..++.++||||+|+++|+|++|+.||...... +....+... ..+
T Consensus 159 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (291)
T cd07844 159 TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEF 238 (291)
T ss_pred cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcccc
Confidence 1122235788999998865 45788999999999999999999999765521 111111000 000
Q ss_pred ------CCC-----CChhhhH--HHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 373 ------PFK-----APAKLYA--RGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 373 ------~~~-----~~~~~~~--~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
... ......+ ..+.+++.+||+.+|++|||+.+++.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~ 288 (291)
T cd07844 239 KPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH 288 (291)
T ss_pred ccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence 000 0001122 678899999999999999999998753
No 339
>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]
Probab=100.00 E-value=1.7e-36 Score=287.75 Aligned_cols=241 Identities=24% Similarity=0.396 Sum_probs=206.2
Q ss_pred ceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEeccCC
Q 013214 160 SVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234 (447)
Q Consensus 160 ~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 234 (447)
.+.||+|.||+|| .+|++||||++.+..+.. +....+++|+.+|+++.||.||.+.-.|+..++++.|||-+ .
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~-kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~ 646 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPT-KQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-H 646 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCC-chHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-c
Confidence 4679999999987 589999999999887754 44488999999999999999999999999999999999999 5
Q ss_pred CCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCC---CEEEeecccccccccCCCC
Q 013214 235 GDLRAFLK--RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG---NLKVADFGVSKLLTVKEDR 309 (447)
Q Consensus 235 g~L~~~l~--~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~---~vkl~Dfg~~~~~~~~~~~ 309 (447)
|++.+++- +.+++++.....++.||+.||.|||-++ |+|+||||+|||+.+.. .+||||||+++.++.. .
T Consensus 647 GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk--s 721 (888)
T KOG4236|consen 647 GDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK--S 721 (888)
T ss_pred chHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchh--h
Confidence 67777664 4578999999999999999999999999 99999999999998654 6999999999998754 3
Q ss_pred CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHH
Q 013214 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELI 389 (447)
Q Consensus 310 ~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 389 (447)
...+..|||.|+|||++....|+.+-|+||.|+++|.-++|..||.. ++++..++......-.+.++..++.+..++|
T Consensus 722 FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNE--dEdIndQIQNAaFMyPp~PW~eis~~AidlI 799 (888)
T KOG4236|consen 722 FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNE--DEDINDQIQNAAFMYPPNPWSEISPEAIDLI 799 (888)
T ss_pred hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCC--ccchhHHhhccccccCCCchhhcCHHHHHHH
Confidence 34567899999999999999999999999999999999999999974 4445555533333333345778899999999
Q ss_pred HHHcccCCCCCCCHHHHHHH
Q 013214 390 EECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 390 ~~cl~~dp~~Rps~~~~l~~ 409 (447)
..+|+..=.+|-|....+.+
T Consensus 800 n~LLqVkm~kRysvdk~lsh 819 (888)
T KOG4236|consen 800 NNLLQVKMRKRYSVDKSLSH 819 (888)
T ss_pred HHHHHHHHHHhcchHhhccc
Confidence 99999999999999877654
No 340
>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase
Probab=100.00 E-value=2.8e-35 Score=286.44 Aligned_cols=248 Identities=26% Similarity=0.426 Sum_probs=192.2
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeC-----Cc
Q 013214 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS-----SP 224 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~ 224 (447)
.+|+..+.||+|++|.++. +|+.||+|.+... ........+.+|+.+++.++||||+++++++... ..
T Consensus 5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPF--EHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEeccc--ccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence 3688889999999998763 6899999998642 2233456678899999999999999999887644 35
Q ss_pred eEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccc
Q 013214 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304 (447)
Q Consensus 225 ~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~ 304 (447)
.++++||+. ++|.+++.. ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++....
T Consensus 83 ~~lv~e~~~-~~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~ 157 (336)
T cd07849 83 VYIVQELME-TDLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIAD 157 (336)
T ss_pred EEEEehhcc-cCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceeecc
Confidence 799999995 588887743 56999999999999999999999999 9999999999999999999999999987654
Q ss_pred cCCCC--CcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcC-----------
Q 013214 305 VKEDR--PLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ----------- 370 (447)
Q Consensus 305 ~~~~~--~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~----------- 370 (447)
..... ......+++.|+|||.+.+ ..++.++|+||+|+++|+|++|+.||.+.+.......+....
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (336)
T cd07849 158 PEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCI 237 (336)
T ss_pred ccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHh
Confidence 32211 1123457889999998654 467889999999999999999999997654322111110000
Q ss_pred ----------CCCCC------CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 371 ----------RPPFK------APAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 371 ----------~~~~~------~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
..+.. ...+.+++.+.++|.+||+.||++|||+.+++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 238 ISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred hchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00000 0112356789999999999999999999999987
No 341
>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5. Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the
Probab=100.00 E-value=1.6e-35 Score=287.93 Aligned_cols=250 Identities=23% Similarity=0.369 Sum_probs=196.6
Q ss_pred cCcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEe----CCce
Q 013214 155 LDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ----SSPM 225 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----~~~~ 225 (447)
.+|+..+.||.|++|.++ .+|+.||+|++..... .......+.+|+.++++++||||+++++++.. ....
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFD-VPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccc-cccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 467778899999998775 3689999999875432 22345667789999999999999999988753 3468
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeeccccccccc
Q 013214 226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305 (447)
Q Consensus 226 ~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~ 305 (447)
++++||+. ++|.+++.....+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||++.....
T Consensus 84 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 159 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSS 159 (334)
T ss_pred EEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecccccceeecc
Confidence 99999995 699999987778999999999999999999999998 99999999999999999999999999876543
Q ss_pred CCCCC---cccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhc------------
Q 013214 306 KEDRP---LTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR------------ 369 (447)
Q Consensus 306 ~~~~~---~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~------------ 369 (447)
..... .....++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||...+.......+...
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~ 239 (334)
T cd07855 160 SPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRI 239 (334)
T ss_pred cCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhh
Confidence 22111 123457888999998765 46788999999999999999999999776543221111100
Q ss_pred ------------C-CCCC--CCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 370 ------------Q-RPPF--KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 370 ------------~-~~~~--~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
. .... ....+..+..+.++|.+||+.+|++||++.+++.+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 240 GSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred chhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 0 0010 00113457889999999999999999999999874
No 342
>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase. Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm
Probab=100.00 E-value=4.9e-35 Score=279.29 Aligned_cols=248 Identities=26% Similarity=0.399 Sum_probs=191.8
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeEEEEeCCc-----
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSP----- 224 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~----- 224 (447)
+|+..+.||+|+||.++. +|+.||+|....... .......+.+|+.+++.+ +||||+++++++.....
T Consensus 2 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMD-EEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhcc-ccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 577788999999998763 688999998865432 222335677899999999 46999999999887665
Q ss_pred eEEEEeccCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcC-CCCEEEeecc
Q 013214 225 MMIVTEYLPKGDLRAFLKRK-----GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD-SGNLKVADFG 298 (447)
Q Consensus 225 ~~lv~e~~~~g~L~~~l~~~-----~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~-~~~vkl~Dfg 298 (447)
.+++|||++ ++|.+++... ..+++..++.++.|++.||.|||+.+ ++|+||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLD-SDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccC-cCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence 899999997 4898888643 34799999999999999999999999 999999999999998 8899999999
Q ss_pred cccccccCCCCCcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhc-CC-----
Q 013214 299 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR-QR----- 371 (447)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~-~~----- 371 (447)
++....... .......+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.+..+....+... ..
T Consensus 157 ~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (295)
T cd07837 157 LGRAFSIPV-KSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQV 235 (295)
T ss_pred cceecCCCc-cccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence 987653321 11222345788999998865 45788999999999999999999999876543322221110 00
Q ss_pred -------------CCCC-----CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 372 -------------PPFK-----APAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 372 -------------~~~~-----~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
+.+. ...+.++..+.++|.+||..||.+||++.+++.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 236 WPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred CcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 0000 0112467889999999999999999999998864
No 343
>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants. Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati
Probab=100.00 E-value=2.5e-35 Score=286.91 Aligned_cols=252 Identities=26% Similarity=0.394 Sum_probs=198.3
Q ss_pred CcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeC-----Cce
Q 013214 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS-----SPM 225 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~~ 225 (447)
+|...+.||+|+||.++ .+|+.||+|.+..... .......+.+|+.+++.++||||+++++++... ...
T Consensus 6 ~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 84 (337)
T cd07858 6 KYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFD-NRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDV 84 (337)
T ss_pred ceeEEEEeccCCCeEEEEEEecCCCCeEEEEEeccccc-ccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcE
Confidence 68888899999999876 3688999999875432 223345667899999999999999999987644 347
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeeccccccccc
Q 013214 226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305 (447)
Q Consensus 226 ~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~ 305 (447)
++++||+. ++|.+++...+.+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++.....
T Consensus 85 ~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 160 (337)
T cd07858 85 YIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLARTTSE 160 (337)
T ss_pred EEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCccccccCC
Confidence 99999994 799999988888999999999999999999999999 99999999999999999999999999886543
Q ss_pred CCCCCcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhc---------------
Q 013214 306 KEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR--------------- 369 (447)
Q Consensus 306 ~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~--------------- 369 (447)
.. .......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||.+.+.......+...
T Consensus 161 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (337)
T cd07858 161 KG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNE 239 (337)
T ss_pred Cc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCch
Confidence 22 12233456888999998765 46889999999999999999999999765432211111000
Q ss_pred ------------CCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH--HHHH
Q 013214 370 ------------QRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR--LESI 413 (447)
Q Consensus 370 ------------~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~--l~~~ 413 (447)
..+.+....+.+++.+.++|++||+.||++|||+.+++++ ++.+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 240 KARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred hhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 0011111123467889999999999999999999999987 5544
No 344
>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the
Probab=100.00 E-value=7.6e-35 Score=280.67 Aligned_cols=250 Identities=23% Similarity=0.364 Sum_probs=192.2
Q ss_pred CcccceeeecceEEEEEE-------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeC--CceE
Q 013214 156 DFTNSVEITKGTFILAFW-------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--SPMM 226 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~~ 226 (447)
+|...+.||+|++|.++. .++.||+|.+...........+.+.+|+.+++.++||||+++++++... ..++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 366778899999997762 5789999999864322233345677899999999999999999999988 7899
Q ss_pred EEEeccCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcC----CCCEEEeec
Q 013214 227 IVTEYLPKGDLRAFLKRK-----GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD----SGNLKVADF 297 (447)
Q Consensus 227 lv~e~~~~g~L~~~l~~~-----~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~----~~~vkl~Df 297 (447)
+||||++ ++|.+.+... ..+++..++.++.|++.||.|||+.+ ++|+||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 9999996 5777776432 25889999999999999999999999 999999999999999 899999999
Q ss_pred ccccccccCCC--CCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCch---------HHH
Q 013214 298 GVSKLLTVKED--RPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV---------PKA 365 (447)
Q Consensus 298 g~~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~---------~~~ 365 (447)
|++........ .......+++.|+|||.+.+. .++.++|+||||+++|+|++|+.||........ ...
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99886543222 112234568889999987664 578899999999999999999999986654320 000
Q ss_pred H-H------------------------hcCCCCCCC--Ch------hhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 366 Y-A------------------------ARQRPPFKA--PA------KLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 366 ~-~------------------------~~~~~~~~~--~~------~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
+ . ......++. .. ...+..+.+++.+||+.||++|||+.+++++
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 0 0 000111110 00 0345678999999999999999999999864
No 345
>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase. Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.
Probab=100.00 E-value=6.3e-35 Score=276.48 Aligned_cols=244 Identities=22% Similarity=0.338 Sum_probs=189.3
Q ss_pred cccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeEEEEeC--CceEEE
Q 013214 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQS--SPMMIV 228 (447)
Q Consensus 157 ~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~--~~~~lv 228 (447)
|+..+.||+|+||.++. +++.||+|.++.... ..... ...+|+.+++++ +|||++++++++.++ +..+++
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~-~~~~~-~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 78 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFK-SLEQV-NNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV 78 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccC-Cchhh-hHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence 45567899999987753 688999999875432 22222 334688888888 499999999999987 889999
Q ss_pred EeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCC
Q 013214 229 TEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307 (447)
Q Consensus 229 ~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~ 307 (447)
+||++ ++|.+.+... ..+++.++..++.|++.||.|||+.+ ++|+||||+||+++. +.+||+|||++.......
T Consensus 79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~ 153 (282)
T cd07831 79 FELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKP 153 (282)
T ss_pred EecCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence 99996 5888888764 56899999999999999999999999 999999999999999 999999999987654321
Q ss_pred CCCcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcC---------------C
Q 013214 308 DRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ---------------R 371 (447)
Q Consensus 308 ~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~---------------~ 371 (447)
......++..|+|||.+.. ..++.++|+|||||++|+|++|..||...+..+......... .
T Consensus 154 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
T cd07831 154 --PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRH 231 (282)
T ss_pred --CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccccc
Confidence 2223456889999997654 456889999999999999999999998765433222221100 0
Q ss_pred CC--CC--------CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 372 PP--FK--------APAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 372 ~~--~~--------~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
.. ++ .....++..+.++|.+||+.+|++||++.+++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 232 MNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred ccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 00 00 0112467899999999999999999999999864
No 346
>PHA02882 putative serine/threonine kinase; Provisional
Probab=100.00 E-value=1.3e-34 Score=276.45 Aligned_cols=251 Identities=16% Similarity=0.160 Sum_probs=185.4
Q ss_pred CcCcccceeeecceEEEEEE-----c---CeEEEEEEcCcccCCC--HH-H-----HHHHHHHHHHHhcCCCCcccceeE
Q 013214 154 ELDFTNSVEITKGTFILAFW-----R---GIQVAVKKLGEEVISD--DD-R-----VRAFRDELALLQKIRHPNVVQFLG 217 (447)
Q Consensus 154 ~~~~~~~~~lg~G~~~~~~~-----~---g~~vavK~~~~~~~~~--~~-~-----~~~~~~E~~~l~~l~hp~iv~~~~ 217 (447)
..+|++.+.||+|+||.|+. + +..+|+|+........ +. . ......+...+..+.|++++++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 35788999999999999873 2 3466777543322110 00 0 011223344556678999999999
Q ss_pred EEEeCC----ceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEE
Q 013214 218 AVTQSS----PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK 293 (447)
Q Consensus 218 ~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vk 293 (447)
++.... ..++++|++ ..++.+.+......++..+..++.|++.||.|||+.+ ++||||||+|||++.++.++
T Consensus 91 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~~~~ 166 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKL-VENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNNRGY 166 (294)
T ss_pred eeeEecCCceEEEEEEehh-ccCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCcEE
Confidence 765443 347888887 4578877776666788889999999999999999998 99999999999999999999
Q ss_pred EeecccccccccCCC------CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCch-HHHH
Q 013214 294 VADFGVSKLLTVKED------RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV-PKAY 366 (447)
Q Consensus 294 l~Dfg~~~~~~~~~~------~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~-~~~~ 366 (447)
|+|||+++....... .......||+.|+|||.+.+..++.++|||||||++|+|++|+.||........ ....
T Consensus 167 l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~ 246 (294)
T PHA02882 167 IIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAA 246 (294)
T ss_pred EEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHh
Confidence 999999976532111 111234689999999999998999999999999999999999999987743321 1111
Q ss_pred H----hc-CCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHH
Q 013214 367 A----AR-QRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRL 410 (447)
Q Consensus 367 ~----~~-~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l 410 (447)
. .. ..... ..+..++.+.++++.||..+|++||++.++++.+
T Consensus 247 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 247 KCDFIKRLHEGKI--KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HHHHHHHhhhhhh--ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 0 00 11111 1234578899999999999999999999999865
No 347
>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl
Probab=100.00 E-value=6.4e-35 Score=280.31 Aligned_cols=251 Identities=24% Similarity=0.358 Sum_probs=191.0
Q ss_pred CcCcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCC-----
Q 013214 154 ELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS----- 223 (447)
Q Consensus 154 ~~~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~----- 223 (447)
..+|+..+.||+|+||.++ .+++.||+|.+....... .....+.+|+.++++++||||+++++++....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKE-GFPITALREIKILQLLKHENVVNLIEICRTKATPYNR 89 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcC-CchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence 3468888999999999876 268899999886543221 22234567999999999999999999887654
Q ss_pred ---ceEEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeeccc
Q 013214 224 ---PMMIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGV 299 (447)
Q Consensus 224 ---~~~lv~e~~~~g~L~~~l~~~~-~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~ 299 (447)
..+++|||+. ++|.+.+.... .+++.+++.++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||+
T Consensus 90 ~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~ 165 (310)
T cd07865 90 YKGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGL 165 (310)
T ss_pred CCceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCCC
Confidence 3599999995 68888886543 6899999999999999999999998 99999999999999999999999999
Q ss_pred ccccccCCCC---CcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcC-C--C
Q 013214 300 SKLLTVKEDR---PLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-R--P 372 (447)
Q Consensus 300 ~~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~-~--~ 372 (447)
+......... ......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...+.......+.... . +
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (310)
T cd07865 166 ARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITP 245 (310)
T ss_pred cccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence 8765432211 11233467889999988664 46789999999999999999999998665433222211100 0 0
Q ss_pred ---------------CCCCC----------hhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 373 ---------------PFKAP----------AKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 373 ---------------~~~~~----------~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
.++.. ....++.+.++|.+||..||.+|||+.+++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 246 EVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred hhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 00000 00124567899999999999999999999864
No 348
>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]
Probab=100.00 E-value=5.6e-36 Score=248.38 Aligned_cols=248 Identities=24% Similarity=0.439 Sum_probs=202.3
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|...++||+|++|+|+. +++.||+|.++.+.- ++-.-....+|+.+++.++|.|||++++...++..+-+|+|
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddd-degvpssalreicllkelkhknivrl~dvlhsdkkltlvfe 81 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCC-CCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHH
Confidence 456667899999999974 678999999986542 22233556779999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 013214 231 YLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (447)
Q Consensus 231 ~~~~g~L~~~l~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~ 309 (447)
|| ..+|..+..+ ++.++.+.+..++.|++.||.++|+++ ++|||+||+|.+|+.+|.+|++|||+++.++.+. +
T Consensus 82 ~c-dqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipv-r 156 (292)
T KOG0662|consen 82 FC-DQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPV-R 156 (292)
T ss_pred Hh-hHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCce-E
Confidence 99 5699999876 577999999999999999999999999 9999999999999999999999999999876542 3
Q ss_pred CcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhc-CCC------------CC
Q 013214 310 PLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAAR-QRP------------PF 374 (447)
Q Consensus 310 ~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~-~~~------------~~ 374 (447)
..+....|.+|.+|.++.+. -|+++.|+||-||++.|+.. |++.|++.+..+....+... +.+ .+
T Consensus 157 cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdy 236 (292)
T KOG0662|consen 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDY 236 (292)
T ss_pred eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCC
Confidence 34445569999999998876 58889999999999999986 88889988766655554221 111 11
Q ss_pred ---CCC---------hhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 375 ---KAP---------AKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 375 ---~~~---------~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
+.. .+..+..-++++++++.-+|.+|.++++.+++
T Consensus 237 k~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 237 KPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred cccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 111 12344567899999999999999999988764
No 349
>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=1e-36 Score=312.05 Aligned_cols=251 Identities=24% Similarity=0.324 Sum_probs=213.8
Q ss_pred CcCcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEE
Q 013214 154 ELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 228 (447)
Q Consensus 154 ~~~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 228 (447)
.-+|.+.+.||+|+||-|. .+++.+|+|++.+..........-|..|-++|..-+.+-|++++-.|.++.++|+|
T Consensus 74 ~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlV 153 (1317)
T KOG0612|consen 74 AEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLV 153 (1317)
T ss_pred HHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEE
Confidence 3478888999999999663 47889999999875444444457789999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 013214 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (447)
Q Consensus 229 ~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~ 308 (447)
|||++||+|-.++.+.+++++..+..++..++-||..+|+.| +|||||||+|||+|..|++||+|||.+-.+.....
T Consensus 154 MdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~ 230 (1317)
T KOG0612|consen 154 MDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGT 230 (1317)
T ss_pred EecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccchhHHhcCCCCc
Confidence 999999999999998889999999999999999999999999 99999999999999999999999999887765544
Q ss_pred CCcccCCCCCcccCCcccCC-----CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcC-CCCCCCChhhhH
Q 013214 309 RPLTCQDTSCRYVAPEVFKN-----EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RPPFKAPAKLYA 382 (447)
Q Consensus 309 ~~~~~~~~t~~y~aPE~~~~-----~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 382 (447)
.......|||.|.+||++.. +.|++.+|+||+||++|||+.|..||...+..+....|-... .-.|| ....+|
T Consensus 231 V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP-~~~~VS 309 (1317)
T KOG0612|consen 231 VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFP-DETDVS 309 (1317)
T ss_pred EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCC-cccccC
Confidence 44566789999999999853 468899999999999999999999999888777766663332 44554 234589
Q ss_pred HHHHHHHHHHcccCCCCCCC---HHHHHHH
Q 013214 383 RGLKELIEECWNEKPAKRPT---FRQIITR 409 (447)
Q Consensus 383 ~~l~~li~~cl~~dp~~Rps---~~~~l~~ 409 (447)
++.++||.+.+ -+|+.|.. +.++..|
T Consensus 310 eeakdLI~~ll-~~~e~RLgrngiedik~H 338 (1317)
T KOG0612|consen 310 EEAKDLIEALL-CDREVRLGRNGIEDIKNH 338 (1317)
T ss_pred HHHHHHHHHHh-cChhhhcccccHHHHHhC
Confidence 99999999887 56778877 7777654
No 350
>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=7e-37 Score=289.44 Aligned_cols=239 Identities=24% Similarity=0.363 Sum_probs=213.6
Q ss_pred CcccceeeecceEEEE---EEcCeE--EEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILA---FWRGIQ--VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~---~~~g~~--vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
++....-||-|+||.| ...++. +|+|++++.++.+.++.+....|-++|...+.|+||++|-.|.++..+|++||
T Consensus 421 dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmE 500 (732)
T KOG0614|consen 421 DLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLME 500 (732)
T ss_pred hhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHH
Confidence 3445556899999976 345555 89999999888888888999999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCC
Q 013214 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (447)
Q Consensus 231 ~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~ 310 (447)
-|-||.|+..+++++.+++.++..++..+++|+.|||+++ |+.|||||+|.+++.+|.+||.|||+++.+... ..
T Consensus 501 aClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g--~K 575 (732)
T KOG0614|consen 501 ACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG--RK 575 (732)
T ss_pred hhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhccC--Cc
Confidence 9999999999999999999999999999999999999999 999999999999999999999999999987653 34
Q ss_pred cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcC-CCCCCCChhhhHHHHHHHH
Q 013214 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RPPFKAPAKLYARGLKELI 389 (447)
Q Consensus 311 ~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li 389 (447)
...++|||.|.|||++....++.++|.||||+++|||++|.+||.+.++......+..+. ... .|+.++....+||
T Consensus 576 TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~---~Pr~I~k~a~~Li 652 (732)
T KOG0614|consen 576 TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIE---FPRRITKTATDLI 652 (732)
T ss_pred eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhh---cccccchhHHHHH
Confidence 456789999999999999999999999999999999999999999999888777764443 222 2467888999999
Q ss_pred HHHcccCCCCCCC
Q 013214 390 EECWNEKPAKRPT 402 (447)
Q Consensus 390 ~~cl~~dp~~Rps 402 (447)
+++...+|.+|..
T Consensus 653 k~LCr~~P~ERLG 665 (732)
T KOG0614|consen 653 KKLCRDNPTERLG 665 (732)
T ss_pred HHHHhcCcHhhhc
Confidence 9999999999976
No 351
>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta. Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig
Probab=100.00 E-value=1.2e-34 Score=281.14 Aligned_cols=244 Identities=21% Similarity=0.415 Sum_probs=188.5
Q ss_pred eeecc--eEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEeccCC
Q 013214 162 EITKG--TFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234 (447)
Q Consensus 162 ~lg~G--~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 234 (447)
.||.| +|+.|+ .+|+.||+|++..... ..+..+.+.+|+.+++.++||||+++++++...+..++++||+.+
T Consensus 5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENC-TEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HhCCcccCceeEEEEEEcCCCcEEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 45655 777664 2689999999875533 345567889999999999999999999999999999999999999
Q ss_pred CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCC--
Q 013214 235 GDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP-- 310 (447)
Q Consensus 235 g~L~~~l~~~--~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~-- 310 (447)
++|.+++.+. ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++++||+.+..........
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (328)
T cd08226 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV 160 (328)
T ss_pred CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence 9999998764 34889999999999999999999998 9999999999999999999999998543221110000
Q ss_pred ----cccCCCCCcccCCcccCCC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcC-CC-----------
Q 013214 311 ----LTCQDTSCRYVAPEVFKNE--EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RP----------- 372 (447)
Q Consensus 311 ----~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~-~~----------- 372 (447)
.....++..|+|||.+.+. .++.++||||||+++|+|++|+.||......+......... ..
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (328)
T cd08226 161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEE 240 (328)
T ss_pred cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhh
Confidence 0112345679999998764 47789999999999999999999998665433221111100 00
Q ss_pred ------------------------------CC-CCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 373 ------------------------------PF-KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 373 ------------------------------~~-~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
.. ......+++.+.++|++||+.||++|||+.+++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~ 308 (328)
T cd08226 241 SRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH 308 (328)
T ss_pred hhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 00 01123467789999999999999999999999864
No 352
>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase. Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and
Probab=100.00 E-value=4e-35 Score=284.53 Aligned_cols=255 Identities=27% Similarity=0.403 Sum_probs=203.8
Q ss_pred CcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCC-----ce
Q 013214 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS-----PM 225 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-----~~ 225 (447)
+|+..+.||.|++|.++ .+|+.||+|.+.... ......+.+.+|+.+++.++||||+++++++.... ..
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVF-DDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDV 79 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeecccc-ccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccce
Confidence 46777899999998775 247899999987542 22344567888999999999999999999988765 78
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeeccccccccc
Q 013214 226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305 (447)
Q Consensus 226 ~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~ 305 (447)
+++|||+. ++|.+++.+..++++..+..++.|++.||.+||+.+ ++|+||||+||+++.++.++|+|||.+.....
T Consensus 80 ~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~~~ 155 (330)
T cd07834 80 YIVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDP 155 (330)
T ss_pred EEEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEeecc
Confidence 99999996 689999988788999999999999999999999999 99999999999999999999999999987654
Q ss_pred CCC--CCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCC-C--------
Q 013214 306 KED--RPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRP-P-------- 373 (447)
Q Consensus 306 ~~~--~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~-~-------- 373 (447)
... .......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...+..+....+...... .
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 235 (330)
T cd07834 156 DEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFIT 235 (330)
T ss_pred cccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhcc
Confidence 321 122334568889999999887 7889999999999999999999999877654333322111100 0
Q ss_pred ------------------CCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH--HHHHHh
Q 013214 374 ------------------FKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR--LESINN 415 (447)
Q Consensus 374 ------------------~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~--l~~~~~ 415 (447)
+....+..+..+.++|.+||+.+|.+||++.+++.+ ++.+..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~ 297 (330)
T cd07834 236 SEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD 297 (330)
T ss_pred ccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence 000112356789999999999999999999999975 444443
No 353
>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7. Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it
Probab=100.00 E-value=2.1e-34 Score=275.21 Aligned_cols=246 Identities=28% Similarity=0.483 Sum_probs=191.6
Q ss_pred cCcccceeeecceEEEEE---E--cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeEEEEeCCceEEE
Q 013214 155 LDFTNSVEITKGTFILAF---W--RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIV 228 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~---~--~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv 228 (447)
.+|...+.||+|++|.++ + +++.||+|.++.... ......+..|+.++... .||||+++++++......+++
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v 92 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN--KEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFIC 92 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCC--hHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEE
Confidence 467778899999998775 3 389999999875432 22344555677666666 599999999999999999999
Q ss_pred EeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccC
Q 013214 229 TEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHE-NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306 (447)
Q Consensus 229 ~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~ql~~~l~~lH~-~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~ 306 (447)
|||+ ++++.+.+.. ...+++..+..++.|++.|+.|||+ .+ ++|+||+|+||++++++.+||+|||++......
T Consensus 93 ~e~~-~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~ 168 (296)
T cd06618 93 MELM-STCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLVDS 168 (296)
T ss_pred eecc-CcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhccCC
Confidence 9998 4678877765 4568999999999999999999998 46 999999999999999999999999998765432
Q ss_pred CCCCcccCCCCCcccCCcccCCCC----CCCchhHHHHHHHHHHHHhCCCCCCCCCCC-chHHHHHhcCCCCCCCChhhh
Q 013214 307 EDRPLTCQDTSCRYVAPEVFKNEE----YDTKVDVFSFALILQEMIEGCPPFTMKHDN-EVPKAYAARQRPPFKAPAKLY 381 (447)
Q Consensus 307 ~~~~~~~~~~t~~y~aPE~~~~~~----~~~~~Di~slG~~l~~l~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 381 (447)
.. .....++..|+|||.+.+.. ++.++|+||||+++|+|++|+.||...... +....+.....+..+ ....+
T Consensus 169 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 245 (296)
T cd06618 169 KA--KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLP-PNEGF 245 (296)
T ss_pred Cc--ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCC-CCCCC
Confidence 11 12234677899999987543 778999999999999999999999764332 222222222222222 22246
Q ss_pred HHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 382 ARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 382 ~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
+.++.+++.+||+.||++||++.+++.+
T Consensus 246 ~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 246 SPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 7889999999999999999999999876
No 354
>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]
Probab=100.00 E-value=1.4e-34 Score=299.74 Aligned_cols=258 Identities=30% Similarity=0.526 Sum_probs=214.1
Q ss_pred CcccCCCCcCcccceeeecceEEEEEE------------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCccc
Q 013214 147 EYEIDPHELDFTNSVEITKGTFILAFW------------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVV 213 (447)
Q Consensus 147 ~~~i~~~~~~~~~~~~lg~G~~~~~~~------------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv 213 (447)
.++++...+.+. +.+|+|.||.+.+ ....||||.++.... ....+.+..|+++|+.+ +||||+
T Consensus 290 ~~e~~~~~l~~~--~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~--~~~~~~~~~El~~m~~~g~H~niv 365 (609)
T KOG0200|consen 290 KWEIPRENLKLG--KYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENAS--SSEKKDLMSELNVLKELGKHPNIV 365 (609)
T ss_pred ceeechhhcccc--ceeecccccceEeEEEeecccccccceEEEEEEecccccC--cHHHHHHHHHHHHHHHhcCCcchh
Confidence 567776665444 4899999997752 146899999987653 36678899999999999 699999
Q ss_pred ceeEEEEeCCceEEEEeccCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeC
Q 013214 214 QFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG----------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHR 277 (447)
Q Consensus 214 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------------~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~ 277 (447)
.++|+|..++.+++++||+..|+|.++++.++ .++..+.+.++.||+.|++||++.. ++||
T Consensus 366 ~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHR 442 (609)
T KOG0200|consen 366 NLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHR 442 (609)
T ss_pred hheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccch
Confidence 99999999999999999999999999998765 3888899999999999999999998 9999
Q ss_pred CCCCCCEEEcCCCCEEEeecccccccccCCCCCcccCC--CCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCC
Q 013214 278 DLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD--TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPF 354 (447)
Q Consensus 278 Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~--~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~ 354 (447)
||-.+|||+.++..+||+|||+++.............. -+..|||||.+....++.++||||||+++||++| |..||
T Consensus 443 DLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PY 522 (609)
T KOG0200|consen 443 DLAARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPY 522 (609)
T ss_pred hhhhhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCC
Confidence 99999999999999999999999854332222111111 3566999999999999999999999999999999 99999
Q ss_pred CCCC-CCchHHHHHhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHH
Q 013214 355 TMKH-DNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESIN 414 (447)
Q Consensus 355 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~ 414 (447)
.+.. ..++.+.+..+.+... |..+++++.++|+.||+.+|++||++.++.+.++...
T Consensus 523 p~~~~~~~l~~~l~~G~r~~~---P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l 580 (609)
T KOG0200|consen 523 PGIPPTEELLEFLKEGNRMEQ---PEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHL 580 (609)
T ss_pred CCCCcHHHHHHHHhcCCCCCC---CCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHH
Confidence 9865 4445454544445554 4456789999999999999999999999999999854
No 355
>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They
Probab=100.00 E-value=1.1e-34 Score=274.88 Aligned_cols=247 Identities=26% Similarity=0.424 Sum_probs=197.7
Q ss_pred cccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEec
Q 013214 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (447)
Q Consensus 157 ~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 231 (447)
|...+.||.|++|.++. +|+.+++|.+...... ......+.+|+.++++++||||+++++++..+...++++||
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 79 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFES-EGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEF 79 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEecccccc-chhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEec
Confidence 45567899999987753 6889999998765432 23446778899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCC
Q 013214 232 LPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (447)
Q Consensus 232 ~~~g~L~~~l~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~ 310 (447)
++ ++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||.+....... ..
T Consensus 80 ~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~~ 154 (283)
T cd05118 80 MD-TDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RP 154 (283)
T ss_pred cC-CCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-cc
Confidence 96 588888866 457899999999999999999999999 9999999999999999999999999987665432 12
Q ss_pred cccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcC-C-----------------
Q 013214 311 LTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-R----------------- 371 (447)
Q Consensus 311 ~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~-~----------------- 371 (447)
.....++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...+..+....+.... .
T Consensus 155 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd05118 155 YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYK 234 (283)
T ss_pred ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhh
Confidence 2334567889999998776 78889999999999999999999998766533322221110 0
Q ss_pred --------CCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 372 --------PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 372 --------~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
.......+.++..+.++|.+||+.||.+||++.+++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 235 FSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 00011123467889999999999999999999999864
No 356
>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both
Probab=100.00 E-value=2.4e-34 Score=273.08 Aligned_cols=246 Identities=27% Similarity=0.436 Sum_probs=193.0
Q ss_pred cccceeeecceEEEEE---E--cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC---CCCcccceeEEEEeCCc----
Q 013214 157 FTNSVEITKGTFILAF---W--RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI---RHPNVVQFLGAVTQSSP---- 224 (447)
Q Consensus 157 ~~~~~~lg~G~~~~~~---~--~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~hp~iv~~~~~~~~~~~---- 224 (447)
|+..+.||.|+||.++ . +++.||+|++..... .......+.+|+.+++++ +|||++++++++.....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~ 79 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLS-EEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL 79 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccc-cchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence 4566789999998775 2 478999999975433 222334566677777666 59999999999988776
Q ss_pred -eEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeeccccc
Q 013214 225 -MMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK 301 (447)
Q Consensus 225 -~~lv~e~~~~g~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~ 301 (447)
.+++|||+. ++|.+++.... .+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+.
T Consensus 80 ~~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 80 KLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred eeEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcce
Confidence 999999996 58999887643 4899999999999999999999998 9999999999999999999999999987
Q ss_pred ccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCC----------
Q 013214 302 LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQR---------- 371 (447)
Q Consensus 302 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~---------- 371 (447)
...... ......++..|+|||.+.+..++.++|+||||+++|+|++|++||......+....+.....
T Consensus 156 ~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07838 156 IYSFEM--ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRN 233 (287)
T ss_pred eccCCc--ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCC
Confidence 654321 11223467889999999888889999999999999999999999987665443333311100
Q ss_pred -------------CCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 372 -------------PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 372 -------------~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
.......+..++.+.++|.+||+.||.+||++.+++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 234 VSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred cccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 00011122456788999999999999999999998864
No 357
>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]
Probab=100.00 E-value=7.2e-37 Score=268.28 Aligned_cols=246 Identities=26% Similarity=0.404 Sum_probs=195.2
Q ss_pred CcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeEEEEeCCceEEEE
Q 013214 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVT 229 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~ 229 (447)
+.+....||.|+||.|. ..|+..|||+++.... +...+++..|.+...+- +.||||++||.+..++..|+.|
T Consensus 65 ~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~--~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCM 142 (361)
T KOG1006|consen 65 NLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI--EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICM 142 (361)
T ss_pred hHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc--hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeH
Confidence 55566789999999885 4799999999986643 45566777788775555 7999999999999999999999
Q ss_pred eccCCCCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccc
Q 013214 230 EYLPKGDLRAFLK-----RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304 (447)
Q Consensus 230 e~~~~g~L~~~l~-----~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~ 304 (447)
|.| .-||..+-+ ++..+++...-.+......||.||-..- .|+|||+||+|||++..|.+||||||.+-.+.
T Consensus 143 ELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv 219 (361)
T KOG1006|consen 143 ELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLV 219 (361)
T ss_pred HHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHH
Confidence 999 467765543 3456899888889999999999998765 39999999999999999999999999987553
Q ss_pred cCCCCCcccCCCCCcccCCcccCCC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCCC-chHHHHHhcCCCCC---CCCh
Q 013214 305 VKEDRPLTCQDTSCRYVAPEVFKNE--EYDTKVDVFSFALILQEMIEGCPPFTMKHDN-EVPKAYAARQRPPF---KAPA 378 (447)
Q Consensus 305 ~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~-~~~~~~~~~~~~~~---~~~~ 378 (447)
.. ...+.-.|-..|||||.+... .|+.++|+||||++|||+.||+.||...+.. +....+ ..+.++. +...
T Consensus 220 ~S--iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~V-v~gdpp~l~~~~~~ 296 (361)
T KOG1006|consen 220 DS--IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQV-VIGDPPILLFDKEC 296 (361)
T ss_pred HH--HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHH-HcCCCCeecCcccc
Confidence 22 222333455679999998643 5889999999999999999999999988752 222233 3333332 2233
Q ss_pred hhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 379 KLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 379 ~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
..++..+..+|..|+..|-..||++.++.++
T Consensus 297 ~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 297 VHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred cccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 4588999999999999999999999998753
No 358
>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely
Probab=100.00 E-value=7.1e-35 Score=279.11 Aligned_cols=250 Identities=26% Similarity=0.409 Sum_probs=194.3
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCC------
Q 013214 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS------ 223 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~------ 223 (447)
.+|+..+.||+|+||.++. +|+.||+|.+..... .......+.+|+.++++++||||+++++++.+..
T Consensus 7 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~ 85 (302)
T cd07864 7 DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNE-KEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFK 85 (302)
T ss_pred hhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeeccc-ccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhcc
Confidence 3677788999999988762 578999999875432 1222345678999999999999999999887654
Q ss_pred ----ceEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecc
Q 013214 224 ----PMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298 (447)
Q Consensus 224 ----~~~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg 298 (447)
..++++||+++ ++.+.+.+. ..+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||
T Consensus 86 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl~dfg 161 (302)
T cd07864 86 KDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADFG 161 (302)
T ss_pred ccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEeCccc
Confidence 78999999965 777777654 46899999999999999999999999 9999999999999999999999999
Q ss_pred cccccccCCCCCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcC-CC----
Q 013214 299 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RP---- 372 (447)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~-~~---- 372 (447)
.+...............++..|+|||.+.+. .++.++||||||+++|+|++|++||......+....+.... .+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (302)
T cd07864 162 LARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAV 241 (302)
T ss_pred ccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhh
Confidence 9886654332222333457789999987653 56889999999999999999999998655433332221111 00
Q ss_pred --CC-------------------CCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 373 --PF-------------------KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 373 --~~-------------------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
.+ ......++..+.+++.+||+.||.+||++.+++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 242 WPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred cccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00 00112357889999999999999999999998864
No 359
>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15. Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul
Probab=100.00 E-value=1.2e-34 Score=282.19 Aligned_cols=249 Identities=26% Similarity=0.406 Sum_probs=195.1
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeEEEEeC--CceE
Q 013214 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQS--SPMM 226 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~--~~~~ 226 (447)
.+|+..+.||+|+||.++. +|+.+|+|++..... .......+.+|+.+++++ +||||+++++++... ...+
T Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 85 (337)
T cd07852 7 RKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFR-NATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY 85 (337)
T ss_pred hHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccC-cchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence 3677888999999987752 578999998865322 233445677899999999 999999999998654 3589
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccC
Q 013214 227 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306 (447)
Q Consensus 227 lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~ 306 (447)
++|||+. ++|..++.++ .+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++......
T Consensus 86 lv~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~ 160 (337)
T cd07852 86 LVFEYME-TDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSLSEL 160 (337)
T ss_pred EEecccc-cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhccccc
Confidence 9999996 6999988765 7888999999999999999999998 999999999999999999999999998765432
Q ss_pred CC----CCcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhc------------
Q 013214 307 ED----RPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR------------ 369 (447)
Q Consensus 307 ~~----~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~------------ 369 (447)
.. .......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||......+....+...
T Consensus 161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd07852 161 EENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESI 240 (337)
T ss_pred cccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHH
Confidence 21 12223457889999998755 45778999999999999999999999765543322221111
Q ss_pred ---------------CCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 370 ---------------QRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 370 ---------------~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
....+....+.++.++.++|.+||+.||++|||+.+++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 241 KSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 0111111223367889999999999999999999999975
No 360
>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]
Probab=100.00 E-value=3.9e-35 Score=286.54 Aligned_cols=233 Identities=27% Similarity=0.429 Sum_probs=194.3
Q ss_pred CcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeEEEEeCCceEEEE
Q 013214 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVT 229 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~ 229 (447)
+|.....+|.|+|+.+. .+++..++|++.+.. .+..+|..++... +||||+++.+.+.+....|+||
T Consensus 323 ~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~-------~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 323 SYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA-------DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred hhccccccCCCCccceeeeeccccccchhheeccccc-------cccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 56666779999998764 468899999997652 1234577666666 7999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEE-cCCCCEEEeecccccccccCCC
Q 013214 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR-DDSGNLKVADFGVSKLLTVKED 308 (447)
Q Consensus 230 e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill-~~~~~vkl~Dfg~~~~~~~~~~ 308 (447)
|++.|+-+.+.+...+... ..+..|+.+|+.|+.|||++| ++|||+||+|||+ ++.++++|+|||.++.....
T Consensus 396 e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-- 469 (612)
T KOG0603|consen 396 ELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS-- 469 (612)
T ss_pred hhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCchh--
Confidence 9999998888887766555 788889999999999999999 9999999999999 69999999999999876543
Q ss_pred CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCC-chHHHHHhcCCCCCCCChhhhHHHHHH
Q 013214 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDN-EVPKAYAARQRPPFKAPAKLYARGLKE 387 (447)
Q Consensus 309 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~ 387 (447)
.....-|..|.|||++....+++.+|+||||++||+|++|+.||...... ++... ...+++. ..+|.+.++
T Consensus 470 --~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~---i~~~~~s---~~vS~~AKd 541 (612)
T KOG0603|consen 470 --CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTR---IQMPKFS---ECVSDEAKD 541 (612)
T ss_pred --hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHh---hcCCccc---cccCHHHHH
Confidence 11223478899999999999999999999999999999999999987766 22222 2233332 568999999
Q ss_pred HHHHHcccCCCCCCCHHHHHHH
Q 013214 388 LIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 388 li~~cl~~dp~~Rps~~~~l~~ 409 (447)
|+..||+.||.+||++.++..+
T Consensus 542 Ll~~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 542 LLQQLLQVDPALRLGADEIGAH 563 (612)
T ss_pred HHHHhccCChhhCcChhhhccC
Confidence 9999999999999999999875
No 361
>PTZ00024 cyclin-dependent protein kinase; Provisional
Probab=100.00 E-value=3.6e-34 Score=278.54 Aligned_cols=247 Identities=24% Similarity=0.363 Sum_probs=193.8
Q ss_pred cceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHH-----------HHHHHHHHHHHHhcCCCCcccceeEEEEeC
Q 013214 159 NSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDD-----------RVRAFRDELALLQKIRHPNVVQFLGAVTQS 222 (447)
Q Consensus 159 ~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~-----------~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 222 (447)
..+.||.|+||.++. +++.||+|.+......... ....+.+|+.+++.++||||+++++++...
T Consensus 13 ~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 92 (335)
T PTZ00024 13 KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEG 92 (335)
T ss_pred hhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecC
Confidence 456799999998763 6889999988654322110 012467899999999999999999999999
Q ss_pred CceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccc
Q 013214 223 SPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 302 (447)
Q Consensus 223 ~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~ 302 (447)
+..+++|||+. |+|.+++.....+++.....++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++..
T Consensus 93 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl~dfg~~~~ 168 (335)
T PTZ00024 93 DFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARR 168 (335)
T ss_pred CcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEECCccceee
Confidence 99999999995 699999988788999999999999999999999999 99999999999999999999999999876
Q ss_pred cccCC-------------CCCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHh
Q 013214 303 LTVKE-------------DRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA 368 (447)
Q Consensus 303 ~~~~~-------------~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~ 368 (447)
..... ........+++.|+|||.+.+. .++.++|+||||+++|+|++|+.||...+..+....+..
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i~~ 248 (335)
T PTZ00024 169 YGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFE 248 (335)
T ss_pred cccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 54111 1111223457789999998764 468899999999999999999999987765443332211
Q ss_pred cC-CCC---C--------------------CCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 369 RQ-RPP---F--------------------KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 369 ~~-~~~---~--------------------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
.. .+. + .......+..+.++|.+||+.+|++||++.+++.+
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~ 313 (335)
T PTZ00024 249 LLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKH 313 (335)
T ss_pred HhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence 11 000 0 00012346789999999999999999999999863
No 362
>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check
Probab=100.00 E-value=2.5e-34 Score=269.30 Aligned_cols=246 Identities=27% Similarity=0.445 Sum_probs=194.2
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCC--CHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEE
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVIS--DDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 228 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 228 (447)
+|...+.||+|+||.++. .+..+++|.++..... .......+..|+.+++.++||||+++++++.+....+++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 467778999999998862 3445666665432211 112234566789999999999999999999998999999
Q ss_pred EeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccc
Q 013214 229 TEYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304 (447)
Q Consensus 229 ~e~~~~g~L~~~l~~----~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~ 304 (447)
+||+++++|.+++.+ ...+++..+..++.|++.|+.|||+.+ ++|+||||+||+++. +.++|+|||.+....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence 999999999998864 356899999999999999999999998 999999999999975 579999999987653
Q ss_pred cCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHH
Q 013214 305 VKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARG 384 (447)
Q Consensus 305 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (447)
.... ......+++.|+|||.+.+..++.++|+||||+++|+|++|..||.................+. .+..++.+
T Consensus 157 ~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~ 232 (260)
T cd08222 157 GSCD-LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPS---LPETYSRQ 232 (260)
T ss_pred CCcc-cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCC---CcchhcHH
Confidence 3221 1223456788999999988888899999999999999999999997655443333332222222 34567789
Q ss_pred HHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 385 LKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 385 l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
+.++|.+||..||++||++.+++++
T Consensus 233 ~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 233 LNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred HHHHHHHHhcCChhhCcCHHHHhhC
Confidence 9999999999999999999999864
No 363
>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase. Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481
Probab=100.00 E-value=6e-34 Score=299.21 Aligned_cols=144 Identities=29% Similarity=0.516 Sum_probs=131.3
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEE
Q 013214 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 229 (447)
.+|.+.+.||+|+||.|+. +++.||+|++.............+..|+.+++.++||||+++++.+......|+||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 4678889999999998862 48899999997655555666678899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeeccccc
Q 013214 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK 301 (447)
Q Consensus 230 e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~ 301 (447)
||+.+++|.+++...+.+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999999988888999999999999999999999998 9999999999999999999999999875
No 364
>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1. Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co
Probab=100.00 E-value=4.5e-34 Score=277.45 Aligned_cols=249 Identities=22% Similarity=0.348 Sum_probs=192.0
Q ss_pred CcccceeeecceEEEEEE-----c--CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeEEEEeC----C
Q 013214 156 DFTNSVEITKGTFILAFW-----R--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQS----S 223 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~--g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~----~ 223 (447)
+|...+.||+|+||.++. + +..||+|.+.... ......+.+.+|+.+++++ +||||+++++.+... .
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVF-SKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccc-ccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence 366778899999998752 3 6789999987432 2333456678899999999 599999999875432 4
Q ss_pred ceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeeccccccc
Q 013214 224 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (447)
Q Consensus 224 ~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~ 303 (447)
..++++||+. ++|.+++.....+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++...
T Consensus 80 ~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~~~ 155 (332)
T cd07857 80 ELYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGF 155 (332)
T ss_pred cEEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCceec
Confidence 5789999984 799999988888999999999999999999999999 999999999999999999999999999765
Q ss_pred ccCCC---CCcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhc----------
Q 013214 304 TVKED---RPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR---------- 369 (447)
Q Consensus 304 ~~~~~---~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~---------- 369 (447)
..... .......+++.|+|||.+.+ ..++.++|+||+|+++|+|++|+.||...+.......+...
T Consensus 156 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (332)
T cd07857 156 SENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLS 235 (332)
T ss_pred ccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 43211 11123457889999998765 46789999999999999999999999865532221111000
Q ss_pred -----------------CCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 370 -----------------QRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 370 -----------------~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
....+....+..+..+.+++.+||+.||.+|||+.+++.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 236 RIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred hhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0111111122346789999999999999999999999854
No 365
>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase. Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13
Probab=100.00 E-value=3.1e-34 Score=279.72 Aligned_cols=250 Identities=25% Similarity=0.386 Sum_probs=194.1
Q ss_pred cCcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCC------
Q 013214 155 LDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS------ 223 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~------ 223 (447)
.+|.....||+|++|.++ .+|+.||+|++..... .......+.+|+.+++.++||||+++++++....
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQ-SEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccc-cccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 367778899999998775 3689999999875432 2233456788999999999999999999987543
Q ss_pred ceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeeccccccc
Q 013214 224 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (447)
Q Consensus 224 ~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~ 303 (447)
..++++||+. .+|.++. ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++...
T Consensus 94 ~~~lv~e~~~-~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~~~~ 167 (342)
T cd07879 94 DFYLVMPYMQ-TDLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLARHA 167 (342)
T ss_pred eEEEEecccc-cCHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCCcCC
Confidence 4699999995 5777765 346899999999999999999999999 999999999999999999999999998754
Q ss_pred ccCCCCCcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcC------------
Q 013214 304 TVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ------------ 370 (447)
Q Consensus 304 ~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~------------ 370 (447)
.. ......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||.+.+.......+....
T Consensus 168 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (342)
T cd07879 168 DA----EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLE 243 (342)
T ss_pred CC----CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhc
Confidence 32 1223456788999999866 467889999999999999999999998765332222211100
Q ss_pred ----------CCCCC-----CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH--HHHHHh
Q 013214 371 ----------RPPFK-----APAKLYARGLKELIEECWNEKPAKRPTFRQIITR--LESINN 415 (447)
Q Consensus 371 ----------~~~~~-----~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~--l~~~~~ 415 (447)
.+..+ ...+..+..+.++|++||+.||++||++.+++.+ ++.+..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 244 DKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred ccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence 00010 0112356778999999999999999999999966 666654
No 366
>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the
Probab=100.00 E-value=3.4e-34 Score=271.40 Aligned_cols=247 Identities=28% Similarity=0.485 Sum_probs=196.0
Q ss_pred cccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEec
Q 013214 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (447)
Q Consensus 157 ~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 231 (447)
|+....||+|++|.++. +++.||+|.+.... ......+.+..|+.+++.++|||++++++++.+....++++||
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 79 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN-EEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEY 79 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEecccc-ccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecC
Confidence 34556789999987763 58999999987653 2233345677899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCC
Q 013214 232 LPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (447)
Q Consensus 232 ~~~g~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~ 310 (447)
++ ++|.+++.+. ..+++..+..++.|++.||.+||+.+ ++|+||+|+||++++++.++|+|||.+....... ..
T Consensus 80 ~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~-~~ 154 (282)
T cd07829 80 CD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPL-RT 154 (282)
T ss_pred cC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCc-cc
Confidence 96 6999999876 57999999999999999999999999 9999999999999999999999999987654322 12
Q ss_pred cccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcC-------------------
Q 013214 311 LTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ------------------- 370 (447)
Q Consensus 311 ~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~------------------- 370 (447)
......+..|+|||.+.+. .++.++|+||||+++|++++|+.||......+....+....
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (282)
T cd07829 155 YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKP 234 (282)
T ss_pred cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccc
Confidence 2233456789999998776 78889999999999999999999998765433222211100
Q ss_pred -CCCCC-----CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 371 -RPPFK-----APAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 371 -~~~~~-----~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
.+.+. ...+..+..+.++|++||..||++||++.+++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 235 TFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred cccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 00100 1112346789999999999999999999998863
No 367
>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili
Probab=100.00 E-value=1e-33 Score=268.37 Aligned_cols=245 Identities=24% Similarity=0.395 Sum_probs=191.3
Q ss_pred cccceeeecceEEEEE---E--cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC-CCcccceeEEEEeCCceEEEEe
Q 013214 157 FTNSVEITKGTFILAF---W--RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 157 ~~~~~~lg~G~~~~~~---~--~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~lv~e 230 (447)
|+..+.||.|++|.++ . +++.|++|.+...... .......+|+..+++++ |||++++++++..++..+++||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 78 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS--WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE 78 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc--hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence 4566789999998775 2 5788999998754322 11223456899999998 9999999999999999999999
Q ss_pred ccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 013214 231 YLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (447)
Q Consensus 231 ~~~~g~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~ 308 (447)
|+ +|+|.+++.... .+++..+..++.|++.+|.|||+++ ++|+||+|+||++++++.++|+|||.+.......
T Consensus 79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~- 153 (283)
T cd07830 79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP- 153 (283)
T ss_pred cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCC-
Confidence 99 789999998764 6899999999999999999999999 9999999999999999999999999987654321
Q ss_pred CCcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCC---------------
Q 013214 309 RPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRP--------------- 372 (447)
Q Consensus 309 ~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~--------------- 372 (447)
......++..|+|||.+.+ ..++.++|+||||+++++|++|+.||......+...........
T Consensus 154 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07830 154 -PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASK 232 (283)
T ss_pred -CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcc
Confidence 2233456888999998754 45788999999999999999999999766543322211110000
Q ss_pred ---CC--------CCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 373 ---PF--------KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 373 ---~~--------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
.+ ....+..+..+.+++++||+.||++||++.+++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 233 LGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred ccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 00 00011225779999999999999999999998764
No 368
>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase. Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12
Probab=100.00 E-value=6.7e-34 Score=277.41 Aligned_cols=243 Identities=24% Similarity=0.383 Sum_probs=192.4
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCC------c
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS------P 224 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~------~ 224 (447)
+|+..+.||+|+||.++. +|..||+|++.... ........+.+|+.+++.++||||+++++++.... .
T Consensus 16 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 94 (343)
T cd07880 16 RYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHD 94 (343)
T ss_pred ceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccce
Confidence 688888999999998752 68899999986543 23334556788999999999999999999987654 3
Q ss_pred eEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccc
Q 013214 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304 (447)
Q Consensus 225 ~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~ 304 (447)
.+++|||+ +++|.+++.. ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++....
T Consensus 95 ~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~ 169 (343)
T cd07880 95 FYLVMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQTD 169 (343)
T ss_pred EEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccccccc
Confidence 58999999 7899888764 56899999999999999999999999 9999999999999999999999999987643
Q ss_pred cCCCCCcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcC-C-----------
Q 013214 305 VKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-R----------- 371 (447)
Q Consensus 305 ~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~-~----------- 371 (447)
.. .....+++.|+|||.+.+ ..++.++|+||||+++|++++|+.||...+.......+.... .
T Consensus 170 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (343)
T cd07880 170 SE----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQS 245 (343)
T ss_pred cC----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcc
Confidence 21 123356888999998866 357889999999999999999999998655322211111100 0
Q ss_pred ----------C-----CCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHH
Q 013214 372 ----------P-----PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIIT 408 (447)
Q Consensus 372 ----------~-----~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~ 408 (447)
+ .+......+++.+.++|.+|++.||.+|||+.+++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 246 EDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred hhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0 000111245677999999999999999999999995
No 369
>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1. Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U
Probab=100.00 E-value=7.5e-34 Score=275.28 Aligned_cols=246 Identities=28% Similarity=0.440 Sum_probs=193.3
Q ss_pred CcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEe-CCceEE
Q 013214 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ-SSPMMI 227 (447)
Q Consensus 154 ~~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~l 227 (447)
..+|+..+.||.|+||.++. +|+.||+|++..... .....+.+..|+.+++.++||||+++++++.. ....++
T Consensus 9 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~l 87 (328)
T cd07856 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFS-TPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYF 87 (328)
T ss_pred ccceEEEEeecccCCeEEEEEEECCCCCEEEEEEeccccc-ccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEE
Confidence 34688889999999998763 688999998865432 23344667789999999999999999999875 457899
Q ss_pred EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCC
Q 013214 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307 (447)
Q Consensus 228 v~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~ 307 (447)
++||+ +++|.++++. .++++..+..++.|+++||.|||+.+ ++|+||+|+||++++++.++|+|||.+.....
T Consensus 88 v~e~~-~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~-- 160 (328)
T cd07856 88 VTELL-GTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQDP-- 160 (328)
T ss_pred Eeehh-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccccccCC--
Confidence 99999 6789888764 45888889999999999999999999 99999999999999999999999999875432
Q ss_pred CCCcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHH-------------------
Q 013214 308 DRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYA------------------- 367 (447)
Q Consensus 308 ~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~------------------- 367 (447)
......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||...........+.
T Consensus 161 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (328)
T cd07856 161 --QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENT 238 (328)
T ss_pred --CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhh
Confidence 1123456788999998765 468899999999999999999999997654311110000
Q ss_pred -----h-cCCC--CCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 368 -----A-RQRP--PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 368 -----~-~~~~--~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
. .... +.....+.++..+.++|.+||+.+|++||++.+++.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 239 LRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred HHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0 0000 1111112456889999999999999999999999876
No 370
>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]
Probab=100.00 E-value=1.3e-34 Score=298.96 Aligned_cols=243 Identities=30% Similarity=0.484 Sum_probs=186.7
Q ss_pred CcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEe---------
Q 013214 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ--------- 221 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--------- 221 (447)
+|.....||+||||.|+ .+|+.+|||+++... .......+.+|+.++.+++|||||++|..+.+
T Consensus 480 DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~--s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e 557 (1351)
T KOG1035|consen 480 DFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA--SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE 557 (1351)
T ss_pred hhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch--HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence 56677789999999876 489999999998764 55666788899999999999999999843200
Q ss_pred --------------------------------------------------------------------------------
Q 013214 222 -------------------------------------------------------------------------------- 221 (447)
Q Consensus 222 -------------------------------------------------------------------------------- 221 (447)
T Consensus 558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e 637 (1351)
T KOG1035|consen 558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE 637 (1351)
T ss_pred ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence
Q ss_pred ----------------------C--------CceEEEEeccCCCCHHHHHHhcCCC-CHHHHHHHHHHHHHHHHHHHhCC
Q 013214 222 ----------------------S--------SPMMIVTEYLPKGDLRAFLKRKGAL-KPSTAVRFALDIARGMNYLHENK 270 (447)
Q Consensus 222 ----------------------~--------~~~~lv~e~~~~g~L~~~l~~~~~l-~~~~~~~i~~ql~~~l~~lH~~~ 270 (447)
+ ..+||-||||+...|.++++++... .....|+++++|++||.|+|+.|
T Consensus 638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~g 717 (1351)
T KOG1035|consen 638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQG 717 (1351)
T ss_pred CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCc
Confidence 0 1268999999887777777766544 57889999999999999999999
Q ss_pred CCCeEeCCCCCCCEEEcCCCCEEEeecccccccc-----------------cCCCCCcccCCCCCcccCCcccCCCC---
Q 013214 271 PVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT-----------------VKEDRPLTCQDTSCRYVAPEVFKNEE--- 330 (447)
Q Consensus 271 ~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~-----------------~~~~~~~~~~~~t~~y~aPE~~~~~~--- 330 (447)
+|||||||.||+++++..|||+|||++.... .......+...||.-|+|||++.+..
T Consensus 718 ---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~ 794 (1351)
T KOG1035|consen 718 ---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNK 794 (1351)
T ss_pred ---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccccc
Confidence 9999999999999999999999999998721 01112346678999999999997654
Q ss_pred CCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCC---hhhhHHHHHHHHHHHcccCCCCCCCHHHHH
Q 013214 331 YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAP---AKLYARGLKELIEECWNEKPAKRPTFRQII 407 (447)
Q Consensus 331 ~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dp~~Rps~~~~l 407 (447)
|+.|+|+||||++++||+. ||.+. .|-...+..-....++.. ...--+.-..+|+.|++.||.+|||+.+++
T Consensus 795 Yn~KiDmYSLGIVlFEM~y---PF~Ts--MERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL 869 (1351)
T KOG1035|consen 795 YNSKIDMYSLGIVLFEMLY---PFGTS--MERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELL 869 (1351)
T ss_pred ccchhhhHHHHHHHHHHhc---cCCch--HHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHh
Confidence 9999999999999999984 45532 222222211112222222 111123456899999999999999999998
Q ss_pred H
Q 013214 408 T 408 (447)
Q Consensus 408 ~ 408 (447)
+
T Consensus 870 ~ 870 (1351)
T KOG1035|consen 870 N 870 (1351)
T ss_pred h
Confidence 6
No 371
>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase. Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14
Probab=100.00 E-value=9.9e-34 Score=276.44 Aligned_cols=246 Identities=26% Similarity=0.363 Sum_probs=192.4
Q ss_pred CcCcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeC------
Q 013214 154 ELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS------ 222 (447)
Q Consensus 154 ~~~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~------ 222 (447)
..+|...+.||+|+||.++ .+|+.||+|++..... .....+.+.+|+.++++++||||+++++++...
T Consensus 16 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~ 94 (345)
T cd07877 16 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 94 (345)
T ss_pred cCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcch-hhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccccc
Confidence 3468888899999999875 3688999999875422 233345677899999999999999999988643
Q ss_pred CceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccc
Q 013214 223 SPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 302 (447)
Q Consensus 223 ~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~ 302 (447)
...+++++++ +++|.+++.. ..+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||++..
T Consensus 95 ~~~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~dfg~~~~ 169 (345)
T cd07877 95 NDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARH 169 (345)
T ss_pred ccEEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEEEeccccccc
Confidence 3468888887 7899887764 46899999999999999999999999 99999999999999999999999999875
Q ss_pred cccCCCCCcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcC-C---------
Q 013214 303 LTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-R--------- 371 (447)
Q Consensus 303 ~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~-~--------- 371 (447)
... ......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||...+.......+.... .
T Consensus 170 ~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (345)
T cd07877 170 TDD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 245 (345)
T ss_pred ccc----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhc
Confidence 432 2233456888999998866 467889999999999999999999997655433222211100 0
Q ss_pred -----------------CCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 372 -----------------PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 372 -----------------~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
..+.......++.+.++|.+||+.||.+||++.+++.+
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 246 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred ccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 00000111246788999999999999999999999976
No 372
>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]
Probab=100.00 E-value=3.7e-35 Score=262.73 Aligned_cols=249 Identities=24% Similarity=0.389 Sum_probs=190.6
Q ss_pred CcccceeeecceEEEEEEc---------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEe-CCce
Q 013214 156 DFTNSVEITKGTFILAFWR---------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ-SSPM 225 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~~---------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~ 225 (447)
.|.....||+|++|.||.. ...+|+|+++.+...+.-. ....+|+.+++.++|||++.+..++.. +..+
T Consensus 25 ~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS-~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 25 EYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGIS-MSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcC-HHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 5777889999999999842 3479999997653222222 345679999999999999999998877 7889
Q ss_pred EEEEeccCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCC----CCEEEee
Q 013214 226 MIVTEYLPKGDLRAFLKR-----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS----GNLKVAD 296 (447)
Q Consensus 226 ~lv~e~~~~g~L~~~l~~-----~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~----~~vkl~D 296 (447)
++++||.+ -+|++.++- ...++...+..+++||+.|+.|||++. |+||||||+|||+..+ |.|||+|
T Consensus 104 ~l~fdYAE-hDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 104 WLLFDYAE-HDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred EEEehhhh-hhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEeec
Confidence 99999995 599999863 245899999999999999999999999 9999999999999877 8999999
Q ss_pred cccccccccCCC--CCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCC-------C---chH
Q 013214 297 FGVSKLLTVKED--RPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHD-------N---EVP 363 (447)
Q Consensus 297 fg~~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~-------~---~~~ 363 (447)
||+++.+...-. ........|.+|.|||.+.+. .|++..|||++||++.||++-++.|.+... . ++.
T Consensus 180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~ 259 (438)
T KOG0666|consen 180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLD 259 (438)
T ss_pred ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHH
Confidence 999998764321 122334568999999998876 688899999999999999999888764321 1 111
Q ss_pred HHHHhcCCCCC---------CCC-----------------------hhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 364 KAYAARQRPPF---------KAP-----------------------AKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 364 ~~~~~~~~~~~---------~~~-----------------------~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
+....-+.|.- +.. ...-++..-+|+.++|..||.+|.|+++.+++
T Consensus 260 rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh 337 (438)
T KOG0666|consen 260 RIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEH 337 (438)
T ss_pred HHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcc
Confidence 11111111110 000 00112347789999999999999999998875
No 373
>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase. Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK
Probab=100.00 E-value=2.7e-34 Score=280.25 Aligned_cols=245 Identities=27% Similarity=0.378 Sum_probs=194.6
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCc-----
Q 013214 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP----- 224 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~----- 224 (447)
.+|.....||+|++|.++. +++.||+|++..... .......+.+|+.+++.++|||++++.+++.....
T Consensus 15 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07851 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQ-SAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQ 93 (343)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccc-hhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccc
Confidence 3688889999999998762 578999999865432 23344567789999999999999999988766554
Q ss_pred -eEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeeccccccc
Q 013214 225 -MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (447)
Q Consensus 225 -~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~ 303 (447)
.++++||+ +++|.+++.. .++++..+..++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||++...
T Consensus 94 ~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~~~~~ 168 (343)
T cd07851 94 DVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLARHT 168 (343)
T ss_pred cEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEccccccccc
Confidence 89999999 6799998865 56999999999999999999999999 999999999999999999999999998765
Q ss_pred ccCCCCCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCC-----------
Q 013214 304 TVKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQR----------- 371 (447)
Q Consensus 304 ~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~----------- 371 (447)
... .....++..|+|||.+.+. .++.++|+||||+++|+|++|+.||......+....+.....
T Consensus 169 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 244 (343)
T cd07851 169 DDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKIS 244 (343)
T ss_pred ccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcc
Confidence 422 2334568889999987653 678899999999999999999999986654433222211110
Q ss_pred ----------------CCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 372 ----------------PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 372 ----------------~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
+.+......+++.+.++|++||+.||++|||+.+++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 245 SESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred chhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 00111112357889999999999999999999999864
No 374
>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins. Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic
Probab=100.00 E-value=5.4e-34 Score=274.03 Aligned_cols=251 Identities=27% Similarity=0.392 Sum_probs=190.8
Q ss_pred CcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCC-----
Q 013214 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS----- 223 (447)
Q Consensus 154 ~~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~----- 223 (447)
..+|+..+.||.|++|.++. +++.+|+|.+......+ .....+.+|+.+++.++||||+++++++....
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 85 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKD-GFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKR 85 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCC-CcchhHHHHHHHHHhcCCCCccchhhheecccccccc
Confidence 34788889999999998762 57899999886543222 12234678999999999999999999875433
Q ss_pred ---ceEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeeccc
Q 013214 224 ---PMMIVTEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGV 299 (447)
Q Consensus 224 ---~~~lv~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~ 299 (447)
.+++++||+. ++|...+.. ...+++..+..++.|+++||.|||+.+ ++|+||||+||++++++.++|+|||+
T Consensus 86 ~~~~~~lv~~~~~-~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~ 161 (311)
T cd07866 86 KRGSVYMVTPYMD-HDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFGL 161 (311)
T ss_pred cCceEEEEEecCC-cCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCcc
Confidence 4699999995 577777764 346999999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCCCC----------cccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHh
Q 013214 300 SKLLTVKEDRP----------LTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA 368 (447)
Q Consensus 300 ~~~~~~~~~~~----------~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~ 368 (447)
+.......... .....+++.|+|||.+.+. .++.++||||||+++|+|++|++||.+.+.......+..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~ 241 (311)
T cd07866 162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFK 241 (311)
T ss_pred chhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 87654322111 1223457789999987654 578899999999999999999999987665433332211
Q ss_pred cCCC----------------------CCCC----ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 369 RQRP----------------------PFKA----PAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 369 ~~~~----------------------~~~~----~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
.... ..+. ....+++.+.+++.+||+.||.+|||+.+++.+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 242 LCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred HhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 1100 0000 001234678899999999999999999998864
No 375
>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]
Probab=100.00 E-value=4.7e-34 Score=283.54 Aligned_cols=255 Identities=24% Similarity=0.481 Sum_probs=219.8
Q ss_pred cCcccceeeecceEEEEEEc---------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCce
Q 013214 155 LDFTNSVEITKGTFILAFWR---------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~~---------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 225 (447)
......+.||+|+||+|+.. .-+||+|++... ...+.-.++..|+-.|.++.|||++++++++..+. +
T Consensus 696 telkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~--t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~ 772 (1177)
T KOG1025|consen 696 TELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEF--TSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-L 772 (1177)
T ss_pred hhhhhhceeccccceeEEeeeEecCCceecceeEEEEeecc--CCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-H
Confidence 35566778999999998742 257999988754 34555678899999999999999999999998765 8
Q ss_pred EEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccc
Q 013214 226 MIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304 (447)
Q Consensus 226 ~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~ 304 (447)
.||++|++.|+|.++++.+ +++-....+.|..||++||.|||.++ ++||||-.+|||+.+-.++|+.|||+++...
T Consensus 773 qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~ 849 (1177)
T KOG1025|consen 773 QLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLA 849 (1177)
T ss_pred HHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccC
Confidence 8999999999999999865 56889999999999999999999999 9999999999999999999999999999876
Q ss_pred cCCCC-CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCCCCChhhhH
Q 013214 305 VKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYA 382 (447)
Q Consensus 305 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 382 (447)
..... ......-.+.|||-|.+....++.++|||||||++||++| |..||.+....++...+....+.+ .++.++
T Consensus 850 ~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRLs---qPpiCt 926 (1177)
T KOG1025|consen 850 PDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERLS---QPPICT 926 (1177)
T ss_pred cccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccCC---CCCCcc
Confidence 54332 2233445678999999999999999999999999999999 999999999999988887777644 355678
Q ss_pred HHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhh
Q 013214 383 RGLKELIEECWNEKPAKRPTFRQIITRLESINNSIN 418 (447)
Q Consensus 383 ~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~~~ 418 (447)
..+.-++.+||..|+..||+++++..++.++.+...
T Consensus 927 iDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardpq 962 (1177)
T KOG1025|consen 927 IDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDPQ 962 (1177)
T ss_pred HHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCcc
Confidence 899999999999999999999999999988776554
No 376
>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6. Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi
Probab=100.00 E-value=6.8e-34 Score=277.32 Aligned_cols=247 Identities=23% Similarity=0.392 Sum_probs=189.7
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeC-------
Q 013214 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS------- 222 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~------- 222 (447)
.+|...+.||.|+||.++. +|..||+|.+..... ...+.+.+|+.+++.++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~---~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP---QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTED 81 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC---chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccc
Confidence 5788889999999998862 588999998865432 3446678899999999999999999876543
Q ss_pred -------CceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcC-CCCEEE
Q 013214 223 -------SPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD-SGNLKV 294 (447)
Q Consensus 223 -------~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~-~~~vkl 294 (447)
...++++||++ ++|.+++.. +.+++..+..++.|++.||.|||+.+ ++|+||||+||+++. ++.++|
T Consensus 82 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~kl 156 (342)
T cd07854 82 VGSLTELNSVYIVQEYME-TDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKI 156 (342)
T ss_pred cccccccceEEEEeeccc-ccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEEE
Confidence 35789999996 689888754 46899999999999999999999999 999999999999984 557899
Q ss_pred eecccccccccCCCC--CcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhc--
Q 013214 295 ADFGVSKLLTVKEDR--PLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR-- 369 (447)
Q Consensus 295 ~Dfg~~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~-- 369 (447)
+|||.+......... ......++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||...+..+........
T Consensus 157 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~ 236 (342)
T cd07854 157 GDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVP 236 (342)
T ss_pred CCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence 999998765322111 1122346788999998654 46778999999999999999999999766543222211110
Q ss_pred ---------------------CCCC---CCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 370 ---------------------QRPP---FKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 370 ---------------------~~~~---~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
.... .....+.++.++.++|.+||+.||.+|||+.+++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 237 VVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred CCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 0000 000112356789999999999999999999999864
No 377
>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins. Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha
Probab=100.00 E-value=1.4e-33 Score=260.61 Aligned_cols=215 Identities=19% Similarity=0.251 Sum_probs=172.9
Q ss_pred ceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEeccCCCCHHHH
Q 013214 166 GTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAF 240 (447)
Q Consensus 166 G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~ 240 (447)
|.++.|+ .+|+.+|+|.++... ...+|...+....||||+++++++......+++|||+++|+|.++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~--------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 75 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS--------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSH 75 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh--------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHH
Confidence 5555544 478999999987542 122344455556799999999999999999999999999999999
Q ss_pred HHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCCcccCCCCCcc
Q 013214 241 LKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRY 320 (447)
Q Consensus 241 l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~t~~y 320 (447)
+.+...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++++|||.+...... .....++..|
T Consensus 76 l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~y 148 (237)
T cd05576 76 ISKFLNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVENMY 148 (237)
T ss_pred HHHhcCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcCccc
Confidence 988778999999999999999999999998 999999999999999999999999987654322 1223346779
Q ss_pred cCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCC
Q 013214 321 VAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKR 400 (447)
Q Consensus 321 ~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R 400 (447)
+|||...+..++.++|+||+|+++|+|++|+.|+...... ........ .+..+++.+.++|++||+.||++|
T Consensus 149 ~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-----~~~~~~~~---~~~~~~~~~~~li~~~l~~dp~~R 220 (237)
T cd05576 149 CAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG-----INTHTTLN---IPEWVSEEARSLLQQLLQFNPTER 220 (237)
T ss_pred cCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh-----cccccccC---CcccCCHHHHHHHHHHccCCHHHh
Confidence 9999998888899999999999999999999887643221 00001111 234467889999999999999999
Q ss_pred CCH
Q 013214 401 PTF 403 (447)
Q Consensus 401 ps~ 403 (447)
|++
T Consensus 221 ~~~ 223 (237)
T cd05576 221 LGA 223 (237)
T ss_pred cCC
Confidence 996
No 378
>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=4.1e-34 Score=258.35 Aligned_cols=240 Identities=24% Similarity=0.404 Sum_probs=202.3
Q ss_pred CcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeEEEEeCCceEEEE
Q 013214 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVT 229 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~ 229 (447)
+|...+.||+|++..|. .+.+.+|+|+++++.+.+++...=.+.|-.+..+- +||++|-+..+|..+.++++|.
T Consensus 251 df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvi 330 (593)
T KOG0695|consen 251 DFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVI 330 (593)
T ss_pred cceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEE
Confidence 57778899999998663 57889999999998887777777677888888777 7999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 013214 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (447)
Q Consensus 230 e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~ 309 (447)
||++||+|--+++++++++++.+..+...|+-||.|||++| |+.||+|.+|+|++..|++||+|+|+.+..-.+ ..
T Consensus 331 eyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~l~~-gd 406 (593)
T KOG0695|consen 331 EYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGP-GD 406 (593)
T ss_pred EEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcCCCC-Cc
Confidence 99999999999999999999999999999999999999999 999999999999999999999999998753322 23
Q ss_pred CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCC--C-CC----CchHHHHHhcCCCCCCCChhhhH
Q 013214 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTM--K-HD----NEVPKAYAARQRPPFKAPAKLYA 382 (447)
Q Consensus 310 ~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~--~-~~----~~~~~~~~~~~~~~~~~~~~~~~ 382 (447)
..+...|||.|.|||++.+..|..++|+|+||++++||+.|+.||+. + ++ ++..-++.......+ ++..|
T Consensus 407 ~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiri---prsls 483 (593)
T KOG0695|consen 407 TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRI---PRSLS 483 (593)
T ss_pred ccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccc---cceee
Confidence 34567899999999999999999999999999999999999999962 1 12 122222223332222 45566
Q ss_pred HHHHHHHHHHcccCCCCCCC
Q 013214 383 RGLKELIEECWNEKPAKRPT 402 (447)
Q Consensus 383 ~~l~~li~~cl~~dp~~Rps 402 (447)
.....+++..|+.||.+|..
T Consensus 484 vkas~vlkgflnkdp~erlg 503 (593)
T KOG0695|consen 484 VKASHVLKGFLNKDPKERLG 503 (593)
T ss_pred hhhHHHHHHhhcCCcHHhcC
Confidence 77788999999999999954
No 379
>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=2.7e-33 Score=261.99 Aligned_cols=256 Identities=30% Similarity=0.487 Sum_probs=199.7
Q ss_pred CcCcccceeeecceEEEE---EEcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC--CCCcccceeEEEEeCC----c
Q 013214 154 ELDFTNSVEITKGTFILA---FWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI--RHPNVVQFLGAVTQSS----P 224 (447)
Q Consensus 154 ~~~~~~~~~lg~G~~~~~---~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l--~hp~iv~~~~~~~~~~----~ 224 (447)
..+....+.||+|.||.| .|.|+.||||++... .+ +.+.+|.++.+.. +|+||+.+++.-..+. .
T Consensus 210 arqI~L~e~IGkGRyGEVwrG~wrGe~VAVKiF~sr--dE----~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQ 283 (513)
T KOG2052|consen 210 ARQIVLQEIIGKGRFGEVWRGRWRGEDVAVKIFSSR--DE----RSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQ 283 (513)
T ss_pred hheeEEEEEecCccccceeeccccCCceEEEEeccc--ch----hhhhhHHHHHHHHHhccchhhhhhhccccCCCceEE
Confidence 346677789999999865 699999999999632 11 4556677766654 9999999998765432 5
Q ss_pred eEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-----CCCCCeEeCCCCCCCEEEcCCCCEEEeeccc
Q 013214 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHE-----NKPVPIIHRDLEPSNILRDDSGNLKVADFGV 299 (447)
Q Consensus 225 ~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~-----~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~ 299 (447)
+|||++|-+.|||+|||.+ ..++.+...+++..++.||+|||. +|+..|.|||||+.|||+.+++...|+|+|+
T Consensus 284 LwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGL 362 (513)
T KOG2052|consen 284 LWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 362 (513)
T ss_pred EEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeecee
Confidence 8999999999999999987 669999999999999999999994 6777799999999999999999999999999
Q ss_pred ccccccCC---CCCcccCCCCCcccCCcccCCCC----C--CCchhHHHHHHHHHHHHhC----------CCCCCCCCC-
Q 013214 300 SKLLTVKE---DRPLTCQDTSCRYVAPEVFKNEE----Y--DTKVDVFSFALILQEMIEG----------CPPFTMKHD- 359 (447)
Q Consensus 300 ~~~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~----~--~~~~Di~slG~~l~~l~tg----------~~p~~~~~~- 359 (447)
|....... +.+.....||.+|||||++...- + -..+||||||.++||+..+ ++||.+.-+
T Consensus 363 Av~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~ 442 (513)
T KOG2052|consen 363 AVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPS 442 (513)
T ss_pred eEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCC
Confidence 97655432 23446678999999999986541 1 1369999999999999753 468865433
Q ss_pred ----CchHHHHHhc-CCCCCCCChhhhH--HHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhh
Q 013214 360 ----NEVPKAYAAR-QRPPFKAPAKLYA--RGLKELIEECWNEKPAKRPTFRQIITRLESINNS 416 (447)
Q Consensus 360 ----~~~~~~~~~~-~~~~~~~~~~~~~--~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~ 416 (447)
++..+.+... .+|.++..+...+ ..+.++|+.||..||.-|.|+-.+-+.|.++.+.
T Consensus 443 DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~~ 506 (513)
T KOG2052|consen 443 DPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSNS 506 (513)
T ss_pred CCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhcC
Confidence 2233333222 3666654444333 4678899999999999999999999999888763
No 380
>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]
Probab=100.00 E-value=3.5e-33 Score=280.06 Aligned_cols=245 Identities=27% Similarity=0.422 Sum_probs=204.7
Q ss_pred CcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeEEEEe-----CCc
Q 013214 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQ-----SSP 224 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~-----~~~ 224 (447)
.+.+...||.|++|.|+ .+|+.+|+|+....... .+++..|.++++.+ .|||++.+|+++.- .+.
T Consensus 20 ~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~----deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~Dq 95 (953)
T KOG0587|consen 20 IFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE----EEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQ 95 (953)
T ss_pred ccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc----cHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCe
Confidence 45566789999998876 47889999998765422 24677799999999 69999999999853 467
Q ss_pred eEEEEeccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccc
Q 013214 225 MMIVTEYLPKGDLRAFLKR--KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 302 (447)
Q Consensus 225 ~~lv~e~~~~g~L~~~l~~--~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~ 302 (447)
+|||||||.+||..|+++. ..++.++.+..|+..++.|+.|||.+. ++|||||=.|||++.++.|||+|||.+..
T Consensus 96 LWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKLvDFGvSaQ 172 (953)
T KOG0587|consen 96 LWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQ 172 (953)
T ss_pred EEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEEeeeeeeee
Confidence 9999999999999999975 356899999999999999999999999 99999999999999999999999999987
Q ss_pred cccCCCCCcccCCCCCcccCCcccCCC-----CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCC
Q 013214 303 LTVKEDRPLTCQDTSCRYVAPEVFKNE-----EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAP 377 (447)
Q Consensus 303 ~~~~~~~~~~~~~~t~~y~aPE~~~~~-----~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 377 (447)
+.....+. ....|||.|||||++... .|+.++|+||||++..||.-|.+|+.++.+....-.+.....| -...
T Consensus 173 ldsT~grR-nT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPP-kLkr 250 (953)
T KOG0587|consen 173 LDSTVGRR-NTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPP-KLKR 250 (953)
T ss_pred eecccccc-cCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCc-cccc
Confidence 76543333 446789999999998653 4677999999999999999999999988887665555222222 2334
Q ss_pred hhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 378 AKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 378 ~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
+..++.++.++|..||..|.++||++.+++++
T Consensus 251 p~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 251 PKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred hhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 67899999999999999999999999998864
No 381
>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional
Probab=100.00 E-value=9.7e-33 Score=304.23 Aligned_cols=246 Identities=23% Similarity=0.372 Sum_probs=189.5
Q ss_pred CcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
.+.....||+|+||.|| .+|..||+|++..... ....|++.+++++||||+++++++.+....++|||
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~E 763 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS-------IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHE 763 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc-------ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEe
Confidence 35566789999999886 3678999999864321 11246888999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCC
Q 013214 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (447)
Q Consensus 231 ~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~ 310 (447)
|+++|+|.++++. +++.++..++.|++.|++|||...+.+++||||||+||+++.++..++. ||.+.....
T Consensus 764 y~~~g~L~~~l~~---l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~----- 834 (968)
T PLN00113 764 YIEGKNLSEVLRN---LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT----- 834 (968)
T ss_pred CCCCCcHHHHHhc---CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc-----
Confidence 9999999999963 8899999999999999999995533349999999999999998887775 665443211
Q ss_pred cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCC--chHHHHHh---c------CCCCCC---C
Q 013214 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDN--EVPKAYAA---R------QRPPFK---A 376 (447)
Q Consensus 311 ~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~--~~~~~~~~---~------~~~~~~---~ 376 (447)
.....+|+.|+|||++.+..++.++|||||||++|||++|+.||...... ........ . ..+... .
T Consensus 835 ~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (968)
T PLN00113 835 DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVS 914 (968)
T ss_pred CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCC
Confidence 11235688999999999889999999999999999999999998643221 11111100 0 011111 1
Q ss_pred ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhh
Q 013214 377 PAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSI 417 (447)
Q Consensus 377 ~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~~ 417 (447)
.......++.+++.+||+.||++||++.++++.|+.+.+..
T Consensus 915 ~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~ 955 (968)
T PLN00113 915 VNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSS 955 (968)
T ss_pred ccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhccc
Confidence 12233456788999999999999999999999999876643
No 382
>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]
Probab=100.00 E-value=2e-33 Score=276.76 Aligned_cols=252 Identities=26% Similarity=0.413 Sum_probs=197.2
Q ss_pred cccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeC------Cce
Q 013214 157 FTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS------SPM 225 (447)
Q Consensus 157 ~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~------~~~ 225 (447)
+...+.||+|+||.|+ .+|+.||||.+.... .....+...+|++++++++|||||++++.-+.. +..
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~--~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~ 92 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES--SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLP 92 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhc--ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccc
Confidence 4455689999999886 479999999998654 345567788999999999999999999876543 346
Q ss_pred EEEEeccCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEc--CCC--CEEEeecc
Q 013214 226 MIVTEYLPKGDLRAFLKRK---GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD--DSG--NLKVADFG 298 (447)
Q Consensus 226 ~lv~e~~~~g~L~~~l~~~---~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~--~~~--~vkl~Dfg 298 (447)
.++||||.||||...+.+. ..+++.+.+.++.+++.||.|||++| |+||||||.||++- .+| .-||+|||
T Consensus 93 vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG 169 (732)
T KOG4250|consen 93 VLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFG 169 (732)
T ss_pred eEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeeccc
Confidence 8999999999999999753 45999999999999999999999999 99999999999975 334 37999999
Q ss_pred cccccccCCCCCcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCc----hHHHHHhcCC--
Q 013214 299 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNE----VPKAYAARQR-- 371 (447)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~----~~~~~~~~~~-- 371 (447)
.|+.++.. ....+..||..|++||.+.. ..|+..+|.|||||++|++.||..||....... +.-.+..+..
T Consensus 170 ~Arel~d~--s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~ 247 (732)
T KOG4250|consen 170 AARELDDN--SLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSG 247 (732)
T ss_pred ccccCCCC--CeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCc
Confidence 99987654 35567889999999999984 788999999999999999999999997555432 2211111110
Q ss_pred ----------------CCCCCChhh----hHHHHHHHHHHHcccCCCCCC--CHHHHHHHHHHHHhh
Q 013214 372 ----------------PPFKAPAKL----YARGLKELIEECWNEKPAKRP--TFRQIITRLESINNS 416 (447)
Q Consensus 372 ----------------~~~~~~~~~----~~~~l~~li~~cl~~dp~~Rp--s~~~~l~~l~~~~~~ 416 (447)
..++. +.. .-..+..++..+|..+|++|- .+.+....+.++.+.
T Consensus 248 v~i~~~~~eNgpv~~s~~lP~-p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~ 313 (732)
T KOG4250|consen 248 VAIGAQEEENGPVEWSSTLPQ-PNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNL 313 (732)
T ss_pred eeEeeecccCCceeeeccCCC-cccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhh
Confidence 01111 112 223466778889999999998 777777777765543
No 383
>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]
Probab=100.00 E-value=7.5e-33 Score=260.82 Aligned_cols=256 Identities=28% Similarity=0.432 Sum_probs=201.5
Q ss_pred CcccceeeecceEEEEE---EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC--CCCcccceeEEEEeCC----ceE
Q 013214 156 DFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI--RHPNVVQFLGAVTQSS----PMM 226 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~---~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l--~hp~iv~~~~~~~~~~----~~~ 226 (447)
..+....+|+|.||.|+ .+++.||||+++ ....+.|++|-++.+.. +|+||++++++-.... ..+
T Consensus 211 pl~l~eli~~Grfg~V~KaqL~~~~VAVKifp------~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eyw 284 (534)
T KOG3653|consen 211 PLQLLELIGRGRFGCVWKAQLDNRLVAVKIFP------EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYW 284 (534)
T ss_pred chhhHHHhhcCccceeehhhccCceeEEEecC------HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCcccccee
Confidence 34455678999999887 478999999985 34567899999998876 7999999999865444 789
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC------CCCeEeCCCCCCCEEEcCCCCEEEeecccc
Q 013214 227 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENK------PVPIIHRDLEPSNILRDDSGNLKVADFGVS 300 (447)
Q Consensus 227 lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~------~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~ 300 (447)
||+||.+.|+|.++|+.+ .+++....+++..+++||+|||+.. +.+|+|||||+.|||+.++++..|+|||+|
T Consensus 285 LVt~fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLA 363 (534)
T KOG3653|consen 285 LVTEFHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLA 363 (534)
T ss_pred EEeeeccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecccee
Confidence 999999999999999764 5899999999999999999999754 337999999999999999999999999999
Q ss_pred cccccCC-CCCcccCCCCCcccCCcccCCC-CCC-----CchhHHHHHHHHHHHHhCCCCCCC-C---------------
Q 013214 301 KLLTVKE-DRPLTCQDTSCRYVAPEVFKNE-EYD-----TKVDVFSFALILQEMIEGCPPFTM-K--------------- 357 (447)
Q Consensus 301 ~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~-~~~-----~~~Di~slG~~l~~l~tg~~p~~~-~--------------- 357 (447)
..+.... ..+.....||.+|||||++.+. .+. .+.||||+|.++||++++..-+.. .
T Consensus 364 l~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~h 443 (534)
T KOG3653|consen 364 LRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNH 443 (534)
T ss_pred EEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCC
Confidence 8876442 2333456799999999998764 222 369999999999999986543321 0
Q ss_pred -CCCchHHHH-HhcCCCCCCCChh--hhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhh
Q 013214 358 -HDNEVPKAY-AARQRPPFKAPAK--LYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSIN 418 (447)
Q Consensus 358 -~~~~~~~~~-~~~~~~~~~~~~~--~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~~~ 418 (447)
..++....+ ..+.||.++..+. .....+++.++.||+.||+-|.|+.=+-+.+..+...-+
T Consensus 444 Pt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~ 508 (534)
T KOG3653|consen 444 PTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWE 508 (534)
T ss_pred CCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCC
Confidence 112233333 3344777655433 234678999999999999999999999888888776554
No 384
>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]
Probab=100.00 E-value=6.1e-34 Score=261.91 Aligned_cols=243 Identities=26% Similarity=0.319 Sum_probs=193.6
Q ss_pred CcCcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC--CCc----ccceeEEEEeC
Q 013214 154 ELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR--HPN----VVQFLGAVTQS 222 (447)
Q Consensus 154 ~~~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--hp~----iv~~~~~~~~~ 222 (447)
.-+|.+...+|+|+||.|. .++..||||+++. -....++.+-|+++++++. .|+ ++++.++|...
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~----V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyr 163 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKN----VDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYR 163 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHH----HHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhcc
Confidence 4478888899999999875 3578999999873 3455566778999999993 333 78888889999
Q ss_pred CceEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCC-----------
Q 013214 223 SPMMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS----------- 289 (447)
Q Consensus 223 ~~~~lv~e~~~~g~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~----------- 289 (447)
++.|+|+|.+ |-|+.+++++++ +++...+..++.|+++++++||+.+ ++|-||||+|||+.+.
T Consensus 164 ghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~ 239 (415)
T KOG0671|consen 164 GHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKK 239 (415)
T ss_pred CceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCc
Confidence 9999999999 779999999875 4889999999999999999999999 9999999999997532
Q ss_pred ---------CCEEEeecccccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCC
Q 013214 290 ---------GNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDN 360 (447)
Q Consensus 290 ---------~~vkl~Dfg~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~ 360 (447)
-.|+++|||+|.+-... ......|..|.|||++.+-+++.++||||+||+|+|+++|...|++.++.
T Consensus 240 ~~~~r~~ks~~I~vIDFGsAtf~~e~----hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~ 315 (415)
T KOG0671|consen 240 VCFIRPLKSTAIKVIDFGSATFDHEH----HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENL 315 (415)
T ss_pred cceeccCCCcceEEEecCCcceeccC----cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcH
Confidence 25899999999875432 24456788999999999999999999999999999999999999988765
Q ss_pred chH---HHHHhcCCC------------------CCCC---------------Ch-------hhhHHHHHHHHHHHcccCC
Q 013214 361 EVP---KAYAARQRP------------------PFKA---------------PA-------KLYARGLKELIEECWNEKP 397 (447)
Q Consensus 361 ~~~---~~~~~~~~~------------------~~~~---------------~~-------~~~~~~l~~li~~cl~~dp 397 (447)
|-. +.+ .+..| ..+. +. ..--..+-+||++||..||
T Consensus 316 EHLaMMerI-lGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP 394 (415)
T KOG0671|consen 316 EHLAMMERI-LGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDP 394 (415)
T ss_pred HHHHHHHHh-hCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCc
Confidence 521 111 11000 0000 00 0112358899999999999
Q ss_pred CCCCCHHHHHHH
Q 013214 398 AKRPTFRQIITR 409 (447)
Q Consensus 398 ~~Rps~~~~l~~ 409 (447)
.+|+|+.|++++
T Consensus 395 ~~RiTl~EAL~H 406 (415)
T KOG0671|consen 395 ARRITLREALSH 406 (415)
T ss_pred cccccHHHHhcC
Confidence 999999999874
No 385
>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=8.4e-34 Score=264.65 Aligned_cols=251 Identities=24% Similarity=0.393 Sum_probs=200.6
Q ss_pred CcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHH----HHHHHHHHHHHHhcCCCCcccceeEEEE-eCCce
Q 013214 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDD----RVRAFRDELALLQKIRHPNVVQFLGAVT-QSSPM 225 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~----~~~~~~~E~~~l~~l~hp~iv~~~~~~~-~~~~~ 225 (447)
+|.....||+|||..|+ ...+.||+|+-....-+.++ ......+|.++-+.+.||.||++|++|. +.+.+
T Consensus 464 RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsF 543 (775)
T KOG1151|consen 464 RYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSF 543 (775)
T ss_pred HHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccc
Confidence 56677789999997664 46789999987655433332 3345678999999999999999999986 45678
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcC---CCCEEEeecccccc
Q 013214 226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD---SGNLKVADFGVSKL 302 (447)
Q Consensus 226 ~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~---~~~vkl~Dfg~~~~ 302 (447)
|.|+|||+|.+|.-+|+.+.-+++.++..|+.||+.||.||.+.. .||+|-||||.|||+-+ .|.+||+|||++..
T Consensus 544 CTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKITDFGLSKI 622 (775)
T KOG1151|consen 544 CTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKITDFGLSKI 622 (775)
T ss_pred eeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEeeecchhhh
Confidence 999999999999999999999999999999999999999999987 57999999999999863 57899999999998
Q ss_pred cccCCCCC------cccCCCCCcccCCcccCCC----CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCc-hH-HHHHhcC
Q 013214 303 LTVKEDRP------LTCQDTSCRYVAPEVFKNE----EYDTKVDVFSFALILQEMIEGCPPFTMKHDNE-VP-KAYAARQ 370 (447)
Q Consensus 303 ~~~~~~~~------~~~~~~t~~y~aPE~~~~~----~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~-~~-~~~~~~~ 370 (447)
+....... .....||.+|++||.+.-+ +.+.++||||+||++|+++.|+.||....... +. +......
T Consensus 623 MdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIlkA 702 (775)
T KOG1151|consen 623 MDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTILKA 702 (775)
T ss_pred ccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchhcc
Confidence 86543321 2456789999999987533 67789999999999999999999998654322 11 1111111
Q ss_pred -CCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHH
Q 013214 371 -RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIIT 408 (447)
Q Consensus 371 -~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~ 408 (447)
.-.|+ .-+.++++.+.+|++||+.--++|....++..
T Consensus 703 tEVqFP-~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 703 TEVQFP-PKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred eeccCC-CCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 12232 24567899999999999999999999888764
No 386
>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain. Phosphotransferases. Serine or threonine-specific kinase subfamily.
Probab=100.00 E-value=5.3e-32 Score=249.62 Aligned_cols=237 Identities=34% Similarity=0.540 Sum_probs=193.2
Q ss_pred cceEEEEEE--cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEeccCCCCHHHHHH
Q 013214 165 KGTFILAFW--RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK 242 (447)
Q Consensus 165 ~G~~~~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~ 242 (447)
.|..+.+.. +|+.+++|++........ .+.+.+|+..+++++|+|++++++.+......++++||+++++|.+++.
T Consensus 2 ~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~ 79 (244)
T smart00220 2 FGKVYLARDKKTGKLVAIKVIKKEKIKKK--RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLK 79 (244)
T ss_pred ceEEEEEEECCCCcEEEEEEecccccccH--HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHH
Confidence 355555554 469999999875533221 5788899999999999999999999999899999999999889999998
Q ss_pred hcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCCcccCCCCCcccC
Q 013214 243 RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVA 322 (447)
Q Consensus 243 ~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~t~~y~a 322 (447)
....++...++.++.+++.++.+||+.+ ++|+||+|+||+++.++.++++|||.+....... ......++..|++
T Consensus 80 ~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~ 154 (244)
T smart00220 80 KRGRLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEYMA 154 (244)
T ss_pred hccCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCCCC
Confidence 7766899999999999999999999998 9999999999999999999999999998765432 2233456788999
Q ss_pred CcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCC
Q 013214 323 PEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPT 402 (447)
Q Consensus 323 PE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps 402 (447)
||.+.+..++.++|+||||++++++++|..||......+...................++..+.+++.+||..+|++||+
T Consensus 155 pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~ 234 (244)
T smart00220 155 PEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLT 234 (244)
T ss_pred HHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhccC
Confidence 99998888899999999999999999999999874333332222222222222222226788999999999999999999
Q ss_pred HHHHHH
Q 013214 403 FRQIIT 408 (447)
Q Consensus 403 ~~~~l~ 408 (447)
+.++++
T Consensus 235 ~~~~~~ 240 (244)
T smart00220 235 AEEALQ 240 (244)
T ss_pred HHHHhh
Confidence 999986
No 387
>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]
Probab=100.00 E-value=7e-33 Score=268.27 Aligned_cols=240 Identities=24% Similarity=0.362 Sum_probs=198.8
Q ss_pred cccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEec
Q 013214 157 FTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (447)
Q Consensus 157 ~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 231 (447)
|...+-||-|+||.|. .+...+|.|.+.+...-..++....+.|-+||..-..+-||++|-.|.+.+.+|+||||
T Consensus 631 Fvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdY 710 (1034)
T KOG0608|consen 631 FVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDY 710 (1034)
T ss_pred eEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEec
Confidence 5556789999999774 35567899988776555666777788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCC--
Q 013214 232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR-- 309 (447)
Q Consensus 232 ~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~-- 309 (447)
++||++-.+|-+-+-+.++.+..++.++..|+++.|..| +|||||||+|||||.+|+|||+|||+..-+....+.
T Consensus 711 IPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskY 787 (1034)
T KOG0608|consen 711 IPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY 787 (1034)
T ss_pred cCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccceecccccc
Confidence 999999999999999999999999999999999999999 999999999999999999999999997543211000
Q ss_pred -------------C--------------------------cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhC
Q 013214 310 -------------P--------------------------LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEG 350 (447)
Q Consensus 310 -------------~--------------------------~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg 350 (447)
. .....||+.|+|||++....++..+|+||.|++||+|+.|
T Consensus 788 Yq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g 867 (1034)
T KOG0608|consen 788 YQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVG 867 (1034)
T ss_pred ccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhC
Confidence 0 0234589999999999999999999999999999999999
Q ss_pred CCCCCCCCCCchHHHHHhcCCCCC-CCChhhhHHHHHHHHHHHcccCCCCCC
Q 013214 351 CPPFTMKHDNEVPKAYAARQRPPF-KAPAKLYARGLKELIEECWNEKPAKRP 401 (447)
Q Consensus 351 ~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dp~~Rp 401 (447)
++||-..++.+....+.... ..+ .....++|+++.++|.++. .+++.|.
T Consensus 868 ~~pf~~~tp~~tq~kv~nw~-~~l~~~~~~~ls~e~~~li~kLc-~sad~RL 917 (1034)
T KOG0608|consen 868 QPPFLADTPGETQYKVINWR-NFLHIPYQGNLSKEALDLIQKLC-CSADSRL 917 (1034)
T ss_pred CCCccCCCCCcceeeeeehh-hccccccccccCHHHHHHHHHHh-cChhhhh
Confidence 99999998888766653332 222 1235678889999987644 4566664
No 388
>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]
Probab=100.00 E-value=3.5e-34 Score=249.55 Aligned_cols=250 Identities=24% Similarity=0.369 Sum_probs=191.4
Q ss_pred cCcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEe--------
Q 013214 155 LDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ-------- 221 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-------- 221 (447)
..|.....||+|+||.|+ .+|+.||+|++-.+.....-. ....+|+++|..++|+|++.+++.|..
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfp-italreikiL~~lkHenv~nliEic~tk~Tp~~r~ 95 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFP-ITALREIKILQLLKHENVVNLIEICRTKATPTNRD 95 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCc-HHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccc
Confidence 356667789999999664 578889999775432222222 234569999999999999999887743
Q ss_pred CCceEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccc
Q 013214 222 SSPMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS 300 (447)
Q Consensus 222 ~~~~~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~ 300 (447)
...+|+||++|+ .+|.-.+... -+++..++.+++.++..||.|+|+.. |+|||+|++|+||+.+|.+||+|||++
T Consensus 96 r~t~ylVf~~ce-hDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGla 171 (376)
T KOG0669|consen 96 RATFYLVFDFCE-HDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGLA 171 (376)
T ss_pred cceeeeeHHHhh-hhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeeccccc
Confidence 234899999995 5898888655 56999999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCC---CcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcC---CCC
Q 013214 301 KLLTVKEDR---PLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ---RPP 373 (447)
Q Consensus 301 ~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~---~~~ 373 (447)
+.+...... ..+....|.+|++||.+.+. .++++.|+|.-||++.+|++|.+.+.+.+.......+.... .+.
T Consensus 172 r~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tke 251 (376)
T KOG0669|consen 172 RAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKE 251 (376)
T ss_pred cceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcc
Confidence 766543222 13445569999999998876 78999999999999999999999988766544333321110 111
Q ss_pred CCCC---------------h-------h------hhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 374 FKAP---------------A-------K------LYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 374 ~~~~---------------~-------~------~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
.++. + + .-.++..+|++.+|..||.+|+++++++++
T Consensus 252 vWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 252 VWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred cCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence 1100 0 0 012467899999999999999999998875
No 389
>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]
Probab=99.98 E-value=2.3e-33 Score=280.18 Aligned_cols=240 Identities=26% Similarity=0.394 Sum_probs=186.0
Q ss_pred cccceeeecceEEE----EEEcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeEEEEeCCceEEEEec
Q 013214 157 FTNSVEITKGTFIL----AFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEY 231 (447)
Q Consensus 157 ~~~~~~lg~G~~~~----~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~ 231 (447)
|...+.+|.|+-|+ +.+.|+.||||++-.+. ..-..+|+..|+.- .||||+++|+.-.+++..||..|.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye~R~VAVKrll~e~------~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalEL 584 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYEGREVAVKRLLEEF------FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALEL 584 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeCCceehHHHHhhHh------HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehH
Confidence 44455677776654 45789999999986432 24557899999999 699999999999999999999999
Q ss_pred cCCCCHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcC---C--CCEEEeecccccc
Q 013214 232 LPKGDLRAFLKRKGA----LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD---S--GNLKVADFGVSKL 302 (447)
Q Consensus 232 ~~~g~L~~~l~~~~~----l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~---~--~~vkl~Dfg~~~~ 302 (447)
| ..+|.+++...+. ......+.++.|+++||+|||+.+ |+||||||+||||+. + .+++|+|||+++.
T Consensus 585 C-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKk 660 (903)
T KOG1027|consen 585 C-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKK 660 (903)
T ss_pred h-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccc
Confidence 9 5799999987411 122455788999999999999998 999999999999986 3 4689999999998
Q ss_pred cccCCCC--CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCCCCChh
Q 013214 303 LTVKEDR--PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAK 379 (447)
Q Consensus 303 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (447)
+..+... ......||.+|+|||++....-+..+||||+||++|+.++ |.+||.+.-..+. .+.... ..+....+
T Consensus 661 l~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~--NIl~~~-~~L~~L~~ 737 (903)
T KOG1027|consen 661 LAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA--NILTGN-YTLVHLEP 737 (903)
T ss_pred cCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhh--hhhcCc-cceeeecc
Confidence 8755432 2356678999999999999888889999999999999998 5999996654432 221221 11111111
Q ss_pred hhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 380 LYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 380 ~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
....+..+||.+|++.+|..||++.+++.|
T Consensus 738 ~~d~eA~dLI~~ml~~dP~~RPsa~~VL~H 767 (903)
T KOG1027|consen 738 LPDCEAKDLISRMLNPDPQLRPSATDVLNH 767 (903)
T ss_pred CchHHHHHHHHHhcCCCcccCCCHHHHhCC
Confidence 111288999999999999999999999754
No 390
>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]
Probab=99.97 E-value=1.1e-31 Score=227.50 Aligned_cols=212 Identities=26% Similarity=0.440 Sum_probs=168.5
Q ss_pred CcccceeeecceEEEE-----EEcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeEEEEeCCceEEEE
Q 013214 156 DFTNSVEITKGTFILA-----FWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVT 229 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~-----~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~ 229 (447)
......+||+|++|.+ ..+|+..|+|+++... +.....+..+|+++..+. .+|++|.+||.......+++.|
T Consensus 47 ~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tv--n~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcM 124 (282)
T KOG0984|consen 47 DLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATV--NSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICM 124 (282)
T ss_pred hhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhc--ChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeH
Confidence 3445568999999976 3689999999998653 334455667788887666 7999999999999999999999
Q ss_pred eccCCCCHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeeccccccccc
Q 013214 230 EYLPKGDLRAFL----KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305 (447)
Q Consensus 230 e~~~~g~L~~~l----~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~ 305 (447)
|.|+ -||..+- ++++.+++...=+++..+.+||.|||++- .++|||+||+|||++..|++|+||||.+-.+..
T Consensus 125 E~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~d 201 (282)
T KOG0984|consen 125 ELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGYLVD 201 (282)
T ss_pred HHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccceeehh
Confidence 9994 5886654 34667899999999999999999999975 599999999999999999999999999876543
Q ss_pred CCCCCcccCCCCCcccCCcccCCC----CCCCchhHHHHHHHHHHHHhCCCCCCCCCC-CchHHHHHhcCCCCC
Q 013214 306 KEDRPLTCQDTSCRYVAPEVFKNE----EYDTKVDVFSFALILQEMIEGCPPFTMKHD-NEVPKAYAARQRPPF 374 (447)
Q Consensus 306 ~~~~~~~~~~~t~~y~aPE~~~~~----~~~~~~Di~slG~~l~~l~tg~~p~~~~~~-~~~~~~~~~~~~~~~ 374 (447)
. ...+...|-..|||||.+..+ .|+.++||||||+++.||.+++.||+.... .+..+++.....|.+
T Consensus 202 S--iAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVeep~P~L 273 (282)
T KOG0984|consen 202 S--IAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEEPSPQL 273 (282)
T ss_pred h--hHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcCCCCCC
Confidence 2 222223345679999988543 688899999999999999999999997764 345555544444444
No 391
>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]
Probab=99.97 E-value=7.7e-32 Score=255.98 Aligned_cols=243 Identities=24% Similarity=0.360 Sum_probs=194.8
Q ss_pred CcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC------CCcccceeEEEEeCCc
Q 013214 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR------HPNVVQFLGAVTQSSP 224 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~------hp~iv~~~~~~~~~~~ 224 (447)
.|.+....|+|.|+.|. ..|+.||||++..+.... ..=..|+.+|+.++ --|+++++-.|...++
T Consensus 433 RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~----KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknH 508 (752)
T KOG0670|consen 433 RYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMH----KTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNH 508 (752)
T ss_pred eeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHh----hhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcce
Confidence 57777778999999875 468899999998554332 33356999999995 2379999999999999
Q ss_pred eEEEEeccCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCC-CEEEeecccc
Q 013214 225 MMIVTEYLPKGDLRAFLKRKG---ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG-NLKVADFGVS 300 (447)
Q Consensus 225 ~~lv~e~~~~g~L~~~l~~~~---~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~-~vkl~Dfg~~ 300 (447)
+|||+|.+ .-+|.++|++-+ .|....+..++.|+.-||..|-..+ |+|+||||+|||+++.. .+||||||+|
T Consensus 509 LClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLCDfGSA 584 (752)
T KOG0670|consen 509 LCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLCDFGSA 584 (752)
T ss_pred eEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeeccCccc
Confidence 99999999 579999998755 4888999999999999999999998 99999999999999654 5899999999
Q ss_pred cccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHh-cC-C-------
Q 013214 301 KLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA-RQ-R------- 371 (447)
Q Consensus 301 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~-~~-~------- 371 (447)
...+... .+.+..+..|.|||++.+-.|+...|+||+||+||||+||+..|++.+........-. .+ .
T Consensus 585 ~~~~ene---itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRK 661 (752)
T KOG0670|consen 585 SFASENE---ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRK 661 (752)
T ss_pred ccccccc---ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhh
Confidence 8765432 2334456679999999999999999999999999999999999998887665433211 00 0
Q ss_pred -----------------------------------------------CCCCCChhhhHHHHHHHHHHHcccCCCCCCCHH
Q 013214 372 -----------------------------------------------PPFKAPAKLYARGLKELIEECWNEKPAKRPTFR 404 (447)
Q Consensus 372 -----------------------------------------------~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ 404 (447)
+.++...+..-..+.+|+..||..||++|.|..
T Consensus 662 gqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~n 741 (752)
T KOG0670|consen 662 GQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVN 741 (752)
T ss_pred cchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHH
Confidence 001111222335699999999999999999999
Q ss_pred HHHHH
Q 013214 405 QIITR 409 (447)
Q Consensus 405 ~~l~~ 409 (447)
+++.+
T Consensus 742 qAL~H 746 (752)
T KOG0670|consen 742 QALKH 746 (752)
T ss_pred HHhcC
Confidence 98864
No 392
>PLN03224 probable serine/threonine protein kinase; Provisional
Probab=99.97 E-value=7.1e-30 Score=256.11 Aligned_cols=250 Identities=18% Similarity=0.211 Sum_probs=177.0
Q ss_pred CCcCcccceeeecceEEEEEE---------------------cCeEEEEEEcCcccCCCHHHHHH--------------H
Q 013214 153 HELDFTNSVEITKGTFILAFW---------------------RGIQVAVKKLGEEVISDDDRVRA--------------F 197 (447)
Q Consensus 153 ~~~~~~~~~~lg~G~~~~~~~---------------------~g~~vavK~~~~~~~~~~~~~~~--------------~ 197 (447)
...+|...+.||+|+||.||. .++.||||++.... ....++ .
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~---~~~~~~fl~e~~~~~~~~e~~ 219 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDR---QGVRQDFLKTGTLAKGSAETG 219 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccc---hhhHHHHHhhhhhhhcccchh
Confidence 345788999999999999873 34679999986432 111222 2
Q ss_pred HHHHHHHhcCCCCc-----ccceeEEEEe--------CCceEEEEeccCCCCHHHHHHhcC-------------------
Q 013214 198 RDELALLQKIRHPN-----VVQFLGAVTQ--------SSPMMIVTEYLPKGDLRAFLKRKG------------------- 245 (447)
Q Consensus 198 ~~E~~~l~~l~hp~-----iv~~~~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~~------------------- 245 (447)
..|+.++.+++|.+ +++++++|.. .+..++|+||+++++|.++++...
T Consensus 220 ~vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~ 299 (507)
T PLN03224 220 MVEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPD 299 (507)
T ss_pred HHHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhh
Confidence 34666677776554 3667777653 356899999999999999986421
Q ss_pred -----CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCCcccCCCCCcc
Q 013214 246 -----ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRY 320 (447)
Q Consensus 246 -----~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~t~~y 320 (447)
.+++..+..++.|++.+|.|||+.+ ++||||||+||+++.++.+||+|||++...............+++.|
T Consensus 300 ~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y 376 (507)
T PLN03224 300 NMPQDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRY 376 (507)
T ss_pred hcccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcce
Confidence 1345678889999999999999998 99999999999999999999999999875543222222223347899
Q ss_pred cCCcccCCCC--------------------C--CCchhHHHHHHHHHHHHhCCC-CCCCCCCCc--------hHHHH--H
Q 013214 321 VAPEVFKNEE--------------------Y--DTKVDVFSFALILQEMIEGCP-PFTMKHDNE--------VPKAY--A 367 (447)
Q Consensus 321 ~aPE~~~~~~--------------------~--~~~~Di~slG~~l~~l~tg~~-p~~~~~~~~--------~~~~~--~ 367 (447)
+|||.+.... + ..+.|+||+||++|+|++|.. ||....... ..... .
T Consensus 377 ~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~ 456 (507)
T PLN03224 377 SPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMY 456 (507)
T ss_pred eChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhh
Confidence 9999875432 1 124799999999999999875 665322111 00000 0
Q ss_pred hcCCCCCCCChhhhHHHHHHHHHHHcccCC---CCCCCHHHHHHH
Q 013214 368 ARQRPPFKAPAKLYARGLKELIEECWNEKP---AKRPTFRQIITR 409 (447)
Q Consensus 368 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp---~~Rps~~~~l~~ 409 (447)
......++ .....++...+++.+||..+| .+|+|++++++|
T Consensus 457 ~~~~~~~~-~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 457 KGQKYDFS-LLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred cccCCCcc-cccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 11122332 234467889999999999766 689999999875
No 393
>PLN03225 Serine/threonine-protein kinase SNT7; Provisional
Probab=99.97 E-value=2.5e-30 Score=265.62 Aligned_cols=246 Identities=19% Similarity=0.225 Sum_probs=162.8
Q ss_pred CCcCcccceeeecceEEEEEE-----c----CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEE-----
Q 013214 153 HELDFTNSVEITKGTFILAFW-----R----GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGA----- 218 (447)
Q Consensus 153 ~~~~~~~~~~lg~G~~~~~~~-----~----g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~----- 218 (447)
...+|...+.||+|+||.||. + +..||+|++..... . +...+| .++...+.++..++..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~---e~~~~e--~l~~~~~~~~~~~~~~~~~~~ 202 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--V---EIWMNE--RVRRACPNSCADFVYGFLEPV 202 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--h---HHHHHH--HHHhhchhhHHHHHHhhhccc
Confidence 344788899999999999873 3 78999998764321 1 111111 1122222222222211
Q ss_pred -EEeCCceEEEEeccCCCCHHHHHHhcCC--------------------CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeC
Q 013214 219 -VTQSSPMMIVTEYLPKGDLRAFLKRKGA--------------------LKPSTAVRFALDIARGMNYLHENKPVPIIHR 277 (447)
Q Consensus 219 -~~~~~~~~lv~e~~~~g~L~~~l~~~~~--------------------l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~ 277 (447)
.......++++||+.+++|.+++..... .....+..++.|++.||.|||+.+ |+||
T Consensus 203 ~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHR 279 (566)
T PLN03225 203 SSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHR 279 (566)
T ss_pred ccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeC
Confidence 2455678999999999999999875421 112345679999999999999998 9999
Q ss_pred CCCCCCEEEcC-CCCEEEeecccccccccCCCCCcccCCCCCcccCCcccCCC----------------------CCCCc
Q 013214 278 DLEPSNILRDD-SGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE----------------------EYDTK 334 (447)
Q Consensus 278 Dikp~Nill~~-~~~vkl~Dfg~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~----------------------~~~~~ 334 (447)
||||+|||++. ++.+||+|||++...............+++.|+|||.+... .++.+
T Consensus 280 DLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k 359 (566)
T PLN03225 280 DVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDR 359 (566)
T ss_pred cCCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCC
Confidence 99999999995 67999999999986544333333456678999999965322 23345
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcC----------CCCCCCC-------hhhhHHHHHHHHHHHcccCC
Q 013214 335 VDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ----------RPPFKAP-------AKLYARGLKELIEECWNEKP 397 (447)
Q Consensus 335 ~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~----------~~~~~~~-------~~~~~~~l~~li~~cl~~dp 397 (447)
+|||||||++|+|+++..|+..... .....+.... .+..... ....+....+||.+||+.||
T Consensus 360 ~DVwSlGviL~el~~~~~~~~~~~~-~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP 438 (566)
T PLN03225 360 FDIYSAGLIFLQMAFPNLRSDSNLI-QFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKG 438 (566)
T ss_pred cccHHHHHHHHHHHhCcCCCchHHH-HHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCc
Confidence 6999999999999997766442110 0001110000 0000000 00012235589999999999
Q ss_pred CCCCCHHHHHHH
Q 013214 398 AKRPTFRQIITR 409 (447)
Q Consensus 398 ~~Rps~~~~l~~ 409 (447)
++|||+.+++++
T Consensus 439 ~kR~ta~e~L~H 450 (566)
T PLN03225 439 RQRISAKAALAH 450 (566)
T ss_pred ccCCCHHHHhCC
Confidence 999999999986
No 394
>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]
Probab=99.97 E-value=3.4e-32 Score=239.72 Aligned_cols=250 Identities=24% Similarity=0.414 Sum_probs=198.2
Q ss_pred CcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeC-----Cce
Q 013214 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS-----SPM 225 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~~ 225 (447)
+.+-.+.||.|+||.|. .+|+.||+|++.. .+..--....+.+|++++..++|.|++..++...-. ..+
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pn-vfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEi 132 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPN-VFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQEL 132 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcch-HHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHH
Confidence 44556789999999876 4799999999864 333444556777899999999999999988876533 246
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeeccccccccc
Q 013214 226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305 (447)
Q Consensus 226 ~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~ 305 (447)
|.++|.+ ..+|...+.+...++.+.+.-++.||++||+|||+.+ |+||||||.|.|++++..+||||||+++....
T Consensus 133 YV~TELm-QSDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee~ 208 (449)
T KOG0664|consen 133 YVLTELM-QSDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWDQ 208 (449)
T ss_pred HHHHHHH-HhhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccch
Confidence 8899999 5789998888888999999999999999999999999 99999999999999999999999999998766
Q ss_pred CCCCCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhc-CCC-----------
Q 013214 306 KEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR-QRP----------- 372 (447)
Q Consensus 306 ~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~-~~~----------- 372 (447)
......+....|-.|.|||++.+. .|+...||||.||++.||+.++..|...++.+..+.+... +.|
T Consensus 209 d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEG 288 (449)
T KOG0664|consen 209 RDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEG 288 (449)
T ss_pred hhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhh
Confidence 555555555568889999999875 7889999999999999999999999877765544433111 111
Q ss_pred -------------CCCC-----ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHH
Q 013214 373 -------------PFKA-----PAKLYARGLKELIEECWNEKPAKRPTFRQIITRL 410 (447)
Q Consensus 373 -------------~~~~-----~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l 410 (447)
.++. .+..-..+...++..++..||++|.+..+.+.++
T Consensus 289 Ak~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 289 AKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred hHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 1110 0112233566788899999999999999988765
No 395
>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]
Probab=99.97 E-value=3.8e-30 Score=237.04 Aligned_cols=255 Identities=23% Similarity=0.368 Sum_probs=209.7
Q ss_pred CcccceeeecceEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeC-Cc
Q 013214 156 DFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS-SP 224 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~ 224 (447)
+++....+-+|+||.++. +.+.|-+|.++.. .++-+...+..|.-.+....|||+.++.+++..+ ..
T Consensus 285 Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~--AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~ 362 (563)
T KOG1024|consen 285 RVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH--ASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYAT 362 (563)
T ss_pred heechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc--ccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCc
Confidence 344555678899998763 2456777877654 3455667788899899999999999999987654 56
Q ss_pred eEEEEeccCCCCHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEee
Q 013214 225 MMIVTEYLPKGDLRAFLKRK--------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296 (447)
Q Consensus 225 ~~lv~e~~~~g~L~~~l~~~--------~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~D 296 (447)
.+.++.++.-|+|..++... ..++..+...++.|++.|+.|||+++ ++|.||..+|.+|++.-++||+|
T Consensus 363 P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~LqVkltD 439 (563)
T KOG1024|consen 363 PFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQLQVKLTD 439 (563)
T ss_pred ceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhheeEEecc
Confidence 78899999999999999732 12667788889999999999999999 99999999999999999999999
Q ss_pred cccccccccCCCCCc-ccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCC
Q 013214 297 FGVSKLLTVKEDRPL-TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPF 374 (447)
Q Consensus 297 fg~~~~~~~~~~~~~-~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~ 374 (447)
=.+++.+-....... ...-.+..||+||.+....|+..+|+||||+++|||+| |+.||..-++.|....+..+.+..-
T Consensus 440 saLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGyRlaQ 519 (563)
T KOG1024|consen 440 SALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGYRLAQ 519 (563)
T ss_pred chhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccceecC
Confidence 999987643322111 22234778999999999999999999999999999999 9999999999998877766665543
Q ss_pred CCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhh
Q 013214 375 KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSIN 418 (447)
Q Consensus 375 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~~~ 418 (447)
|-++|+++-.+|.-||+.+|++||+++++..-|.+...++.
T Consensus 520 ---P~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~qlt 560 (563)
T KOG1024|consen 520 ---PFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQLT 560 (563)
T ss_pred ---CCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHHHh
Confidence 45788999999999999999999999999999998877654
No 396
>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]
Probab=99.97 E-value=2.3e-30 Score=233.19 Aligned_cols=247 Identities=26% Similarity=0.361 Sum_probs=191.6
Q ss_pred CcCcccceeeecceEEEEE----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeC------C
Q 013214 154 ELDFTNSVEITKGTFILAF----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS------S 223 (447)
Q Consensus 154 ~~~~~~~~~lg~G~~~~~~----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~------~ 223 (447)
..+|...+.+|.|.-..+. ..+++||+|++..+.. ....-++..+|..++..++|+||++++.+|.-. .
T Consensus 16 ~~Ry~nL~p~~~g~~~v~~a~D~v~~~~v~ikk~~~pf~-n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQIVVAAFDQVLGRPVAIKKLSRPFQ-NQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCceEEecchhhccCceehhhhcCccc-cCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 3456666677777663222 4689999999877633 333334556799999999999999999998644 3
Q ss_pred ceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeeccccccc
Q 013214 224 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (447)
Q Consensus 224 ~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~ 303 (447)
..|+|||+| ..+|...+. -.++-.+...++.|++.|++|||+.| |+||||||+||++..++.+|+.|||+++..
T Consensus 95 e~y~v~e~m-~~nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar~e 168 (369)
T KOG0665|consen 95 EVYLVMELM-DANLCQVIL--MELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLARTE 168 (369)
T ss_pred hHHHHHHhh-hhHHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhccc
Confidence 479999999 579988887 45778899999999999999999999 999999999999999999999999999864
Q ss_pred ccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHH-hcCC-----------
Q 013214 304 TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYA-ARQR----------- 371 (447)
Q Consensus 304 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~-~~~~----------- 371 (447)
... ...+.+..|..|.|||++.+..+.+.+||||+||++.||++|+..|.+.+.-+...++. .-+.
T Consensus 169 ~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~ 246 (369)
T KOG0665|consen 169 DTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQP 246 (369)
T ss_pred Ccc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhH
Confidence 432 34466778889999999999889999999999999999999999998765422211110 0000
Q ss_pred ---------CC---------CC--------CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 372 ---------PP---------FK--------APAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 372 ---------~~---------~~--------~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
+. ++ ...+.-+..+++++.+||..||++|.|+.+++.|
T Consensus 247 ~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 247 TVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred HHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 00 00 0111234568899999999999999999999875
No 397
>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]
Probab=99.96 E-value=1.3e-29 Score=218.17 Aligned_cols=241 Identities=20% Similarity=0.392 Sum_probs=187.0
Q ss_pred cCcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC-CCcccceeEEEEeC--CceE
Q 013214 155 LDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQS--SPMM 226 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~--~~~~ 226 (447)
.+|++.+++|+|.++.|+ .+.+.++||+++.- ....+.+|+.+|+.+. ||||+++++...++ ....
T Consensus 38 ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV------kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktpa 111 (338)
T KOG0668|consen 38 DDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV------KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPS 111 (338)
T ss_pred chHHHHHHHcCccHhhHhcccccCCCceEEEeeechH------HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCch
Confidence 468888999999997664 57889999999743 2367889999999995 99999999988654 5678
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcC-CCCEEEeeccccccccc
Q 013214 227 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD-SGNLKVADFGVSKLLTV 305 (447)
Q Consensus 227 lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~-~~~vkl~Dfg~~~~~~~ 305 (447)
+++||+++.+....- ..++...+..++.+++.||.||||.| |.|||+||.|++||. .-.++|+|+|+|.++..
T Consensus 112 LiFE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp 185 (338)
T KOG0668|consen 112 LIFEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 185 (338)
T ss_pred hHhhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhcCC
Confidence 999999877766544 34788889999999999999999999 999999999999994 45699999999999875
Q ss_pred CCCCCcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCC-CCCCchHHHHHhc--------------
Q 013214 306 KEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTM-KHDNEVPKAYAAR-------------- 369 (447)
Q Consensus 306 ~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~tg~~p~~~-~~~~~~~~~~~~~-------------- 369 (447)
.. .......+..|.-||.+.. +.|+.+-|+|||||++..|+..+.||-. .++.+....+...
T Consensus 186 ~~--eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~ 263 (338)
T KOG0668|consen 186 GK--EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQ 263 (338)
T ss_pred Cc--eeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHc
Confidence 43 2333445667889998765 4688999999999999999998888753 3332222221110
Q ss_pred --CCCCCC-----------------CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 370 --QRPPFK-----------------APAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 370 --~~~~~~-----------------~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
-.|.+. .....++++..+++.++|..|-++|+|++|.+.+
T Consensus 264 i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 264 IDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred cCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 001110 1112356899999999999999999999998864
No 398
>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]
Probab=99.96 E-value=1.9e-30 Score=253.29 Aligned_cols=246 Identities=26% Similarity=0.421 Sum_probs=208.4
Q ss_pred CcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|.....+|+|++|-|+ .+++..|+|+++.+ ..+...-++.|+-+++-.+||||+.+++.+.....++++||
T Consensus 16 dyellqrvgsgTygdvyKaRd~~s~elaavkvVkLe---p~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME 92 (829)
T KOG0576|consen 16 DYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLE---PGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME 92 (829)
T ss_pred chhheeeecCCcccchhhhcccccCchhhheeeecc---CCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence 45666789999999886 36889999999865 33445667789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCC
Q 013214 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (447)
Q Consensus 231 ~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~ 310 (447)
||.||+|++.-+-.+++++.++..+.+..+++++|||+.| =+|||||=.||++++.|.+|++|||.+..+...- ..
T Consensus 93 ycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitati-~K 168 (829)
T KOG0576|consen 93 YCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITATI-AK 168 (829)
T ss_pred ecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhhh-hh
Confidence 9999999998888899999999999999999999999999 7999999999999999999999999987665432 22
Q ss_pred cccCCCCCcccCCccc---CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHh-cCCCCCCCChhhhHHHHH
Q 013214 311 LTCQDTSCRYVAPEVF---KNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA-RQRPPFKAPAKLYARGLK 386 (447)
Q Consensus 311 ~~~~~~t~~y~aPE~~---~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~ 386 (447)
...+.||+.|||||+- +.+.|+..+|+|++|++..|+-.-++|..+..+.+.....-. ...++-......+++.+.
T Consensus 169 rksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~fh 248 (829)
T KOG0576|consen 169 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEFFH 248 (829)
T ss_pred hhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchHHHH
Confidence 3567899999999975 456789999999999999999888888666555554444322 235555556677899999
Q ss_pred HHHHHHcccCCCCCCCHHHHHH
Q 013214 387 ELIEECWNEKPAKRPTFRQIIT 408 (447)
Q Consensus 387 ~li~~cl~~dp~~Rps~~~~l~ 408 (447)
++++.++..+|++||+++.++.
T Consensus 249 ~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 249 NFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred HHHHHHhcCCCccCCChhhhee
Confidence 9999999999999999998876
No 399
>cd00180 PKc Catalytic domain of Protein Kinases. Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which
Probab=99.96 E-value=1.2e-27 Score=215.17 Aligned_cols=206 Identities=37% Similarity=0.650 Sum_probs=176.0
Q ss_pred eecceEEEEE---Ec--CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEeccCCCCH
Q 013214 163 ITKGTFILAF---WR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237 (447)
Q Consensus 163 lg~G~~~~~~---~~--g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L 237 (447)
||+|.+|.++ .. |+.+++|+........ ..+.+.+|+..++.++|++++++++++......++++||+.+++|
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l 78 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSL 78 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh--HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcH
Confidence 4677776554 33 8999999987553211 456788999999999999999999999998999999999998999
Q ss_pred HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcC-CCCEEEeecccccccccCCCCCcccCC
Q 013214 238 RAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD-SGNLKVADFGVSKLLTVKEDRPLTCQD 315 (447)
Q Consensus 238 ~~~l~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~-~~~vkl~Dfg~~~~~~~~~~~~~~~~~ 315 (447)
.+++... ..++...++.++.+++.++.+||+.+ ++|+||+|.||+++. ++.++|+|||.+........ ......
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~ 154 (215)
T cd00180 79 KDLLKENEGKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIV 154 (215)
T ss_pred HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhccc
Confidence 9999875 56899999999999999999999998 999999999999999 89999999999876543321 122344
Q ss_pred CCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHHHHHcc
Q 013214 316 TSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWN 394 (447)
Q Consensus 316 ~t~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 394 (447)
+...|++||.+... ..+.++|+|++|++++++ ..+.+++..|++
T Consensus 155 ~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-----------------------------------~~~~~~l~~~l~ 199 (215)
T cd00180 155 GTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-----------------------------------PELKDLIRKMLQ 199 (215)
T ss_pred CCCCccChhHhcccCCCCchhhhHHHHHHHHHH-----------------------------------HHHHHHHHHHhh
Confidence 67789999999877 778899999999999999 567899999999
Q ss_pred cCCCCCCCHHHHHHH
Q 013214 395 EKPAKRPTFRQIITR 409 (447)
Q Consensus 395 ~dp~~Rps~~~~l~~ 409 (447)
.||.+||++.+++++
T Consensus 200 ~~p~~R~~~~~l~~~ 214 (215)
T cd00180 200 KDPEKRPSAKEILEH 214 (215)
T ss_pred CCcccCcCHHHHhhC
Confidence 999999999999875
No 400
>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]
Probab=99.95 E-value=9.3e-29 Score=237.86 Aligned_cols=195 Identities=24% Similarity=0.394 Sum_probs=170.3
Q ss_pred CcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHH-----HHHHHHHHhcCC---CCcccceeEEEEeC
Q 013214 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRA-----FRDELALLQKIR---HPNVVQFLGAVTQS 222 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~-----~~~E~~~l~~l~---hp~iv~~~~~~~~~ 222 (447)
+|...+.+|+|+||.|. .+...|++|.+.++.+-.+..+++ .-.|+++|..++ |+||++++++|+++
T Consensus 562 ~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEdd 641 (772)
T KOG1152|consen 562 DYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDD 641 (772)
T ss_pred cceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecC
Confidence 58888899999999874 356789999998876544443332 446999999996 99999999999999
Q ss_pred CceEEEEecc-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeeccccc
Q 013214 223 SPMMIVTEYL-PKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK 301 (447)
Q Consensus 223 ~~~~lv~e~~-~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~ 301 (447)
+..||+||-- +|-+|.+++...+.+++.++..|++|++.|+++||+.| |+|||||-+|+.++.+|-+||+|||++.
T Consensus 642 d~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidfgsaa 718 (772)
T KOG1152|consen 642 DYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDFGSAA 718 (772)
T ss_pred CeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeeccchh
Confidence 9999999986 45699999999999999999999999999999999999 9999999999999999999999999987
Q ss_pred ccccCCCCCcccCCCCCcccCCcccCCCCCC-CchhHHHHHHHHHHHHhCCCCCCC
Q 013214 302 LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYD-TKVDVFSFALILQEMIEGCPPFTM 356 (447)
Q Consensus 302 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~~l~~l~tg~~p~~~ 356 (447)
... +.+...+.||..|.|||++.+.+|- ..-|||++|+++|.+...+.||..
T Consensus 719 ~~k---sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 719 YTK---SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred hhc---CCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 654 3455667899999999999988765 468999999999999999999864
No 401
>smart00221 STYKc Protein kinase; unclassified specificity. Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.
Probab=99.95 E-value=5.7e-27 Score=213.79 Aligned_cols=199 Identities=33% Similarity=0.564 Sum_probs=168.1
Q ss_pred cccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEec
Q 013214 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (447)
Q Consensus 157 ~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 231 (447)
|.....||.|+++.++. +++.+|+|.+...... ...+.+.+|+..++.++|+|++++++++......++++||
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~ 78 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEY 78 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEec
Confidence 34567889999887652 4789999999765322 2567888999999999999999999999998999999999
Q ss_pred cCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCC
Q 013214 232 LPKGDLRAFLKRKGA-LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (447)
Q Consensus 232 ~~~g~L~~~l~~~~~-l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~ 310 (447)
+++++|.+++..... +++.....++.+++.++.+||+.+ ++|+|++|.||+++.++.++|+|||.+..........
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~ 155 (225)
T smart00221 79 CEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAAL 155 (225)
T ss_pred cCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccc
Confidence 999999999988766 899999999999999999999998 9999999999999999999999999988765432112
Q ss_pred cccCCCCCcccCCccc-CCCCCCCchhHHHHHHHHHHHHhCCCCCCC-CCCC
Q 013214 311 LTCQDTSCRYVAPEVF-KNEEYDTKVDVFSFALILQEMIEGCPPFTM-KHDN 360 (447)
Q Consensus 311 ~~~~~~t~~y~aPE~~-~~~~~~~~~Di~slG~~l~~l~tg~~p~~~-~~~~ 360 (447)
.....++..|++||.+ ....++.++|+|+||+++++|++|+.||.. .++.
T Consensus 156 ~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~ 207 (225)
T smart00221 156 LKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFT 207 (225)
T ss_pred ccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhH
Confidence 2334567789999998 666778899999999999999999999976 4443
No 402
>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]
Probab=99.95 E-value=3.2e-28 Score=214.53 Aligned_cols=252 Identities=18% Similarity=0.322 Sum_probs=191.7
Q ss_pred CCCcccCCCCc--CcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCccccee
Q 013214 145 VPEYEIDPHEL--DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFL 216 (447)
Q Consensus 145 ~~~~~i~~~~~--~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~ 216 (447)
++..++...++ .|.+.+.+|+|.||... .+.+.+++|.++.+ .....+|.+|...--.+ .|.||+..|
T Consensus 12 I~~~el~kv~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p----~tt~~dF~rEfhY~~~Ls~H~hIi~tY 87 (378)
T KOG1345|consen 12 IPMEELKKVDLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP----QTTQADFVREFHYSFFLSPHQHIIDTY 87 (378)
T ss_pred cccccccccchhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc----hhhHHHHHHHhccceeeccchhhhHHH
Confidence 45555554443 58888899999999764 46789999998754 34567899999876666 589999887
Q ss_pred EE-EEeCCceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcC--CCCEE
Q 013214 217 GA-VTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD--SGNLK 293 (447)
Q Consensus 217 ~~-~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~--~~~vk 293 (447)
+. |+..+..++++||++.|+|.+-+.. ..+.+.....++.|+++|+.|||+++ +||||||.+||||-. ..++|
T Consensus 88 ~vaFqt~d~YvF~qE~aP~gdL~snv~~-~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvK 163 (378)
T KOG1345|consen 88 EVAFQTSDAYVFVQEFAPRGDLRSNVEA-AGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVK 163 (378)
T ss_pred HHHhhcCceEEEeeccCccchhhhhcCc-ccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEE
Confidence 64 6777888999999999999987754 34778888999999999999999999 999999999999863 34899
Q ss_pred EeecccccccccCCCCCcccCCCCCcccCCcccCC---C--CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCch----HH
Q 013214 294 VADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN---E--EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV----PK 364 (447)
Q Consensus 294 l~Dfg~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~---~--~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~----~~ 364 (447)
|||||.++..+..... ..-+..|.+||.... + ...+.+|+|.||+++|.++||++||+....... ..
T Consensus 164 lcDFG~t~k~g~tV~~----~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~ 239 (378)
T KOG1345|consen 164 LCDFGLTRKVGTTVKY----LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWE 239 (378)
T ss_pred eeecccccccCceehh----hhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHH
Confidence 9999998865432211 123566889987532 2 567889999999999999999999985443221 12
Q ss_pred HHHhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHH
Q 013214 365 AYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIIT 408 (447)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~ 408 (447)
....+..+..+......++.+..+.++-+..+|++|-...+..+
T Consensus 240 ~w~~rk~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk 283 (378)
T KOG1345|consen 240 QWLKRKNPALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKK 283 (378)
T ss_pred HHhcccCccCchhhcccCHHHHHHHHHhcCCcccccchhHHHHH
Confidence 22233355555566678889999999999999999944444433
No 403
>smart00750 KIND kinase non-catalytic C-lobe domain. It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features
Probab=99.95 E-value=1.2e-26 Score=204.10 Aligned_cols=165 Identities=18% Similarity=0.280 Sum_probs=131.3
Q ss_pred CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCCccc
Q 013214 235 GDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTC 313 (447)
Q Consensus 235 g~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~ 313 (447)
|+|.+++.++ ..+++.+++.++.|++.||.|||+.+ ||+||+++.++.+|+ ||++...... .
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~------~ 63 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPE------Q 63 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeeccc------c
Confidence 6899999874 45999999999999999999999875 999999999999999 9998765432 1
Q ss_pred CCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCc-hHHHHHhcCCCC---CCCChhhhHH--HHHH
Q 013214 314 QDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNE-VPKAYAARQRPP---FKAPAKLYAR--GLKE 387 (447)
Q Consensus 314 ~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~-~~~~~~~~~~~~---~~~~~~~~~~--~l~~ 387 (447)
..+|+.|+|||++.+..++.++|||||||++|+|++|+.||....... ....+.....+. -......++. .+.+
T Consensus 64 ~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 143 (176)
T smart00750 64 SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFAD 143 (176)
T ss_pred CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHH
Confidence 246899999999999999999999999999999999999997654322 222222221111 1112334454 6999
Q ss_pred HHHHHcccCCCCCCCHHHHHHHHHHHHhh
Q 013214 388 LIEECWNEKPAKRPTFRQIITRLESINNS 416 (447)
Q Consensus 388 li~~cl~~dp~~Rps~~~~l~~l~~~~~~ 416 (447)
+|.+||+.||.+||++.++++++..+..+
T Consensus 144 ~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~ 172 (176)
T smart00750 144 FMRVCASRLPQRREAANHYLAHCRALFAE 172 (176)
T ss_pred HHHHHHhcccccccCHHHHHHHHHHHHHH
Confidence 99999999999999999999998776543
No 404
>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=99.94 E-value=2.2e-26 Score=217.80 Aligned_cols=129 Identities=29% Similarity=0.380 Sum_probs=107.0
Q ss_pred CCCcCcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC-----CC---cccceeEE
Q 013214 152 PHELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-----HP---NVVQFLGA 218 (447)
Q Consensus 152 ~~~~~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----hp---~iv~~~~~ 218 (447)
+...+|...++||.|-|++|. ...+.||+|+.+. .+-..+....|+.+|+++. |+ +||++++.
T Consensus 75 F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKS----AqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~ 150 (590)
T KOG1290|consen 75 FNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKS----AQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDH 150 (590)
T ss_pred ccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEeh----hhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeecc
Confidence 334578999999999998875 3568999999873 2334566678999999983 33 59999999
Q ss_pred EEeC----CceEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEc
Q 013214 219 VTQS----SPMMIVTEYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD 287 (447)
Q Consensus 219 ~~~~----~~~~lv~e~~~~g~L~~~l~~~--~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~ 287 (447)
|... .++|+|+|++ |.+|..++... +.++...+..|++|++.||.|||+.. +|||-||||+|||+.
T Consensus 151 FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 151 FKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLC 222 (590)
T ss_pred ceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeee
Confidence 9753 5799999999 78999999865 45999999999999999999999976 599999999999984
No 405
>PLN00181 protein SPA1-RELATED; Provisional
Probab=99.94 E-value=1.7e-27 Score=256.25 Aligned_cols=195 Identities=16% Similarity=0.209 Sum_probs=140.6
Q ss_pred cCCC-CcccceeEEE-------EeCCceEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEe
Q 013214 206 KIRH-PNVVQFLGAV-------TQSSPMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIH 276 (447)
Q Consensus 206 ~l~h-p~iv~~~~~~-------~~~~~~~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H 276 (447)
.++| +||++++++| .....++.++||+ +++|.+++... ..+++.++..++.||+.||.|||++| |+|
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g---IvH 103 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQG---IVV 103 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCC---eee
Confidence 3445 5777777776 2334678889988 67999999753 45999999999999999999999999 999
Q ss_pred CCCCCCCEEEcCCC-------------------CEEEeecccccccccCCC---------------CCcccCCCCCcccC
Q 013214 277 RDLEPSNILRDDSG-------------------NLKVADFGVSKLLTVKED---------------RPLTCQDTSCRYVA 322 (447)
Q Consensus 277 ~Dikp~Nill~~~~-------------------~vkl~Dfg~~~~~~~~~~---------------~~~~~~~~t~~y~a 322 (447)
|||||+|||++..+ .+|++|||+++....... .......+|+.|+|
T Consensus 104 rDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A 183 (793)
T PLN00181 104 HNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTS 183 (793)
T ss_pred ccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEC
Confidence 99999999996544 455666666543211000 00011347888999
Q ss_pred CcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCC
Q 013214 323 PEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPT 402 (447)
Q Consensus 323 PE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps 402 (447)
||++.+..++.++|||||||++|||++|..|+.... .....+.....++. .....+...+++.+||+.+|.+||+
T Consensus 184 PE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~L~~~P~~Rps 258 (793)
T PLN00181 184 PEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRVLPPQ---ILLNWPKEASFCLWLLHPEPSCRPS 258 (793)
T ss_pred hhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhhcChh---hhhcCHHHHHHHHHhCCCChhhCcC
Confidence 999999899999999999999999999988865322 11112211111111 1111345668889999999999999
Q ss_pred HHHHHHH
Q 013214 403 FRQIITR 409 (447)
Q Consensus 403 ~~~~l~~ 409 (447)
+.+++++
T Consensus 259 ~~eil~h 265 (793)
T PLN00181 259 MSELLQS 265 (793)
T ss_pred hHHHhhc
Confidence 9999864
No 406
>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]
Probab=99.94 E-value=1.3e-25 Score=203.53 Aligned_cols=258 Identities=15% Similarity=0.254 Sum_probs=213.5
Q ss_pred CCcCcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeEEEEeCCceE
Q 013214 153 HELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMM 226 (447)
Q Consensus 153 ~~~~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~ 226 (447)
.-..|.++++||+|+||..+ .++++||||.-+.... ..++..|....+.+ ..++|+..|-+.....+..
T Consensus 26 VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~-----APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~Ni 100 (449)
T KOG1165|consen 26 VGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE-----APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNI 100 (449)
T ss_pred ecccceeccccccCcceeeecccccccCceEEEEeccccCC-----cchHHHHHHHHHHHcCCCCCCceeeeccccchhh
Confidence 34579999999999998754 6899999997764432 24677899999988 5899999999888888889
Q ss_pred EEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCC-----CEEEeecccc
Q 013214 227 IVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG-----NLKVADFGVS 300 (447)
Q Consensus 227 lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~-----~vkl~Dfg~~ 300 (447)
||+|++ |.||+|++.-. +.++..++..++.|++.-++++|++. +|.|||||+|+||...+ .|.++|||++
T Consensus 101 LVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmA 176 (449)
T KOG1165|consen 101 LVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMA 176 (449)
T ss_pred hhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccch
Confidence 999999 88999998744 56999999999999999999999999 99999999999998654 4899999999
Q ss_pred cccccCCCCC------cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcC----
Q 013214 301 KLLTVKEDRP------LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ---- 370 (447)
Q Consensus 301 ~~~~~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~---- 370 (447)
+.+..+.... ..+..||.+||+-..+.+...+.+.|+-|||-++.+.+.|..||.+..-....+....-+
T Consensus 177 K~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr 256 (449)
T KOG1165|consen 177 KEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKR 256 (449)
T ss_pred hhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccc
Confidence 9876543322 245679999999999999999999999999999999999999999877655444432222
Q ss_pred CCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhhc
Q 013214 371 RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINH 419 (447)
Q Consensus 371 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~~~~ 419 (447)
..++...+.++|.++...++-.-..+-.+-|..+-+...+.++......
T Consensus 257 ~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g~ 305 (449)
T KOG1165|consen 257 STPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLGE 305 (449)
T ss_pred cCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcCC
Confidence 2233334567889999999998899999999999999999888877643
No 407
>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]
Probab=99.93 E-value=5.3e-26 Score=212.38 Aligned_cols=244 Identities=21% Similarity=0.360 Sum_probs=186.6
Q ss_pred cCcccceeeecceEEEEEE--------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeEEEEeCCce
Q 013214 155 LDFTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPM 225 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~ 225 (447)
..|....+||+|+|+.|+. ..+.||+|.+..... . ..+.+|+++|..+ .+.||+++.+++..++..
T Consensus 36 ~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~--p---~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v 110 (418)
T KOG1167|consen 36 NAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS--P---SRILNELEMLYRLGGSDNIIKLNGCFRNNDQV 110 (418)
T ss_pred hhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC--c---hHHHHHHHHHHHhccchhhhcchhhhccCCee
Confidence 3567778999999998862 578999999875432 2 4578899999999 699999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEc-CCCCEEEeecccccccc
Q 013214 226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVADFGVSKLLT 304 (447)
Q Consensus 226 ~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~-~~~~vkl~Dfg~~~~~~ 304 (447)
++|+||++.....++... ++..++..+++.++.||.++|.+| |+||||||+|++.+ ..+.-.|+|||++....
T Consensus 111 ~ivlp~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d 184 (418)
T KOG1167|consen 111 AIVLPYFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYD 184 (418)
T ss_pred EEEecccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechhHHHHH
Confidence 999999998888887754 678899999999999999999999 99999999999998 56778999999987221
Q ss_pred cCC--------------C-----------------------------CCcccCCCCCcccCCcccCC-CCCCCchhHHHH
Q 013214 305 VKE--------------D-----------------------------RPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSF 340 (447)
Q Consensus 305 ~~~--------------~-----------------------------~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~sl 340 (447)
... . .......||++|.|||++.. +..+++.||||.
T Consensus 185 ~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~ 264 (418)
T KOG1167|consen 185 GYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSA 264 (418)
T ss_pred hhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeec
Confidence 000 0 00023458999999999765 467789999999
Q ss_pred HHHHHHHHhCCCCCCCCCCCc--------------hHHHHHhcCC------------------------CCCC-------
Q 013214 341 ALILQEMIEGCPPFTMKHDNE--------------VPKAYAARQR------------------------PPFK------- 375 (447)
Q Consensus 341 G~~l~~l~tg~~p~~~~~~~~--------------~~~~~~~~~~------------------------~~~~------- 375 (447)
|+++..+++++.||-.....- +.+.-...++ ..+.
T Consensus 265 GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~ 344 (418)
T KOG1167|consen 265 GVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNT 344 (418)
T ss_pred cceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccce
Confidence 999999999999985433210 0000000000 0000
Q ss_pred ---CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 376 ---APAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 376 ---~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
.....++..+-+++++|+..||.+|.|+++.+++
T Consensus 345 ~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 345 EREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred eeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 0011234578899999999999999999999875
No 408
>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]
Probab=99.92 E-value=2.9e-24 Score=186.69 Aligned_cols=259 Identities=17% Similarity=0.228 Sum_probs=208.0
Q ss_pred cCcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC-CCcccceeEEEEeCCceEEE
Q 013214 155 LDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIV 228 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~lv 228 (447)
..|...++||+|+||-.+ .+|+.||+|.-+..... .++.-|..+.+.++ ...|+.+..+..+...-.+|
T Consensus 15 gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h-----pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlV 89 (341)
T KOG1163|consen 15 GKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH-----PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLV 89 (341)
T ss_pred cceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC-----cchhHHHHHHHHhccCCCCchhhhhccccccceee
Confidence 468889999999998655 58999999987654432 35667889999995 56788888888888889999
Q ss_pred EeccCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcC---CCCEEEeecccccccc
Q 013214 229 TEYLPKGDLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD---SGNLKVADFGVSKLLT 304 (447)
Q Consensus 229 ~e~~~~g~L~~~l~-~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~---~~~vkl~Dfg~~~~~~ 304 (447)
||.+ |.+|++.+. ..+.++..+++-++-|++.-++|+|.++ ++||||||+|+|+.- ...+.++|||+|+.+.
T Consensus 90 MdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~ 165 (341)
T KOG1163|consen 90 MDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR 165 (341)
T ss_pred eecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhhc
Confidence 9999 889999886 3466999999999999999999999999 999999999999873 3469999999998764
Q ss_pred cCCCC------CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHH---HHhcC-CCCC
Q 013214 305 VKEDR------PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKA---YAARQ-RPPF 374 (447)
Q Consensus 305 ~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~---~~~~~-~~~~ 374 (447)
..... ......||.+|.+-....+-..+.+.|+-|+|.++.++..|..||++.......+. +.... ..+.
T Consensus 166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~i 245 (341)
T KOG1163|consen 166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPI 245 (341)
T ss_pred cccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCH
Confidence 32211 12345689999998888777788999999999999999999999998876543333 22221 2222
Q ss_pred CCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhhcccc
Q 013214 375 KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINHKRR 422 (447)
Q Consensus 375 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~~~~~~~ 422 (447)
...+..+|.++.-.+.-|-..--++-|....+.+.+..+....+....
T Consensus 246 e~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln~~~d 293 (341)
T KOG1163|consen 246 EVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLNHQYD 293 (341)
T ss_pred HHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhccccCC
Confidence 234556788999999999999999999999999999999988877643
No 409
>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]
Probab=99.92 E-value=1.4e-23 Score=202.34 Aligned_cols=255 Identities=20% Similarity=0.307 Sum_probs=197.3
Q ss_pred CcccceeeecceEEEEEE----c--CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC----CCcccceeEEE-EeCCc
Q 013214 156 DFTNSVEITKGTFILAFW----R--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR----HPNVVQFLGAV-TQSSP 224 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~----~--g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~----hp~iv~~~~~~-~~~~~ 224 (447)
+|...+.||+|+||.++. . ...+|+|.......... ..+..|..++..+. .+++.++++.. .....
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~---~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~ 95 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP---SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF 95 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC---ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence 788999999999998873 1 24789998765422111 14667888888886 26899999998 47778
Q ss_pred eEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCC-----CCEEEeec
Q 013214 225 MMIVTEYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS-----GNLKVADF 297 (447)
Q Consensus 225 ~~lv~e~~~~g~L~~~l~~~--~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~-----~~vkl~Df 297 (447)
.++||+.+ |.+|.++.... +.++..++..++.|++.+|.++|+.| ++||||||+|+++... ..++|.||
T Consensus 96 ~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDf 171 (322)
T KOG1164|consen 96 NFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDF 171 (322)
T ss_pred eEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEec
Confidence 89999999 88999988654 46999999999999999999999999 9999999999999865 35999999
Q ss_pred ccccccc--cCC------CCC-cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHh
Q 013214 298 GVSKLLT--VKE------DRP-LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA 368 (447)
Q Consensus 298 g~~~~~~--~~~------~~~-~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~ 368 (447)
|+++... ... ... .....||.+|.++..+.+...+++.|+||++.++.++..|..||..............
T Consensus 172 Glar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~ 251 (322)
T KOG1164|consen 172 GLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEK 251 (322)
T ss_pred CCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHH
Confidence 9998322 111 111 1235589999999999999999999999999999999999999987665433333322
Q ss_pred cCCCCCCC-ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhh
Q 013214 369 RQRPPFKA-PAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSI 417 (447)
Q Consensus 369 ~~~~~~~~-~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~~ 417 (447)
........ .....+.++.++...+-..+...+|....+...++......
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 252 DPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred HhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 22111111 12334577888888888899999999999999988876654
No 410
>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]
Probab=99.89 E-value=1e-21 Score=188.75 Aligned_cols=250 Identities=27% Similarity=0.460 Sum_probs=198.2
Q ss_pred cccceeeecceEEEEEE--cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCC-cccceeEEEEeCCceEEEEeccC
Q 013214 157 FTNSVEITKGTFILAFW--RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP-NVVQFLGAVTQSSPMMIVTEYLP 233 (447)
Q Consensus 157 ~~~~~~lg~G~~~~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp-~iv~~~~~~~~~~~~~lv~e~~~ 233 (447)
|.....||.|+|+.++. ....+++|.+.............+.+|..++..+.|+ +++++.+.+......+++++++.
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 81 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVD 81 (384)
T ss_pred ceeEEeecCCCCeEEEEEEeccEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCC
Confidence 45667899999987763 2367899999876554444677889999999999888 79999999977777899999999
Q ss_pred CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCC-CEEEeecccccccccCCCC
Q 013214 234 KGDLRAFLKRKG---ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG-NLKVADFGVSKLLTVKEDR 309 (447)
Q Consensus 234 ~g~L~~~l~~~~---~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~-~vkl~Dfg~~~~~~~~~~~ 309 (447)
++++.+++.... .++......++.|++.++.|+|+.+ ++|||+||+||+++..+ .++++|||.+.........
T Consensus 82 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 158 (384)
T COG0515 82 GGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST 158 (384)
T ss_pred CCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence 999998877665 7899999999999999999999999 99999999999999988 6999999998755433221
Q ss_pred -----CcccCCCCCcccCCcccCC---CCCCCchhHHHHHHHHHHHHhCCCCCCCCCC----CchHHHHHhcCCC-CCCC
Q 013214 310 -----PLTCQDTSCRYVAPEVFKN---EEYDTKVDVFSFALILQEMIEGCPPFTMKHD----NEVPKAYAARQRP-PFKA 376 (447)
Q Consensus 310 -----~~~~~~~t~~y~aPE~~~~---~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~----~~~~~~~~~~~~~-~~~~ 376 (447)
......++..|++||.+.+ ...+...|+||+|++++++++|..||..... ......+.....+ ....
T Consensus 159 ~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (384)
T COG0515 159 SSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASP 238 (384)
T ss_pred ccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccccc
Confidence 2355678999999999987 5788899999999999999999999876664 2333333222222 1111
Q ss_pred Chh----hhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 377 PAK----LYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 377 ~~~----~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
... .....+.+++..++..+|..|.+..+....
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 239 LSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred cCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 111 113578899999999999999999887765
No 411
>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]
Probab=99.89 E-value=2.3e-24 Score=220.95 Aligned_cols=246 Identities=26% Similarity=0.371 Sum_probs=185.2
Q ss_pred cceeeecceEEEEEE-----cCeEEEEEEcCc---ccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 159 NSVEITKGTFILAFW-----RGIQVAVKKLGE---EVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 159 ~~~~lg~G~~~~~~~-----~g~~vavK~~~~---~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
..+.+|.|.+|.++. ....++.|.... ...........+..|+.+-..++|||++.....+.+.....-.||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 455778888883331 122233332221 111122222236678888888999999887777666555555699
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCC--
Q 013214 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED-- 308 (447)
Q Consensus 231 ~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~-- 308 (447)
||++ +|..++.+.+.+...++..++.|++.|+.|+|+.| +.|||+|++|+++..+|.+||+|||.+.....+-.
T Consensus 402 ~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~ 477 (601)
T KOG0590|consen 402 YCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKN 477 (601)
T ss_pred cccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccCcchh
Confidence 9998 99999998888999999999999999999999999 99999999999999999999999999876554332
Q ss_pred -CCcccCCCCCcccCCcccCCCCCCC-chhHHHHHHHHHHHHhCCCCCCCCCCCchH--HHHHhcCC---CCCCCChhhh
Q 013214 309 -RPLTCQDTSCRYVAPEVFKNEEYDT-KVDVFSFALILQEMIEGCPPFTMKHDNEVP--KAYAARQR---PPFKAPAKLY 381 (447)
Q Consensus 309 -~~~~~~~~t~~y~aPE~~~~~~~~~-~~Di~slG~~l~~l~tg~~p~~~~~~~~~~--~~~~~~~~---~~~~~~~~~~ 381 (447)
.......|+..|+|||.+.+..|++ ..||||.|+++..|.+|+.||......+.. ......++ .........+
T Consensus 478 ~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 557 (601)
T KOG0590|consen 478 IHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSLL 557 (601)
T ss_pred hhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHHhc
Confidence 2335567899999999999999987 589999999999999999999866654432 11111111 1111234567
Q ss_pred HHHHHHHHHHHcccCCCCCCCHHHHHH
Q 013214 382 ARGLKELIEECWNEKPAKRPTFRQIIT 408 (447)
Q Consensus 382 ~~~l~~li~~cl~~dp~~Rps~~~~l~ 408 (447)
+...+.+|.+||+.||.+|.|+++|++
T Consensus 558 p~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 558 PRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred hhhHHHHHHHHccCChhheecHHHHhh
Confidence 788999999999999999999999987
No 412
>PRK09188 serine/threonine protein kinase; Provisional
Probab=99.89 E-value=1.8e-22 Score=194.60 Aligned_cols=168 Identities=21% Similarity=0.227 Sum_probs=126.7
Q ss_pred cccCCCCcCcccceeeecceEEEEEE------cCeEEEEEEcCcccC--CCHHHHHHHHHHHHHHhcCCCCcccc-eeEE
Q 013214 148 YEIDPHELDFTNSVEITKGTFILAFW------RGIQVAVKKLGEEVI--SDDDRVRAFRDELALLQKIRHPNVVQ-FLGA 218 (447)
Q Consensus 148 ~~i~~~~~~~~~~~~lg~G~~~~~~~------~g~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~-~~~~ 218 (447)
..+.+...+|...+.||+|+||.|+. +++.||||++..... ......+.+.+|++++++++|+|+++ +++.
T Consensus 11 ~~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~ 90 (365)
T PRK09188 11 DQIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT 90 (365)
T ss_pred cccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc
Confidence 34445556799999999999998872 467789998753311 13345567899999999999999985 4432
Q ss_pred EEeCCceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCC-CCCCEEEcCCCCEEEeec
Q 013214 219 VTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDL-EPSNILRDDSGNLKVADF 297 (447)
Q Consensus 219 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Di-kp~Nill~~~~~vkl~Df 297 (447)
+..+++|||++|++|... .. .. ...++.|++++|.|||+.| |+|||| ||+|||++.++.+||+||
T Consensus 91 ----~~~~LVmE~~~G~~L~~~-~~---~~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDF 156 (365)
T PRK09188 91 ----GKDGLVRGWTEGVPLHLA-RP---HG---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDF 156 (365)
T ss_pred ----CCcEEEEEccCCCCHHHh-Cc---cc---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEEC
Confidence 457999999999999732 11 11 1467899999999999999 999999 999999999999999999
Q ss_pred ccccccccCCCC-------CcccCCCCCcccCCcccCCC
Q 013214 298 GVSKLLTVKEDR-------PLTCQDTSCRYVAPEVFKNE 329 (447)
Q Consensus 298 g~~~~~~~~~~~-------~~~~~~~t~~y~aPE~~~~~ 329 (447)
|+++.+...... ......+++.|+|||.+...
T Consensus 157 GlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 157 QLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred ccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 999866433211 11234567789999988543
No 413
>KOG4412 consensus 26S proteasome regulatory complex, subunit PSMD10 [Posttranslational modification, protein turnover, chaperones]
Probab=99.88 E-value=8e-23 Score=168.98 Aligned_cols=103 Identities=35% Similarity=0.352 Sum_probs=53.2
Q ss_pred ccchhhHHHHHHHcCCHHHHHHHHHc-CCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCCCCCCccccccc
Q 013214 37 EIKPEFRLMFLANERDVEGIKELLDS-GIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIY 115 (447)
Q Consensus 37 ~~~g~t~lh~a~~~~~~~~~~~Ll~~-g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tpl~~a~~ 115 (447)
|-.||||||.||..|+.++++.|+.. |+|+|..+..|+||||||+..|+.+++++|+++|+.++.+|..|.||||-|+.
T Consensus 69 DdaGWtPlhia~s~g~~evVk~Ll~r~~advna~tn~G~T~LHyAagK~r~eIaqlLle~ga~i~~kD~~~qtplHRAAa 148 (226)
T KOG4412|consen 69 DDAGWTPLHIAASNGNDEVVKELLNRSGADVNATTNGGQTCLHYAAGKGRLEIAQLLLEKGALIRIKDKQGQTPLHRAAA 148 (226)
T ss_pred cccCCchhhhhhhcCcHHHHHHHhcCCCCCcceecCCCcceehhhhcCChhhHHHHHHhcCCCCcccccccCchhHHHHh
Confidence 33445555555555555555555544 55555555555555555555555555555555555555555555555555555
Q ss_pred cchHHHHHHHHHhCCCCCCCcccc
Q 013214 116 YKNHEVIKLLEKHGAKPLMAPMHV 139 (447)
Q Consensus 116 ~~~~~~~~~L~~~~a~~~~~~~~~ 139 (447)
.|+.+++++|+..|+.+++.+..+
T Consensus 149 vGklkvie~Li~~~a~~n~qDk~G 172 (226)
T KOG4412|consen 149 VGKLKVIEYLISQGAPLNTQDKYG 172 (226)
T ss_pred ccchhhHHHHHhcCCCCCcccccC
Confidence 555555555555555544444333
No 414
>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]
Probab=99.87 E-value=6.4e-23 Score=210.80 Aligned_cols=244 Identities=20% Similarity=0.291 Sum_probs=174.0
Q ss_pred CcccceeeecceEEEEE---E-cCeEEEEEEcCccc-CCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAF---W-RGIQVAVKKLGEEV-ISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~---~-~g~~vavK~~~~~~-~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
++...+.+|++.|-++. . .|. |.||++.+.. .-+-....+-.+|++ ...+++||++++.-....++..|+|-+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 46677789999996543 2 344 8999886432 111122222233444 566699999999888778888899999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCC
Q 013214 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (447)
Q Consensus 231 ~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~ 310 (447)
|. ..+|+|.+..++.+..-+...++.|++.|+.-+|..| |+|||||.+|||+++-..+.|+||..-+..=.+.+.+
T Consensus 102 yv-khnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNP 177 (1431)
T KOG1240|consen 102 YV-KHNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNP 177 (1431)
T ss_pred HH-hhhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCCCc
Confidence 99 5699999998888889999999999999999999999 9999999999999999999999998765332222222
Q ss_pred --cc----cCCCCCcccCCcccCCC-----------CCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCC
Q 013214 311 --LT----CQDTSCRYVAPEVFKNE-----------EYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRP 372 (447)
Q Consensus 311 --~~----~~~~t~~y~aPE~~~~~-----------~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~ 372 (447)
.. ....-..|.|||.+... ..+++.||||+||++.||++ |++||.-. ++.... .+..-
T Consensus 178 adf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS---QL~aYr-~~~~~ 253 (1431)
T KOG1240|consen 178 ADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS---QLLAYR-SGNAD 253 (1431)
T ss_pred ccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH---HHHhHh-ccCcc
Confidence 11 12233469999988541 15678999999999999998 89988611 111110 11000
Q ss_pred CCCCChh-hhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 373 PFKAPAK-LYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 373 ~~~~~~~-~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
....... --+..++++|..|++.||.+|.|+++.++.
T Consensus 254 ~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 254 DPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred CHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 0000000 012368899999999999999999999886
No 415
>KOG4412 consensus 26S proteasome regulatory complex, subunit PSMD10 [Posttranslational modification, protein turnover, chaperones]
Probab=99.86 E-value=5.4e-22 Score=164.06 Aligned_cols=109 Identities=28% Similarity=0.378 Sum_probs=102.0
Q ss_pred CCCCCCCccchhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCCCCCCc
Q 013214 30 GLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTP 109 (447)
Q Consensus 30 ~~d~~~~~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tp 109 (447)
+.|+|..+..|.|+|||||..|+.+++++|+++|+.++.+|..|+||||.|+..|...++++|+..||.+|.+|+.|+||
T Consensus 96 ~advna~tn~G~T~LHyAagK~r~eIaqlLle~ga~i~~kD~~~qtplHRAAavGklkvie~Li~~~a~~n~qDk~G~Tp 175 (226)
T KOG4412|consen 96 GADVNATTNGGQTCLHYAAGKGRLEIAQLLLEKGALIRIKDKQGQTPLHRAAAVGKLKVIEYLISQGAPLNTQDKYGFTP 175 (226)
T ss_pred CCCcceecCCCcceehhhhcCChhhHHHHHHhcCCCCcccccccCchhHHHHhccchhhHHHHHhcCCCCCcccccCccH
Confidence 56667777788889999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccccccchHHHHHHHHHhCCCCCCCccc
Q 013214 110 LGDAIYYKNHEVIKLLEKHGAKPLMAPMH 138 (447)
Q Consensus 110 l~~a~~~~~~~~~~~L~~~~a~~~~~~~~ 138 (447)
||.|...|+.+...+|+++||++...+..
T Consensus 176 L~~al~e~~~d~a~lLV~~gAd~~~edke 204 (226)
T KOG4412|consen 176 LHHALAEGHPDVAVLLVRAGADTDREDKE 204 (226)
T ss_pred HHHHHhccCchHHHHHHHhccceeecccc
Confidence 99998889999999999999998776553
No 416
>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]
Probab=99.86 E-value=1.3e-22 Score=199.15 Aligned_cols=222 Identities=22% Similarity=0.325 Sum_probs=184.4
Q ss_pred eecceEEEEE--------EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC-CCcccceeEEEEeCCceEEEEeccC
Q 013214 163 ITKGTFILAF--------WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVTEYLP 233 (447)
Q Consensus 163 lg~G~~~~~~--------~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~lv~e~~~ 233 (447)
+|.|.||.|+ ..|.-+|+|++++......... ....|-.++...+ ||+++++.-.++.+...+++.++..
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~-~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT-HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhccccccccccccc-ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 5788888764 3567788998876544333222 5567888888886 9999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCCccc
Q 013214 234 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTC 313 (447)
Q Consensus 234 ~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~ 313 (447)
||+|...+.+...+.+.....+...++-++.++|+.+ ++|+|+|++||+++.+|++++.|||+++..-.. ..
T Consensus 81 gg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~-----~~ 152 (612)
T KOG0603|consen 81 GGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKE-----KI 152 (612)
T ss_pred cchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhh-----hh
Confidence 9999999988888899999999999999999999999 999999999999999999999999999864322 11
Q ss_pred CCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHHHHHc
Q 013214 314 QDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECW 393 (447)
Q Consensus 314 ~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 393 (447)
.+||..|||||++. .....+|.||||+++++|++|..||.. ++...+ .+.... .+...+...++++..++
T Consensus 153 ~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~I-l~~~~~---~p~~l~~~a~~~~~~l~ 222 (612)
T KOG0603|consen 153 ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRI-LKAELE---MPRELSAEARSLFRQLF 222 (612)
T ss_pred cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHH-hhhccC---CchhhhHHHHHHHHHHH
Confidence 27899999999997 567889999999999999999999997 444444 222222 25667889999999999
Q ss_pred ccCCCCCCCH
Q 013214 394 NEKPAKRPTF 403 (447)
Q Consensus 394 ~~dp~~Rps~ 403 (447)
..+|.+|...
T Consensus 223 ~r~p~nrLg~ 232 (612)
T KOG0603|consen 223 KRNPENRLGA 232 (612)
T ss_pred hhCHHHHhcc
Confidence 9999999755
No 417
>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional
Probab=99.84 E-value=4.3e-21 Score=172.31 Aligned_cols=170 Identities=10% Similarity=0.164 Sum_probs=131.7
Q ss_pred CcCcccceeeecceEEEEE---EcCeEEEEEEcCcccCCCHHHHHH------HHHHHHHHhcCCCCcccceeEEEEeC--
Q 013214 154 ELDFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRA------FRDELALLQKIRHPNVVQFLGAVTQS-- 222 (447)
Q Consensus 154 ~~~~~~~~~lg~G~~~~~~---~~g~~vavK~~~~~~~~~~~~~~~------~~~E~~~l~~l~hp~iv~~~~~~~~~-- 222 (447)
+.+|+..+.+|.|+||.|+ .++..+|+|.+.......+...+. +.+|+..+.++.||+|..+.+++...
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~ 109 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAER 109 (232)
T ss_pred hCceEEEEEecCCCceEEEEEecCCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeeccc
Confidence 4478888999999999876 356789999998765555444444 57899999999999999999886543
Q ss_pred ------CceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEee
Q 013214 223 ------SPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296 (447)
Q Consensus 223 ------~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~D 296 (447)
...+++|||++|.+|.++.. +++ ....+++.++..+|+.| ++|||+||+||+++++| ++|+|
T Consensus 110 ~~~~~~~~~~lvmEyi~G~tL~~~~~----~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g-i~liD 177 (232)
T PRK10359 110 KTLRYAHTYIMLIEYIEGVELNDMPE----ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG-LRIID 177 (232)
T ss_pred ccccccCCeEEEEEEECCccHHHhhh----ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-EEEEE
Confidence 35789999999999988632 333 34569999999999999 99999999999999988 99999
Q ss_pred cccccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHH
Q 013214 297 FGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMI 348 (447)
Q Consensus 297 fg~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~ 348 (447)
||........ ... ..++....++.++|+||||+++..+.
T Consensus 178 fg~~~~~~e~--~a~-----------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 178 LSGKRCTAQR--KAK-----------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CCCcccccch--hhH-----------HHHHHHhHhcccccccceeEeehHHH
Confidence 9987643211 100 01344455677999999999987664
No 418
>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]
Probab=99.83 E-value=3.3e-20 Score=182.14 Aligned_cols=212 Identities=30% Similarity=0.503 Sum_probs=165.9
Q ss_pred HhcCCCCcccceeEEEEeCCceEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe-EeCCCCC
Q 013214 204 LQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPI-IHRDLEP 281 (447)
Q Consensus 204 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i-~H~Dikp 281 (447)
|+.+.|.|+.+++|.+.++...+.|.+||..|+|.+.+.. .-.++......++++++.||.|+|..- + .|+.+++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~---i~~hg~l~s 77 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSP---IGYHGALKS 77 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCc---ceeeeeecc
Confidence 3577899999999999999999999999999999999987 345888888899999999999999975 4 9999999
Q ss_pred CCEEEcCCCCEEEeeccccccccc-CCCCCcccCCCCCcccCCcccCCCC-------CCCchhHHHHHHHHHHHHhCCCC
Q 013214 282 SNILRDDSGNLKVADFGVSKLLTV-KEDRPLTCQDTSCRYVAPEVFKNEE-------YDTKVDVFSFALILQEMIEGCPP 353 (447)
Q Consensus 282 ~Nill~~~~~vkl~Dfg~~~~~~~-~~~~~~~~~~~t~~y~aPE~~~~~~-------~~~~~Di~slG~~l~~l~tg~~p 353 (447)
.|.+++....+||+|||+...... .............-|.|||.+.... .+.+.|+||+|++++|+++.+.|
T Consensus 78 ~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~ 157 (484)
T KOG1023|consen 78 SNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP 157 (484)
T ss_pred ccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence 999999999999999999876532 1111111222345699999987641 35679999999999999999999
Q ss_pred CCCCCCC----chHHHHHhcCCCCCCCChh---hhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhh
Q 013214 354 FTMKHDN----EVPKAYAARQRPPFKAPAK---LYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSIN 418 (447)
Q Consensus 354 ~~~~~~~----~~~~~~~~~~~~~~~~~~~---~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~~~ 418 (447)
|...... ++...+...+..++.+... ..++++..+++.||..+|.+||+++.+...++.+.....
T Consensus 158 ~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~~~ 229 (484)
T KOG1023|consen 158 FDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKGGS 229 (484)
T ss_pred cccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccccc
Confidence 9864432 3333433323333322111 345578999999999999999999999998888776543
No 419
>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain. The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c
Probab=99.83 E-value=2.2e-20 Score=165.71 Aligned_cols=137 Identities=20% Similarity=0.234 Sum_probs=105.7
Q ss_pred eeeecceEEEEEE----cCeEEEEEEcCcccCCCHHH-----------------------HHHHHHHHHHHhcCCCCccc
Q 013214 161 VEITKGTFILAFW----RGIQVAVKKLGEEVISDDDR-----------------------VRAFRDELALLQKIRHPNVV 213 (447)
Q Consensus 161 ~~lg~G~~~~~~~----~g~~vavK~~~~~~~~~~~~-----------------------~~~~~~E~~~l~~l~hp~iv 213 (447)
..||+|++|.|+. +|+.||+|+++......... ......|+.++.++.++++.
T Consensus 3 ~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~ 82 (190)
T cd05147 3 GCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIP 82 (190)
T ss_pred CccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCC
Confidence 4699999998863 68999999997543211110 11234599999999888775
Q ss_pred ceeEEEEeCCceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCeEeCCCCCCCEEEcCCCCE
Q 013214 214 QFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYL-HENKPVPIIHRDLEPSNILRDDSGNL 292 (447)
Q Consensus 214 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~l-H~~~~~~i~H~Dikp~Nill~~~~~v 292 (447)
........ ..++||||++|+++.....+..+++..++..++.|++.+|.++ |+.| ++||||||+||+++ ++.+
T Consensus 83 ~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~-~~~v 156 (190)
T cd05147 83 CPEPILLK--SHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH-DGKL 156 (190)
T ss_pred CCcEEEec--CCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-CCcE
Confidence 44433222 2389999998887766544556799999999999999999999 6888 99999999999998 4789
Q ss_pred EEeeccccccc
Q 013214 293 KVADFGVSKLL 303 (447)
Q Consensus 293 kl~Dfg~~~~~ 303 (447)
+|+|||++...
T Consensus 157 ~LiDFG~a~~~ 167 (190)
T cd05147 157 YIIDVSQSVEH 167 (190)
T ss_pred EEEEccccccC
Confidence 99999998754
No 420
>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A.
Probab=99.82 E-value=1.1e-20 Score=174.76 Aligned_cols=231 Identities=19% Similarity=0.305 Sum_probs=149.2
Q ss_pred CcCcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCC----------CcccceeEE
Q 013214 154 ELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRH----------PNVVQFLGA 218 (447)
Q Consensus 154 ~~~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h----------p~iv~~~~~ 218 (447)
..++.....||.|+++.++ .+|+++|+|+............+++++|.-....+.+ -.++..++.
T Consensus 11 ~r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~ 90 (288)
T PF14531_consen 11 PRTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDL 90 (288)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEE
T ss_pred ceEEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEE
Confidence 3356677889999999876 3689999998866554555567778777755555422 123333332
Q ss_pred EEe---------C---C-----ceEEEEeccCCCCHHHHHHh---cCC----CCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 013214 219 VTQ---------S---S-----PMMIVTEYLPKGDLRAFLKR---KGA----LKPSTAVRFALDIARGMNYLHENKPVPI 274 (447)
Q Consensus 219 ~~~---------~---~-----~~~lv~e~~~~g~L~~~l~~---~~~----l~~~~~~~i~~ql~~~l~~lH~~~~~~i 274 (447)
..- . . ..+++|+-+ .++|.+++.. ... +.......+..|+++.+++||+.| +
T Consensus 91 ~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---l 166 (288)
T PF14531_consen 91 LRIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---L 166 (288)
T ss_dssp EEETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred EEEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---e
Confidence 211 1 1 246788888 5799888642 222 222334456689999999999999 9
Q ss_pred EeCCCCCCCEEEcCCCCEEEeecccccccccCCCCCcccCCCCCcccCCcccCCC--------CCCCchhHHHHHHHHHH
Q 013214 275 IHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE--------EYDTKVDVFSFALILQE 346 (447)
Q Consensus 275 ~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--------~~~~~~Di~slG~~l~~ 346 (447)
+|+||||+|++++.+|.++|+||+.....+... .....+..|.|||..... .++.+.|.|+||+++|.
T Consensus 167 VHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~----~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~ 242 (288)
T PF14531_consen 167 VHGDIKPENFLLDQDGGVFLGDFSSLVRAGTRY----RCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYS 242 (288)
T ss_dssp EEST-SGGGEEE-TTS-EEE--GGGEEETTEEE----EGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHH
T ss_pred EecccceeeEEEcCCCCEEEcChHHHeecCcee----eccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHH
Confidence 999999999999999999999998776544221 112335678999976432 46788999999999999
Q ss_pred HHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCC
Q 013214 347 MIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKR 400 (447)
Q Consensus 347 l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R 400 (447)
|++|+.||........... .+. .+.++|+.++.||+.+|+.||.+|
T Consensus 243 lWC~~lPf~~~~~~~~~~~-------~f~-~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 243 LWCGRLPFGLSSPEADPEW-------DFS-RCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHSS-STCCCGGGSTSGG-------GGT-TSS---HHHHHHHHHHT-SSGGGS
T ss_pred HHHccCCCCCCCccccccc-------cch-hcCCcCHHHHHHHHHHccCCcccC
Confidence 9999999986654332211 111 233678999999999999999988
No 421
>PRK12274 serine/threonine protein kinase; Provisional
Probab=99.81 E-value=2.9e-19 Score=157.15 Aligned_cols=186 Identities=13% Similarity=0.067 Sum_probs=134.1
Q ss_pred cceeeecceEEEEEE---cCeEEEEEEcCcccCCCHH-HHHHHHHHHHHHhcCC-CCcccceeEEEEeCCceEEEEeccC
Q 013214 159 NSVEITKGTFILAFW---RGIQVAVKKLGEEVISDDD-RVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVTEYLP 233 (447)
Q Consensus 159 ~~~~lg~G~~~~~~~---~g~~vavK~~~~~~~~~~~-~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~lv~e~~~ 233 (447)
....|++|+||.+++ .+.+++.+.+......... ....+.+|+++|++++ |+++++++++ ...+++|||+.
T Consensus 6 ~~~~l~~~~f~~v~~~~~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~ 81 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRGGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLA 81 (218)
T ss_pred cceeecCCCcceEEEeecCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeec
Confidence 345789999998875 4567776666543221111 1225789999999994 5889999886 34699999999
Q ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCC-CCCCEEEcCCCCEEEeecccccccccCCCC---
Q 013214 234 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDL-EPSNILRDDSGNLKVADFGVSKLLTVKEDR--- 309 (447)
Q Consensus 234 ~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Di-kp~Nill~~~~~vkl~Dfg~~~~~~~~~~~--- 309 (447)
|.+|.+.... ....++.|++.++.++|+.| |+|||| ||+||+++.++.++|+|||++.........
T Consensus 82 G~~L~~~~~~-------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~ 151 (218)
T PRK12274 82 GAAMYQRPPR-------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRL 151 (218)
T ss_pred CccHHhhhhh-------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHH
Confidence 9998764321 12357789999999999999 999999 799999999999999999999854432210
Q ss_pred -C--------cccCCCCCcccCCcccCCC-CCC-CchhHHHHHHHHHHHHhCCCCCCCCC
Q 013214 310 -P--------LTCQDTSCRYVAPEVFKNE-EYD-TKVDVFSFALILQEMIEGCPPFTMKH 358 (447)
Q Consensus 310 -~--------~~~~~~t~~y~aPE~~~~~-~~~-~~~Di~slG~~l~~l~tg~~p~~~~~ 358 (447)
. ......++.+++|+...-- ..+ ...+.++.|.-+|.++|+..|..+.+
T Consensus 152 L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 152 LAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred HHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 0 0011246677777643211 223 56788999999999999998876544
No 422
>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain. The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro
Probab=99.80 E-value=4.8e-19 Score=157.60 Aligned_cols=139 Identities=19% Similarity=0.175 Sum_probs=107.7
Q ss_pred ceeeecceEEEEEE----cCeEEEEEEcCcccCCCH----------------------H-HHHHHHHHHHHHhcCCCCcc
Q 013214 160 SVEITKGTFILAFW----RGIQVAVKKLGEEVISDD----------------------D-RVRAFRDELALLQKIRHPNV 212 (447)
Q Consensus 160 ~~~lg~G~~~~~~~----~g~~vavK~~~~~~~~~~----------------------~-~~~~~~~E~~~l~~l~hp~i 212 (447)
...||+|++|.|+. +|+.||||+++....... . ....+..|...+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 35799999998863 589999999876521100 0 01234679999999999988
Q ss_pred cceeEEEEeCCceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeCCCCCCCEEEcCCCC
Q 013214 213 VQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHE-NKPVPIIHRDLEPSNILRDDSGN 291 (447)
Q Consensus 213 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~-~~~~~i~H~Dikp~Nill~~~~~ 291 (447)
.....+.... .++||||++|+++........+++......++.|++.++.++|+ .| ++||||||+||+++ ++.
T Consensus 82 ~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~-~~~ 155 (190)
T cd05145 82 PVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH-DGK 155 (190)
T ss_pred CCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-CCC
Confidence 6554443332 48999999887654443344668888999999999999999999 88 99999999999999 889
Q ss_pred EEEeecccccccc
Q 013214 292 LKVADFGVSKLLT 304 (447)
Q Consensus 292 vkl~Dfg~~~~~~ 304 (447)
++|+|||++....
T Consensus 156 ~~liDFG~a~~~~ 168 (190)
T cd05145 156 PYIIDVSQAVELD 168 (190)
T ss_pred EEEEEcccceecC
Confidence 9999999987654
No 423
>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]
Probab=99.80 E-value=3.5e-19 Score=165.43 Aligned_cols=196 Identities=21% Similarity=0.287 Sum_probs=144.3
Q ss_pred CCCcccceeEEEEe---------------------------CCceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHH
Q 013214 208 RHPNVVQFLGAVTQ---------------------------SSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIA 260 (447)
Q Consensus 208 ~hp~iv~~~~~~~~---------------------------~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~ 260 (447)
+||||+++.++|.+ ...+|+||..+ ..+|..++..+. .+.....-++.|++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~~-~s~r~~~~~laQlL 351 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTRH-RSYRTGRVILAQLL 351 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcCC-CchHHHHHHHHHHH
Confidence 69999999887743 23589999998 469999997654 46667778899999
Q ss_pred HHHHHHHhCCCCCeEeCCCCCCCEEEc--CCC--CEEEeeccccccccc-----CCCCCcccCCCCCcccCCcccCCCC-
Q 013214 261 RGMNYLHENKPVPIIHRDLEPSNILRD--DSG--NLKVADFGVSKLLTV-----KEDRPLTCQDTSCRYVAPEVFKNEE- 330 (447)
Q Consensus 261 ~~l~~lH~~~~~~i~H~Dikp~Nill~--~~~--~vkl~Dfg~~~~~~~-----~~~~~~~~~~~t~~y~aPE~~~~~~- 330 (447)
+|+.|||.+| +.|||+|++|||+. +++ .+.++|||.+-.-.. +-....-..+|....||||+....+
T Consensus 352 Eav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PG 428 (598)
T KOG4158|consen 352 EAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPG 428 (598)
T ss_pred HHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCC
Confidence 9999999999 99999999999985 333 478999997642111 1111122345777899999975431
Q ss_pred ----CC-CchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHH
Q 013214 331 ----YD-TKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQ 405 (447)
Q Consensus 331 ----~~-~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ 405 (447)
.+ .|+|.|+.|.+.||++....||.......+. ........++..+..+++.+++++...|+.||.+|+|..-
T Consensus 429 p~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~--~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~i 506 (598)
T KOG4158|consen 429 PNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLD--TRTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNI 506 (598)
T ss_pred CceeeccchhhhhhhhhhHHHHhccCCcccccchheec--hhhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCccH
Confidence 22 4899999999999999999999874332221 1112223344456678899999999999999999998765
Q ss_pred HHHHH
Q 013214 406 IITRL 410 (447)
Q Consensus 406 ~l~~l 410 (447)
..+.|
T Consensus 507 AANvl 511 (598)
T KOG4158|consen 507 AANVL 511 (598)
T ss_pred HHhHH
Confidence 54443
No 424
>PRK10345 hypothetical protein; Provisional
Probab=99.80 E-value=4.9e-19 Score=158.56 Aligned_cols=135 Identities=17% Similarity=0.274 Sum_probs=104.1
Q ss_pred CcccceeeecceEEEEEE---cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-----CCCcccceeEEEEeCC---c
Q 013214 156 DFTNSVEITKGTFILAFW---RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-----RHPNVVQFLGAVTQSS---P 224 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~---~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-----~hp~iv~~~~~~~~~~---~ 224 (447)
++.....||+|+++.||. ++.. +||++.... ....+.+.+|+.+++.+ .||||++++++++++. .
T Consensus 3 ~L~~~~~LG~G~~~~Vy~hp~~~~k-~IKv~~~~~---~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~ 78 (210)
T PRK10345 3 RLSEQSPLGTGRHRKCYAHPEDAQR-CIKIVYHRG---DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGY 78 (210)
T ss_pred ecCCcceecCCCceEEEECCCCcCe-EEEEEeccc---cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeE
Confidence 345567899999999984 2333 577775432 22346789999999999 5799999999998874 3
Q ss_pred eE-EEEec--cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHH-HHHHhCCCCCeEeCCCCCCCEEEcCC----CCEEEee
Q 013214 225 MM-IVTEY--LPKGDLRAFLKRKGALKPSTAVRFALDIARGM-NYLHENKPVPIIHRDLEPSNILRDDS----GNLKVAD 296 (447)
Q Consensus 225 ~~-lv~e~--~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l-~~lH~~~~~~i~H~Dikp~Nill~~~----~~vkl~D 296 (447)
++ +|+|| +.+++|.+++++. .+++. ..++.|++.++ .|||+++ |+||||||+||+++.. +.++|+|
T Consensus 79 v~~~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiD 152 (210)
T PRK10345 79 VYDVIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCD 152 (210)
T ss_pred EEEEEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEE
Confidence 33 78999 5579999999764 46655 35678888777 9999999 9999999999999743 3799999
Q ss_pred cccc
Q 013214 297 FGVS 300 (447)
Q Consensus 297 fg~~ 300 (447)
|+.+
T Consensus 153 g~G~ 156 (210)
T PRK10345 153 NIGE 156 (210)
T ss_pred CCCC
Confidence 5443
No 425
>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]
Probab=99.80 E-value=8.5e-19 Score=183.76 Aligned_cols=258 Identities=19% Similarity=0.228 Sum_probs=188.6
Q ss_pred CCcccCCCCcCcccceeeecceEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC---CCcccceeEE
Q 013214 146 PEYEIDPHELDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR---HPNVVQFLGA 218 (447)
Q Consensus 146 ~~~~i~~~~~~~~~~~~lg~G~~~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~---hp~iv~~~~~ 218 (447)
+..++......|.+.++||+|+||.||+ +|+.||+|+-+.....+--- =.+++.+++ -+.|..+..+
T Consensus 689 ~~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfYI------~~q~~~RLk~~~~~~~~~~~~a 762 (974)
T KOG1166|consen 689 PNTEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFYI------CLQVMERLKPQMLPSIMHISSA 762 (974)
T ss_pred ccceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceeeee------hHHHHHhhchhhhcchHHHHHH
Confidence 3445555566899999999999999985 68999999887654332111 122333443 2345555555
Q ss_pred EEeCCceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCC-------CC
Q 013214 219 VTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS-------GN 291 (447)
Q Consensus 219 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~-------~~ 291 (447)
..-.+.-++|+||.+.|+|.+++..++.+++..+..+..|++..+.+||..+ |||+||||+|.++... --
T Consensus 763 ~~~~~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~ 839 (974)
T KOG1166|consen 763 HVFQNASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKG 839 (974)
T ss_pred HccCCcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccc
Confidence 5666777999999999999999998888999999999999999999999999 9999999999998632 24
Q ss_pred EEEeecccccccccCCCC-CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcC
Q 013214 292 LKVADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (447)
Q Consensus 292 vkl~Dfg~~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~ 370 (447)
++|+|||.+..+....+. .......|-.+-++|+..+..++..+|.|.|+.+++.|+.|+..= ...+.
T Consensus 840 l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q-----------~~~g~ 908 (974)
T KOG1166|consen 840 LYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME-----------VKNGS 908 (974)
T ss_pred eEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH-----------hcCCc
Confidence 999999999877654443 345566788899999999999999999999999999999996542 10111
Q ss_pred CCCCCC-ChhhhH-HHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhhcccch
Q 013214 371 RPPFKA-PAKLYA-RGLKELIEECWNEKPAKRPTFRQIITRLESINNSINHKRRW 423 (447)
Q Consensus 371 ~~~~~~-~~~~~~-~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~~~~~~~~ 423 (447)
.-.... .++.+. +-..++...+|..|-..=|...++...++.....-...-++
T Consensus 909 ~~~~~~~~~Ry~~~~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~~~~~~~~~ 963 (974)
T KOG1166|consen 909 SWMVKTNFPRYWKRDMWNKFFDLLLNPDCDTLPNLQELRTELEEVLAEHFTGLRE 963 (974)
T ss_pred ceeccccchhhhhHHHHHHHHHHHhCcCcccchhHHHHHHHHHHHHHHHHHHHHH
Confidence 000000 011111 23557788888855555588888888888766655543333
No 426
>PHA02743 Viral ankyrin protein; Provisional
Probab=99.79 E-value=2.5e-19 Score=155.52 Aligned_cols=107 Identities=20% Similarity=0.157 Sum_probs=95.6
Q ss_pred CCCCCCCccchhhHHHHHHHcCCHHH---HHHHHHcCCCCCCCC-CCCCCHHHHHHHcCcHHHHHHHHH-cCCCCCCCCC
Q 013214 30 GLDDDGEEIKPEFRLMFLANERDVEG---IKELLDSGIDVNFRD-IDNRTALHVAACQGFTEVVSLLLE-RGADVDPKDR 104 (447)
Q Consensus 30 ~~d~~~~~~~g~t~lh~a~~~~~~~~---~~~Ll~~g~d~n~~d-~~g~t~Lh~A~~~g~~~~v~~Ll~-~ga~~~~~d~ 104 (447)
+.+.+.+|..|+||||+||..|+.+. +++|++.|+++|.+| ..|+||||+|+..|+.+++++|++ .|++++.+|.
T Consensus 47 g~~~~~~d~~g~t~Lh~Aa~~g~~~~~~~i~~Ll~~Gadin~~d~~~g~TpLh~A~~~g~~~iv~~Ll~~~gad~~~~d~ 126 (166)
T PHA02743 47 GHLLHRYDHHGRQCTHMVAWYDRANAVMKIELLVNMGADINARELGTGNTLLHIAASTKNYELAEWLCRQLGVNLGAINY 126 (166)
T ss_pred chhhhccCCCCCcHHHHHHHhCccCHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHhCCHHHHHHHHhccCCCccCcCC
Confidence 44455666678899999999988654 899999999999998 589999999999999999999995 7999999999
Q ss_pred CCCCccccccccchHHHHHHHHHhCCCCCCCc
Q 013214 105 WGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAP 136 (447)
Q Consensus 105 ~g~tpl~~a~~~~~~~~~~~L~~~~a~~~~~~ 136 (447)
.|.||||+|+..++.+++++|+++|++++...
T Consensus 127 ~g~tpL~~A~~~~~~~iv~~Ll~~ga~~~~~~ 158 (166)
T PHA02743 127 QHETAYHIAYKMRDRRMMEILRANGAVCDDPL 158 (166)
T ss_pred CCCCHHHHHHHcCCHHHHHHHHHcCCCCCCcc
Confidence 99999999999999999999999999986543
No 427
>PHA02859 ankyrin repeat protein; Provisional
Probab=99.78 E-value=3.2e-19 Score=160.79 Aligned_cols=135 Identities=19% Similarity=0.184 Sum_probs=91.5
Q ss_pred cccceeeeec---ccCCCCccccchhcccCCCCCCCccchhhHHHHHHHc---CCHHHHHHHHHcCCCCCCCCCCCCCHH
Q 013214 4 KVPVRTTLLK---QSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANE---RDVEGIKELLDSGIDVNFRDIDNRTAL 77 (447)
Q Consensus 4 ~~~~~~~~~~---~~~~~~~~~~~~a~~n~~d~~~~~~~g~t~lh~a~~~---~~~~~~~~Ll~~g~d~n~~d~~g~t~L 77 (447)
.+|+..++.+ ...+.....+.|||+|..+. ..|+||||+|+.. ++.+++++|+++|+|+|.+|.+|.|||
T Consensus 52 ~TpLh~a~~~~~~~~eiv~~Ll~~gadvn~~~~----~~g~TpLh~a~~~~~~~~~eiv~~Ll~~gadin~~d~~G~TpL 127 (209)
T PHA02859 52 ETPIFSCLEKDKVNVEILKFLIENGADVNFKTR----DNNLSALHHYLSFNKNVEPEILKILIDSGSSITEEDEDGKNLL 127 (209)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHCCCCCCccCC----CCCCCHHHHHHHhCccccHHHHHHHHHCCCCCCCcCCCCCCHH
Confidence 3455555432 22344444555666655431 2466778877653 367888888888888888888888888
Q ss_pred HHHHH--cCcHHHHHHHHHcCCCCCCCCCCCCCcccc-ccccchHHHHHHHHHhCCCCCCCccccccc
Q 013214 78 HVAAC--QGFTEVVSLLLERGADVDPKDRWGSTPLGD-AIYYKNHEVIKLLEKHGAKPLMAPMHVKHA 142 (447)
Q Consensus 78 h~A~~--~g~~~~v~~Ll~~ga~~~~~d~~g~tpl~~-a~~~~~~~~~~~L~~~~a~~~~~~~~~~~~ 142 (447)
|+|+. .++.+++++|++.|++++.+|..|.||||. |+..++.+++++|+++|+++...+..+.++
T Consensus 128 h~a~~~~~~~~~iv~~Li~~gadin~~d~~g~t~Lh~~a~~~~~~~iv~~Ll~~Gadi~~~d~~g~tp 195 (209)
T PHA02859 128 HMYMCNFNVRINVIKLLIDSGVSFLNKDFDNNNILYSYILFHSDKKIFDFLTSLGIDINETNKSGYNC 195 (209)
T ss_pred HHHHHhccCCHHHHHHHHHcCCCcccccCCCCcHHHHHHHhcCCHHHHHHHHHcCCCCCCCCCCCCCH
Confidence 88765 357788888888888888888888888874 555677788888888888777665544443
No 428
>KOG0509 consensus Ankyrin repeat and DHHC-type Zn-finger domain containing proteins [General function prediction only]
Probab=99.77 E-value=6.3e-19 Score=172.56 Aligned_cols=113 Identities=28% Similarity=0.322 Sum_probs=106.0
Q ss_pred CCCCCCCccchhhHHHHHHHcCCHHHHHHHHHcCCCCCCCC-CCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCCCCCC
Q 013214 30 GLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRD-IDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGST 108 (447)
Q Consensus 30 ~~d~~~~~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d-~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~t 108 (447)
+.+.+..|.+|-|+||+||.+|+.+++++|+++|||||..+ .-|.||||+|+++|+..+|.+|+++|||++.+|..|.|
T Consensus 68 g~~v~~~D~~g~tlLHWAAiNNrl~v~r~li~~gadvn~~gG~l~stPLHWAar~G~~~vv~lLlqhGAdpt~~D~~G~~ 147 (600)
T KOG0509|consen 68 GESVNNPDREGVTLLHWAAINNRLDVARYLISHGADVNAIGGVLGSTPLHWAARNGHISVVDLLLQHGADPTLKDKQGLT 147 (600)
T ss_pred CcCCCCCCcCCccceeHHHHcCcHHHHHHHHHcCCCccccCCCCCCCcchHHHHcCcHHHHHHHHHcCCCCceecCCCCc
Confidence 77788888889999999999999999999999999999998 77899999999999999999999999999999999999
Q ss_pred ccccccccchHHHHHHHHHhCCCCCCCccccccc
Q 013214 109 PLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHA 142 (447)
Q Consensus 109 pl~~a~~~~~~~~~~~L~~~~a~~~~~~~~~~~~ 142 (447)
|+|.|++.++.-++-+|+.+|++++..+..+.++
T Consensus 148 ~lHla~~~~~~~~vayll~~~~d~d~~D~~grTp 181 (600)
T KOG0509|consen 148 PLHLAAQFGHTALVAYLLSKGADIDLRDNNGRTP 181 (600)
T ss_pred HHHHHHHhCchHHHHHHHHhcccCCCcCCCCCCH
Confidence 9999999999999999999999998887766555
No 429
>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]
Probab=99.77 E-value=9.8e-19 Score=180.13 Aligned_cols=225 Identities=27% Similarity=0.409 Sum_probs=159.4
Q ss_pred cccccccCCCCCcccCCCCcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCC
Q 013214 136 PMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210 (447)
Q Consensus 136 ~~~~~~~~~~~~~~i~~~~~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp 210 (447)
++...++..-......+.+.+|...+.|..|++|.||. +.+++|+|+=+...+ +++ ++..-..|
T Consensus 64 p~~~~s~~~~~as~~~p~e~df~~IklisngAygavylvrh~~trqrfa~kiNkq~li--------lRn---ilt~a~np 132 (1205)
T KOG0606|consen 64 PMTDESPESRGASRRAPSESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQNLI--------LRN---ILTFAGNP 132 (1205)
T ss_pred CCCCCCcccccccccCCCccccceeEeeccCCCCceeeeeccccccchhhcccccchh--------hhc---cccccCCc
Confidence 44444443322334456677888888999999987763 367788843221110 111 33333444
Q ss_pred cccceeEEEEeCCceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCC
Q 013214 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG 290 (447)
Q Consensus 211 ~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~ 290 (447)
++| |+=...++.-++++.+. +.+++|+|+.+ |+|||+||+|.+|+.-|
T Consensus 133 fvv---------------------gDc~tllk~~g~lPvdm--------vla~Eylh~yg---ivhrdlkpdnllIT~mG 180 (1205)
T KOG0606|consen 133 FVV---------------------GDCATLLKNIGPLPVDM--------VLAVEYLHSYG---IVHRDLKPDNLLITSMG 180 (1205)
T ss_pred cee---------------------chhhhhcccCCCCcchh--------hHHhHhhccCC---eecCCCCCCcceeeecc
Confidence 444 44444455545555433 77899999999 99999999999999999
Q ss_pred CEEEeecccccccccCCCC--------------CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 013214 291 NLKVADFGVSKLLTVKEDR--------------PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTM 356 (447)
Q Consensus 291 ~vkl~Dfg~~~~~~~~~~~--------------~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~ 356 (447)
++|+.|||+++........ ......|||.|.|||++..+.|...+|+|++|+++|+.+-|+.||.+
T Consensus 181 hiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffG 260 (1205)
T KOG0606|consen 181 HIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFG 260 (1205)
T ss_pred cccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccC
Confidence 9999999998754221100 01345789999999999999999999999999999999999999999
Q ss_pred CCCCchHHHHHhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHH
Q 013214 357 KHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFR 404 (447)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ 404 (447)
.+++++...+.... ..++..-..+++++++++.++|+.+|..|--..
T Consensus 261 dtpeelfg~visd~-i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ 307 (1205)
T KOG0606|consen 261 DTPEELFGQVISDD-IEWPEEDEALPPEAQDLIEQLLRQNPLCRLGTG 307 (1205)
T ss_pred CCHHHHHhhhhhhh-ccccccCcCCCHHHHHHHHHHHHhChHhhcccc
Confidence 99988877664333 222222344678999999999999999995433
No 430
>KOG0509 consensus Ankyrin repeat and DHHC-type Zn-finger domain containing proteins [General function prediction only]
Probab=99.77 E-value=3e-19 Score=174.83 Aligned_cols=126 Identities=29% Similarity=0.350 Sum_probs=112.3
Q ss_pred cccCCCCccccchhcccCCCCCCCccchhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHH
Q 013214 13 KQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLL 92 (447)
Q Consensus 13 ~~~~~~~~~~~~~a~~n~~d~~~~~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~L 92 (447)
|.-++.-...++|||+|..+.+ -+.|||||||++|++.++.+|+++|||++.+|.+|.||||+||..|+.-+|-+|
T Consensus 89 Nrl~v~r~li~~gadvn~~gG~----l~stPLHWAar~G~~~vv~lLlqhGAdpt~~D~~G~~~lHla~~~~~~~~vayl 164 (600)
T KOG0509|consen 89 NRLDVARYLISHGADVNAIGGV----LGSTPLHWAARNGHISVVDLLLQHGADPTLKDKQGLTPLHLAAQFGHTALVAYL 164 (600)
T ss_pred CcHHHHHHHHHcCCCccccCCC----CCCCcchHHHHcCcHHHHHHHHHcCCCCceecCCCCcHHHHHHHhCchHHHHHH
Confidence 3444555667889999988864 367899999999999999999999999999999999999999999999999999
Q ss_pred HHcCCCCCCCCCCCCCccccccccchHHHHHHHHHhCCCCCCCc-cccccc
Q 013214 93 LERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAP-MHVKHA 142 (447)
Q Consensus 93 l~~ga~~~~~d~~g~tpl~~a~~~~~~~~~~~L~~~~a~~~~~~-~~~~~~ 142 (447)
+..|+|+|.+|.+|+||||||+++|....+..|++.|+.+...+ .++.++
T Consensus 165 l~~~~d~d~~D~~grTpLmwAaykg~~~~v~~LL~f~a~~~~~d~~~g~Tp 215 (600)
T KOG0509|consen 165 LSKGADIDLRDNNGRTPLMWAAYKGFALFVRRLLKFGASLLLTDDNHGNTP 215 (600)
T ss_pred HHhcccCCCcCCCCCCHHHHHHHhcccHHHHHHHHhcccccccccccCCch
Confidence 99999999999999999999999998877999999999998776 555544
No 431
>PF12796 Ank_2: Ankyrin repeats (3 copies); InterPro: IPR020683 This entry represents the ankyrin repeat-containing domain. These domains contain multiple repeats of a beta(2)-alpha(2) motif. The ankyrin repeat is one of the most common protein-protein interaction motifs in nature. Ankyrin repeats are tandemly repeated modules of about 33 amino acids. They occur in a large number of functionally diverse proteins mainly from eukaryotes. The few known examples from prokaryotes and viruses may be the result of horizontal gene transfers []. The repeat has been found in proteins of diverse function such as transcriptional initiators, cell-cycle regulators, cytoskeletal, ion transporters and signal transducers. The ankyrin fold appears to be defined by its structure rather than its function since there is no specific sequence or structure which is universally recognised by it. The conserved fold of the ankyrin repeat unit is known from several crystal and solution structures [, , , ]. Each repeat folds into a helix-loop-helix structure with a beta-hairpin/loop region projecting out from the helices at a 90o angle. The repeats stack together to form an L-shaped structure [, ].; PDB: 3AAA_C 3F6Q_A 2KBX_A 3IXE_A 3TWR_D 3TWV_A 3TWT_B 3TWQ_A 3TWS_A 3TWX_B ....
Probab=99.77 E-value=2e-18 Score=133.67 Aligned_cols=88 Identities=43% Similarity=0.574 Sum_probs=83.0
Q ss_pred HHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCCCCCCccccccccchHHHHH
Q 013214 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIK 123 (447)
Q Consensus 44 lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tpl~~a~~~~~~~~~~ 123 (447)
||+||..|+.+++++|++.+.+++. |+||||+|+..|+.+++++|+++|++++.+|..|+||||+|+.+|+.++++
T Consensus 1 L~~A~~~~~~~~~~~ll~~~~~~~~----~~~~l~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~~~ 76 (89)
T PF12796_consen 1 LHIAAQNGNLEILKFLLEKGADINL----GNTALHYAAENGNLEIVKLLLENGADINSQDKNGNTALHYAAENGNLEIVK 76 (89)
T ss_dssp HHHHHHTTTHHHHHHHHHTTSTTTS----SSBHHHHHHHTTTHHHHHHHHHTTTCTT-BSTTSSBHHHHHHHTTHHHHHH
T ss_pred CHHHHHcCCHHHHHHHHHCcCCCCC----CCCHHHHHHHcCCHHHHHHHHHhcccccccCCCCCCHHHHHHHcCCHHHHH
Confidence 7999999999999999999999987 899999999999999999999999999999999999999999999999999
Q ss_pred HHHHhCCCCCCC
Q 013214 124 LLEKHGAKPLMA 135 (447)
Q Consensus 124 ~L~~~~a~~~~~ 135 (447)
+|+++|++++.+
T Consensus 77 ~Ll~~g~~~~~~ 88 (89)
T PF12796_consen 77 LLLEHGADVNIR 88 (89)
T ss_dssp HHHHTTT-TTSS
T ss_pred HHHHcCCCCCCc
Confidence 999999998764
No 432
>PHA02791 ankyrin-like protein; Provisional
Probab=99.76 E-value=2.6e-18 Score=160.86 Aligned_cols=107 Identities=15% Similarity=0.091 Sum_probs=82.1
Q ss_pred CCCCCCCccchhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCC-CHHHHHHHcCcHHHHHHHHHcCCCCCCCC-CCCC
Q 013214 30 GLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNR-TALHVAACQGFTEVVSLLLERGADVDPKD-RWGS 107 (447)
Q Consensus 30 ~~d~~~~~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~-t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d-~~g~ 107 (447)
|.|.+.+|..|+||||+||..|+.+++++|+++|+++|.++..|+ ||||+|+..|+.++|++|+++|.+. .| ..|.
T Consensus 84 Gadvn~~d~~G~TpLh~Aa~~g~~eivk~Ll~~gadin~~~~~g~~TpL~~Aa~~g~~eivk~LL~~~~~~--~d~~~g~ 161 (284)
T PHA02791 84 GMDDSQFDDKGNTALYYAVDSGNMQTVKLFVKKNWRLMFYGKTGWKTSFYHAVMLNDVSIVSYFLSEIPST--FDLAILL 161 (284)
T ss_pred CCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHCCCCcCccCCCCCcHHHHHHHHcCCHHHHHHHHhcCCcc--cccccCc
Confidence 444455566778888888888888888888888888888877774 7888888888888888888776543 22 2478
Q ss_pred CccccccccchHHHHHHHHHhCCCCCCCccc
Q 013214 108 TPLGDAIYYKNHEVIKLLEKHGAKPLMAPMH 138 (447)
Q Consensus 108 tpl~~a~~~~~~~~~~~L~~~~a~~~~~~~~ 138 (447)
||||+|+..|+.+++++|+++|++++..+..
T Consensus 162 TpLh~Aa~~g~~eiv~lLL~~gAd~n~~d~~ 192 (284)
T PHA02791 162 SCIHITIKNGHVDMMILLLDYMTSTNTNNSL 192 (284)
T ss_pred cHHHHHHHcCCHHHHHHHHHCCCCCCcccCC
Confidence 8888888888888888888888888776543
No 433
>PHA02791 ankyrin-like protein; Provisional
Probab=99.75 E-value=5.8e-18 Score=158.51 Aligned_cols=100 Identities=26% Similarity=0.272 Sum_probs=93.6
Q ss_pred CCCccchhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCCCCCCccccc
Q 013214 34 DGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDA 113 (447)
Q Consensus 34 ~~~~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tpl~~a 113 (447)
+..|.+|+||||+|+..|+.+++++|++.|+++|..| |+||||+|+..|+.+++++|++.|++++.+|..|+||||+|
T Consensus 24 ~~~D~~G~TpLh~Aa~~g~~eiv~~Ll~~ga~~n~~d--~~TpLh~Aa~~g~~eiV~lLL~~Gadvn~~d~~G~TpLh~A 101 (284)
T PHA02791 24 FKADVHGHSALYYAIADNNVRLVCTLLNAGALKNLLE--NEFPLHQAATLEDTKIVKILLFSGMDDSQFDDKGNTALYYA 101 (284)
T ss_pred CCCCCCCCcHHHHHHHcCCHHHHHHHHHCcCCCcCCC--CCCHHHHHHHCCCHHHHHHHHHCCCCCCCCCCCCCCHHHHH
Confidence 3567789999999999999999999999999999875 78999999999999999999999999999999999999999
Q ss_pred cccchHHHHHHHHHhCCCCCCC
Q 013214 114 IYYKNHEVIKLLEKHGAKPLMA 135 (447)
Q Consensus 114 ~~~~~~~~~~~L~~~~a~~~~~ 135 (447)
+..|+.+++++|+++|++++..
T Consensus 102 a~~g~~eivk~Ll~~gadin~~ 123 (284)
T PHA02791 102 VDSGNMQTVKLFVKKNWRLMFY 123 (284)
T ss_pred HHcCCHHHHHHHHHCCCCcCcc
Confidence 9999999999999999987554
No 434
>PHA02741 hypothetical protein; Provisional
Probab=99.74 E-value=4.2e-18 Score=148.47 Aligned_cols=102 Identities=21% Similarity=0.274 Sum_probs=92.9
Q ss_pred CCCCCCCccchhhHHHHHHHcCC----HHHHHHHHHcCCCCCCCCC-CCCCHHHHHHHcCcHHHHHHHHH-cCCCCCCCC
Q 013214 30 GLDDDGEEIKPEFRLMFLANERD----VEGIKELLDSGIDVNFRDI-DNRTALHVAACQGFTEVVSLLLE-RGADVDPKD 103 (447)
Q Consensus 30 ~~d~~~~~~~g~t~lh~a~~~~~----~~~~~~Ll~~g~d~n~~d~-~g~t~Lh~A~~~g~~~~v~~Ll~-~ga~~~~~d 103 (447)
+.+.+.+|..|+||||+|+..|+ .+++++|++.|+|+|.+|. +|+||||+|+..++.+++++|++ .|++++.+|
T Consensus 50 ga~in~~d~~g~T~Lh~A~~~g~~~~~~~ii~~Ll~~gadin~~~~~~g~TpLh~A~~~~~~~iv~~Ll~~~g~~~~~~n 129 (169)
T PHA02741 50 AAALNATDDAGQMCIHIAAEKHEAQLAAEIIDHLIELGADINAQEMLEGDTALHLAAHRRDHDLAEWLCCQPGIDLHFCN 129 (169)
T ss_pred hhhhhccCCCCCcHHHHHHHcCChHHHHHHHHHHHHcCCCCCCCCcCCCCCHHHHHHHcCCHHHHHHHHhCCCCCCCcCC
Confidence 34455666678899999999999 5899999999999999985 99999999999999999999998 599999999
Q ss_pred CCCCCccccccccchHHHHHHHHHhCCC
Q 013214 104 RWGSTPLGDAIYYKNHEVIKLLEKHGAK 131 (447)
Q Consensus 104 ~~g~tpl~~a~~~~~~~~~~~L~~~~a~ 131 (447)
..|.||||+|...++.+++++|+++++.
T Consensus 130 ~~g~tpL~~A~~~~~~~iv~~L~~~~~~ 157 (169)
T PHA02741 130 ADNKSPFELAIDNEDVAMMQILREIVAT 157 (169)
T ss_pred CCCCCHHHHHHHCCCHHHHHHHHHHHHH
Confidence 9999999999999999999999998765
No 435
>PHA02736 Viral ankyrin protein; Provisional
Probab=99.74 E-value=1.1e-18 Score=149.83 Aligned_cols=100 Identities=20% Similarity=0.218 Sum_probs=92.4
Q ss_pred CCCccchhhHHHHHHHcCCH---HHHHHHHHcCCCCCCCC-CCCCCHHHHHHHcCcHHHHHHHHH-cCCCCCCCCCCCCC
Q 013214 34 DGEEIKPEFRLMFLANERDV---EGIKELLDSGIDVNFRD-IDNRTALHVAACQGFTEVVSLLLE-RGADVDPKDRWGST 108 (447)
Q Consensus 34 ~~~~~~g~t~lh~a~~~~~~---~~~~~Ll~~g~d~n~~d-~~g~t~Lh~A~~~g~~~~v~~Ll~-~ga~~~~~d~~g~t 108 (447)
+..|.+|+||||+||..|+. +++++|++.|+|+|.+| .+|+||||+|+..|+.+++++|++ .|++++.+|..|.|
T Consensus 49 ~~~d~~g~t~Lh~a~~~~~~~~~e~v~~Ll~~gadin~~~~~~g~T~Lh~A~~~~~~~i~~~Ll~~~g~d~n~~~~~g~t 128 (154)
T PHA02736 49 LEYNRHGKQCVHIVSNPDKADPQEKLKLLMEWGADINGKERVFGNTPLHIAVYTQNYELATWLCNQPGVNMEILNYAFKT 128 (154)
T ss_pred HHhcCCCCEEEEeecccCchhHHHHHHHHHHcCCCccccCCCCCCcHHHHHHHhCCHHHHHHHHhCCCCCCccccCCCCC
Confidence 45577899999999999986 46889999999999998 599999999999999999999998 49999999999999
Q ss_pred ccccccccchHHHHHHHHHhCCCCC
Q 013214 109 PLGDAIYYKNHEVIKLLEKHGAKPL 133 (447)
Q Consensus 109 pl~~a~~~~~~~~~~~L~~~~a~~~ 133 (447)
|||+|+..|+.+++++|+++|+++.
T Consensus 129 pL~~A~~~~~~~i~~~Ll~~ga~~~ 153 (154)
T PHA02736 129 PYYVACERHDAKMMNILRAKGAQCK 153 (154)
T ss_pred HHHHHHHcCCHHHHHHHHHcCCCCC
Confidence 9999999999999999999998864
No 436
>PHA02741 hypothetical protein; Provisional
Probab=99.74 E-value=6.6e-18 Score=147.19 Aligned_cols=110 Identities=20% Similarity=0.176 Sum_probs=96.2
Q ss_pred CCCCccchhhHHHHHHHcCCHHHHHHHHH------cCCCCCCCCCCCCCHHHHHHHcCc----HHHHHHHHHcCCCCCCC
Q 013214 33 DDGEEIKPEFRLMFLANERDVEGIKELLD------SGIDVNFRDIDNRTALHVAACQGF----TEVVSLLLERGADVDPK 102 (447)
Q Consensus 33 ~~~~~~~g~t~lh~a~~~~~~~~~~~Ll~------~g~d~n~~d~~g~t~Lh~A~~~g~----~~~v~~Ll~~ga~~~~~ 102 (447)
.+.++..|+||||+||..|+.++++.|+. .|+++|.+|..|+||||+|+..|+ .+++++|+++|+++|.+
T Consensus 14 ~~~~~~~g~t~Lh~Aa~~g~~~~v~~l~~~~~~~~~ga~in~~d~~g~T~Lh~A~~~g~~~~~~~ii~~Ll~~gadin~~ 93 (169)
T PHA02741 14 IAEKNSEGENFFHEAARCGCFDIIARFTPFIRGDCHAAALNATDDAGQMCIHIAAEKHEAQLAAEIIDHLIELGADINAQ 93 (169)
T ss_pred hhccccCCCCHHHHHHHcCCHHHHHHHHHHhccchhhhhhhccCCCCCcHHHHHHHcCChHHHHHHHHHHHHcCCCCCCC
Confidence 34556678899999999999999999854 369999999999999999999998 58999999999999999
Q ss_pred CC-CCCCccccccccchHHHHHHHHH-hCCCCCCCccccccc
Q 013214 103 DR-WGSTPLGDAIYYKNHEVIKLLEK-HGAKPLMAPMHVKHA 142 (447)
Q Consensus 103 d~-~g~tpl~~a~~~~~~~~~~~L~~-~~a~~~~~~~~~~~~ 142 (447)
|. .|+||||+|+..++.+++++|++ .|+++...+....++
T Consensus 94 ~~~~g~TpLh~A~~~~~~~iv~~Ll~~~g~~~~~~n~~g~tp 135 (169)
T PHA02741 94 EMLEGDTALHLAAHRRDHDLAEWLCCQPGIDLHFCNADNKSP 135 (169)
T ss_pred CcCCCCCHHHHHHHcCCHHHHHHHHhCCCCCCCcCCCCCCCH
Confidence 85 99999999999999999999997 589887765544433
No 437
>PRK14879 serine/threonine protein kinase; Provisional
Probab=99.74 E-value=1.1e-16 Score=144.95 Aligned_cols=134 Identities=23% Similarity=0.378 Sum_probs=111.0
Q ss_pred eeeecceEEEEE---EcCeEEEEEEcCcccCCCHH-----HHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEecc
Q 013214 161 VEITKGTFILAF---WRGIQVAVKKLGEEVISDDD-----RVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYL 232 (447)
Q Consensus 161 ~~lg~G~~~~~~---~~g~~vavK~~~~~~~~~~~-----~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 232 (447)
+.||+|++|.++ +.|..+++|........... ....+.+|+.++..+.|+++.....++......+++|||+
T Consensus 2 ~~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 81 (211)
T PRK14879 2 KLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYI 81 (211)
T ss_pred cccccCceEEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEe
Confidence 468999998775 57899999986543322221 2345778999999999999888777777778889999999
Q ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccc
Q 013214 233 PKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 302 (447)
Q Consensus 233 ~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~ 302 (447)
+|++|.+.+..... ....++.+++.+|.++|+.+ ++|+|++|.||+++ ++.++++|||.+..
T Consensus 82 ~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 82 EGEPLKDLINSNGM----EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred CCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999865432 77889999999999999999 99999999999999 78899999998763
No 438
>PHA02795 ankyrin-like protein; Provisional
Probab=99.73 E-value=2.3e-18 Score=167.47 Aligned_cols=130 Identities=23% Similarity=0.125 Sum_probs=107.1
Q ss_pred ccceeee-ecccCCCCccccchhc-ccCCCCCCCccchhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHH
Q 013214 5 VPVRTTL-LKQSSLAPDRERKEAE-LNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAAC 82 (447)
Q Consensus 5 ~~~~~~~-~~~~~~~~~~~~~~a~-~n~~d~~~~~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~ 82 (447)
+|+..+. .+...+..+..+.||+ .|..+.+..+..|.|++|.|+..++.+++++|+++|||+|.+|.+|+||||+|+.
T Consensus 151 t~lh~A~~~~~~eIVk~Lls~Ga~~~n~~~~~l~~~~~~t~l~~a~~~~~~eIve~LIs~GADIN~kD~~G~TpLh~Aa~ 230 (437)
T PHA02795 151 NAYFRGICKKESSVVEFILNCGIPDENDVKLDLYKIIQYTRGFLVDEPTVLEIYKLCIPYIEDINQLDAGGRTLLYRAIY 230 (437)
T ss_pred CHHHHHHHcCcHHHHHHHHhcCCcccccccchhhhhhccchhHHHHhcCHHHHHHHHHhCcCCcCcCCCCCCCHHHHHHH
Confidence 3444444 2456666677777763 3333333444567889999999999999999999999999999999999999999
Q ss_pred cCcHHHHHHHHHcCCCCCCCCCCCCCccccccccc--------hHHHHHHHHHhCCCCCC
Q 013214 83 QGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYK--------NHEVIKLLEKHGAKPLM 134 (447)
Q Consensus 83 ~g~~~~v~~Ll~~ga~~~~~d~~g~tpl~~a~~~~--------~~~~~~~L~~~~a~~~~ 134 (447)
.|+.+++++|+++||++|.+|..|.||||+|+..| +.+++++|+++|+++..
T Consensus 231 ~g~~eiVelLL~~GAdIN~~d~~G~TpLh~Aa~~g~~~~~~~~~~eIvelLL~~gadI~~ 290 (437)
T PHA02795 231 AGYIDLVSWLLENGANVNAVMSNGYTCLDVAVDRGSVIARRETHLKILEILLREPLSIDC 290 (437)
T ss_pred cCCHHHHHHHHHCCCCCCCcCCCCCCHHHHHHHcCCcccccccHHHHHHHHHhCCCCCCc
Confidence 99999999999999999999999999999999988 46899999999988754
No 439
>PHA02878 ankyrin repeat protein; Provisional
Probab=99.73 E-value=1.1e-17 Score=170.19 Aligned_cols=108 Identities=31% Similarity=0.436 Sum_probs=99.1
Q ss_pred cCCCCCCCccc-hhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCCCCC
Q 013214 29 NGLDDDGEEIK-PEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGS 107 (447)
Q Consensus 29 n~~d~~~~~~~-g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~ 107 (447)
+|.|.+..+.. |+||||+||..|+.+++++|+++|+|+|.+|..|+||||+|+..|+.+++++|++.|++++.+|..|.
T Consensus 156 ~gadin~~~~~~g~tpLh~A~~~~~~~iv~~Ll~~gad~n~~d~~g~tpLh~A~~~~~~~iv~~Ll~~ga~in~~d~~g~ 235 (477)
T PHA02878 156 YGADINMKDRHKGNTALHYATENKDQRLTELLLSYGANVNIPDKTNNSPLHHAVKHYNKPIVHILLENGASTDARDKCGN 235 (477)
T ss_pred cCCCCCccCCCCCCCHHHHHHhCCCHHHHHHHHHCCCCCCCcCCCCCCHHHHHHHhCCHHHHHHHHHcCCCCCCCCCCCC
Confidence 35555556666 89999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred Ccccccccc-chHHHHHHHHHhCCCCCCCc
Q 013214 108 TPLGDAIYY-KNHEVIKLLEKHGAKPLMAP 136 (447)
Q Consensus 108 tpl~~a~~~-~~~~~~~~L~~~~a~~~~~~ 136 (447)
||||+|+.. ++.+++++|+++|++++...
T Consensus 236 TpLh~A~~~~~~~~iv~~Ll~~gadvn~~~ 265 (477)
T PHA02878 236 TPLHISVGYCKDYDILKLLLEHGVDVNAKS 265 (477)
T ss_pred CHHHHHHHhcCCHHHHHHHHHcCCCCCccC
Confidence 999999975 68999999999999987643
No 440
>PHA02859 ankyrin repeat protein; Provisional
Probab=99.73 E-value=1.7e-17 Score=149.62 Aligned_cols=109 Identities=25% Similarity=0.269 Sum_probs=94.7
Q ss_pred CCCCccchhhHHHHHHHcC--CHHHHHHHHHcCCCCCCCC-CCCCCHHHHHHHc---CcHHHHHHHHHcCCCCCCCCCCC
Q 013214 33 DDGEEIKPEFRLMFLANER--DVEGIKELLDSGIDVNFRD-IDNRTALHVAACQ---GFTEVVSLLLERGADVDPKDRWG 106 (447)
Q Consensus 33 ~~~~~~~g~t~lh~a~~~~--~~~~~~~Ll~~g~d~n~~d-~~g~t~Lh~A~~~---g~~~~v~~Ll~~ga~~~~~d~~g 106 (447)
.+..+..|.||||+|+..+ +.+++++|+++|+|+|.++ ..|+||||+|+.. ++.+++++|+++|+++|.+|..|
T Consensus 44 ~n~~~~~g~TpLh~a~~~~~~~~eiv~~Ll~~gadvn~~~~~~g~TpLh~a~~~~~~~~~eiv~~Ll~~gadin~~d~~G 123 (209)
T PHA02859 44 VNDCNDLYETPIFSCLEKDKVNVEILKFLIENGADVNFKTRDNNLSALHHYLSFNKNVEPEILKILIDSGSSITEEDEDG 123 (209)
T ss_pred hhccCccCCCHHHHHHHcCCCCHHHHHHHHHCCCCCCccCCCCCCCHHHHHHHhCccccHHHHHHHHHCCCCCCCcCCCC
Confidence 3445677899999999855 8999999999999999997 5899999998864 47999999999999999999999
Q ss_pred CCccccccc--cchHHHHHHHHHhCCCCCCCcccccc
Q 013214 107 STPLGDAIY--YKNHEVIKLLEKHGAKPLMAPMHVKH 141 (447)
Q Consensus 107 ~tpl~~a~~--~~~~~~~~~L~~~~a~~~~~~~~~~~ 141 (447)
.||||+|+. .++.+++++|+++|++++..+..+.+
T Consensus 124 ~TpLh~a~~~~~~~~~iv~~Li~~gadin~~d~~g~t 160 (209)
T PHA02859 124 KNLLHMYMCNFNVRINVIKLLIDSGVSFLNKDFDNNN 160 (209)
T ss_pred CCHHHHHHHhccCCHHHHHHHHHcCCCcccccCCCCc
Confidence 999999876 46899999999999999876554433
No 441
>PHA02874 ankyrin repeat protein; Provisional
Probab=99.73 E-value=1.7e-17 Score=167.00 Aligned_cols=107 Identities=33% Similarity=0.491 Sum_probs=101.0
Q ss_pred CCCCCCCccchhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCCCCCCc
Q 013214 30 GLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTP 109 (447)
Q Consensus 30 ~~d~~~~~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tp 109 (447)
|.|.+.++..|.||||+||..|+.+++++|++.|+|+|.+|.+|.||||+|+..|+.+++++|+++|++++..|..|.||
T Consensus 114 g~d~n~~~~~g~T~Lh~A~~~~~~~~v~~Ll~~gad~n~~d~~g~tpLh~A~~~~~~~iv~~Ll~~g~~~n~~~~~g~tp 193 (434)
T PHA02874 114 GIDVNIKDAELKTFLHYAIKKGDLESIKMLFEYGADVNIEDDNGCYPIHIAIKHNFFDIIKLLLEKGAYANVKDNNGESP 193 (434)
T ss_pred cCCCCCCCCCCccHHHHHHHCCCHHHHHHHHhCCCCCCCcCCCCCCHHHHHHHCCcHHHHHHHHHCCCCCCCCCCCCCCH
Confidence 55667778889999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccccccchHHHHHHHHHhCCCCCCCc
Q 013214 110 LGDAIYYKNHEVIKLLEKHGAKPLMAP 136 (447)
Q Consensus 110 l~~a~~~~~~~~~~~L~~~~a~~~~~~ 136 (447)
||+|+..|+.+++++|+++|+++....
T Consensus 194 L~~A~~~g~~~iv~~Ll~~g~~i~~~~ 220 (434)
T PHA02874 194 LHNAAEYGDYACIKLLIDHGNHIMNKC 220 (434)
T ss_pred HHHHHHcCCHHHHHHHHhCCCCCcCCC
Confidence 999999999999999999999876544
No 442
>KOG0508 consensus Ankyrin repeat protein [General function prediction only]
Probab=99.72 E-value=3.4e-18 Score=160.94 Aligned_cols=104 Identities=29% Similarity=0.381 Sum_probs=94.7
Q ss_pred CCCCCCCccchhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCCCCCCc
Q 013214 30 GLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTP 109 (447)
Q Consensus 30 ~~d~~~~~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tp 109 (447)
|++.|..+....|||-.||..|+.+++++|+++|+|++..|..|.|.||+||+.||.+|+++|++.|||+|.++..|+|+
T Consensus 107 ga~VN~tT~TNStPLraACfDG~leivKyLvE~gad~~IanrhGhTcLmIa~ykGh~~I~qyLle~gADvn~ks~kGNTA 186 (615)
T KOG0508|consen 107 GASVNDTTRTNSTPLRAACFDGHLEIVKYLVEHGADPEIANRHGHTCLMIACYKGHVDIAQYLLEQGADVNAKSYKGNTA 186 (615)
T ss_pred cCccccccccCCccHHHHHhcchhHHHHHHHHcCCCCcccccCCCeeEEeeeccCchHHHHHHHHhCCCcchhcccCchH
Confidence 34555555666789999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccccccchHHHHHHHHHhCCCCC
Q 013214 110 LGDAIYYKNHEVIKLLEKHGAKPL 133 (447)
Q Consensus 110 l~~a~~~~~~~~~~~L~~~~a~~~ 133 (447)
||.|+..|+.+++++|+++|+.+.
T Consensus 187 LH~caEsG~vdivq~Ll~~ga~i~ 210 (615)
T KOG0508|consen 187 LHDCAESGSVDIVQLLLKHGAKID 210 (615)
T ss_pred HHhhhhcccHHHHHHHHhCCceee
Confidence 999999999999999999988763
No 443
>KOG0512 consensus Fetal globin-inducing factor (contains ankyrin repeats) [Transcription]
Probab=99.72 E-value=1.9e-17 Score=136.17 Aligned_cols=94 Identities=35% Similarity=0.435 Sum_probs=88.0
Q ss_pred hHHHHHHHcCCHHHHHHHHHcCCC-CCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCCCCCCccccccccchHH
Q 013214 42 FRLMFLANERDVEGIKELLDSGID-VNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHE 120 (447)
Q Consensus 42 t~lh~a~~~~~~~~~~~Ll~~g~d-~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tpl~~a~~~~~~~ 120 (447)
-.+.+|+..+....|+.|++..+| +|.+|.+|.||||.|+++|+.+||+.|+..||+++++...|+||||-||.+.+.+
T Consensus 65 rl~lwaae~nrl~eV~~lL~e~an~vNtrD~D~YTpLHRAaYn~h~div~~ll~~gAn~~a~T~~GWTPLhSAckWnN~~ 144 (228)
T KOG0512|consen 65 RLLLWAAEKNRLTEVQRLLSEKANHVNTRDEDEYTPLHRAAYNGHLDIVHELLLSGANKEAKTNEGWTPLHSACKWNNFE 144 (228)
T ss_pred HHHHHHHhhccHHHHHHHHHhccccccccccccccHHHHHHhcCchHHHHHHHHccCCcccccccCccchhhhhcccchh
Confidence 347899999999999999988777 9999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCC
Q 013214 121 VIKLLEKHGAKPLMA 135 (447)
Q Consensus 121 ~~~~L~~~~a~~~~~ 135 (447)
++..|+++|++++..
T Consensus 145 va~~LLqhgaDVnA~ 159 (228)
T KOG0512|consen 145 VAGRLLQHGADVNAQ 159 (228)
T ss_pred HHHHHHhccCccccc
Confidence 999999999998654
No 444
>KOG0512 consensus Fetal globin-inducing factor (contains ankyrin repeats) [Transcription]
Probab=99.72 E-value=1.5e-17 Score=136.86 Aligned_cols=95 Identities=27% Similarity=0.244 Sum_probs=87.3
Q ss_pred CCCCccchhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCCCCCCcccc
Q 013214 33 DDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGD 112 (447)
Q Consensus 33 ~~~~~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tpl~~ 112 (447)
.|.+|.+|.||||-|+++|+.+++..|+..|||++++...||||||-||.+++.+++.+||++|||+|+..+...||||+
T Consensus 90 vNtrD~D~YTpLHRAaYn~h~div~~ll~~gAn~~a~T~~GWTPLhSAckWnN~~va~~LLqhgaDVnA~t~g~ltpLhl 169 (228)
T KOG0512|consen 90 VNTRDEDEYTPLHRAAYNGHLDIVHELLLSGANKEAKTNEGWTPLHSACKWNNFEVAGRLLQHGADVNAQTKGLLTPLHL 169 (228)
T ss_pred ccccccccccHHHHHHhcCchHHHHHHHHccCCcccccccCccchhhhhcccchhHHHHHHhccCcccccccccchhhHH
Confidence 57888899999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccchH-HHHHHHHH
Q 013214 113 AIYYKNH-EVIKLLEK 127 (447)
Q Consensus 113 a~~~~~~-~~~~~L~~ 127 (447)
|+...+. ..+.+|+.
T Consensus 170 aa~~rn~r~t~~~Ll~ 185 (228)
T KOG0512|consen 170 AAGNRNSRDTLELLLH 185 (228)
T ss_pred hhcccchHHHHHHHhh
Confidence 9987654 45555553
No 445
>PHA02875 ankyrin repeat protein; Provisional
Probab=99.71 E-value=2.9e-17 Score=164.35 Aligned_cols=100 Identities=24% Similarity=0.239 Sum_probs=89.6
Q ss_pred ccchhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCCCCCCcccccccc
Q 013214 37 EIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYY 116 (447)
Q Consensus 37 ~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tpl~~a~~~ 116 (447)
+.+|+||||+||..|+.+++++|+++|+|+|.+|.+|.||||+|+..|+.+++++|+++|++++.+|..|.||||+|+..
T Consensus 99 ~~~g~tpL~~A~~~~~~~iv~~Ll~~gad~~~~~~~g~tpLh~A~~~~~~~~v~~Ll~~g~~~~~~d~~g~TpL~~A~~~ 178 (413)
T PHA02875 99 YKDGMTPLHLATILKKLDIMKLLIARGADPDIPNTDKFSPLHLAVMMGDIKGIELLIDHKACLDIEDCCGCTPLIIAMAK 178 (413)
T ss_pred cCCCCCHHHHHHHhCCHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHc
Confidence 45688999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred chHHHHHHHHHhCCCCCCCc
Q 013214 117 KNHEVIKLLEKHGAKPLMAP 136 (447)
Q Consensus 117 ~~~~~~~~L~~~~a~~~~~~ 136 (447)
|+.+++++|+++|++++...
T Consensus 179 g~~eiv~~Ll~~ga~~n~~~ 198 (413)
T PHA02875 179 GDIAICKMLLDSGANIDYFG 198 (413)
T ss_pred CCHHHHHHHHhCCCCCCcCC
Confidence 99999999999999887643
No 446
>PLN03192 Voltage-dependent potassium channel; Provisional
Probab=99.71 E-value=2.7e-17 Score=177.30 Aligned_cols=111 Identities=27% Similarity=0.282 Sum_probs=97.5
Q ss_pred cCCCCCCCccchhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHH--------------------------
Q 013214 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAAC-------------------------- 82 (447)
Q Consensus 29 n~~d~~~~~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~-------------------------- 82 (447)
+|.|+|..|.+|+||||+||..|+.++++.|+++|+|+|.+|.+|+||||+|+.
T Consensus 547 ~G~d~n~~d~~G~TpLh~Aa~~g~~~~v~~Ll~~gadin~~d~~G~TpL~~A~~~g~~~iv~~L~~~~~~~~~~~~~~~L 626 (823)
T PLN03192 547 AKLDPDIGDSKGRTPLHIAASKGYEDCVLVLLKHACNVHIRDANGNTALWNAISAKHHKIFRILYHFASISDPHAAGDLL 626 (823)
T ss_pred CCCCCCCCCCCCCCHHHHHHHcChHHHHHHHHhcCCCCCCcCCCCCCHHHHHHHhCCHHHHHHHHhcCcccCcccCchHH
Confidence 455566677788999999999999999999999999999999999999886554
Q ss_pred -----cCcHHHHHHHHHcCCCCCCCCCCCCCccccccccchHHHHHHHHHhCCCCCCCcccc
Q 013214 83 -----QGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHV 139 (447)
Q Consensus 83 -----~g~~~~v~~Ll~~ga~~~~~d~~g~tpl~~a~~~~~~~~~~~L~~~~a~~~~~~~~~ 139 (447)
+|+.+++++|+++|+|+|.+|.+|.||||+|+..|+.+++++|+++|++++..+.+.
T Consensus 627 ~~Aa~~g~~~~v~~Ll~~Gadin~~d~~G~TpLh~A~~~g~~~iv~~Ll~~GAdv~~~~~~g 688 (823)
T PLN03192 627 CTAAKRNDLTAMKELLKQGLNVDSEDHQGATALQVAMAEDHVDMVRLLIMNGADVDKANTDD 688 (823)
T ss_pred HHHHHhCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHCCcHHHHHHHHHcCCCCCCCCCCC
Confidence 555566777888999999999999999999999999999999999999998765544
No 447
>PHA02743 Viral ankyrin protein; Provisional
Probab=99.71 E-value=1.7e-17 Score=144.07 Aligned_cols=113 Identities=19% Similarity=0.191 Sum_probs=93.9
Q ss_pred cCCCCCCCccchhhHHHHHHHcCCH----HHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHH---HHHHHHcCCCCCC
Q 013214 29 NGLDDDGEEIKPEFRLMFLANERDV----EGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEV---VSLLLERGADVDP 101 (447)
Q Consensus 29 n~~d~~~~~~~g~t~lh~a~~~~~~----~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~---v~~Ll~~ga~~~~ 101 (447)
|+.|.+..+.++.++||+||..|+. +++++|++.|+++|.+|.+|+||||+|+..|+.+. +++|++.|+++|.
T Consensus 9 ~~~~~~~~~~~~~~~l~~a~~~g~~~~l~~~~~~l~~~g~~~~~~d~~g~t~Lh~Aa~~g~~~~~~~i~~Ll~~Gadin~ 88 (166)
T PHA02743 9 NNLGAVEIDEDEQNTFLRICRTGNIYELMEVAPFISGDGHLLHRYDHHGRQCTHMVAWYDRANAVMKIELLVNMGADINA 88 (166)
T ss_pred cchHHhhhccCCCcHHHHHHHcCCHHHHHHHHHHHhhcchhhhccCCCCCcHHHHHHHhCccCHHHHHHHHHHcCCCCCC
Confidence 3444444444555679999999998 66667888999999999999999999999988654 8999999999999
Q ss_pred CC-CCCCCccccccccchHHHHHHHHH-hCCCCCCCcccccc
Q 013214 102 KD-RWGSTPLGDAIYYKNHEVIKLLEK-HGAKPLMAPMHVKH 141 (447)
Q Consensus 102 ~d-~~g~tpl~~a~~~~~~~~~~~L~~-~~a~~~~~~~~~~~ 141 (447)
+| ..|.||||+|+..++.+++++|+. .|+++........+
T Consensus 89 ~d~~~g~TpLh~A~~~g~~~iv~~Ll~~~gad~~~~d~~g~t 130 (166)
T PHA02743 89 RELGTGNTLLHIAASTKNYELAEWLCRQLGVNLGAINYQHET 130 (166)
T ss_pred CCCCCCCcHHHHHHHhCCHHHHHHHHhccCCCccCcCCCCCC
Confidence 98 589999999999999999999995 89998766544433
No 448
>PHA02884 ankyrin repeat protein; Provisional
Probab=99.71 E-value=4.5e-17 Score=152.52 Aligned_cols=99 Identities=19% Similarity=0.113 Sum_probs=79.4
Q ss_pred HHHHHHHcCCHHHHHHHHHcCCCCCCCC----CCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCC-CCCCCCccccccccc
Q 013214 43 RLMFLANERDVEGIKELLDSGIDVNFRD----IDNRTALHVAACQGFTEVVSLLLERGADVDPK-DRWGSTPLGDAIYYK 117 (447)
Q Consensus 43 ~lh~a~~~~~~~~~~~Ll~~g~d~n~~d----~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~-d~~g~tpl~~a~~~~ 117 (447)
+||.|+..|+.+++++|+++|||+|.++ ..|.||||+|+..|+.+++++|+++|||+|.+ +..|.||||+|+..+
T Consensus 36 lL~~A~~~~~~eivk~LL~~GAdiN~~~~~sd~~g~TpLh~Aa~~~~~eivklLL~~GADVN~~~~~~g~TpLh~Aa~~~ 115 (300)
T PHA02884 36 ILYSSIKFHYTDIIDAILKLGADPEAPFPLSENSKTNPLIYAIDCDNDDAAKLLIRYGADVNRYAEEAKITPLYISVLHG 115 (300)
T ss_pred HHHHHHHcCCHHHHHHHHHCCCCccccCcccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCcCcccCCCCCCHHHHHHHcC
Confidence 4566777788888888888888888874 57888888888888888888888888888876 457888888888888
Q ss_pred hHHHHHHHHHhCCCCCCCcccccc
Q 013214 118 NHEVIKLLEKHGAKPLMAPMHVKH 141 (447)
Q Consensus 118 ~~~~~~~L~~~~a~~~~~~~~~~~ 141 (447)
+.+++++|+++|++++.....+.+
T Consensus 116 ~~eivklLL~~GAdin~kd~~G~T 139 (300)
T PHA02884 116 CLKCLEILLSYGADINIQTNDMVT 139 (300)
T ss_pred CHHHHHHHHHCCCCCCCCCCCCCC
Confidence 888888888888888766544433
No 449
>PHA02946 ankyin-like protein; Provisional
Probab=99.71 E-value=3.9e-17 Score=163.69 Aligned_cols=112 Identities=21% Similarity=0.245 Sum_probs=96.4
Q ss_pred cCCCCCCCccchhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcC--cHHHHHHHHHcCCCCCC-CCCC
Q 013214 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQG--FTEVVSLLLERGADVDP-KDRW 105 (447)
Q Consensus 29 n~~d~~~~~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g--~~~~v~~Ll~~ga~~~~-~d~~ 105 (447)
+|.|++.++.+|+||||+||..|+.+++++|+++|+|+|.+|.+|+||||+|+..+ ..+++++|+++|++++. .|..
T Consensus 61 ~Gadvn~~d~~G~TpLh~Aa~~g~~eiv~lLL~~GAdin~~d~~g~TpLh~A~~~~~~~~e~v~lLl~~Gadin~~~d~~ 140 (446)
T PHA02946 61 RGYSPNETDDDGNYPLHIASKINNNRIVAMLLTHGADPNACDKQHKTPLYYLSGTDDEVIERINLLVQYGAKINNSVDEE 140 (446)
T ss_pred CcCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCcCCCCCCCCCCCCHHHHHHHcCCchHHHHHHHHHcCCCcccccCCC
Confidence 44555566667889999999999999999999999999999999999999998876 48899999999999995 6899
Q ss_pred CCCccccccccchHHHHHHHHHhCCCCCCCcccccc
Q 013214 106 GSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKH 141 (447)
Q Consensus 106 g~tpl~~a~~~~~~~~~~~L~~~~a~~~~~~~~~~~ 141 (447)
|.|||+ |+..++.+++++|++.|++++..+..+.+
T Consensus 141 g~tpL~-aa~~~~~~vv~~Ll~~gad~~~~d~~G~t 175 (446)
T PHA02946 141 GCGPLL-ACTDPSERVFKKIMSIGFEARIVDKFGKN 175 (446)
T ss_pred CCcHHH-HHHCCChHHHHHHHhccccccccCCCCCC
Confidence 999997 66778999999999999998776554433
No 450
>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]
Probab=99.70 E-value=2.4e-18 Score=166.07 Aligned_cols=170 Identities=27% Similarity=0.404 Sum_probs=127.2
Q ss_pred ceEEEEeccCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccc
Q 013214 224 PMMIVTEYLPKGDLRAFLKRKG---ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS 300 (447)
Q Consensus 224 ~~~lv~e~~~~g~L~~~l~~~~---~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~ 300 (447)
.+++.|++|...+|.+++..+. ..+......+..|++.|+.| ++ .+|+|+||.||+...+..+||.|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhhe
Confidence 5789999999999999997543 36777888999999999999 66 999999999999999999999999998
Q ss_pred cccccCC-----CCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCC
Q 013214 301 KLLTVKE-----DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPF 374 (447)
Q Consensus 301 ~~~~~~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~ 374 (447)
....... ....+...||..||+||.+.+..|+.++||||||++++|++. -.-++.... ....+..+..|+.
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~---t~~d~r~g~ip~~ 480 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIA---TLTDIRDGIIPPE 480 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHH---hhhhhhcCCCChH
Confidence 7665443 122345678999999999999999999999999999999997 222222111 1111112222210
Q ss_pred CCChhhhHHHHHHHHHHHcccCCCCCCCHHH
Q 013214 375 KAPAKLYARGLKELIEECWNEKPAKRPTFRQ 405 (447)
Q Consensus 375 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ 405 (447)
...++ +.-..|+.+++...|.+||++.+
T Consensus 481 --~~~d~-p~e~~ll~~lls~~p~~RP~~~~ 508 (516)
T KOG1033|consen 481 --FLQDY-PEEYTLLQQLLSPSPEERPSAIE 508 (516)
T ss_pred --HhhcC-cHHHHHHHHhcCCCcccCchHHH
Confidence 11122 23347899999999999994443
No 451
>PHA02875 ankyrin repeat protein; Provisional
Probab=99.70 E-value=5.8e-17 Score=162.18 Aligned_cols=107 Identities=25% Similarity=0.320 Sum_probs=98.8
Q ss_pred cCCCCCCCccchhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCCCCC-
Q 013214 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGS- 107 (447)
Q Consensus 29 n~~d~~~~~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~- 107 (447)
.|.|++..+.+|+||||+|+..|+.+++++|+++|+++|.+|..|+||||+|+..|+.+++++|+++|++++..+..|.
T Consensus 124 ~gad~~~~~~~g~tpLh~A~~~~~~~~v~~Ll~~g~~~~~~d~~g~TpL~~A~~~g~~eiv~~Ll~~ga~~n~~~~~~~~ 203 (413)
T PHA02875 124 RGADPDIPNTDKFSPLHLAVMMGDIKGIELLIDHKACLDIEDCCGCTPLIIAMAKGDIAICKMLLDSGANIDYFGKNGCV 203 (413)
T ss_pred CCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHhCCCCCCcCCCCCCc
Confidence 3455566667789999999999999999999999999999999999999999999999999999999999999998886
Q ss_pred CccccccccchHHHHHHHHHhCCCCCCC
Q 013214 108 TPLGDAIYYKNHEVIKLLEKHGAKPLMA 135 (447)
Q Consensus 108 tpl~~a~~~~~~~~~~~L~~~~a~~~~~ 135 (447)
||+|+|+..|+.+++++|+++|++++..
T Consensus 204 t~l~~A~~~~~~~iv~~Ll~~gad~n~~ 231 (413)
T PHA02875 204 AALCYAIENNKIDIVRLFIKRGADCNIM 231 (413)
T ss_pred hHHHHHHHcCCHHHHHHHHHCCcCcchH
Confidence 7899999999999999999999998753
No 452
>PHA02716 CPXV016; CPX019; EVM010; Provisional
Probab=99.70 E-value=4.4e-17 Score=169.00 Aligned_cols=107 Identities=20% Similarity=0.171 Sum_probs=65.1
Q ss_pred CCCCCCccchhhHHHHHHHcCC--HHHHHHHHHcCCCCCCCCCCCCCHHHHH----------------------------
Q 013214 31 LDDDGEEIKPEFRLMFLANERD--VEGIKELLDSGIDVNFRDIDNRTALHVA---------------------------- 80 (447)
Q Consensus 31 ~d~~~~~~~g~t~lh~a~~~~~--~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A---------------------------- 80 (447)
.|.+.+|..|+||||+|+..|+ .+++++|+++|||+|.+|..|+||||+|
T Consensus 203 ADVN~kD~~G~TPLH~Aa~~g~~~~eIVklLLe~GADVN~kD~~G~TPLh~Ai~~a~n~~~EIvkiLie~~d~n~~~~~~ 282 (764)
T PHA02716 203 VNVNLQNNHLITPLHTYLITGNVCASVIKKIIELGGDMDMKCVNGMSPIMTYIINIDNINPEITNIYIESLDGNKVKNIP 282 (764)
T ss_pred CCCCCCCCCCCCHHHHHHHcCCCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHhhhccCHHHHHHHHHhccccccccch
Confidence 3333444455666666666663 3666666666666666666666666653
Q ss_pred ---------HHcCcHHHHHHHHHcCCCCCCCCCCCCCccccccc--cchHHHHHHHHHhCCCCCCCcc
Q 013214 81 ---------ACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIY--YKNHEVIKLLEKHGAKPLMAPM 137 (447)
Q Consensus 81 ---------~~~g~~~~v~~Ll~~ga~~~~~d~~g~tpl~~a~~--~~~~~~~~~L~~~~a~~~~~~~ 137 (447)
+..|+.+++++|+++|++++.+|..|+||||+|+. .++.+++++|+++|++++..+.
T Consensus 283 ~~L~~~i~AA~~g~leiVklLLe~GAdIN~kD~~G~TPLH~Aaa~~~~~~eIVklLLe~GADIN~kD~ 350 (764)
T PHA02716 283 MILHSYITLARNIDISVVYSFLQPGVKLHYKDSAGRTCLHQYILRHNISTDIIKLLHEYGNDLNEPDN 350 (764)
T ss_pred hhhHHHHHHHHcCCHHHHHHHHhCCCceeccCCCCCCHHHHHHHHhCCCchHHHHHHHcCCCCccCCC
Confidence 23355666666666666666666666666666543 3456666666666666655443
No 453
>PHA03095 ankyrin-like protein; Provisional
Probab=99.69 E-value=6.9e-17 Score=164.52 Aligned_cols=111 Identities=29% Similarity=0.332 Sum_probs=99.1
Q ss_pred CCCCCCCccchhhHHHHHHHcC---CHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcC-cHHHHHHHHHcCCCCCCCCCC
Q 013214 30 GLDDDGEEIKPEFRLMFLANER---DVEGIKELLDSGIDVNFRDIDNRTALHVAACQG-FTEVVSLLLERGADVDPKDRW 105 (447)
Q Consensus 30 ~~d~~~~~~~g~t~lh~a~~~~---~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g-~~~~v~~Ll~~ga~~~~~d~~ 105 (447)
|.|.+.++..|.||||+|+..+ +.+++++|++.|+|+|.+|..|+||||+|+..| +.+++++|+++|++++.+|..
T Consensus 37 ga~vn~~~~~g~t~Lh~a~~~~~~~~~~iv~~Ll~~Gadin~~~~~g~TpLh~A~~~~~~~~iv~lLl~~ga~in~~~~~ 116 (471)
T PHA03095 37 GADVNFRGEYGKTPLHLYLHYSSEKVKDIVRLLLEAGADVNAPERCGFTPLHLYLYNATTLDVIKLLIKAGADVNAKDKV 116 (471)
T ss_pred CCCcccCCCCCCCHHHHHHHhcCCChHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHcCCcHHHHHHHHHcCCCCCCCCCC
Confidence 4444555566788999999999 999999999999999999999999999999999 599999999999999999999
Q ss_pred CCCcccccc--ccchHHHHHHHHHhCCCCCCCccccc
Q 013214 106 GSTPLGDAI--YYKNHEVIKLLEKHGAKPLMAPMHVK 140 (447)
Q Consensus 106 g~tpl~~a~--~~~~~~~~~~L~~~~a~~~~~~~~~~ 140 (447)
|.||||+|+ ..++.+++++|+++|++++..+..+.
T Consensus 117 g~tpLh~a~~~~~~~~~iv~~Ll~~gad~~~~d~~g~ 153 (471)
T PHA03095 117 GRTPLHVYLSGFNINPKVIRLLLRKGADVNALDLYGM 153 (471)
T ss_pred CCCHHHHHhhCCcCCHHHHHHHHHcCCCCCccCCCCC
Confidence 999999999 56789999999999999877655443
No 454
>KOG0502 consensus Integral membrane ankyrin-repeat protein Kidins220 (protein kinase D substrate) [General function prediction only]
Probab=99.69 E-value=5.1e-17 Score=138.75 Aligned_cols=104 Identities=27% Similarity=0.288 Sum_probs=97.6
Q ss_pred CCCccchhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCCCCCCccccc
Q 013214 34 DGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDA 113 (447)
Q Consensus 34 ~~~~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tpl~~a 113 (447)
|.-|..|.|||+||+.+|+++++++|++.|||++...+...|+|.+|++.|..++|++|+.++.|+|.-|.+|-|||-||
T Consensus 154 N~~De~GfTpLiWAaa~G~i~vV~fLL~~GAdp~~lgk~resALsLAt~ggytdiV~lLL~r~vdVNvyDwNGgTpLlyA 233 (296)
T KOG0502|consen 154 NACDEFGFTPLIWAAAKGHIPVVQFLLNSGADPDALGKYRESALSLATRGGYTDIVELLLTREVDVNVYDWNGGTPLLYA 233 (296)
T ss_pred cCccccCchHhHHHHhcCchHHHHHHHHcCCChhhhhhhhhhhHhHHhcCChHHHHHHHHhcCCCcceeccCCCceeeee
Confidence 44556788999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccchHHHHHHHHHhCCCCCCCcc
Q 013214 114 IYYKNHEVIKLLEKHGAKPLMAPM 137 (447)
Q Consensus 114 ~~~~~~~~~~~L~~~~a~~~~~~~ 137 (447)
++.++.++++.|+..||++.....
T Consensus 234 vrgnhvkcve~Ll~sGAd~t~e~d 257 (296)
T KOG0502|consen 234 VRGNHVKCVESLLNSGADVTQEDD 257 (296)
T ss_pred ecCChHHHHHHHHhcCCCcccccc
Confidence 999999999999999999876543
No 455
>PHA02878 ankyrin repeat protein; Provisional
Probab=99.69 E-value=9.2e-17 Score=163.55 Aligned_cols=111 Identities=24% Similarity=0.255 Sum_probs=99.0
Q ss_pred CCCCCCCccchhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHc-CcHHHHHHHHHcCCCCCCCCC-CCC
Q 013214 30 GLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQ-GFTEVVSLLLERGADVDPKDR-WGS 107 (447)
Q Consensus 30 ~~d~~~~~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~-g~~~~v~~Ll~~ga~~~~~d~-~g~ 107 (447)
|.|.+..+..|+||||+|+..|+.+++++|++.|+|+|.+|..|+||||+|+.. ++.+++++|+++|+++|.++. .|.
T Consensus 191 gad~n~~d~~g~tpLh~A~~~~~~~iv~~Ll~~ga~in~~d~~g~TpLh~A~~~~~~~~iv~~Ll~~gadvn~~~~~~g~ 270 (477)
T PHA02878 191 GANVNIPDKTNNSPLHHAVKHYNKPIVHILLENGASTDARDKCGNTPLHISVGYCKDYDILKLLLEHGVDVNAKSYILGL 270 (477)
T ss_pred CCCCCCcCCCCCCHHHHHHHhCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHhcCCHHHHHHHHHcCCCCCccCCCCCC
Confidence 344555667789999999999999999999999999999999999999999976 789999999999999999986 899
Q ss_pred CccccccccchHHHHHHHHHhCCCCCCCccccccc
Q 013214 108 TPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHA 142 (447)
Q Consensus 108 tpl~~a~~~~~~~~~~~L~~~~a~~~~~~~~~~~~ 142 (447)
||||+| .++.+++++|+++|++++..+..+.++
T Consensus 271 TpLh~A--~~~~~~v~~Ll~~gadin~~d~~g~Tp 303 (477)
T PHA02878 271 TALHSS--IKSERKLKLLLEYGADINSLNSYKLTP 303 (477)
T ss_pred CHHHHH--ccCHHHHHHHHHCCCCCCCcCCCCCCH
Confidence 999999 467899999999999998876655544
No 456
>TIGR03724 arch_bud32 Kae1-associated kinase Bud32. Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.
Probab=99.69 E-value=3.4e-16 Score=140.39 Aligned_cols=129 Identities=26% Similarity=0.374 Sum_probs=104.5
Q ss_pred eecceEEEEE---EcCeEEEEEEcCcccCCCH-----HHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEeccCC
Q 013214 163 ITKGTFILAF---WRGIQVAVKKLGEEVISDD-----DRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234 (447)
Q Consensus 163 lg~G~~~~~~---~~g~~vavK~~~~~~~~~~-----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 234 (447)
||+|++|.++ ++|..|++|.......... .....+.+|+++++.+.|+++.....++......+++|||++|
T Consensus 2 ig~G~~~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~g 81 (199)
T TIGR03724 2 IAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIEG 81 (199)
T ss_pred CCCCceEEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEECC
Confidence 7899998776 6788999998654322221 1235677899999999988766665556666778999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccc
Q 013214 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 302 (447)
Q Consensus 235 g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~ 302 (447)
++|.+.+..... .++.+++.+|.++|+.+ ++|+|++|.||+++ ++.++++|||++..
T Consensus 82 ~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 82 KPLKDVIEEGND-------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred ccHHHHHhhcHH-------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 999998765321 78899999999999999 99999999999999 78999999998764
No 457
>PHA02884 ankyrin repeat protein; Provisional
Probab=99.69 E-value=9e-17 Score=150.49 Aligned_cols=112 Identities=19% Similarity=0.167 Sum_probs=96.8
Q ss_pred ccCCCCccccchhcccCCCCCCCccchhhHHHHHHHcCCHHHHHHHHHcCCCCCCC-CCCCCCHHHHHHHcCcHHHHHHH
Q 013214 14 QSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFR-DIDNRTALHVAACQGFTEVVSLL 92 (447)
Q Consensus 14 ~~~~~~~~~~~~a~~n~~d~~~~~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~-d~~g~t~Lh~A~~~g~~~~v~~L 92 (447)
...+.....+.|||+|..+. ..+..|.||||+|+..|+.+++++|+++|||+|.+ +..|.||||+|+..|+.+++++|
T Consensus 45 ~~eivk~LL~~GAdiN~~~~-~sd~~g~TpLh~Aa~~~~~eivklLL~~GADVN~~~~~~g~TpLh~Aa~~~~~eivklL 123 (300)
T PHA02884 45 YTDIIDAILKLGADPEAPFP-LSENSKTNPLIYAIDCDNDDAAKLLIRYGADVNRYAEEAKITPLYISVLHGCLKCLEIL 123 (300)
T ss_pred CHHHHHHHHHCCCCccccCc-ccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCcCcccCCCCCCHHHHHHHcCCHHHHHHH
Confidence 34455556778888877653 12346899999999999999999999999999986 46899999999999999999999
Q ss_pred HHcCCCCCCCCCCCCCccccccccchHHHHHHHH
Q 013214 93 LERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLE 126 (447)
Q Consensus 93 l~~ga~~~~~d~~g~tpl~~a~~~~~~~~~~~L~ 126 (447)
+++||+++.+|..|.||+|+|+..++.+++.++.
T Consensus 124 L~~GAdin~kd~~G~TpL~~A~~~~~~~~~~~~~ 157 (300)
T PHA02884 124 LSYGADINIQTNDMVTPIELALMICNNFLAFMIC 157 (300)
T ss_pred HHCCCCCCCCCCCCCCHHHHHHHhCChhHHHHhc
Confidence 9999999999999999999999988888876664
No 458
>PHA02798 ankyrin-like protein; Provisional
Probab=99.68 E-value=6.8e-17 Score=164.92 Aligned_cols=107 Identities=25% Similarity=0.306 Sum_probs=95.4
Q ss_pred cCCCCCCCccchhhHHHHHHHc-----CCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcC---cHHHHHHHHHcCCCCC
Q 013214 29 NGLDDDGEEIKPEFRLMFLANE-----RDVEGIKELLDSGIDVNFRDIDNRTALHVAACQG---FTEVVSLLLERGADVD 100 (447)
Q Consensus 29 n~~d~~~~~~~g~t~lh~a~~~-----~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g---~~~~v~~Ll~~ga~~~ 100 (447)
+|.|.+..+..|.||||.|+.+ +..+++++|+++|+|+|.+|.+|+||||+|+.++ +.+++++|+++||+++
T Consensus 60 ~Gadvn~~d~~g~TpL~~~~~n~~~~~~~~~iv~~Ll~~GadiN~~d~~G~TpLh~a~~~~~~~~~~iv~~Ll~~Gadvn 139 (489)
T PHA02798 60 LGANVNGLDNEYSTPLCTILSNIKDYKHMLDIVKILIENGADINKKNSDGETPLYCLLSNGYINNLEILLFMIENGADTT 139 (489)
T ss_pred CCCCCCCCCCCCCChHHHHHHhHHhHHhHHHHHHHHHHCCCCCCCCCCCcCcHHHHHHHcCCcChHHHHHHHHHcCCCcc
Confidence 3444455556778889998864 6799999999999999999999999999999876 7899999999999999
Q ss_pred CCCCCCCCccccccccch---HHHHHHHHHhCCCCCCC
Q 013214 101 PKDRWGSTPLGDAIYYKN---HEVIKLLEKHGAKPLMA 135 (447)
Q Consensus 101 ~~d~~g~tpl~~a~~~~~---~~~~~~L~~~~a~~~~~ 135 (447)
.+|..|.||||+|+..++ .+++++|+++|++++..
T Consensus 140 ~~d~~g~tpL~~a~~~~~~~~~~vv~~Ll~~gadin~~ 177 (489)
T PHA02798 140 LLDKDGFTMLQVYLQSNHHIDIEIIKLLLEKGVDINTH 177 (489)
T ss_pred ccCCCCCcHHHHHHHcCCcchHHHHHHHHHhCCCcccc
Confidence 999999999999999887 99999999999998764
No 459
>smart00090 RIO RIO-like kinase.
Probab=99.68 E-value=2.1e-16 Score=144.96 Aligned_cols=141 Identities=20% Similarity=0.139 Sum_probs=106.8
Q ss_pred cccceeeecceEEEEE------EcCeEEEEEEcCcccCCC-------------------H--HHHHHHHHHHHHHhcCCC
Q 013214 157 FTNSVEITKGTFILAF------WRGIQVAVKKLGEEVISD-------------------D--DRVRAFRDELALLQKIRH 209 (447)
Q Consensus 157 ~~~~~~lg~G~~~~~~------~~g~~vavK~~~~~~~~~-------------------~--~~~~~~~~E~~~l~~l~h 209 (447)
|...+.||+|++|.++ .+|+.||+|+++...... . .....+..|+.+++++.+
T Consensus 30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~ 109 (237)
T smart00090 30 SAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYE 109 (237)
T ss_pred HHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence 5566789999998774 368999999887542110 0 012345689999999975
Q ss_pred C--cccceeEEEEeCCceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEc
Q 013214 210 P--NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD 287 (447)
Q Consensus 210 p--~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~ 287 (447)
. .++++++. ...++||||++|++|.........+...+...++.|++.++.+||+.+ .++|+||||+||+++
T Consensus 110 ~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Dikp~NIli~ 183 (237)
T smart00090 110 AGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEG--ELVHGDLSEYNILVH 183 (237)
T ss_pred cCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCCChhhEEEE
Confidence 3 34444443 235899999998888776544455677777899999999999999987 399999999999999
Q ss_pred CCCCEEEeecccccccc
Q 013214 288 DSGNLKVADFGVSKLLT 304 (447)
Q Consensus 288 ~~~~vkl~Dfg~~~~~~ 304 (447)
++.++|+|||.+....
T Consensus 184 -~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 184 -DGKVVIIDVSQSVELD 199 (237)
T ss_pred -CCCEEEEEChhhhccC
Confidence 8899999999987543
No 460
>PHA03095 ankyrin-like protein; Provisional
Probab=99.68 E-value=1.1e-16 Score=163.06 Aligned_cols=101 Identities=23% Similarity=0.262 Sum_probs=51.6
Q ss_pred CCCCCccchhhHHHHHHHcCCH--HHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCCCCCCc
Q 013214 32 DDDGEEIKPEFRLMFLANERDV--EGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTP 109 (447)
Q Consensus 32 d~~~~~~~g~t~lh~a~~~~~~--~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tp 109 (447)
|++.+|..|+||||+||..|+. ..++.|++.|+|+|.+|..|+||||+|+..|+.+++++|+++||+++.+|..|.||
T Consensus 214 ~~~~~d~~g~tpLh~Aa~~~~~~~~~v~~ll~~g~din~~d~~g~TpLh~A~~~~~~~~v~~LL~~gad~n~~~~~g~tp 293 (471)
T PHA03095 214 DPAATDMLGNTPLHSMATGSSCKRSLVLPLLIAGISINARNRYGQTPLHYAAVFNNPRACRRLIALGADINAVSSDGNTP 293 (471)
T ss_pred CCcccCCCCCCHHHHHHhcCCchHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCH
Confidence 3333444445555555554442 34444555555555555555555555555555555555555555555555555555
Q ss_pred cccccccchHHHHHHHHHhCCCC
Q 013214 110 LGDAIYYKNHEVIKLLEKHGAKP 132 (447)
Q Consensus 110 l~~a~~~~~~~~~~~L~~~~a~~ 132 (447)
||+|+..|+.++++.|++.++++
T Consensus 294 l~~A~~~~~~~~v~~LL~~~~~~ 316 (471)
T PHA03095 294 LSLMVRNNNGRAVRAALAKNPSA 316 (471)
T ss_pred HHHHHHhCCHHHHHHHHHhCCCH
Confidence 55555555555555555554443
No 461
>PHA03100 ankyrin repeat protein; Provisional
Probab=99.67 E-value=1.5e-16 Score=162.33 Aligned_cols=101 Identities=30% Similarity=0.412 Sum_probs=53.3
Q ss_pred CccchhhHHHHHHHcC--CHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCCCC------C
Q 013214 36 EEIKPEFRLMFLANER--DVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWG------S 107 (447)
Q Consensus 36 ~~~~g~t~lh~a~~~~--~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g------~ 107 (447)
.+..|.||||+|+..| +.+++++|+++|+|+|.+|..|.||||+|+..|+.+++++|+++|++++..+..| .
T Consensus 137 ~~~~g~t~L~~A~~~~~~~~~iv~~Ll~~g~din~~d~~g~tpL~~A~~~~~~~iv~~Ll~~ga~~~~~~~~~~~~~~~~ 216 (480)
T PHA03100 137 KNSDGENLLHLYLESNKIDLKILKLLIDKGVDINAKNRYGYTPLHIAVEKGNIDVIKFLLDNGADINAGDIETLLFTIFE 216 (480)
T ss_pred cCCCCCcHHHHHHHcCCChHHHHHHHHHCCCCcccccCCCCCHHHHHHHhCCHHHHHHHHHcCCCccCCCCCCCcHHHHH
Confidence 3334445555555555 5555555555555555555555555555555555555555555555555555444 4
Q ss_pred Cccccccccch--HHHHHHHHHhCCCCCCCc
Q 013214 108 TPLGDAIYYKN--HEVIKLLEKHGAKPLMAP 136 (447)
Q Consensus 108 tpl~~a~~~~~--~~~~~~L~~~~a~~~~~~ 136 (447)
||+|+|+..++ .+++++|+++|++++..+
T Consensus 217 t~l~~a~~~~~~~~~iv~~Ll~~g~din~~d 247 (480)
T PHA03100 217 TPLHIAACYNEITLEVVNYLLSYGVPINIKD 247 (480)
T ss_pred hHHHHHHHhCcCcHHHHHHHHHcCCCCCCCC
Confidence 55555555554 555555555555544433
No 462
>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated
Probab=99.66 E-value=1.2e-15 Score=157.05 Aligned_cols=134 Identities=24% Similarity=0.239 Sum_probs=108.7
Q ss_pred cccceeeecceEEEEEE---cCeEEEEEEcCcccCC-----CHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEE
Q 013214 157 FTNSVEITKGTFILAFW---RGIQVAVKKLGEEVIS-----DDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 228 (447)
Q Consensus 157 ~~~~~~lg~G~~~~~~~---~g~~vavK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 228 (447)
|...+.||+|+||.|+. .+..+++|+....... .....+.+.+|+++++.++|++++....++......+++
T Consensus 335 ~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv 414 (535)
T PRK09605 335 KIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIV 414 (535)
T ss_pred cCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEE
Confidence 45577899999999874 5556666643222111 112235688999999999999999888877777788999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccc
Q 013214 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 302 (447)
Q Consensus 229 ~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~ 302 (447)
|||++|++|.+++. ....++.+++.+|.+||+.+ ++|||+||+||++ .++.++|+|||+++.
T Consensus 415 ~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 415 MEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred EEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 99999999999885 34678999999999999999 9999999999999 678999999999874
No 463
>PHA02716 CPXV016; CPX019; EVM010; Provisional
Probab=99.66 E-value=2.4e-16 Score=163.53 Aligned_cols=109 Identities=20% Similarity=0.172 Sum_probs=90.6
Q ss_pred CCCCCC-ccchhhHHHHHHHc--CCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCc--HHHHHHHHHcCCCCCCCCCC
Q 013214 31 LDDDGE-EIKPEFRLMFLANE--RDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF--TEVVSLLLERGADVDPKDRW 105 (447)
Q Consensus 31 ~d~~~~-~~~g~t~lh~a~~~--~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~--~~~v~~Ll~~ga~~~~~d~~ 105 (447)
.|.+.+ +..|+||||+|+.. ++.+++++|+++|+|+|.+|.+|+||||+|+..|+ .++|++|+++|||+|.+|..
T Consensus 167 ADIN~~~d~~G~TpLH~A~~n~~~~~eIVklLLe~GADVN~kD~~G~TPLH~Aa~~g~~~~eIVklLLe~GADVN~kD~~ 246 (764)
T PHA02716 167 VNLNYVCKKTGYGILHAYLGNMYVDIDILEWLCNNGVNVNLQNNHLITPLHTYLITGNVCASVIKKIIELGGDMDMKCVN 246 (764)
T ss_pred CCcccccCCCCCcHHHHHHHhccCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCCCCHHHHHHHHHcCCCCCCCCCC
Confidence 444444 56688999998654 67899999999999999999999999999999995 59999999999999999999
Q ss_pred CCCcccccc-------------------------------------ccchHHHHHHHHHhCCCCCCCcccc
Q 013214 106 GSTPLGDAI-------------------------------------YYKNHEVIKLLEKHGAKPLMAPMHV 139 (447)
Q Consensus 106 g~tpl~~a~-------------------------------------~~~~~~~~~~L~~~~a~~~~~~~~~ 139 (447)
|+||||+|+ ..|+.+++++|+++|++++..+..+
T Consensus 247 G~TPLh~Ai~~a~n~~~EIvkiLie~~d~n~~~~~~~~L~~~i~AA~~g~leiVklLLe~GAdIN~kD~~G 317 (764)
T PHA02716 247 GMSPIMTYIINIDNINPEITNIYIESLDGNKVKNIPMILHSYITLARNIDISVVYSFLQPGVKLHYKDSAG 317 (764)
T ss_pred CCCHHHHHHHhhhccCHHHHHHHHHhccccccccchhhhHHHHHHHHcCCHHHHHHHHhCCCceeccCCCC
Confidence 999999753 3456777888888888776655443
No 464
>PHA02798 ankyrin-like protein; Provisional
Probab=99.66 E-value=2.5e-16 Score=160.73 Aligned_cols=105 Identities=24% Similarity=0.325 Sum_probs=80.3
Q ss_pred CCCCCCCccchhhHHHHHHHcC---CHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCc---HHHHHHHHHcCCCCCCCC
Q 013214 30 GLDDDGEEIKPEFRLMFLANER---DVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF---TEVVSLLLERGADVDPKD 103 (447)
Q Consensus 30 ~~d~~~~~~~g~t~lh~a~~~~---~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~---~~~v~~Ll~~ga~~~~~d 103 (447)
|.|.|..+.+|+||||+|+.++ +.+++++|+++|+|+|.+|.+|.||||+|+..|+ .+++++|+++|++++.++
T Consensus 99 GadiN~~d~~G~TpLh~a~~~~~~~~~~iv~~Ll~~Gadvn~~d~~g~tpL~~a~~~~~~~~~~vv~~Ll~~gadin~~~ 178 (489)
T PHA02798 99 GADINKKNSDGETPLYCLLSNGYINNLEILLFMIENGADTTLLDKDGFTMLQVYLQSNHHIDIEIIKLLLEKGVDINTHN 178 (489)
T ss_pred CCCCCCCCCCcCcHHHHHHHcCCcChHHHHHHHHHcCCCccccCCCCCcHHHHHHHcCCcchHHHHHHHHHhCCCccccc
Confidence 3444445556788899999875 6899999999999999999999999999999887 899999999888887764
Q ss_pred -CCCCCcccccccc----chHHHHHHHHHhCCCCCC
Q 013214 104 -RWGSTPLGDAIYY----KNHEVIKLLEKHGAKPLM 134 (447)
Q Consensus 104 -~~g~tpl~~a~~~----~~~~~~~~L~~~~a~~~~ 134 (447)
..|.||+|.++.. ++.+++++|+++|+++..
T Consensus 179 ~~~~~t~Lh~~~~~~~~~~~~~ivk~Li~~Ga~i~~ 214 (489)
T PHA02798 179 NKEKYDTLHCYFKYNIDRIDADILKLFVDNGFIINK 214 (489)
T ss_pred CcCCCcHHHHHHHhccccCCHHHHHHHHHCCCCccc
Confidence 4566777665443 356677777776665543
No 465
>PHA03100 ankyrin repeat protein; Provisional
Probab=99.66 E-value=2.9e-16 Score=160.31 Aligned_cols=95 Identities=29% Similarity=0.456 Sum_probs=48.2
Q ss_pred chhhHHHHHH--HcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcC--cHHHHHHHHHcCCCCCCCCCCCCCcccccc
Q 013214 39 KPEFRLMFLA--NERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQG--FTEVVSLLLERGADVDPKDRWGSTPLGDAI 114 (447)
Q Consensus 39 ~g~t~lh~a~--~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g--~~~~v~~Ll~~ga~~~~~d~~g~tpl~~a~ 114 (447)
.|.||||+|+ ..|+.+++++|+++|+|+|.+|..|.||||+|+..| +.+++++|+++|++++.+|..|.||||+|+
T Consensus 105 ~g~tpL~~A~~~~~~~~~iv~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~~iv~~Ll~~g~din~~d~~g~tpL~~A~ 184 (480)
T PHA03100 105 NGITPLLYAISKKSNSYSIVEYLLDNGANVNIKNSDGENLLHLYLESNKIDLKILKLLIDKGVDINAKNRYGYTPLHIAV 184 (480)
T ss_pred CCCchhhHHHhcccChHHHHHHHHHcCCCCCccCCCCCcHHHHHHHcCCChHHHHHHHHHCCCCcccccCCCCCHHHHHH
Confidence 3444455555 555555555555555555555555555555555555 455555555555555555555555555555
Q ss_pred ccchHHHHHHHHHhCCCCC
Q 013214 115 YYKNHEVIKLLEKHGAKPL 133 (447)
Q Consensus 115 ~~~~~~~~~~L~~~~a~~~ 133 (447)
..|+.+++++|+++|+++.
T Consensus 185 ~~~~~~iv~~Ll~~ga~~~ 203 (480)
T PHA03100 185 EKGNIDVIKFLLDNGADIN 203 (480)
T ss_pred HhCCHHHHHHHHHcCCCcc
Confidence 5555555555555554443
No 466
>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]
Probab=99.65 E-value=1.2e-17 Score=171.57 Aligned_cols=251 Identities=24% Similarity=0.381 Sum_probs=193.1
Q ss_pred CcCcccceeeecceEEEEE------EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC-CCcccceeEEEEeCCceE
Q 013214 154 ELDFTNSVEITKGTFILAF------WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMM 226 (447)
Q Consensus 154 ~~~~~~~~~lg~G~~~~~~------~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~ 226 (447)
...|...+.||+|.|+.+. .....+|+|.+.... ...........|..+-+.+. |+|++.+++...+.+..+
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~ 97 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYL 97 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCcccc
Confidence 4466667779999998654 234556777665443 23444556667888888886 999999999999999999
Q ss_pred EEEeccCCCCHHHHH-HhcC-CCCHHHHHHHHHHHHHHHHHHH-hCCCCCeEeCCCCCCCEEEcCCC-CEEEeecccccc
Q 013214 227 IVTEYLPKGDLRAFL-KRKG-ALKPSTAVRFALDIARGMNYLH-ENKPVPIIHRDLEPSNILRDDSG-NLKVADFGVSKL 302 (447)
Q Consensus 227 lv~e~~~~g~L~~~l-~~~~-~l~~~~~~~i~~ql~~~l~~lH-~~~~~~i~H~Dikp~Nill~~~~-~vkl~Dfg~~~~ 302 (447)
+.++|..|+++.+.+ .... ..+...+..++.|+..++.|+| ..+ +.|+|+||+|.+++..+ .++++|||+|..
T Consensus 98 ~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~ 174 (601)
T KOG0590|consen 98 LSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATA 174 (601)
T ss_pred cccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhcc
Confidence 999999999999988 5444 5777888899999999999999 887 99999999999999999 999999999987
Q ss_pred ccc--CCCCCcccCCC-CCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCC-CCCCCC
Q 013214 303 LTV--KEDRPLTCQDT-SCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQR-PPFKAP 377 (447)
Q Consensus 303 ~~~--~~~~~~~~~~~-t~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~-~~~~~~ 377 (447)
+.. ..........| ++.|+|||...+. ...+..|+||.|+++..+++|..||................+ ......
T Consensus 175 ~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (601)
T KOG0590|consen 175 YRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLP 254 (601)
T ss_pred ccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCc
Confidence 765 22223334456 9999999999884 445789999999999999999999986655432211111111 111223
Q ss_pred hhhhHHHHHHHHHHHcccCCCCCCCHHHHHH
Q 013214 378 AKLYARGLKELIEECWNEKPAKRPTFRQIIT 408 (447)
Q Consensus 378 ~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~ 408 (447)
+...+....+++.+++..+|..|.+.+++-.
T Consensus 255 ~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 255 WNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred cccCChhhhhcccccccCCchhccccccccc
Confidence 4556778889999999999999999888754
No 467
>PHA02874 ankyrin repeat protein; Provisional
Probab=99.65 E-value=6.2e-16 Score=155.65 Aligned_cols=69 Identities=38% Similarity=0.474 Sum_probs=37.6
Q ss_pred CCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCCCCCCccccccccchHHHHHHHHHhCCCCCC
Q 013214 66 VNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLM 134 (447)
Q Consensus 66 ~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tpl~~a~~~~~~~~~~~L~~~~a~~~~ 134 (447)
+|.+|..|.||||+|+..|+.+++++|+++|++++.+|..|.||||+|+..++.+++++|+++|++++.
T Consensus 117 ~n~~~~~g~T~Lh~A~~~~~~~~v~~Ll~~gad~n~~d~~g~tpLh~A~~~~~~~iv~~Ll~~g~~~n~ 185 (434)
T PHA02874 117 VNIKDAELKTFLHYAIKKGDLESIKMLFEYGADVNIEDDNGCYPIHIAIKHNFFDIIKLLLEKGAYANV 185 (434)
T ss_pred CCCCCCCCccHHHHHHHCCCHHHHHHHHhCCCCCCCcCCCCCCHHHHHHHCCcHHHHHHHHHCCCCCCC
Confidence 344455555555555555555555555555555555555555555555555555555555555555443
No 468
>KOG4177 consensus Ankyrin [Cell wall/membrane/envelope biogenesis]
Probab=99.65 E-value=1.5e-16 Score=168.21 Aligned_cols=108 Identities=34% Similarity=0.344 Sum_probs=102.9
Q ss_pred hhcccCCCCCCCccchhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCC
Q 013214 25 EAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDR 104 (447)
Q Consensus 25 ~a~~n~~d~~~~~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~ 104 (447)
..--.|++.+-++..|.||||.||..|++++|++|+++|+|+|.+|+.|+||||.||..|+.+|+++|+++||++|+.|.
T Consensus 525 ~l~~~ga~v~~~~~r~~TpLh~A~~~g~v~~VkfLLe~gAdv~ak~~~G~TPLH~Aa~~G~~~i~~LLlk~GA~vna~d~ 604 (1143)
T KOG4177|consen 525 ILLEHGANVDLRTGRGYTPLHVAVHYGNVDLVKFLLEHGADVNAKDKLGYTPLHQAAQQGHNDIAELLLKHGASVNAADL 604 (1143)
T ss_pred HHhhcCCceehhcccccchHHHHHhcCCchHHHHhhhCCccccccCCCCCChhhHHHHcChHHHHHHHHHcCCCCCcccc
Confidence 33446888899999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCccccccccchHHHHHHHHHhCCCC
Q 013214 105 WGSTPLGDAIYYKNHEVIKLLEKHGAKP 132 (447)
Q Consensus 105 ~g~tpl~~a~~~~~~~~~~~L~~~~a~~ 132 (447)
+|.|||++|...|+.++++.+...++++
T Consensus 605 ~g~TpL~iA~~lg~~~~~k~l~~~~~~~ 632 (1143)
T KOG4177|consen 605 DGFTPLHIAVRLGYLSVVKLLKVVTATP 632 (1143)
T ss_pred cCcchhHHHHHhcccchhhHHHhccCcc
Confidence 9999999999999999999999999983
No 469
>PHA02876 ankyrin repeat protein; Provisional
Probab=99.64 E-value=5.1e-16 Score=164.94 Aligned_cols=113 Identities=28% Similarity=0.325 Sum_probs=94.7
Q ss_pred CCCCCCCccchhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCc-HHHHHHHHHcCCCCCCCCCCCCC
Q 013214 30 GLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF-TEVVSLLLERGADVDPKDRWGST 108 (447)
Q Consensus 30 ~~d~~~~~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~-~~~v~~Ll~~ga~~~~~d~~g~t 108 (447)
|.|.+.++..|+||||+|+..|+.+++++|++.|+|++..+..|.||||+|+..++ ..++++|+++|+++|.+|..|+|
T Consensus 365 gadin~~d~~G~TpLh~Aa~~~~~~iv~~Ll~~gad~~~~~~~g~T~Lh~A~~~~~~~~~vk~Ll~~gadin~~d~~G~T 444 (682)
T PHA02876 365 GANVNARDYCDKTPIHYAAVRNNVVIINTLLDYGADIEALSQKIGTALHFALCGTNPYMSVKTLIDRGANVNSKNKDLST 444 (682)
T ss_pred CCCCccCCCCCCCHHHHHHHcCCHHHHHHHHHCCCCccccCCCCCchHHHHHHcCCHHHHHHHHHhCCCCCCcCCCCCCh
Confidence 44555566678888999999999999999999999999999889999999987665 56789999999999999999999
Q ss_pred ccccccccc-hHHHHHHHHHhCCCCCCCccccccc
Q 013214 109 PLGDAIYYK-NHEVIKLLEKHGAKPLMAPMHVKHA 142 (447)
Q Consensus 109 pl~~a~~~~-~~~~~~~L~~~~a~~~~~~~~~~~~ 142 (447)
|||+|+..+ +.+++++|+++|++++..+..+.++
T Consensus 445 pLh~Aa~~~~~~~iv~lLl~~Gad~n~~d~~g~tp 479 (682)
T PHA02876 445 PLHYACKKNCKLDVIEMLLDNGADVNAINIQNQYP 479 (682)
T ss_pred HHHHHHHhCCcHHHHHHHHHCCCCCCCCCCCCCCH
Confidence 999998866 6899999999999988776655544
No 470
>KOG0508 consensus Ankyrin repeat protein [General function prediction only]
Probab=99.64 E-value=6.6e-16 Score=145.68 Aligned_cols=112 Identities=30% Similarity=0.325 Sum_probs=105.8
Q ss_pred CCCCCCccchhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCCCCCCcc
Q 013214 31 LDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPL 110 (447)
Q Consensus 31 ~d~~~~~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tpl 110 (447)
+.-++.+..|-+||..|+..|+.++++.|+++|++||.......|||--||.-|+.++|++|+++|||++..|..|.|.|
T Consensus 75 V~FDge~IegappLWaAsaAGHl~vVk~L~~~ga~VN~tT~TNStPLraACfDG~leivKyLvE~gad~~IanrhGhTcL 154 (615)
T KOG0508|consen 75 VRFDGETIEGAPPLWAASAAGHLEVVKLLLRRGASVNDTTRTNSTPLRAACFDGHLEIVKYLVEHGADPEIANRHGHTCL 154 (615)
T ss_pred EEeCCcccCCCchhhHHhccCcHHHHHHHHHhcCccccccccCCccHHHHHhcchhHHHHHHHHcCCCCcccccCCCeeE
Confidence 34578888999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccccchHHHHHHHHHhCCCCCCCccccccc
Q 013214 111 GDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHA 142 (447)
Q Consensus 111 ~~a~~~~~~~~~~~L~~~~a~~~~~~~~~~~~ 142 (447)
++|++.|+.+++++|++.|+|++.+..++.++
T Consensus 155 mIa~ykGh~~I~qyLle~gADvn~ks~kGNTA 186 (615)
T KOG0508|consen 155 MIACYKGHVDIAQYLLEQGADVNAKSYKGNTA 186 (615)
T ss_pred EeeeccCchHHHHHHHHhCCCcchhcccCchH
Confidence 99999999999999999999999988776655
No 471
>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed
Probab=99.63 E-value=4.4e-15 Score=136.51 Aligned_cols=138 Identities=20% Similarity=0.211 Sum_probs=105.4
Q ss_pred cccceeeecceEEEEEEcCeEEEEEEcCcccC----------CCHHHHHHHHHHHHHHhcCCCCcc--cceeEEEEeCCc
Q 013214 157 FTNSVEITKGTFILAFWRGIQVAVKKLGEEVI----------SDDDRVRAFRDELALLQKIRHPNV--VQFLGAVTQSSP 224 (447)
Q Consensus 157 ~~~~~~lg~G~~~~~~~~g~~vavK~~~~~~~----------~~~~~~~~~~~E~~~l~~l~hp~i--v~~~~~~~~~~~ 224 (447)
+...+..|.|+++.+...+..++||....... .+......+.+|+.++.++.|+++ ++.+++......
T Consensus 37 ~~lg~~~g~gtv~~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~ 116 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHG 116 (239)
T ss_pred ceeecCCCCccEEEEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecC
Confidence 33445678888888888999999998753211 112234567889999999988775 667776443322
Q ss_pred ----eEEEEeccCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeeccc
Q 013214 225 ----MMIVTEYLPK-GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGV 299 (447)
Q Consensus 225 ----~~lv~e~~~~-g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~ 299 (447)
.++|||+++| .+|.+++.. .++++. .+.+++.++.+||+.| |+|+||||.|||++.++.++|+|||.
T Consensus 117 ~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LIDfg~ 188 (239)
T PRK01723 117 LFYRADILIERIEGARDLVALLQE-APLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLIDFDR 188 (239)
T ss_pred cceeeeEEEEecCCCCCHHHHHhc-CCCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEEECCC
Confidence 3599999987 689988865 345544 3568999999999999 99999999999999988999999998
Q ss_pred ccc
Q 013214 300 SKL 302 (447)
Q Consensus 300 ~~~ 302 (447)
+..
T Consensus 189 ~~~ 191 (239)
T PRK01723 189 GEL 191 (239)
T ss_pred ccc
Confidence 764
No 472
>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain. The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom
Probab=99.63 E-value=1.9e-15 Score=135.44 Aligned_cols=135 Identities=21% Similarity=0.107 Sum_probs=102.6
Q ss_pred cccceeeecceEEEEE---E-cCeEEEEEEcCcccCCCH-------------------HHHHHHHHHHHHHhcCCCC--c
Q 013214 157 FTNSVEITKGTFILAF---W-RGIQVAVKKLGEEVISDD-------------------DRVRAFRDELALLQKIRHP--N 211 (447)
Q Consensus 157 ~~~~~~lg~G~~~~~~---~-~g~~vavK~~~~~~~~~~-------------------~~~~~~~~E~~~l~~l~hp--~ 211 (447)
|...+.||+|+||.++ . +|+.||||++........ ........|..++..+.|+ .
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 96 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP 96 (198)
T ss_pred hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence 5556789999999886 2 589999998764321000 0112356789999998777 4
Q ss_pred ccceeEEEEeCCceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCC
Q 013214 212 VVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291 (447)
Q Consensus 212 iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~ 291 (447)
+++.++ ....+++|||++|++|..... ......++.+++.++.++|+.+ ++|+||||+||++++++.
T Consensus 97 v~~~~~----~~~~~lv~e~~~g~~L~~~~~------~~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p~Nill~~~~~ 163 (198)
T cd05144 97 VPKPID----WNRHAVVMEYIDGVELYRVRV------LEDPEEVLDEILEEIVKAYKHG---IIHGDLSEFNILVDDDEK 163 (198)
T ss_pred CCceee----cCCceEEEEEeCCcchhhccc------cccHHHHHHHHHHHHHHHHHCC---CCcCCCCcccEEEcCCCc
Confidence 455544 245589999999999876532 1345678899999999999998 999999999999999999
Q ss_pred EEEeecccccccc
Q 013214 292 LKVADFGVSKLLT 304 (447)
Q Consensus 292 vkl~Dfg~~~~~~ 304 (447)
++|+|||++....
T Consensus 164 ~~liDfg~~~~~~ 176 (198)
T cd05144 164 IYIIDWPQMVSTD 176 (198)
T ss_pred EEEEECCccccCC
Confidence 9999999986443
No 473
>KOG0510 consensus Ankyrin repeat protein [General function prediction only]
Probab=99.63 E-value=5.3e-16 Score=155.19 Aligned_cols=99 Identities=28% Similarity=0.332 Sum_probs=48.3
Q ss_pred CCCccchhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHH-c-CCCCCCCCCCCCCccc
Q 013214 34 DGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLE-R-GADVDPKDRWGSTPLG 111 (447)
Q Consensus 34 ~~~~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~-~-ga~~~~~d~~g~tpl~ 111 (447)
+.+|.+|.||||+||+.|+.+.++.|+..|+++|.++.++.||||.||..|+.++|+-||+ . -..+|..|..|.||||
T Consensus 267 ~~~d~dg~tpLH~a~r~G~~~svd~Ll~~Ga~I~~kn~d~~spLH~AA~yg~~ntv~rLL~~~~~rllne~D~~g~tpLH 346 (929)
T KOG0510|consen 267 NDEDNDGCTPLHYAARQGGPESVDNLLGFGASINSKNKDEESPLHFAAIYGRINTVERLLQESDTRLLNESDLHGMTPLH 346 (929)
T ss_pred hcccccCCchHHHHHHcCChhHHHHHHHcCCcccccCCCCCCchHHHHHcccHHHHHHHHhCcCccccccccccCCCchh
Confidence 3344444555555555555555555555555555555555555555555555544444444 2 2234444444444444
Q ss_pred cccccchHHHHHHHHHhCCCC
Q 013214 112 DAIYYKNHEVIKLLEKHGAKP 132 (447)
Q Consensus 112 ~a~~~~~~~~~~~L~~~~a~~ 132 (447)
.|+..|+.+++++|++.||..
T Consensus 347 laa~~gH~~v~qlLl~~GA~~ 367 (929)
T KOG0510|consen 347 LAAKSGHDRVVQLLLNKGALF 367 (929)
T ss_pred hhhhcCHHHHHHHHHhcChhh
Confidence 444444444444444444443
No 474
>PHA02730 ankyrin-like protein; Provisional
Probab=99.62 E-value=1e-15 Score=156.09 Aligned_cols=114 Identities=15% Similarity=0.104 Sum_probs=96.5
Q ss_pred CCccccchhcccCCCCCCCccchhhHHHHHHHcCC----HHHHHHHHHcCC--CCCCCCCCCCCHHHH---HHHcC----
Q 013214 18 APDRERKEAELNGLDDDGEEIKPEFRLMFLANERD----VEGIKELLDSGI--DVNFRDIDNRTALHV---AACQG---- 84 (447)
Q Consensus 18 ~~~~~~~~a~~n~~d~~~~~~~g~t~lh~a~~~~~----~~~~~~Ll~~g~--d~n~~d~~g~t~Lh~---A~~~g---- 84 (447)
..++.+.|||+|. . ..|+||||+||..++ .+++++|+++|+ |+|.+|.+|+||||. |...+
T Consensus 362 velLIs~GAdIN~-----k-~~G~TpLH~Aa~~nnn~i~~eIvelLIs~Ga~~dIN~kd~~G~T~Lh~~i~a~~~n~~~~ 435 (672)
T PHA02730 362 LRCMLDNGATMDK-----T-TDNNYPLHDYFVNNNNIVDVNVVRFIVENNGHMAINHVSNNGRLCMYGLILSRFNNCGYH 435 (672)
T ss_pred HHHHHHCCCCCCc-----C-CCCCcHHHHHHHHcCCcchHHHHHHHHHcCCCccccccccCCCchHhHHHHHHhcccccc
Confidence 3445667888774 2 468899999998875 899999999997 699999999999994 33332
Q ss_pred -----cHHHHHHHHHcCCCCCCCCCCCCCccccccccchHHHHHHHHHhCCCCCCCcc
Q 013214 85 -----FTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPM 137 (447)
Q Consensus 85 -----~~~~v~~Ll~~ga~~~~~d~~g~tpl~~a~~~~~~~~~~~L~~~~a~~~~~~~ 137 (447)
..+++++|+++||++|.+|..|.||||+|+..++.+++++|+++||+++....
T Consensus 436 ~~e~~~~~ivk~LIs~GADINakD~~G~TPLh~Aa~~~~~eive~LI~~GAdIN~~d~ 493 (672)
T PHA02730 436 CYETILIDVFDILSKYMDDIDMIDNENKTLLYYAVDVNNIQFARRLLEYGASVNTTSR 493 (672)
T ss_pred ccchhHHHHHHHHHhcccchhccCCCCCCHHHHHHHhCCHHHHHHHHHCCCCCCCCCC
Confidence 23579999999999999999999999999999999999999999999977653
No 475
>KOG4214 consensus Myotrophin and similar proteins [Transcription]
Probab=99.62 E-value=5.9e-16 Score=113.93 Aligned_cols=92 Identities=28% Similarity=0.504 Sum_probs=68.3
Q ss_pred HHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCCCCCCccccccccchHHHH
Q 013214 43 RLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVI 122 (447)
Q Consensus 43 ~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tpl~~a~~~~~~~~~ 122 (447)
.+.|++.+|..+-++..+..|.|||..- .|+||||+|+..|..+++++|+..||+++.+|+.|-|||--|++.|+.+++
T Consensus 5 ~~~W~vkNG~~DeVk~~v~~g~nVn~~~-ggR~plhyAAD~GQl~ilefli~iGA~i~~kDKygITPLLsAvwEGH~~cV 83 (117)
T KOG4214|consen 5 SVAWNVKNGEIDEVKQSVNEGLNVNEIY-GGRTPLHYAADYGQLSILEFLISIGANIQDKDKYGITPLLSAVWEGHRDCV 83 (117)
T ss_pred hHhhhhccCcHHHHHHHHHccccHHHHh-CCcccchHhhhcchHHHHHHHHHhccccCCccccCCcHHHHHHHHhhHHHH
Confidence 3567777777777777777777776554 677777777777777777777777777777777777777777777777777
Q ss_pred HHHHHhCCCCCCC
Q 013214 123 KLLEKHGAKPLMA 135 (447)
Q Consensus 123 ~~L~~~~a~~~~~ 135 (447)
++|++.||+-.+.
T Consensus 84 klLL~~GAdrt~~ 96 (117)
T KOG4214|consen 84 KLLLQNGADRTIH 96 (117)
T ss_pred HHHHHcCccccee
Confidence 7777777775443
No 476
>PHA02795 ankyrin-like protein; Provisional
Probab=99.62 E-value=1.1e-15 Score=148.76 Aligned_cols=121 Identities=16% Similarity=0.057 Sum_probs=102.0
Q ss_pred cCCCCccccchhcccCCCCCCCccchhhHHHHHHHcCCHHHHHHHHHcCCCCC-CC-----CCCCCCHHHHHHHcCcHHH
Q 013214 15 SSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVN-FR-----DIDNRTALHVAACQGFTEV 88 (447)
Q Consensus 15 ~~~~~~~~~~~a~~n~~d~~~~~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n-~~-----d~~g~t~Lh~A~~~g~~~~ 88 (447)
..+.......|||+|..+ +.||+|+|+..|+.+++++|+++|++.+ .. +..|.||+|.|+..++.++
T Consensus 131 ~eiV~~LI~~GADIn~~~-------~~t~lh~A~~~~~~eIVk~Lls~Ga~~~n~~~~~l~~~~~~t~l~~a~~~~~~eI 203 (437)
T PHA02795 131 IDIVDFMVDHGAVIYKIE-------CLNAYFRGICKKESSVVEFILNCGIPDENDVKLDLYKIIQYTRGFLVDEPTVLEI 203 (437)
T ss_pred HHHHHHHHHCCCCCCCCC-------CCCHHHHHHHcCcHHHHHHHHhcCCcccccccchhhhhhccchhHHHHhcCHHHH
Confidence 334455567788887643 3689999999999999999999998543 22 2348899999999999999
Q ss_pred HHHHHHcCCCCCCCCCCCCCccccccccchHHHHHHHHHhCCCCCCCccccccc
Q 013214 89 VSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHA 142 (447)
Q Consensus 89 v~~Ll~~ga~~~~~d~~g~tpl~~a~~~~~~~~~~~L~~~~a~~~~~~~~~~~~ 142 (447)
+++|+++||++|.+|..|.||||+|+..|+.+++++|+++|++++.....+.++
T Consensus 204 ve~LIs~GADIN~kD~~G~TpLh~Aa~~g~~eiVelLL~~GAdIN~~d~~G~Tp 257 (437)
T PHA02795 204 YKLCIPYIEDINQLDAGGRTLLYRAIYAGYIDLVSWLLENGANVNAVMSNGYTC 257 (437)
T ss_pred HHHHHhCcCCcCcCCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCCH
Confidence 999999999999999999999999999999999999999999998776554443
No 477
>PHA02736 Viral ankyrin protein; Provisional
Probab=99.61 E-value=4.9e-16 Score=133.39 Aligned_cols=107 Identities=26% Similarity=0.334 Sum_probs=85.9
Q ss_pred CCCCccchhhHHHHHHHcCCHHHHHHHHHcCC--C-----CCCCCCCCCCHHHHHHHcCcH---HHHHHHHHcCCCCCCC
Q 013214 33 DDGEEIKPEFRLMFLANERDVEGIKELLDSGI--D-----VNFRDIDNRTALHVAACQGFT---EVVSLLLERGADVDPK 102 (447)
Q Consensus 33 ~~~~~~~g~t~lh~a~~~~~~~~~~~Ll~~g~--d-----~n~~d~~g~t~Lh~A~~~g~~---~~v~~Ll~~ga~~~~~ 102 (447)
.+..|.+|+||||+||..|+. ++++...+. + ++.+|.+|+||||+|+..|+. +++++|++.|++++.+
T Consensus 10 ~~~~d~~g~tpLh~A~~~g~~--~~l~~~~~~~~~~~~~~~~~~d~~g~t~Lh~a~~~~~~~~~e~v~~Ll~~gadin~~ 87 (154)
T PHA02736 10 ASEPDIEGENILHYLCRNGGV--TDLLAFKNAISDENRYLVLEYNRHGKQCVHIVSNPDKADPQEKLKLLMEWGADINGK 87 (154)
T ss_pred HHhcCCCCCCHHHHHHHhCCH--HHHHHHHHHhcchhHHHHHHhcCCCCEEEEeecccCchhHHHHHHHHHHcCCCcccc
Confidence 455667799999999999984 333333322 2 345789999999999999987 4689999999999999
Q ss_pred C-CCCCCccccccccchHHHHHHHHH-hCCCCCCCcccccc
Q 013214 103 D-RWGSTPLGDAIYYKNHEVIKLLEK-HGAKPLMAPMHVKH 141 (447)
Q Consensus 103 d-~~g~tpl~~a~~~~~~~~~~~L~~-~~a~~~~~~~~~~~ 141 (447)
| ..|+||||+|+..++.+++++|++ .|++++..+..+.+
T Consensus 88 ~~~~g~T~Lh~A~~~~~~~i~~~Ll~~~g~d~n~~~~~g~t 128 (154)
T PHA02736 88 ERVFGNTPLHIAVYTQNYELATWLCNQPGVNMEILNYAFKT 128 (154)
T ss_pred CCCCCCcHHHHHHHhCCHHHHHHHHhCCCCCCccccCCCCC
Confidence 8 499999999999999999999998 48888766544433
No 478
>PHA02989 ankyrin repeat protein; Provisional
Probab=99.61 E-value=1.9e-15 Score=154.52 Aligned_cols=107 Identities=21% Similarity=0.258 Sum_probs=85.7
Q ss_pred cCCCCCCCccchhhHHHHHHHc---CCHHHHHHHHHcCCCC-CCCCCCCCCHHHHHHHc--CcHHHHHHHHHcCCCCCC-
Q 013214 29 NGLDDDGEEIKPEFRLMFLANE---RDVEGIKELLDSGIDV-NFRDIDNRTALHVAACQ--GFTEVVSLLLERGADVDP- 101 (447)
Q Consensus 29 n~~d~~~~~~~g~t~lh~a~~~---~~~~~~~~Ll~~g~d~-n~~d~~g~t~Lh~A~~~--g~~~~v~~Ll~~ga~~~~- 101 (447)
+|.|.+.++..|+||||.|+.. |+.+++++|+++|||+ +.+|..|+||||+|+.. ++.+++++|+++|++++.
T Consensus 97 ~Gadin~~d~~g~tpL~~a~~~~~~~~~eiv~~Ll~~Gadin~~~d~~g~tpLh~a~~~~~~~~~iv~~Ll~~Gadi~~~ 176 (494)
T PHA02989 97 FGADINLKTFNGVSPIVCFIYNSNINNCDMLRFLLSKGINVNDVKNSRGYNLLHMYLESFSVKKDVIKILLSFGVNLFEK 176 (494)
T ss_pred CCCCCCCCCCCCCcHHHHHHHhcccCcHHHHHHHHHCCCCcccccCCCCCCHHHHHHHhccCCHHHHHHHHHcCCCcccc
Confidence 4444555566678889987755 6789999999999999 78899999999998754 578999999999999888
Q ss_pred CCCCCCCcccccccc----chHHHHHHHHHhCCCCCCC
Q 013214 102 KDRWGSTPLGDAIYY----KNHEVIKLLEKHGAKPLMA 135 (447)
Q Consensus 102 ~d~~g~tpl~~a~~~----~~~~~~~~L~~~~a~~~~~ 135 (447)
.+..|.||||+|+.. ++.+++++|+++|++++..
T Consensus 177 ~~~~g~tpL~~a~~~~~~~~~~~iv~~Ll~~Ga~vn~~ 214 (494)
T PHA02989 177 TSLYGLTPMNIYLRNDIDVISIKVIKYLIKKGVNIETN 214 (494)
T ss_pred ccccCCChHHHHHhcccccccHHHHHHHHhCCCCcccc
Confidence 678888998887665 4788899999988887644
No 479
>PHA02989 ankyrin repeat protein; Provisional
Probab=99.60 E-value=2.5e-15 Score=153.65 Aligned_cols=113 Identities=20% Similarity=0.229 Sum_probs=98.1
Q ss_pred CCCCccccchhcccCCCCCCCccchhhHHHHHHH------cCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHc---CcH
Q 013214 16 SLAPDRERKEAELNGLDDDGEEIKPEFRLMFLAN------ERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQ---GFT 86 (447)
Q Consensus 16 ~~~~~~~~~~a~~n~~d~~~~~~~g~t~lh~a~~------~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~---g~~ 86 (447)
.+...+.+.|||+|..+ .+.||||.|+. .++.+++++|+++|||+|.+|.+|+||||.|+.. |+.
T Consensus 51 ~iv~~Ll~~GAdvn~~~------~~~tpL~~a~~~~~~~~~~~~~iv~~Ll~~Gadin~~d~~g~tpL~~a~~~~~~~~~ 124 (494)
T PHA02989 51 KIVKLLIDNGADVNYKG------YIETPLCAVLRNREITSNKIKKIVKLLLKFGADINLKTFNGVSPIVCFIYNSNINNC 124 (494)
T ss_pred HHHHHHHHcCCCccCCC------CCCCcHHHHHhccCcchhhHHHHHHHHHHCCCCCCCCCCCCCcHHHHHHHhcccCcH
Confidence 34555667788887653 35799999875 5789999999999999999999999999998865 679
Q ss_pred HHHHHHHHcCCCC-CCCCCCCCCcccccccc--chHHHHHHHHHhCCCCCC
Q 013214 87 EVVSLLLERGADV-DPKDRWGSTPLGDAIYY--KNHEVIKLLEKHGAKPLM 134 (447)
Q Consensus 87 ~~v~~Ll~~ga~~-~~~d~~g~tpl~~a~~~--~~~~~~~~L~~~~a~~~~ 134 (447)
+++++|+++|||+ +.+|..|.||||+|+.. ++.+++++|+++|++++.
T Consensus 125 eiv~~Ll~~Gadin~~~d~~g~tpLh~a~~~~~~~~~iv~~Ll~~Gadi~~ 175 (494)
T PHA02989 125 DMLRFLLSKGINVNDVKNSRGYNLLHMYLESFSVKKDVIKILLSFGVNLFE 175 (494)
T ss_pred HHHHHHHHCCCCcccccCCCCCCHHHHHHHhccCCHHHHHHHHHcCCCccc
Confidence 9999999999999 89999999999998754 689999999999999876
No 480
>PHA02917 ankyrin-like protein; Provisional
Probab=99.60 E-value=2.4e-15 Score=156.78 Aligned_cols=108 Identities=20% Similarity=0.184 Sum_probs=92.4
Q ss_pred cCCCCCCCccchhhHHHHHHHc---CCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcC---------------------
Q 013214 29 NGLDDDGEEIKPEFRLMFLANE---RDVEGIKELLDSGIDVNFRDIDNRTALHVAACQG--------------------- 84 (447)
Q Consensus 29 n~~d~~~~~~~g~t~lh~a~~~---~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g--------------------- 84 (447)
++.+.+.+|.+|+||||+||.. |+.+++++|++.|+|++.+|.+|+||||+|+..|
T Consensus 21 ~~~~~~~~d~~g~t~Lh~a~~~~~~~~~~~v~~Ll~~ga~v~~~~~~g~TpL~~Aa~~g~~~v~~~~~~~Ll~~~~~~n~ 100 (661)
T PHA02917 21 DRDPNDTRNQFKNNALHAYLFNEHCNNVEVVKLLLDSGTNPLHKNWRQLTPLEEYTNSRHVKVNKDIAMALLEATGYSNI 100 (661)
T ss_pred ccCcccccCCCCCcHHHHHHHhhhcCcHHHHHHHHHCCCCccccCCCCCCHHHHHHHcCChhHHHHHHHHHHhccCCCCC
Confidence 4555566677888999997665 8899999999999999999999999999887644
Q ss_pred --------------cHHHHHHHHHcCCCCCCCCCCCCCccccc--cccchHHHHHHHHHhCCCCCCCc
Q 013214 85 --------------FTEVVSLLLERGADVDPKDRWGSTPLGDA--IYYKNHEVIKLLEKHGAKPLMAP 136 (447)
Q Consensus 85 --------------~~~~v~~Ll~~ga~~~~~d~~g~tpl~~a--~~~~~~~~~~~L~~~~a~~~~~~ 136 (447)
+.++|++|+++|||+|.+|..|.||||+| +..|+.+++++|+++|++++...
T Consensus 101 ~~~~~~~~~a~~~~~~e~vk~Ll~~Gadin~~d~~g~T~L~~~~a~~~~~~eivklLi~~Ga~vn~~d 168 (661)
T PHA02917 101 NDFNIFSYMKSKNVDVDLIKVLVEHGFDLSVKCENHRSVIENYVMTDDPVPEIIDLFIENGCSVLYED 168 (661)
T ss_pred CCcchHHHHHhhcCCHHHHHHHHHcCCCCCccCCCCccHHHHHHHccCCCHHHHHHHHHcCCCccccc
Confidence 45789999999999999999999999954 45789999999999999997543
No 481
>KOG4214 consensus Myotrophin and similar proteins [Transcription]
Probab=99.60 E-value=7.6e-16 Score=113.36 Aligned_cols=85 Identities=22% Similarity=0.258 Sum_probs=75.4
Q ss_pred ccCCCCCCCccchhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCCCCC
Q 013214 28 LNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGS 107 (447)
Q Consensus 28 ~n~~d~~~~~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~ 107 (447)
..|.|.|. ...|+|||||||..|..+++++|+..|||++.+|+.|.|||--|++.||.++|++|++.||+-..+..+|.
T Consensus 23 ~~g~nVn~-~~ggR~plhyAAD~GQl~ilefli~iGA~i~~kDKygITPLLsAvwEGH~~cVklLL~~GAdrt~~~PdG~ 101 (117)
T KOG4214|consen 23 NEGLNVNE-IYGGRTPLHYAADYGQLSILEFLISIGANIQDKDKYGITPLLSAVWEGHRDCVKLLLQNGADRTIHAPDGT 101 (117)
T ss_pred HccccHHH-HhCCcccchHhhhcchHHHHHHHHHhccccCCccccCCcHHHHHHHHhhHHHHHHHHHcCcccceeCCCch
Confidence 34445553 34799999999999999999999999999999999999999999999999999999999999999988998
Q ss_pred Cccccc
Q 013214 108 TPLGDA 113 (447)
Q Consensus 108 tpl~~a 113 (447)
+.+..+
T Consensus 102 ~~~eat 107 (117)
T KOG4214|consen 102 ALIEAT 107 (117)
T ss_pred hHHhhc
Confidence 777543
No 482
>KOG0510 consensus Ankyrin repeat protein [General function prediction only]
Probab=99.59 E-value=2.3e-15 Score=150.78 Aligned_cols=118 Identities=31% Similarity=0.291 Sum_probs=103.2
Q ss_pred ccchhcccCCCCCCCccchhhHHHHHHHcCCHHHHHHHHH-cC-CCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCC
Q 013214 22 ERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLD-SG-IDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADV 99 (447)
Q Consensus 22 ~~~~a~~n~~d~~~~~~~g~t~lh~a~~~~~~~~~~~Ll~-~g-~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~ 99 (447)
.+.||++|.++ .++.||||.||..|+.++++.|++ .| ..+|..|..|.||||+|+.+||..++++|++.||+.
T Consensus 293 l~~Ga~I~~kn-----~d~~spLH~AA~yg~~ntv~rLL~~~~~rllne~D~~g~tpLHlaa~~gH~~v~qlLl~~GA~~ 367 (929)
T KOG0510|consen 293 LGFGASINSKN-----KDEESPLHFAAIYGRINTVERLLQESDTRLLNESDLHGMTPLHLAAKSGHDRVVQLLLNKGALF 367 (929)
T ss_pred HHcCCcccccC-----CCCCCchHHHHHcccHHHHHHHHhCcCccccccccccCCCchhhhhhcCHHHHHHHHHhcChhh
Confidence 45666666655 556677999999999999999998 54 679999999999999999999999999999999998
Q ss_pred C---CCCCCCCCccccccccchHHHHHHHHHhCCCCCCCcccccccCC
Q 013214 100 D---PKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHARE 144 (447)
Q Consensus 100 ~---~~d~~g~tpl~~a~~~~~~~~~~~L~~~~a~~~~~~~~~~~~~~ 144 (447)
. ..|.+|.||||.|+..|+..++++|+.+||++...+..+.++-.
T Consensus 368 ~~~~e~D~dg~TaLH~Aa~~g~~~av~~Li~~Ga~I~~~n~~g~SA~~ 415 (929)
T KOG0510|consen 368 LNMSEADSDGNTALHLAAKYGNTSAVQKLISHGADIGVKNKKGKSAFD 415 (929)
T ss_pred hcccccccCCchhhhHHHHhccHHHHHHHHHcCCceeecccccccccc
Confidence 8 56999999999999999999999999999999887766655543
No 483
>KOG0514 consensus Ankyrin repeat protein [General function prediction only]
Probab=99.59 E-value=7.9e-16 Score=140.79 Aligned_cols=107 Identities=29% Similarity=0.326 Sum_probs=81.9
Q ss_pred CccchhhHHHHHHHcCCHHHHHHHHHcC-CCCCCCCCCCCC--------------------------------------H
Q 013214 36 EEIKPEFRLMFLANERDVEGIKELLDSG-IDVNFRDIDNRT--------------------------------------A 76 (447)
Q Consensus 36 ~~~~g~t~lh~a~~~~~~~~~~~Ll~~g-~d~n~~d~~g~t--------------------------------------~ 76 (447)
-|.+|+|+||||+..+|.++|+.||+.| +|+|.+|.-|+| +
T Consensus 264 aDsNGNTALHYsVSHaNF~VV~~LLDSgvC~VD~qNrAGYtpiMLaALA~lk~~~d~~vV~~LF~mgnVNaKAsQ~gQTA 343 (452)
T KOG0514|consen 264 ADSNGNTALHYAVSHANFDVVSILLDSGVCDVDQQNRAGYTPVMLAALAKLKQPADRTVVERLFKMGDVNAKASQHGQTA 343 (452)
T ss_pred hcCCCCeeeeeeecccchHHHHHHhccCcccccccccccccHHHHHHHHhhcchhhHHHHHHHHhccCcchhhhhhcchh
Confidence 3445566688888888888888888776 677766555544 4
Q ss_pred HHHHHHcCcHHHHHHHHHcCCCCCCCCCCCCCccccccccchHHHHHHHHHh-CCCCCCCccccccc
Q 013214 77 LHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKH-GAKPLMAPMHVKHA 142 (447)
Q Consensus 77 Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tpl~~a~~~~~~~~~~~L~~~-~a~~~~~~~~~~~~ 142 (447)
|++|+.+|+.++|+.||..|||+|.+|.+|.|+|+.|+.+|++|++++|+.. ++++...+..++++
T Consensus 344 LMLAVSHGr~d~vk~LLacgAdVNiQDdDGSTALMCA~EHGhkEivklLLA~p~cd~sLtD~DgSTA 410 (452)
T KOG0514|consen 344 LMLAVSHGRVDMVKALLACGADVNIQDDDGSTALMCAAEHGHKEIVKLLLAVPSCDISLTDVDGSTA 410 (452)
T ss_pred hhhhhhcCcHHHHHHHHHccCCCccccCCccHHHhhhhhhChHHHHHHHhccCcccceeecCCCchh
Confidence 6677888888999999999999999999999999999999999999988864 34554444444444
No 484
>PHA02946 ankyin-like protein; Provisional
Probab=99.59 E-value=3.9e-15 Score=149.32 Aligned_cols=112 Identities=18% Similarity=0.243 Sum_probs=89.6
Q ss_pred CCCCCCCccchhhHHHHHHHcC--CHHHHHHHHHcCCCCCC-CCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCCCC
Q 013214 30 GLDDDGEEIKPEFRLMFLANER--DVEGIKELLDSGIDVNF-RDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWG 106 (447)
Q Consensus 30 ~~d~~~~~~~g~t~lh~a~~~~--~~~~~~~Ll~~g~d~n~-~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g 106 (447)
|.|++.+|.+|+||||+|+..+ ..+++++|+++|+|+|. .|.+|.|||| ||..|+.+++++|++.|++++.+|..|
T Consensus 95 GAdin~~d~~g~TpLh~A~~~~~~~~e~v~lLl~~Gadin~~~d~~g~tpL~-aa~~~~~~vv~~Ll~~gad~~~~d~~G 173 (446)
T PHA02946 95 GADPNACDKQHKTPLYYLSGTDDEVIERINLLVQYGAKINNSVDEEGCGPLL-ACTDPSERVFKKIMSIGFEARIVDKFG 173 (446)
T ss_pred cCCCCCCCCCCCCHHHHHHHcCCchHHHHHHHHHcCCCcccccCCCCCcHHH-HHHCCChHHHHHHHhccccccccCCCC
Confidence 3344445666788899988766 47889999999999995 6888999997 666788999999999999999999999
Q ss_pred CCccccccccc--hHHHHHHHHHhCCCCCCCccccccc
Q 013214 107 STPLGDAIYYK--NHEVIKLLEKHGAKPLMAPMHVKHA 142 (447)
Q Consensus 107 ~tpl~~a~~~~--~~~~~~~L~~~~a~~~~~~~~~~~~ 142 (447)
+||||+|+..+ +.+++++|+++|++++..+..+.++
T Consensus 174 ~t~Lh~A~~~~~~~~~~v~~Ll~~Gadin~~d~~G~Tp 211 (446)
T PHA02946 174 KNHIHRHLMSDNPKASTISWMMKLGISPSKPDHDGNTP 211 (446)
T ss_pred CCHHHHHHHhcCCCHHHHHHHHHcCCCCcccCCCCCCH
Confidence 99999887654 4688999999999988766554443
No 485
>PF13857 Ank_5: Ankyrin repeats (many copies); PDB: 1SW6_A 3EHR_B 3EHQ_A.
Probab=99.58 E-value=8.7e-16 Score=107.15 Aligned_cols=55 Identities=53% Similarity=0.668 Sum_probs=32.2
Q ss_pred HHHcC-CCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCCCCCCccccc
Q 013214 59 LLDSG-IDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDA 113 (447)
Q Consensus 59 Ll~~g-~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tpl~~a 113 (447)
||++| +|+|.+|..|.||||+||..|+.+++++|++.|+|++.+|..|+||+|+|
T Consensus 1 LL~~~~~~~n~~d~~G~T~LH~A~~~g~~~~v~~Ll~~g~d~~~~d~~G~Tpl~~A 56 (56)
T PF13857_consen 1 LLEHGPADVNAQDKYGNTPLHWAARYGHSEVVRLLLQNGADPNAKDKDGQTPLHYA 56 (56)
T ss_dssp -----T--TT---TTS--HHHHHHHHT-HHHHHHHHHCT--TT---TTS--HHHH-
T ss_pred CCccCcCCCcCcCCCCCcHHHHHHHcCcHHHHHHHHHCcCCCCCCcCCCCCHHHhC
Confidence 57788 89999999999999999999999999999999999999999999999987
No 486
>PF12796 Ank_2: Ankyrin repeats (3 copies); InterPro: IPR020683 This entry represents the ankyrin repeat-containing domain. These domains contain multiple repeats of a beta(2)-alpha(2) motif. The ankyrin repeat is one of the most common protein-protein interaction motifs in nature. Ankyrin repeats are tandemly repeated modules of about 33 amino acids. They occur in a large number of functionally diverse proteins mainly from eukaryotes. The few known examples from prokaryotes and viruses may be the result of horizontal gene transfers []. The repeat has been found in proteins of diverse function such as transcriptional initiators, cell-cycle regulators, cytoskeletal, ion transporters and signal transducers. The ankyrin fold appears to be defined by its structure rather than its function since there is no specific sequence or structure which is universally recognised by it. The conserved fold of the ankyrin repeat unit is known from several crystal and solution structures [, , , ]. Each repeat folds into a helix-loop-helix structure with a beta-hairpin/loop region projecting out from the helices at a 90o angle. The repeats stack together to form an L-shaped structure [, ].; PDB: 3AAA_C 3F6Q_A 2KBX_A 3IXE_A 3TWR_D 3TWV_A 3TWT_B 3TWQ_A 3TWS_A 3TWX_B ....
Probab=99.58 E-value=5.7e-15 Score=114.24 Aligned_cols=64 Identities=42% Similarity=0.587 Sum_probs=59.7
Q ss_pred hhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCC
Q 013214 40 PEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103 (447)
Q Consensus 40 g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d 103 (447)
|+||||+||..|+.+++++|++.|+|+|.+|.+|+||||+|+.+|+.+++++|+++|++++.+|
T Consensus 26 ~~~~l~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~n 89 (89)
T PF12796_consen 26 GNTALHYAAENGNLEIVKLLLENGADINSQDKNGNTALHYAAENGNLEIVKLLLEHGADVNIRN 89 (89)
T ss_dssp SSBHHHHHHHTTTHHHHHHHHHTTTCTT-BSTTSSBHHHHHHHTTHHHHHHHHHHTTT-TTSS-
T ss_pred CCCHHHHHHHcCCHHHHHHHHHhcccccccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCcC
Confidence 7789999999999999999999999999999999999999999999999999999999999876
No 487
>PHA02876 ankyrin repeat protein; Provisional
Probab=99.57 E-value=7e-15 Score=156.31 Aligned_cols=106 Identities=33% Similarity=0.355 Sum_probs=76.5
Q ss_pred CCCCCCccchhhHHHHHHHcC-CHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHc-CcHHHHHHHHHcCCCCCCCCCCCCC
Q 013214 31 LDDDGEEIKPEFRLMFLANER-DVEGIKELLDSGIDVNFRDIDNRTALHVAACQ-GFTEVVSLLLERGADVDPKDRWGST 108 (447)
Q Consensus 31 ~d~~~~~~~g~t~lh~a~~~~-~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~-g~~~~v~~Ll~~ga~~~~~d~~g~t 108 (447)
.|.+..+.+|+||||+|+..| +.+.++.|++.|+|+|.+|..|+||||+|+.. ++.+++++|++.|+++|.+|..|.|
T Consensus 298 adin~~d~~g~TpLh~Aa~~g~~~~~v~~Ll~~gadin~~d~~g~TpLh~A~~~~~~~~iv~lLl~~gadin~~d~~G~T 377 (682)
T PHA02876 298 ADVNAKNIKGETPLYLMAKNGYDTENIRTLIMLGADVNAADRLYITPLHQASTLDRNKDIVITLLELGANVNARDYCDKT 377 (682)
T ss_pred CCCCCcCCCCCCHHHHHHHhCCCHHHHHHHHHcCCCCCCcccCCCcHHHHHHHhCCcHHHHHHHHHcCCCCccCCCCCCC
Confidence 334444555667777777777 47777777777777777777777777777764 3577777777777777777777778
Q ss_pred ccccccccchHHHHHHHHHhCCCCCCCc
Q 013214 109 PLGDAIYYKNHEVIKLLEKHGAKPLMAP 136 (447)
Q Consensus 109 pl~~a~~~~~~~~~~~L~~~~a~~~~~~ 136 (447)
|||+|+..|+.+++++|+++|+++....
T Consensus 378 pLh~Aa~~~~~~iv~~Ll~~gad~~~~~ 405 (682)
T PHA02876 378 PIHYAAVRNNVVIINTLLDYGADIEALS 405 (682)
T ss_pred HHHHHHHcCCHHHHHHHHHCCCCccccC
Confidence 8887777777778888887777765443
No 488
>PHA02917 ankyrin-like protein; Provisional
Probab=99.57 E-value=6.2e-15 Score=153.69 Aligned_cols=104 Identities=30% Similarity=0.252 Sum_probs=92.0
Q ss_pred CCCCCCCccchhhHHHHHHHcC-----------------------CHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcH
Q 013214 30 GLDDDGEEIKPEFRLMFLANER-----------------------DVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFT 86 (447)
Q Consensus 30 ~~d~~~~~~~g~t~lh~a~~~~-----------------------~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~ 86 (447)
|.+.+..+.+|+||||.||+.+ ..++++.|+++|||+|.+|..|+||||+|+..++.
T Consensus 386 ga~~~~~~~~G~TpL~~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~Ll~~GAdIN~kd~~G~TpLh~Aa~~~~~ 465 (661)
T PHA02917 386 GGDAVNHLDDGEIPIGHLCKSNYGCYNFYTYTYKKGLCDMSYACPILSTINICLPYLKDINMIDKRGETLLHKAVRYNKQ 465 (661)
T ss_pred CCCccccCCCCCChhHHHHHhcccchhhhhhhhhhccchhhhhhhhHHHHHHHHHCCCCCCCCCCCCcCHHHHHHHcCCH
Confidence 3444444556999999988543 35678999999999999999999999999999999
Q ss_pred HHHHHHHHcCCCCCCCCCCCCCccccccc-cchHHHHHHHHHhCCCCC
Q 013214 87 EVVSLLLERGADVDPKDRWGSTPLGDAIY-YKNHEVIKLLEKHGAKPL 133 (447)
Q Consensus 87 ~~v~~Ll~~ga~~~~~d~~g~tpl~~a~~-~~~~~~~~~L~~~~a~~~ 133 (447)
+++++|+++|++++.+|..|.||||+|+. .++.+++++|+.+|+++.
T Consensus 466 ~~v~~Ll~~GAdin~~d~~G~T~L~~A~~~~~~~~iv~~LL~~ga~i~ 513 (661)
T PHA02917 466 SLVSLLLESGSDVNIRSNNGYTCIAIAINESRNIELLKMLLCHKPTLD 513 (661)
T ss_pred HHHHHHHHCcCCCCCCCCCCCCHHHHHHHhCCCHHHHHHHHHcCCChh
Confidence 99999999999999999999999999996 678999999999998875
No 489
>PHA02730 ankyrin-like protein; Provisional
Probab=99.56 E-value=8.8e-15 Score=149.28 Aligned_cols=100 Identities=16% Similarity=0.178 Sum_probs=87.9
Q ss_pred CCccchhhHHHHHHHcC---CHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcC--cHHHHHHHHHcCC--CCCCCCCCCC
Q 013214 35 GEEIKPEFRLMFLANER---DVEGIKELLDSGIDVNFRDIDNRTALHVAACQG--FTEVVSLLLERGA--DVDPKDRWGS 107 (447)
Q Consensus 35 ~~~~~g~t~lh~a~~~~---~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g--~~~~v~~Ll~~ga--~~~~~d~~g~ 107 (447)
.+|.+|+||||+|+..| +.+++++|+++|||+|.+|.+|+||||+|+..+ +.++|++|++.|+ +++..++.++
T Consensus 36 ~kd~~G~TaLh~A~~~~~~~~~eivklLLs~GAdin~kD~~G~TPLh~Aa~~~~~~~eIv~~Ll~~~~~~~~~~~~~~~d 115 (672)
T PHA02730 36 HIDRRGNNALHCYVSNKCDTDIKIVRLLLSRGVERLCRNNEGLTPLGVYSKRKYVKSQIVHLLISSYSNASNELTSNIND 115 (672)
T ss_pred hcCCCCCcHHHHHHHcCCcCcHHHHHHHHhCCCCCcccCCCCCChHHHHHHcCCCcHHHHHHHHhcCCCCCcccccccCC
Confidence 55667889999999997 599999999999999999999999999999977 7999999999955 5588888899
Q ss_pred Cccccccc--cchHHHHHHHHH-hCCCCCC
Q 013214 108 TPLGDAIY--YKNHEVIKLLEK-HGAKPLM 134 (447)
Q Consensus 108 tpl~~a~~--~~~~~~~~~L~~-~~a~~~~ 134 (447)
+|++.++. +++.+++++|++ .++++..
T Consensus 116 ~~l~~y~~s~n~~~~~vk~Li~~~~~~~~~ 145 (672)
T PHA02730 116 FDLYSYMSSDNIDLRLLKYLIVDKRIRPSK 145 (672)
T ss_pred chHHHHHHhcCCcHHHHHHHHHhcCCChhh
Confidence 99998877 889999999997 5566653
No 490
>PF13637 Ank_4: Ankyrin repeats (many copies); PDB: 3B95_A 3B7B_A 3F6Q_A 2KBX_A 3IXE_A 2DWZ_C 2DVW_A 3AJI_A 1S70_B 2HE0_A ....
Probab=99.56 E-value=6.6e-15 Score=102.14 Aligned_cols=54 Identities=39% Similarity=0.524 Sum_probs=45.5
Q ss_pred hhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHH
Q 013214 40 PEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLL 93 (447)
Q Consensus 40 g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll 93 (447)
|+||||+||..|+.+++++|+++|+|+|.+|.+|+||||+|++.|+.+++++|+
T Consensus 1 g~t~lh~A~~~g~~~~~~~Ll~~~~din~~d~~g~t~lh~A~~~g~~~~~~~Ll 54 (54)
T PF13637_consen 1 GRTPLHWAARSGNLEIVKLLLEHGADINAQDEDGRTPLHYAAKNGNIDIVKFLL 54 (54)
T ss_dssp SSBHHHHHHHTT-HHHHHHHHHTTSGTT-B-TTS--HHHHHHHTT-HHHHHHHH
T ss_pred CChHHHHHHHhCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHccCHHHHHHHC
Confidence 689999999999999999999999999999999999999999999999999986
No 491
>KOG0514 consensus Ankyrin repeat protein [General function prediction only]
Probab=99.56 E-value=6.3e-15 Score=134.95 Aligned_cols=90 Identities=37% Similarity=0.441 Sum_probs=86.1
Q ss_pred chhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHc-CCCCCCCCCCCCCccccccccc
Q 013214 39 KPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLER-GADVDPKDRWGSTPLGDAIYYK 117 (447)
Q Consensus 39 ~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~-ga~~~~~d~~g~tpl~~a~~~~ 117 (447)
-|.|+|++|+..|++++++.||..|||||.+|.+|.|+|++||.+||.+++++||.. ++|+...|.+|.|+|.+|...|
T Consensus 339 ~gQTALMLAVSHGr~d~vk~LLacgAdVNiQDdDGSTALMCA~EHGhkEivklLLA~p~cd~sLtD~DgSTAl~IAleag 418 (452)
T KOG0514|consen 339 HGQTALMLAVSHGRVDMVKALLACGADVNIQDDDGSTALMCAAEHGHKEIVKLLLAVPSCDISLTDVDGSTALSIALEAG 418 (452)
T ss_pred hcchhhhhhhhcCcHHHHHHHHHccCCCccccCCccHHHhhhhhhChHHHHHHHhccCcccceeecCCCchhhhhHHhcC
Confidence 588999999999999999999999999999999999999999999999999999986 8999999999999999999999
Q ss_pred hHHHHHHHHHh
Q 013214 118 NHEVIKLLEKH 128 (447)
Q Consensus 118 ~~~~~~~L~~~ 128 (447)
+.||.-+|-.+
T Consensus 419 h~eIa~mlYa~ 429 (452)
T KOG0514|consen 419 HREIAVMLYAH 429 (452)
T ss_pred chHHHHHHHHH
Confidence 99999887654
No 492
>cd05119 RIO RIO kinase family, catalytic domain. The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct
Probab=99.55 E-value=3.3e-14 Score=126.12 Aligned_cols=134 Identities=23% Similarity=0.221 Sum_probs=93.7
Q ss_pred eeeecceEEEEEE----cCeEEEEEEcCcccCCCHHHHHH---------------------HHHHHHHHhcCCCC--ccc
Q 013214 161 VEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRA---------------------FRDELALLQKIRHP--NVV 213 (447)
Q Consensus 161 ~~lg~G~~~~~~~----~g~~vavK~~~~~~~~~~~~~~~---------------------~~~E~~~l~~l~hp--~iv 213 (447)
+.||+|+||.++. +|+.||+|++............. ...|...+..+.+. .+.
T Consensus 3 ~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~ 82 (187)
T cd05119 3 GPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPVP 82 (187)
T ss_pred cccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCCC
Confidence 5689999998863 58999999886543221111111 13566666666433 355
Q ss_pred ceeEEEEeCCceEEEEeccCCCCHHH-HHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeCCCCCCCEEEcCCCC
Q 013214 214 QFLGAVTQSSPMMIVTEYLPKGDLRA-FLKRKGALKPSTAVRFALDIARGMNYLHE-NKPVPIIHRDLEPSNILRDDSGN 291 (447)
Q Consensus 214 ~~~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~l~~~~~~~i~~ql~~~l~~lH~-~~~~~i~H~Dikp~Nill~~~~~ 291 (447)
+.++. ...+++|||++++.+.. .+.... . ...+..++.+++.++.++|+ .+ ++|+||||+||+++ ++.
T Consensus 83 ~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-~-~~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~-~~~ 152 (187)
T cd05119 83 KPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-L-LEDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD-DGK 152 (187)
T ss_pred ceEec----CCCEEEEEEeCCCCccChhhhhhh-h-cccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-CCc
Confidence 55543 24589999998854321 111111 1 16678899999999999999 88 99999999999999 899
Q ss_pred EEEeecccccccc
Q 013214 292 LKVADFGVSKLLT 304 (447)
Q Consensus 292 vkl~Dfg~~~~~~ 304 (447)
++++|||++....
T Consensus 153 ~~liDfg~a~~~~ 165 (187)
T cd05119 153 VYIIDVPQAVEID 165 (187)
T ss_pred EEEEECccccccc
Confidence 9999999987543
No 493
>PHA02792 ankyrin-like protein; Provisional
Probab=99.54 E-value=6.9e-15 Score=148.51 Aligned_cols=113 Identities=16% Similarity=0.104 Sum_probs=71.1
Q ss_pred CCCccccchhcccCCCCCCCccchhhHHHHHHHcCCH---HHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHH
Q 013214 17 LAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDV---EGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLL 93 (447)
Q Consensus 17 ~~~~~~~~~a~~n~~d~~~~~~~g~t~lh~a~~~~~~---~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll 93 (447)
+...+.+.|||+|..|.++ .+.||||+|+..+.. +++++|+++|||+|.+|..|+||||+|+..++.+++++|+
T Consensus 354 IVelLIs~GADIN~kD~~g---~~~TpLh~A~~n~~~~v~~IlklLIs~GADIN~kD~~G~TPLh~Aa~~~n~eivelLL 430 (631)
T PHA02792 354 VVEYILKNGNVVVEDDDNI---INIMPLFPTLSIHESDVLSILKLCKPYIDDINKIDKHGRSILYYCIESHSVSLVEWLI 430 (631)
T ss_pred HHHHHHHcCCchhhhcCCC---CChhHHHHHHHhccHhHHHHHHHHHhcCCccccccccCcchHHHHHHcCCHHHHHHHH
Confidence 3344455566666555443 234667766655543 3466667777777777777777777777777777777777
Q ss_pred HcCCCCCCCCCCCCCccccccc----------cchHHHHHHHHHhCCCC
Q 013214 94 ERGADVDPKDRWGSTPLGDAIY----------YKNHEVIKLLEKHGAKP 132 (447)
Q Consensus 94 ~~ga~~~~~d~~g~tpl~~a~~----------~~~~~~~~~L~~~~a~~ 132 (447)
++||+++.+|..|.|||++|+. ....++++.|+++|.++
T Consensus 431 s~GADIN~kD~~G~TpL~~A~~~~~~~~~~i~~~~~~il~lLLs~~p~i 479 (631)
T PHA02792 431 DNGADINITTKYGSTCIGICVILAHACIPEIAELYIKILEIILSKLPTI 479 (631)
T ss_pred HCCCCCCCcCCCCCCHHHHHHHHHhcccHHHHHHHHHHHHHHHhcCCCh
Confidence 7777777777777777777654 11244566666666544
No 494
>PLN03192 Voltage-dependent potassium channel; Provisional
Probab=99.54 E-value=2e-14 Score=155.22 Aligned_cols=96 Identities=28% Similarity=0.452 Sum_probs=88.6
Q ss_pred ccchhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCCCCCCcccccccc
Q 013214 37 EIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYY 116 (447)
Q Consensus 37 ~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tpl~~a~~~ 116 (447)
+.++.++||.||..|+.++++.|++.|+|+|.+|.+|+||||+||..|+.+++++|+++|+++|.+|.+|+||||+|+..
T Consensus 522 ~~~~~~~L~~Aa~~g~~~~l~~Ll~~G~d~n~~d~~G~TpLh~Aa~~g~~~~v~~Ll~~gadin~~d~~G~TpL~~A~~~ 601 (823)
T PLN03192 522 DPNMASNLLTVASTGNAALLEELLKAKLDPDIGDSKGRTPLHIAASKGYEDCVLVLLKHACNVHIRDANGNTALWNAISA 601 (823)
T ss_pred CccchhHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHcChHHHHHHHHhcCCCCCCcCCCCCCHHHHHHHh
Confidence 33567889999999999999999999999999999999999999999999999999999999999999999999999998
Q ss_pred chHHHHHHHHHhCCCC
Q 013214 117 KNHEVIKLLEKHGAKP 132 (447)
Q Consensus 117 ~~~~~~~~L~~~~a~~ 132 (447)
|+.+++++|++.++..
T Consensus 602 g~~~iv~~L~~~~~~~ 617 (823)
T PLN03192 602 KHHKIFRILYHFASIS 617 (823)
T ss_pred CCHHHHHHHHhcCccc
Confidence 8888888887766543
No 495
>cd00204 ANK ankyrin repeats; ankyrin repeats mediate protein-protein interactions in very diverse families of proteins. The number of ANK repeats in a protein can range from 2 to over 20 (ankyrins, for example). ANK repeats may occur in combinations with other types of domains. The structural repeat unit contains two antiparallel helices and a beta-hairpin, repeats are stacked in a superhelical arrangement; this alignment contains 4 consecutive repeats.
Probab=99.54 E-value=4.6e-14 Score=115.78 Aligned_cols=101 Identities=44% Similarity=0.565 Sum_probs=93.9
Q ss_pred CccchhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCCCCCCccccccc
Q 013214 36 EEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIY 115 (447)
Q Consensus 36 ~~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tpl~~a~~ 115 (447)
++.+|.||||+|+..++.++++.|++.|++++..+..|.||||+|+..++.+++++|++.|++++..+..|.||+|+|+.
T Consensus 3 ~~~~g~t~l~~a~~~~~~~~i~~li~~~~~~~~~~~~g~~~l~~a~~~~~~~~~~~ll~~~~~~~~~~~~~~~~l~~a~~ 82 (126)
T cd00204 3 RDEDGRTPLHLAASNGHLEVVKLLLENGADVNAKDNDGRTPLHLAAKNGHLEIVKLLLEKGADVNARDKDGNTPLHLAAR 82 (126)
T ss_pred cCcCCCCHHHHHHHcCcHHHHHHHHHcCCCCCccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCccccCCCCCCHHHHHHH
Confidence 34678899999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cchHHHHHHHHHhCCCCCCCc
Q 013214 116 YKNHEVIKLLEKHGAKPLMAP 136 (447)
Q Consensus 116 ~~~~~~~~~L~~~~a~~~~~~ 136 (447)
.++.+++++|++.+.++....
T Consensus 83 ~~~~~~~~~L~~~~~~~~~~~ 103 (126)
T cd00204 83 NGNLDVVKLLLKHGADVNARD 103 (126)
T ss_pred cCcHHHHHHHHHcCCCCcccC
Confidence 999999999999986655543
No 496
>PTZ00322 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase; Provisional
Probab=99.53 E-value=4.4e-14 Score=148.22 Aligned_cols=96 Identities=42% Similarity=0.529 Sum_probs=90.1
Q ss_pred hHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCCCCCCccccccccchHHH
Q 013214 42 FRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEV 121 (447)
Q Consensus 42 t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tpl~~a~~~~~~~~ 121 (447)
+.|+.||..|+.+.++.|++.|+|+|.+|.+|+||||+||.+|+.+++++|+++|++++.+|..|.||||+|+..|+.++
T Consensus 84 ~~L~~aa~~G~~~~vk~LL~~Gadin~~d~~G~TpLh~Aa~~g~~eiv~~LL~~Gadvn~~d~~G~TpLh~A~~~g~~~i 163 (664)
T PTZ00322 84 VELCQLAASGDAVGARILLTGGADPNCRDYDGRTPLHIACANGHVQVVRVLLEFGADPTLLDKDGKTPLELAEENGFREV 163 (664)
T ss_pred HHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHCCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHCCcHHH
Confidence 46899999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHh-------CCCCCCCcc
Q 013214 122 IKLLEKH-------GAKPLMAPM 137 (447)
Q Consensus 122 ~~~L~~~-------~a~~~~~~~ 137 (447)
+++|+++ |+++.....
T Consensus 164 v~~Ll~~~~~~~~~ga~~~~~~~ 186 (664)
T PTZ00322 164 VQLLSRHSQCHFELGANAKPDSF 186 (664)
T ss_pred HHHHHhCCCcccccCCCCCcccc
Confidence 9999999 666655443
No 497
>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family. The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves
Probab=99.52 E-value=1.1e-13 Score=117.67 Aligned_cols=131 Identities=19% Similarity=0.182 Sum_probs=106.5
Q ss_pred ceeeecceEEEEE---EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCC--CcccceeEEEEeCCceEEEEeccCC
Q 013214 160 SVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRH--PNVVQFLGAVTQSSPMMIVTEYLPK 234 (447)
Q Consensus 160 ~~~lg~G~~~~~~---~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h--p~iv~~~~~~~~~~~~~lv~e~~~~ 234 (447)
.+.||.|.++.++ ..+..+++|....... ...+.+|...++.+.+ +++++++.+....+..++++||+++
T Consensus 3 ~~~i~~g~~~~v~~~~~~~~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g 77 (155)
T cd05120 3 IKLLKGGLTNRVYLLGTKDEDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEG 77 (155)
T ss_pred ceecccccccceEEEEecCCeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCC
Confidence 3568888887665 4567899999865432 3567889999999976 5899999988887889999999988
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccc
Q 013214 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 302 (447)
Q Consensus 235 g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~ 302 (447)
+++..+ +......++.++++++.++|.....+++|+|++|.||++++.+.++++|||.+..
T Consensus 78 ~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 78 ETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred eecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 777654 4566677889999999999986323499999999999999989999999998764
No 498
>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]
Probab=99.52 E-value=2.7e-14 Score=126.88 Aligned_cols=111 Identities=26% Similarity=0.364 Sum_probs=94.0
Q ss_pred cccchhcccCCCCCCCccchhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCC
Q 013214 21 RERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVD 100 (447)
Q Consensus 21 ~~~~~a~~n~~d~~~~~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~ 100 (447)
+.+.||-+|..+ ....||||.||..|+.++++.|++..+|+|+.|+.|+|||||||.+|...+++-|++.||.++
T Consensus 53 ll~rgarvn~tn-----mgddtplhlaaahghrdivqkll~~kadvnavnehgntplhyacfwgydqiaedli~~ga~v~ 127 (448)
T KOG0195|consen 53 LLSRGARVNSTN-----MGDDTPLHLAAAHGHRDIVQKLLSRKADVNAVNEHGNTPLHYACFWGYDQIAEDLISCGAAVN 127 (448)
T ss_pred HHhccccccccc-----CCCCcchhhhhhcccHHHHHHHHHHhcccchhhccCCCchhhhhhhcHHHHHHHHHhccceee
Confidence 345555555544 445678999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCCccccccccchHHHHHHHHHhCCCCCCCc
Q 013214 101 PKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAP 136 (447)
Q Consensus 101 ~~d~~g~tpl~~a~~~~~~~~~~~L~~~~a~~~~~~ 136 (447)
..|++|.||+..|.-.-...+.+.-.++|..++.-+
T Consensus 128 icnk~g~tpldkakp~l~~~l~e~aek~gq~~nrip 163 (448)
T KOG0195|consen 128 ICNKKGMTPLDKAKPMLKNTLLEIAEKHGQSPNRIP 163 (448)
T ss_pred ecccCCCCchhhhchHHHHHHHHHHHHhCCCCCccc
Confidence 999999999998866555566777777887765433
No 499
>KOG4177 consensus Ankyrin [Cell wall/membrane/envelope biogenesis]
Probab=99.52 E-value=2.4e-14 Score=151.75 Aligned_cols=107 Identities=36% Similarity=0.436 Sum_probs=97.7
Q ss_pred ccchhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCCCCCCcccccccc
Q 013214 37 EIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYY 116 (447)
Q Consensus 37 ~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tpl~~a~~~ 116 (447)
...|-|++|.|+..+.+.+++.+++.|++++.++.+|+||||.||..|+.++|++|+++|||++.+|+.|+||||.|+..
T Consensus 504 ~~~~l~~lhla~~~~~v~~~~~l~~~ga~v~~~~~r~~TpLh~A~~~g~v~~VkfLLe~gAdv~ak~~~G~TPLH~Aa~~ 583 (1143)
T KOG4177|consen 504 AKKGLTPLHLAADEDTVKVAKILLEHGANVDLRTGRGYTPLHVAVHYGNVDLVKFLLEHGADVNAKDKLGYTPLHQAAQQ 583 (1143)
T ss_pred chhccchhhhhhhhhhHHHHHHHhhcCCceehhcccccchHHHHHhcCCchHHHHhhhCCccccccCCCCCChhhHHHHc
Confidence 34567778888888888888888888999999999999999999999999999999999999999999999999999999
Q ss_pred chHHHHHHHHHhCCCCCCCcccccccC
Q 013214 117 KNHEVIKLLEKHGAKPLMAPMHVKHAR 143 (447)
Q Consensus 117 ~~~~~~~~L~~~~a~~~~~~~~~~~~~ 143 (447)
|+.+++++|+++|++++.......++.
T Consensus 584 G~~~i~~LLlk~GA~vna~d~~g~TpL 610 (1143)
T KOG4177|consen 584 GHNDIAELLLKHGASVNAADLDGFTPL 610 (1143)
T ss_pred ChHHHHHHHHHcCCCCCcccccCcchh
Confidence 999999999999999998877766654
No 500
>KOG0505 consensus Myosin phosphatase, regulatory subunit [Posttranslational modification, protein turnover, chaperones; Signal transduction mechanisms]
Probab=99.50 E-value=2.2e-14 Score=138.03 Aligned_cols=114 Identities=31% Similarity=0.345 Sum_probs=80.6
Q ss_pred cCCCCCCCccchhhHHHHHHHcCCHHHHHHHHHcCCCCCC----------------------------------------
Q 013214 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNF---------------------------------------- 68 (447)
Q Consensus 29 n~~d~~~~~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~---------------------------------------- 68 (447)
+++++|..|..||||||.|+..|+..++++|+++|+++-.
T Consensus 95 ~ga~Vn~~d~e~wtPlhaaascg~~~i~~~li~~gA~~~avNsdg~~P~dl~e~ea~~~~l~~~~~r~gi~iea~R~~~e 174 (527)
T KOG0505|consen 95 NGANVNAQDNEGWTPLHAAASCGYLNIVEYLIQHGANLLAVNSDGNMPYDLAEDEATLDVLETEMARQGIDIEAARKAEE 174 (527)
T ss_pred hcCCccccccccCCcchhhcccccHHHHHHHHHhhhhhhhccCCCCCccccccCcchhHHHHHHHHHhcccHHHHhhhhH
Confidence 4444555555566677777777777777777776654221
Q ss_pred -------------------CCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCCCCCCccccccccchHHHHHHHHHhC
Q 013214 69 -------------------RDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHG 129 (447)
Q Consensus 69 -------------------~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tpl~~a~~~~~~~~~~~L~~~~ 129 (447)
++..|-|+||.|+.+|..+++++|+++|.+++.+|.+|+||||.|+.+|..+++++|+++|
T Consensus 175 ~~ml~D~~q~l~~G~~~d~~~~rG~T~lHvAaa~Gy~e~~~lLl~ag~~~~~~D~dgWtPlHAAA~Wg~~~~~elL~~~g 254 (527)
T KOG0505|consen 175 QTMLDDARQWLNAGAELDARHARGATALHVAAANGYTEVAALLLQAGYSVNIKDYDGWTPLHAAAHWGQEDACELLVEHG 254 (527)
T ss_pred HHHHHHHHHHHhccccccccccccchHHHHHHhhhHHHHHHHHHHhccCcccccccCCCcccHHHHhhhHhHHHHHHHhh
Confidence 2233566677777777778888888888888888888888888888888888888888888
Q ss_pred CCCCCCccccccc
Q 013214 130 AKPLMAPMHVKHA 142 (447)
Q Consensus 130 a~~~~~~~~~~~~ 142 (447)
+++.+.......+
T Consensus 255 a~~d~~t~~g~~p 267 (527)
T KOG0505|consen 255 ADMDAKTKMGETP 267 (527)
T ss_pred cccchhhhcCCCC
Confidence 8876654444443
Done!